data_2m2k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m2k _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -69.03 -34.11 74.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.233 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.5 p -70.35 -33.95 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.08 0.467 . . . . 0.0 109.832 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.412 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 30.2 mmt180 -70.3 -43.46 70.31 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.747 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.889 HG21 ' HG2' ' A' ' 103' ' ' PRO . 53.9 mt -57.61 -42.14 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.885 175.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.3 m -56.92 -34.71 68.22 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.489 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.71 -35.69 80.92 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.889 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.543 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.8 -34.18 73.37 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.46 0.648 . . . . 0.0 109.64 178.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.12 -25.47 65.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.894 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.768 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 59.1 t30 -70.19 -34.57 73.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.553 176.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 1.9 ttt180 -59.88 -27.09 66.4 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.015 170.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.573 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 69.5 m-85 -106.01 25.67 10.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.906 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 48' ' ' PHE . 21.9 mtpp 74.13 102.41 0.07 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 124.075 0.859 . . . . 0.0 110.505 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.768 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 16.4 ttp180 -93.54 104.62 16.74 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.289 0.566 . . . . 0.0 110.607 -176.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.509 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -69.41 114.79 26.57 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.892 175.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.459 ' HD2' ' HD1' ' A' ' 51' ' ' TYR . 34.7 Cg_exo -57.68 131.82 46.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.714 2.276 . . . . 0.0 111.573 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.725 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.16 -25.2 63.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.885 -170.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -64.6 -32.45 74.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.0 0.429 . . . . 0.0 111.182 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 59' ' ' LYS . . . -74.15 -31.78 62.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.511 178.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 60' ' ' ARG . 3.4 mm? -74.76 -42.6 57.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.665 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.718 ' HB3' ' HB2' ' A' ' 126' ' ' SER . 2.5 ptp180 -64.41 -17.95 64.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.751 0.31 . . . . 0.0 111.334 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.7 mt -108.33 4.41 24.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.921 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.665 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 39.2 ttmt -145.6 -75.27 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 111.556 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.699 ' HB2' HD13 ' A' ' 56' ' ' LEU . 33.5 mmt180 -106.85 87.57 2.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.844 0.354 . . . . 0.0 110.193 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.729 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . 4.7 mt-30 -85.95 156.17 20.59 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.488 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 170.44 116.76 0.39 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 118.851 -1.642 . . . . 0.0 113.854 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.789 ' H ' HD12 ' A' ' 127' ' ' LEU . 58.9 t -110.18 123.42 66.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.45 165.65 33.99 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.658 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 42.4 mt-30 -103.57 124.46 48.84 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.537 HG21 HD11 ' A' ' 123' ' ' ILE . 77.4 t -122.22 113.63 39.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.433 -173.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.511 ' HB3' HG22 ' A' ' 82' ' ' VAL . 20.6 ptt180 -108.38 141.03 40.81 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -156.9 157.59 35.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.559 0.695 . . . . 0.0 112.412 -171.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 6.4 m -101.92 129.91 48.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.577 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.502 HD11 ' CE1' ' A' ' 68' ' ' PHE . 48.2 mt -121.78 139.84 53.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.12 0.486 . . . . 0.0 112.286 -168.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.747 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 21.4 t70 -82.18 155.68 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.827 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG3' ' HB3' ' A' ' 107' ' ' PRO . 58.0 ttt180 -51.51 -41.43 60.99 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -174.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -87.08 12.22 11.97 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.019 0.437 . . . . 0.0 111.038 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.33 53.82 4.27 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.421 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.747 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 67.9 t60 -112.4 114.97 27.96 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 4.1 p -48.79 120.35 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.523 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.1 mt -110.49 -40.26 4.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.744 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -152.66 146.01 24.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.279 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.738 HG12 ' HD3' ' A' ' 99' ' ' LYS . 28.4 t -142.39 130.91 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.7 m -128.24 128.16 44.17 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.819 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.9 tp -72.91 123.03 22.63 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -99.4 -52.03 9.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.461 -171.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.9 m -141.31 138.61 33.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.492 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.7 t -131.41 131.38 43.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.935 0.398 . . . . 0.0 110.698 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.03 8.38 26.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.489 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.11 69.98 0.83 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.702 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -115.57 89.7 23.46 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -77.94 -84.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.591 2.194 . . . . 0.0 112.021 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.5 m -66.16 -18.32 65.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.332 0.587 . . . . 0.0 110.966 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 13.7 mt -75.41 -45.09 41.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.245 -176.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 16.9 t70 -55.17 -41.75 72.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.079 -169.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -54.28 -49.71 68.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.819 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.94 -47.93 15.49 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.518 ' HB ' ' CE2' ' A' ' 125' ' ' PHE . 42.1 pt -63.35 -38.8 83.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.56 HE22 HD13 ' A' ' 123' ' ' ILE . 75.4 mm-40 -79.08 -31.34 44.36 Favored 'General case' 0 C--O 1.199 -1.594 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.605 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.84 -39.25 65.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.1 tp -67.53 -54.77 17.14 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.487 176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.628 HG12 HG22 ' A' ' 123' ' ' ILE . 52.9 t -87.41 -45.52 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.738 ' HD3' HG12 ' A' ' 79' ' ' VAL . 3.2 tppp? -56.32 -40.23 74.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.148 0.579 . . . . 0.0 110.518 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -84.38 -31.02 24.95 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.828 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.559 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -105.65 63.15 0.68 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.808 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.7 m -89.13 99.43 1.59 Allowed Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.889 ' HG2' HG21 ' A' ' 41' ' ' ILE . 74.5 Cg_endo -103.55 166.59 0.23 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.922 3.082 . . . . 0.0 114.611 -170.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.501 HD22 ' CD ' ' A' ' 108' ' ' PRO . 37.1 tp -143.16 96.49 5.87 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.722 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.496 ' HA ' ' CZ ' ' A' ' 44' ' ' ARG . 33.1 Cg_endo -78.06 -44.92 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.3 2.0 . . . . 0.0 113.671 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.499 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 15.4 m -92.95 107.88 28.11 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.484 ' HB3' ' HG3' ' A' ' 72' ' ' ARG . 21.2 Cg_exo -66.59 106.12 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.312 2.675 . . . . 0.0 112.977 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.891 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 41.6 Cg_endo -88.87 65.76 2.77 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.543 2.829 . . . . 0.0 112.128 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.573 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -51.07 -51.7 50.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.78 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -78.79 9.33 4.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.79 -176.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.891 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -105.84 -30.15 9.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.165 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.656 ' HB2' ' HA ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -114.3 15.55 18.05 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 3.9 m -72.58 87.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 169.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 4.7 p30 159.74 -19.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.916 -167.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.45 ' C ' ' HG1' ' A' ' 116' ' ' THR . . . 163.66 -86.7 0.1 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.391 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.656 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -160.75 177.08 10.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 69' ' ' THR . 11.2 m -100.1 108.77 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 121.877 0.846 . . . . 0.0 110.105 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -113.63 112.49 23.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.635 HD11 ' HG ' ' A' ' 121' ' ' LEU . 2.1 pp -142.84 154.63 44.35 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.225 -173.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.469 HG22 HG22 ' A' ' 82' ' ' VAL . 92.8 m -92.44 125.85 37.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.421 -177.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.635 ' HG ' HD11 ' A' ' 119' ' ' LEU . 64.2 mt -130.38 122.85 20.17 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.393 176.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.658 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.3 Cg_exo -74.75 119.2 5.6 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.642 1.562 . . . . 0.0 110.726 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.628 HG22 HG12 ' A' ' 98' ' ' VAL . 20.6 pt -89.62 121.07 39.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -111.97 121.71 45.76 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 119.379 -0.928 . . . . 0.0 112.256 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.573 ' CD1' ' HG ' ' A' ' 56' ' ' LEU . 89.7 m-85 -114.09 131.54 56.36 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.409 -1.723 . . . . 0.0 106.816 163.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.718 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 8.7 m -56.98 103.42 0.11 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 -170.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.789 HD12 ' H ' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -97.65 108.85 21.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.915 -171.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.431 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 46.4 mtm105 . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.734 173.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.483 ' CH2' HD21 ' A' ' 121' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.62 0.247 . . . . 0.0 110.733 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' HD2' ' N ' ' A' ' 39' ' ' SER . 4.4 ppt_? -69.54 -28.19 65.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.156 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.488 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 13.1 m -66.47 -36.36 82.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.428 ' HB3' ' HB2' ' A' ' 105' ' ' PRO . 17.8 mmm-85 -73.31 -43.69 60.43 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.338 177.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.739 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 34.8 mt -57.99 -36.84 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.634 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.448 ' O ' ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -61.38 -45.04 96.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.6 -38.66 95.97 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.499 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.739 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 8.5 ptt180 -56.69 -34.6 67.57 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.928 0.394 . . . . 0.0 110.13 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -32.26 47.62 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.623 -175.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 6.5 t30 -70.69 -29.19 65.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.035 0.921 . . . . 0.0 108.722 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -18.72 36.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.561 -1.654 . . . . 0.0 111.083 173.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.4 ' HB2' ' HB1' ' A' ' 101' ' ' ALA . 29.8 m-85 -125.74 -57.64 1.44 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -158.37 102.85 1.76 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.333 0.653 . . . . 0.0 109.822 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 64.1 ttt-85 -128.54 103.53 7.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.35 0.595 . . . . 0.0 109.942 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.45 130.17 23.21 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.917 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.06 134.16 58.62 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.966 2.444 . . . . 0.0 111.936 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.9 -21.43 61.06 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.53 -174.263 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.78 -38.52 55.9 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.6 0.562 . . . . 0.0 110.762 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.11 -42.43 47.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.315 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.4 mm? -64.22 -34.81 78.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.963 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 21.7 mtm180 -62.71 -14.63 46.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.757 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.2 mp -119.62 14.36 12.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.75 0.31 . . . . 0.0 110.931 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.771 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 39.0 ttmt -142.25 -76.52 0.27 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.702 0.287 . . . . 0.0 110.859 -176.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.771 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 39.6 mmt180 -130.95 100.63 5.31 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.0 167.84 11.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.74 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.78 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.74 144.48 3.92 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.727 -1.225 . . . . 0.0 113.272 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 p -111.13 128.17 67.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.53 164.62 29.45 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.097 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.477 ' O ' HG23 ' A' ' 82' ' ' VAL . 35.8 tt0 -103.65 125.13 49.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.575 HG23 HD13 ' A' ' 123' ' ' ILE . 49.3 t -127.31 114.79 38.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.763 -171.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.567 ' HG2' HG21 ' A' ' 82' ' ' VAL . 5.1 ptp180 -114.68 144.35 43.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.6 OUTLIER -160.1 164.07 33.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.75 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 7.3 m -108.4 131.93 54.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.562 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.589 HD21 ' HB3' ' A' ' 102' ' ' SER . 61.9 mt -119.05 138.29 52.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.73 -172.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.458 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 29.4 t70 -81.2 158.45 24.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.821 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.85 -36.67 70.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -81.6 3.11 26.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.12 0.486 . . . . 0.0 111.258 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . 81.4 35.52 22.95 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.298 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.478 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 42.4 t60 -100.38 110.83 23.05 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 5.8 p -48.44 111.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.645 0.736 . . . . 0.0 111.002 173.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 48.9 mt -99.65 -23.5 15.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.581 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.69 157.58 36.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.836 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.602 HG23 ' HG3' ' A' ' 99' ' ' LYS . 13.6 p -159.82 133.85 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.2 m -144.48 130.15 19.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.704 0.288 . . . . 0.0 111.065 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.702 HD22 ' HB2' ' A' ' 84' ' ' SER . 24.5 tp -74.78 110.1 8.8 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.567 HG21 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -84.84 -39.22 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.155 -171.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.0 m -150.56 151.15 32.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.762 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.702 ' HB2' HD22 ' A' ' 81' ' ' LEU . 45.7 t -140.11 142.77 36.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.875 0.369 . . . . 0.0 110.572 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.18 19.42 19.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.243 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.13 63.41 0.84 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.686 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.779 ' HA ' HD13 ' A' ' 90' ' ' LEU . 1.1 mm? -119.1 82.99 23.05 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.08 -83.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.369 2.046 . . . . 0.0 111.973 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 66.5 m -68.64 -17.91 64.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.397 0.618 . . . . 0.0 110.339 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.779 HD13 ' HA ' ' A' ' 87' ' ' LEU . 16.2 mt -70.24 -34.03 72.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.632 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.536 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 3.7 t70 -54.12 -44.53 71.39 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.467 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 89' ' ' SER . 11.2 ptm180 -54.31 -48.49 71.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.489 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 8.1 tp10 -77.88 -53.46 7.45 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 122.016 -0.427 . . . . 0.0 111.789 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 90' ' ' LEU . 36.7 pt -64.76 -37.08 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -172.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.595 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.4 mm-40 -82.21 -28.31 32.06 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.45 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.653 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.88 -43.43 81.26 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.87 -58.37 7.0 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.008 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.731 HG13 HG21 ' A' ' 123' ' ' ILE . 93.0 t -89.05 -50.4 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.602 ' HG3' HG23 ' A' ' 79' ' ' VAL . 35.6 ttmt -67.32 -29.99 69.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.649 -173.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.653 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 4.1 tmt_? -89.07 -47.17 8.29 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.664 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.638 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -86.0 73.75 10.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.044 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.589 ' HB3' HD21 ' A' ' 70' ' ' LEU . 67.4 m -109.52 92.3 11.64 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-O 122.063 0.935 . . . . 0.0 110.531 171.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.696 ' HG2' ' HG3' ' A' ' 44' ' ' ARG . 3.3 Cg_endo -96.33 178.44 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 1 C-N-CA 125.457 4.105 . . . . 0.0 112.052 170.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.736 HD22 ' HD2' ' A' ' 108' ' ' PRO . 12.2 tp -134.65 99.15 13.0 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.428 ' HB2' ' HB3' ' A' ' 40' ' ' ARG . 86.6 Cg_endo -77.15 -28.51 5.8 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.449 1.433 . . . . 0.0 112.77 -173.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.51 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 2.9 t -122.46 107.83 34.07 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.708 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.38 108.3 1.35 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.062 2.508 . . . . 0.0 112.612 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.736 ' HD2' HD22 ' A' ' 104' ' ' LEU . 41.9 Cg_endo -86.71 66.45 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.159 2.572 . . . . 0.0 111.312 177.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.698 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -49.69 -46.28 49.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.864 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.69 -32.49 67.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.592 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 108' ' ' PRO . . . -81.09 -31.31 34.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.12 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.698 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -116.62 18.58 14.94 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 109' ' ' ALA . 3.2 m -71.29 88.95 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 168.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 6.9 p30 159.34 -23.07 0.0 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.152 -168.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.56 -84.53 0.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.002 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.474 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.3 OUTLIER -159.67 175.69 12.89 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.218 0.607 . . . . 0.0 109.491 -176.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.75 ' O ' ' HA ' ' A' ' 69' ' ' THR . 4.0 m -103.02 107.99 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-O 121.396 0.617 . . . . 0.0 111.251 -174.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.536 ' HG2' ' HG1' ' A' ' 69' ' ' THR . 1.1 tm-20 -103.57 112.14 24.92 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.658 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 3.5 pp -142.09 149.33 39.73 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.622 -173.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.2 m -87.94 124.58 33.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.627 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.658 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 32.2 mt -123.77 122.03 26.46 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.556 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.05 120.89 5.9 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.197 1.932 . . . . 0.0 110.933 176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.731 HG21 HG13 ' A' ' 98' ' ' VAL . 12.2 pt -104.69 123.19 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -126.26 124.31 40.09 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 122.206 1.003 . . . . 0.0 111.581 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -113.17 139.13 49.02 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.41 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 14.4 m -57.99 101.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.805 0.336 . . . . 0.0 111.558 -172.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.78 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.4 OUTLIER -94.88 106.06 18.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.917 -174.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.304 177.577 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.51 ' CH2' HD21 ' A' ' 121' ' ' LEU . 1.4 p-90 . . . . . 0 N--CA 1.457 -0.094 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.15 -31.48 70.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 110.247 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.0 m -70.84 -34.53 71.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.469 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.54 ' CB ' ' HG2' ' A' ' 105' ' ' PRO . 48.9 mtt180 -64.8 -44.96 88.25 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.433 0.635 . . . . 0.0 109.443 174.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.534 HG22 ' HD2' ' A' ' 103' ' ' PRO . 75.8 mt -59.62 -38.67 76.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.322 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 m -55.75 -32.31 63.3 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.17 -43.01 82.28 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.713 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.573 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 9.2 mpt_? -69.07 -32.53 72.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.098 0.475 . . . . 0.0 110.769 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.95 -32.41 73.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.422 0.63 . . . . 0.0 109.754 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.8 t-20 -71.2 -31.29 67.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.822 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.538 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 2.0 ttt180 -53.34 -28.34 28.16 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.961 172.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -100.85 -57.09 2.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.705 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -173.56 116.98 0.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 55.4 ttp180 -133.47 103.83 6.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.217 0.532 . . . . 0.0 110.312 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -98.79 142.94 25.45 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.993 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.86 132.8 51.51 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.877 2.384 . . . . 0.0 111.83 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.667 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -62.36 -23.89 67.05 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -171.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.48 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 15.3 m-20 -65.2 -33.53 76.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.643 0.259 . . . . 0.0 110.815 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.84 71.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.249 0.547 . . . . 0.0 110.112 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -73.45 -40.31 64.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.61 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.684 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 83.2 mtt180 -55.65 -30.86 61.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.984 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 54' ' ' ASP . 61.6 mt -99.04 14.41 29.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.038 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.423 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 24.8 ttmm -145.8 -74.64 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 111.049 -177.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.542 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 23.0 mmt180 -127.38 84.44 2.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.384 0.612 . . . . 0.0 110.232 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.684 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 24.4 pt20 -94.27 115.29 27.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.06 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.827 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -154.79 130.02 2.74 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.56 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.861 ' H ' HD12 ' A' ' 127' ' ' LEU . 7.1 p -103.78 133.39 47.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.006 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.85 168.12 38.24 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.16 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 56.7 mt-30 -100.29 137.65 38.44 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.541 HG21 HD11 ' A' ' 123' ' ' ILE . 39.8 t -128.22 114.03 32.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.237 0.541 . . . . 0.0 110.46 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 34.4 ttp180 -103.71 125.04 49.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.554 ' CE1' HD13 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -144.1 156.99 44.57 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.508 0.67 . . . . 0.0 112.625 -174.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.793 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 23.3 m -106.43 124.32 49.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.429 173.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.554 HD13 ' CE1' ' A' ' 68' ' ' PHE . 39.9 mt -116.96 147.69 42.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.24 0.543 . . . . 0.0 111.953 -169.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.531 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 29.3 t70 -88.41 161.81 16.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.399 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -48.96 -40.39 30.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.543 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -88.76 7.14 35.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.989 0.423 . . . . 0.0 111.062 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . 76.61 40.25 27.63 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.162 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.531 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 45.2 t60 -103.06 123.81 47.34 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.48 118.89 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.417 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 71' ' ' ASP . 26.0 mt -106.19 -53.45 2.63 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.231 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.61 149.59 52.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.802 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.429 HG11 ' HB3' ' A' ' 68' ' ' PHE . 2.4 m -145.67 125.35 6.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.442 0.639 . . . . 0.0 110.857 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.9 m -124.71 123.83 40.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.425 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 23.1 tp -78.68 106.48 10.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.484 0.659 . . . . 0.0 109.882 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -86.66 -41.96 15.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.049 178.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.434 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 13.2 t 68.67 -178.03 0.22 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.396 167.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.421 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 40.8 m -153.59 -56.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.024 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.59 -77.4 0.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.7 98.67 0.11 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.747 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -117.6 87.63 26.66 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.532 0.166 . . . . 0.0 110.655 -177.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.76 -81.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.685 2.257 . . . . 0.0 111.869 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.5 m -65.74 -18.46 65.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.525 0.679 . . . . 0.0 110.328 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.708 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 25.2 mt -73.67 -36.13 65.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.191 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.464 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 4.4 t70 -54.18 -51.41 64.43 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 123.613 0.571 . . . . 0.0 111.725 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -54.58 -43.67 72.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -77.4 -53.92 7.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.833 0.349 . . . . 0.0 111.737 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 90' ' ' LEU . 40.2 pt -74.12 -33.08 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.654 -172.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.77 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 79.0 mm-40 -82.57 -24.11 34.14 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 120.981 0.42 . . . . 0.0 110.39 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.707 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.65 -47.27 80.12 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.552 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -65.11 -56.11 14.84 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.514 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.782 HG13 HG22 ' A' ' 123' ' ' ILE . 79.3 t -89.17 -50.11 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.77 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 34.9 ttmt -68.84 -30.09 68.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.238 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.707 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 2.6 tmt_? -86.86 -39.99 15.31 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.774 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.676 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -97.41 63.84 1.82 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.737 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.4 m -94.6 98.49 3.14 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 110.093 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.676 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 98.9 Cg_endo -108.65 172.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 124.195 3.263 . . . . 0.0 114.386 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.54 ' HG ' HD11 ' A' ' 70' ' ' LEU . 6.2 mt -143.89 120.59 6.52 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.733 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.54 ' HG2' ' CB ' ' A' ' 40' ' ' ARG . 6.2 Cg_exo -72.83 -54.13 0.12 Allowed 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.86 2.374 . . . . 0.0 111.936 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 25.4 m -88.7 115.22 62.84 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.411 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 106' ' ' THR . 30.5 Cg_endo -64.17 107.6 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.09 2.527 . . . . 0.0 112.225 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.604 ' HB2' ' HB1' ' A' ' 111' ' ' ALA . 81.3 Cg_endo -83.38 62.74 7.45 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.772 2.314 . . . . 0.0 111.832 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.815 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -59.18 -41.91 89.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.297 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.72 -7.95 48.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.622 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.604 ' HB1' ' HB2' ' A' ' 108' ' ' PRO . . . -99.38 -32.04 11.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.604 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.815 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -110.02 17.49 21.02 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -176.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 109' ' ' ALA . 3.4 m -70.57 88.09 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 168.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 7.5 p30 161.93 -27.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.606 -1.634 . . . . 0.0 107.846 -170.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.85 -76.15 0.15 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.906 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.6 OUTLIER -160.27 174.42 14.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.793 ' O ' ' HA ' ' A' ' 69' ' ' THR . 15.8 m -103.3 108.94 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.377 0.608 . . . . 0.0 111.061 -175.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 28.0 tt0 -105.36 111.7 24.52 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.679 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -142.36 147.22 35.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.462 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.467 HG21 HG23 ' A' ' 82' ' ' VAL . 86.8 m -87.59 122.13 30.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.33 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.679 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 26.0 mt -124.7 122.5 25.7 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.927 172.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.671 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.2 Cg_exo -73.8 119.93 6.15 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.771 1.647 . . . . 0.0 110.726 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.782 HG22 HG13 ' A' ' 98' ' ' VAL . 23.8 pt -95.46 99.52 9.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.569 ' HA ' HG21 ' A' ' 63' ' ' VAL . 5.5 p-10 -90.24 121.49 32.31 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.449 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 41.5 m-85 -113.36 141.3 47.21 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 163.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 3.3 m -64.15 101.87 0.45 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.861 HD12 ' H ' ' A' ' 63' ' ' VAL . 1.2 tt -90.13 84.11 6.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.204 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 128' ' ' ARG . 21.0 mtm180 . . . . . 0 N--CA 1.448 -0.554 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.46 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 4.9 t90 . . . . . 0 C--O 1.227 -0.129 0 CA-C-O 120.929 0.395 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.745 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . 17.3 ptp180 -69.15 -29.79 67.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.892 -173.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.0 p -64.69 -38.21 90.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.576 ' C ' ' HG3' ' A' ' 105' ' ' PRO . 4.2 mmm180 -74.76 -37.96 62.33 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.745 ' HB ' ' HA ' ' A' ' 38' ' ' ARG . 21.5 mt -57.69 -38.1 62.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.808 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 m -60.23 -45.71 92.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 174.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.51 -50.48 67.34 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.39 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.808 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -68.35 -29.29 67.99 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.213 0.507 . . . . 0.0 111.297 -177.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.78 -30.84 71.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.526 0.679 . . . . 0.0 109.654 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.548 ' HB2' ' HD3' ' A' ' 50' ' ' ARG . 8.4 t30 -71.31 -29.59 65.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.543 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.666 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 9.2 ttt180 -52.96 -25.04 10.7 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.223 172.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.536 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 74.4 m-85 -113.29 -59.15 2.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.266 176.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -164.62 103.38 0.82 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 122.394 0.278 . . . . 0.0 110.568 -174.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.548 ' HD3' ' HB2' ' A' ' 46' ' ' ASN . 15.7 ttt180 -133.17 106.43 7.59 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.605 0.716 . . . . 0.0 111.124 177.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.429 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.3 t80 -105.18 142.97 25.79 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.2 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.96 132.21 50.93 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.92 2.413 . . . . 0.0 112.108 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.654 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.55 -24.89 66.95 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -55.97 -41.74 75.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.67 0.271 . . . . 0.0 110.832 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.64 -30.87 68.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.87 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 60' ' ' ARG . 3.6 mm? -74.44 -41.51 60.72 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.613 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 28.4 mtm180 -61.28 -24.39 66.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.246 0.546 . . . . 0.0 110.162 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.8 tp -91.57 -13.72 31.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.748 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.662 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 38.2 ttpt -131.64 -72.46 0.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.88 -172.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.662 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 36.8 mmt180 -109.69 92.02 3.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.853 0.359 . . . . 0.0 110.315 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 90' ' ' LEU . 42.6 mt-30 -86.54 169.34 12.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.551 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.61 119.71 0.81 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.472 -1.347 . . . . 0.0 113.627 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.06 123.57 66.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.34 165.7 36.17 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.678 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 68.7 mt-30 -103.09 130.82 50.35 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 t -119.57 114.29 43.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.364 -171.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.508 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 31.3 ttp85 -107.65 137.63 45.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.638 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -152.28 153.65 34.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.494 0.664 . . . . 0.0 111.948 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.673 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 30.4 m -99.18 133.58 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.299 170.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.57 HD12 ' HG ' ' A' ' 104' ' ' LEU . 63.7 mt -121.92 140.23 52.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.379 0.609 . . . . 0.0 112.211 -170.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.548 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 17.1 t70 -83.88 159.64 21.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.565 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.451 ' HG3' ' OH ' ' A' ' 112' ' ' TYR . 22.2 ttt180 -53.39 -40.58 65.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.866 0.365 . . . . 0.0 111.452 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -89.46 16.2 8.01 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 111.056 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 103' ' ' PRO . . . 71.89 46.17 38.78 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.811 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.548 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 72.2 t60 -104.3 114.3 28.45 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.3 p -49.21 123.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.112 0.482 . . . . 0.0 111.162 173.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.612 HD13 HG22 ' A' ' 69' ' ' THR . 35.3 mt -110.0 -45.97 3.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.266 0.555 . . . . 0.0 110.571 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.28 149.14 52.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.981 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 m -136.74 124.22 32.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.0 m -144.11 121.76 11.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.5 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' A' ' 84' ' ' SER . 25.8 tp -76.18 111.95 12.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 173.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.733 HG23 HG21 ' A' ' 120' ' ' THR . 0.2 OUTLIER -85.36 -38.35 12.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.68 -170.684 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.442 ' HB3' ' HG3' ' A' ' 65' ' ' GLN . 8.4 t -148.05 149.17 31.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.642 ' HB2' HD23 ' A' ' 81' ' ' LEU . 46.3 t -149.07 149.14 30.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.22 0.533 . . . . 0.0 111.216 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.99 -18.09 15.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.583 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.409 ' C ' HD11 ' A' ' 87' ' ' LEU . . . 120.43 80.63 0.62 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.944 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.77 HD13 HD11 ' A' ' 127' ' ' LEU . 0.4 OUTLIER -117.51 91.23 37.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.87 -79.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.992 2.461 . . . . 0.0 112.556 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.6 p -70.58 -18.62 62.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.394 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.724 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 17.9 mt -74.34 -39.93 62.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.131 -175.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 15.4 t70 -54.58 -43.24 71.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.785 -170.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -54.01 -52.33 61.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -78.25 -48.03 16.65 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.909 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 90' ' ' LEU . 42.4 pt -62.98 -36.83 77.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.656 0.265 . . . . 0.0 111.4 -176.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.668 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.9 mm-40 -82.79 -25.85 32.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.073 0.463 . . . . 0.0 110.633 177.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.742 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -57.1 -45.55 83.31 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.441 HD22 HG21 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -64.87 -56.82 11.05 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.0 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.73 HG11 HG21 ' A' ' 123' ' ' ILE . 94.2 t -89.3 -50.52 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.668 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 35.1 ttmt -70.14 -27.47 64.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.619 0.247 . . . . 0.0 111.391 -173.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.742 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 20.9 tpt180 -88.34 -41.73 12.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.911 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.612 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -91.78 78.26 5.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.063 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.525 ' HB3' HD22 ' A' ' 70' ' ' LEU . 17.2 m -111.65 90.25 12.33 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.349 171.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.808 ' HG2' ' HG2' ' A' ' 44' ' ' ARG . 9.5 Cg_endo -104.91 -179.98 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.926 1 C-N-CA 125.992 4.462 . . . . 0.0 111.383 171.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.57 ' HG ' HD12 ' A' ' 70' ' ' LEU . 35.7 mt -136.38 127.95 17.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 169.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.737 ' HD3' ' HD2' ' A' ' 44' ' ' ARG . 57.0 Cg_endo -74.75 -24.23 13.59 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.514 2.143 . . . . 0.0 111.836 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 t -132.89 116.33 14.62 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.112 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.73 108.78 0.4 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.93 2.42 . . . . 0.0 111.717 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.528 ' HG2' ' CE2' ' A' ' 112' ' ' TYR . 82.0 Cg_endo -75.62 65.08 6.61 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.683 2.255 . . . . 0.0 111.563 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.583 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.2 -41.98 80.4 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.818 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.8 2.29 4.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.573 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -113.23 -34.74 5.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.509 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.674 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -115.2 16.75 16.89 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -174.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.6 m -71.38 88.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 4.9 p30 159.82 -29.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 113.661 -1.608 . . . . 0.0 107.404 -168.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.38 -84.55 0.1 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.355 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.495 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 1.3 p -149.6 167.39 26.5 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -171.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 112' ' ' TYR . 20.7 m -107.71 122.43 62.0 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 CA-C-O 120.904 0.383 . . . . 0.0 111.014 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.507 ' HB3' ' HG1' ' A' ' 69' ' ' THR . 5.3 pt-20 -112.8 120.04 40.09 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.684 HD11 ' HG ' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -140.14 143.35 36.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.972 0.415 . . . . 0.0 111.606 -175.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.733 HG21 HG23 ' A' ' 82' ' ' VAL . 98.9 m -96.3 116.34 28.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.857 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.684 ' HG ' HD11 ' A' ' 119' ' ' LEU . 62.7 mt -119.21 122.76 29.27 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.275 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.3 Cg_exo -73.12 120.73 6.76 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.056 1.837 . . . . 0.0 111.427 177.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.73 HG21 HG11 ' A' ' 98' ' ' VAL . 21.6 pt -102.49 117.73 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -119.61 123.47 43.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.184 0.993 . . . . 0.0 112.508 -175.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.551 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 89.7 m-85 -115.23 133.02 56.42 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.604 166.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -57.66 103.73 0.15 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.044 0.45 . . . . 0.0 111.971 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.77 HD11 HD13 ' A' ' 87' ' ' LEU . 12.5 mt -84.01 104.0 13.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.181 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 121.348 0.594 . . . . 0.0 110.267 175.619 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.435 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -68.48 -41.44 80.09 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.767 -171.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.8 p -64.79 -36.36 84.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.143 0.497 . . . . 0.0 110.434 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.449 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 30.8 mmt180 -73.93 -43.25 58.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.347 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.489 HG12 ' HD3' ' A' ' 105' ' ' PRO . 76.0 mt -57.01 -43.58 81.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.3 m -60.31 -30.61 69.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.881 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.33 -52.57 34.79 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.274 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 1.019 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.7 -28.41 65.81 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 175.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -53.86 -35.04 61.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.523 0.678 . . . . 0.0 109.362 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.733 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 24.1 t-20 -71.93 -34.18 68.85 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.941 177.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.525 ' HB3' ' HA ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -52.88 -28.15 21.79 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.277 173.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.591 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 95.8 m-85 -95.39 -59.23 1.93 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.947 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.591 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 21.1 mmmt -178.28 114.47 0.07 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.336 1.054 . . . . 0.0 108.923 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.733 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 41.8 ttp180 -129.54 105.38 8.04 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.273 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 2.7 t80 -90.32 134.92 30.34 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.844 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 32.3 Cg_exo -60.32 132.4 43.66 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.327 2.685 . . . . 0.0 112.566 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.21 -27.41 65.7 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.266 -171.122 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.19 -40.82 74.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.851 0.358 . . . . 0.0 110.713 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.51 -30.99 62.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.565 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 53' ' ' LYS . 3.7 mm? -65.91 -38.48 88.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.884 0.373 . . . . 0.0 110.204 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -61.8 -17.32 55.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.534 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.1 mt -111.99 -0.68 15.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 111.129 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -128.44 -70.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.03 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.752 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 28.9 mmt180 -136.68 101.53 4.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.318 0.58 . . . . 0.0 110.107 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.552 ' HG3' ' HA ' ' A' ' 127' ' ' LEU . 3.2 pt20 -113.48 160.37 18.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.546 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.725 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 153.27 142.89 3.56 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.389 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -107.31 125.53 63.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.993 0.425 . . . . 0.0 109.996 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.15 164.4 26.19 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.421 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 48.2 mt-30 -103.85 129.28 51.31 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.411 HG22 HD12 ' A' ' 123' ' ' ILE . 51.6 t -127.74 118.18 48.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.617 ' HG2' HG21 ' A' ' 82' ' ' VAL . 15.6 ptt180 -112.96 143.65 43.89 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -159.57 152.92 22.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.41 0.624 . . . . 0.0 112.502 -168.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.6 m -95.16 126.45 40.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.468 171.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.497 HD13 ' CE1' ' A' ' 68' ' ' PHE . 51.0 mt -117.34 143.82 45.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.173 0.511 . . . . 0.0 111.99 -170.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.671 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 22.2 t70 -86.28 154.96 20.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.13 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -53.21 -35.01 59.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.202 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -99.72 13.15 34.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.16 0.505 . . . . 0.0 111.154 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.53 40.59 12.56 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.812 -0.631 . . . . 0.0 113.388 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.671 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 68.8 t60 -103.31 118.02 35.83 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.13 113.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.22 0.533 . . . . 0.0 111.149 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.44 -48.72 4.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.46 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.81 155.68 46.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.605 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -149.98 129.6 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 123.485 0.491 . . . . 0.0 110.026 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -142.32 125.66 16.58 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.279 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.583 HD23 ' HB2' ' A' ' 84' ' ' SER . 34.2 tp -70.0 122.45 19.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.617 HG21 ' HG2' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -97.48 -41.65 11.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.183 -174.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 m -149.35 131.05 15.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.872 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.583 ' HB2' HD23 ' A' ' 81' ' ' LEU . 45.0 t -138.95 111.01 7.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.61 -62.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.14 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.425 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . -157.05 62.85 0.32 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.876 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.923 ' HA ' HD13 ' A' ' 90' ' ' LEU . 1.6 mm? -114.35 86.78 12.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 4.7 Cg_exo -77.16 -78.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.435 2.09 . . . . 0.0 111.545 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.1 p -74.79 -18.67 60.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.69 0.757 . . . . 0.0 110.242 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.923 HD13 ' HA ' ' A' ' 87' ' ' LEU . 10.5 mt -70.44 -38.7 74.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.404 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -54.49 -50.85 66.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.413 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.2 -40.88 71.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.221 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.488 ' CB ' ' HG3' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -78.22 -53.2 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.516 -173.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 90' ' ' LEU . 37.0 pt -64.74 -36.05 76.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.677 0.275 . . . . 0.0 111.727 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.631 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.9 mm-40 -79.22 -27.55 42.5 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 120.955 0.407 . . . . 0.0 110.506 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.38 -46.34 76.53 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 173.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.466 HD23 HG21 ' A' ' 98' ' ' VAL . 1.4 tp -67.59 -54.96 15.44 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.742 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.762 HG13 HG21 ' A' ' 123' ' ' ILE . 95.1 t -87.81 -48.62 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.631 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 40.3 ttmt -65.05 -23.29 67.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.046 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 30.9 tpt180 -93.6 -27.33 16.66 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.009 173.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.572 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -114.71 75.16 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.808 0.337 . . . . 0.0 111.29 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.4 m -108.34 95.06 14.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.225 0.536 . . . . 0.0 110.275 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 1.019 ' HB2' ' HG3' ' A' ' 44' ' ' ARG . 84.8 Cg_endo -113.74 122.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 124.482 3.454 . . . . 0.0 114.604 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.447 HD23 ' HD2' ' A' ' 105' ' ' PRO . 1.1 mt -92.02 123.75 61.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 172.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.553 ' HG3' ' HD3' ' A' ' 44' ' ' ARG . 1.7 Cg_endo -77.88 -59.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.568 2.179 . . . . 0.0 112.267 177.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.606 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 t -65.5 129.18 94.31 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.983 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.4 103.46 1.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.844 2.363 . . . . 0.0 112.267 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.805 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 68.5 Cg_endo -85.81 55.99 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.732 2.288 . . . . 0.0 111.524 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.729 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -54.38 -45.83 72.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.575 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.82 -6.84 51.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.291 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.805 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -98.36 -21.61 16.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.511 -177.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.832 ' HB3' HG12 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -124.3 17.79 9.04 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.4 m -71.1 89.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.965 0.888 . . . . 0.0 108.896 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER 157.43 -13.78 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 113.19 -1.823 . . . . 0.0 107.903 -172.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.06 -90.72 0.1 Allowed Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.032 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.537 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -160.57 175.09 13.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.308 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.832 HG12 ' HB3' ' A' ' 112' ' ' TYR . 10.8 m -101.99 114.47 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.417 0.627 . . . . 0.0 111.115 -175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -115.72 112.69 22.42 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 172.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.507 HD13 ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -144.11 152.61 41.17 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.328 -175.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 82' ' ' VAL . 86.6 m -90.47 124.67 35.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.151 0.501 . . . . 0.0 111.77 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.507 ' HG ' HD13 ' A' ' 119' ' ' LEU . 57.8 mt -126.76 123.45 23.79 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.861 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 11.5 Cg_exo -70.61 120.09 6.83 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.066 1.844 . . . . 0.0 111.277 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.762 HG21 HG13 ' A' ' 98' ' ' VAL . 33.0 pt -94.5 99.17 9.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -98.95 123.62 43.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.068 0.937 . . . . 0.0 111.923 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.566 ' HE2' ' HE2' ' A' ' 53' ' ' LYS . 59.8 m-85 -115.16 125.25 53.2 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 162.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.9 p -57.55 105.12 0.22 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.503 0.668 . . . . 0.0 111.327 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.725 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -83.19 99.26 9.83 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.759 -173.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.407 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 53.4 mtp180 . . . . . 0 C--N 1.322 -0.61 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.52 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.6 t90 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.567 0.222 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -67.85 -30.03 69.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.104 0.478 . . . . 0.0 110.515 -174.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.4 -36.45 82.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.171 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.418 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 24.1 mmm180 -73.64 -41.36 62.85 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.346 0.594 . . . . 0.0 109.589 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.408 HG22 ' HG2' ' A' ' 103' ' ' PRO . 87.6 mt -61.39 -42.35 93.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.041 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t -55.59 -39.62 70.95 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.002 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.14 99.1 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.878 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.588 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 8.6 mpt_? -69.35 -34.69 74.98 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.787 0.327 . . . . 0.0 110.809 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.558 HD13 HG22 ' A' ' 98' ' ' VAL . 1.1 tt -65.11 -27.68 68.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.72 0.771 . . . . 0.0 109.581 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.604 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 10.3 t30 -71.96 -37.67 69.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.885 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -56.73 -27.8 59.89 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.609 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.497 ' HE2' ' HB3' ' A' ' 103' ' ' PRO . 94.9 m-85 -88.51 -56.87 3.13 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.866 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 mtmm 172.96 103.43 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.209 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.604 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 52.7 ttp180 -108.4 103.03 12.1 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -72.38 131.59 84.73 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.59 131.14 32.11 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.71 2.274 . . . . 0.0 112.131 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.597 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.92 -21.33 63.29 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.407 -173.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -52.97 -38.59 62.27 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.505 0.503 . . . . 0.0 110.792 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.74 -43.65 45.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.154 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 53' ' ' LYS . 3.2 mm? -64.07 -41.02 97.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.323 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.674 ' HG3' ' HG ' ' A' ' 58' ' ' LEU . 27.6 ptt180 -61.66 -19.72 62.62 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.361 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.674 ' HG ' ' HG3' ' A' ' 57' ' ' ARG . 82.9 mt -116.07 14.17 15.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.461 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.745 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 40.3 ttpt -151.21 -74.48 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 0.0 111.791 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.745 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 24.4 mmt180 -112.1 84.89 2.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.522 0.677 . . . . 0.0 110.183 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 126' ' ' SER . 3.1 pt20 -111.19 166.52 11.02 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.272 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.748 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.59 147.34 4.57 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.186 -1.483 . . . . 0.0 113.91 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.739 ' H ' HD12 ' A' ' 127' ' ' LEU . 61.9 t -116.13 124.94 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -151.97 166.15 30.87 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.432 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.616 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 56.8 mt-30 -101.85 132.15 47.78 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.447 HG13 ' CD2' ' A' ' 68' ' ' PHE . 56.1 t -124.26 113.23 35.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.404 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -103.02 121.75 43.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -142.53 165.64 26.84 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.466 0.651 . . . . 0.0 112.121 -171.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 11.9 m -114.99 127.78 55.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.005 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.483 HD13 ' CE1' ' A' ' 68' ' ' PHE . 46.5 mt -116.3 132.34 56.7 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.246 0.546 . . . . 0.0 111.784 -169.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.55 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 26.5 t70 -71.65 155.32 40.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.42 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 46.2 mtp180 -59.32 -18.81 41.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.294 -175.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.726 HE21 ' HA ' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -108.1 14.9 24.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.923 0.392 . . . . 0.0 111.279 177.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 77.54 49.26 7.38 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.714 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 19.1 t60 -114.84 126.49 54.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.87 121.91 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.187 0.517 . . . . 0.0 111.42 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 71' ' ' ASP . 52.7 mt -111.88 -47.53 3.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.251 0.548 . . . . 0.0 110.587 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.88 150.61 51.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.858 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.44 116.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.314 0.578 . . . . 0.0 110.386 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.6 m -127.43 127.12 43.59 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.888 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.6 tp -77.32 112.31 13.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.249 0.547 . . . . 0.0 110.466 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.588 HG22 HG21 ' A' ' 120' ' ' THR . 0.0 OUTLIER -96.28 -43.81 12.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.449 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 21.3 t 65.96 173.1 0.23 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.743 169.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.616 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 26.5 m -146.7 -67.11 0.27 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.23 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.25 -86.08 0.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.66 96.8 0.1 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.995 -174.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.855 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -120.1 84.46 33.52 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.36 -76.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 111.956 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 m -70.32 -18.42 63.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.529 0.68 . . . . 0.0 110.136 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.855 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.8 mt -75.8 -36.7 59.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.387 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 14.4 t70 -54.54 -47.76 72.78 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.671 0.607 . . . . 0.0 111.834 -172.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -52.71 -51.9 58.44 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -170.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 22.8 tt0 -77.97 -48.21 16.77 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.221 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 90' ' ' LEU . 38.3 pt -62.76 -35.99 73.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 120.578 0.228 . . . . 0.0 111.217 -176.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.59 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 74.5 mm-40 -82.32 -28.25 31.77 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-O 120.951 0.405 . . . . 0.0 110.589 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.659 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.96 -46.5 78.56 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 170.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 tp -67.26 -55.66 13.04 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.904 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.677 HG13 HG22 ' A' ' 123' ' ' ILE . 72.1 t -87.83 -49.05 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.59 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.9 ttmt -66.52 -19.71 65.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.666 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.659 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 14.2 tpp180 -91.24 -49.94 6.1 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.68 169.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.625 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -90.87 64.76 5.58 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.698 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -89.7 99.48 1.79 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.145 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.625 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 71.9 Cg_endo -102.31 174.76 0.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.737 2.958 . . . . 0.0 114.176 -174.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.552 HD22 ' CD ' ' A' ' 108' ' ' PRO . 32.0 tp -144.69 102.13 4.59 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.726 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.418 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 6.1 Cg_exo -68.25 -77.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.134 1.889 . . . . 0.0 112.866 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.432 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.5 p -80.59 119.03 75.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.702 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 26.8 Cg_exo -62.75 108.65 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.209 2.606 . . . . 0.0 112.806 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.823 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 86.4 Cg_endo -83.02 62.15 7.59 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.172 2.581 . . . . 0.0 111.68 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.705 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -52.33 -44.69 65.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.612 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.94 -9.97 59.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.123 -176.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.823 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -99.35 -23.88 15.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.818 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.705 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -117.02 17.58 14.88 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.535 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.8 m -71.68 88.42 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 168.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.535 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 5.7 p30 157.17 -16.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 113.989 -1.46 . . . . 0.0 108.002 -168.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.37 -85.1 0.14 Allowed Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.421 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.537 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.2 OUTLIER -154.71 176.5 12.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.744 ' O ' ' HA ' ' A' ' 69' ' ' THR . 3.7 m -99.98 107.61 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.995 0.903 . . . . 0.0 110.183 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 31.8 tt0 -107.95 111.16 23.12 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.04 175.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.743 HD11 ' HG ' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -147.33 155.06 41.67 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.346 -172.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.588 HG21 HG22 ' A' ' 82' ' ' VAL . 89.3 m -98.08 118.66 35.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.531 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.743 ' HG ' HD11 ' A' ' 119' ' ' LEU . 30.5 mt -124.18 127.76 25.24 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.409 175.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.5 Cg_exo -72.22 119.36 6.11 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.942 1.761 . . . . 0.0 110.768 175.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.677 HG22 HG13 ' A' ' 98' ' ' VAL . 40.7 pt -90.29 103.25 14.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -101.71 123.44 45.7 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.763 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -114.33 150.55 34.35 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 166.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 7.8 m -63.26 101.81 0.34 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.638 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.748 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.3 tt -89.58 102.63 15.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.905 0.383 . . . . 0.0 110.379 -174.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.417 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 36.3 mtp180 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.775 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.51 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.602 0.239 . . . . 0.0 111.217 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -67.93 -38.31 82.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.23 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.82 -30.57 65.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.884 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.45 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 60.0 mtt180 -68.2 -41.72 80.93 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 172.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 37' ' ' TRP . 88.8 mt -59.05 -46.03 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.855 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.7 m -56.47 -29.79 62.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.892 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.69 -43.03 69.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.567 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.497 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.51 -34.27 74.04 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.102 0.477 . . . . 0.0 110.465 178.076 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 101' ' ' ALA . 1.3 tt -61.17 -33.48 73.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.96 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.821 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.2 t-20 -70.85 -37.87 73.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.696 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -27.39 34.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.901 175.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.79 -62.07 1.29 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.236 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 29.6 mtpp -164.0 103.14 0.88 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.821 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 56.3 ttp180 -117.81 103.29 9.83 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.58 176.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -77.3 112.8 25.92 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.11 131.38 44.94 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.592 2.194 . . . . 0.0 112.107 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.575 ' HE2' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -58.66 -22.69 57.55 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.683 -174.337 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.541 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 6.6 m-20 -55.07 -39.11 68.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.754 0.312 . . . . 0.0 110.982 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.12 -36.21 61.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.215 0.531 . . . . 0.0 110.417 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 60' ' ' ARG . 3.4 mm? -67.6 -35.62 79.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.745 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.541 ' HE ' ' HA ' ' A' ' 54' ' ' ASP . 46.8 mtm180 -54.1 -39.42 66.36 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 111.923 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.403 ' N ' HD11 ' A' ' 58' ' ' LEU . 7.5 mp -94.62 -23.41 17.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.287 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.743 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 6.6 ttpp -113.56 -81.9 0.6 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.749 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 19.3 mmt180 -103.19 83.07 2.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.4 0.619 . . . . 0.0 111.42 -173.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.475 ' O ' HD11 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -105.29 144.06 32.6 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.854 173.219 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 1.024 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 162.08 131.9 1.27 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.675 -170.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.84 125.53 58.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.985 0.421 . . . . 0.0 110.843 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.7 164.76 24.34 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 55.5 mt-30 -115.42 127.13 55.14 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.419 HG13 ' HE2' ' A' ' 99' ' ' LYS . 27.4 m -118.07 139.64 44.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.347 0.594 . . . . 0.0 110.825 -174.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 45.4 ttp180 -112.98 138.09 50.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.908 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -154.96 148.91 25.72 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.343 0.592 . . . . 0.0 112.116 -177.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 15.3 m -93.51 129.72 39.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 169.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.628 HD11 ' HG ' ' A' ' 104' ' ' LEU . 47.5 mt -121.31 136.69 54.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.203 0.525 . . . . 0.0 111.915 -170.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 14.4 t70 -83.56 161.73 21.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.677 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 73' ' ' GLN . 2.4 ptp180 -54.78 -35.9 64.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.693 0.282 . . . . 0.0 111.632 -177.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.472 ' N ' ' HG2' ' A' ' 72' ' ' ARG . 15.4 pt20 -87.39 12.05 13.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.351 . . . . 0.0 111.26 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.85 34.17 48.93 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.876 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 64.6 t60 -92.57 104.8 17.06 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.8 p -48.92 123.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.467 0.651 . . . . 0.0 111.377 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 13.6 mt -107.7 -43.08 4.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.528 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.85 153.58 51.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.865 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.421 ' HB ' ' HD2' ' A' ' 99' ' ' LYS . 11.3 m -140.15 129.36 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.302 0.572 . . . . 0.0 110.812 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.6 m -145.42 120.48 10.08 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.868 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 84' ' ' SER . 26.1 tp -72.97 108.25 5.78 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.528 HG23 HG22 ' A' ' 120' ' ' THR . 0.2 OUTLIER -80.46 -42.36 21.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.898 -172.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.434 ' HB3' ' HB2' ' A' ' 65' ' ' GLN . 8.6 t -140.22 147.27 39.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.212 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.475 ' HB2' HD22 ' A' ' 81' ' ' LEU . 28.6 t -142.88 131.88 23.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.831 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.54 17.5 6.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.013 0.435 . . . . 0.0 110.856 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.505 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 94.86 65.92 1.0 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.926 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.902 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -111.81 90.08 12.4 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 117.085 0.442 . . . . 0.0 109.954 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 6.1 Cg_exo -73.91 -74.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.714 2.276 . . . . 0.0 111.802 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.4 m -74.89 -19.22 60.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.431 0.634 . . . . 0.0 110.386 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.902 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 9.6 mt -76.89 -42.37 40.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.762 -172.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.555 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 28.6 t70 -54.95 -50.16 69.59 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.67 0.606 . . . . 0.0 112.414 -170.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -53.25 -44.28 68.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -77.05 -53.17 8.14 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.794 0.33 . . . . 0.0 111.784 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.444 ' O ' HD11 ' A' ' 97' ' ' LEU . 34.0 pt -60.53 -35.85 66.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.631 -176.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.678 HE22 HD12 ' A' ' 123' ' ' ILE . 51.3 mm-40 -82.91 -21.58 34.15 Favored 'General case' 0 C--O 1.205 -1.273 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.129 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.05 -54.06 44.52 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.142 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -75.72 -46.24 32.21 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.543 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.721 HG13 HG22 ' A' ' 123' ' ' ILE . 30.8 t -62.55 -49.21 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 1.3 tppp? -70.82 -35.63 72.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.191 -169.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -80.71 -34.9 34.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.848 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.631 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -101.15 67.65 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.193 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.0 m -97.33 97.69 4.12 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.182 0.515 . . . . 0.0 109.781 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.631 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 88.0 Cg_endo -107.93 173.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.245 3.297 . . . . 0.0 114.553 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.628 ' HG ' HD11 ' A' ' 70' ' ' LEU . 14.1 mt -140.61 122.39 9.45 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.617 171.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 12.2 Cg_endo -82.06 -40.17 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.657 2.238 . . . . 0.0 111.676 174.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.465 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 12.8 m -94.92 103.46 11.73 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.374 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.87 106.76 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.564 2.176 . . . . 0.0 112.234 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.627 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 67.9 Cg_endo -83.0 58.19 6.25 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.751 2.301 . . . . 0.0 111.813 -176.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.774 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.55 -46.21 77.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.832 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.92 -23.02 66.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.158 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -86.72 -35.89 18.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.075 -175.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.774 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -105.78 15.91 26.04 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.008 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 3.6 m -72.15 89.52 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 169.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 2.3 p30 159.75 -22.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.212 -169.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 162.42 -85.09 0.11 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.737 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.552 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -159.4 173.22 16.57 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.758 HG12 ' HB3' ' A' ' 112' ' ' TYR . 24.5 m -104.98 110.4 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 121.328 0.585 . . . . 0.0 110.961 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 43.9 tt0 -107.78 110.65 22.5 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 170.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.607 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.7 pp -135.41 155.62 50.26 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.39 -174.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.528 HG22 HG23 ' A' ' 82' ' ' VAL . 99.9 m -101.08 129.13 46.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.107 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.607 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 54.3 mt -128.56 130.49 23.51 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 2.9 Cg_exo -76.12 121.48 6.17 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.791 2.327 . . . . 0.0 111.565 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.721 HG22 HG13 ' A' ' 98' ' ' VAL . 43.0 pt -97.76 99.98 9.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.49 119.04 29.58 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.124 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.575 ' CE2' ' HE2' ' A' ' 53' ' ' LYS . 83.2 m-85 -116.25 120.19 38.14 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 162.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.5 m -58.74 102.5 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -169.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 1.024 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 3.4 mt -73.23 114.13 11.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.104 0.478 . . . . 0.0 110.248 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.639 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.637 ' HA ' ' HG2' ' A' ' 40' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.574 ' HG3' ' N ' ' A' ' 39' ' ' SER . 9.6 ptp180 -63.6 -39.96 95.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.243 0.544 . . . . 0.0 109.874 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.574 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 3.5 m -67.58 -30.39 69.99 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.602 -178.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.637 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 16.8 mmt180 -71.72 -43.35 66.02 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.283 176.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.611 HG23 ' HD2' ' A' ' 103' ' ' PRO . 76.2 mt -59.85 -49.04 85.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.222 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.1 t -57.04 -30.24 64.08 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.605 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -68.21 -44.94 73.64 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.043 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.503 ' NE ' ' HB3' ' A' ' 105' ' ' PRO . 9.5 mpt_? -69.66 -34.49 74.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.973 0.416 . . . . 0.0 110.322 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 101' ' ' ALA . 2.7 tt -59.52 -32.28 70.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.761 0.791 . . . . 0.0 109.076 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 1.033 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 28.4 t30 -70.99 -42.32 69.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.156 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 8.0 ptt180 -61.29 -18.54 58.99 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.298 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -100.54 -58.47 1.89 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.153 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -162.59 103.08 1.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.864 0.466 . . . . 0.0 110.314 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 1.033 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 5.7 tpt180 -134.05 103.12 5.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.405 ' HB3' HD22 ' A' ' 56' ' ' LEU . 1.8 t80 -89.16 138.14 29.08 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.223 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.56 131.62 41.8 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.806 2.337 . . . . 0.0 111.996 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.541 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.01 -25.68 67.07 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.037 -173.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.1 -41.05 67.84 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.323 0.389 . . . . 0.0 110.913 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.1 -38.73 75.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.743 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.5 mm? -66.53 -38.73 87.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.549 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 69.8 mtt180 -65.71 -13.95 60.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.386 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.6 mt -110.85 2.1 18.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.792 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.609 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 21.1 ttmm -137.92 -74.42 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.532 -173.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.609 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 38.4 mmt180 -126.55 106.4 9.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 110.335 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.538 ' O ' HD11 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -117.78 158.19 25.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.612 178.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.973 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 153.29 144.17 3.85 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 119.79 -1.195 . . . . 0.0 113.345 -177.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.752 ' H ' HD13 ' A' ' 127' ' ' LEU . 2.8 p -104.13 122.77 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.373 0.606 . . . . 0.0 110.132 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.79 151.35 21.25 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 21.9 tt0 -105.63 135.42 47.06 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.53 131.67 71.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.014 0.435 . . . . 0.0 110.777 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -115.04 140.9 48.67 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.31 153.74 27.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.209 0.528 . . . . 0.0 111.757 -175.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 21.1 m -96.89 130.39 44.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.8 173.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.429 HD11 ' O ' ' A' ' 103' ' ' PRO . 49.6 mt -118.35 133.98 55.43 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.111 0.481 . . . . 0.0 111.677 -173.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.71 155.9 30.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.186 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -55.75 -33.71 64.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.003 0.43 . . . . 0.0 110.285 175.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -76.68 6.25 6.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.129 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.23 36.82 63.61 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.395 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -113.29 122.45 47.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 8.6 p -48.75 127.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.927 0.767 . . . . 0.0 111.522 172.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.414 ' CD1' HG21 ' A' ' 116' ' ' THR . 36.0 mt -113.71 -43.85 3.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.224 0.535 . . . . 0.0 110.73 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.79 154.21 48.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.168 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.489 HG11 ' HG3' ' A' ' 99' ' ' LYS . 3.1 m -147.66 127.08 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.0 m -144.64 127.83 16.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 tp -76.38 108.64 9.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.741 HG21 HG22 ' A' ' 120' ' ' THR . 0.0 OUTLIER -74.63 -34.26 34.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.637 0.732 . . . . 0.0 109.056 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.9 t 75.29 171.39 0.27 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.605 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -153.67 -52.44 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.682 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.93 -79.1 0.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 168.49 103.68 0.17 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.513 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.761 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.7 OUTLIER -119.39 103.96 46.22 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -84.44 -81.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.24 1.96 . . . . 0.0 111.991 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.2 p -71.0 -19.02 62.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.192 0.52 . . . . 0.0 110.529 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.761 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 8.9 mt -75.12 -32.26 61.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.908 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 15.8 t70 -54.48 -50.38 67.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.896 -171.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 93' ' ' GLU . 17.0 ptp180 -52.64 -46.89 67.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.569 -175.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 11.1 mt-10 -78.46 -53.94 6.7 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.496 HD12 ' HG ' ' A' ' 87' ' ' LEU . 34.2 pt -62.32 -33.91 61.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.559 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 56.1 mm-40 -82.02 -29.56 31.94 Favored 'General case' 0 C--O 1.203 -1.392 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.371 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.78 68.47 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.136 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.515 HD22 HG21 ' A' ' 98' ' ' VAL . 0.7 OUTLIER -63.81 -54.64 31.95 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.763 176.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.76 HG13 HG23 ' A' ' 123' ' ' ILE . 39.4 t -85.15 -48.55 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.559 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -63.59 -34.34 77.59 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.211 0.604 . . . . 0.0 110.865 -174.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.49 -48.3 19.99 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.247 0.546 . . . . 0.0 109.689 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.636 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -93.34 58.83 2.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.398 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.477 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.9 m -95.84 99.23 4.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.334 0.588 . . . . 0.0 109.939 174.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.636 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 72.9 Cg_endo -103.42 176.17 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 124.712 3.608 . . . . 0.0 113.441 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.648 HD21 ' HD2' ' A' ' 108' ' ' PRO . 38.5 tp -142.04 91.0 8.16 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.503 ' HB3' ' NE ' ' A' ' 44' ' ' ARG . 11.9 Cg_endo -70.46 -53.13 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.246 1.964 . . . . 0.0 112.824 -174.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.541 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 23.2 p -92.08 106.25 16.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -68.3 106.16 1.35 Allowed 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.822 2.348 . . . . 0.0 112.621 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.648 ' HD2' HD21 ' A' ' 104' ' ' LEU . 44.9 Cg_endo -86.66 61.18 4.4 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.195 2.596 . . . . 0.0 111.194 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.728 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.46 -41.54 80.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.17 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.99 -25.76 67.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.511 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.97 -29.76 21.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.78 ' HD2' HG12 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.72 16.41 16.39 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -172.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.527 HG11 ' O ' ' A' ' 109' ' ' ALA . 2.5 m -71.36 88.36 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.628 HD21 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 154.95 -15.35 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 113.426 -1.716 . . . . 0.0 108.609 -167.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.628 ' N ' HD21 ' A' ' 114' ' ' ASN . . . 168.96 -100.21 0.16 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.828 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.675 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.3 OUTLIER -161.15 176.67 11.04 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.78 HG12 ' HD2' ' A' ' 112' ' ' TYR . 12.3 m -101.5 108.77 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.585 0.707 . . . . 0.0 110.754 -177.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -99.0 111.25 23.7 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.598 HD12 ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -134.49 152.85 52.06 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.843 -173.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.741 HG22 HG21 ' A' ' 82' ' ' VAL . 54.8 m -103.42 128.07 50.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.395 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.598 ' HG ' HD12 ' A' ' 119' ' ' LEU . 98.3 mt -132.94 125.19 19.03 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.481 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 3.2 Cg_exo -79.97 120.18 4.14 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.947 1.764 . . . . 0.0 111.785 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.76 HG23 HG13 ' A' ' 98' ' ' VAL . 41.6 pt -96.6 98.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 3.4 p-10 -107.03 124.94 50.37 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.693 -176.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -111.75 141.65 45.09 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 165.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.4 m -57.76 102.49 0.1 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.034 0.445 . . . . 0.0 111.614 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.973 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -85.9 69.69 10.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.331 -175.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.813 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.33 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 . . . . . 0 C--O 1.225 -0.197 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -67.95 -35.76 78.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.453 -170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 p -63.48 -40.39 96.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.266 0.555 . . . . 0.0 110.144 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.487 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 50.8 mmm-85 -74.99 -46.24 36.56 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.268 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.562 HG23 ' HG2' ' A' ' 103' ' ' PRO . 58.3 mt -57.46 -43.19 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.549 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.7 m -59.73 -44.43 93.76 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.603 0.24 . . . . 0.0 111.51 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.85 -33.98 88.7 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.457 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.622 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 27.9 ttt85 -69.83 -35.73 75.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.75 0.309 . . . . 0.0 110.347 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.499 ' HB3' ' HD2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -64.28 -31.55 72.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.379 0.609 . . . . 0.0 109.667 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.63 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 11.4 t30 -70.97 -30.69 67.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.631 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 47.9 ttt180 -70.18 -29.03 65.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.84 171.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 49' ' ' LYS . 61.3 m-85 -99.62 25.25 7.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.202 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 48' ' ' PHE . 13.0 tmtt? 74.2 103.36 0.07 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.493 0.664 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.63 ' HB3' ' HA ' ' A' ' 46' ' ' ASN . 32.3 ttt180 -137.89 108.0 6.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.191 -176.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.532 ' HB3' HD21 ' A' ' 56' ' ' LEU . 6.2 t80 -61.78 134.6 94.06 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.43 129.13 8.55 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.987 2.458 . . . . 0.0 112.06 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.759 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -71.49 -25.28 62.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.125 -163.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -66.93 -33.26 75.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.958 0.408 . . . . 0.0 110.77 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.85 -30.32 70.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.415 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.6 mm? -78.41 -41.68 32.31 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.765 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 51.4 mtm180 -75.1 -10.89 59.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.05 -0.406 . . . . 0.0 111.994 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 33.3 tp -105.58 17.06 24.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.466 0.65 . . . . 0.0 109.803 176.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.545 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 25.0 ttmm -146.01 -54.27 0.27 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.371 -175.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.869 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 17.9 mmt180 -126.32 83.28 2.15 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.866 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 126' ' ' SER . 0.8 OUTLIER -100.15 137.3 38.78 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.552 -179.051 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.911 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 171.99 160.61 20.92 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.669 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 p -116.35 125.72 73.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.173 0.511 . . . . 0.0 110.527 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.93 159.27 23.46 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.558 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 49.9 tt0 -104.27 123.74 47.9 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 121' ' ' LEU . 9.5 p -127.01 126.68 68.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.408 0.623 . . . . 0.0 111.041 -167.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -115.82 144.94 43.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.717 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -158.97 155.14 27.02 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.066 0.46 . . . . 0.0 110.937 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 22.0 m -100.52 129.35 46.45 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 171.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 75.5 mt -113.95 140.59 48.27 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.724 0.773 . . . . 0.0 112.146 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 27.9 t70 -77.7 165.16 24.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.85 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.509 ' HA ' ' OH ' ' A' ' 112' ' ' TYR . 38.6 mtp180 -54.39 -35.72 63.15 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.531 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -83.03 6.16 19.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 110.817 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.8 40.1 53.49 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.623 -176.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 71.1 t60 -108.14 138.16 44.89 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.379 -0.41 . . . . 0.0 110.349 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 100' ' ' ARG . 10.5 p -59.24 130.94 23.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.348 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 71' ' ' ASP . 56.5 mt -120.27 -40.77 2.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.292 0.568 . . . . 0.0 110.282 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.2 148.04 51.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.981 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.77 123.99 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 123.564 0.54 . . . . 0.0 109.807 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.1 m -144.53 118.75 9.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.841 0.353 . . . . 0.0 111.376 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 84' ' ' SER . 34.3 tp -85.03 106.73 16.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -87.24 -46.69 16.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.196 -170.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 m -144.78 112.64 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.633 ' HB2' HD23 ' A' ' 81' ' ' LEU . 34.5 t -106.32 137.77 43.69 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.59 -7.56 59.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.266 0.555 . . . . 0.0 110.536 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.73 -86.23 0.14 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 1.12 ' HA ' HD13 ' A' ' 90' ' ' LEU . 2.3 mm? 44.24 59.03 13.38 Favored Pre-proline 0 CA--C 1.534 0.335 0 O-C-N 124.304 0.649 . . . . 0.0 112.495 173.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -61.92 -71.44 0.03 OUTLIER 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 121.334 1.356 . . . . 0.0 111.936 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 t -76.92 -18.64 58.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.462 0.649 . . . . 0.0 110.055 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 1.12 HD13 ' HA ' ' A' ' 87' ' ' LEU . 6.6 mt -75.91 -41.31 52.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.517 -172.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.449 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 19.2 t70 -53.95 -47.0 71.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.502 -172.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -54.64 -37.28 65.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.471 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.869 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 2.3 tp10 -78.49 -54.88 5.68 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.0 pt -68.8 -35.46 69.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.562 -173.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.6 ' NE2' HD13 ' A' ' 123' ' ' ILE . 56.5 mm-40 -79.87 -27.55 40.06 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.788 0.328 . . . . 0.0 110.649 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.24 -46.95 76.03 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.117 173.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.435 ' O ' HD22 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -63.97 -57.59 9.25 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.698 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.645 HG11 HG22 ' A' ' 123' ' ' ILE . 80.5 t -87.6 -48.82 15.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.586 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.7 ttmt -67.18 -27.09 66.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.044 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.543 ' HD3' ' C ' ' A' ' 100' ' ' ARG . 3.2 tmt_? -85.43 -53.92 4.9 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.016 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.434 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -96.49 65.52 2.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.739 0.304 . . . . 0.0 111.105 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.476 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 16.1 m -78.04 107.85 6.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.807 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.622 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 39.6 Cg_endo -101.49 139.41 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 124.022 3.148 . . . . 0.0 113.963 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.434 HD22 ' O ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -125.98 107.11 25.28 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 171.374 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.487 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 11.5 Cg_exo -65.05 -62.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 122.715 2.277 . . . . 0.0 112.622 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.499 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 8.8 t -80.73 123.28 82.58 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.706 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 14.9 Cg_exo -69.47 107.67 1.85 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.047 2.498 . . . . 0.0 111.862 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.563 ' HB2' ' HB1' ' A' ' 111' ' ' ALA . 43.1 Cg_endo -84.52 59.97 5.91 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.927 2.418 . . . . 0.0 111.542 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.679 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -54.27 -48.88 70.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.086 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -75.02 6.95 3.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.707 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.563 ' HB1' ' HB2' ' A' ' 108' ' ' PRO . . . -106.96 -38.1 6.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.797 ' HB3' HG11 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -106.88 18.05 22.33 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 109' ' ' ALA . 2.4 m -69.9 87.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 122.447 1.118 . . . . 0.0 108.34 172.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 5.5 p30 166.54 -39.04 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.109 -1.86 . . . . 0.0 107.526 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.08 -75.17 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.987 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.475 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.8 OUTLIER -160.14 174.07 14.83 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.953 0.501 . . . . 0.0 109.958 -178.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.797 HG11 ' HB3' ' A' ' 112' ' ' TYR . 10.4 m -105.02 109.07 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 121.282 0.563 . . . . 0.0 110.861 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -103.42 111.77 24.36 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 169.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.603 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -142.97 150.18 39.34 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.91 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.2 m -99.79 128.14 45.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.209 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.603 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 83.7 mt -126.73 123.54 23.85 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.559 176.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 51.9 Cg_endo -73.32 123.64 8.87 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.547 1.498 . . . . 0.0 111.921 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.645 HG22 HG11 ' A' ' 98' ' ' VAL . 8.1 pt -98.45 97.84 6.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.42 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -104.16 124.07 48.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.673 0.749 . . . . 0.0 112.199 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -117.06 151.2 37.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.397 169.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.581 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 10.3 m -61.02 102.8 0.22 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.063 0.227 . . . . 0.0 110.656 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.911 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.3 tt -83.26 77.15 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.236 0.541 . . . . 0.0 110.787 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.485 175.285 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.496 ' CZ3' HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.191 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -67.89 -33.13 74.14 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.315 -170.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.5 p -70.85 -31.28 67.92 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.455 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 21.5 mmt180 -68.19 -46.18 71.35 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.525 HG21 ' HD2' ' A' ' 103' ' ' PRO . 88.8 mt -57.45 -44.76 85.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.211 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.5 t -56.2 -36.31 68.27 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.539 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.75 -42.4 98.6 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.507 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.612 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.75 -32.29 70.74 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.114 0.483 . . . . 0.0 110.7 177.159 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.27 -31.43 71.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.477 0.656 . . . . 0.0 109.696 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.59 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 10.0 t30 -71.52 -34.26 69.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.598 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -54.02 -25.56 21.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.592 173.066 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.582 ' HE2' ' HB3' ' A' ' 103' ' ' PRO . 97.5 m-85 -100.0 -61.11 1.41 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.017 174.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 11.6 mmmm -170.72 110.31 0.36 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.487 0.715 . . . . 0.0 109.533 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.59 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 45.7 ttp180 -125.03 111.91 15.93 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.985 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.615 ' H ' HD11 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -82.63 137.93 44.3 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.505 177.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.87 131.2 40.55 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.582 2.188 . . . . 0.0 111.622 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.679 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.63 -23.35 62.93 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.65 -171.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -53.69 -46.57 70.76 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.265 0.353 . . . . 0.0 111.145 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.9 -29.87 68.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.016 0.436 . . . . 0.0 111.477 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 60' ' ' ARG . 3.2 mm? -75.47 -42.35 53.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 0.0 110.34 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 57' ' ' ARG . 59.9 mtt180 -70.65 -12.01 61.29 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 pp -109.79 7.74 24.29 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.972 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.595 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 19.3 ttpp -158.14 -69.8 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.595 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 22.2 mmt180 -90.23 82.6 6.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.257 1.027 . . . . 0.0 110.063 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.63 ' O ' HD12 ' A' ' 90' ' ' LEU . 24.4 mt-30 -105.17 159.16 16.07 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.345 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.42 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.29 131.6 1.72 Allowed Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.795 -1.193 . . . . 0.0 112.656 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.562 HG23 ' HB2' ' A' ' 124' ' ' ASP . 60.6 t -104.22 123.08 57.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.98 166.4 30.42 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.142 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.56 ' O ' HG21 ' A' ' 82' ' ' VAL . 53.8 mt-30 -102.75 131.43 49.6 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.488 HG22 HD13 ' A' ' 123' ' ' ILE . 20.8 t -126.66 117.08 47.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.069 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.613 ' HD3' ' OE2' ' A' ' 118' ' ' GLU . 10.8 ttm180 -109.48 139.49 44.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.568 -176.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.422 ' CD1' HD22 ' A' ' 70' ' ' LEU . 8.1 p90 -159.2 154.64 25.73 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 26.4 m -96.86 140.9 30.74 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.357 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 104' ' ' LEU . 65.4 mt -124.37 138.58 54.36 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.588 0.709 . . . . 0.0 112.683 -170.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.594 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 13.6 t70 -73.04 157.65 36.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.435 172.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -57.67 -27.35 62.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.876 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -100.39 15.27 28.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.864 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.682 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 75.8 46.76 13.21 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.094 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 53.2 t60 -110.52 122.23 47.24 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.6 p -50.57 116.38 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.551 0.691 . . . . 0.0 111.488 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.5 mt -100.81 -44.48 5.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.521 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.44 161.94 33.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.02 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.467 HG21 ' HG3' ' A' ' 99' ' ' LYS . 7.5 p -160.23 117.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.372 0.606 . . . . 0.0 109.589 175.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.2 m -124.37 112.83 17.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.714 -177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.0 tp -69.38 105.77 2.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.56 0.695 . . . . 0.0 109.818 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -86.98 -54.83 7.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.491 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 32.4 t 63.18 -175.01 0.15 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.249 170.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -152.03 -63.13 0.17 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.79 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.96 -37.98 13.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.975 0.417 . . . . 0.0 111.396 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.76 104.17 2.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.406 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.84 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 1.7 mm? -103.01 103.41 33.79 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.48 -80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.959 2.439 . . . . 0.0 112.862 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 m -69.34 -19.5 63.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.442 0.639 . . . . 0.0 110.387 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.84 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.7 mt -75.7 -31.55 59.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.203 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 9.9 t70 -54.26 -48.9 70.66 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.602 0.564 . . . . 0.0 111.665 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -53.21 -45.7 68.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -171.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.577 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 16.8 tt0 -78.77 -53.35 7.21 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.961 -176.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.585 HG21 ' HB3' ' A' ' 60' ' ' ARG . 38.7 pt -67.1 -37.31 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.662 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 78.6 mm-40 -81.59 -25.72 35.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 120.881 0.372 . . . . 0.0 110.908 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.87 -43.47 77.18 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 169.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.615 HD11 ' H ' ' A' ' 51' ' ' TYR . 1.4 tp -67.6 -56.81 7.96 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.824 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.58 HG12 HG21 ' A' ' 123' ' ' ILE . 63.9 t -88.53 -49.13 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -175.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.662 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.6 ttmt -65.16 -22.56 66.93 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.003 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.428 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 2.6 tmt_? -90.99 -55.21 3.64 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.885 -0.509 . . . . 0.0 109.766 173.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.643 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -84.21 73.73 10.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 0.0 110.807 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.423 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 9.1 m -99.27 98.01 6.09 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 121.335 0.588 . . . . 0.0 109.577 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.643 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 93.6 Cg_endo -105.43 176.46 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 124.227 3.285 . . . . 0.0 113.686 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.682 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 4.0 tt -144.02 115.36 5.52 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.561 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.455 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 5.1 Cg_exo -70.75 -72.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.71 2.273 . . . . 0.0 112.757 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.43 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -86.16 117.22 68.32 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.492 -177.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.479 ' HA ' HD21 ' A' ' 104' ' ' LEU . 24.8 Cg_exo -64.06 106.44 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.266 2.644 . . . . 0.0 112.293 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.639 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 61.4 Cg_endo -88.72 67.41 2.83 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.228 2.619 . . . . 0.0 112.071 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.774 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.69 -43.4 76.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.19 0.519 . . . . 0.0 110.051 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -72.52 -2.17 18.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.636 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.639 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -105.52 -29.69 10.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.774 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -106.66 16.52 24.42 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.576 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.6 m -71.44 89.16 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 168.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 4.4 p30 161.29 -24.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.89 -169.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.4 -76.01 0.19 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.697 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.462 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -159.99 173.86 15.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.115 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 69' ' ' THR . 4.4 m -105.04 109.1 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.024 0.44 . . . . 0.0 111.235 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.613 ' OE2' ' HD3' ' A' ' 67' ' ' ARG . 32.6 tt0 -110.0 112.17 24.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.661 HD11 HD11 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -122.59 150.36 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.463 -175.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.476 HG22 HG23 ' A' ' 82' ' ' VAL . 29.3 m -102.09 119.01 38.09 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.413 0.625 . . . . 0.0 110.181 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.661 HD11 HD11 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -116.66 122.87 31.12 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -175.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 2.6 Cg_exo -75.29 120.16 5.86 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.603 1.535 . . . . 0.0 111.564 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.58 HG21 HG12 ' A' ' 98' ' ' VAL . 4.3 pt -104.0 114.8 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.562 ' HB2' HG23 ' A' ' 63' ' ' VAL . 5.1 p-10 -118.97 125.25 48.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.027 0.918 . . . . 0.0 111.794 -176.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.519 ' HE1' ' HE2' ' A' ' 53' ' ' LYS . 98.6 m-85 -114.22 131.02 56.62 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.215 -1.357 . . . . 0.0 107.8 167.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.9 m -60.52 102.93 0.2 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.992 0.182 . . . . 0.0 111.282 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.601 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 3.3 mt -76.6 87.91 3.29 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.456 0.646 . . . . 0.0 110.498 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 . . . . . 0 N--CA 1.444 -0.757 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.523 179.687 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.6 m0 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 120.303 0.097 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -67.02 -44.09 81.18 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.7 p -65.72 -38.75 90.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.43 0.633 . . . . 0.0 109.744 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.628 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 1.7 mmt180 -68.6 -47.57 66.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.751 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.474 HG23 ' HG2' ' A' ' 103' ' ' PRO . 43.7 mt -62.64 -37.55 79.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.589 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.8 m -55.09 -37.54 66.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.332 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -66.72 -44.59 89.13 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.057 176.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.523 ' O ' ' HB3' ' A' ' 47' ' ' ARG . 11.5 mpt_? -70.16 -32.36 70.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.032 0.444 . . . . 0.0 111.37 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -32.68 74.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.642 0.734 . . . . 0.0 109.367 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.665 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 14.4 t-20 -71.14 -30.97 67.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.589 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 3.2 ttt180 -58.45 -18.82 31.59 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.651 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -115.44 -59.34 2.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.366 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -160.43 105.64 1.47 Allowed 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 122.942 0.497 . . . . 0.0 109.798 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.665 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 22.0 tpt180 -105.78 102.52 11.96 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.08 176.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.555 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -90.3 125.7 59.17 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.364 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.34 132.36 29.21 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.37 2.047 . . . . 0.0 111.523 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.5 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.68 -23.62 66.21 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.581 -175.134 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.31 -42.84 82.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.913 0.387 . . . . 0.0 110.837 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.74 71.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.802 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.693 ' HG ' ' HE2' ' A' ' 125' ' ' PHE . 3.7 mm? -75.91 -41.31 52.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.259 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.614 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 98.5 mtt180 -58.08 -29.72 65.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.134 0.493 . . . . 0.0 111.307 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.9 mt -100.07 17.11 21.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.097 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.86 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 38.4 ttmt -145.86 -77.59 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.372 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.86 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 36.3 mmt180 -126.71 98.06 5.23 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -176.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.614 ' HG2' ' HA ' ' A' ' 57' ' ' ARG . 47.4 mt-30 -92.66 115.87 28.5 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.941 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -155.53 125.28 1.63 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.737 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.733 HG23 ' HA ' ' A' ' 124' ' ' ASP . 7.1 p -103.91 133.22 48.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.175 0.512 . . . . 0.0 109.969 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.05 168.44 34.54 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.622 -175.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.695 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 83.2 mt-30 -99.74 140.53 33.81 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.429 HG11 ' CD2' ' A' ' 68' ' ' PHE . 53.7 t -128.7 114.18 32.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.695 -173.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 22.7 ttp180 -106.2 129.08 54.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -147.83 151.51 36.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.295 0.569 . . . . 0.0 112.191 -174.218 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 9.0 m -99.94 125.61 45.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 169.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.66 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 41.7 mt -116.26 134.68 54.64 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.168 0.508 . . . . 0.0 111.757 -170.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 16.4 t70 -73.96 154.02 39.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.314 177.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -49.4 -40.75 37.37 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.34 0.4 . . . . 0.0 111.805 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -89.35 14.03 12.15 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 111.309 -176.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.47 47.13 9.17 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.118 177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.583 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 73.6 t60 -109.58 116.18 31.28 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 p -48.74 115.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.331 0.586 . . . . 0.0 111.554 173.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.0 mt -103.3 -41.89 5.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.978 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -139.25 146.08 39.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.818 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.76 117.13 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.422 0.63 . . . . 0.0 110.951 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 m -130.13 125.66 35.62 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.87 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.9 tp -71.6 119.07 15.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.205 0.526 . . . . 0.0 110.065 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.534 HG23 HG23 ' A' ' 120' ' ' THR . 0.1 OUTLIER -96.71 -38.78 8.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.982 179.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 12.4 t 67.06 -178.26 0.21 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.404 170.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.544 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 39.8 m -154.92 -58.04 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.289 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.13 -66.6 0.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.327 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.65 104.82 0.19 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.753 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.809 ' HA ' HD13 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -118.42 77.82 13.98 Favored Pre-proline 0 C--N 1.32 -0.686 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.358 -178.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.63 -78.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.234 1.956 . . . . 0.0 111.809 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.9 m -67.68 -17.63 64.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.413 0.625 . . . . 0.0 110.297 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.809 HD13 ' HA ' ' A' ' 87' ' ' LEU . 17.6 mt -75.21 -33.66 61.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.921 -176.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 18.5 t70 -53.98 -50.52 66.37 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.591 0.557 . . . . 0.0 112.031 -173.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.59 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.7 OUTLIER -54.56 -48.6 71.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.76 -55.19 5.54 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -174.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.631 HG12 ' O ' ' A' ' 90' ' ' LEU . 36.0 pt -68.61 -34.05 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.407 0.623 . . . . 0.0 110.933 -171.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.791 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.8 mm-40 -84.66 -17.46 38.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.005 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 92' ' ' ARG . . . -55.64 -55.78 28.05 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.835 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.599 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.2 -48.19 21.32 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.148 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.599 ' N ' HD22 ' A' ' 97' ' ' LEU . 55.8 t -70.54 -49.49 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.791 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.9 ttmt -73.97 -16.53 61.07 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 122.064 -0.398 . . . . 0.0 110.724 -173.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -88.29 -47.37 8.47 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.678 171.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.614 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -92.32 67.79 4.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.801 0.334 . . . . 0.0 110.914 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.2 m -95.57 99.67 5.06 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.291 0.567 . . . . 0.0 110.005 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 90.8 Cg_endo -102.79 176.32 0.18 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.042 3.161 . . . . 0.0 113.711 -175.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 48.9 tp -142.9 85.6 9.87 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.304 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.628 ' CG ' ' HB2' ' A' ' 40' ' ' ARG . 10.0 Cg_endo -59.44 -53.94 2.99 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.278 1.986 . . . . 0.0 112.677 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.625 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.4 m -81.03 116.74 64.54 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.75 99.23 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.986 2.457 . . . . 0.0 111.118 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.769 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 37.9 Cg_endo -90.93 66.45 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.363 2.708 . . . . 0.0 112.386 -171.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.719 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.59 -45.92 84.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.203 0.525 . . . . 0.0 109.921 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -67.22 -6.28 17.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.7 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -101.41 -36.19 8.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.488 -178.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.841 ' HB3' HG11 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -112.43 18.85 18.12 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -171.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 109' ' ' ALA . 2.2 m -69.26 88.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.134 0.969 . . . . 0.0 108.686 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 3.8 p30 164.11 -27.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.459 -1.7 . . . . 0.0 107.636 -170.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 172.28 -81.92 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.09 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.492 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.3 OUTLIER -160.81 175.49 12.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.841 HG11 ' HB3' ' A' ' 112' ' ' TYR . 10.7 m -102.35 108.69 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.329 0.585 . . . . 0.0 110.842 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 37.0 tt0 -108.8 112.5 24.8 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 170.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.692 HD11 ' HG ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -136.38 154.35 50.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 -173.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.534 HG23 HG23 ' A' ' 82' ' ' VAL . 98.6 m -98.43 113.44 25.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.703 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.692 ' HG ' HD11 ' A' ' 119' ' ' LEU . 42.7 mt -117.95 123.76 29.31 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.19 176.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.2 Cg_exo -73.53 118.9 5.67 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.994 1.796 . . . . 0.0 111.212 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.592 HG23 HG11 ' A' ' 98' ' ' VAL . 33.5 pt -93.61 116.68 35.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.733 ' HA ' HG23 ' A' ' 63' ' ' VAL . 1.5 t70 -100.53 120.91 40.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.996 0.903 . . . . 0.0 112.856 -172.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.693 ' HE2' ' HG ' ' A' ' 56' ' ' LEU . 6.7 m-85 -115.6 130.53 56.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 160.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 61' ' ' GLN . 13.4 m -59.19 103.46 0.18 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.294 0.497 . . . . 0.0 110.703 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.941 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -77.76 66.76 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.059 -177.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 121.182 0.515 . . . . 0.0 109.857 179.142 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.288 0.566 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 38' ' ' ARG . 5.7 ptp180 -66.02 -31.97 73.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.83 -177.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.3 p -71.23 -33.13 69.59 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.435 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 10.1 mmt180 -70.65 -46.28 63.54 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.536 ' N ' ' HG3' ' A' ' 105' ' ' PRO . 80.3 mt -57.31 -45.8 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.866 175.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.9 m -61.42 -34.43 75.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.485 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -66.38 -37.81 93.07 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.44 -0.886 . . . . 0.0 110.996 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.65 ' NE ' ' HA ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -69.22 -33.71 73.72 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.314 0.578 . . . . 0.0 110.185 176.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.39 -26.02 67.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.777 177.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.617 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.4 t-20 -70.56 -33.58 71.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.39 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.549 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 1.4 ttt180 -55.27 -28.4 53.13 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.357 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.578 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 91.2 m-85 -99.45 -58.99 1.8 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.219 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 48' ' ' PHE . 32.5 mtmt -178.91 103.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.521 1.128 . . . . 0.0 108.691 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.617 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 55.4 ttp180 -110.77 104.39 13.03 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.791 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.504 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -92.24 126.58 52.32 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.26 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.93 133.13 51.63 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 123.009 2.473 . . . . 0.0 112.462 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.592 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.61 -26.3 66.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.216 -169.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.68 -35.82 77.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.17 0.51 . . . . 0.0 110.5 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.46 63.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.547 HD13 ' HB2' ' A' ' 60' ' ' ARG . 3.6 mm? -75.98 -42.69 47.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.671 0.272 . . . . 0.0 110.965 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.417 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 4.4 ptp180 -66.6 -11.91 55.56 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.952 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -112.94 10.57 18.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.24 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.604 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 23.1 ttmm -150.92 -77.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.121 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 1.045 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 28.5 mmt180 -112.34 84.58 2.0 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -94.91 170.95 9.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.274 -178.345 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.765 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.58 123.28 0.99 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.093 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.622 HG13 HD12 ' A' ' 127' ' ' LEU . 6.9 p -104.76 125.55 59.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.223 0.535 . . . . 0.0 109.866 176.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.67 165.15 28.8 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.883 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 36.2 tt0 -103.98 124.37 48.88 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.528 HG21 HD12 ' A' ' 123' ' ' ILE . 60.5 t -128.63 118.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.73 -170.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -113.14 145.54 40.77 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.405 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -156.86 157.6 35.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.311 0.577 . . . . 0.0 111.788 -175.142 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 1.9 m -107.74 127.56 53.79 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 172.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 36.6 mt -117.56 132.04 56.59 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.253 0.549 . . . . 0.0 111.997 -166.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.451 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 20.6 t70 -68.79 152.22 45.6 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.23 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.469 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 69.6 mtt180 -61.41 -17.27 53.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.449 -1.25 . . . . 0.0 112.414 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -101.03 3.83 41.79 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.321 0.582 . . . . 0.0 110.331 175.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 86.89 41.49 6.71 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.25 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.451 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 79.9 t60 -114.35 125.63 54.08 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 8.6 p -53.3 122.25 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.357 0.598 . . . . 0.0 111.267 175.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.8 mt -104.34 -40.84 5.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.632 0.729 . . . . 0.0 109.552 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.59 151.55 47.37 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.636 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.17 122.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.358 0.599 . . . . 0.0 110.027 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.1 m -129.3 127.63 41.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.343 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.635 HD21 ' HB2' ' A' ' 84' ' ' SER . 25.4 tp -75.54 107.81 7.93 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.64 HG23 HG22 ' A' ' 120' ' ' THR . 0.1 OUTLIER -83.42 -41.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.382 -170.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.6 m -154.44 135.31 13.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.88 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.635 ' HB2' HD21 ' A' ' 81' ' ' LEU . 34.1 t -122.93 135.86 54.65 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.79 -19.36 41.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.657 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.423 ' H ' HD23 ' A' ' 87' ' ' LEU . . . 133.12 63.33 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.973 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.901 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -118.23 87.65 30.27 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.97 -73.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.554 2.169 . . . . 0.0 111.769 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 9.3 m -72.91 -18.92 61.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.34 0.59 . . . . 0.0 110.245 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.901 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 17.0 mt -76.83 -37.25 56.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.719 -175.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.433 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 17.0 t70 -54.6 -48.82 71.7 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.189 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 89' ' ' SER . 16.8 ptp180 -54.34 -42.25 70.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.595 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 1.045 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 4.9 tp10 -77.79 -54.66 6.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.978 0.418 . . . . 0.0 111.949 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.518 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 38.1 pt -72.48 -33.48 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.754 -172.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.615 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 77.1 mm-40 -82.52 -25.95 32.95 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 120.867 0.365 . . . . 0.0 110.737 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.01 -43.44 77.7 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 169.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.499 HD22 HG21 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -66.6 -57.05 8.04 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.14 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.564 HG12 HG22 ' A' ' 123' ' ' ILE . 79.3 t -88.42 -49.49 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 36.3 ttmt -65.54 -24.65 67.17 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.63 0.372 . . . . 0.0 111.329 -174.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 28.3 tpt180 -97.14 -35.78 10.68 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.492 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.529 ' HB1' ' CD2' ' A' ' 48' ' ' PHE . . . -102.78 61.78 0.81 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.834 177.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.495 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 6.3 m -83.11 104.64 3.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.261 0.553 . . . . 0.0 109.995 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.619 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 37.9 Cg_endo -99.81 153.32 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.769 2.979 . . . . 0.0 114.604 -171.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.72 HD23 ' HD2' ' A' ' 108' ' ' PRO . 22.4 tp -125.41 100.48 32.11 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.342 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.65 ' HA ' ' NE ' ' A' ' 44' ' ' ARG . 2.4 Cg_endo -69.0 -81.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.142 1.894 . . . . 0.0 113.278 -174.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 31.5 m -79.91 110.21 15.13 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 27.0 Cg_exo -62.16 108.01 0.63 Allowed 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.898 2.399 . . . . 0.0 112.098 -175.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.72 ' HD2' HD23 ' A' ' 104' ' ' LEU . 97.9 Cg_endo -75.49 62.48 6.26 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.072 2.515 . . . . 0.0 111.569 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.764 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -58.33 -35.47 71.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.383 0.611 . . . . 0.0 110.24 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.33 -7.79 27.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.945 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -113.45 -21.53 10.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -175.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.764 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -131.76 19.56 4.64 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -168.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.547 HG11 ' O ' ' A' ' 109' ' ' ALA . 1.1 m -69.8 89.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 122.412 1.101 . . . . 0.0 109.753 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.631 HD21 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 160.94 -16.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 112.723 -2.035 . . . . 0.0 107.752 -172.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.631 ' N ' HD21 ' A' ' 114' ' ' ASN . . . 172.2 -92.46 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.341 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.504 ' OG1' HG21 ' A' ' 69' ' ' THR . 0.6 OUTLIER -161.44 176.41 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 122.894 0.477 . . . . 0.0 110.245 -173.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 69' ' ' THR . 2.9 m -104.94 119.03 53.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.485 -173.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.582 ' HG3' ' HG1' ' A' ' 69' ' ' THR . 22.0 tt0 -104.14 112.45 25.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.6 HD13 ' HG ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -133.52 154.3 50.95 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.631 -174.311 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.64 HG22 HG23 ' A' ' 82' ' ' VAL . 62.5 m -109.23 123.3 49.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.772 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.6 ' HG ' HD13 ' A' ' 119' ' ' LEU . 65.1 mt -129.91 128.38 22.89 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.366 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.2 Cg_exo -73.45 119.36 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.647 1.565 . . . . 0.0 110.385 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.567 HD11 ' NE2' ' A' ' 95' ' ' GLN . 19.4 pt -95.42 126.04 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -114.94 121.54 43.48 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.26 -176.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.518 ' CE1' ' HB ' ' A' ' 94' ' ' ILE . 75.7 m-85 -113.25 120.03 39.77 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 159.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.9 m -56.43 103.66 0.11 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.118 0.485 . . . . 0.0 111.381 -168.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.765 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.1 mt -70.78 94.87 1.07 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.451 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 . . . . . 0 N--CA 1.442 -0.848 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.645 -179.756 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.588 ' O ' HG13 ' A' ' 41' ' ' ILE . 8.7 p-90 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.572 ' HA ' HD12 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -69.16 -36.05 76.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.374 0.534 . . . . 0.0 111.666 -174.321 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -33.62 74.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.805 0.812 . . . . 0.0 109.795 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.49 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 27.0 mmm180 -73.0 -32.73 65.33 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.507 175.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 37' ' ' TRP . 62.1 mt -61.04 -39.71 83.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.512 173.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -55.14 -39.94 70.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.835 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.16 -36.5 92.98 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.952 173.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.641 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -69.36 -34.9 75.28 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.374 0.607 . . . . 0.0 110.097 178.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -26.76 66.84 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.3 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.607 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 11.6 t30 -70.43 -33.38 71.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.788 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 7.6 ptt180 -60.41 -17.99 47.71 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.018 173.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -109.58 -58.54 2.03 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.495 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -167.88 101.41 0.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.694 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.607 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 17.0 ttp180 -111.55 102.31 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.218 171.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.542 ' HD1' ' HD2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -97.63 117.11 65.7 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.568 -173.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.542 ' HD2' ' HD1' ' A' ' 51' ' ' TYR . 52.8 Cg_exo -53.35 131.06 41.46 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.659 2.239 . . . . 0.0 111.65 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.579 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.67 -25.2 67.24 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.552 -173.067 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -56.61 -43.26 80.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.046 0.45 . . . . 0.0 110.803 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.18 -30.81 69.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 110.554 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.541 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 3.6 mm? -74.55 -32.94 62.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.524 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.846 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 22.2 mtm180 -62.0 -20.32 63.78 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.748 0.308 . . . . 0.0 111.54 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 mp -107.15 14.84 25.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.65 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.803 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 37.5 ttpt -150.79 -84.61 0.09 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.295 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.803 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 32.3 mmt-85 -122.02 86.27 2.55 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.936 -0.478 . . . . 0.0 111.426 -174.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.846 ' HG2' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -111.68 115.23 28.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.151 0.501 . . . . 0.0 110.448 172.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.841 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -146.54 140.05 8.47 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.544 175.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.907 HG12 HD11 ' A' ' 127' ' ' LEU . 7.1 p -103.61 138.14 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.991 0.424 . . . . 0.0 109.915 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.541 ' HA3' ' OG ' ' A' ' 83' ' ' SER . . . -168.02 169.27 41.29 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.684 -176.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 54.0 mt-30 -98.87 141.07 32.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.414 HG11 ' CE2' ' A' ' 68' ' ' PHE . 55.4 t -130.83 114.65 27.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.485 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 21.9 ttm180 -111.71 141.37 45.4 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -174.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CE1' HD13 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -159.22 155.5 27.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.153 0.501 . . . . 0.0 111.605 -176.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.712 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 48.8 m -98.47 123.92 42.88 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 170.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.462 HD13 ' CE1' ' A' ' 68' ' ' PHE . 73.0 mt -113.42 148.45 35.84 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.145 0.498 . . . . 0.0 112.29 -170.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.638 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 33.4 t70 -92.79 166.68 12.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.627 175.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -53.87 -39.81 66.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -90.12 9.1 29.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.042 0.448 . . . . 0.0 111.164 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.434 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . 77.13 47.3 9.34 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.084 -175.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.638 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 78.9 t60 -100.28 100.77 11.63 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.3 p -47.47 115.01 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.763 0.792 . . . . 0.0 111.457 176.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 15.5 mt -98.32 -35.3 10.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.987 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -136.31 143.76 44.33 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.102 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.5 m -119.19 129.46 75.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.035 0.445 . . . . 0.0 110.082 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 69.8 m -130.99 122.23 26.47 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.323 0.582 . . . . 0.0 110.911 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.5 tp -78.96 115.62 18.76 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.783 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -121.64 -25.17 2.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.118 -177.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.541 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 7.5 t -48.96 119.54 3.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.913 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -144.35 43.49 1.41 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.428 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.69 13.88 18.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.089 0.471 . . . . 0.0 110.33 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.596 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 81.18 61.1 2.15 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.768 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.8 OUTLIER -110.84 84.15 4.05 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.495 -179.304 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.596 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 5.7 Cg_exo -78.05 -75.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.677 2.251 . . . . 0.0 112.142 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.3 p -69.29 -18.98 63.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.495 0.664 . . . . 0.0 110.497 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.749 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 28.4 mt -74.62 -39.59 62.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.269 -175.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.52 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 4.8 t70 -53.4 -50.47 65.1 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.585 0.553 . . . . 0.0 111.875 -173.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -54.58 -45.65 73.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.63 -53.51 7.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.792 0.329 . . . . 0.0 111.332 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 90' ' ' LEU . 48.1 pt -70.26 -32.45 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -171.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.578 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 25.7 mm-40 -82.48 -30.04 30.18 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.281 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.54 -44.66 81.1 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 170.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.606 HD22 HG22 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -60.88 -59.42 5.41 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.289 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.632 HG13 HG22 ' A' ' 123' ' ' ILE . 76.2 t -89.94 -49.39 13.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 38.1 ttmt -66.18 -27.23 67.85 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -172.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 29.8 tpt180 -91.2 -30.8 16.46 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.492 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.616 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -108.08 67.69 0.68 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.936 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 5.5 m -96.49 97.96 3.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.226 0.536 . . . . 0.0 110.458 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.641 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 37.5 Cg_endo -104.14 168.56 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.471 3.447 . . . . 0.0 114.599 -173.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.573 HD13 ' HG3' ' A' ' 108' ' ' PRO . 19.9 mt -145.39 122.4 6.15 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.309 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.49 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 7.9 Cg_endo -82.39 -47.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.587 2.191 . . . . 0.0 111.664 175.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.0 m -90.27 113.31 56.93 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.742 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.18 108.3 0.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.601 2.2 . . . . 0.0 111.451 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.646 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 94.3 Cg_endo -82.07 51.1 3.67 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.831 2.354 . . . . 0.0 112.901 -173.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.637 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -60.74 -37.7 82.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.284 0.564 . . . . 0.0 109.625 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -75.06 3.71 8.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.875 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.646 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -113.51 -23.44 9.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.777 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.766 ' HB3' HG11 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -127.5 18.27 6.91 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.289 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.4 m -70.36 88.32 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 122.198 0.999 . . . . 0.0 109.19 175.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.567 HD21 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 158.58 -12.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 113.284 -1.78 . . . . 0.0 108.645 -170.014 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.567 ' N ' HD21 ' A' ' 114' ' ' ASN . . . 163.13 -87.08 0.1 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.449 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.435 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.7 OUTLIER -160.23 175.39 12.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -175.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.766 HG11 ' HB3' ' A' ' 112' ' ' TYR . 5.7 m -103.22 107.94 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -109.82 110.06 20.93 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 170.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.515 HD12 ' HG ' ' A' ' 121' ' ' LEU . 1.4 pp -143.46 146.36 33.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.875 0.369 . . . . 0.0 110.308 -174.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.405 ' CG2' ' HB3' ' A' ' 65' ' ' GLN . 86.2 m -93.98 117.08 29.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.191 -177.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.515 ' HG ' HD12 ' A' ' 119' ' ' LEU . 46.9 mt -111.13 122.87 36.66 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.5 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 4.7 Cg_exo -74.08 119.14 5.69 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.885 1.723 . . . . 0.0 110.617 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.632 HG22 HG13 ' A' ' 98' ' ' VAL . 18.7 pt -98.34 118.26 44.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.501 ' HA ' HG21 ' A' ' 63' ' ' VAL . 12.6 t70 -108.03 122.23 46.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.719 0.771 . . . . 0.0 112.087 -172.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.468 ' CE2' ' HG ' ' A' ' 56' ' ' LEU . 34.3 m-85 -115.9 142.04 47.3 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 162.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m -67.8 103.04 1.33 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.603 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.907 HD11 HG12 ' A' ' 63' ' ' VAL . 2.0 mt -77.97 81.49 4.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.461 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 . . . . . 0 N--CA 1.44 -0.927 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.475 -179.646 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.544 ' CZ2' HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.637 0.256 . . . . 0.0 111.364 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -68.87 -30.6 69.15 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.117 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.6 p -62.41 -40.01 95.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.075 176.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.447 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 16.2 mmm180 -73.64 -39.65 64.34 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.707 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.675 HG21 ' HD2' ' A' ' 103' ' ' PRO . 79.4 mt -60.36 -50.49 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.173 176.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 m -58.51 -43.26 89.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.841 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.14 -36.32 93.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.86 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.607 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 11.4 ttt-85 -69.16 -32.02 71.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 120.851 0.358 . . . . 0.0 110.328 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.81 ' HB3' ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -62.99 -31.46 72.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.207 0.527 . . . . 0.0 109.966 178.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.728 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 26.7 t-20 -71.74 -35.19 70.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.61 174.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 68.3 ttt180 -67.09 -26.65 66.83 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.608 175.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -92.03 7.58 41.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.564 172.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? 67.99 102.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.263 -175.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.81 ' HD2' ' HB3' ' A' ' 45' ' ' LEU . 4.6 ptm180 -118.17 130.31 56.03 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' HB3' HD21 ' A' ' 56' ' ' LEU . 16.9 t80 -60.91 132.3 91.93 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.39 129.86 13.82 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.55 2.833 . . . . 0.0 112.301 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.807 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -64.53 -20.9 66.5 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.795 -172.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -52.6 -41.25 63.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.669 0.271 . . . . 0.0 111.08 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.89 -36.14 59.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.761 0.315 . . . . 0.0 111.338 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.5 mm? -74.23 -43.04 58.64 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.308 -175.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -76.07 -15.42 60.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.973 0.416 . . . . 0.0 111.358 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.9 tp -86.23 -9.73 55.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.674 0.749 . . . . 0.0 109.266 174.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.863 ' HD2' ' HG2' ' A' ' 93' ' ' GLU . 23.2 ttmm -115.03 -57.76 2.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.47 -173.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.751 ' HG3' ' HB2' ' A' ' 93' ' ' GLU . 30.1 mmt180 -127.08 122.45 34.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.784 -175.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -126.41 114.57 18.37 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.993 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -149.7 143.09 10.36 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.961 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.532 ' H ' HD13 ' A' ' 127' ' ' LEU . 5.3 p -104.43 127.64 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.027 0.441 . . . . 0.0 109.947 176.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.39 167.51 32.98 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.465 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 82' ' ' VAL . 14.6 mm100 -101.86 131.54 48.14 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.8 t -126.6 114.18 36.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.204 0.526 . . . . 0.0 110.339 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 27.0 ttm180 -101.32 141.89 33.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.417 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -157.71 152.42 25.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.989 0.423 . . . . 0.0 111.299 -178.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.776 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 9.4 m -101.64 127.31 48.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.641 173.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.692 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 28.2 mt -119.5 135.4 54.79 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.1 -172.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.425 ' HB2' HD22 ' A' ' 77' ' ' LEU . 20.2 t70 -76.07 152.77 36.76 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.896 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -55.06 -26.64 39.03 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 123.4 0.437 . . . . 0.0 111.787 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -84.31 -1.79 55.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 110.687 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.778 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 88.45 23.71 36.0 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.851 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -95.92 117.48 30.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.494 0.188 . . . . 0.0 110.553 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -48.99 120.42 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.374 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 71' ' ' ASP . 55.7 mt -109.77 -51.26 2.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.713 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -132.42 154.78 49.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.392 -177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.932 HG13 ' HG3' ' A' ' 99' ' ' LYS . 57.9 t -139.82 122.99 17.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 44.0 m -119.22 105.94 11.86 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.9 tp -68.24 110.79 4.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.55 0.69 . . . . 0.0 110.664 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.744 HG22 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -99.3 -52.83 8.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.929 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.497 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 23.1 t 65.7 177.91 0.21 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.203 172.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.508 ' OG ' ' HG2' ' A' ' 65' ' ' GLN . 50.3 m -139.17 -69.7 0.42 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.097 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.36 -75.83 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.49 ' C ' ' HD3' ' A' ' 88' ' ' PRO . . . -176.9 97.51 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.329 -175.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.725 ' HA ' HD11 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -120.56 68.55 15.09 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 178.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 3.6 Cg_exo -77.81 -66.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.386 2.057 . . . . 0.0 112.139 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.6 t -73.11 -18.63 61.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.689 0.757 . . . . 0.0 109.78 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.725 HD11 ' HA ' ' A' ' 87' ' ' LEU . 32.8 mt -76.02 -30.74 58.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.576 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.52 -45.88 69.9 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.808 0.693 . . . . 0.0 111.896 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.601 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 8.5 ptp180 -53.01 -51.09 62.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -172.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.863 ' HG2' ' HD2' ' A' ' 59' ' ' LYS . 1.7 mp0 -77.04 -55.39 5.5 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 90' ' ' LEU . 22.2 pt -69.88 -32.82 53.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 111.386 -172.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.775 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 75.1 mm-40 -83.49 -18.32 38.92 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.507 176.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -54.73 -55.23 32.09 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.851 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.608 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -75.75 -52.43 10.48 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.031 177.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 123' ' ' ILE . 91.3 t -65.44 -49.43 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.932 ' HG3' HG13 ' A' ' 79' ' ' VAL . 40.4 ttmt -74.61 -29.24 61.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.556 0.217 . . . . 0.0 110.906 -172.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.571 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -78.11 -42.13 32.92 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.828 176.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.562 ' HB3' HH11 ' A' ' 100' ' ' ARG . . . -117.11 73.98 0.89 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.692 0.282 . . . . 0.0 111.663 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.7 m -82.96 108.71 13.4 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.105 0.479 . . . . 0.0 110.35 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.675 ' HD2' HG21 ' A' ' 41' ' ' ILE . 16.2 Cg_endo -97.12 139.08 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.23 3.287 . . . . 0.0 113.947 -175.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.778 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 40.3 tp -116.31 91.51 33.14 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 174.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.447 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 53.1 Cg_endo -79.45 -39.35 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.293 1.995 . . . . 0.0 113.603 -174.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.431 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.5 m -102.9 110.81 64.24 Favored Pre-proline 0 C--N 1.319 -0.761 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.92 107.77 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.242 2.628 . . . . 0.0 112.954 -175.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.658 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 48.9 Cg_endo -89.8 66.57 2.12 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.299 2.666 . . . . 0.0 111.659 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.807 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.1 -41.29 78.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.416 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -73.46 1.44 9.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.859 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.658 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -110.89 -27.97 8.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.691 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.807 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -105.16 16.31 25.99 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.5 m -72.27 87.89 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER 157.18 -9.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.417 -171.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.68 -80.16 0.2 Allowed Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.063 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.46 ' C ' ' HB3' ' A' ' 112' ' ' TYR . 1.0 OUTLIER -156.42 176.17 13.05 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.776 ' O ' ' HA ' ' A' ' 69' ' ' THR . 6.6 m -99.26 106.22 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 119.676 1.125 . . . . 0.0 110.259 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -105.52 109.22 21.12 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 168.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.683 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -139.73 147.45 40.9 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.493 -172.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.744 HG23 HG22 ' A' ' 82' ' ' VAL . 36.3 m -94.43 113.65 25.54 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.778 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.683 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 35.0 mt -114.73 126.8 27.47 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.992 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 6.2 Cg_exo -75.29 118.78 5.31 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 121.401 1.401 . . . . 0.0 110.636 177.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.634 HG21 HG11 ' A' ' 98' ' ' VAL . 32.5 pt -93.3 97.1 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -99.03 121.88 41.55 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 122.302 1.048 . . . . 0.0 112.041 -171.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -114.74 142.83 45.99 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.754 -1.567 . . . . 0.0 107.057 165.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.1 m -65.56 103.35 0.84 Allowed 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.246 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.993 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -75.42 61.8 1.29 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.791 -176.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 128' ' ' ARG . 48.6 mtm180 . . . . . 0 N--CA 1.447 -0.581 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.454 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.475 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.227 -0.126 0 CA-C-O 120.665 0.269 . . . . 0.0 111.078 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -33.87 75.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.666 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.1 m -67.08 -35.87 80.76 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.428 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 18.2 mmt180 -70.65 -42.01 71.39 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.918 177.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.699 HG23 ' HG2' ' A' ' 103' ' ' PRO . 92.2 mt -59.65 -44.06 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.2 177.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.9 t -55.68 -37.62 68.56 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.801 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -69.46 -37.63 79.07 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.081 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.64 -34.11 73.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.154 0.502 . . . . 0.0 110.634 178.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.604 HD13 HG11 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -68.27 -26.9 65.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.641 0.734 . . . . 0.0 109.526 177.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.666 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 5.9 t30 -70.28 -35.1 73.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.258 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.55 -29.86 59.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.624 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -96.29 -59.33 1.86 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.515 178.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -158.53 119.31 3.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.121 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.666 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -136.07 102.61 5.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.404 0.621 . . . . 0.0 110.275 174.59 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.498 ' HB3' HD23 ' A' ' 56' ' ' LEU . 3.1 t80 -86.53 132.09 43.8 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.848 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.32 130.19 36.48 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 122.741 2.294 . . . . 0.0 112.363 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.53 ' HA ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -60.81 -29.39 69.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.354 -170.521 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.78 -33.82 70.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 0.0 110.316 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.79 -39.14 61.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.293 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 53' ' ' LYS . 3.4 mm? -64.53 -40.97 96.6 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.743 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.458 ' HD3' HH11 ' A' ' 128' ' ' ARG . 60.5 mtt180 -59.07 -22.71 61.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.867 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.7 mt -102.43 -8.67 20.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.793 0.33 . . . . 0.0 110.964 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -112.51 -68.77 0.91 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.827 -176.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.664 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 6.0 ppt_? -155.01 142.9 20.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.062 0.458 . . . . 0.0 110.888 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.422 ' O ' HD21 ' A' ' 90' ' ' LEU . 13.0 mm100 -138.5 177.74 7.66 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 1.042 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.22 146.75 4.42 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.52 -1.324 . . . . 0.0 113.989 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.3 t -106.35 124.16 61.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.28 163.31 26.4 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.699 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.428 ' O ' HG22 ' A' ' 82' ' ' VAL . 85.0 mt-30 -106.45 125.87 51.54 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 121' ' ' LEU . 12.1 p -123.85 125.0 70.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.64 -170.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -113.47 134.96 54.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.838 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.7 OUTLIER -157.11 158.13 35.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.955 0.407 . . . . 0.0 111.694 -175.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 26.6 m -99.37 134.21 42.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.229 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.447 HD21 ' HB3' ' A' ' 102' ' ' SER . 75.7 mt -117.01 142.97 46.28 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.573 0.545 . . . . 0.0 111.255 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -97.43 169.83 9.47 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.874 175.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -50.81 -42.61 58.38 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -94.37 24.3 4.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.728 0.299 . . . . 0.0 111.48 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.653 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 68.11 47.77 57.31 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.185 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.443 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 66.3 t60 -100.51 117.43 34.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 p -48.88 122.9 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 123.816 0.697 . . . . 0.0 110.913 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 88.6 mt -116.71 -44.99 2.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.35 158.13 40.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.472 ' HB ' ' HD3' ' A' ' 99' ' ' LYS . 13.4 m -145.32 117.28 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.533 0.521 . . . . 0.0 110.178 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.2 m -141.7 131.93 24.92 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.864 0.364 . . . . 0.0 111.249 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.7 tp -83.63 120.0 25.44 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.633 HG21 HG22 ' A' ' 120' ' ' THR . 0.1 OUTLIER -95.9 -58.74 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.345 -175.282 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.9 m -141.84 113.36 7.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.921 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.5 t -107.08 117.14 33.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.21 -46.82 66.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.496 -175.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.627 ' H ' HD21 ' A' ' 87' ' ' LEU . . . -176.35 58.91 0.1 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.913 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.93 ' HA ' HD12 ' A' ' 90' ' ' LEU . 1.6 mm? -118.05 89.61 35.07 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HB2' ' H ' ' A' ' 89' ' ' SER . 4.3 Cg_exo -77.33 -83.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.23 1.953 . . . . 0.0 111.338 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 3.5 m -67.41 -17.92 64.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.674 0.75 . . . . 0.0 110.104 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 87' ' ' LEU . 8.0 mt -75.5 -33.49 60.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.215 -175.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 13.6 t70 -54.87 -49.69 70.53 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.76 0.662 . . . . 0.0 111.371 -173.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 89' ' ' SER . 5.0 ptp180 -53.86 -50.53 66.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.094 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 20.7 tt0 -77.99 -42.06 33.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -173.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.575 HG22 ' NH1' ' A' ' 60' ' ' ARG . 30.3 pt -60.63 -40.68 85.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.885 -177.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.662 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 50.1 mm-40 -82.39 -30.52 30.18 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.957 0.408 . . . . 0.0 110.94 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.92 -52.31 64.57 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.923 173.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.689 HD22 HG22 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -62.2 -56.58 17.21 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.949 -178.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.922 HG13 HG21 ' A' ' 123' ' ' ILE . 58.5 t -88.14 -50.54 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -176.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.662 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 35.6 ttmt -63.7 -38.8 92.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.409 0.151 . . . . 0.0 111.409 -172.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -79.23 -16.85 55.88 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.662 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.37 53.09 0.77 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 51.0 m -65.45 107.4 1.45 Allowed Pre-proline 0 C--O 1.234 0.279 0 O-C-N 123.514 0.509 . . . . 0.0 110.79 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.699 ' HG2' HG23 ' A' ' 41' ' ' ILE . 50.2 Cg_endo -101.79 154.87 0.35 Allowed 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 123.847 3.032 . . . . 0.0 114.002 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.653 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 2.1 tp -142.57 107.63 5.55 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.141 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.428 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 4.0 Cg_exo -75.0 -56.94 0.06 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.22 1.947 . . . . 0.0 112.435 178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.501 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 10.6 m -90.2 110.36 39.94 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.684 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.507 ' HA ' HD22 ' A' ' 104' ' ' LEU . 42.2 Cg_endo -68.64 107.13 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.942 2.428 . . . . 0.0 112.16 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.85 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 51.1 Cg_endo -87.88 71.3 2.93 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.018 2.478 . . . . 0.0 111.754 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.643 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -56.29 -46.56 79.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.93 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -76.09 7.82 3.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.796 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.85 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.17 -23.26 10.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.485 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.752 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -122.01 16.68 10.85 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -177.738 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 109' ' ' ALA . 2.7 m -71.65 89.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.971 0.891 . . . . 0.0 108.954 172.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 3.5 p30 161.61 -28.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.082 -169.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 175.7 -89.4 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.111 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.665 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -161.6 175.56 11.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.752 HG13 ' HB3' ' A' ' 112' ' ' TYR . 11.5 m -102.85 109.31 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.313 0.578 . . . . 0.0 110.98 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 43.2 tt0 -111.93 111.62 22.68 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 170.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.574 HD11 ' HG ' ' A' ' 121' ' ' LEU . 3.8 pp -137.01 155.11 50.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.162 -175.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.633 HG22 HG21 ' A' ' 82' ' ' VAL . 86.4 m -95.11 125.45 39.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.374 -176.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.574 ' HG ' HD11 ' A' ' 119' ' ' LEU . 77.9 mt -125.74 131.4 24.0 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.093 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 6.4 Cg_exo -74.47 121.43 6.77 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.071 1.847 . . . . 0.0 111.369 175.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.922 HG21 HG13 ' A' ' 98' ' ' VAL . 3.1 pt -96.25 98.31 7.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -94.04 121.11 35.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.892 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 80.4 m-85 -116.93 128.89 55.66 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 163.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 m -63.59 102.92 0.48 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.719 0.295 . . . . 0.0 111.022 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 1.042 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 5.0 mt -64.12 103.84 0.66 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.259 0.552 . . . . 0.0 111.551 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.458 HH11 ' HD3' ' A' ' 57' ' ' ARG . 64.5 mtp180 . . . . . 0 N--CA 1.448 -0.53 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.071 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.458 ' O ' HG13 ' A' ' 41' ' ' ILE . 12.0 p-90 . . . . . 0 N--CA 1.455 -0.175 0 N-CA-C 111.329 0.122 . . . . 0.0 111.329 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.547 ' HD3' ' N ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -69.2 -25.4 64.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.243 0.544 . . . . 0.0 110.125 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.547 ' N ' ' HD3' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -71.95 -34.58 69.12 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.499 ' CB ' ' HG2' ' A' ' 105' ' ' PRO . 34.1 mmt180 -74.24 -36.12 63.87 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.377 175.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.617 HG23 ' HD2' ' A' ' 103' ' ' PRO . 61.8 mt -57.32 -47.22 84.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.713 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.1 m -56.23 -35.13 67.0 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.011 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.23 -52.35 47.93 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.386 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.759 ' HD3' ' HB2' ' A' ' 103' ' ' PRO . 9.4 ptp180 -70.08 -27.46 64.63 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.538 -0.39 . . . . 0.0 111.731 175.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tt -54.25 -38.1 65.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -71.08 -31.67 68.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.297 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HB3' ' HA ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -53.16 -26.64 17.78 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.382 173.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -101.75 -57.16 2.13 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.479 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.506 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 4.2 mtpp -172.76 102.8 0.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.097 -177.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -144.69 104.56 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.203 0.525 . . . . 0.0 110.26 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.473 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.5 t80 -96.47 144.5 27.95 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.299 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -53.05 133.59 52.62 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.101 2.534 . . . . 0.0 112.397 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.535 ' HE2' ' HE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -62.02 -21.13 64.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.633 -171.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -53.07 -37.57 61.74 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.452 0.47 . . . . 0.0 110.827 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.71 -38.97 53.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.637 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 60' ' ' ARG . 3.6 mm? -69.41 -41.54 76.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.068 -173.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.575 ' HA ' ' HG3' ' A' ' 61' ' ' GLN . 7.8 ptp85 -67.16 -8.88 34.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.14 0.495 . . . . 0.0 110.851 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.0 tp -118.93 12.81 12.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.262 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.693 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 25.3 ttmm -154.47 -67.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.693 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.799 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 36.6 mmt180 -119.98 84.53 2.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.675 0.274 . . . . 0.0 110.308 -177.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.575 ' HG3' ' HA ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -86.15 177.65 7.46 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.6 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.52 122.42 0.94 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.244 -1.455 . . . . 0.0 113.787 176.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -110.82 124.48 67.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.34 166.6 33.23 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.825 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.471 ' O ' HG21 ' A' ' 82' ' ' VAL . 2.7 mp0 -102.12 124.38 47.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 178.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.2 t -119.73 114.23 43.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.293 -173.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -115.03 124.71 52.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.748 -174.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -148.13 163.85 35.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.306 0.574 . . . . 0.0 112.136 -174.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 40.9 m -105.2 131.99 51.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.014 174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 104' ' ' LEU . 86.8 mt -118.76 142.0 48.1 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -172.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.572 ' OD1' ' HG2' ' A' ' 73' ' ' GLN . 13.8 t70 -89.58 160.18 16.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.244 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.591 ' HB3' ' HH ' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -58.47 -32.09 68.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.687 0.279 . . . . 0.0 111.322 -177.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.573 ' N ' ' HG2' ' A' ' 72' ' ' ARG . 25.4 pt20 -94.04 14.51 19.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.204 0.526 . . . . 0.0 111.246 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.41 ' HA2' ' H ' ' A' ' 104' ' ' LEU . . . 78.01 33.8 39.94 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.248 177.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.476 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 67.6 t60 -97.1 101.88 13.54 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.44 122.26 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 121.388 0.614 . . . . 0.0 110.92 173.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 15.2 mt -108.21 -40.79 5.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.437 -175.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.5 158.43 39.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.27 117.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.167 0.508 . . . . 0.0 109.997 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.7 m -140.58 120.93 14.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.917 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 29.3 tp -81.41 106.37 13.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -82.22 -44.64 19.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.894 -170.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.1 m -155.41 155.14 33.05 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.372 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.476 ' HB2' ' CD2' ' A' ' 87' ' ' LEU . 53.4 p -163.34 147.44 10.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.85 0.357 . . . . 0.0 110.944 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.5 -9.38 58.87 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -173.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.407 ' C ' HD11 ' A' ' 87' ' ' LEU . . . 120.67 73.13 0.34 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.176 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.904 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -114.4 96.62 43.65 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -177.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.67 -83.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.75 2.3 . . . . 0.0 111.888 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 m -66.15 -18.29 65.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.63 0.728 . . . . 0.0 110.107 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.904 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 20.4 mt -75.78 -39.28 57.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.056 -176.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.42 -50.93 68.51 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -169.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.515 ' HD2' ' H ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -61.63 -36.13 79.88 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.005 -171.43 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.799 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 8.8 tp10 -76.59 -52.64 9.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 90' ' ' LEU . 39.9 pt -65.11 -35.02 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 69.9 mm-40 -81.81 -28.68 33.0 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.678 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.582 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -57.45 -48.22 79.75 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -61.81 -58.16 9.04 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.216 -178.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.695 HG12 HG21 ' A' ' 123' ' ' ILE . 91.6 t -89.22 -50.05 13.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 8.9 ttpp -70.7 -24.99 62.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -170.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.582 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 9.6 tpp180 -90.99 -24.98 19.93 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.061 174.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.607 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -114.04 73.41 0.82 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.312 -178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.8 m -108.43 95.02 14.82 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.392 0.615 . . . . 0.0 110.59 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.759 ' HB2' ' HD3' ' A' ' 44' ' ' ARG . 61.1 Cg_endo -112.51 110.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 124.723 3.615 . . . . 0.0 114.04 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.645 HD22 ' HD2' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -86.32 123.42 71.44 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 171.055 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.645 ' HD2' HD22 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -80.6 -57.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.73 2.287 . . . . 0.0 112.751 -177.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -63.43 116.24 24.19 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.37 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.52 106.02 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.106 2.537 . . . . 0.0 112.171 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.633 ' HG3' HD11 ' A' ' 104' ' ' LEU . 63.7 Cg_endo -94.64 45.77 0.21 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.995 2.463 . . . . 0.0 112.82 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.6 ' O ' HG13 ' A' ' 113' ' ' VAL . . . -57.17 -41.51 79.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 109.91 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.03 -18.27 63.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.355 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.84 -29.45 22.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.779 -177.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.892 ' HB3' HG12 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -121.43 19.15 11.34 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -171.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.5 m -69.15 89.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 122.092 0.949 . . . . 0.0 108.947 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 7.0 p30 161.67 -18.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.943 -169.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.7 -87.82 0.1 Allowed Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.113 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.615 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -162.36 176.09 10.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.892 HG12 ' HB3' ' A' ' 112' ' ' TYR . 12.6 m -102.21 109.49 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 121.541 0.686 . . . . 0.0 110.719 -175.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 25.8 tt0 -107.96 110.94 22.8 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 173.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.593 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -141.04 155.26 46.2 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -174.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 50.6 m -98.74 122.75 42.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.147 0.499 . . . . 0.0 111.264 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.593 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 47.8 mt -118.22 123.88 29.07 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.993 174.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 5.2 Cg_exo -73.3 119.72 6.15 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.311 2.007 . . . . 0.0 111.241 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.695 HG21 HG12 ' A' ' 98' ' ' VAL . 32.0 pt -99.17 101.9 12.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -104.3 122.44 45.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.224 1.011 . . . . 0.0 111.722 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.6 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 85.4 m-85 -114.13 129.74 56.61 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.865 -1.516 . . . . 0.0 106.94 165.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.3 m -57.63 103.2 0.12 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.153 0.502 . . . . 0.0 111.979 -169.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.816 HD13 HD13 ' A' ' 87' ' ' LEU . 13.3 mt -80.46 82.15 6.55 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.771 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.803 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.521 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.579 ' HA ' ' HG2' ' A' ' 40' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -67.84 -32.68 73.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.202 0.91 . . . . 0.0 109.872 -176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.3 p -66.53 -36.44 82.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.938 176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.579 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 10.2 mmt180 -69.52 -44.62 70.66 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.575 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.683 HG22 ' HG2' ' A' ' 103' ' ' PRO . 83.8 mt -63.68 -43.86 98.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.585 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.8 m -57.25 -33.58 67.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.946 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.63 -34.67 73.21 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.682 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.791 ' HD3' ' HB3' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -70.75 -40.31 72.77 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 121.279 0.561 . . . . 0.0 110.151 178.1 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.05 -25.77 64.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.75 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.941 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 24.4 t-20 -69.3 -33.99 74.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.986 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 0.4 OUTLIER -61.44 -20.45 63.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.949 174.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.5 ' CG ' ' HB1' ' A' ' 101' ' ' ALA . 97.3 m-85 -106.71 -60.28 1.69 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.615 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -164.99 102.93 0.77 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.548 0.739 . . . . 0.0 109.037 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.941 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 24.6 tpt180 -113.54 103.15 10.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.527 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 0.9 OUTLIER -105.45 132.31 20.99 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 32.4 Cg_exo -58.97 132.1 45.55 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.824 2.349 . . . . 0.0 111.721 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.19 -23.14 65.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.958 -173.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.72 -40.21 83.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.565 0.222 . . . . 0.0 110.853 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.0 -33.65 75.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.113 0.483 . . . . 0.0 110.475 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -72.65 -41.56 65.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 57' ' ' ARG . 49.5 mtm180 -58.07 -31.07 66.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.012 0.434 . . . . 0.0 110.422 176.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.9 tp -93.85 -0.49 55.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.951 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.754 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 24.5 ttmm -142.04 -75.42 0.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -175.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.754 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 26.3 mmt180 -119.79 89.78 3.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.901 0.381 . . . . 0.0 110.427 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -92.14 179.17 5.65 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.521 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.604 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.26 124.05 1.05 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.169 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.705 ' H ' HD12 ' A' ' 127' ' ' LEU . 7.3 p -110.36 127.05 67.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.44 167.07 36.16 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.727 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.658 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 50.3 mt-30 -102.3 125.11 48.91 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.483 HG22 HD12 ' A' ' 123' ' ' ILE . 24.3 t -121.47 114.42 43.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.712 -176.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.709 ' HG2' HG22 ' A' ' 82' ' ' VAL . 5.9 ptp180 -106.19 144.17 33.28 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -152.91 152.0 30.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.094 0.473 . . . . 0.0 111.853 -174.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 22.5 m -96.41 126.94 41.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.371 171.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 58.7 mt -117.8 135.76 53.85 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.203 0.525 . . . . 0.0 112.069 -169.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.522 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 15.4 t70 -77.27 152.51 34.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.476 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.3 ttp-105 -60.98 -25.28 66.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.119 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -89.61 -1.43 58.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.968 0.413 . . . . 0.0 111.012 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.96 36.88 6.53 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.04 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.522 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 55.6 t60 -104.3 120.96 42.34 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 p -53.81 117.27 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.313 0.578 . . . . 0.0 111.07 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.447 HD21 ' HD2' ' A' ' 75' ' ' HIS . 42.2 mt -101.86 -37.46 8.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.477 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -146.89 152.97 39.56 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.66 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.0 m -147.24 132.37 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 123.45 0.469 . . . . 0.0 109.836 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -144.28 132.67 22.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.37 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.698 HD22 ' HB2' ' A' ' 84' ' ' SER . 37.3 tp -75.5 120.88 21.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.738 HG23 HG23 ' A' ' 120' ' ' THR . 0.2 OUTLIER -96.67 -47.63 12.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.899 -173.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -142.26 145.46 34.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.346 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.698 ' HB2' HD22 ' A' ' 81' ' ' LEU . 40.7 t -137.8 148.61 45.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.023 0.44 . . . . 0.0 111.212 -176.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.58 15.32 25.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.219 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.81 76.02 1.31 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.173 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.716 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -116.51 71.11 4.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.803 0.302 . . . . 0.0 110.295 178.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.85 -68.36 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 121.804 1.669 . . . . 0.0 112.482 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.491 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 7.9 m -72.08 -18.69 61.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.233 0.54 . . . . 0.0 110.035 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.716 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 26.2 mt -77.32 -32.35 55.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.145 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.538 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 7.3 t70 -53.39 -37.95 62.94 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.4 0.438 . . . . 0.0 111.88 -173.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.541 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 13.6 ptm180 -53.57 -54.79 32.45 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.47 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -78.53 -55.12 5.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.522 HG13 ' HG2' ' A' ' 95' ' ' GLN . 40.0 pt -60.21 -38.88 78.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.646 -172.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.715 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 76.0 mm-40 -84.58 -20.86 30.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.603 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -55.1 -54.1 47.45 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.163 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.599 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.77 -48.72 17.82 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.06 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.692 HG13 HG22 ' A' ' 123' ' ' ILE . 55.8 t -70.26 -50.18 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.715 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.3 ttmt -75.88 -32.1 59.53 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.318 -0.239 . . . . 0.0 111.361 -171.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -89.16 -18.8 26.42 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.052 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB1' ' CG ' ' A' ' 48' ' ' PHE . . . -120.24 56.4 0.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.603 0.24 . . . . 0.0 111.098 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 19.4 m -80.52 106.75 5.73 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.114 0.483 . . . . 0.0 110.112 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.683 ' HG2' HG22 ' A' ' 41' ' ' ILE . 62.9 Cg_endo -101.78 165.1 0.33 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 124.038 3.159 . . . . 0.0 114.486 -171.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 33.2 tp -142.08 94.25 7.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.159 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.791 ' HB3' ' HD3' ' A' ' 44' ' ' ARG . 50.5 Cg_endo -77.25 -49.7 0.1 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.442 2.095 . . . . 0.0 113.665 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.446 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 22.3 m -88.58 110.45 37.03 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.01 107.68 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.112 2.542 . . . . 0.0 112.451 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.707 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 52.1 Cg_endo -89.15 59.99 2.31 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.135 2.557 . . . . 0.0 111.853 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.653 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.05 -47.05 75.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.165 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.2 10.0 2.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.433 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -112.12 -30.39 7.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.932 0.396 . . . . 0.0 111.616 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.653 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -121.16 18.41 11.58 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.402 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -70.59 88.3 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.212 1.006 . . . . 0.0 108.446 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.615 HD21 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 158.92 -15.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 113.116 -1.856 . . . . 0.0 108.383 -168.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.615 ' N ' HD21 ' A' ' 114' ' ' ASN . . . 163.91 -90.84 0.1 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.175 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.428 ' CA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -161.06 177.03 10.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -175.151 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 69' ' ' THR . 12.9 m -102.75 109.88 27.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.467 0.651 . . . . 0.0 110.861 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 24.7 tt0 -109.35 109.99 21.02 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.73 HD11 ' HG ' ' A' ' 121' ' ' LEU . 1.5 pp -135.12 152.37 51.58 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.656 -173.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.738 HG23 HG23 ' A' ' 82' ' ' VAL . 87.9 m -96.72 113.44 25.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.212 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.73 ' HG ' HD11 ' A' ' 119' ' ' LEU . 62.5 mt -119.48 122.94 28.97 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.965 0.412 . . . . 0.0 110.711 177.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.658 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 12.0 Cg_exo -70.65 119.19 6.14 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.709 1.606 . . . . 0.0 110.554 174.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.692 HG22 HG13 ' A' ' 98' ' ' VAL . 35.1 pt -93.98 118.77 40.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -107.47 120.31 41.83 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 118.821 -1.151 . . . . 0.0 112.35 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.508 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 37.9 m-85 -115.65 126.69 54.46 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 160.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.0 m -56.54 104.01 0.13 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.242 0.544 . . . . 0.0 111.052 -172.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.705 HD12 ' H ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -100.6 105.46 16.86 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.854 -171.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.6 mtp-105 . . . . . 0 N--CA 1.441 -0.878 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 173.705 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HD2' ' N ' ' A' ' 39' ' ' SER . 7.5 ppt_? -68.12 -31.02 70.32 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -168.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.443 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 32.2 m -69.16 -32.52 71.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 0.0 109.823 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -75.86 -44.49 40.48 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.75 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.412 HG23 ' HD2' ' A' ' 103' ' ' PRO . 86.5 mt -58.77 -43.45 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.937 177.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 t -57.43 -38.8 74.98 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.882 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.13 -42.25 96.6 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.843 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.494 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.38 -33.77 73.54 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.803 0.335 . . . . 0.0 110.72 178.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.452 HD11 HG23 ' A' ' 98' ' ' VAL . 2.1 tt -62.15 -31.93 72.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.398 0.618 . . . . 0.0 109.832 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.699 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 8.7 t30 -71.69 -34.26 69.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.797 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -29.64 58.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.682 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.522 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 98.8 m-85 -94.73 -59.22 1.97 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.78 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 34.1 mmtt -174.82 104.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.622 0.769 . . . . 0.0 109.488 -177.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.699 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 29.1 ttp180 -128.28 103.91 7.43 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.485 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -81.41 138.17 48.29 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.382 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -49.87 131.53 29.83 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.132 2.555 . . . . 0.0 111.961 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.754 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -63.96 -23.68 67.43 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -170.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -58.76 -38.58 78.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.652 0.263 . . . . 0.0 111.069 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.03 -30.74 70.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.787 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 53' ' ' LYS . 3.1 mm? -77.25 -41.47 40.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.918 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 41.0 mtm180 -62.85 -23.04 67.11 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.381 0.61 . . . . 0.0 110.5 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 tp -102.09 4.04 39.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.753 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.562 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 40.3 ttpt -149.71 -75.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.562 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 26.2 mmt180 -99.03 84.27 3.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.453 0.644 . . . . 0.0 110.742 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 126' ' ' SER . 10.7 pt20 -104.95 127.78 52.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.948 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 1.016 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -179.55 129.77 1.41 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.268 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.805 ' H ' HD13 ' A' ' 127' ' ' LEU . 96.2 t -104.96 127.17 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.119 0.485 . . . . 0.0 110.238 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.85 166.61 30.92 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.664 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 56.0 mt-30 -101.02 136.82 40.25 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.464 HG22 HD12 ' A' ' 123' ' ' ILE . 39.0 t -129.5 114.21 30.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.562 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.518 ' HG2' HG23 ' A' ' 82' ' ' VAL . 13.3 ptt180 -115.35 139.38 50.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -154.3 163.37 40.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.655 -171.401 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 2.7 m -106.62 120.74 42.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.887 172.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.493 HD11 ' CE1' ' A' ' 68' ' ' PHE . 73.1 mt -106.48 138.52 42.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.75 -173.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -74.71 153.89 38.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.25 175.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 72' ' ' ARG . 4.2 ttp180 -61.05 -24.76 66.45 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.281 0.363 . . . . 0.0 111.333 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -80.6 -8.58 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.114 0.483 . . . . 0.0 110.421 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.732 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 89.04 35.42 8.19 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.268 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -109.2 124.61 51.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.665 0.269 . . . . 0.0 110.557 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -51.86 125.31 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.558 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.502 ' CD1' HG21 ' A' ' 116' ' ' THR . 35.3 mt -115.18 -51.29 2.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.235 0.54 . . . . 0.0 110.558 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.37 152.42 49.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.379 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.4 m -146.37 128.94 8.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.137 0.494 . . . . 0.0 110.208 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.1 m -134.68 123.95 24.52 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.585 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.9 tp -76.72 108.43 9.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.294 0.569 . . . . 0.0 110.299 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.655 HG21 HG22 ' A' ' 120' ' ' THR . 0.0 OUTLIER -83.35 -42.26 17.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.982 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t 66.93 176.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.904 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.426 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 68.7 m -158.63 -67.74 0.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.979 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.23 -76.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.41 98.83 0.13 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.343 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.785 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -119.67 82.47 26.53 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -177.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.9 -75.28 0.01 OUTLIER 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.442 2.095 . . . . 0.0 111.866 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 8.4 m -70.69 -19.08 62.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.373 0.606 . . . . 0.0 110.197 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.785 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 14.6 mt -75.75 -34.08 60.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.715 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.449 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 1.8 t70 -54.33 -44.01 71.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.299 -175.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 89' ' ' SER . 11.6 ptp180 -53.58 -52.63 59.16 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -172.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.483 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 19.3 mt-10 -78.83 -54.21 6.31 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.607 HG12 ' O ' ' A' ' 90' ' ' LEU . 40.7 pt -63.32 -36.96 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.64 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.8 mm-40 -82.21 -26.83 32.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 122.055 -0.403 . . . . 0.0 110.825 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.621 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.85 -44.72 82.43 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.58 HD23 HG22 ' A' ' 98' ' ' VAL . 1.4 tp -68.24 -55.29 12.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.636 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.635 HG13 HG21 ' A' ' 123' ' ' ILE . 81.3 t -88.75 -48.27 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.64 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 16.4 ttpp -70.33 -15.13 62.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.391 -175.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.621 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 20.3 tpp180 -98.59 -35.14 10.31 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.797 170.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.616 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -101.13 64.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 110.969 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.6 m -93.79 100.82 5.09 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.28 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 72.3 Cg_endo -101.73 173.78 0.26 Allowed 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.919 3.079 . . . . 0.0 113.689 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.732 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 17.0 tp -143.22 97.33 5.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.326 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -72.42 -62.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.652 1.568 . . . . 0.0 111.933 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.655 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -76.62 111.57 16.66 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.828 177.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.15 103.58 1.77 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.421 2.748 . . . . 0.0 112.406 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.695 ' HD2' HD23 ' A' ' 104' ' ' LEU . 41.3 Cg_endo -83.07 68.94 7.3 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.075 2.516 . . . . 0.0 110.913 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.782 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.27 -42.29 73.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.189 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.42 8.84 3.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.02 0.438 . . . . 0.0 111.46 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.42 -16.84 12.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.938 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.782 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -133.02 17.01 4.16 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.0 m -72.0 87.57 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 7.7 p30 157.79 -25.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.078 -167.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 172.64 -92.68 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.896 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.618 ' HB ' HG21 ' A' ' 69' ' ' THR . 0.6 OUTLIER -158.89 174.75 14.51 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.784 0.434 . . . . 0.0 109.913 -175.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.678 HG11 ' CD2' ' A' ' 112' ' ' TYR . 2.9 m -103.72 109.74 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 CA-C-O 121.114 0.483 . . . . 0.0 111.607 -171.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 24.9 tt0 -97.51 112.02 24.05 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.515 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.3 pp -142.26 155.14 45.21 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.655 HG22 HG21 ' A' ' 82' ' ' VAL . 87.1 m -101.07 126.49 47.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.614 -175.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.515 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 69.9 mt -129.41 123.49 21.48 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.36 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.9 Cg_exo -76.22 121.21 6.0 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.006 1.804 . . . . 0.0 110.886 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.635 HG21 HG13 ' A' ' 98' ' ' VAL . 24.1 pt -96.59 112.57 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.52 120.98 36.71 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.84 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.436 ' HE2' ' HE2' ' A' ' 53' ' ' LYS . 95.9 m-85 -114.94 129.56 56.73 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 159.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 31.8 m -57.23 103.11 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -169.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 1.016 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -87.5 98.07 11.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.258 -177.511 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.425 ' HD2' ' C ' ' A' ' 128' ' ' ARG . 6.2 ppt_? . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.311 . . . . 0.0 111.704 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.526 ' CZ2' HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -68.21 -37.88 81.34 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.19 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 p -68.95 -31.29 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.326 0.584 . . . . 0.0 109.804 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.452 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 5.4 mmm-85 -68.84 -39.56 79.9 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.414 176.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.557 HG23 ' HD2' ' A' ' 103' ' ' PRO . 83.4 mt -63.91 -51.2 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.124 176.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.2 m -56.42 -32.74 65.16 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.784 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.81 -47.03 92.25 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.962 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 47' ' ' ARG . 20.9 mtp180 -69.19 -34.77 75.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.854 0.359 . . . . 0.0 111.017 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.671 HD11 HG22 ' A' ' 98' ' ' VAL . 1.4 tt -62.44 -30.67 71.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.664 0.745 . . . . 0.0 109.652 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 1.099 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 8.4 t30 -70.89 -34.83 71.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.542 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -58.0 -34.9 70.5 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.702 172.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.424 ' HB2' ' HB1' ' A' ' 101' ' ' ALA . 76.3 m-85 -91.91 -59.53 2.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.515 -175.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -162.14 102.09 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.503 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 1.099 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 12.7 tpt180 -130.88 103.34 6.51 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.491 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.433 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.1 t80 -87.32 131.88 42.9 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.823 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.8 131.71 45.65 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.732 2.288 . . . . 0.0 112.001 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.85 -23.68 65.32 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.27 -173.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -55.59 -42.9 75.47 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.577 0.548 . . . . 0.0 110.231 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.64 -41.03 79.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.632 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.478 HD22 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -62.44 -41.12 98.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.845 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.571 ' HG2' ' HB2' ' A' ' 126' ' ' SER . 98.5 mtt180 -59.51 -15.52 18.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.3 -24.02 9.12 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.04 0.448 . . . . 0.0 111.114 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.943 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 18.0 ttmm -102.45 -72.63 0.68 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.943 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 30.5 mmt180 -124.22 84.33 2.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.377 0.608 . . . . 0.0 110.14 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 126' ' ' SER . 14.1 pt20 -98.92 115.96 30.07 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.041 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.982 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -165.72 143.23 8.25 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.489 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.776 ' H ' HD11 ' A' ' 127' ' ' LEU . 46.7 t -103.58 123.42 57.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.0 165.24 26.29 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.36 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.703 ' H ' ' HA ' ' A' ' 83' ' ' SER . 56.2 mt-30 -105.15 143.42 33.36 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.4 114.62 21.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.637 0.732 . . . . 0.0 109.576 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.428 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 27.1 ttt180 -106.51 138.42 42.73 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -159.95 171.58 19.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.318 0.58 . . . . 0.0 111.956 -173.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.651 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 7.8 m -118.82 130.03 55.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.946 173.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.2 mt -111.14 140.46 45.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.762 -172.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.1 160.35 23.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.73 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.431 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 42.1 mtm180 -54.07 -36.86 63.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.298 0.57 . . . . 0.0 110.878 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -81.1 0.07 37.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.229 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 80.71 45.32 7.88 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.109 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -110.93 124.53 52.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.7 p -57.24 111.09 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.497 0.665 . . . . 0.0 110.703 174.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.5 mt -100.99 -41.04 6.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.931 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.28 158.27 40.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.222 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 m -144.89 121.65 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 123.613 0.57 . . . . 0.0 109.915 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 35.7 m -126.29 114.89 18.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.057 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.8 tp -78.29 118.74 20.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.427 0.632 . . . . 0.0 110.662 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -108.1 -58.42 3.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.26 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.703 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 19.1 t 62.05 179.64 0.13 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.979 0.419 . . . . 0.0 111.32 176.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.9 m -154.58 -74.36 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.87 -68.68 0.32 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -169.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.95 84.25 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.825 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.915 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -120.68 93.44 48.54 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -176.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.15 -79.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.578 2.185 . . . . 0.0 111.347 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -75.92 -17.2 59.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.543 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.915 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.7 mt -72.1 -38.3 69.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.728 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 14.0 t70 -54.58 -51.14 66.21 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.607 0.567 . . . . 0.0 111.61 -172.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.402 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 9.4 ptp180 -53.73 -40.54 66.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.128 -177.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.409 ' CB ' ' HG3' ' A' ' 60' ' ' ARG . 5.7 mm-40 -78.07 -58.11 3.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.559 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 32.5 pt -66.75 -43.74 89.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.723 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.798 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 48.4 mm-40 -67.98 -51.16 50.58 Favored 'General case' 0 C--O 1.193 -1.893 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.643 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.46 -31.28 61.82 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.097 0.862 . . . . 0.0 111.434 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.82 -54.47 38.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.838 173.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.713 HG12 HG21 ' A' ' 123' ' ' ILE . 79.9 t -86.48 -33.55 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.306 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.798 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.5 ttmt -66.72 -25.15 66.38 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.4 1.08 . . . . 0.0 110.951 -169.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -104.23 -19.4 14.13 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.967 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.522 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -112.44 45.52 1.29 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.797 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.7 m -81.75 107.54 8.59 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.116 0.484 . . . . 0.0 110.255 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 41' ' ' ILE . 73.0 Cg_endo -99.79 175.07 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.539 2.826 . . . . 0.0 113.259 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.778 HD22 ' HD2' ' A' ' 108' ' ' PRO . 16.1 tp -143.46 90.52 7.16 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.921 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.452 ' CG ' ' HB2' ' A' ' 40' ' ' ARG . 10.1 Cg_endo -67.36 -62.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.984 1.79 . . . . 0.0 112.078 -177.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.595 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 t -79.1 116.97 64.18 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.06 103.04 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.068 2.512 . . . . 0.0 111.626 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.778 ' HD2' HD22 ' A' ' 104' ' ' LEU . 45.2 Cg_endo -81.66 68.92 7.9 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.904 2.403 . . . . 0.0 111.764 -177.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.604 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -58.91 -42.85 90.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.646 178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -67.72 1.9 2.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.832 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -112.53 -35.85 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.676 0.274 . . . . 0.0 111.575 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.606 ' CD2' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -118.79 17.51 13.47 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -171.169 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.469 HG11 ' O ' ' A' ' 109' ' ' ALA . 2.5 m -70.98 89.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 8.2 p30 160.87 -26.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.744 -1.571 . . . . 0.0 107.588 -170.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 175.21 -88.25 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.936 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.495 ' HB ' HG23 ' A' ' 69' ' ' THR . 0.8 OUTLIER -160.0 175.7 12.7 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 122.933 0.493 . . . . 0.0 110.01 -174.283 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 69' ' ' THR . 2.6 m -103.2 108.98 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.301 0.572 . . . . 0.0 110.778 -175.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.543 ' HG2' ' HG1' ' A' ' 69' ' ' THR . 8.5 tm-20 -103.27 111.65 24.14 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.676 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -151.72 156.44 40.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.155 0.502 . . . . 0.0 111.943 -171.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 61.4 m -96.13 126.39 41.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.189 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.676 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 33.0 mt -128.54 137.9 31.92 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.092 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 3.4 Cg_endo -87.57 119.8 1.41 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.329 2.019 . . . . 0.0 112.066 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.713 HG21 HG12 ' A' ' 98' ' ' VAL . 9.8 pt -97.07 97.87 6.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.745 0.784 . . . . 0.0 109.198 172.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -97.16 125.72 41.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.043 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.559 ' CE1' ' HB ' ' A' ' 94' ' ' ILE . 83.5 m-85 -114.28 151.42 32.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 168.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.571 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 5.0 m -64.86 102.58 0.61 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.089 -0.245 . . . . 0.0 111.296 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.982 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -92.1 95.15 9.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.106 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.412 ' HB2' ' OE1' ' A' ' 61' ' ' GLN . 80.1 mtm180 . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 120.966 0.412 . . . . 0.0 110.224 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.506 ' O ' HG13 ' A' ' 41' ' ' ILE . 2.4 p-90 . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 39' ' ' SER . 13.6 ptt180 -66.59 -39.17 88.27 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.956 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.406 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 2.1 m -66.75 -33.79 76.42 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.487 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 33.0 mmm180 -75.87 -36.28 59.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.458 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.554 HG23 ' HG2' ' A' ' 103' ' ' PRO . 59.8 mt -58.09 -46.14 88.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.83 174.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -55.93 -42.56 76.29 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.783 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.99 -37.35 94.16 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.768 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.672 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 1.6 ttm180 -67.77 -34.91 77.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.157 0.503 . . . . 0.0 110.352 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.68 -29.72 70.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.552 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.677 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.7 t-20 -71.14 -36.89 72.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.582 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -57.47 -30.56 65.17 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.772 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.407 ' HB2' ' HB1' ' A' ' 101' ' ' ALA . 64.6 m-85 -94.96 -56.68 2.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.183 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -175.35 102.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.414 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.677 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 28.1 ttp180 -130.73 104.12 6.99 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.062 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.53 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -84.9 133.63 43.04 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.825 178.032 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -56.37 132.2 50.42 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.888 2.392 . . . . 0.0 111.737 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HE3' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.03 -23.43 65.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.086 -172.086 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.83 -33.74 73.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.042 0.448 . . . . 0.0 110.953 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.47 -32.41 60.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.7 mm? -71.8 -34.43 69.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.725 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 30.4 mtm180 -69.35 -10.32 57.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.624 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.45 17.43 12.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.397 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.673 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 19.6 ttmm -150.75 -76.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.818 0.342 . . . . 0.0 111.096 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.673 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 3.4 mmp_? -128.39 90.42 3.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 0.0 110.484 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.438 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 21.6 pt20 -119.08 114.93 23.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.911 -178.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.786 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -160.05 149.79 19.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.803 178.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.533 ' H ' HD11 ' A' ' 127' ' ' LEU . 45.7 t -104.61 125.29 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.708 0.29 . . . . 0.0 110.336 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.7 160.31 25.61 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.757 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 44.0 tt0 -103.96 125.05 50.06 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.491 HG23 HD11 ' A' ' 123' ' ' ILE . 62.5 t -129.44 116.7 40.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.619 -169.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.608 ' HG2' HG22 ' A' ' 82' ' ' VAL . 12.2 ptt180 -109.13 145.31 35.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.62 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -157.75 151.0 23.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -171.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 21.6 m -94.38 126.81 39.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.402 171.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.428 HD11 ' CE1' ' A' ' 68' ' ' PHE . 55.5 mt -122.38 139.37 53.91 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -170.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.465 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 12.6 t70 -79.43 156.11 28.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.037 173.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.738 ' HB2' ' HB3' ' A' ' 107' ' ' PRO . 25.9 ptt180 -63.14 -21.52 66.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.084 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.458 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 4.0 pt20 -87.97 -4.49 58.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.251 0.548 . . . . 0.0 110.087 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.409 ' CA ' ' H ' ' A' ' 104' ' ' LEU . . . 87.2 38.89 7.6 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.116 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.465 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 80.4 t60 -100.35 114.05 27.25 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 p -48.95 116.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.089 172.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.3 mt -104.84 -40.38 5.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.982 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -147.78 146.55 29.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.388 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.756 HG13 ' HG3' ' A' ' 99' ' ' LYS . 58.8 t -143.18 129.87 17.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 m -136.04 120.39 17.98 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.71 HD22 ' HB2' ' A' ' 84' ' ' SER . 35.3 tp -60.36 120.11 9.24 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.608 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -90.95 -46.74 14.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.894 -175.415 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -148.61 143.82 26.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.127 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.71 ' HB2' HD22 ' A' ' 81' ' ' LEU . 30.1 t -134.45 108.47 8.15 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.13 -37.99 89.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.081 -175.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.613 ' H ' HD22 ' A' ' 87' ' ' LEU . . . 167.8 56.84 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.882 -178.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.714 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -121.07 74.79 28.66 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -177.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 3.6 Cg_exo -75.96 -65.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.457 2.104 . . . . 0.0 111.639 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.2 t -74.02 -24.12 59.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.267 0.556 . . . . 0.0 110.181 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.714 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 31.0 mt -73.06 -31.49 64.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.346 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.41 -45.59 72.97 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.785 0.678 . . . . 0.0 112.144 -172.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -54.21 -49.4 69.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -172.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.481 ' CB ' ' HG3' ' A' ' 60' ' ' ARG . 9.2 tp10 -78.29 -53.45 7.29 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -175.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 90' ' ' LEU . 38.6 pt -63.03 -34.28 65.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -174.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.672 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.8 mm-40 -82.18 -28.78 31.86 Favored 'General case' 0 C--O 1.212 -0.91 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.691 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.32 -41.05 75.38 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.466 HD13 ' H ' ' A' ' 51' ' ' TYR . 1.4 tp -68.27 -56.95 6.83 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.684 -1.143 . . . . 0.0 112.097 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.784 HG12 HG21 ' A' ' 123' ' ' ILE . 85.8 t -88.41 -48.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.756 ' HG3' HG13 ' A' ' 79' ' ' VAL . 37.7 ttmt -64.91 -21.88 66.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.244 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 5.9 tpp180 -95.39 -35.44 11.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.042 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.567 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -106.18 74.3 1.03 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.629 0.252 . . . . 0.0 110.859 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 14.0 m -94.21 99.46 3.82 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.991 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.672 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 94.8 Cg_endo -100.6 151.82 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.711 2.941 . . . . 0.0 114.525 -173.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.558 HD21 ' HD2' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -143.8 114.91 5.56 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 173.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.657 ' HA ' ' CZ ' ' A' ' 44' ' ' ARG . 2.6 Cg_endo -74.15 -58.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.678 2.252 . . . . 0.0 112.838 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 4.6 t -72.72 124.63 90.98 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.737 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.738 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 12.1 Cg_exo -70.41 105.68 1.64 Allowed 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.539 2.159 . . . . 0.0 111.162 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.742 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 69.3 Cg_endo -87.83 58.0 3.0 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.906 2.404 . . . . 0.0 112.862 -172.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.627 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -60.36 -41.65 94.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.112 0.482 . . . . 0.0 109.941 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -75.51 5.93 5.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.065 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.742 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -113.43 -24.85 9.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.43 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.835 ' HB3' HG11 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -123.85 19.97 9.29 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.29 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 109' ' ' ALA . 1.7 m -69.49 89.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 6.4 p30 162.51 -25.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 113.208 -1.815 . . . . 0.0 107.46 -168.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.456 ' C ' ' HG1' ' A' ' 116' ' ' THR . . . 165.08 -83.85 0.1 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.109 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.53 ' CA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -160.26 174.16 14.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.835 HG11 ' HB3' ' A' ' 112' ' ' TYR . 27.8 m -102.92 109.73 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.532 0.682 . . . . 0.0 110.799 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 35.0 tt0 -108.7 111.71 23.64 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 166.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.593 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -135.01 155.27 51.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -175.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.556 HG23 HG23 ' A' ' 82' ' ' VAL . 92.7 m -96.03 119.55 34.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.441 -175.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.593 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 42.6 mt -124.98 122.77 25.49 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.454 174.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.4 Cg_exo -72.72 119.32 6.02 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.897 1.731 . . . . 0.0 110.828 175.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.784 HG21 HG12 ' A' ' 98' ' ' VAL . 35.2 pt -91.58 103.63 14.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.41 124.46 41.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.024 0.916 . . . . 0.0 111.566 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -113.32 135.41 53.88 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 163.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.9 m -58.66 102.8 0.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.265 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.786 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.3 tt -86.53 81.15 8.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.127 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.387 -179.342 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.6 m -130.25 15.4 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.071 0.462 . . . . 0.0 110.898 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -88.84 -24.03 22.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.59 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -93.66 -26.67 16.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.24 0.543 . . . . 0.0 110.247 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.645 ' HG3' ' HD3' ' A' ' 12' ' ' PRO . 12.8 mm100 -84.87 41.72 0.88 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.869 -169.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -81.5 35.14 0.39 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.254 0.549 . . . . 0.0 111.197 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.5 t -106.25 -0.37 10.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.768 0.794 . . . . 0.0 109.083 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.28 25.84 50.01 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.582 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.57 108.94 5.21 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.78 0.324 . . . . 0.0 110.956 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -83.81 144.65 11.11 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.867 2.378 . . . . 0.0 111.749 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.645 ' HD3' ' HG3' ' A' ' 6' ' ' GLN . 24.2 Cg_exo -63.12 115.81 3.2 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.755 2.304 . . . . 0.0 111.699 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.13 79.38 1.38 Allowed 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.734 2.289 . . . . 0.0 112.452 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.06 121.58 2.36 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.615 ' HE ' ' HB2' ' A' ' 17' ' ' ASP . 20.9 ttt180 -79.28 112.15 16.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.853 0.359 . . . . 0.0 111.309 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.57 95.48 7.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.615 ' HB2' ' HE ' ' A' ' 15' ' ' ARG . 24.8 t70 -115.7 159.8 20.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.984 -173.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -53.95 -43.86 70.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.185 0.517 . . . . 0.0 110.308 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 m -83.55 -48.55 10.14 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.215 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.907 ' HB3' ' HB3' ' A' ' 25' ' ' ARG . . . -97.72 59.8 1.5 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.488 -174.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.69 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . . . -86.86 -56.38 0.34 Allowed Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.987 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.69 ' HD3' ' HB2' ' A' ' 21' ' ' ALA . 9.9 Cg_endo -90.28 -88.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.293 1.995 . . . . 0.0 113.347 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -118.28 -2.64 11.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.042 0.448 . . . . 0.0 111.231 -176.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.4 ' OG1' ' HD2' ' A' ' 22' ' ' PRO . 1.1 p -77.98 40.35 0.32 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.372 -173.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.907 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 21.5 ptt180 -138.69 2.9 2.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.461 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.1 mt -119.98 -9.11 9.7 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.368 0.604 . . . . 0.0 110.777 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 m -101.98 107.96 54.52 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.398 -172.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -83.58 59.09 6.23 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.836 2.357 . . . . 0.0 112.213 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 54.3 31.57 14.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.094 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.31 30.62 18.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.475 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -83.38 -47.84 11.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.408 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 51.69 58.49 5.42 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.591 0.557 . . . . 0.0 111.702 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.4 119.15 0.58 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.041 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -85.34 65.72 9.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.289 0.566 . . . . 0.0 110.041 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -144.14 146.79 32.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.994 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -68.93 94.31 0.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -75.6 -23.37 56.44 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -171.088 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -69.03 -34.11 74.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.233 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.5 p -70.35 -33.95 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.08 0.467 . . . . 0.0 109.832 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.412 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 30.2 mmt180 -70.3 -43.46 70.31 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.747 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.889 HG21 ' HG2' ' A' ' 103' ' ' PRO . 53.9 mt -57.61 -42.14 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.885 175.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.3 m -56.92 -34.71 68.22 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.489 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.71 -35.69 80.92 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.889 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.543 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.8 -34.18 73.37 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.46 0.648 . . . . 0.0 109.64 178.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.12 -25.47 65.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.894 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.768 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 59.1 t30 -70.19 -34.57 73.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.553 176.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 1.9 ttt180 -59.88 -27.09 66.4 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.015 170.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.573 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 69.5 m-85 -106.01 25.67 10.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.906 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 48' ' ' PHE . 21.9 mtpp 74.13 102.41 0.07 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 124.075 0.859 . . . . 0.0 110.505 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.768 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 16.4 ttp180 -93.54 104.62 16.74 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.289 0.566 . . . . 0.0 110.607 -176.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.509 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -69.41 114.79 26.57 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.892 175.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.459 ' HD2' ' HD1' ' A' ' 51' ' ' TYR . 34.7 Cg_exo -57.68 131.82 46.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.714 2.276 . . . . 0.0 111.573 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.725 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.16 -25.2 63.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.885 -170.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -64.6 -32.45 74.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.0 0.429 . . . . 0.0 111.182 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 59' ' ' LYS . . . -74.15 -31.78 62.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.511 178.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 60' ' ' ARG . 3.4 mm? -74.76 -42.6 57.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.665 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.718 ' HB3' ' HB2' ' A' ' 126' ' ' SER . 2.5 ptp180 -64.41 -17.95 64.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.751 0.31 . . . . 0.0 111.334 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.7 mt -108.33 4.41 24.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.921 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.665 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 39.2 ttmt -145.6 -75.27 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 111.556 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.699 ' HB2' HD13 ' A' ' 56' ' ' LEU . 33.5 mmt180 -106.85 87.57 2.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.844 0.354 . . . . 0.0 110.193 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.729 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . 4.7 mt-30 -85.95 156.17 20.59 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.488 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 170.44 116.76 0.39 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 118.851 -1.642 . . . . 0.0 113.854 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.789 ' H ' HD12 ' A' ' 127' ' ' LEU . 58.9 t -110.18 123.42 66.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.45 165.65 33.99 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.658 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 42.4 mt-30 -103.57 124.46 48.84 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.537 HG21 HD11 ' A' ' 123' ' ' ILE . 77.4 t -122.22 113.63 39.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.433 -173.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.511 ' HB3' HG22 ' A' ' 82' ' ' VAL . 20.6 ptt180 -108.38 141.03 40.81 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.542 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -156.9 157.59 35.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.559 0.695 . . . . 0.0 112.412 -171.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 6.4 m -101.92 129.91 48.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.577 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.502 HD11 ' CE1' ' A' ' 68' ' ' PHE . 48.2 mt -121.78 139.84 53.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.12 0.486 . . . . 0.0 112.286 -168.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.747 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 21.4 t70 -82.18 155.68 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.827 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG3' ' HB3' ' A' ' 107' ' ' PRO . 58.0 ttt180 -51.51 -41.43 60.99 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -174.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -87.08 12.22 11.97 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.019 0.437 . . . . 0.0 111.038 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.33 53.82 4.27 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.421 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.747 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 67.9 t60 -112.4 114.97 27.96 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 4.1 p -48.79 120.35 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.523 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.1 mt -110.49 -40.26 4.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.744 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -152.66 146.01 24.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.279 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.738 HG12 ' HD3' ' A' ' 99' ' ' LYS . 28.4 t -142.39 130.91 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.7 m -128.24 128.16 44.17 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.819 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.9 tp -72.91 123.03 22.63 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -99.4 -52.03 9.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.461 -171.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.9 m -141.31 138.61 33.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.492 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.7 t -131.41 131.38 43.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.935 0.398 . . . . 0.0 110.698 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.03 8.38 26.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.489 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 103.11 69.98 0.83 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.702 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -115.57 89.7 23.46 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HG2' ' O ' ' A' ' 131' ' ' GLY . 4.6 Cg_exo -77.94 -84.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.591 2.194 . . . . 0.0 112.021 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.5 m -66.16 -18.32 65.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.332 0.587 . . . . 0.0 110.966 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 13.7 mt -75.41 -45.09 41.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.245 -176.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 16.9 t70 -55.17 -41.75 72.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.079 -169.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -54.28 -49.71 68.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.819 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.94 -47.93 15.49 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.518 ' HB ' ' CE2' ' A' ' 125' ' ' PHE . 42.1 pt -63.35 -38.8 83.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.56 HE22 HD13 ' A' ' 123' ' ' ILE . 75.4 mm-40 -79.08 -31.34 44.36 Favored 'General case' 0 C--O 1.199 -1.594 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.605 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.84 -39.25 65.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.1 tp -67.53 -54.77 17.14 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.487 176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.628 HG12 HG22 ' A' ' 123' ' ' ILE . 52.9 t -87.41 -45.52 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.738 ' HD3' HG12 ' A' ' 79' ' ' VAL . 3.2 tppp? -56.32 -40.23 74.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.148 0.579 . . . . 0.0 110.518 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -84.38 -31.02 24.95 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.828 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.559 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -105.65 63.15 0.68 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.808 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.7 m -89.13 99.43 1.59 Allowed Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.889 ' HG2' HG21 ' A' ' 41' ' ' ILE . 74.5 Cg_endo -103.55 166.59 0.23 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.922 3.082 . . . . 0.0 114.611 -170.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.501 HD22 ' CD ' ' A' ' 108' ' ' PRO . 37.1 tp -143.16 96.49 5.87 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.722 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.496 ' HA ' ' CZ ' ' A' ' 44' ' ' ARG . 33.1 Cg_endo -78.06 -44.92 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.3 2.0 . . . . 0.0 113.671 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.499 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 15.4 m -92.95 107.88 28.11 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.484 ' HB3' ' HG3' ' A' ' 72' ' ' ARG . 21.2 Cg_exo -66.59 106.12 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.312 2.675 . . . . 0.0 112.977 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.891 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 41.6 Cg_endo -88.87 65.76 2.77 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.543 2.829 . . . . 0.0 112.128 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.573 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -51.07 -51.7 50.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.78 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -78.79 9.33 4.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.79 -176.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.891 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -105.84 -30.15 9.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.165 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.656 ' HB2' ' HA ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -114.3 15.55 18.05 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 3.9 m -72.58 87.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 169.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 4.7 p30 159.74 -19.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.916 -167.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.45 ' C ' ' HG1' ' A' ' 116' ' ' THR . . . 163.66 -86.7 0.1 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.391 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.656 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -160.75 177.08 10.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 69' ' ' THR . 11.2 m -100.1 108.77 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 121.877 0.846 . . . . 0.0 110.105 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -113.63 112.49 23.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.635 HD11 ' HG ' ' A' ' 121' ' ' LEU . 2.1 pp -142.84 154.63 44.35 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.225 -173.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.469 HG22 HG22 ' A' ' 82' ' ' VAL . 92.8 m -92.44 125.85 37.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.421 -177.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.635 ' HG ' HD11 ' A' ' 119' ' ' LEU . 64.2 mt -130.38 122.85 20.17 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.393 176.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.658 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.3 Cg_exo -74.75 119.2 5.6 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.642 1.562 . . . . 0.0 110.726 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.628 HG22 HG12 ' A' ' 98' ' ' VAL . 20.6 pt -89.62 121.07 39.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -111.97 121.71 45.76 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 119.379 -0.928 . . . . 0.0 112.256 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.573 ' CD1' ' HG ' ' A' ' 56' ' ' LEU . 89.7 m-85 -114.09 131.54 56.36 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.409 -1.723 . . . . 0.0 106.816 163.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.718 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 8.7 m -56.98 103.42 0.11 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 -170.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.789 HD12 ' H ' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -97.65 108.85 21.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.915 -171.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.431 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 46.4 mtm105 -84.15 -53.2 5.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.734 173.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 165.52 50.11 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.776 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.509 ' HB2' HD23 ' A' ' 90' ' ' LEU . . . -90.95 172.27 8.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.773 0.321 . . . . 0.0 110.799 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 88' ' ' PRO . . . 83.6 24.27 50.77 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 40.0 p90 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.327 -177.238 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 tttm . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 121.125 0.488 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.2 t -117.99 -58.1 3.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.264 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -96.62 91.56 5.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.204 0.526 . . . . 0.0 110.817 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 5' ' ' GLU . 4.0 pt-20 -101.63 104.49 15.35 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.704 0.764 . . . . 0.0 109.148 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -70.75 -59.47 2.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.699 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.8 t -108.08 119.13 38.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.944 0.402 . . . . 0.0 110.259 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.09 78.85 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.516 0.674 . . . . 0.0 109.712 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.61 -179.16 41.79 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.317 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -115.61 93.62 37.59 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.917 0.359 . . . . 0.0 110.816 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.47 114.22 3.86 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.137 2.558 . . . . 0.0 111.738 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 73.1 Cg_endo -75.73 155.74 39.64 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.475 2.117 . . . . 0.0 112.12 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 6.8 Cg_exo -73.98 52.2 2.57 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.199 2.599 . . . . 0.0 112.071 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.62 103.64 0.22 Allowed Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 mtm180 -91.33 49.88 1.67 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 59.55 29.58 19.16 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.387 0.613 . . . . 0.0 110.057 -173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -68.92 140.02 55.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.95 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.4 tttp 53.63 52.25 13.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.781 0.801 . . . . 0.0 110.5 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.4 m -132.25 5.2 4.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.017 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.1 47.99 1.51 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.27 0.557 . . . . 0.0 110.679 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.638 ' HB1' ' HD3' ' A' ' 22' ' ' PRO . . . -77.68 -55.6 1.23 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.542 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.638 ' HD3' ' HB1' ' A' ' 21' ' ' ALA . 90.6 Cg_endo -87.08 23.97 0.78 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.277 1.984 . . . . 0.0 112.28 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 67.06 104.04 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.153 -177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.6 m -66.9 -18.95 65.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.756 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -66.35 -11.64 52.29 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.959 0.409 . . . . 0.0 110.398 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.3 mt -112.51 19.1 17.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.367 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.7 m -139.98 78.16 24.94 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.835 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.09 133.46 18.08 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.441 2.094 . . . . 0.0 110.613 171.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -126.55 3.05 6.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.8 99.54 8.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.727 0.299 . . . . 0.0 110.973 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -83.12 155.5 23.78 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.86 70.31 4.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -173.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.471 ' HA2' ' CE2' ' A' ' 37' ' ' TRP . . . 107.33 -163.16 13.18 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.654 -0.784 . . . . 0.0 114.011 170.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 57.56 61.54 2.43 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.649 0.78 . . . . 0.0 112.207 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.45 ' CG ' ' H ' ' A' ' 36' ' ' ASN . 14.2 t70 -155.55 -168.27 2.77 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.45 ' H ' ' CG ' ' A' ' 35' ' ' ASP . 17.7 m120 -83.08 6.72 18.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.106 0.479 . . . . 0.0 110.357 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.483 ' CH2' HD21 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -61.78 -30.76 71.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.733 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' HD2' ' N ' ' A' ' 39' ' ' SER . 4.4 ppt_? -69.54 -28.19 65.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.156 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.488 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 13.1 m -66.47 -36.36 82.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.428 ' HB3' ' HB2' ' A' ' 105' ' ' PRO . 17.8 mmm-85 -73.31 -43.69 60.43 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.338 177.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.739 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 34.8 mt -57.99 -36.84 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.634 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.448 ' O ' ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -61.38 -45.04 96.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.6 -38.66 95.97 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.499 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.739 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 8.5 ptt180 -56.69 -34.6 67.57 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.928 0.394 . . . . 0.0 110.13 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -32.26 47.62 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.623 -175.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 6.5 t30 -70.69 -29.19 65.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.035 0.921 . . . . 0.0 108.722 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -18.72 36.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.561 -1.654 . . . . 0.0 111.083 173.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.4 ' HB2' ' HB1' ' A' ' 101' ' ' ALA . 29.8 m-85 -125.74 -57.64 1.44 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 176.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -158.37 102.85 1.76 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.333 0.653 . . . . 0.0 109.822 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 64.1 ttt-85 -128.54 103.53 7.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.35 0.595 . . . . 0.0 109.942 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.45 130.17 23.21 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.917 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.06 134.16 58.62 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.966 2.444 . . . . 0.0 111.936 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.9 -21.43 61.06 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.53 -174.263 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.78 -38.52 55.9 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.6 0.562 . . . . 0.0 110.762 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.11 -42.43 47.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.315 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.4 mm? -64.22 -34.81 78.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.963 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.584 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 21.7 mtm180 -62.71 -14.63 46.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.757 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.2 mp -119.62 14.36 12.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.75 0.31 . . . . 0.0 110.931 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.771 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 39.0 ttmt -142.25 -76.52 0.27 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.702 0.287 . . . . 0.0 110.859 -176.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.771 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 39.6 mmt180 -130.95 100.63 5.31 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.0 167.84 11.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.74 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.78 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.74 144.48 3.92 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.727 -1.225 . . . . 0.0 113.272 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 p -111.13 128.17 67.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.53 164.62 29.45 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.097 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.477 ' O ' HG23 ' A' ' 82' ' ' VAL . 35.8 tt0 -103.65 125.13 49.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.575 HG23 HD13 ' A' ' 123' ' ' ILE . 49.3 t -127.31 114.79 38.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.763 -171.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.567 ' HG2' HG21 ' A' ' 82' ' ' VAL . 5.1 ptp180 -114.68 144.35 43.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.6 OUTLIER -160.1 164.07 33.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.75 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 7.3 m -108.4 131.93 54.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.562 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.589 HD21 ' HB3' ' A' ' 102' ' ' SER . 61.9 mt -119.05 138.29 52.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.73 -172.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.458 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 29.4 t70 -81.2 158.45 24.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.821 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.85 -36.67 70.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -81.6 3.11 26.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.12 0.486 . . . . 0.0 111.258 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . 81.4 35.52 22.95 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.298 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.478 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 42.4 t60 -100.38 110.83 23.05 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 5.8 p -48.44 111.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.645 0.736 . . . . 0.0 111.002 173.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 48.9 mt -99.65 -23.5 15.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.581 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.69 157.58 36.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.836 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.602 HG23 ' HG3' ' A' ' 99' ' ' LYS . 13.6 p -159.82 133.85 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.2 m -144.48 130.15 19.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.704 0.288 . . . . 0.0 111.065 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.702 HD22 ' HB2' ' A' ' 84' ' ' SER . 24.5 tp -74.78 110.1 8.8 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.567 HG21 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -84.84 -39.22 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.155 -171.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.0 m -150.56 151.15 32.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.762 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.702 ' HB2' HD22 ' A' ' 81' ' ' LEU . 45.7 t -140.11 142.77 36.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.875 0.369 . . . . 0.0 110.572 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.18 19.42 19.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.243 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.13 63.41 0.84 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.686 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.779 ' HA ' HD13 ' A' ' 90' ' ' LEU . 1.1 mm? -119.1 82.99 23.05 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.08 -83.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.369 2.046 . . . . 0.0 111.973 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 66.5 m -68.64 -17.91 64.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.397 0.618 . . . . 0.0 110.339 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.779 HD13 ' HA ' ' A' ' 87' ' ' LEU . 16.2 mt -70.24 -34.03 72.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.632 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.536 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 3.7 t70 -54.12 -44.53 71.39 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.467 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 89' ' ' SER . 11.2 ptm180 -54.31 -48.49 71.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.489 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 8.1 tp10 -77.88 -53.46 7.45 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 122.016 -0.427 . . . . 0.0 111.789 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 90' ' ' LEU . 36.7 pt -64.76 -37.08 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -172.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.595 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.4 mm-40 -82.21 -28.31 32.06 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.45 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.653 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.88 -43.43 81.26 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.87 -58.37 7.0 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.008 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.731 HG13 HG21 ' A' ' 123' ' ' ILE . 93.0 t -89.05 -50.4 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.602 ' HG3' HG23 ' A' ' 79' ' ' VAL . 35.6 ttmt -67.32 -29.99 69.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.649 -173.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.653 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 4.1 tmt_? -89.07 -47.17 8.29 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.664 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.638 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -86.0 73.75 10.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.044 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.589 ' HB3' HD21 ' A' ' 70' ' ' LEU . 67.4 m -109.52 92.3 11.64 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-O 122.063 0.935 . . . . 0.0 110.531 171.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.696 ' HG2' ' HG3' ' A' ' 44' ' ' ARG . 3.3 Cg_endo -96.33 178.44 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 1 C-N-CA 125.457 4.105 . . . . 0.0 112.052 170.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.736 HD22 ' HD2' ' A' ' 108' ' ' PRO . 12.2 tp -134.65 99.15 13.0 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.428 ' HB2' ' HB3' ' A' ' 40' ' ' ARG . 86.6 Cg_endo -77.15 -28.51 5.8 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.449 1.433 . . . . 0.0 112.77 -173.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.51 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 2.9 t -122.46 107.83 34.07 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.708 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.38 108.3 1.35 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.062 2.508 . . . . 0.0 112.612 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.736 ' HD2' HD22 ' A' ' 104' ' ' LEU . 41.9 Cg_endo -86.71 66.45 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.159 2.572 . . . . 0.0 111.312 177.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.698 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -49.69 -46.28 49.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.864 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.69 -32.49 67.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.592 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 108' ' ' PRO . . . -81.09 -31.31 34.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.12 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.698 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -116.62 18.58 14.94 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 109' ' ' ALA . 3.2 m -71.29 88.95 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 168.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.506 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 6.9 p30 159.34 -23.07 0.0 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.152 -168.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.56 -84.53 0.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.002 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.474 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.3 OUTLIER -159.67 175.69 12.89 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.218 0.607 . . . . 0.0 109.491 -176.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.75 ' O ' ' HA ' ' A' ' 69' ' ' THR . 4.0 m -103.02 107.99 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-O 121.396 0.617 . . . . 0.0 111.251 -174.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.536 ' HG2' ' HG1' ' A' ' 69' ' ' THR . 1.1 tm-20 -103.57 112.14 24.92 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.658 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 3.5 pp -142.09 149.33 39.73 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.622 -173.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.2 m -87.94 124.58 33.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.627 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.658 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 32.2 mt -123.77 122.03 26.46 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.556 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.05 120.89 5.9 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.197 1.932 . . . . 0.0 110.933 176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.731 HG21 HG13 ' A' ' 98' ' ' VAL . 12.2 pt -104.69 123.19 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -126.26 124.31 40.09 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 122.206 1.003 . . . . 0.0 111.581 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -113.17 139.13 49.02 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.41 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 14.4 m -57.99 101.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.805 0.336 . . . . 0.0 111.558 -172.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.78 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.4 OUTLIER -94.88 106.06 18.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.917 -174.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -131.61 19.08 4.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.304 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.25 -110.78 1.57 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.362 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -81.99 45.91 0.96 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -172.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -169.87 101.5 0.17 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.194 -0.527 . . . . 0.0 111.899 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 9.1 p90 . . . . . 0 C--O 1.244 0.814 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.448 179.078 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.611 ' HB2' ' HZ2' ' A' ' 2' ' ' LYS . 4.7 ttmp? . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.446 HG22 ' HG3' ' A' ' 4' ' ' GLN . 29.3 m -73.49 -28.57 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.282 0.563 . . . . 0.0 110.144 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.524 ' H ' ' HG2' ' A' ' 2' ' ' LYS . 45.7 mt-30 -99.57 75.55 1.95 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.934 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -87.11 41.91 1.0 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.738 0.78 . . . . 0.0 109.259 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -84.49 -55.13 4.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.932 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.4 m -84.26 84.25 7.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.015 0.436 . . . . 0.0 110.526 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.0 t -103.04 -50.0 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.366 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.41 -155.53 23.54 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.304 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 67.83 74.01 0.33 Allowed Pre-proline 0 N--CA 1.464 0.273 0 C-N-CA 123.442 0.697 . . . . 0.0 111.364 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.593 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 70.2 Cg_endo -75.73 130.92 12.96 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.488 2.125 . . . . 0.0 112.032 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 37.5 Cg_endo -92.69 100.09 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.269 2.646 . . . . 0.0 112.645 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 11' ' ' PRO . 3.4 Cg_exo -80.12 74.94 5.31 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.014 2.476 . . . . 0.0 111.641 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.74 -51.61 4.34 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.253 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -121.67 -80.35 0.62 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.788 -0.242 . . . . 0.0 110.971 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.437 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . . . 61.83 96.2 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.816 0.697 . . . . 0.0 111.451 -177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -76.64 -42.41 42.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.583 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.1 tptt 53.11 80.67 0.1 Allowed 'General case' 0 C--O 1.235 0.308 0 O-C-N 124.025 0.828 . . . . 0.0 111.502 174.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -81.0 60.59 4.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.115 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.68 88.98 7.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.472 0.653 . . . . 0.0 110.198 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.01 169.07 12.31 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.834 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.26 -19.82 17.83 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 121.984 1.789 . . . . 0.0 112.732 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -81.93 -15.7 52.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.902 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.3 p -88.79 38.58 0.89 Allowed 'General case' 0 C--N 1.332 -0.165 0 O-C-N 121.942 -0.474 . . . . 0.0 111.221 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -116.82 -53.95 2.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.205 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 26' ' ' LEU . 3.5 mm? -103.17 28.73 6.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.249 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 p -112.61 93.58 24.2 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.088 0.47 . . . . 0.0 111.067 177.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -78.97 58.94 7.16 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.657 2.238 . . . . 0.0 112.092 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -127.63 139.76 52.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.639 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 63.32 74.04 0.44 Allowed 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.892 0.745 . . . . 0.0 112.44 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -81.74 50.58 1.54 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.124 0.488 . . . . 0.0 110.913 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.4 167.54 14.82 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.11 -146.18 5.35 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.328 -1.415 . . . . 0.0 113.676 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.4 mp0 -75.77 124.23 26.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.091 -0.554 . . . . 0.0 112.085 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.544 ' CG ' ' H ' ' A' ' 36' ' ' ASN . 5.3 p-10 -159.61 -72.99 0.08 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.509 169.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.544 ' H ' ' CG ' ' A' ' 35' ' ' ASP . 0.1 OUTLIER -178.44 38.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.51 ' CH2' HD21 ' A' ' 121' ' ' LEU . 1.4 p-90 -63.95 -29.99 71.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.829 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.15 -31.48 70.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 110.247 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.0 m -70.84 -34.53 71.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.469 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.54 ' CB ' ' HG2' ' A' ' 105' ' ' PRO . 48.9 mtt180 -64.8 -44.96 88.25 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.433 0.635 . . . . 0.0 109.443 174.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.534 HG22 ' HD2' ' A' ' 103' ' ' PRO . 75.8 mt -59.62 -38.67 76.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.322 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 m -55.75 -32.31 63.3 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.17 -43.01 82.28 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.713 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.573 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 9.2 mpt_? -69.07 -32.53 72.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.098 0.475 . . . . 0.0 110.769 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.95 -32.41 73.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.422 0.63 . . . . 0.0 109.754 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.8 t-20 -71.2 -31.29 67.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.822 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.538 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 2.0 ttt180 -53.34 -28.34 28.16 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.961 172.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -100.85 -57.09 2.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.705 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -173.56 116.98 0.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 55.4 ttp180 -133.47 103.83 6.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.217 0.532 . . . . 0.0 110.312 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -98.79 142.94 25.45 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.993 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.86 132.8 51.51 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.877 2.384 . . . . 0.0 111.83 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.667 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -62.36 -23.89 67.05 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -171.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.48 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 15.3 m-20 -65.2 -33.53 76.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.643 0.259 . . . . 0.0 110.815 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.84 71.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.249 0.547 . . . . 0.0 110.112 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -73.45 -40.31 64.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.61 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.684 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 83.2 mtt180 -55.65 -30.86 61.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.984 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 54' ' ' ASP . 61.6 mt -99.04 14.41 29.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.038 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.423 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 24.8 ttmm -145.8 -74.64 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 111.049 -177.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.542 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 23.0 mmt180 -127.38 84.44 2.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.384 0.612 . . . . 0.0 110.232 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.684 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 24.4 pt20 -94.27 115.29 27.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.06 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.827 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -154.79 130.02 2.74 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.56 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.861 ' H ' HD12 ' A' ' 127' ' ' LEU . 7.1 p -103.78 133.39 47.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.006 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.85 168.12 38.24 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.16 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 56.7 mt-30 -100.29 137.65 38.44 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.541 HG21 HD11 ' A' ' 123' ' ' ILE . 39.8 t -128.22 114.03 32.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.237 0.541 . . . . 0.0 110.46 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 34.4 ttp180 -103.71 125.04 49.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.554 ' CE1' HD13 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -144.1 156.99 44.57 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.508 0.67 . . . . 0.0 112.625 -174.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.793 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 23.3 m -106.43 124.32 49.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.429 173.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.554 HD13 ' CE1' ' A' ' 68' ' ' PHE . 39.9 mt -116.96 147.69 42.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.24 0.543 . . . . 0.0 111.953 -169.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.531 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 29.3 t70 -88.41 161.81 16.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.399 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -48.96 -40.39 30.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.543 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -88.76 7.14 35.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.989 0.423 . . . . 0.0 111.062 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . 76.61 40.25 27.63 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.162 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.531 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 45.2 t60 -103.06 123.81 47.34 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.48 118.89 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.417 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 71' ' ' ASP . 26.0 mt -106.19 -53.45 2.63 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.231 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.61 149.59 52.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.802 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.429 HG11 ' HB3' ' A' ' 68' ' ' PHE . 2.4 m -145.67 125.35 6.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.442 0.639 . . . . 0.0 110.857 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.9 m -124.71 123.83 40.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.425 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 23.1 tp -78.68 106.48 10.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.484 0.659 . . . . 0.0 109.882 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -86.66 -41.96 15.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.049 178.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.434 ' HB2' ' HG ' ' A' ' 81' ' ' LEU . 13.2 t 68.67 -178.03 0.22 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.396 167.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.421 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 40.8 m -153.59 -56.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.024 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.59 -77.4 0.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.7 98.67 0.11 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.747 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -117.6 87.63 26.66 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.532 0.166 . . . . 0.0 110.655 -177.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.76 -81.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.685 2.257 . . . . 0.0 111.869 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.5 m -65.74 -18.46 65.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.525 0.679 . . . . 0.0 110.328 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.708 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 25.2 mt -73.67 -36.13 65.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.191 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.464 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 4.4 t70 -54.18 -51.41 64.43 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 123.613 0.571 . . . . 0.0 111.725 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -54.58 -43.67 72.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -77.4 -53.92 7.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.833 0.349 . . . . 0.0 111.737 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 90' ' ' LEU . 40.2 pt -74.12 -33.08 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.654 -172.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.77 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 79.0 mm-40 -82.57 -24.11 34.14 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 120.981 0.42 . . . . 0.0 110.39 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.707 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.65 -47.27 80.12 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.552 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -65.11 -56.11 14.84 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.514 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.782 HG13 HG22 ' A' ' 123' ' ' ILE . 79.3 t -89.17 -50.11 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.77 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 34.9 ttmt -68.84 -30.09 68.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.238 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.707 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 2.6 tmt_? -86.86 -39.99 15.31 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.774 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.676 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -97.41 63.84 1.82 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.737 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.4 m -94.6 98.49 3.14 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 110.093 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.676 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 98.9 Cg_endo -108.65 172.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 124.195 3.263 . . . . 0.0 114.386 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.54 ' HG ' HD11 ' A' ' 70' ' ' LEU . 6.2 mt -143.89 120.59 6.52 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.733 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.54 ' HG2' ' CB ' ' A' ' 40' ' ' ARG . 6.2 Cg_exo -72.83 -54.13 0.12 Allowed 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.86 2.374 . . . . 0.0 111.936 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 25.4 m -88.7 115.22 62.84 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.411 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 106' ' ' THR . 30.5 Cg_endo -64.17 107.6 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.09 2.527 . . . . 0.0 112.225 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.604 ' HB2' ' HB1' ' A' ' 111' ' ' ALA . 81.3 Cg_endo -83.38 62.74 7.45 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.772 2.314 . . . . 0.0 111.832 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.815 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -59.18 -41.91 89.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.297 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.72 -7.95 48.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.622 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.604 ' HB1' ' HB2' ' A' ' 108' ' ' PRO . . . -99.38 -32.04 11.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.604 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.815 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -110.02 17.49 21.02 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -176.107 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 109' ' ' ALA . 3.4 m -70.57 88.09 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 168.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 7.5 p30 161.93 -27.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.606 -1.634 . . . . 0.0 107.846 -170.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.85 -76.15 0.15 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.906 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.6 OUTLIER -160.27 174.42 14.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.793 ' O ' ' HA ' ' A' ' 69' ' ' THR . 15.8 m -103.3 108.94 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.377 0.608 . . . . 0.0 111.061 -175.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 28.0 tt0 -105.36 111.7 24.52 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.679 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -142.36 147.22 35.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.462 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.467 HG21 HG23 ' A' ' 82' ' ' VAL . 86.8 m -87.59 122.13 30.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.33 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.679 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 26.0 mt -124.7 122.5 25.7 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.927 172.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.671 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.2 Cg_exo -73.8 119.93 6.15 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.771 1.647 . . . . 0.0 110.726 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.782 HG22 HG13 ' A' ' 98' ' ' VAL . 23.8 pt -95.46 99.52 9.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.569 ' HA ' HG21 ' A' ' 63' ' ' VAL . 5.5 p-10 -90.24 121.49 32.31 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.449 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 41.5 m-85 -113.36 141.3 47.21 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 163.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 3.3 m -64.15 101.87 0.45 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.861 HD12 ' H ' ' A' ' 63' ' ' VAL . 1.2 tt -90.13 84.11 6.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.204 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 128' ' ' ARG . 21.0 mtm180 -77.31 -20.18 55.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.46 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 141.06 106.02 0.61 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.528 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.499 ' HB3' HD23 ' A' ' 90' ' ' LEU . . . -157.58 155.2 29.77 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.05 31.69 19.55 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.317 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 21.2 p90 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.629 -0.701 . . . . 0.0 110.423 -177.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.486 ' H2 ' ' CD ' ' A' ' 5' ' ' GLU . 49.5 mtmt . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.916 0.389 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.11 -31.15 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.43 0.633 . . . . 0.0 109.694 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -137.04 -28.66 0.94 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.368 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.486 ' CD ' ' H2 ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -84.82 63.42 8.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.436 -176.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -85.26 52.9 2.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.364 0.602 . . . . 0.0 109.978 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.7 t -95.94 102.32 14.1 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.893 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 p -102.4 99.62 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.499 0.666 . . . . 0.0 110.658 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.89 108.9 0.58 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.129 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.05 80.94 67.2 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.938 0.399 . . . . 0.0 109.946 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 87.0 Cg_endo -82.15 129.5 6.06 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.641 2.227 . . . . 0.0 112.799 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 3.3 Cg_exo -77.77 104.24 1.83 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.085 2.523 . . . . 0.0 110.725 171.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.84 120.1 6.93 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.771 2.314 . . . . 0.0 112.29 -173.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.76 -35.13 79.35 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -147.8 -66.32 0.25 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.289 -0.455 . . . . 0.0 109.773 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.42 124.51 42.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.183 0.516 . . . . 0.0 111.854 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -161.59 -157.72 0.51 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.509 ' HB3' ' HZ1' ' A' ' 18' ' ' LYS . 7.9 mtpm? 56.34 40.09 29.91 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.201 0.524 . . . . 0.0 110.278 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -98.74 -44.83 6.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.045 -174.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.39 118.64 4.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.666 0.269 . . . . 0.0 111.063 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.969 ' HB1' ' HD3' ' A' ' 22' ' ' PRO . . . -126.33 -62.78 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.5 173.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.969 ' HD3' ' HB1' ' A' ' 21' ' ' ALA . 2.5 Cg_endo -85.07 -10.47 8.05 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.083 1.855 . . . . 0.0 111.797 171.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.49 ' OE1' ' HD2' ' A' ' 22' ' ' PRO . 25.1 mp0 -83.41 -9.69 58.87 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.543 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.446 ' HA ' ' OG1' ' A' ' 27' ' ' THR . 4.9 m -64.79 -7.53 11.42 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.97 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.421 ' HG3' ' HG ' ' A' ' 26' ' ' LEU . 35.3 ptt180 -75.33 -16.04 60.44 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.935 -0.478 . . . . 0.0 110.981 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.421 ' HG ' ' HG3' ' A' ' 25' ' ' ARG . 80.0 mt -115.95 17.43 15.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.953 0.406 . . . . 0.0 110.856 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 24' ' ' THR . 41.5 p -122.75 86.06 49.7 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.87 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.96 145.76 15.83 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.965 2.443 . . . . 0.0 111.166 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -79.56 -10.65 59.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.067 0.461 . . . . 0.0 110.966 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.01 120.58 26.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.44 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -86.14 -41.53 14.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.475 -173.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 59.69 -157.43 0.33 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.848 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.42 103.44 0.2 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.549 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -81.23 138.89 35.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.083 0.468 . . . . 0.0 109.827 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -174.73 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.873 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -154.79 30.66 0.41 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.65 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -88.69 -37.2 15.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.42 -174.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.745 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . 17.3 ptp180 -69.15 -29.79 67.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.892 -173.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.0 p -64.69 -38.21 90.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.576 ' C ' ' HG3' ' A' ' 105' ' ' PRO . 4.2 mmm180 -74.76 -37.96 62.33 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.745 ' HB ' ' HA ' ' A' ' 38' ' ' ARG . 21.5 mt -57.69 -38.1 62.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.808 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 m -60.23 -45.71 92.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 174.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.51 -50.48 67.34 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.39 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.808 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -68.35 -29.29 67.99 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.213 0.507 . . . . 0.0 111.297 -177.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.78 -30.84 71.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.526 0.679 . . . . 0.0 109.654 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.548 ' HB2' ' HD3' ' A' ' 50' ' ' ARG . 8.4 t30 -71.31 -29.59 65.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.543 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.666 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 9.2 ttt180 -52.96 -25.04 10.7 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.223 172.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.536 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 74.4 m-85 -113.29 -59.15 2.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.266 176.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -164.62 103.38 0.82 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 122.394 0.278 . . . . 0.0 110.568 -174.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.548 ' HD3' ' HB2' ' A' ' 46' ' ' ASN . 15.7 ttt180 -133.17 106.43 7.59 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.605 0.716 . . . . 0.0 111.124 177.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.429 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.3 t80 -105.18 142.97 25.79 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.2 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.96 132.21 50.93 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.92 2.413 . . . . 0.0 112.108 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.654 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.55 -24.89 66.95 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -55.97 -41.74 75.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.67 0.271 . . . . 0.0 110.832 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.64 -30.87 68.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.87 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 60' ' ' ARG . 3.6 mm? -74.44 -41.51 60.72 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.613 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 28.4 mtm180 -61.28 -24.39 66.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.246 0.546 . . . . 0.0 110.162 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.8 tp -91.57 -13.72 31.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.748 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.662 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 38.2 ttpt -131.64 -72.46 0.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.88 -172.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.662 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 36.8 mmt180 -109.69 92.02 3.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.853 0.359 . . . . 0.0 110.315 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 90' ' ' LEU . 42.6 mt-30 -86.54 169.34 12.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.551 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.61 119.71 0.81 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.472 -1.347 . . . . 0.0 113.627 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.06 123.57 66.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.34 165.7 36.17 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.678 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 68.7 mt-30 -103.09 130.82 50.35 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 t -119.57 114.29 43.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.364 -171.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.508 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 31.3 ttp85 -107.65 137.63 45.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.638 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -152.28 153.65 34.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.494 0.664 . . . . 0.0 111.948 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.673 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 30.4 m -99.18 133.58 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.299 170.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.57 HD12 ' HG ' ' A' ' 104' ' ' LEU . 63.7 mt -121.92 140.23 52.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.379 0.609 . . . . 0.0 112.211 -170.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.548 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 17.1 t70 -83.88 159.64 21.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.565 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.451 ' HG3' ' OH ' ' A' ' 112' ' ' TYR . 22.2 ttt180 -53.39 -40.58 65.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.866 0.365 . . . . 0.0 111.452 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -89.46 16.2 8.01 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 111.056 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 103' ' ' PRO . . . 71.89 46.17 38.78 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.811 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.548 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 72.2 t60 -104.3 114.3 28.45 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.3 p -49.21 123.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.112 0.482 . . . . 0.0 111.162 173.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.612 HD13 HG22 ' A' ' 69' ' ' THR . 35.3 mt -110.0 -45.97 3.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.266 0.555 . . . . 0.0 110.571 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.28 149.14 52.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.981 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 m -136.74 124.22 32.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.0 m -144.11 121.76 11.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.5 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' A' ' 84' ' ' SER . 25.8 tp -76.18 111.95 12.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 173.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.733 HG23 HG21 ' A' ' 120' ' ' THR . 0.2 OUTLIER -85.36 -38.35 12.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.68 -170.684 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.442 ' HB3' ' HG3' ' A' ' 65' ' ' GLN . 8.4 t -148.05 149.17 31.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.642 ' HB2' HD23 ' A' ' 81' ' ' LEU . 46.3 t -149.07 149.14 30.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.22 0.533 . . . . 0.0 111.216 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.99 -18.09 15.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.583 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.409 ' C ' HD11 ' A' ' 87' ' ' LEU . . . 120.43 80.63 0.62 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.944 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.77 HD13 HD11 ' A' ' 127' ' ' LEU . 0.4 OUTLIER -117.51 91.23 37.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.87 -79.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.992 2.461 . . . . 0.0 112.556 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.6 p -70.58 -18.62 62.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.394 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.724 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 17.9 mt -74.34 -39.93 62.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.131 -175.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 15.4 t70 -54.58 -43.24 71.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.785 -170.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -54.01 -52.33 61.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -78.25 -48.03 16.65 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.909 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 90' ' ' LEU . 42.4 pt -62.98 -36.83 77.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.656 0.265 . . . . 0.0 111.4 -176.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.668 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.9 mm-40 -82.79 -25.85 32.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.073 0.463 . . . . 0.0 110.633 177.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.742 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -57.1 -45.55 83.31 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.441 HD22 HG21 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -64.87 -56.82 11.05 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.0 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.73 HG11 HG21 ' A' ' 123' ' ' ILE . 94.2 t -89.3 -50.52 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.668 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 35.1 ttmt -70.14 -27.47 64.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.619 0.247 . . . . 0.0 111.391 -173.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.742 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 20.9 tpt180 -88.34 -41.73 12.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.911 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.612 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -91.78 78.26 5.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.063 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.525 ' HB3' HD22 ' A' ' 70' ' ' LEU . 17.2 m -111.65 90.25 12.33 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.349 171.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.808 ' HG2' ' HG2' ' A' ' 44' ' ' ARG . 9.5 Cg_endo -104.91 -179.98 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.926 1 C-N-CA 125.992 4.462 . . . . 0.0 111.383 171.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.57 ' HG ' HD12 ' A' ' 70' ' ' LEU . 35.7 mt -136.38 127.95 17.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 169.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.737 ' HD3' ' HD2' ' A' ' 44' ' ' ARG . 57.0 Cg_endo -74.75 -24.23 13.59 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.514 2.143 . . . . 0.0 111.836 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 t -132.89 116.33 14.62 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.112 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.73 108.78 0.4 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.93 2.42 . . . . 0.0 111.717 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.528 ' HG2' ' CE2' ' A' ' 112' ' ' TYR . 82.0 Cg_endo -75.62 65.08 6.61 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.683 2.255 . . . . 0.0 111.563 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.583 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.2 -41.98 80.4 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.818 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.8 2.29 4.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.573 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -113.23 -34.74 5.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.509 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.674 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -115.2 16.75 16.89 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -174.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.6 m -71.38 88.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 4.9 p30 159.82 -29.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 113.661 -1.608 . . . . 0.0 107.404 -168.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.38 -84.55 0.1 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.355 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.495 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 1.3 p -149.6 167.39 26.5 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -171.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 112' ' ' TYR . 20.7 m -107.71 122.43 62.0 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 CA-C-O 120.904 0.383 . . . . 0.0 111.014 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.507 ' HB3' ' HG1' ' A' ' 69' ' ' THR . 5.3 pt-20 -112.8 120.04 40.09 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.684 HD11 ' HG ' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -140.14 143.35 36.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.972 0.415 . . . . 0.0 111.606 -175.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.733 HG21 HG23 ' A' ' 82' ' ' VAL . 98.9 m -96.3 116.34 28.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.857 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.684 ' HG ' HD11 ' A' ' 119' ' ' LEU . 62.7 mt -119.21 122.76 29.27 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.275 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.3 Cg_exo -73.12 120.73 6.76 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.056 1.837 . . . . 0.0 111.427 177.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.73 HG21 HG11 ' A' ' 98' ' ' VAL . 21.6 pt -102.49 117.73 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -119.61 123.47 43.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.184 0.993 . . . . 0.0 112.508 -175.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.551 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 89.7 m-85 -115.23 133.02 56.42 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.604 166.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -57.66 103.73 0.15 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.044 0.45 . . . . 0.0 111.971 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.77 HD11 HD13 ' A' ' 87' ' ' LEU . 12.5 mt -84.01 104.0 13.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.181 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -149.81 29.05 0.76 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.348 0.594 . . . . 0.0 110.267 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -149.14 -77.68 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.462 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.432 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -98.43 36.14 1.67 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.246 0.546 . . . . 0.0 111.092 -176.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.675 ' HA3' HD23 ' A' ' 127' ' ' LEU . . . 177.83 109.49 0.25 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.456 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 . . . . . 0 N--CA 1.438 -1.053 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.41 178.291 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 121.166 0.507 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.4 t -117.14 -39.85 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 172.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -116.22 94.91 4.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.666 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -80.33 76.57 7.13 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -95.68 50.83 1.24 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.477 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.32 -32.28 64.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.138 176.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.69 157.42 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.959 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.34 84.57 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.932 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.7 101.49 11.77 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 120.606 0.241 . . . . 0.0 111.286 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.26 142.86 68.47 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.783 2.322 . . . . 0.0 110.865 173.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.23 110.35 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.092 2.528 . . . . 0.0 112.115 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.99 122.94 11.38 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.408 2.738 . . . . 0.0 112.848 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -102.26 -170.98 27.11 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.825 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -104.26 153.42 21.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.837 0.351 . . . . 0.0 110.342 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.17 49.73 1.87 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.125 0.488 . . . . 0.0 111.08 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.2 135.08 41.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.499 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.7 tttm 71.81 -52.97 0.69 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.086 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m 61.49 70.9 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.637 0.732 . . . . 0.0 110.544 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.47 84.92 1.63 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.198 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . . . -80.35 165.79 44.1 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.164 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 21' ' ' ALA . 87.0 Cg_exo -48.36 -32.62 20.49 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.542 2.161 . . . . 0.0 113.262 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -68.9 -39.74 79.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.384 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.6 p -85.88 30.1 0.68 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.034 0.445 . . . . 0.0 111.207 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.674 ' HG3' ' HG ' ' A' ' 26' ' ' LEU . 36.1 ptt180 -72.12 -25.5 61.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.259 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.674 ' HG ' ' HG3' ' A' ' 25' ' ' ARG . 97.2 mt -129.96 31.43 4.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.068 0.461 . . . . 0.0 110.792 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.7 m -146.6 103.72 3.97 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.43 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -83.98 124.9 3.51 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.801 2.334 . . . . 0.0 112.703 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -105.05 119.12 38.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.913 0.387 . . . . 0.0 110.62 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . . . -94.61 101.77 13.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.078 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -87.28 83.97 7.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.066 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.47 -33.98 28.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.511 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -156.68 134.9 4.22 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -75.85 73.74 2.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.507 0.67 . . . . 0.0 110.644 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 t70 72.44 -5.86 1.71 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.184 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -75.96 -8.55 57.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.145 0.498 . . . . 0.0 110.698 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.435 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -78.83 -17.08 56.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.328 -175.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -68.48 -41.44 80.09 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.767 -171.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.8 p -64.79 -36.36 84.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.143 0.497 . . . . 0.0 110.434 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.449 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 30.8 mmt180 -73.93 -43.25 58.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.347 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.489 HG12 ' HD3' ' A' ' 105' ' ' PRO . 76.0 mt -57.01 -43.58 81.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.3 m -60.31 -30.61 69.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.881 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.33 -52.57 34.79 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.274 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 1.019 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.7 -28.41 65.81 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 175.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -53.86 -35.04 61.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.523 0.678 . . . . 0.0 109.362 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.733 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 24.1 t-20 -71.93 -34.18 68.85 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.941 177.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.525 ' HB3' ' HA ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -52.88 -28.15 21.79 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.277 173.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.591 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 95.8 m-85 -95.39 -59.23 1.93 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.947 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.591 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 21.1 mmmt -178.28 114.47 0.07 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.336 1.054 . . . . 0.0 108.923 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.733 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 41.8 ttp180 -129.54 105.38 8.04 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.273 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 2.7 t80 -90.32 134.92 30.34 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.844 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 32.3 Cg_exo -60.32 132.4 43.66 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.327 2.685 . . . . 0.0 112.566 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.21 -27.41 65.7 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.266 -171.122 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.19 -40.82 74.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.851 0.358 . . . . 0.0 110.713 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.51 -30.99 62.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.565 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 53' ' ' LYS . 3.7 mm? -65.91 -38.48 88.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.884 0.373 . . . . 0.0 110.204 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -61.8 -17.32 55.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.534 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.1 mt -111.99 -0.68 15.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 111.129 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -128.44 -70.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.03 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.752 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 28.9 mmt180 -136.68 101.53 4.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.318 0.58 . . . . 0.0 110.107 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.552 ' HG3' ' HA ' ' A' ' 127' ' ' LEU . 3.2 pt20 -113.48 160.37 18.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.546 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.725 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 153.27 142.89 3.56 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.389 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -107.31 125.53 63.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.993 0.425 . . . . 0.0 109.996 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.15 164.4 26.19 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.421 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 48.2 mt-30 -103.85 129.28 51.31 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.411 HG22 HD12 ' A' ' 123' ' ' ILE . 51.6 t -127.74 118.18 48.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.617 ' HG2' HG21 ' A' ' 82' ' ' VAL . 15.6 ptt180 -112.96 143.65 43.89 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -159.57 152.92 22.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.41 0.624 . . . . 0.0 112.502 -168.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.6 m -95.16 126.45 40.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.468 171.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.497 HD13 ' CE1' ' A' ' 68' ' ' PHE . 51.0 mt -117.34 143.82 45.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.173 0.511 . . . . 0.0 111.99 -170.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.671 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 22.2 t70 -86.28 154.96 20.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.13 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -53.21 -35.01 59.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.202 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -99.72 13.15 34.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.16 0.505 . . . . 0.0 111.154 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.53 40.59 12.56 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.812 -0.631 . . . . 0.0 113.388 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.671 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 68.8 t60 -103.31 118.02 35.83 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.13 113.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.22 0.533 . . . . 0.0 111.149 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.44 -48.72 4.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.46 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.81 155.68 46.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.605 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -149.98 129.6 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 123.485 0.491 . . . . 0.0 110.026 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -142.32 125.66 16.58 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.279 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.583 HD23 ' HB2' ' A' ' 84' ' ' SER . 34.2 tp -70.0 122.45 19.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.617 HG21 ' HG2' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -97.48 -41.65 11.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.183 -174.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 m -149.35 131.05 15.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.872 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.583 ' HB2' HD23 ' A' ' 81' ' ' LEU . 45.0 t -138.95 111.01 7.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.61 -62.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.14 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . -157.05 62.85 0.32 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.876 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.923 ' HA ' HD13 ' A' ' 90' ' ' LEU . 1.6 mm? -114.35 86.78 12.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 4.7 Cg_exo -77.16 -78.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.435 2.09 . . . . 0.0 111.545 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.1 p -74.79 -18.67 60.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.69 0.757 . . . . 0.0 110.242 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.923 HD13 ' HA ' ' A' ' 87' ' ' LEU . 10.5 mt -70.44 -38.7 74.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.404 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -54.49 -50.85 66.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.413 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.2 -40.88 71.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.221 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.488 ' CB ' ' HG3' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -78.22 -53.2 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.516 -173.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 90' ' ' LEU . 37.0 pt -64.74 -36.05 76.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.677 0.275 . . . . 0.0 111.727 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.631 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.9 mm-40 -79.22 -27.55 42.5 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 120.955 0.407 . . . . 0.0 110.506 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.38 -46.34 76.53 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 173.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.466 HD23 HG21 ' A' ' 98' ' ' VAL . 1.4 tp -67.59 -54.96 15.44 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.742 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.762 HG13 HG21 ' A' ' 123' ' ' ILE . 95.1 t -87.81 -48.62 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.631 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 40.3 ttmt -65.05 -23.29 67.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.046 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 30.9 tpt180 -93.6 -27.33 16.66 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.009 173.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.572 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -114.71 75.16 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.808 0.337 . . . . 0.0 111.29 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.4 m -108.34 95.06 14.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.225 0.536 . . . . 0.0 110.275 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 1.019 ' HB2' ' HG3' ' A' ' 44' ' ' ARG . 84.8 Cg_endo -113.74 122.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 124.482 3.454 . . . . 0.0 114.604 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.447 HD23 ' HD2' ' A' ' 105' ' ' PRO . 1.1 mt -92.02 123.75 61.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 172.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.553 ' HG3' ' HD3' ' A' ' 44' ' ' ARG . 1.7 Cg_endo -77.88 -59.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.568 2.179 . . . . 0.0 112.267 177.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.606 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 t -65.5 129.18 94.31 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.983 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.4 103.46 1.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.844 2.363 . . . . 0.0 112.267 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.805 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 68.5 Cg_endo -85.81 55.99 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.732 2.288 . . . . 0.0 111.524 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.729 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -54.38 -45.83 72.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.575 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.82 -6.84 51.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.291 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.805 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -98.36 -21.61 16.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.511 -177.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.832 ' HB3' HG12 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -124.3 17.79 9.04 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.4 m -71.1 89.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.965 0.888 . . . . 0.0 108.896 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER 157.43 -13.78 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 113.19 -1.823 . . . . 0.0 107.903 -172.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.06 -90.72 0.1 Allowed Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.032 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.537 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -160.57 175.09 13.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.308 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.832 HG12 ' HB3' ' A' ' 112' ' ' TYR . 10.8 m -101.99 114.47 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.417 0.627 . . . . 0.0 111.115 -175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -115.72 112.69 22.42 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 172.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.507 HD13 ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -144.11 152.61 41.17 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.328 -175.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 82' ' ' VAL . 86.6 m -90.47 124.67 35.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.151 0.501 . . . . 0.0 111.77 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.507 ' HG ' HD13 ' A' ' 119' ' ' LEU . 57.8 mt -126.76 123.45 23.79 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.861 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 11.5 Cg_exo -70.61 120.09 6.83 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.066 1.844 . . . . 0.0 111.277 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.762 HG21 HG13 ' A' ' 98' ' ' VAL . 33.0 pt -94.5 99.17 9.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -98.95 123.62 43.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.068 0.937 . . . . 0.0 111.923 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.566 ' HE2' ' HE2' ' A' ' 53' ' ' LYS . 59.8 m-85 -115.16 125.25 53.2 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 162.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.9 p -57.55 105.12 0.22 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.503 0.668 . . . . 0.0 111.327 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.725 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -83.19 99.26 9.83 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.759 -173.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.407 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 53.4 mtp180 -81.0 -47.96 12.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.52 174.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.58 66.8 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.931 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.771 ' HB2' HD22 ' A' ' 90' ' ' LEU . . . -105.47 5.58 31.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.122 0.487 . . . . 0.0 110.839 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -97.92 62.38 0.93 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.602 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 21.2 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.993 -177.65 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.0 mttp . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.3 t 55.73 69.05 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.437 0.637 . . . . 0.0 111.472 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -149.96 159.68 44.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.424 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.31 126.28 54.84 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -105.03 12.69 31.94 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.835 -172.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.7 m 67.64 -80.54 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.145 0.578 . . . . 0.0 111.116 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 36.6 t -119.55 -28.72 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.154 0.502 . . . . 0.0 110.349 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.52 10.12 48.39 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.832 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.52 127.62 29.99 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.38 125.69 5.83 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.589 2.193 . . . . 0.0 112.76 -178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.47 114.5 4.05 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.941 2.427 . . . . 0.0 111.6 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.58 66.16 6.53 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.928 2.418 . . . . 0.0 113.061 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.33 70.63 0.99 Allowed Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.215 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.619 ' HD3' ' O ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -154.94 131.51 10.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.158 0.504 . . . . 0.0 111.131 178.136 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.6 147.85 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.35 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -85.84 20.23 2.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.919 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -118.12 -16.94 9.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.72 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 p -126.0 -72.85 0.64 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.935 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.95 43.16 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.445 0.641 . . . . 0.0 110.88 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' N ' ' HD2' ' A' ' 22' ' ' PRO . . . -76.04 -48.49 3.49 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.57 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 21' ' ' ALA . 72.1 Cg_endo -75.73 40.54 0.72 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.286 1.99 . . . . 0.0 112.926 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 58.03 41.73 23.72 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.22 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -66.52 -18.43 65.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.288 0.566 . . . . 0.0 110.909 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 25' ' ' ARG . 1.6 ptm180 -72.06 -20.81 61.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.982 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.6 tp -166.36 70.77 0.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.643 ' HB ' ' HD3' ' A' ' 28' ' ' PRO . 17.3 m -63.05 -54.59 44.85 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.427 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 27' ' ' THR . 71.7 Cg_endo -80.44 106.25 1.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.615 1.543 . . . . 0.0 110.643 170.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.425 ' HE1' ' HB3' ' A' ' 31' ' ' GLN . 3.6 t80 -74.68 82.87 2.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.387 0.613 . . . . 0.0 110.59 -175.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.45 71.95 9.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.228 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.425 ' HB3' ' HE1' ' A' ' 29' ' ' TYR . 3.8 pt20 -85.77 67.15 9.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.329 0.585 . . . . 0.0 110.904 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.54 -41.26 8.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.759 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -134.88 90.21 0.24 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -92.83 -11.82 32.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.112 0.482 . . . . 0.0 110.575 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -118.94 -73.97 0.62 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.674 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -114.77 77.56 1.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.099 0.476 . . . . 0.0 110.319 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -119.18 -37.46 3.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.042 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -67.85 -30.03 69.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.104 0.478 . . . . 0.0 110.515 -174.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.4 -36.45 82.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.171 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.418 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 24.1 mmm180 -73.64 -41.36 62.85 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.346 0.594 . . . . 0.0 109.589 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.408 HG22 ' HG2' ' A' ' 103' ' ' PRO . 87.6 mt -61.39 -42.35 93.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.041 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t -55.59 -39.62 70.95 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.002 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.14 99.1 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.878 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.588 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 8.6 mpt_? -69.35 -34.69 74.98 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.787 0.327 . . . . 0.0 110.809 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.558 HD13 HG22 ' A' ' 98' ' ' VAL . 1.1 tt -65.11 -27.68 68.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.72 0.771 . . . . 0.0 109.581 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.604 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 10.3 t30 -71.96 -37.67 69.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.885 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -56.73 -27.8 59.89 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.609 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.497 ' HE2' ' HB3' ' A' ' 103' ' ' PRO . 94.9 m-85 -88.51 -56.87 3.13 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.866 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 mtmm 172.96 103.43 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.209 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.604 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 52.7 ttp180 -108.4 103.03 12.1 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -72.38 131.59 84.73 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.59 131.14 32.11 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.71 2.274 . . . . 0.0 112.131 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.597 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.92 -21.33 63.29 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.407 -173.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -52.97 -38.59 62.27 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.505 0.503 . . . . 0.0 110.792 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.74 -43.65 45.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.154 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 53' ' ' LYS . 3.2 mm? -64.07 -41.02 97.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.323 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.674 ' HG3' ' HG ' ' A' ' 58' ' ' LEU . 27.6 ptt180 -61.66 -19.72 62.62 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.361 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.674 ' HG ' ' HG3' ' A' ' 57' ' ' ARG . 82.9 mt -116.07 14.17 15.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.461 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.745 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 40.3 ttpt -151.21 -74.48 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 0.0 111.791 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.745 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 24.4 mmt180 -112.1 84.89 2.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.522 0.677 . . . . 0.0 110.183 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 126' ' ' SER . 3.1 pt20 -111.19 166.52 11.02 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.272 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.748 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.59 147.34 4.57 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.186 -1.483 . . . . 0.0 113.91 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.739 ' H ' HD12 ' A' ' 127' ' ' LEU . 61.9 t -116.13 124.94 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -151.97 166.15 30.87 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.432 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.616 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 56.8 mt-30 -101.85 132.15 47.78 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.447 HG13 ' CD2' ' A' ' 68' ' ' PHE . 56.1 t -124.26 113.23 35.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.404 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -103.02 121.75 43.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -142.53 165.64 26.84 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.466 0.651 . . . . 0.0 112.121 -171.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 11.9 m -114.99 127.78 55.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.005 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.483 HD13 ' CE1' ' A' ' 68' ' ' PHE . 46.5 mt -116.3 132.34 56.7 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.246 0.546 . . . . 0.0 111.784 -169.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.55 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 26.5 t70 -71.65 155.32 40.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.42 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 46.2 mtp180 -59.32 -18.81 41.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.294 -175.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.726 HE21 ' HA ' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -108.1 14.9 24.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.923 0.392 . . . . 0.0 111.279 177.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 77.54 49.26 7.38 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.714 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 19.1 t60 -114.84 126.49 54.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.87 121.91 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.187 0.517 . . . . 0.0 111.42 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 71' ' ' ASP . 52.7 mt -111.88 -47.53 3.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.251 0.548 . . . . 0.0 110.587 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.88 150.61 51.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.858 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.44 116.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.314 0.578 . . . . 0.0 110.386 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.6 m -127.43 127.12 43.59 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.888 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.6 tp -77.32 112.31 13.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.249 0.547 . . . . 0.0 110.466 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.588 HG22 HG21 ' A' ' 120' ' ' THR . 0.0 OUTLIER -96.28 -43.81 12.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.449 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 21.3 t 65.96 173.1 0.23 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.743 169.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.616 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 26.5 m -146.7 -67.11 0.27 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.23 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.25 -86.08 0.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.66 96.8 0.1 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.995 -174.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.855 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -120.1 84.46 33.52 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.36 -76.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 111.956 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 m -70.32 -18.42 63.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.529 0.68 . . . . 0.0 110.136 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.855 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.8 mt -75.8 -36.7 59.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.387 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 14.4 t70 -54.54 -47.76 72.78 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.671 0.607 . . . . 0.0 111.834 -172.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -52.71 -51.9 58.44 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -170.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.516 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 22.8 tt0 -77.97 -48.21 16.77 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.221 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 90' ' ' LEU . 38.3 pt -62.76 -35.99 73.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 120.578 0.228 . . . . 0.0 111.217 -176.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.59 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 74.5 mm-40 -82.32 -28.25 31.77 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-O 120.951 0.405 . . . . 0.0 110.589 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.659 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.96 -46.5 78.56 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 170.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 tp -67.26 -55.66 13.04 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.904 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.677 HG13 HG22 ' A' ' 123' ' ' ILE . 72.1 t -87.83 -49.05 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.59 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.9 ttmt -66.52 -19.71 65.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.666 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.659 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 14.2 tpp180 -91.24 -49.94 6.1 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.68 169.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.625 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -90.87 64.76 5.58 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.698 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -89.7 99.48 1.79 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.145 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.625 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 71.9 Cg_endo -102.31 174.76 0.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.737 2.958 . . . . 0.0 114.176 -174.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.552 HD22 ' CD ' ' A' ' 108' ' ' PRO . 32.0 tp -144.69 102.13 4.59 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.726 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.418 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 6.1 Cg_exo -68.25 -77.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.134 1.889 . . . . 0.0 112.866 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.432 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.5 p -80.59 119.03 75.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.702 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 26.8 Cg_exo -62.75 108.65 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.209 2.606 . . . . 0.0 112.806 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.823 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 86.4 Cg_endo -83.02 62.15 7.59 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.172 2.581 . . . . 0.0 111.68 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.705 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -52.33 -44.69 65.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.612 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.94 -9.97 59.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.123 -176.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.823 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -99.35 -23.88 15.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.818 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.705 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -117.02 17.58 14.88 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.535 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.8 m -71.68 88.42 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 168.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.535 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 5.7 p30 157.17 -16.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 113.989 -1.46 . . . . 0.0 108.002 -168.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.37 -85.1 0.14 Allowed Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.421 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.537 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.2 OUTLIER -154.71 176.5 12.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.744 ' O ' ' HA ' ' A' ' 69' ' ' THR . 3.7 m -99.98 107.61 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.995 0.903 . . . . 0.0 110.183 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 31.8 tt0 -107.95 111.16 23.12 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.04 175.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.743 HD11 ' HG ' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -147.33 155.06 41.67 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.346 -172.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.588 HG21 HG22 ' A' ' 82' ' ' VAL . 89.3 m -98.08 118.66 35.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.531 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.743 ' HG ' HD11 ' A' ' 119' ' ' LEU . 30.5 mt -124.18 127.76 25.24 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.409 175.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.5 Cg_exo -72.22 119.36 6.11 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.942 1.761 . . . . 0.0 110.768 175.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.677 HG22 HG13 ' A' ' 98' ' ' VAL . 40.7 pt -90.29 103.25 14.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -101.71 123.44 45.7 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.763 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -114.33 150.55 34.35 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 166.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 7.8 m -63.26 101.81 0.34 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.638 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.748 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.3 tt -89.58 102.63 15.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.905 0.383 . . . . 0.0 110.379 -174.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.417 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 36.3 mtp180 -98.59 -58.36 1.98 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.775 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.55 -156.61 8.48 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.892 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.476 ' CB ' HD22 ' A' ' 90' ' ' LEU . . . 69.47 -55.79 0.57 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.688 0.795 . . . . 0.0 112.007 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.48 -32.96 85.06 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.836 -0.506 . . . . 0.0 111.836 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.89 176.292 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.772 0.32 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.583 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 2.5 p -90.16 -72.5 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.047 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.583 ' HB2' ' O ' ' A' ' 3' ' ' VAL . 61.0 tt0 159.02 57.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.671 0.789 . . . . 0.0 109.581 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -165.35 115.2 1.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.647 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -128.34 3.52 5.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.008 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.9 t -75.88 -33.6 59.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.235 0.541 . . . . 0.0 109.922 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.37 5.42 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.825 0.821 . . . . 0.0 109.648 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.94 -166.44 33.03 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.97 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -128.53 111.52 19.27 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.6 0.2 . . . . 0.0 110.88 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -62.48 137.96 67.88 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.849 2.366 . . . . 0.0 111.896 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.58 120.33 7.92 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.986 2.457 . . . . 0.0 112.067 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.79 57.47 6.51 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.893 2.395 . . . . 0.0 112.663 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.19 161.07 24.16 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.231 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.474 ' HG2' ' H ' ' A' ' 17' ' ' ASP . 32.8 ttp-105 -142.84 136.95 29.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.28 25.81 10.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.235 0.54 . . . . 0.0 110.36 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.474 ' H ' ' HG2' ' A' ' 15' ' ' ARG . 12.7 m-20 -124.03 76.02 1.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.654 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -105.58 -78.36 0.57 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.1 p -85.01 57.54 4.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.069 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.639 ' HA ' ' HB ' ' A' ' 24' ' ' THR . . . -140.46 71.62 1.37 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.983 -176.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.864 ' HB1' ' HD3' ' A' ' 22' ' ' PRO . . . -110.58 -66.55 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.864 ' HD3' ' HB1' ' A' ' 21' ' ' ALA . 1.3 Cg_endo -83.35 -82.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.323 2.015 . . . . 0.0 113.289 -174.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -101.87 23.93 10.69 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.922 0.392 . . . . 0.0 111.552 -174.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.639 ' HB ' ' HA ' ' A' ' 20' ' ' ALA . 2.4 m -96.91 19.69 12.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.991 0.901 . . . . 0.0 110.139 176.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.497 ' HE ' ' HA ' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -105.95 -50.87 3.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 171.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.1 mt -138.85 82.13 1.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.016 173.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.7 t -68.38 134.2 91.07 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.348 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.15 107.21 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.844 2.362 . . . . 0.0 111.89 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -79.89 79.21 6.44 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.811 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.71 141.3 57.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.92 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.717 HE21 ' HA ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -135.87 138.1 42.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.907 -178.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.93 116.3 10.62 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.59 79.89 0.27 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.361 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -128.87 148.48 50.91 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 172.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -101.93 -26.56 13.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.013 0.435 . . . . 0.0 110.883 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.542 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 64.9 t30 -91.58 -1.32 57.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.441 -175.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.51 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.5 OUTLIER -60.23 -33.5 72.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.602 0.239 . . . . 0.0 111.217 -177.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -67.93 -38.31 82.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.23 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.82 -30.57 65.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.884 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 60.0 mtt180 -68.2 -41.72 80.93 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 172.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 37' ' ' TRP . 88.8 mt -59.05 -46.03 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.855 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.7 m -56.47 -29.79 62.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.892 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.69 -43.03 69.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.567 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.497 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.51 -34.27 74.04 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.102 0.477 . . . . 0.0 110.465 178.076 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 101' ' ' ALA . 1.3 tt -61.17 -33.48 73.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.96 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.821 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.2 t-20 -70.85 -37.87 73.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.696 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -27.39 34.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.901 175.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.79 -62.07 1.29 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.236 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 29.6 mtpp -164.0 103.14 0.88 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.821 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 56.3 ttp180 -117.81 103.29 9.83 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.58 176.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -77.3 112.8 25.92 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.11 131.38 44.94 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.592 2.194 . . . . 0.0 112.107 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.575 ' HE2' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -58.66 -22.69 57.55 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.683 -174.337 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.541 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 6.6 m-20 -55.07 -39.11 68.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.754 0.312 . . . . 0.0 110.982 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.12 -36.21 61.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.215 0.531 . . . . 0.0 110.417 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 60' ' ' ARG . 3.4 mm? -67.6 -35.62 79.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.745 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.541 ' HE ' ' HA ' ' A' ' 54' ' ' ASP . 46.8 mtm180 -54.1 -39.42 66.36 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 111.923 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.403 ' N ' HD11 ' A' ' 58' ' ' LEU . 7.5 mp -94.62 -23.41 17.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.287 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.743 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 6.6 ttpp -113.56 -81.9 0.6 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.749 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 19.3 mmt180 -103.19 83.07 2.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.4 0.619 . . . . 0.0 111.42 -173.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.48 HE22 ' CB ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -105.29 144.06 32.6 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.854 173.219 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 1.024 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 162.08 131.9 1.27 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.675 -170.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.84 125.53 58.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.985 0.421 . . . . 0.0 110.843 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.7 164.76 24.34 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 55.5 mt-30 -115.42 127.13 55.14 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.419 HG13 ' HE2' ' A' ' 99' ' ' LYS . 27.4 m -118.07 139.64 44.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.347 0.594 . . . . 0.0 110.825 -174.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 45.4 ttp180 -112.98 138.09 50.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.908 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -154.96 148.91 25.72 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.343 0.592 . . . . 0.0 112.116 -177.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 15.3 m -93.51 129.72 39.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 169.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.628 HD11 ' HG ' ' A' ' 104' ' ' LEU . 47.5 mt -121.31 136.69 54.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.203 0.525 . . . . 0.0 111.915 -170.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 14.4 t70 -83.56 161.73 21.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.677 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 73' ' ' GLN . 2.4 ptp180 -54.78 -35.9 64.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.693 0.282 . . . . 0.0 111.632 -177.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.472 ' N ' ' HG2' ' A' ' 72' ' ' ARG . 15.4 pt20 -87.39 12.05 13.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.351 . . . . 0.0 111.26 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.85 34.17 48.93 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.876 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 64.6 t60 -92.57 104.8 17.06 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.8 p -48.92 123.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.467 0.651 . . . . 0.0 111.377 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 13.6 mt -107.7 -43.08 4.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.528 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.85 153.58 51.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.865 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.421 ' HB ' ' HD2' ' A' ' 99' ' ' LYS . 11.3 m -140.15 129.36 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.302 0.572 . . . . 0.0 110.812 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.6 m -145.42 120.48 10.08 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.868 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 84' ' ' SER . 26.1 tp -72.97 108.25 5.78 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.528 HG23 HG22 ' A' ' 120' ' ' THR . 0.2 OUTLIER -80.46 -42.36 21.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.898 -172.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.434 ' HB3' ' HB2' ' A' ' 65' ' ' GLN . 8.6 t -140.22 147.27 39.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.212 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.475 ' HB2' HD22 ' A' ' 81' ' ' LEU . 28.6 t -142.88 131.88 23.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.831 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.54 17.5 6.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.013 0.435 . . . . 0.0 110.856 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.505 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 94.86 65.92 1.0 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.926 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.902 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -111.81 90.08 12.4 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 117.085 0.442 . . . . 0.0 109.954 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 6.1 Cg_exo -73.91 -74.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.714 2.276 . . . . 0.0 111.802 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.4 m -74.89 -19.22 60.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.431 0.634 . . . . 0.0 110.386 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.902 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 9.6 mt -76.89 -42.37 40.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.762 -172.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.555 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 28.6 t70 -54.95 -50.16 69.59 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.67 0.606 . . . . 0.0 112.414 -170.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -53.25 -44.28 68.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -77.05 -53.17 8.14 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.794 0.33 . . . . 0.0 111.784 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.444 ' O ' HD11 ' A' ' 97' ' ' LEU . 34.0 pt -60.53 -35.85 66.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.631 -176.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.678 HE22 HD12 ' A' ' 123' ' ' ILE . 51.3 mm-40 -82.91 -21.58 34.15 Favored 'General case' 0 C--O 1.205 -1.273 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.129 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.05 -54.06 44.52 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.142 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -75.72 -46.24 32.21 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.543 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.721 HG13 HG22 ' A' ' 123' ' ' ILE . 30.8 t -62.55 -49.21 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 1.3 tppp? -70.82 -35.63 72.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.191 -169.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -80.71 -34.9 34.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.848 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.631 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -101.15 67.65 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.193 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.0 m -97.33 97.69 4.12 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.182 0.515 . . . . 0.0 109.781 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.631 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 88.0 Cg_endo -107.93 173.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.245 3.297 . . . . 0.0 114.553 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.628 ' HG ' HD11 ' A' ' 70' ' ' LEU . 14.1 mt -140.61 122.39 9.45 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.617 171.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 12.2 Cg_endo -82.06 -40.17 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.657 2.238 . . . . 0.0 111.676 174.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.465 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 12.8 m -94.92 103.46 11.73 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.374 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.87 106.76 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.564 2.176 . . . . 0.0 112.234 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.627 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 67.9 Cg_endo -83.0 58.19 6.25 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.751 2.301 . . . . 0.0 111.813 -176.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.774 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.55 -46.21 77.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.832 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.92 -23.02 66.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.158 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.627 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -86.72 -35.89 18.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.075 -175.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.774 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -105.78 15.91 26.04 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.008 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 3.6 m -72.15 89.52 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 169.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 2.3 p30 159.75 -22.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.212 -169.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 162.42 -85.09 0.11 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.737 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.552 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -159.4 173.22 16.57 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.758 HG12 ' HB3' ' A' ' 112' ' ' TYR . 24.5 m -104.98 110.4 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 121.328 0.585 . . . . 0.0 110.961 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 43.9 tt0 -107.78 110.65 22.5 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 170.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.607 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.7 pp -135.41 155.62 50.26 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.39 -174.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.528 HG22 HG23 ' A' ' 82' ' ' VAL . 99.9 m -101.08 129.13 46.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.107 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.607 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 54.3 mt -128.56 130.49 23.51 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 2.9 Cg_exo -76.12 121.48 6.17 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.791 2.327 . . . . 0.0 111.565 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.721 HG22 HG13 ' A' ' 98' ' ' VAL . 43.0 pt -97.76 99.98 9.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.49 119.04 29.58 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.124 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.575 ' CE2' ' HE2' ' A' ' 53' ' ' LYS . 83.2 m-85 -116.25 120.19 38.14 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 162.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.5 m -58.74 102.5 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -169.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 1.024 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 3.4 mt -73.23 114.13 11.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.104 0.478 . . . . 0.0 110.248 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.68 24.75 4.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.639 -175.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 145.42 61.12 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.819 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.48 ' CB ' HE22 ' A' ' 61' ' ' GLN . . . -169.0 164.55 11.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 89.29 -6.68 83.24 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.543 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 30.0 p90 . . . . . 0 C--O 1.252 1.195 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.014 179.026 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.77 29.24 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.215 0.531 . . . . 0.0 110.561 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -131.81 50.26 2.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -89.28 78.22 7.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.37 -170.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -91.52 -60.41 1.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.154 0.502 . . . . 0.0 110.349 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 10' ' ' ALA . 23.9 t -94.64 117.97 30.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.52 -177.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.81 -57.36 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.542 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.84 24.63 14.4 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.106 -0.569 . . . . 0.0 113.605 -174.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HB2' ' OG ' ' A' ' 7' ' ' SER . . . -114.64 111.86 45.89 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.23 121.46 8.76 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.654 2.236 . . . . 0.0 111.823 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 40.3 Cg_endo -67.93 122.78 9.93 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.695 2.263 . . . . 0.0 111.782 178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 28.0 Cg_exo -62.08 111.39 1.23 Allowed 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.7 2.266 . . . . 0.0 111.994 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -93.34 -54.4 1.71 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.632 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -127.6 110.42 12.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.727 0.299 . . . . 0.0 111.265 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.66 -55.59 4.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 46.54 73.18 0.19 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.328 -1.306 . . . . 0.0 112.85 170.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -137.66 138.53 39.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.622 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 m -88.68 -18.3 28.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.343 0.592 . . . . 0.0 110.333 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.3 61.7 6.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.806 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.736 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . . . -118.73 -60.25 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.869 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.736 ' HD3' ' HB2' ' A' ' 21' ' ' ALA . 4.1 Cg_exo -74.99 -87.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.925 1.75 . . . . 0.0 113.041 -176.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -110.49 -27.57 8.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.609 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -78.22 44.53 0.5 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.228 0.537 . . . . 0.0 111.497 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.692 ' HG3' ' HG ' ' A' ' 26' ' ' LEU . 8.6 ptp180 -100.43 -18.94 16.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.247 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.692 ' HG ' ' HG3' ' A' ' 25' ' ' ARG . 83.9 mt -117.07 11.28 14.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.267 0.556 . . . . 0.0 110.384 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.1 p -89.33 121.37 69.44 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.722 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -68.92 103.91 1.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.532 2.155 . . . . 0.0 109.965 172.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -90.32 45.3 1.25 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.534 0.683 . . . . 0.0 110.637 -174.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 111' ' ' ALA . . . -90.31 -10.58 43.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.422 170.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' A' ' 31' ' ' GLN . 8.0 pt20 -82.7 60.94 5.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.803 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.9 130.87 38.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.912 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.03 21.6 0.17 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.054 -0.594 . . . . 0.0 111.802 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.55 -40.39 3.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.051 -176.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.5 t70 66.72 139.14 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.509 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 178.46 -27.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.311 -1.313 . . . . 0.0 107.819 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.637 ' HA ' ' HG2' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -74.99 -8.18 55.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.118 -178.032 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.574 ' HG3' ' N ' ' A' ' 39' ' ' SER . 9.6 ptp180 -63.6 -39.96 95.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.243 0.544 . . . . 0.0 109.874 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.574 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 3.5 m -67.58 -30.39 69.99 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.602 -178.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.637 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 16.8 mmt180 -71.72 -43.35 66.02 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.283 176.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.611 HG23 ' HD2' ' A' ' 103' ' ' PRO . 76.2 mt -59.85 -49.04 85.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.222 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.1 t -57.04 -30.24 64.08 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.605 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -68.21 -44.94 73.64 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.043 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.503 ' NE ' ' HB3' ' A' ' 105' ' ' PRO . 9.5 mpt_? -69.66 -34.49 74.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.973 0.416 . . . . 0.0 110.322 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 101' ' ' ALA . 2.7 tt -59.52 -32.28 70.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.761 0.791 . . . . 0.0 109.076 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 1.033 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 28.4 t30 -70.99 -42.32 69.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.156 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 8.0 ptt180 -61.29 -18.54 58.99 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.298 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -100.54 -58.47 1.89 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.153 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -162.59 103.08 1.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.864 0.466 . . . . 0.0 110.314 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 1.033 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 5.7 tpt180 -134.05 103.12 5.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.405 ' HB3' HD22 ' A' ' 56' ' ' LEU . 1.8 t80 -89.16 138.14 29.08 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.223 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.56 131.62 41.8 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.806 2.337 . . . . 0.0 111.996 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.541 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.01 -25.68 67.07 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.037 -173.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.1 -41.05 67.84 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.323 0.389 . . . . 0.0 110.913 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.1 -38.73 75.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.743 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.5 mm? -66.53 -38.73 87.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.549 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 69.8 mtt180 -65.71 -13.95 60.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.386 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.6 mt -110.85 2.1 18.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.792 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.609 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 21.1 ttmm -137.92 -74.42 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.532 -173.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.609 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 38.4 mmt180 -126.55 106.4 9.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 110.335 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.538 ' O ' HD11 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -117.78 158.19 25.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.612 178.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.973 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 153.29 144.17 3.85 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 119.79 -1.195 . . . . 0.0 113.345 -177.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.752 ' H ' HD13 ' A' ' 127' ' ' LEU . 2.8 p -104.13 122.77 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.373 0.606 . . . . 0.0 110.132 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.79 151.35 21.25 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 21.9 tt0 -105.63 135.42 47.06 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.53 131.67 71.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.014 0.435 . . . . 0.0 110.777 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -115.04 140.9 48.67 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.31 153.74 27.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.209 0.528 . . . . 0.0 111.757 -175.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 21.1 m -96.89 130.39 44.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.8 173.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.429 HD11 ' O ' ' A' ' 103' ' ' PRO . 49.6 mt -118.35 133.98 55.43 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.111 0.481 . . . . 0.0 111.677 -173.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.71 155.9 30.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.186 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -55.75 -33.71 64.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.003 0.43 . . . . 0.0 110.285 175.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -76.68 6.25 6.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.129 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.23 36.82 63.61 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.395 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -113.29 122.45 47.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 8.6 p -48.75 127.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.927 0.767 . . . . 0.0 111.522 172.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.414 ' CD1' HG21 ' A' ' 116' ' ' THR . 36.0 mt -113.71 -43.85 3.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.224 0.535 . . . . 0.0 110.73 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.79 154.21 48.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.168 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.489 HG11 ' HG3' ' A' ' 99' ' ' LYS . 3.1 m -147.66 127.08 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.0 m -144.64 127.83 16.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 tp -76.38 108.64 9.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.741 HG21 HG22 ' A' ' 120' ' ' THR . 0.0 OUTLIER -74.63 -34.26 34.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.637 0.732 . . . . 0.0 109.056 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.9 t 75.29 171.39 0.27 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.605 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -153.67 -52.44 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.682 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.93 -79.1 0.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 168.49 103.68 0.17 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.513 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.761 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.7 OUTLIER -119.39 103.96 46.22 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -84.44 -81.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.24 1.96 . . . . 0.0 111.991 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.2 p -71.0 -19.02 62.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.192 0.52 . . . . 0.0 110.529 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.761 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 8.9 mt -75.12 -32.26 61.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.908 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 15.8 t70 -54.48 -50.38 67.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.896 -171.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 93' ' ' GLU . 17.0 ptp180 -52.64 -46.89 67.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.569 -175.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 11.1 mt-10 -78.46 -53.94 6.7 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.496 HD12 ' HG ' ' A' ' 87' ' ' LEU . 34.2 pt -62.32 -33.91 61.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.559 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 56.1 mm-40 -82.02 -29.56 31.94 Favored 'General case' 0 C--O 1.203 -1.392 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.371 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.78 68.47 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.136 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.515 HD22 HG21 ' A' ' 98' ' ' VAL . 0.7 OUTLIER -63.81 -54.64 31.95 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.763 176.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.76 HG13 HG23 ' A' ' 123' ' ' ILE . 39.4 t -85.15 -48.55 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.559 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -63.59 -34.34 77.59 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.211 0.604 . . . . 0.0 110.865 -174.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.49 -48.3 19.99 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.247 0.546 . . . . 0.0 109.689 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.636 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -93.34 58.83 2.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.398 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.477 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.9 m -95.84 99.23 4.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.334 0.588 . . . . 0.0 109.939 174.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.636 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 72.9 Cg_endo -103.42 176.17 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 124.712 3.608 . . . . 0.0 113.441 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.648 HD21 ' HD2' ' A' ' 108' ' ' PRO . 38.5 tp -142.04 91.0 8.16 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.503 ' HB3' ' NE ' ' A' ' 44' ' ' ARG . 11.9 Cg_endo -70.46 -53.13 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.246 1.964 . . . . 0.0 112.824 -174.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.541 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 23.2 p -92.08 106.25 16.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -68.3 106.16 1.35 Allowed 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.822 2.348 . . . . 0.0 112.621 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.648 ' HD2' HD21 ' A' ' 104' ' ' LEU . 44.9 Cg_endo -86.66 61.18 4.4 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.195 2.596 . . . . 0.0 111.194 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.728 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.46 -41.54 80.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.17 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.99 -25.76 67.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.511 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.97 -29.76 21.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.78 ' HD2' HG12 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.72 16.41 16.39 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -172.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.527 HG11 ' O ' ' A' ' 109' ' ' ALA . 2.5 m -71.36 88.36 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.628 HD21 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 154.95 -15.35 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 113.426 -1.716 . . . . 0.0 108.609 -167.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.628 ' N ' HD21 ' A' ' 114' ' ' ASN . . . 168.96 -100.21 0.16 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.828 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.675 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.3 OUTLIER -161.15 176.67 11.04 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.78 HG12 ' HD2' ' A' ' 112' ' ' TYR . 12.3 m -101.5 108.77 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.585 0.707 . . . . 0.0 110.754 -177.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -99.0 111.25 23.7 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.598 HD12 ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -134.49 152.85 52.06 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.843 -173.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.741 HG22 HG21 ' A' ' 82' ' ' VAL . 54.8 m -103.42 128.07 50.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.395 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.598 ' HG ' HD12 ' A' ' 119' ' ' LEU . 98.3 mt -132.94 125.19 19.03 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.481 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 3.2 Cg_exo -79.97 120.18 4.14 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.947 1.764 . . . . 0.0 111.785 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.76 HG23 HG13 ' A' ' 98' ' ' VAL . 41.6 pt -96.6 98.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 3.4 p-10 -107.03 124.94 50.37 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.693 -176.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -111.75 141.65 45.09 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 165.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.4 m -57.76 102.49 0.1 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.034 0.445 . . . . 0.0 111.614 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.973 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -85.9 69.69 10.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.331 -175.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 25.76 5.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.33 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 162.12 179.15 36.57 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.481 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.52 ' HB2' HD23 ' A' ' 90' ' ' LEU . . . 74.37 -50.01 0.67 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.557 0.743 . . . . 0.0 112.479 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.502 ' HA3' HD22 ' A' ' 127' ' ' LEU . . . -71.04 -25.33 75.94 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.381 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 29.4 p90 . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.716 178.104 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.8 mttp . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 110.559 -0.163 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 67.9 t 72.85 -49.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.623 0.769 . . . . 0.0 112.418 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -60.71 -24.85 65.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -173.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -65.68 -35.07 79.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.183 0.516 . . . . 0.0 109.937 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -81.57 -22.52 37.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.453 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m -85.85 67.89 10.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.354 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.01 -51.6 38.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.91 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.91 163.06 33.02 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.729 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.98 106.82 13.81 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.684 0.278 . . . . 0.0 110.637 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -62.09 135.1 52.89 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.759 2.306 . . . . 0.0 111.87 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.76 119.95 6.56 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.674 2.249 . . . . 0.0 112.392 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.52 -12.23 20.53 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.073 2.515 . . . . 0.0 112.115 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.21 139.45 15.65 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -102.73 148.71 25.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.007 0.432 . . . . 0.0 111.081 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -160.08 99.51 1.36 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.519 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -125.87 130.79 52.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.136 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -133.61 104.71 6.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.707 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.2 p 64.46 -7.16 0.25 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.644 1.178 . . . . 0.0 113.742 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.444 ' O ' ' HB ' ' A' ' 24' ' ' THR . . . -94.68 36.35 1.18 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.599 0.714 . . . . 0.0 110.859 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.576 ' H ' ' HD2' ' A' ' 22' ' ' PRO . . . -114.7 -54.53 0.04 OUTLIER Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.492 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HD2' ' H ' ' A' ' 21' ' ' ALA . 56.6 Cg_endo -72.71 -19.22 24.42 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 121.492 1.461 . . . . 0.0 111.775 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.43 ' NE2' ' HA ' ' A' ' 23' ' ' GLN . 12.8 mm-40 -120.7 41.07 3.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.22 0.533 . . . . 0.0 111.066 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.5 HG21 ' O ' ' A' ' 21' ' ' ALA . 14.8 t -98.46 29.54 3.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.017 0.913 . . . . 0.0 108.877 172.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -96.12 -73.42 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.467 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.6 mp -141.46 65.61 1.38 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.495 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -67.67 126.02 92.04 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 121.073 0.463 . . . . 0.0 111.231 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -83.64 14.52 2.37 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.954 2.436 . . . . 0.0 112.387 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -103.93 31.39 4.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.492 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.475 ' HB3' HG12 ' A' ' 117' ' ' VAL . . . -88.33 20.58 3.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.81 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.506 HE22 HD13 ' A' ' 119' ' ' LEU . 6.1 tp-100 -81.47 73.1 8.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.402 0.62 . . . . 0.0 109.751 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.21 -4.56 59.1 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.107 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.6 115.94 4.04 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.187 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -91.52 -1.62 57.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.266 0.555 . . . . 0.0 110.372 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -97.55 119.31 35.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -72.81 119.05 16.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.028 0.442 . . . . 0.0 110.728 -174.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 -82.43 25.04 0.65 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.797 -174.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -67.95 -35.76 78.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.453 -170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 p -63.48 -40.39 96.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.266 0.555 . . . . 0.0 110.144 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.487 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 50.8 mmm-85 -74.99 -46.24 36.56 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.268 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.562 HG23 ' HG2' ' A' ' 103' ' ' PRO . 58.3 mt -57.46 -43.19 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.549 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.7 m -59.73 -44.43 93.76 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.603 0.24 . . . . 0.0 111.51 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.85 -33.98 88.7 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.457 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.622 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 27.9 ttt85 -69.83 -35.73 75.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.75 0.309 . . . . 0.0 110.347 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.499 ' HB3' ' HD2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -64.28 -31.55 72.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.379 0.609 . . . . 0.0 109.667 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.63 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 11.4 t30 -70.97 -30.69 67.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.631 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 47.9 ttt180 -70.18 -29.03 65.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.84 171.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 49' ' ' LYS . 61.3 m-85 -99.62 25.25 7.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.202 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 48' ' ' PHE . 13.0 tmtt? 74.2 103.36 0.07 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.493 0.664 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.63 ' HB3' ' HA ' ' A' ' 46' ' ' ASN . 32.3 ttt180 -137.89 108.0 6.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.191 -176.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.532 ' HB3' HD21 ' A' ' 56' ' ' LEU . 6.2 t80 -61.78 134.6 94.06 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.43 129.13 8.55 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.987 2.458 . . . . 0.0 112.06 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.759 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -71.49 -25.28 62.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.125 -163.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -66.93 -33.26 75.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.958 0.408 . . . . 0.0 110.77 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.85 -30.32 70.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.415 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.532 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.6 mm? -78.41 -41.68 32.31 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.765 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 51.4 mtm180 -75.1 -10.89 59.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.05 -0.406 . . . . 0.0 111.994 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 33.3 tp -105.58 17.06 24.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.466 0.65 . . . . 0.0 109.803 176.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.545 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 25.0 ttmm -146.01 -54.27 0.27 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.371 -175.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.869 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 17.9 mmt180 -126.32 83.28 2.15 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.866 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.581 ' HB2' ' O ' ' A' ' 126' ' ' SER . 0.8 OUTLIER -100.15 137.3 38.78 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.552 -179.051 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.911 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 171.99 160.61 20.92 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.669 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 p -116.35 125.72 73.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.173 0.511 . . . . 0.0 110.527 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.93 159.27 23.46 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.558 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 49.9 tt0 -104.27 123.74 47.9 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 121' ' ' LEU . 9.5 p -127.01 126.68 68.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.408 0.623 . . . . 0.0 111.041 -167.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -115.82 144.94 43.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.717 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -158.97 155.14 27.02 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.066 0.46 . . . . 0.0 110.937 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 22.0 m -100.52 129.35 46.45 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 171.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 75.5 mt -113.95 140.59 48.27 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.724 0.773 . . . . 0.0 112.146 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 27.9 t70 -77.7 165.16 24.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.85 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.509 ' HA ' ' OH ' ' A' ' 112' ' ' TYR . 38.6 mtp180 -54.39 -35.72 63.15 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.531 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -83.03 6.16 19.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 110.817 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.8 40.1 53.49 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.623 -176.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 71.1 t60 -108.14 138.16 44.89 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.379 -0.41 . . . . 0.0 110.349 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 100' ' ' ARG . 10.5 p -59.24 130.94 23.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.348 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 71' ' ' ASP . 56.5 mt -120.27 -40.77 2.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.292 0.568 . . . . 0.0 110.282 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.2 148.04 51.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.981 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.77 123.99 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 123.564 0.54 . . . . 0.0 109.807 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.1 m -144.53 118.75 9.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.841 0.353 . . . . 0.0 111.376 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 84' ' ' SER . 34.3 tp -85.03 106.73 16.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -87.24 -46.69 16.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.196 -170.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 m -144.78 112.64 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.633 ' HB2' HD23 ' A' ' 81' ' ' LEU . 34.5 t -106.32 137.77 43.69 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.59 -7.56 59.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.266 0.555 . . . . 0.0 110.536 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.73 -86.23 0.14 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 1.12 ' HA ' HD13 ' A' ' 90' ' ' LEU . 2.3 mm? 44.24 59.03 13.38 Favored Pre-proline 0 CA--C 1.534 0.335 0 O-C-N 124.304 0.649 . . . . 0.0 112.495 173.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -61.92 -71.44 0.03 OUTLIER 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 121.334 1.356 . . . . 0.0 111.936 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 t -76.92 -18.64 58.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.462 0.649 . . . . 0.0 110.055 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 1.12 HD13 ' HA ' ' A' ' 87' ' ' LEU . 6.6 mt -75.91 -41.31 52.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.517 -172.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.449 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 19.2 t70 -53.95 -47.0 71.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.502 -172.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -54.64 -37.28 65.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.471 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.869 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 2.3 tp10 -78.49 -54.88 5.68 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.0 pt -68.8 -35.46 69.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.562 -173.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.6 ' NE2' HD13 ' A' ' 123' ' ' ILE . 56.5 mm-40 -79.87 -27.55 40.06 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.788 0.328 . . . . 0.0 110.649 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.526 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.24 -46.95 76.03 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.117 173.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.435 ' O ' HD22 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -63.97 -57.59 9.25 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.698 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.645 HG11 HG22 ' A' ' 123' ' ' ILE . 80.5 t -87.6 -48.82 15.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.586 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.7 ttmt -67.18 -27.09 66.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.044 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.543 ' HD3' ' C ' ' A' ' 100' ' ' ARG . 3.2 tmt_? -85.43 -53.92 4.9 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.016 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.434 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -96.49 65.52 2.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.739 0.304 . . . . 0.0 111.105 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.476 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 16.1 m -78.04 107.85 6.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.807 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.622 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 39.6 Cg_endo -101.49 139.41 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 124.022 3.148 . . . . 0.0 113.963 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.434 HD22 ' O ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -125.98 107.11 25.28 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 171.374 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.487 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 11.5 Cg_exo -65.05 -62.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 122.715 2.277 . . . . 0.0 112.622 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.499 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 8.8 t -80.73 123.28 82.58 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.706 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 14.9 Cg_exo -69.47 107.67 1.85 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.047 2.498 . . . . 0.0 111.862 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.563 ' HB2' ' HB1' ' A' ' 111' ' ' ALA . 43.1 Cg_endo -84.52 59.97 5.91 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.927 2.418 . . . . 0.0 111.542 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.679 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -54.27 -48.88 70.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.086 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -75.02 6.95 3.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.707 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.563 ' HB1' ' HB2' ' A' ' 108' ' ' PRO . . . -106.96 -38.1 6.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.797 ' HB3' HG11 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -106.88 18.05 22.33 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.552 HG11 ' O ' ' A' ' 109' ' ' ALA . 2.4 m -69.9 87.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 122.447 1.118 . . . . 0.0 108.34 172.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 5.5 p30 166.54 -39.04 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.109 -1.86 . . . . 0.0 107.526 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.08 -75.17 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.987 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.475 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.8 OUTLIER -160.14 174.07 14.83 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.953 0.501 . . . . 0.0 109.958 -178.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.797 HG11 ' HB3' ' A' ' 112' ' ' TYR . 10.4 m -105.02 109.07 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 121.282 0.563 . . . . 0.0 110.861 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -103.42 111.77 24.36 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 169.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.603 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -142.97 150.18 39.34 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.91 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.2 m -99.79 128.14 45.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.209 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.603 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 83.7 mt -126.73 123.54 23.85 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.559 176.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 51.9 Cg_endo -73.32 123.64 8.87 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.547 1.498 . . . . 0.0 111.921 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.645 HG22 HG11 ' A' ' 98' ' ' VAL . 8.1 pt -98.45 97.84 6.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.42 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -104.16 124.07 48.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.673 0.749 . . . . 0.0 112.199 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -117.06 151.2 37.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.397 169.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.581 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 10.3 m -61.02 102.8 0.22 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.063 0.227 . . . . 0.0 110.656 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.911 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.3 tt -83.26 77.15 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.236 0.541 . . . . 0.0 110.787 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -142.45 105.93 4.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.485 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 148.7 -57.36 0.47 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.3 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 90' ' ' LEU . . . -121.3 -171.12 2.15 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.461 ' HA2' HD11 ' A' ' 90' ' ' LEU . . . 91.42 8.76 63.88 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.1 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 24.9 p90 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.487 -0.768 . . . . 0.0 109.815 176.724 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.4 tttm . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 121.061 0.458 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.8 m -125.2 2.34 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.776 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.549 ' HG3' ' HB2' ' A' ' 7' ' ' SER . 44.6 tp60 -108.75 47.21 0.92 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.495 0.664 . . . . 0.0 109.308 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -74.89 118.41 17.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.662 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 64.35 70.09 0.5 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.595 0.712 . . . . 0.0 109.652 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.549 ' HB2' ' HG3' ' A' ' 4' ' ' GLN . 28.3 t -77.98 140.13 39.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.461 -175.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.3 m -99.05 175.43 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.823 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.04 158.22 18.45 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.957 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 12' ' ' PRO . . . -104.32 119.81 52.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.639 0.257 . . . . 0.0 110.963 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 18.1 Cg_endo -92.51 105.25 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.383 2.722 . . . . 0.0 112.286 176.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 10' ' ' ALA . 56.2 Cg_exo -52.09 -45.31 39.82 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.384 2.723 . . . . 0.0 114.71 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 12' ' ' PRO . 58.8 Cg_endo -71.77 54.48 2.05 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 121.923 1.748 . . . . 0.0 113.273 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.77 -42.99 24.42 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 15' ' ' ARG . 19.0 mtm180 -120.2 64.59 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.195 0.521 . . . . 0.0 109.991 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.33 68.36 10.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.347 0.594 . . . . 0.0 110.458 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -89.04 154.2 20.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.683 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 18' ' ' LYS . 11.4 mptt -110.36 77.43 1.05 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.87 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.3 m -78.57 97.77 5.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.246 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.79 109.23 8.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.07 0.462 . . . . 0.0 110.767 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.72 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -151.0 174.08 3.84 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.55 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.72 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 9.8 Cg_endo -54.44 -22.91 29.12 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.157 1.904 . . . . 0.0 112.522 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -81.93 -26.2 34.25 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.6 p -82.79 27.43 0.53 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.106 0.479 . . . . 0.0 111.739 -174.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 22' ' ' PRO . 29.2 ptt180 -125.93 -4.25 6.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.728 173.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.4 mt -143.02 36.94 1.4 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.606 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.497 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 15.2 t -105.52 138.5 19.6 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 27' ' ' THR . 2.7 Cg_exo -77.54 61.1 7.35 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.388 2.725 . . . . 0.0 113.058 -176.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -131.38 109.58 10.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.03 0.443 . . . . 0.0 110.534 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.892 ' HB3' ' HA ' ' A' ' 111' ' ' ALA . . . -99.04 -68.19 0.81 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.722 176.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -174.33 -46.86 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.59 177.35 5.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.182 171.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.749 ' HA2' ' HZ2' ' A' ' 37' ' ' TRP . . . 118.66 3.9 13.67 Favored Glycine 0 CA--C 1.504 -0.631 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.924 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -95.87 -16.46 21.79 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.81 0.814 . . . . 0.0 108.893 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -110.36 162.79 14.31 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.222 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.464 ' OD1' ' HG2' ' A' ' 38' ' ' ARG . 43.1 t-20 -100.67 117.01 33.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.999 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.749 ' HZ2' ' HA2' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -104.87 1.86 29.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -175.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.464 ' HG2' ' OD1' ' A' ' 36' ' ' ASN . 25.0 ptt180 -67.89 -33.13 74.14 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.315 -170.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.5 p -70.85 -31.28 67.92 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.455 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 21.5 mmt180 -68.19 -46.18 71.35 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.525 HG21 ' HD2' ' A' ' 103' ' ' PRO . 88.8 mt -57.45 -44.76 85.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.211 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.5 t -56.2 -36.31 68.27 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.539 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.75 -42.4 98.6 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.507 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.612 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.75 -32.29 70.74 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.114 0.483 . . . . 0.0 110.7 177.159 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.27 -31.43 71.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.477 0.656 . . . . 0.0 109.696 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.59 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 10.0 t30 -71.52 -34.26 69.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.598 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -54.02 -25.56 21.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.592 173.066 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.582 ' HE2' ' HB3' ' A' ' 103' ' ' PRO . 97.5 m-85 -100.0 -61.11 1.41 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.017 174.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 11.6 mmmm -170.72 110.31 0.36 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.487 0.715 . . . . 0.0 109.533 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.59 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 45.7 ttp180 -125.03 111.91 15.93 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.985 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.615 ' H ' HD11 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -82.63 137.93 44.3 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.505 177.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.87 131.2 40.55 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.582 2.188 . . . . 0.0 111.622 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.679 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.63 -23.35 62.93 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.65 -171.493 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -53.69 -46.57 70.76 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.265 0.353 . . . . 0.0 111.145 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.9 -29.87 68.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.016 0.436 . . . . 0.0 111.477 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 60' ' ' ARG . 3.2 mm? -75.47 -42.35 53.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 0.0 110.34 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 57' ' ' ARG . 59.9 mtt180 -70.65 -12.01 61.29 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 pp -109.79 7.74 24.29 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.972 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.595 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 19.3 ttpp -158.14 -69.8 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.595 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 22.2 mmt180 -90.23 82.6 6.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.257 1.027 . . . . 0.0 110.063 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.63 ' O ' HD12 ' A' ' 90' ' ' LEU . 24.4 mt-30 -105.17 159.16 16.07 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.345 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.42 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.29 131.6 1.72 Allowed Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.795 -1.193 . . . . 0.0 112.656 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.562 HG23 ' HB2' ' A' ' 124' ' ' ASP . 60.6 t -104.22 123.08 57.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.98 166.4 30.42 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.142 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.56 ' O ' HG21 ' A' ' 82' ' ' VAL . 53.8 mt-30 -102.75 131.43 49.6 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.488 HG22 HD13 ' A' ' 123' ' ' ILE . 20.8 t -126.66 117.08 47.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.069 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.613 ' HD3' ' OE2' ' A' ' 118' ' ' GLU . 10.8 ttm180 -109.48 139.49 44.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.568 -176.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.422 ' CD1' HD22 ' A' ' 70' ' ' LEU . 8.1 p90 -159.2 154.64 25.73 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.686 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 26.4 m -96.86 140.9 30.74 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.357 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 104' ' ' LEU . 65.4 mt -124.37 138.58 54.36 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.588 0.709 . . . . 0.0 112.683 -170.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.594 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 13.6 t70 -73.04 157.65 36.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.435 172.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -57.67 -27.35 62.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.876 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -100.39 15.27 28.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.864 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.682 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 75.8 46.76 13.21 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.094 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 53.2 t60 -110.52 122.23 47.24 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.6 p -50.57 116.38 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.551 0.691 . . . . 0.0 111.488 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.5 mt -100.81 -44.48 5.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.521 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.44 161.94 33.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.02 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.467 HG21 ' HG3' ' A' ' 99' ' ' LYS . 7.5 p -160.23 117.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.372 0.606 . . . . 0.0 109.589 175.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.2 m -124.37 112.83 17.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.714 -177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.0 tp -69.38 105.77 2.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.56 0.695 . . . . 0.0 109.818 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -86.98 -54.83 7.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.491 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 32.4 t 63.18 -175.01 0.15 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.249 170.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -152.03 -63.13 0.17 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.79 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.96 -37.98 13.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.975 0.417 . . . . 0.0 111.396 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.76 104.17 2.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.406 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.84 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 1.7 mm? -103.01 103.41 33.79 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.48 -80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.959 2.439 . . . . 0.0 112.862 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 m -69.34 -19.5 63.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.442 0.639 . . . . 0.0 110.387 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.84 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.7 mt -75.7 -31.55 59.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.203 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 9.9 t70 -54.26 -48.9 70.66 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.602 0.564 . . . . 0.0 111.665 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -53.21 -45.7 68.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -171.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.577 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 16.8 tt0 -78.77 -53.35 7.21 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.961 -176.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.585 HG21 ' HB3' ' A' ' 60' ' ' ARG . 38.7 pt -67.1 -37.31 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.662 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 78.6 mm-40 -81.59 -25.72 35.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 120.881 0.372 . . . . 0.0 110.908 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.87 -43.47 77.18 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 169.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.615 HD11 ' H ' ' A' ' 51' ' ' TYR . 1.4 tp -67.6 -56.81 7.96 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.824 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.58 HG12 HG21 ' A' ' 123' ' ' ILE . 63.9 t -88.53 -49.13 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -175.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.662 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.6 ttmt -65.16 -22.56 66.93 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.003 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.428 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 2.6 tmt_? -90.99 -55.21 3.64 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.885 -0.509 . . . . 0.0 109.766 173.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.643 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -84.21 73.73 10.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 0.0 110.807 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.423 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 9.1 m -99.27 98.01 6.09 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 121.335 0.588 . . . . 0.0 109.577 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.643 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 93.6 Cg_endo -105.43 176.46 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 124.227 3.285 . . . . 0.0 113.686 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.682 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 4.0 tt -144.02 115.36 5.52 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.561 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.455 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 5.1 Cg_exo -70.75 -72.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.71 2.273 . . . . 0.0 112.757 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.43 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -86.16 117.22 68.32 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.492 -177.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.479 ' HA ' HD21 ' A' ' 104' ' ' LEU . 24.8 Cg_exo -64.06 106.44 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.266 2.644 . . . . 0.0 112.293 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.639 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 61.4 Cg_endo -88.72 67.41 2.83 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.228 2.619 . . . . 0.0 112.071 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.774 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.69 -43.4 76.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.19 0.519 . . . . 0.0 110.051 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -72.52 -2.17 18.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.636 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.892 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . . . -105.52 -29.69 10.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.774 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -106.66 16.52 24.42 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.576 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.6 m -71.44 89.16 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 168.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 4.4 p30 161.29 -24.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.89 -169.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.4 -76.01 0.19 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.697 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.462 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -159.99 173.86 15.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.115 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 69' ' ' THR . 4.4 m -105.04 109.1 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.024 0.44 . . . . 0.0 111.235 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.613 ' OE2' ' HD3' ' A' ' 67' ' ' ARG . 32.6 tt0 -110.0 112.17 24.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.661 HD11 HD11 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -122.59 150.36 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.463 -175.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.476 HG22 HG23 ' A' ' 82' ' ' VAL . 29.3 m -102.09 119.01 38.09 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.413 0.625 . . . . 0.0 110.181 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.661 HD11 HD11 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -116.66 122.87 31.12 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -175.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 2.6 Cg_exo -75.29 120.16 5.86 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.603 1.535 . . . . 0.0 111.564 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.58 HG21 HG12 ' A' ' 98' ' ' VAL . 4.3 pt -104.0 114.8 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.562 ' HB2' HG23 ' A' ' 63' ' ' VAL . 5.1 p-10 -118.97 125.25 48.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.027 0.918 . . . . 0.0 111.794 -176.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.519 ' HE1' ' HE2' ' A' ' 53' ' ' LYS . 98.6 m-85 -114.22 131.02 56.62 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.215 -1.357 . . . . 0.0 107.8 167.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.9 m -60.52 102.93 0.2 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.992 0.182 . . . . 0.0 111.282 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.601 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 3.3 mt -76.6 87.91 3.29 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.456 0.646 . . . . 0.0 110.498 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -80.71 -42.26 22.23 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.523 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -170.03 52.32 0.2 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.376 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.564 ' HB1' HD22 ' A' ' 90' ' ' LEU . . . -124.31 -156.64 0.73 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.664 ' HA2' HD11 ' A' ' 90' ' ' LEU . . . 103.88 -6.88 48.36 Favored Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -176.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 43.0 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.274 -178.318 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.7 tptt . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.15 -9.09 11.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.129 0.49 . . . . 0.0 110.864 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -81.91 69.2 8.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.688 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 13' ' ' PRO . 9.8 tp10 -128.83 91.3 3.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.565 175.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -81.69 83.85 6.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.275 -176.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.0 m -104.9 95.09 5.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.499 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.1 t -86.99 91.0 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.292 0.568 . . . . 0.0 109.849 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.16 -128.39 1.67 Allowed Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.38 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.425 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -80.31 -57.45 0.64 Allowed Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -175.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' A' ' 10' ' ' ALA . 46.5 Cg_endo -67.04 130.68 23.44 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.15 1.9 . . . . 0.0 113.123 -175.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 23.8 Cg_exo -66.19 143.41 71.08 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.973 2.448 . . . . 0.0 111.238 172.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.554 ' HB3' ' O ' ' A' ' 5' ' ' GLU . 31.4 Cg_exo -61.3 87.82 0.09 OUTLIER 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.623 2.882 . . . . 0.0 113.854 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.79 112.39 0.9 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.222 173.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -111.55 141.66 44.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.827 0.346 . . . . 0.0 110.217 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.29 88.15 2.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.198 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.452 ' OD2' ' HG3' ' A' ' 18' ' ' LYS . 6.0 p-10 -66.8 -26.39 66.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.72 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.452 ' HG3' ' OD2' ' A' ' 17' ' ' ASP . 50.8 mttp -104.73 81.32 1.75 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.281 0.562 . . . . 0.0 109.867 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 m -85.27 68.03 10.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.672 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.3 42.42 1.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.297 0.57 . . . . 0.0 110.535 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.45 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . . . -65.7 -51.39 49.78 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.231 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 21' ' ' ALA . 98.7 Cg_endo -80.58 26.99 0.57 Allowed 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.846 1.698 . . . . 0.0 112.464 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.484 ' C ' ' H ' ' A' ' 25' ' ' ARG . 90.7 mt-30 -132.94 -62.95 0.79 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.225 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 26' ' ' LEU . 27.6 m 71.16 -37.38 0.39 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.808 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.484 ' H ' ' C ' ' A' ' 23' ' ' GLN . 37.1 mmt180 63.35 8.55 3.53 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.668 0.747 . . . . 0.0 110.321 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 24' ' ' THR . 3.4 mm? 60.69 37.62 18.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.954 -177.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.6 p -115.92 98.42 51.08 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 121.121 0.486 . . . . 0.0 111.407 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.36 149.97 40.77 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.437 2.091 . . . . 0.0 111.366 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -77.64 53.25 1.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.438 0.637 . . . . 0.0 110.978 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.58 -5.06 56.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.373 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -81.81 57.59 3.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.537 0.684 . . . . 0.0 110.788 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.13 24.91 8.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.564 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.33 71.52 2.99 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.922 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -72.55 68.84 0.83 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.654 0.381 . . . . 0.0 111.595 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 18.6 t70 173.99 -26.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.318 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 35' ' ' ASP . 60.2 m-80 70.64 2.56 4.17 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.845 -171.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.6 m0 54.74 22.69 4.29 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.885 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 35' ' ' ASP . 16.7 ptt180 -67.02 -44.09 81.18 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -170.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.7 p -65.72 -38.75 90.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.43 0.633 . . . . 0.0 109.744 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.628 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 1.7 mmt180 -68.6 -47.57 66.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.751 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.474 HG23 ' HG2' ' A' ' 103' ' ' PRO . 43.7 mt -62.64 -37.55 79.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.589 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.8 m -55.09 -37.54 66.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.332 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -66.72 -44.59 89.13 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.057 176.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.523 ' O ' ' HB3' ' A' ' 47' ' ' ARG . 11.5 mpt_? -70.16 -32.36 70.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.032 0.444 . . . . 0.0 111.37 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -32.68 74.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.642 0.734 . . . . 0.0 109.367 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.665 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 14.4 t-20 -71.14 -30.97 67.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.589 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 3.2 ttt180 -58.45 -18.82 31.59 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.651 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -115.44 -59.34 2.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.366 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -160.43 105.64 1.47 Allowed 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 122.942 0.497 . . . . 0.0 109.798 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.665 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 22.0 tpt180 -105.78 102.52 11.96 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.08 176.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.555 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -90.3 125.7 59.17 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.364 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.34 132.36 29.21 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.37 2.047 . . . . 0.0 111.523 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.5 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.68 -23.62 66.21 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.581 -175.134 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.31 -42.84 82.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.913 0.387 . . . . 0.0 110.837 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.74 71.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.802 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.693 ' HG ' ' HE2' ' A' ' 125' ' ' PHE . 3.7 mm? -75.91 -41.31 52.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.259 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.614 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 98.5 mtt180 -58.08 -29.72 65.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.134 0.493 . . . . 0.0 111.307 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.9 mt -100.07 17.11 21.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.097 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.86 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 38.4 ttmt -145.86 -77.59 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.372 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.86 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 36.3 mmt180 -126.71 98.06 5.23 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -176.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.614 ' HG2' ' HA ' ' A' ' 57' ' ' ARG . 47.4 mt-30 -92.66 115.87 28.5 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.941 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -155.53 125.28 1.63 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.737 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.733 HG23 ' HA ' ' A' ' 124' ' ' ASP . 7.1 p -103.91 133.22 48.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.175 0.512 . . . . 0.0 109.969 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.05 168.44 34.54 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.622 -175.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.695 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 83.2 mt-30 -99.74 140.53 33.81 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.429 HG11 ' CD2' ' A' ' 68' ' ' PHE . 53.7 t -128.7 114.18 32.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.695 -173.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 22.7 ttp180 -106.2 129.08 54.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -147.83 151.51 36.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.295 0.569 . . . . 0.0 112.191 -174.218 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 9.0 m -99.94 125.61 45.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 169.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.66 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 41.7 mt -116.26 134.68 54.64 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.168 0.508 . . . . 0.0 111.757 -170.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 16.4 t70 -73.96 154.02 39.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.314 177.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -49.4 -40.75 37.37 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.34 0.4 . . . . 0.0 111.805 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -89.35 14.03 12.15 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 111.309 -176.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.47 47.13 9.17 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.118 177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.583 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 73.6 t60 -109.58 116.18 31.28 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 p -48.74 115.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.331 0.586 . . . . 0.0 111.554 173.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.0 mt -103.3 -41.89 5.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.978 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -139.25 146.08 39.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.818 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.76 117.13 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.422 0.63 . . . . 0.0 110.951 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 m -130.13 125.66 35.62 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.87 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.9 tp -71.6 119.07 15.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.205 0.526 . . . . 0.0 110.065 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.534 HG23 HG23 ' A' ' 120' ' ' THR . 0.1 OUTLIER -96.71 -38.78 8.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.982 179.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 12.4 t 67.06 -178.26 0.21 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.404 170.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.544 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 39.8 m -154.92 -58.04 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.289 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.13 -66.6 0.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.327 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.65 104.82 0.19 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.753 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.809 ' HA ' HD13 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -118.42 77.82 13.98 Favored Pre-proline 0 C--N 1.32 -0.686 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.358 -178.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.63 -78.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.234 1.956 . . . . 0.0 111.809 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.9 m -67.68 -17.63 64.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.413 0.625 . . . . 0.0 110.297 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.809 HD13 ' HA ' ' A' ' 87' ' ' LEU . 17.6 mt -75.21 -33.66 61.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.921 -176.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 18.5 t70 -53.98 -50.52 66.37 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.591 0.557 . . . . 0.0 112.031 -173.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.59 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.7 OUTLIER -54.56 -48.6 71.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.76 -55.19 5.54 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -174.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.631 HG12 ' O ' ' A' ' 90' ' ' LEU . 36.0 pt -68.61 -34.05 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.407 0.623 . . . . 0.0 110.933 -171.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.791 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.8 mm-40 -84.66 -17.46 38.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.005 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 92' ' ' ARG . . . -55.64 -55.78 28.05 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.835 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.599 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.2 -48.19 21.32 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.148 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.599 ' N ' HD22 ' A' ' 97' ' ' LEU . 55.8 t -70.54 -49.49 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.791 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.9 ttmt -73.97 -16.53 61.07 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 122.064 -0.398 . . . . 0.0 110.724 -173.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -88.29 -47.37 8.47 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.678 171.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.614 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -92.32 67.79 4.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.801 0.334 . . . . 0.0 110.914 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.2 m -95.57 99.67 5.06 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.291 0.567 . . . . 0.0 110.005 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 90.8 Cg_endo -102.79 176.32 0.18 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.042 3.161 . . . . 0.0 113.711 -175.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 48.9 tp -142.9 85.6 9.87 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.304 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.628 ' CG ' ' HB2' ' A' ' 40' ' ' ARG . 10.0 Cg_endo -59.44 -53.94 2.99 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.278 1.986 . . . . 0.0 112.677 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.625 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.4 m -81.03 116.74 64.54 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.75 99.23 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.986 2.457 . . . . 0.0 111.118 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.769 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 37.9 Cg_endo -90.93 66.45 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.363 2.708 . . . . 0.0 112.386 -171.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.719 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.59 -45.92 84.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.203 0.525 . . . . 0.0 109.921 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -67.22 -6.28 17.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.7 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -101.41 -36.19 8.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.488 -178.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.841 ' HB3' HG11 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -112.43 18.85 18.12 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -171.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 109' ' ' ALA . 2.2 m -69.26 88.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.134 0.969 . . . . 0.0 108.686 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 3.8 p30 164.11 -27.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.459 -1.7 . . . . 0.0 107.636 -170.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 172.28 -81.92 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.09 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.492 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.3 OUTLIER -160.81 175.49 12.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.841 HG11 ' HB3' ' A' ' 112' ' ' TYR . 10.7 m -102.35 108.69 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.329 0.585 . . . . 0.0 110.842 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 37.0 tt0 -108.8 112.5 24.8 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 170.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.692 HD11 ' HG ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -136.38 154.35 50.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 -173.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.534 HG23 HG23 ' A' ' 82' ' ' VAL . 98.6 m -98.43 113.44 25.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.703 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.692 ' HG ' HD11 ' A' ' 119' ' ' LEU . 42.7 mt -117.95 123.76 29.31 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.19 176.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.695 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.2 Cg_exo -73.53 118.9 5.67 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.994 1.796 . . . . 0.0 111.212 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.592 HG23 HG11 ' A' ' 98' ' ' VAL . 33.5 pt -93.61 116.68 35.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.733 ' HA ' HG23 ' A' ' 63' ' ' VAL . 1.5 t70 -100.53 120.91 40.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.996 0.903 . . . . 0.0 112.856 -172.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.693 ' HE2' ' HG ' ' A' ' 56' ' ' LEU . 6.7 m-85 -115.6 130.53 56.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 160.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 61' ' ' GLN . 13.4 m -59.19 103.46 0.18 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.294 0.497 . . . . 0.0 110.703 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.941 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -77.76 66.76 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.059 -177.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -84.64 -53.29 5.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.182 0.515 . . . . 0.0 109.857 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -137.92 110.4 0.75 Allowed Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.757 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.653 ' HB3' HD22 ' A' ' 90' ' ' LEU . . . -124.68 168.01 13.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.114 0.483 . . . . 0.0 112.029 -173.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -98.46 76.9 0.57 Allowed Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 33.9 p90 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.357 -178.43 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.727 0.299 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.3 t -82.81 -56.79 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 52.55 68.56 0.81 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.684 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -162.52 -53.24 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.863 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 64.47 81.73 0.2 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.416 0.627 . . . . 0.0 109.809 -173.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -73.66 -28.24 61.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.247 -177.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.68 162.36 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.612 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.42 156.08 11.45 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.483 ' O ' ' HD3' ' A' ' 12' ' ' PRO . . . -115.01 93.5 35.02 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 120.582 0.23 . . . . 0.0 110.585 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -91.85 103.82 0.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.224 2.616 . . . . 0.0 111.614 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.503 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . 26.2 Cg_exo -62.5 112.76 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.732 2.288 . . . . 0.0 111.983 -177.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.84 102.12 0.73 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.072 2.515 . . . . 0.0 111.94 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.16 18.62 0.65 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.144 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.57 ' NE ' ' HA ' ' A' ' 15' ' ' ARG . 1.9 mmp_? 57.75 38.04 27.32 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 122.584 0.353 . . . . 0.0 111.759 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 12' ' ' PRO . . . -85.41 53.86 2.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.327 0.584 . . . . 0.0 110.004 177.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -116.31 115.8 26.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.533 -177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -131.99 11.02 4.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.292 177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -61.08 -67.13 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.565 -173.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.32 41.98 1.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.136 0.494 . . . . 0.0 111.027 -177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.679 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . . . -61.56 -56.19 35.49 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.312 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.679 ' HD3' ' HB2' ' A' ' 21' ' ' ALA . 68.4 Cg_endo -88.05 -2.7 7.12 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.023 1.815 . . . . 0.0 112.431 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' A' ' 25' ' ' ARG . 50.9 mt-30 -88.76 -27.02 21.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.344 -175.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -81.06 44.15 0.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.857 0.837 . . . . 0.0 110.49 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.4 ' H ' ' C ' ' A' ' 23' ' ' GLN . 9.2 ptp180 -101.27 -31.0 11.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.275 172.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -167.02 88.21 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.694 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.3 m -59.84 121.43 58.06 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.816 171.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.08 20.72 0.63 Allowed 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.944 2.43 . . . . 0.0 114.153 -171.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -173.24 107.95 0.16 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.072 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.3 118.46 22.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.408 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -88.58 95.37 10.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.948 0.404 . . . . 0.0 110.633 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.57 117.89 30.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.041 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.6 67.99 3.55 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.803 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 37' ' ' TRP . 0.4 OUTLIER -81.21 80.95 7.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.319 0.58 . . . . 0.0 109.857 178.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -119.15 -40.81 2.79 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.581 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -135.74 32.57 2.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.87 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.405 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -90.08 -25.86 20.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.55 -177.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 38' ' ' ARG . 5.7 ptp180 -66.02 -31.97 73.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.83 -177.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.3 p -71.23 -33.13 69.59 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.435 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 10.1 mmt180 -70.65 -46.28 63.54 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.536 ' N ' ' HG3' ' A' ' 105' ' ' PRO . 80.3 mt -57.31 -45.8 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.866 175.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.9 m -61.42 -34.43 75.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.485 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -66.38 -37.81 93.07 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.44 -0.886 . . . . 0.0 110.996 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.65 ' NE ' ' HA ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -69.22 -33.71 73.72 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.314 0.578 . . . . 0.0 110.185 176.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.39 -26.02 67.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.777 177.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.617 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.4 t-20 -70.56 -33.58 71.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.39 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.549 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 1.4 ttt180 -55.27 -28.4 53.13 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.357 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.578 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 91.2 m-85 -99.45 -58.99 1.8 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.219 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 48' ' ' PHE . 32.5 mtmt -178.91 103.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.521 1.128 . . . . 0.0 108.691 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.617 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 55.4 ttp180 -110.77 104.39 13.03 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.791 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.504 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -92.24 126.58 52.32 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.26 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.93 133.13 51.63 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 123.009 2.473 . . . . 0.0 112.462 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.592 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.61 -26.3 66.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.216 -169.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.68 -35.82 77.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.17 0.51 . . . . 0.0 110.5 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.46 63.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.547 HD13 ' HB2' ' A' ' 60' ' ' ARG . 3.6 mm? -75.98 -42.69 47.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.671 0.272 . . . . 0.0 110.965 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.417 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 4.4 ptp180 -66.6 -11.91 55.56 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.952 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -112.94 10.57 18.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.24 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.604 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 23.1 ttmm -150.92 -77.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.121 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 1.045 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 28.5 mmt180 -112.34 84.58 2.0 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -94.91 170.95 9.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.274 -178.345 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.765 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.58 123.28 0.99 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.093 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.622 HG13 HD12 ' A' ' 127' ' ' LEU . 6.9 p -104.76 125.55 59.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.223 0.535 . . . . 0.0 109.866 176.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.67 165.15 28.8 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.883 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 36.2 tt0 -103.98 124.37 48.88 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.528 HG21 HD12 ' A' ' 123' ' ' ILE . 60.5 t -128.63 118.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.73 -170.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -113.14 145.54 40.77 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.405 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -156.86 157.6 35.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.311 0.577 . . . . 0.0 111.788 -175.142 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 1.9 m -107.74 127.56 53.79 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 172.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 36.6 mt -117.56 132.04 56.59 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.253 0.549 . . . . 0.0 111.997 -166.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.451 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 20.6 t70 -68.79 152.22 45.6 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.23 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.469 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 69.6 mtt180 -61.41 -17.27 53.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.449 -1.25 . . . . 0.0 112.414 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -101.03 3.83 41.79 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.321 0.582 . . . . 0.0 110.331 175.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 86.89 41.49 6.71 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.25 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.451 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 79.9 t60 -114.35 125.63 54.08 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 8.6 p -53.3 122.25 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.357 0.598 . . . . 0.0 111.267 175.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.8 mt -104.34 -40.84 5.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.632 0.729 . . . . 0.0 109.552 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.59 151.55 47.37 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.636 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.17 122.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.358 0.599 . . . . 0.0 110.027 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.1 m -129.3 127.63 41.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.343 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.635 HD21 ' HB2' ' A' ' 84' ' ' SER . 25.4 tp -75.54 107.81 7.93 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.64 HG23 HG22 ' A' ' 120' ' ' THR . 0.1 OUTLIER -83.42 -41.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.382 -170.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.6 m -154.44 135.31 13.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.88 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.635 ' HB2' HD21 ' A' ' 81' ' ' LEU . 34.1 t -122.93 135.86 54.65 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.79 -19.36 41.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.657 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.423 ' H ' HD23 ' A' ' 87' ' ' LEU . . . 133.12 63.33 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.973 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.901 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -118.23 87.65 30.27 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.97 -73.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.554 2.169 . . . . 0.0 111.769 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 9.3 m -72.91 -18.92 61.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.34 0.59 . . . . 0.0 110.245 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.901 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 17.0 mt -76.83 -37.25 56.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.719 -175.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.433 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 17.0 t70 -54.6 -48.82 71.7 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.189 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 89' ' ' SER . 16.8 ptp180 -54.34 -42.25 70.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.595 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 1.045 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 4.9 tp10 -77.79 -54.66 6.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.978 0.418 . . . . 0.0 111.949 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.518 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 38.1 pt -72.48 -33.48 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.754 -172.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.615 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 77.1 mm-40 -82.52 -25.95 32.95 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 120.867 0.365 . . . . 0.0 110.737 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.533 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.01 -43.44 77.7 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 169.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.499 HD22 HG21 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -66.6 -57.05 8.04 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.14 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.564 HG12 HG22 ' A' ' 123' ' ' ILE . 79.3 t -88.42 -49.49 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 36.3 ttmt -65.54 -24.65 67.17 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.63 0.372 . . . . 0.0 111.329 -174.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 28.3 tpt180 -97.14 -35.78 10.68 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.492 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.529 ' HB1' ' CD2' ' A' ' 48' ' ' PHE . . . -102.78 61.78 0.81 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.834 177.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.495 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 6.3 m -83.11 104.64 3.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.261 0.553 . . . . 0.0 109.995 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.619 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 37.9 Cg_endo -99.81 153.32 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.769 2.979 . . . . 0.0 114.604 -171.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.72 HD23 ' HD2' ' A' ' 108' ' ' PRO . 22.4 tp -125.41 100.48 32.11 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.342 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.65 ' HA ' ' NE ' ' A' ' 44' ' ' ARG . 2.4 Cg_endo -69.0 -81.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.142 1.894 . . . . 0.0 113.278 -174.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 31.5 m -79.91 110.21 15.13 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 27.0 Cg_exo -62.16 108.01 0.63 Allowed 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.898 2.399 . . . . 0.0 112.098 -175.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.72 ' HD2' HD23 ' A' ' 104' ' ' LEU . 97.9 Cg_endo -75.49 62.48 6.26 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.072 2.515 . . . . 0.0 111.569 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.764 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -58.33 -35.47 71.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.383 0.611 . . . . 0.0 110.24 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.33 -7.79 27.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.945 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -113.45 -21.53 10.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -175.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.764 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -131.76 19.56 4.64 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -168.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.547 HG11 ' O ' ' A' ' 109' ' ' ALA . 1.1 m -69.8 89.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 122.412 1.101 . . . . 0.0 109.753 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.631 HD21 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 160.94 -16.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 112.723 -2.035 . . . . 0.0 107.752 -172.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.631 ' N ' HD21 ' A' ' 114' ' ' ASN . . . 172.2 -92.46 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.341 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.504 ' OG1' HG21 ' A' ' 69' ' ' THR . 0.6 OUTLIER -161.44 176.41 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 122.894 0.477 . . . . 0.0 110.245 -173.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 69' ' ' THR . 2.9 m -104.94 119.03 53.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.485 -173.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.582 ' HG3' ' HG1' ' A' ' 69' ' ' THR . 22.0 tt0 -104.14 112.45 25.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.6 HD13 ' HG ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -133.52 154.3 50.95 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.631 -174.311 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.64 HG22 HG23 ' A' ' 82' ' ' VAL . 62.5 m -109.23 123.3 49.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.772 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.6 ' HG ' HD13 ' A' ' 119' ' ' LEU . 65.1 mt -129.91 128.38 22.89 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.366 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.2 Cg_exo -73.45 119.36 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.647 1.565 . . . . 0.0 110.385 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.567 HD11 ' NE2' ' A' ' 95' ' ' GLN . 19.4 pt -95.42 126.04 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -114.94 121.54 43.48 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.26 -176.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.518 ' CE1' ' HB ' ' A' ' 94' ' ' ILE . 75.7 m-85 -113.25 120.03 39.77 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 159.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.9 m -56.43 103.66 0.11 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.118 0.485 . . . . 0.0 111.381 -168.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.765 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.1 mt -70.78 94.87 1.07 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.451 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -132.41 31.07 4.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.645 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -153.98 -112.74 0.48 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.006 -1.092 . . . . 0.0 113.85 -172.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.46 ' HB3' HD22 ' A' ' 90' ' ' LEU . . . -79.24 46.31 0.71 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -167.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -113.44 33.19 5.66 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 172.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.44 ' CE1' ' HA ' ' A' ' 130' ' ' ALA . 39.0 p90 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.364 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.516 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 14.3 mptt . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.589 0.233 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.4 m -96.84 -25.18 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.187 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -80.08 -31.02 39.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.427 0.632 . . . . 0.0 110.373 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.516 ' OE1' ' HA ' ' A' ' 2' ' ' LYS . 17.8 mp0 -76.88 8.49 3.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.139 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -92.98 3.51 55.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.933 0.397 . . . . 0.0 110.332 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.8 t -91.1 -162.69 0.94 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.158 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.8 t 61.26 61.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.766 0.793 . . . . 0.0 109.877 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.94 14.49 28.94 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.666 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . . . -63.45 -54.61 42.32 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.811 -0.194 . . . . 0.0 111.369 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 10' ' ' ALA . 62.2 Cg_endo -73.76 129.75 13.87 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 121.658 1.572 . . . . 0.0 112.072 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 24.5 Cg_exo -63.22 139.9 74.68 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.817 2.344 . . . . 0.0 111.645 177.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.91 40.28 0.79 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.999 2.466 . . . . 0.0 112.577 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.98 -111.17 3.77 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.961 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -143.01 127.34 17.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.716 0.293 . . . . 0.0 110.431 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.56 96.54 3.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.918 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.44 -25.7 41.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.467 0.651 . . . . 0.0 109.574 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -86.72 142.71 27.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.062 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -102.72 -22.19 13.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.25 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.54 84.71 7.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.19 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.592 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . . . -146.91 -54.04 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 21' ' ' ALA . 14.7 Cg_exo -68.4 -88.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.949 1.766 . . . . 0.0 113.021 -175.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.436 ' H ' ' HB2' ' A' ' 22' ' ' PRO . 4.7 tp-100 -129.17 32.32 4.73 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.63 0.729 . . . . 0.0 110.3 -177.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 p -68.78 -11.44 60.36 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.493 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -73.3 -15.29 61.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.126 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.4 mt -115.64 45.39 1.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.171 0.51 . . . . 0.0 110.311 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 12.9 t -78.56 133.56 62.99 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.011 176.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 27' ' ' THR . 5.7 Cg_endo -86.67 79.93 1.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.188 2.592 . . . . 0.0 112.629 -177.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.419 ' CE1' ' HB2' ' A' ' 32' ' ' ALA . 67.9 t80 -106.73 108.11 19.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.479 176.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.85 127.5 8.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.749 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 53.22 65.77 1.42 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.963 0.79 . . . . 0.0 111.156 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.557 ' HA ' ' CZ2' ' A' ' 37' ' ' TRP . . . -138.54 47.87 1.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.492 -177.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -135.62 38.35 1.8 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.046 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 36' ' ' ASN . 5.2 tp10 49.63 62.75 2.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 122.144 0.973 . . . . 0.0 110.166 -171.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.13 39.58 0.65 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.804 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 34' ' ' GLU . 38.1 m-80 57.13 61.89 2.41 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.016 -172.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.588 ' O ' HG13 ' A' ' 41' ' ' ILE . 8.7 p-90 -127.27 -51.99 1.4 Allowed 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.82 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.572 ' HA ' HD12 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -69.16 -36.05 76.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.374 0.534 . . . . 0.0 111.666 -174.321 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -33.62 74.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.805 0.812 . . . . 0.0 109.795 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.49 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 27.0 mmm180 -73.0 -32.73 65.33 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.507 175.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 37' ' ' TRP . 62.1 mt -61.04 -39.71 83.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.512 173.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -55.14 -39.94 70.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.835 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.16 -36.5 92.98 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.952 173.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.641 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -69.36 -34.9 75.28 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.374 0.607 . . . . 0.0 110.097 178.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.13 -26.76 66.84 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.3 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.607 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 11.6 t30 -70.43 -33.38 71.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.788 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 7.6 ptt180 -60.41 -17.99 47.71 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.018 173.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -109.58 -58.54 2.03 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.495 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -167.88 101.41 0.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.694 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.607 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 17.0 ttp180 -111.55 102.31 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.218 171.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.542 ' HD1' ' HD2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -97.63 117.11 65.7 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.568 -173.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.542 ' HD2' ' HD1' ' A' ' 51' ' ' TYR . 52.8 Cg_exo -53.35 131.06 41.46 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.659 2.239 . . . . 0.0 111.65 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.579 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.67 -25.2 67.24 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.552 -173.067 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -56.61 -43.26 80.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.046 0.45 . . . . 0.0 110.803 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.18 -30.81 69.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 110.554 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.541 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 3.6 mm? -74.55 -32.94 62.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.524 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.846 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 22.2 mtm180 -62.0 -20.32 63.78 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.748 0.308 . . . . 0.0 111.54 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 mp -107.15 14.84 25.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.65 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.803 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 37.5 ttpt -150.79 -84.61 0.09 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.295 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.803 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 32.3 mmt-85 -122.02 86.27 2.55 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.936 -0.478 . . . . 0.0 111.426 -174.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.846 ' HG2' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -111.68 115.23 28.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.151 0.501 . . . . 0.0 110.448 172.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.841 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -146.54 140.05 8.47 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.544 175.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.907 HG12 HD11 ' A' ' 127' ' ' LEU . 7.1 p -103.61 138.14 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.991 0.424 . . . . 0.0 109.915 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.541 ' HA3' ' OG ' ' A' ' 83' ' ' SER . . . -168.02 169.27 41.29 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.684 -176.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 54.0 mt-30 -98.87 141.07 32.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.414 HG11 ' CE2' ' A' ' 68' ' ' PHE . 55.4 t -130.83 114.65 27.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.485 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 21.9 ttm180 -111.71 141.37 45.4 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -174.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CE1' HD13 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -159.22 155.5 27.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.153 0.501 . . . . 0.0 111.605 -176.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.712 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 48.8 m -98.47 123.92 42.88 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 170.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.462 HD13 ' CE1' ' A' ' 68' ' ' PHE . 73.0 mt -113.42 148.45 35.84 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.145 0.498 . . . . 0.0 112.29 -170.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.638 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 33.4 t70 -92.79 166.68 12.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.627 175.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -53.87 -39.81 66.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -90.12 9.1 29.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.042 0.448 . . . . 0.0 111.164 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.434 ' HA3' ' H ' ' A' ' 104' ' ' LEU . . . 77.13 47.3 9.34 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.084 -175.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.638 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 78.9 t60 -100.28 100.77 11.63 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.3 p -47.47 115.01 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.763 0.792 . . . . 0.0 111.457 176.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 15.5 mt -98.32 -35.3 10.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.987 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -136.31 143.76 44.33 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.102 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.5 m -119.19 129.46 75.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.035 0.445 . . . . 0.0 110.082 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 69.8 m -130.99 122.23 26.47 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.323 0.582 . . . . 0.0 110.911 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.5 tp -78.96 115.62 18.76 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.783 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -121.64 -25.17 2.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.118 -177.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.541 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 7.5 t -48.96 119.54 3.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.913 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -144.35 43.49 1.41 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.428 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.69 13.88 18.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.089 0.471 . . . . 0.0 110.33 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.596 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 81.18 61.1 2.15 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.768 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.749 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.8 OUTLIER -110.84 84.15 4.05 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.495 -179.304 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.596 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 5.7 Cg_exo -78.05 -75.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.677 2.251 . . . . 0.0 112.142 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.3 p -69.29 -18.98 63.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.495 0.664 . . . . 0.0 110.497 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.749 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 28.4 mt -74.62 -39.59 62.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.269 -175.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.52 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 4.8 t70 -53.4 -50.47 65.1 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.585 0.553 . . . . 0.0 111.875 -173.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -54.58 -45.65 73.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.63 -53.51 7.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.792 0.329 . . . . 0.0 111.332 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 90' ' ' LEU . 48.1 pt -70.26 -32.45 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -171.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.578 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 25.7 mm-40 -82.48 -30.04 30.18 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.281 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.54 -44.66 81.1 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 170.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.606 HD22 HG22 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -60.88 -59.42 5.41 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.289 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.632 HG13 HG22 ' A' ' 123' ' ' ILE . 76.2 t -89.94 -49.39 13.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 38.1 ttmt -66.18 -27.23 67.85 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -172.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.531 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 29.8 tpt180 -91.2 -30.8 16.46 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.492 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.616 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -108.08 67.69 0.68 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.936 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.461 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 5.5 m -96.49 97.96 3.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.226 0.536 . . . . 0.0 110.458 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.641 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 37.5 Cg_endo -104.14 168.56 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.471 3.447 . . . . 0.0 114.599 -173.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.573 HD13 ' HG3' ' A' ' 108' ' ' PRO . 19.9 mt -145.39 122.4 6.15 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.309 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.49 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 7.9 Cg_endo -82.39 -47.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.587 2.191 . . . . 0.0 111.664 175.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.0 m -90.27 113.31 56.93 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.742 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.18 108.3 0.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.601 2.2 . . . . 0.0 111.451 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.646 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 94.3 Cg_endo -82.07 51.1 3.67 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.831 2.354 . . . . 0.0 112.901 -173.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.637 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -60.74 -37.7 82.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.284 0.564 . . . . 0.0 109.625 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -75.06 3.71 8.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.875 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.646 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -113.51 -23.44 9.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.777 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.766 ' HB3' HG11 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -127.5 18.27 6.91 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.289 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.4 m -70.36 88.32 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 122.198 0.999 . . . . 0.0 109.19 175.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.567 HD21 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 158.58 -12.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 113.284 -1.78 . . . . 0.0 108.645 -170.014 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.567 ' N ' HD21 ' A' ' 114' ' ' ASN . . . 163.13 -87.08 0.1 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.449 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.435 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.7 OUTLIER -160.23 175.39 12.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -175.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.766 HG11 ' HB3' ' A' ' 112' ' ' TYR . 5.7 m -103.22 107.94 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -109.82 110.06 20.93 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 170.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.515 HD12 ' HG ' ' A' ' 121' ' ' LEU . 1.4 pp -143.46 146.36 33.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.875 0.369 . . . . 0.0 110.308 -174.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.405 ' CG2' ' HB3' ' A' ' 65' ' ' GLN . 86.2 m -93.98 117.08 29.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.191 -177.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.515 ' HG ' HD12 ' A' ' 119' ' ' LEU . 46.9 mt -111.13 122.87 36.66 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.5 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 4.7 Cg_exo -74.08 119.14 5.69 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.885 1.723 . . . . 0.0 110.617 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.632 HG22 HG13 ' A' ' 98' ' ' VAL . 18.7 pt -98.34 118.26 44.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.501 ' HA ' HG21 ' A' ' 63' ' ' VAL . 12.6 t70 -108.03 122.23 46.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.719 0.771 . . . . 0.0 112.087 -172.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.468 ' CE2' ' HG ' ' A' ' 56' ' ' LEU . 34.3 m-85 -115.9 142.04 47.3 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 162.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m -67.8 103.04 1.33 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.603 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.907 HD11 HG12 ' A' ' 63' ' ' VAL . 2.0 mt -77.97 81.49 4.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.461 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -93.24 -52.34 4.59 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.475 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.13 69.71 0.53 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.966 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.702 ' HB1' HE22 ' A' ' 61' ' ' GLN . . . -168.33 -169.24 1.05 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 86' ' ' GLY . . . 93.53 23.16 24.61 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.397 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.4 p90 . . . . . 0 C--O 1.247 0.927 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.563 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' HA ' ' HB2' ' A' ' 5' ' ' GLU . 29.4 mtpp . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.749 0.309 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.42 -60.09 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -99.57 -17.48 17.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 2' ' ' LYS . 1.2 mp0 -77.39 49.97 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.486 175.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -168.45 85.25 0.18 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 m -60.59 122.21 14.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.614 -174.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.6 m -100.45 175.07 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.964 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.33 79.9 0.26 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.53 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.82 85.91 40.33 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.768 0.318 . . . . 0.0 110.327 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -84.2 144.23 10.47 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.213 2.609 . . . . 0.0 112.245 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.85 115.46 3.26 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.879 2.386 . . . . 0.0 111.55 176.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.39 87.18 0.64 Allowed 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.892 2.394 . . . . 0.0 112.921 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.16 57.73 3.36 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.927 175.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -94.84 95.91 8.99 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.78 157.74 29.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.162 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -153.66 -58.99 0.13 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.983 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.626 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -110.63 104.0 12.64 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 173.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.431 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 11.4 m -66.34 -66.5 0.54 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.799 -173.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.58 59.01 0.8 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.847 0.356 . . . . 0.0 111.457 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.932 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . . . -137.8 -63.69 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.817 175.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.932 ' HD3' ' HB2' ' A' ' 21' ' ' ALA . 1.1 Cg_endo -86.64 -28.05 0.66 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 122.24 1.96 . . . . 0.0 111.724 175.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.488 ' C ' ' H ' ' A' ' 25' ' ' ARG . 48.7 mt-30 -83.53 -138.98 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.437 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.624 ' HA ' ' HB ' ' A' ' 27' ' ' THR . 20.5 m 74.33 -31.94 0.22 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.775 0.43 . . . . 0.0 111.129 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 23' ' ' GLN . 14.2 ptt180 -57.06 -33.2 67.01 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.266 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.6 mt -117.84 25.97 10.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.203 0.525 . . . . 0.0 110.171 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.624 ' HB ' ' HA ' ' A' ' 24' ' ' THR . 21.8 m -128.98 78.76 75.8 Favored Pre-proline 0 N--CA 1.445 -0.683 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.284 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.11 100.59 1.4 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.862 2.375 . . . . 0.0 111.726 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -79.52 83.46 5.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.61 -37.01 0.62 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.985 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 60.55 -92.67 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.821 0.7 . . . . 0.0 111.118 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 59.99 13.33 3.64 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.72 109.82 1.12 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.597 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -83.94 -6.71 59.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.413 0.625 . . . . 0.0 110.669 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.93 -103.66 0.06 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -169.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -88.42 72.06 8.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.121 0.486 . . . . 0.0 111.745 -167.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.544 ' CZ2' HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -134.32 -24.83 1.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.364 174.258 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -68.87 -30.6 69.15 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.117 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.6 p -62.41 -40.01 95.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.075 176.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.447 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 16.2 mmm180 -73.64 -39.65 64.34 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.707 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.675 HG21 ' HD2' ' A' ' 103' ' ' PRO . 79.4 mt -60.36 -50.49 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.173 176.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 m -58.51 -43.26 89.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.841 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.14 -36.32 93.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.86 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.607 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 11.4 ttt-85 -69.16 -32.02 71.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 120.851 0.358 . . . . 0.0 110.328 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.81 ' HB3' ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -62.99 -31.46 72.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.207 0.527 . . . . 0.0 109.966 178.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.728 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 26.7 t-20 -71.74 -35.19 70.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.61 174.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 68.3 ttt180 -67.09 -26.65 66.83 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.608 175.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -92.03 7.58 41.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.564 172.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? 67.99 102.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.263 -175.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.81 ' HD2' ' HB3' ' A' ' 45' ' ' LEU . 4.6 ptm180 -118.17 130.31 56.03 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.412 ' HB3' HD21 ' A' ' 56' ' ' LEU . 16.9 t80 -60.91 132.3 91.93 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.39 129.86 13.82 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.55 2.833 . . . . 0.0 112.301 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.807 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -64.53 -20.9 66.5 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.795 -172.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -52.6 -41.25 63.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.669 0.271 . . . . 0.0 111.08 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.89 -36.14 59.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.761 0.315 . . . . 0.0 111.338 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.5 mm? -74.23 -43.04 58.64 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.308 -175.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -76.07 -15.42 60.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.973 0.416 . . . . 0.0 111.358 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.9 tp -86.23 -9.73 55.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.674 0.749 . . . . 0.0 109.266 174.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.863 ' HD2' ' HG2' ' A' ' 93' ' ' GLU . 23.2 ttmm -115.03 -57.76 2.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.47 -173.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.751 ' HG3' ' HB2' ' A' ' 93' ' ' GLU . 30.1 mmt180 -127.08 122.45 34.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.784 -175.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.579 ' H ' ' HB1' ' A' ' 130' ' ' ALA . 38.3 mt-30 -126.41 114.57 18.37 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.993 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -149.7 143.09 10.36 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.961 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.532 ' H ' HD13 ' A' ' 127' ' ' LEU . 5.3 p -104.43 127.64 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.027 0.441 . . . . 0.0 109.947 176.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.39 167.51 32.98 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.465 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 82' ' ' VAL . 14.6 mm100 -101.86 131.54 48.14 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.8 t -126.6 114.18 36.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.204 0.526 . . . . 0.0 110.339 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 27.0 ttm180 -101.32 141.89 33.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.417 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -157.71 152.42 25.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.989 0.423 . . . . 0.0 111.299 -178.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.776 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 9.4 m -101.64 127.31 48.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.641 173.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.692 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 28.2 mt -119.5 135.4 54.79 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.1 -172.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.425 ' HB2' HD22 ' A' ' 77' ' ' LEU . 20.2 t70 -76.07 152.77 36.76 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.896 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -55.06 -26.64 39.03 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 123.4 0.437 . . . . 0.0 111.787 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -84.31 -1.79 55.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 110.687 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.778 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 88.45 23.71 36.0 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.851 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -95.92 117.48 30.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.494 0.188 . . . . 0.0 110.553 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -48.99 120.42 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.374 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 71' ' ' ASP . 55.7 mt -109.77 -51.26 2.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.713 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -132.42 154.78 49.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.392 -177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.932 HG13 ' HG3' ' A' ' 99' ' ' LYS . 57.9 t -139.82 122.99 17.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 44.0 m -119.22 105.94 11.86 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.9 tp -68.24 110.79 4.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.55 0.69 . . . . 0.0 110.664 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.744 HG22 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -99.3 -52.83 8.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.929 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.497 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 23.1 t 65.7 177.91 0.21 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.203 172.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.508 ' OG ' ' HG2' ' A' ' 65' ' ' GLN . 50.3 m -139.17 -69.7 0.42 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.097 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.36 -75.83 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.49 ' C ' ' HD3' ' A' ' 88' ' ' PRO . . . -176.9 97.51 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.329 -175.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.725 ' HA ' HD11 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -120.56 68.55 15.09 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 178.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 3.6 Cg_exo -77.81 -66.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.386 2.057 . . . . 0.0 112.139 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.6 t -73.11 -18.63 61.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.689 0.757 . . . . 0.0 109.78 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.735 HD22 ' HB3' ' A' ' 130' ' ' ALA . 32.8 mt -76.02 -30.74 58.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.576 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.52 -45.88 69.9 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.808 0.693 . . . . 0.0 111.896 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.601 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 8.5 ptp180 -53.01 -51.09 62.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -172.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.863 ' HG2' ' HD2' ' A' ' 59' ' ' LYS . 1.7 mp0 -77.04 -55.39 5.5 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 90' ' ' LEU . 22.2 pt -69.88 -32.82 53.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 111.386 -172.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.775 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 75.1 mm-40 -83.49 -18.32 38.92 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.507 176.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -54.73 -55.23 32.09 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.851 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.608 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -75.75 -52.43 10.48 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.031 177.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.634 HG11 HG21 ' A' ' 123' ' ' ILE . 91.3 t -65.44 -49.43 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.932 ' HG3' HG13 ' A' ' 79' ' ' VAL . 40.4 ttmt -74.61 -29.24 61.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.556 0.217 . . . . 0.0 110.906 -172.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.571 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -78.11 -42.13 32.92 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.828 176.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.562 ' HB3' HH11 ' A' ' 100' ' ' ARG . . . -117.11 73.98 0.89 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.692 0.282 . . . . 0.0 111.663 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.7 m -82.96 108.71 13.4 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.105 0.479 . . . . 0.0 110.35 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.675 ' HD2' HG21 ' A' ' 41' ' ' ILE . 16.2 Cg_endo -97.12 139.08 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.23 3.287 . . . . 0.0 113.947 -175.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.778 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 40.3 tp -116.31 91.51 33.14 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 174.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.447 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 53.1 Cg_endo -79.45 -39.35 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.293 1.995 . . . . 0.0 113.603 -174.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.431 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.5 m -102.9 110.81 64.24 Favored Pre-proline 0 C--N 1.319 -0.761 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.92 107.77 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.242 2.628 . . . . 0.0 112.954 -175.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.658 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 48.9 Cg_endo -89.8 66.57 2.12 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.299 2.666 . . . . 0.0 111.659 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.807 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.1 -41.29 78.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.416 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -73.46 1.44 9.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.859 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.658 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -110.89 -27.97 8.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.691 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.807 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -105.16 16.31 25.99 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.5 m -72.27 87.89 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER 157.18 -9.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.417 -171.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.68 -80.16 0.2 Allowed Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.063 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.46 ' C ' ' HB3' ' A' ' 112' ' ' TYR . 1.0 OUTLIER -156.42 176.17 13.05 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.776 ' O ' ' HA ' ' A' ' 69' ' ' THR . 6.6 m -99.26 106.22 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 119.676 1.125 . . . . 0.0 110.259 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -105.52 109.22 21.12 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 168.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.683 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -139.73 147.45 40.9 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.493 -172.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.744 HG23 HG22 ' A' ' 82' ' ' VAL . 36.3 m -94.43 113.65 25.54 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.778 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.683 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 35.0 mt -114.73 126.8 27.47 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.992 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 6.2 Cg_exo -75.29 118.78 5.31 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 121.401 1.401 . . . . 0.0 110.636 177.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.634 HG21 HG11 ' A' ' 98' ' ' VAL . 32.5 pt -93.3 97.1 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -99.03 121.88 41.55 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 122.302 1.048 . . . . 0.0 112.041 -171.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -114.74 142.83 45.99 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.754 -1.567 . . . . 0.0 107.057 165.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.1 m -65.56 103.35 0.84 Allowed 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.246 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.993 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -75.42 61.8 1.29 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.791 -176.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 128' ' ' ARG . 48.6 mtm180 -79.4 -43.43 23.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.454 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 132' ' ' PHE . . . -179.69 126.33 1.03 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.798 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.735 ' HB3' HD22 ' A' ' 90' ' ' LEU . . . -146.3 71.14 1.24 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.99 4.93 66.55 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -166.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.57 ' HD2' ' H ' ' A' ' 130' ' ' ALA . 92.4 m-85 . . . . . 0 N--CA 1.435 -1.2 0 CA-C-N 114.401 -0.9 . . . . 0.0 109.374 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.887 0.375 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 m -135.96 25.05 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.142 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 58.58 69.4 0.73 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.649 -171.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -53.24 -47.7 68.83 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.024 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -126.61 107.22 10.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.271 0.558 . . . . 0.0 110.258 176.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.437 ' HB2' ' CB ' ' A' ' 10' ' ' ALA . 5.8 p -119.8 88.69 2.98 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.677 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.8 m -87.45 -22.88 6.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.338 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.9 30.45 10.01 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.106 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.437 ' CB ' ' HB2' ' A' ' 7' ' ' SER . . . -111.26 115.85 51.85 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.727 0.298 . . . . 0.0 110.66 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.422 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 6.1 Cg_exo -78.79 124.4 6.21 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.301 2.667 . . . . 0.0 111.727 178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.608 ' HB2' ' HA ' ' A' ' 16' ' ' ALA . 16.0 Cg_exo -68.3 112.23 2.73 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 123.029 2.486 . . . . 0.0 111.77 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.89 129.99 32.88 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.92 2.413 . . . . 0.0 112.614 -176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.28 -86.77 0.7 Allowed Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.433 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 15' ' ' ARG . 18.7 mtp180 -86.75 77.62 9.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.935 0.398 . . . . 0.0 110.712 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.608 ' HA ' ' HB2' ' A' ' 12' ' ' PRO . . . -74.21 -21.24 59.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.602 0.715 . . . . 0.0 109.184 171.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -88.03 94.79 9.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.727 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -140.83 58.01 1.56 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.302 0.572 . . . . 0.0 109.539 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -79.42 116.46 19.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.698 0.761 . . . . 0.0 110.561 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.531 ' HB3' ' HA ' ' A' ' 25' ' ' ARG . . . -108.4 40.16 1.83 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.321 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.681 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . . . -80.02 -52.65 1.01 Allowed Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.992 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.681 ' HD3' ' HB2' ' A' ' 21' ' ' ALA . 7.9 Cg_exo -74.07 -150.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.445 2.097 . . . . 0.0 111.965 177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -71.24 -9.8 58.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.322 . . . . 0.0 111.032 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.437 ' HA ' HG23 ' A' ' 27' ' ' THR . 14.6 p -61.03 -15.31 30.69 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.673 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.545 ' HG3' ' HG ' ' A' ' 26' ' ' LEU . 13.4 ptp180 -64.18 -25.69 68.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.22 177.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.545 ' HG ' ' HG3' ' A' ' 25' ' ' ARG . 96.2 mt -125.22 53.23 1.54 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.171 0.51 . . . . 0.0 110.622 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 24' ' ' THR . 12.4 p -106.57 123.25 39.33 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.997 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.36 117.93 5.3 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.713 2.275 . . . . 0.0 111.542 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -96.14 118.7 33.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.313 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.95 -52.29 0.11 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.446 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 56.53 53.31 8.69 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.671 0.748 . . . . 0.0 110.57 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.59 57.0 2.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.302 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.94 63.73 4.02 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.216 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -84.01 176.37 8.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.904 0.383 . . . . 0.0 110.684 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 36' ' ' ASN . 22.6 t70 -130.54 152.56 49.78 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 26.9 t-20 75.8 -15.15 0.72 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.599 0.562 . . . . 0.0 111.038 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.475 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -58.93 -27.71 65.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.078 178.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -33.87 75.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.666 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.1 m -67.08 -35.87 80.76 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.428 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 18.2 mmt180 -70.65 -42.01 71.39 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.918 177.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.699 HG23 ' HG2' ' A' ' 103' ' ' PRO . 92.2 mt -59.65 -44.06 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.2 177.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.9 t -55.68 -37.62 68.56 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.801 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -69.46 -37.63 79.07 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.081 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.64 -34.11 73.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.154 0.502 . . . . 0.0 110.634 178.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.604 HD13 HG11 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -68.27 -26.9 65.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.641 0.734 . . . . 0.0 109.526 177.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.666 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 5.9 t30 -70.28 -35.1 73.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.258 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.55 -29.86 59.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.624 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -96.29 -59.33 1.86 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.515 178.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -158.53 119.31 3.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.121 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.666 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -136.07 102.61 5.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.404 0.621 . . . . 0.0 110.275 174.59 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.498 ' HB3' HD23 ' A' ' 56' ' ' LEU . 3.1 t80 -86.53 132.09 43.8 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.848 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.32 130.19 36.48 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 122.741 2.294 . . . . 0.0 112.363 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.53 ' HA ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -60.81 -29.39 69.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.354 -170.521 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.78 -33.82 70.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 0.0 110.316 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.79 -39.14 61.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.293 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 53' ' ' LYS . 3.4 mm? -64.53 -40.97 96.6 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.743 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.458 ' HD3' HH11 ' A' ' 128' ' ' ARG . 60.5 mtt180 -59.07 -22.71 61.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.867 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.7 mt -102.43 -8.67 20.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.793 0.33 . . . . 0.0 110.964 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -112.51 -68.77 0.91 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.827 -176.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.664 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 6.0 ppt_? -155.01 142.9 20.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.062 0.458 . . . . 0.0 110.888 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.422 ' O ' HD21 ' A' ' 90' ' ' LEU . 13.0 mm100 -138.5 177.74 7.66 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 1.042 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.22 146.75 4.42 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.52 -1.324 . . . . 0.0 113.989 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.3 t -106.35 124.16 61.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.28 163.31 26.4 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.699 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.428 ' O ' HG22 ' A' ' 82' ' ' VAL . 85.0 mt-30 -106.45 125.87 51.54 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 121' ' ' LEU . 12.1 p -123.85 125.0 70.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.64 -170.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -113.47 134.96 54.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.838 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.7 OUTLIER -157.11 158.13 35.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.955 0.407 . . . . 0.0 111.694 -175.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 26.6 m -99.37 134.21 42.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.229 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.447 HD21 ' HB3' ' A' ' 102' ' ' SER . 75.7 mt -117.01 142.97 46.28 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.573 0.545 . . . . 0.0 111.255 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -97.43 169.83 9.47 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.874 175.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -50.81 -42.61 58.38 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -94.37 24.3 4.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.728 0.299 . . . . 0.0 111.48 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.653 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 68.11 47.77 57.31 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.185 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.443 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 66.3 t60 -100.51 117.43 34.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 p -48.88 122.9 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 123.816 0.697 . . . . 0.0 110.913 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 88.6 mt -116.71 -44.99 2.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.35 158.13 40.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.472 ' HB ' ' HD3' ' A' ' 99' ' ' LYS . 13.4 m -145.32 117.28 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.533 0.521 . . . . 0.0 110.178 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.2 m -141.7 131.93 24.92 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.864 0.364 . . . . 0.0 111.249 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.7 tp -83.63 120.0 25.44 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.633 HG21 HG22 ' A' ' 120' ' ' THR . 0.1 OUTLIER -95.9 -58.74 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.345 -175.282 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.9 m -141.84 113.36 7.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.921 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.5 t -107.08 117.14 33.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.21 -46.82 66.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.496 -175.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.627 ' H ' HD21 ' A' ' 87' ' ' LEU . . . -176.35 58.91 0.1 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.913 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.93 ' HA ' HD12 ' A' ' 90' ' ' LEU . 1.6 mm? -118.05 89.61 35.07 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HB2' ' H ' ' A' ' 89' ' ' SER . 4.3 Cg_exo -77.33 -83.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.23 1.953 . . . . 0.0 111.338 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 3.5 m -67.41 -17.92 64.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.674 0.75 . . . . 0.0 110.104 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 87' ' ' LEU . 8.0 mt -75.5 -33.49 60.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.215 -175.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 13.6 t70 -54.87 -49.69 70.53 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.76 0.662 . . . . 0.0 111.371 -173.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 89' ' ' SER . 5.0 ptp180 -53.86 -50.53 66.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.094 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 20.7 tt0 -77.99 -42.06 33.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -173.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.575 HG22 ' NH1' ' A' ' 60' ' ' ARG . 30.3 pt -60.63 -40.68 85.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.885 -177.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.662 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 50.1 mm-40 -82.39 -30.52 30.18 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.957 0.408 . . . . 0.0 110.94 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.92 -52.31 64.57 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.923 173.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.689 HD22 HG22 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -62.2 -56.58 17.21 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.949 -178.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.922 HG13 HG21 ' A' ' 123' ' ' ILE . 58.5 t -88.14 -50.54 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -176.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.662 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 35.6 ttmt -63.7 -38.8 92.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.409 0.151 . . . . 0.0 111.409 -172.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -79.23 -16.85 55.88 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.662 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.37 53.09 0.77 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 51.0 m -65.45 107.4 1.45 Allowed Pre-proline 0 C--O 1.234 0.279 0 O-C-N 123.514 0.509 . . . . 0.0 110.79 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.699 ' HG2' HG23 ' A' ' 41' ' ' ILE . 50.2 Cg_endo -101.79 154.87 0.35 Allowed 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 123.847 3.032 . . . . 0.0 114.002 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.653 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 2.1 tp -142.57 107.63 5.55 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.141 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.428 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 4.0 Cg_exo -75.0 -56.94 0.06 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.22 1.947 . . . . 0.0 112.435 178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.501 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 10.6 m -90.2 110.36 39.94 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.684 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.507 ' HA ' HD22 ' A' ' 104' ' ' LEU . 42.2 Cg_endo -68.64 107.13 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.942 2.428 . . . . 0.0 112.16 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.85 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 51.1 Cg_endo -87.88 71.3 2.93 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.018 2.478 . . . . 0.0 111.754 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.643 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -56.29 -46.56 79.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.93 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -76.09 7.82 3.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.796 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.85 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.17 -23.26 10.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.485 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.752 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -122.01 16.68 10.85 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -177.738 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 109' ' ' ALA . 2.7 m -71.65 89.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.971 0.891 . . . . 0.0 108.954 172.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 3.5 p30 161.61 -28.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.082 -169.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 175.7 -89.4 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.111 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.665 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -161.6 175.56 11.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.752 HG13 ' HB3' ' A' ' 112' ' ' TYR . 11.5 m -102.85 109.31 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.313 0.578 . . . . 0.0 110.98 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 43.2 tt0 -111.93 111.62 22.68 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 170.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.574 HD11 ' HG ' ' A' ' 121' ' ' LEU . 3.8 pp -137.01 155.11 50.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.162 -175.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.633 HG22 HG21 ' A' ' 82' ' ' VAL . 86.4 m -95.11 125.45 39.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.374 -176.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.574 ' HG ' HD11 ' A' ' 119' ' ' LEU . 77.9 mt -125.74 131.4 24.0 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.093 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 6.4 Cg_exo -74.47 121.43 6.77 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.071 1.847 . . . . 0.0 111.369 175.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.922 HG21 HG13 ' A' ' 98' ' ' VAL . 3.1 pt -96.25 98.31 7.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -94.04 121.11 35.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.892 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 80.4 m-85 -116.93 128.89 55.66 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 163.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 m -63.59 102.92 0.48 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.719 0.295 . . . . 0.0 111.022 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 1.042 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 5.0 mt -64.12 103.84 0.66 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.259 0.552 . . . . 0.0 111.551 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.458 HH11 ' HD3' ' A' ' 57' ' ' ARG . 64.5 mtp180 -102.7 -15.13 16.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.071 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 177.07 -151.98 11.69 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 69.81 -63.92 0.37 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.092 0.557 . . . . 0.0 111.283 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -90.38 56.62 3.53 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 25.4 p90 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.584 -178.101 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.44 ' HE2' ' OE2' ' A' ' 5' ' ' GLU . 59.9 mtpt . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 120.825 0.345 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.0 m -111.53 -17.59 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.427 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -83.87 37.86 0.61 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.086 0.47 . . . . 0.0 111.017 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.44 ' OE2' ' HE2' ' A' ' 2' ' ' LYS . 7.6 mm-40 -92.12 124.48 36.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.938 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -74.37 85.1 1.96 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.2 m -78.87 155.7 28.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.721 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.83 99.37 8.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.093 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.91 149.26 17.17 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.877 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.1 100.53 47.26 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.44 121.15 3.75 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.66 2.24 . . . . 0.0 112.294 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.435 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . 75.8 Cg_exo -50.02 -45.07 34.59 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.431 2.754 . . . . 0.0 114.064 176.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.435 ' HD3' ' HB2' ' A' ' 12' ' ' PRO . 5.1 Cg_exo -81.16 3.63 7.65 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.173 1.916 . . . . 0.0 112.584 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.58 -142.49 38.75 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.603 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -115.39 43.48 2.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.376 0.607 . . . . 0.0 109.902 176.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.69 119.37 30.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.345 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -99.7 -50.48 4.03 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -142.66 114.18 7.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.804 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.3 p -99.0 72.31 1.89 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.068 0.461 . . . . 0.0 111.498 -175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.29 72.56 10.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.682 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.729 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . . . -65.71 -50.71 53.71 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.659 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.729 ' HD3' ' HB2' ' A' ' 21' ' ' ALA . 11.3 Cg_endo -92.63 -166.84 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.639 2.226 . . . . 0.0 110.496 168.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -86.17 43.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.359 0.599 . . . . 0.0 110.486 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 p -75.57 -7.97 55.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.938 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 25' ' ' ARG . 2.0 ptm180 -70.19 -15.75 62.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.164 176.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.2 tp -107.25 37.8 2.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.563 0.697 . . . . 0.0 109.535 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.631 ' H ' ' HD2' ' A' ' 28' ' ' PRO . 89.0 m -114.68 -54.63 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.36 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.631 ' HD2' ' H ' ' A' ' 27' ' ' THR . 54.4 Cg_endo -68.91 169.06 18.66 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.145 1.897 . . . . 0.0 112.36 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -81.05 61.45 4.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.062 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.15 -89.68 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.483 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -152.42 28.98 0.56 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.02 0.438 . . . . 0.0 110.505 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.42 68.3 9.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.652 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.11 -147.29 18.46 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.92 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.71 18.72 7.19 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -172.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -78.72 155.58 29.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.934 0.397 . . . . 0.0 109.969 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 76.5 m-20 -88.7 54.44 3.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.19 0.519 . . . . 0.0 110.6 -178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.458 ' O ' HG13 ' A' ' 41' ' ' ILE . 12.0 p-90 -71.62 -36.28 70.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.329 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.547 ' HD3' ' N ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -69.2 -25.4 64.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.243 0.544 . . . . 0.0 110.125 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.547 ' N ' ' HD3' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -71.95 -34.58 69.12 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.499 ' CB ' ' HG2' ' A' ' 105' ' ' PRO . 34.1 mmt180 -74.24 -36.12 63.87 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.377 175.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.617 HG23 ' HD2' ' A' ' 103' ' ' PRO . 61.8 mt -57.32 -47.22 84.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.713 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.1 m -56.23 -35.13 67.0 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.011 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.23 -52.35 47.93 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.386 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.759 ' HD3' ' HB2' ' A' ' 103' ' ' PRO . 9.4 ptp180 -70.08 -27.46 64.63 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.538 -0.39 . . . . 0.0 111.731 175.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tt -54.25 -38.1 65.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -71.08 -31.67 68.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.297 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HB3' ' HA ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -53.16 -26.64 17.78 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.382 173.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -101.75 -57.16 2.13 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.479 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.506 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 4.2 mtpp -172.76 102.8 0.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.097 -177.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -144.69 104.56 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.203 0.525 . . . . 0.0 110.26 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.473 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.5 t80 -96.47 144.5 27.95 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.299 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -53.05 133.59 52.62 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.101 2.534 . . . . 0.0 112.397 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.535 ' HE2' ' HE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -62.02 -21.13 64.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.633 -171.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -53.07 -37.57 61.74 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.452 0.47 . . . . 0.0 110.827 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.71 -38.97 53.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.637 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.757 HD11 ' HB2' ' A' ' 60' ' ' ARG . 3.6 mm? -69.41 -41.54 76.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.068 -173.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.575 ' HA ' ' HG3' ' A' ' 61' ' ' GLN . 7.8 ptp85 -67.16 -8.88 34.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.14 0.495 . . . . 0.0 110.851 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.0 tp -118.93 12.81 12.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.262 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.693 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 25.3 ttmm -154.47 -67.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.693 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.799 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 36.6 mmt180 -119.98 84.53 2.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.675 0.274 . . . . 0.0 110.308 -177.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.575 ' HG3' ' HA ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -86.15 177.65 7.46 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.6 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.52 122.42 0.94 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.244 -1.455 . . . . 0.0 113.787 176.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -110.82 124.48 67.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.34 166.6 33.23 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.825 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.471 ' O ' HG21 ' A' ' 82' ' ' VAL . 2.7 mp0 -102.12 124.38 47.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 178.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.2 t -119.73 114.23 43.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.293 -173.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -115.03 124.71 52.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.748 -174.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -148.13 163.85 35.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.306 0.574 . . . . 0.0 112.136 -174.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 40.9 m -105.2 131.99 51.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.014 174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 104' ' ' LEU . 86.8 mt -118.76 142.0 48.1 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -172.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.572 ' OD1' ' HG2' ' A' ' 73' ' ' GLN . 13.8 t70 -89.58 160.18 16.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.244 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.591 ' HB3' ' HH ' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -58.47 -32.09 68.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.687 0.279 . . . . 0.0 111.322 -177.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.573 ' N ' ' HG2' ' A' ' 72' ' ' ARG . 25.4 pt20 -94.04 14.51 19.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.204 0.526 . . . . 0.0 111.246 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.41 ' HA2' ' H ' ' A' ' 104' ' ' LEU . . . 78.01 33.8 39.94 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.248 177.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.476 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 67.6 t60 -97.1 101.88 13.54 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.44 122.26 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 121.388 0.614 . . . . 0.0 110.92 173.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 15.2 mt -108.21 -40.79 5.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.437 -175.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.5 158.43 39.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.27 117.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.167 0.508 . . . . 0.0 109.997 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.7 m -140.58 120.93 14.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.917 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 29.3 tp -81.41 106.37 13.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -82.22 -44.64 19.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.894 -170.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.1 m -155.41 155.14 33.05 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.372 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.476 ' HB2' ' CD2' ' A' ' 87' ' ' LEU . 53.4 p -163.34 147.44 10.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.85 0.357 . . . . 0.0 110.944 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.5 -9.38 58.87 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -173.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.407 ' C ' HD11 ' A' ' 87' ' ' LEU . . . 120.67 73.13 0.34 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.176 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.904 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -114.4 96.62 43.65 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -177.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.67 -83.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.75 2.3 . . . . 0.0 111.888 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 m -66.15 -18.29 65.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.63 0.728 . . . . 0.0 110.107 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.904 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 20.4 mt -75.78 -39.28 57.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.056 -176.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.42 -50.93 68.51 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -169.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.515 ' HD2' ' H ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -61.63 -36.13 79.88 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.005 -171.43 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.799 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 8.8 tp10 -76.59 -52.64 9.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 90' ' ' LEU . 39.9 pt -65.11 -35.02 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 69.9 mm-40 -81.81 -28.68 33.0 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.678 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.582 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -57.45 -48.22 79.75 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -61.81 -58.16 9.04 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.216 -178.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.695 HG12 HG21 ' A' ' 123' ' ' ILE . 91.6 t -89.22 -50.05 13.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 8.9 ttpp -70.7 -24.99 62.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -170.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.582 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 9.6 tpp180 -90.99 -24.98 19.93 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.061 174.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.607 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -114.04 73.41 0.82 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.312 -178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.8 m -108.43 95.02 14.82 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.392 0.615 . . . . 0.0 110.59 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.759 ' HB2' ' HD3' ' A' ' 44' ' ' ARG . 61.1 Cg_endo -112.51 110.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 124.723 3.615 . . . . 0.0 114.04 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.645 HD22 ' HD2' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -86.32 123.42 71.44 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 171.055 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.645 ' HD2' HD22 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -80.6 -57.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.73 2.287 . . . . 0.0 112.751 -177.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -63.43 116.24 24.19 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.37 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.52 106.02 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.106 2.537 . . . . 0.0 112.171 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.633 ' HG3' HD11 ' A' ' 104' ' ' LEU . 63.7 Cg_endo -94.64 45.77 0.21 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.995 2.463 . . . . 0.0 112.82 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.6 ' O ' HG13 ' A' ' 113' ' ' VAL . . . -57.17 -41.51 79.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 109.91 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.03 -18.27 63.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.355 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.84 -29.45 22.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.779 -177.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.892 ' HB3' HG12 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -121.43 19.15 11.34 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -171.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.5 m -69.15 89.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 122.092 0.949 . . . . 0.0 108.947 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 7.0 p30 161.67 -18.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.943 -169.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.7 -87.82 0.1 Allowed Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.113 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.615 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -162.36 176.09 10.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.892 HG12 ' HB3' ' A' ' 112' ' ' TYR . 12.6 m -102.21 109.49 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 121.541 0.686 . . . . 0.0 110.719 -175.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 25.8 tt0 -107.96 110.94 22.8 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 173.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.593 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -141.04 155.26 46.2 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -174.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 50.6 m -98.74 122.75 42.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.147 0.499 . . . . 0.0 111.264 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.593 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 47.8 mt -118.22 123.88 29.07 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.993 174.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 5.2 Cg_exo -73.3 119.72 6.15 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.311 2.007 . . . . 0.0 111.241 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.695 HG21 HG12 ' A' ' 98' ' ' VAL . 32.0 pt -99.17 101.9 12.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -104.3 122.44 45.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.224 1.011 . . . . 0.0 111.722 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.6 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 85.4 m-85 -114.13 129.74 56.61 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.865 -1.516 . . . . 0.0 106.94 165.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.3 m -57.63 103.2 0.12 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.153 0.502 . . . . 0.0 111.979 -169.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.816 HD13 HD13 ' A' ' 87' ' ' LEU . 13.3 mt -80.46 82.15 6.55 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.771 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.06 31.84 6.32 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.521 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -158.85 -102.76 0.19 Allowed Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.997 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.442 ' O ' HD11 ' A' ' 90' ' ' LEU . . . -69.68 94.34 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 176.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 117.85 59.41 0.29 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -174.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 11.1 p90 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 119.206 -0.426 . . . . 0.0 111.205 -174.687 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.463 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 6.9 ptpp? . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 121.343 0.592 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.6 m -137.89 5.54 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.617 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -117.89 -18.1 9.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.987 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.463 ' OE1' ' HA ' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -102.87 137.81 40.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.167 0.508 . . . . 0.0 110.612 178.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -112.18 134.35 53.78 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.356 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.6 m -120.53 -35.89 3.31 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.865 176.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 t 51.17 81.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.502 0.667 . . . . 0.0 110.509 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.78 32.86 1.36 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.459 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -64.45 -48.72 74.42 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.707 -0.246 . . . . 0.0 111.102 178.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 39.2 Cg_endo -69.32 120.24 7.11 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.454 1.436 . . . . 0.0 110.268 170.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 19.7 Cg_endo -59.1 127.39 23.98 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.661 2.241 . . . . 0.0 112.32 -175.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 11.6 Cg_exo -71.16 71.99 2.2 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.782 2.321 . . . . 0.0 111.18 176.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.65 -141.48 10.39 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.01 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -115.02 42.31 2.22 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 70.7 -62.67 0.44 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 124.009 0.818 . . . . 0.0 109.994 -172.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 56.31 71.65 0.55 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.994 171.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -82.97 54.11 2.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.428 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.3 m -76.03 -12.62 60.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.695 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.444 ' HA ' ' OG1' ' A' ' 24' ' ' THR . . . -79.19 45.86 0.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.323 0.582 . . . . 0.0 110.733 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.578 ' HB1' ' HD3' ' A' ' 22' ' ' PRO . . . -60.78 -49.46 89.42 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.836 -177.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' HD3' ' HB1' ' A' ' 21' ' ' ALA . 2.9 Cg_exo -77.96 32.05 0.44 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 122.426 2.084 . . . . 0.0 112.358 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 60.4 33.84 20.68 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.474 0.654 . . . . 0.0 110.948 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 20' ' ' ALA . 9.5 p -81.18 36.25 0.41 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.162 0.506 . . . . 0.0 111.301 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -69.37 -36.85 77.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.9 tp -171.72 98.0 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.515 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.8 m -53.32 124.95 41.62 Favored Pre-proline 0 N--CA 1.451 -0.404 0 O-C-N 123.487 0.492 . . . . 0.0 111.512 -176.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.52 148.89 84.35 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.053 2.502 . . . . 0.0 112.684 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.457 ' HD2' ' HB2' ' A' ' 31' ' ' GLN . 72.7 t80 -148.28 135.2 20.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.263 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.754 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . . . -79.39 75.48 5.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.221 0.534 . . . . 0.0 109.922 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.457 ' HB2' ' HD2' ' A' ' 29' ' ' TYR . 8.3 tt0 -85.58 136.31 33.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.67 -176.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.66 104.55 14.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.89 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.43 -127.45 6.08 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.22 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -76.44 -177.86 4.35 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.927 0.394 . . . . 0.0 110.501 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.484 ' OD1' ' HG2' ' A' ' 38' ' ' ARG . 10.0 t70 -78.99 118.95 21.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.886 0.851 . . . . 0.0 112.217 -174.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -146.43 23.07 1.31 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 167.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.579 ' HA ' ' HG2' ' A' ' 40' ' ' ARG . 0.2 OUTLIER -138.48 -24.76 0.94 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -168.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.484 ' HG2' ' OD1' ' A' ' 35' ' ' ASP . 2.1 ptp180 -67.84 -32.68 73.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.202 0.91 . . . . 0.0 109.872 -176.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.3 p -66.53 -36.44 82.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.938 176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.579 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 10.2 mmt180 -69.52 -44.62 70.66 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.575 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.683 HG22 ' HG2' ' A' ' 103' ' ' PRO . 83.8 mt -63.68 -43.86 98.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.585 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.8 m -57.25 -33.58 67.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.946 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.63 -34.67 73.21 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.682 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.791 ' HD3' ' HB3' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -70.75 -40.31 72.77 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 121.279 0.561 . . . . 0.0 110.151 178.1 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.05 -25.77 64.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.75 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.941 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 24.4 t-20 -69.3 -33.99 74.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.986 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 0.4 OUTLIER -61.44 -20.45 63.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.949 174.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.5 ' CG ' ' HB1' ' A' ' 101' ' ' ALA . 97.3 m-85 -106.71 -60.28 1.69 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.615 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -164.99 102.93 0.77 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.548 0.739 . . . . 0.0 109.037 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.941 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 24.6 tpt180 -113.54 103.15 10.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.527 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 0.9 OUTLIER -105.45 132.31 20.99 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 32.4 Cg_exo -58.97 132.1 45.55 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.824 2.349 . . . . 0.0 111.721 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.19 -23.14 65.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.958 -173.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.72 -40.21 83.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.565 0.222 . . . . 0.0 110.853 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.0 -33.65 75.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.113 0.483 . . . . 0.0 110.475 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -72.65 -41.56 65.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 57' ' ' ARG . 49.5 mtm180 -58.07 -31.07 66.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.012 0.434 . . . . 0.0 110.422 176.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.9 tp -93.85 -0.49 55.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.951 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.754 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 24.5 ttmm -142.04 -75.42 0.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -175.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.754 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 26.3 mmt180 -119.79 89.78 3.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.901 0.381 . . . . 0.0 110.427 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -92.14 179.17 5.65 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.521 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.604 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.26 124.05 1.05 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.169 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.705 ' H ' HD12 ' A' ' 127' ' ' LEU . 7.3 p -110.36 127.05 67.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.44 167.07 36.16 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.727 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.658 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 50.3 mt-30 -102.3 125.11 48.91 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.483 HG22 HD12 ' A' ' 123' ' ' ILE . 24.3 t -121.47 114.42 43.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.712 -176.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.709 ' HG2' HG22 ' A' ' 82' ' ' VAL . 5.9 ptp180 -106.19 144.17 33.28 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -152.91 152.0 30.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.094 0.473 . . . . 0.0 111.853 -174.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 22.5 m -96.41 126.94 41.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.371 171.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 58.7 mt -117.8 135.76 53.85 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.203 0.525 . . . . 0.0 112.069 -169.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.522 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 15.4 t70 -77.27 152.51 34.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.476 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.3 ttp-105 -60.98 -25.28 66.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.119 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -89.61 -1.43 58.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.968 0.413 . . . . 0.0 111.012 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.96 36.88 6.53 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.04 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.522 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 55.6 t60 -104.3 120.96 42.34 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 p -53.81 117.27 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.313 0.578 . . . . 0.0 111.07 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.447 HD21 ' HD2' ' A' ' 75' ' ' HIS . 42.2 mt -101.86 -37.46 8.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.477 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -146.89 152.97 39.56 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.66 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.0 m -147.24 132.37 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 123.45 0.469 . . . . 0.0 109.836 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -144.28 132.67 22.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.37 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.698 HD22 ' HB2' ' A' ' 84' ' ' SER . 37.3 tp -75.5 120.88 21.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.738 HG23 HG23 ' A' ' 120' ' ' THR . 0.2 OUTLIER -96.67 -47.63 12.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.899 -173.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -142.26 145.46 34.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.346 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.698 ' HB2' HD22 ' A' ' 81' ' ' LEU . 40.7 t -137.8 148.61 45.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.023 0.44 . . . . 0.0 111.212 -176.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.58 15.32 25.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.219 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.81 76.02 1.31 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.173 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.716 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -116.51 71.11 4.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.803 0.302 . . . . 0.0 110.295 178.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.85 -68.36 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 121.804 1.669 . . . . 0.0 112.482 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.491 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 7.9 m -72.08 -18.69 61.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.233 0.54 . . . . 0.0 110.035 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.716 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 26.2 mt -77.32 -32.35 55.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.145 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.538 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 7.3 t70 -53.39 -37.95 62.94 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.4 0.438 . . . . 0.0 111.88 -173.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.541 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 13.6 ptm180 -53.57 -54.79 32.45 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.47 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -78.53 -55.12 5.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.522 HG13 ' HG2' ' A' ' 95' ' ' GLN . 40.0 pt -60.21 -38.88 78.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.646 -172.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.715 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 76.0 mm-40 -84.58 -20.86 30.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.603 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 92' ' ' ARG . . . -55.1 -54.1 47.45 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.163 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.599 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.77 -48.72 17.82 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.06 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.692 HG13 HG22 ' A' ' 123' ' ' ILE . 55.8 t -70.26 -50.18 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.715 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.3 ttmt -75.88 -32.1 59.53 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.318 -0.239 . . . . 0.0 111.361 -171.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.3 tpp180 -89.16 -18.8 26.42 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.052 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB1' ' CG ' ' A' ' 48' ' ' PHE . . . -120.24 56.4 0.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.603 0.24 . . . . 0.0 111.098 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 19.4 m -80.52 106.75 5.73 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.114 0.483 . . . . 0.0 110.112 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.683 ' HG2' HG22 ' A' ' 41' ' ' ILE . 62.9 Cg_endo -101.78 165.1 0.33 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 124.038 3.159 . . . . 0.0 114.486 -171.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 33.2 tp -142.08 94.25 7.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.159 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.791 ' HB3' ' HD3' ' A' ' 44' ' ' ARG . 50.5 Cg_endo -77.25 -49.7 0.1 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.442 2.095 . . . . 0.0 113.665 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.446 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 22.3 m -88.58 110.45 37.03 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.01 107.68 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.112 2.542 . . . . 0.0 112.451 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.707 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 52.1 Cg_endo -89.15 59.99 2.31 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.135 2.557 . . . . 0.0 111.853 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.653 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.05 -47.05 75.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.165 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.2 10.0 2.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.433 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.754 ' HB3' ' HB2' ' A' ' 30' ' ' ALA . . . -112.12 -30.39 7.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.932 0.396 . . . . 0.0 111.616 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.653 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -121.16 18.41 11.58 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.402 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -70.59 88.3 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.212 1.006 . . . . 0.0 108.446 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.615 HD21 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 158.92 -15.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 113.116 -1.856 . . . . 0.0 108.383 -168.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.615 ' N ' HD21 ' A' ' 114' ' ' ASN . . . 163.91 -90.84 0.1 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.175 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.428 ' CA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -161.06 177.03 10.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -175.151 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 69' ' ' THR . 12.9 m -102.75 109.88 27.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.467 0.651 . . . . 0.0 110.861 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 24.7 tt0 -109.35 109.99 21.02 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.73 HD11 ' HG ' ' A' ' 121' ' ' LEU . 1.5 pp -135.12 152.37 51.58 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.656 -173.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.738 HG23 HG23 ' A' ' 82' ' ' VAL . 87.9 m -96.72 113.44 25.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.212 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.73 ' HG ' HD11 ' A' ' 119' ' ' LEU . 62.5 mt -119.48 122.94 28.97 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.965 0.412 . . . . 0.0 110.711 177.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.658 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 12.0 Cg_exo -70.65 119.19 6.14 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.709 1.606 . . . . 0.0 110.554 174.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.692 HG22 HG13 ' A' ' 98' ' ' VAL . 35.1 pt -93.98 118.77 40.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -107.47 120.31 41.83 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 118.821 -1.151 . . . . 0.0 112.35 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.508 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 37.9 m-85 -115.65 126.69 54.46 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 160.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.0 m -56.54 104.01 0.13 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.242 0.544 . . . . 0.0 111.052 -172.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.705 HD12 ' H ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -100.6 105.46 16.86 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.854 -171.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.6 mtp-105 -86.75 -47.0 9.48 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 173.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 164.11 54.99 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.741 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.473 ' HB1' HD21 ' A' ' 90' ' ' LEU . . . -81.65 -5.42 58.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 0.0 111.787 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -91.12 40.01 3.02 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.941 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 20.7 p90 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.314 -0.851 . . . . 0.0 110.342 -176.78 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.859 0.361 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 16.6 m -124.05 -44.55 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.481 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER 172.69 79.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -99.08 141.38 31.92 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.729 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -105.06 108.24 19.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.731 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.2 m -85.61 128.32 34.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.599 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -146.99 31.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 122.452 1.12 . . . . 0.0 109.195 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.15 68.05 1.18 Allowed Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.974 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -62.82 114.74 13.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.64 0.257 . . . . 0.0 110.892 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 4.1 Cg_exo -81.64 123.87 4.41 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.351 2.7 . . . . 0.0 112.174 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.2 147.8 48.68 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.634 2.222 . . . . 0.0 112.115 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.89 55.92 5.78 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.962 2.442 . . . . 0.0 112.126 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.52 -170.52 29.57 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.015 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.528 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 1.5 mpt_? -114.19 104.45 12.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.864 0.364 . . . . 0.0 110.099 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.6 -20.16 19.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.667 -178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.73 55.47 1.37 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.32 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -88.55 57.63 4.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.713 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.0 p 49.01 68.74 0.66 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.076 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.57 38.53 3.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.409 0.624 . . . . 0.0 111.215 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.731 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . . . -91.81 -52.98 0.28 Allowed Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.002 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.731 ' HD3' ' HB2' ' A' ' 21' ' ' ALA . 5.7 Cg_exo -80.19 -160.18 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.606 2.204 . . . . 0.0 111.324 175.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -86.49 23.59 1.59 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.278 0.561 . . . . 0.0 110.922 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.619 ' HA ' ' OG1' ' A' ' 27' ' ' THR . 3.0 p -68.98 -5.27 20.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.021 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.46 -13.44 61.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.442 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.7 tp -150.83 37.53 0.65 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.165 0.507 . . . . 0.0 111.109 -176.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.619 ' OG1' ' HA ' ' A' ' 24' ' ' THR . 1.8 m -81.99 137.14 46.73 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.221 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 27' ' ' THR . 7.1 Cg_exo -73.58 77.67 2.54 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.815 2.343 . . . . 0.0 112.3 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.559 ' CZ ' ' HB ' ' A' ' 27' ' ' THR . 69.3 m-85 -76.44 126.19 30.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.591 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.73 -32.82 8.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.94 0.4 . . . . 0.0 110.404 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -89.3 43.03 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.374 0.607 . . . . 0.0 110.892 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.32 22.82 3.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.162 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.62 157.35 8.5 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.992 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -96.79 71.6 2.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.558 0.694 . . . . 0.0 110.152 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.31 140.59 58.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.418 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -87.52 103.56 15.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -99.29 16.85 21.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.029 177.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HD2' ' N ' ' A' ' 39' ' ' SER . 7.5 ppt_? -68.12 -31.02 70.32 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -168.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.443 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 32.2 m -69.16 -32.52 71.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 0.0 109.823 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -75.86 -44.49 40.48 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.75 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.412 HG23 ' HD2' ' A' ' 103' ' ' PRO . 86.5 mt -58.77 -43.45 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.937 177.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 t -57.43 -38.8 74.98 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.882 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.13 -42.25 96.6 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.843 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.494 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.38 -33.77 73.54 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.803 0.335 . . . . 0.0 110.72 178.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.452 HD11 HG23 ' A' ' 98' ' ' VAL . 2.1 tt -62.15 -31.93 72.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.398 0.618 . . . . 0.0 109.832 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.699 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 8.7 t30 -71.69 -34.26 69.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.797 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -29.64 58.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.682 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.522 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 98.8 m-85 -94.73 -59.22 1.97 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.78 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 34.1 mmtt -174.82 104.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.622 0.769 . . . . 0.0 109.488 -177.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.699 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 29.1 ttp180 -128.28 103.91 7.43 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.485 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -81.41 138.17 48.29 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.382 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -49.87 131.53 29.83 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.132 2.555 . . . . 0.0 111.961 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.754 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -63.96 -23.68 67.43 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -170.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -58.76 -38.58 78.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.652 0.263 . . . . 0.0 111.069 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.03 -30.74 70.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.787 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 53' ' ' LYS . 3.1 mm? -77.25 -41.47 40.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.918 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 41.0 mtm180 -62.85 -23.04 67.11 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.381 0.61 . . . . 0.0 110.5 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 tp -102.09 4.04 39.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.753 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.562 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 40.3 ttpt -149.71 -75.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.562 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 26.2 mmt180 -99.03 84.27 3.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.453 0.644 . . . . 0.0 110.742 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 126' ' ' SER . 10.7 pt20 -104.95 127.78 52.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.948 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 1.016 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -179.55 129.77 1.41 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.268 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.805 ' H ' HD13 ' A' ' 127' ' ' LEU . 96.2 t -104.96 127.17 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.119 0.485 . . . . 0.0 110.238 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.85 166.61 30.92 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.664 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 56.0 mt-30 -101.02 136.82 40.25 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.464 HG22 HD12 ' A' ' 123' ' ' ILE . 39.0 t -129.5 114.21 30.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.562 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' HG2' HG23 ' A' ' 82' ' ' VAL . 13.3 ptt180 -115.35 139.38 50.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -154.3 163.37 40.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.655 -171.401 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 2.7 m -106.62 120.74 42.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.887 172.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.493 HD11 ' CE1' ' A' ' 68' ' ' PHE . 73.1 mt -106.48 138.52 42.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.75 -173.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -74.71 153.89 38.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.25 175.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 72' ' ' ARG . 4.2 ttp180 -61.05 -24.76 66.45 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.281 0.363 . . . . 0.0 111.333 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -80.6 -8.58 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.114 0.483 . . . . 0.0 110.421 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.732 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 89.04 35.42 8.19 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.268 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -109.2 124.61 51.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.665 0.269 . . . . 0.0 110.557 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -51.86 125.31 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.558 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.502 ' CD1' HG21 ' A' ' 116' ' ' THR . 35.3 mt -115.18 -51.29 2.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.235 0.54 . . . . 0.0 110.558 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.37 152.42 49.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.379 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.4 m -146.37 128.94 8.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.137 0.494 . . . . 0.0 110.208 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.1 m -134.68 123.95 24.52 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.585 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.9 tp -76.72 108.43 9.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.294 0.569 . . . . 0.0 110.299 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.655 HG21 HG22 ' A' ' 120' ' ' THR . 0.0 OUTLIER -83.35 -42.26 17.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.982 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.1 t 66.93 176.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.904 169.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.426 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 68.7 m -158.63 -67.74 0.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.979 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.23 -76.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.41 98.83 0.13 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.343 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.785 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -119.67 82.47 26.53 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -177.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.9 -75.28 0.01 OUTLIER 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.442 2.095 . . . . 0.0 111.866 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 8.4 m -70.69 -19.08 62.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.373 0.606 . . . . 0.0 110.197 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.785 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 14.6 mt -75.75 -34.08 60.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.715 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.449 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 1.8 t70 -54.33 -44.01 71.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.299 -175.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 89' ' ' SER . 11.6 ptp180 -53.58 -52.63 59.16 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -172.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.483 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 19.3 mt-10 -78.83 -54.21 6.31 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.607 HG12 ' O ' ' A' ' 90' ' ' LEU . 40.7 pt -63.32 -36.96 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.64 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.8 mm-40 -82.21 -26.83 32.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 122.055 -0.403 . . . . 0.0 110.825 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.621 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.85 -44.72 82.43 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.58 HD23 HG22 ' A' ' 98' ' ' VAL . 1.4 tp -68.24 -55.29 12.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.636 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.635 HG13 HG21 ' A' ' 123' ' ' ILE . 81.3 t -88.75 -48.27 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.64 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 16.4 ttpp -70.33 -15.13 62.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.391 -175.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.621 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 20.3 tpp180 -98.59 -35.14 10.31 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.797 170.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.616 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -101.13 64.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 110.969 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.6 m -93.79 100.82 5.09 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.28 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 72.3 Cg_endo -101.73 173.78 0.26 Allowed 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.919 3.079 . . . . 0.0 113.689 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.732 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 17.0 tp -143.22 97.33 5.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.326 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -72.42 -62.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.652 1.568 . . . . 0.0 111.933 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.655 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -76.62 111.57 16.66 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.828 177.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.15 103.58 1.77 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.421 2.748 . . . . 0.0 112.406 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.695 ' HD2' HD23 ' A' ' 104' ' ' LEU . 41.3 Cg_endo -83.07 68.94 7.3 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.075 2.516 . . . . 0.0 110.913 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.782 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.27 -42.29 73.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.189 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.423 ' OD1' ' HD2' ' A' ' 28' ' ' PRO . 2.1 m-20 -77.42 8.84 3.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.02 0.438 . . . . 0.0 111.46 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.42 -16.84 12.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.938 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.782 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -133.02 17.01 4.16 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.0 m -72.0 87.57 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 7.7 p30 157.79 -25.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.078 -167.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 172.64 -92.68 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.896 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.618 ' HB ' HG21 ' A' ' 69' ' ' THR . 0.6 OUTLIER -158.89 174.75 14.51 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.784 0.434 . . . . 0.0 109.913 -175.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.678 HG11 ' CD2' ' A' ' 112' ' ' TYR . 2.9 m -103.72 109.74 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 CA-C-O 121.114 0.483 . . . . 0.0 111.607 -171.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 24.9 tt0 -97.51 112.02 24.05 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.515 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.3 pp -142.26 155.14 45.21 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.655 HG22 HG21 ' A' ' 82' ' ' VAL . 87.1 m -101.07 126.49 47.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.614 -175.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.515 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 69.9 mt -129.41 123.49 21.48 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.36 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.9 Cg_exo -76.22 121.21 6.0 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.006 1.804 . . . . 0.0 110.886 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.635 HG21 HG13 ' A' ' 98' ' ' VAL . 24.1 pt -96.59 112.57 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.52 120.98 36.71 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.84 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.436 ' HE2' ' HE2' ' A' ' 53' ' ' LYS . 95.9 m-85 -114.94 129.56 56.73 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 159.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 31.8 m -57.23 103.11 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -169.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 1.016 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -87.5 98.07 11.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.258 -177.511 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.425 ' HD2' ' C ' ' A' ' 128' ' ' ARG . 6.2 ppt_? -134.3 6.2 3.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.311 . . . . 0.0 111.704 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -168.15 40.5 0.23 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.847 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -155.51 39.46 0.39 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.314 0.578 . . . . 0.0 110.019 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -168.98 -38.07 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.129 -174.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 39.8 p90 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.11 -179.794 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.4 t 60.6 87.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 121.375 0.607 . . . . 0.0 110.532 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -108.9 78.48 1.14 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.618 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.509 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -88.46 -8.63 54.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.156 -179.705 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -54.03 -29.7 44.68 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.451 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -69.19 -19.52 63.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.172 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 5' ' ' GLU . 3.2 p -76.38 -9.01 12.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.357 0.599 . . . . 0.0 110.008 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.39 17.93 11.2 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.71 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.753 ' HB1' ' HD3' ' A' ' 11' ' ' PRO . . . -89.16 -53.35 0.34 Allowed Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 119.938 -0.077 . . . . 0.0 111.089 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.753 ' HD3' ' HB1' ' A' ' 10' ' ' ALA . 9.3 Cg_endo -92.81 114.57 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.833 2.356 . . . . 0.0 111.231 173.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.39 112.34 1.55 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.823 2.349 . . . . 0.0 112.527 -177.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.67 -18.67 19.41 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.594 2.196 . . . . 0.0 112.174 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.0 -155.68 16.13 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.91 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -91.1 150.32 21.45 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.68 0.276 . . . . 0.0 110.736 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.11 15.46 9.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.318 0.58 . . . . 0.0 110.33 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -141.31 148.18 39.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.973 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm 54.61 64.39 1.83 Allowed 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.583 0.552 . . . . 0.0 110.248 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -81.65 68.79 8.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.579 0.704 . . . . 0.0 110.861 -175.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.31 54.62 0.79 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.08 177.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.649 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . . . -76.33 165.3 53.93 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.956 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.649 ' HD2' ' HB3' ' A' ' 21' ' ' ALA . 1.4 Cg_endo -43.17 -36.92 6.35 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.462 2.775 . . . . 0.0 114.21 -177.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -93.37 -19.09 21.67 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -173.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.8 p -89.54 45.19 1.26 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.648 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -85.47 -76.6 0.32 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.006 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.433 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 29.3 tp -133.2 17.62 4.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.724 0.773 . . . . 0.0 110.046 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.428 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.3 p -127.84 61.96 53.9 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.879 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 26' ' ' LEU . 86.9 Cg_endo -97.32 27.04 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.09 2.527 . . . . 0.0 112.024 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -128.14 101.61 6.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.296 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.563 ' HB1' HG11 ' A' ' 117' ' ' VAL . . . -81.98 56.41 3.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.048 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -162.57 108.45 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.12 151.07 33.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.476 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.04 -144.03 15.5 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.756 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -113.79 150.06 34.01 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -81.75 68.4 8.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.627 0.727 . . . . 0.0 110.766 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -119.24 -14.24 9.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.39 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.526 ' CZ2' HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -74.26 -19.87 60.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.553 -173.153 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -68.21 -37.88 81.34 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.19 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 p -68.95 -31.29 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.326 0.584 . . . . 0.0 109.804 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.452 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 5.4 mmm-85 -68.84 -39.56 79.9 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.414 176.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.557 HG23 ' HD2' ' A' ' 103' ' ' PRO . 83.4 mt -63.91 -51.2 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.124 176.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.2 m -56.42 -32.74 65.16 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.784 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.81 -47.03 92.25 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.962 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 47' ' ' ARG . 20.9 mtp180 -69.19 -34.77 75.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.854 0.359 . . . . 0.0 111.017 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.671 HD11 HG22 ' A' ' 98' ' ' VAL . 1.4 tt -62.44 -30.67 71.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.664 0.745 . . . . 0.0 109.652 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 1.099 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 8.4 t30 -70.89 -34.83 71.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.542 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -58.0 -34.9 70.5 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.702 172.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.424 ' HB2' ' HB1' ' A' ' 101' ' ' ALA . 76.3 m-85 -91.91 -59.53 2.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.515 -175.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -162.14 102.09 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.503 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 1.099 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 12.7 tpt180 -130.88 103.34 6.51 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.491 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.1 t80 -87.32 131.88 42.9 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.823 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.8 131.71 45.65 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.732 2.288 . . . . 0.0 112.001 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.85 -23.68 65.32 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.27 -173.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -55.59 -42.9 75.47 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.577 0.548 . . . . 0.0 110.231 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.64 -41.03 79.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.632 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.478 HD22 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -62.44 -41.12 98.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.845 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.571 ' HG2' ' HB2' ' A' ' 126' ' ' SER . 98.5 mtt180 -59.51 -15.52 18.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.3 -24.02 9.12 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.04 0.448 . . . . 0.0 111.114 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.943 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 18.0 ttmm -102.45 -72.63 0.68 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.943 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 30.5 mmt180 -124.22 84.33 2.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.377 0.608 . . . . 0.0 110.14 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 126' ' ' SER . 14.1 pt20 -98.92 115.96 30.07 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.041 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.982 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -165.72 143.23 8.25 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.489 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.776 ' H ' HD11 ' A' ' 127' ' ' LEU . 46.7 t -103.58 123.42 57.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.0 165.24 26.29 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.36 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.703 ' H ' ' HA ' ' A' ' 83' ' ' SER . 56.2 mt-30 -105.15 143.42 33.36 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.4 114.62 21.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.637 0.732 . . . . 0.0 109.576 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.428 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 27.1 ttt180 -106.51 138.42 42.73 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -159.95 171.58 19.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.318 0.58 . . . . 0.0 111.956 -173.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.651 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 7.8 m -118.82 130.03 55.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.946 173.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.2 mt -111.14 140.46 45.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.762 -172.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.1 160.35 23.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.73 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.431 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 42.1 mtm180 -54.07 -36.86 63.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.298 0.57 . . . . 0.0 110.878 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -81.1 0.07 37.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.229 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 80.71 45.32 7.88 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.109 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -110.93 124.53 52.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.7 p -57.24 111.09 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.497 0.665 . . . . 0.0 110.703 174.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 80.5 mt -100.99 -41.04 6.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.931 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.28 158.27 40.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.222 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 m -144.89 121.65 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 123.613 0.57 . . . . 0.0 109.915 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 35.7 m -126.29 114.89 18.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.057 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.8 tp -78.29 118.74 20.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.427 0.632 . . . . 0.0 110.662 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -108.1 -58.42 3.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.26 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.703 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 19.1 t 62.05 179.64 0.13 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.979 0.419 . . . . 0.0 111.32 176.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.9 m -154.58 -74.36 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.87 -68.68 0.32 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -169.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.95 84.25 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.825 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.915 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -120.68 93.44 48.54 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -176.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.15 -79.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.578 2.185 . . . . 0.0 111.347 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -75.92 -17.2 59.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.543 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.915 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.7 mt -72.1 -38.3 69.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.728 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 14.0 t70 -54.58 -51.14 66.21 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.607 0.567 . . . . 0.0 111.61 -172.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.402 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 9.4 ptp180 -53.73 -40.54 66.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.128 -177.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.409 ' CB ' ' HG3' ' A' ' 60' ' ' ARG . 5.7 mm-40 -78.07 -58.11 3.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.559 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 32.5 pt -66.75 -43.74 89.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.723 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.798 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 48.4 mm-40 -67.98 -51.16 50.58 Favored 'General case' 0 C--O 1.193 -1.893 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.643 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.46 -31.28 61.82 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.097 0.862 . . . . 0.0 111.434 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.82 -54.47 38.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.838 173.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.713 HG12 HG21 ' A' ' 123' ' ' ILE . 79.9 t -86.48 -33.55 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.306 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.798 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.5 ttmt -66.72 -25.15 66.38 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.4 1.08 . . . . 0.0 110.951 -169.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -104.23 -19.4 14.13 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.967 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.522 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -112.44 45.52 1.29 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.797 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.7 m -81.75 107.54 8.59 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.116 0.484 . . . . 0.0 110.255 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 41' ' ' ILE . 73.0 Cg_endo -99.79 175.07 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.539 2.826 . . . . 0.0 113.259 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.778 HD22 ' HD2' ' A' ' 108' ' ' PRO . 16.1 tp -143.46 90.52 7.16 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.921 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.452 ' CG ' ' HB2' ' A' ' 40' ' ' ARG . 10.1 Cg_endo -67.36 -62.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.984 1.79 . . . . 0.0 112.078 -177.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.595 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 t -79.1 116.97 64.18 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.06 103.04 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.068 2.512 . . . . 0.0 111.626 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.778 ' HD2' HD22 ' A' ' 104' ' ' LEU . 45.2 Cg_endo -81.66 68.92 7.9 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.904 2.403 . . . . 0.0 111.764 -177.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.604 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -58.91 -42.85 90.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.646 178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -67.72 1.9 2.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.832 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -112.53 -35.85 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.676 0.274 . . . . 0.0 111.575 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.606 ' CD2' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -118.79 17.51 13.47 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -171.169 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.469 HG11 ' O ' ' A' ' 109' ' ' ALA . 2.5 m -70.98 89.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 8.2 p30 160.87 -26.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.744 -1.571 . . . . 0.0 107.588 -170.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 175.21 -88.25 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.936 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.495 ' HB ' HG23 ' A' ' 69' ' ' THR . 0.8 OUTLIER -160.0 175.7 12.7 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 122.933 0.493 . . . . 0.0 110.01 -174.283 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 69' ' ' THR . 2.6 m -103.2 108.98 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.301 0.572 . . . . 0.0 110.778 -175.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.543 ' HG2' ' HG1' ' A' ' 69' ' ' THR . 8.5 tm-20 -103.27 111.65 24.14 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.676 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -151.72 156.44 40.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.155 0.502 . . . . 0.0 111.943 -171.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 61.4 m -96.13 126.39 41.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.189 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.676 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 33.0 mt -128.54 137.9 31.92 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.092 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 3.4 Cg_endo -87.57 119.8 1.41 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.329 2.019 . . . . 0.0 112.066 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.713 HG21 HG12 ' A' ' 98' ' ' VAL . 9.8 pt -97.07 97.87 6.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.745 0.784 . . . . 0.0 109.198 172.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -97.16 125.72 41.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.043 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.559 ' CE1' ' HB ' ' A' ' 94' ' ' ILE . 83.5 m-85 -114.28 151.42 32.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 168.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.571 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 5.0 m -64.86 102.58 0.61 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.089 -0.245 . . . . 0.0 111.296 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.982 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -92.1 95.15 9.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.106 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.412 ' HB2' ' OE1' ' A' ' 61' ' ' GLN . 80.1 mtm180 -81.23 -53.13 6.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.966 0.412 . . . . 0.0 110.224 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -165.87 79.23 0.12 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.566 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -144.53 168.37 20.31 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.93 -50.23 2.82 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.471 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 7.0 p90 . . . . . 0 C--O 1.245 0.839 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 175.744 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 120.959 0.409 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.6 t -116.76 -51.76 4.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -179.95 82.89 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.302 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.16 58.51 2.51 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.576 -171.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -92.82 -60.28 1.85 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.045 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.9 t -112.11 41.96 1.87 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.259 0.552 . . . . 0.0 110.052 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 m -116.27 1.82 8.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.332 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.56 3.51 61.26 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.024 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.3 140.57 13.21 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.412 -0.394 . . . . 0.0 109.966 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.55 113.73 2.42 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.472 2.115 . . . . 0.0 110.912 173.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 37.7 Cg_exo -60.26 124.26 14.82 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.744 2.296 . . . . 0.0 112.379 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 3.0 Cg_exo -76.84 8.7 2.99 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.185 2.59 . . . . 0.0 111.994 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.27 -154.19 34.66 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.141 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 54.7 mmt-85 -126.14 -78.03 0.59 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.14 12.8 8.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.3 0.571 . . . . 0.0 109.801 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.13 3.05 28.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.823 -176.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.945 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -101.77 -43.46 5.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.151 0.501 . . . . 0.0 110.094 174.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 60.82 15.95 6.39 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.646 168.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 49.59 43.13 23.97 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.446 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.551 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . . . -113.08 -61.99 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.172 -176.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' A' ' 21' ' ' ALA . 42.8 Cg_endo -69.19 -79.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.784 1.656 . . . . 0.0 113.171 -176.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -144.0 91.27 2.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.937 0.399 . . . . 0.0 110.345 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.8 p -122.64 28.71 7.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.651 177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 25' ' ' ARG . 9.5 ptm180 -95.46 3.46 54.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.583 -176.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.6 tp -169.0 36.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.557 0.694 . . . . 0.0 109.154 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.17 -53.75 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.858 -170.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.22 112.03 1.1 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.384 2.056 . . . . 0.0 113.351 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -81.92 127.37 32.96 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.85 67.53 4.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.952 0.406 . . . . 0.0 111.83 -176.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -90.48 53.06 2.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.449 0.642 . . . . 0.0 110.739 177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.89 129.08 37.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.582 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.44 7.34 2.27 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.175 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -105.25 38.93 1.83 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.119 0.485 . . . . 0.0 110.392 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -152.62 146.02 24.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.162 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -88.59 44.35 1.2 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.291 0.567 . . . . 0.0 110.961 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.506 ' O ' HG13 ' A' ' 41' ' ' ILE . 2.4 p-90 -55.85 -38.56 70.24 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.05 -176.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 39' ' ' SER . 13.6 ptt180 -66.59 -39.17 88.27 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.956 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.406 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 2.1 m -66.75 -33.79 76.42 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.487 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 33.0 mmm180 -75.87 -36.28 59.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.458 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.554 HG23 ' HG2' ' A' ' 103' ' ' PRO . 59.8 mt -58.09 -46.14 88.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.83 174.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -55.93 -42.56 76.29 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.783 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.99 -37.35 94.16 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.768 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.672 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 1.6 ttm180 -67.77 -34.91 77.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.157 0.503 . . . . 0.0 110.352 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.68 -29.72 70.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.552 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.677 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.7 t-20 -71.14 -36.89 72.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.582 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -57.47 -30.56 65.17 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.772 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.407 ' HB2' ' HB1' ' A' ' 101' ' ' ALA . 64.6 m-85 -94.96 -56.68 2.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.183 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -175.35 102.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.414 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.677 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 28.1 ttp180 -130.73 104.12 6.99 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.062 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.53 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -84.9 133.63 43.04 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.825 178.032 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -56.37 132.2 50.42 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.888 2.392 . . . . 0.0 111.737 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HE3' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.03 -23.43 65.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.086 -172.086 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.83 -33.74 73.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.042 0.448 . . . . 0.0 110.953 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.47 -32.41 60.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.7 mm? -71.8 -34.43 69.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.725 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 30.4 mtm180 -69.35 -10.32 57.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.624 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.45 17.43 12.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.397 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.673 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 19.6 ttmm -150.75 -76.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.818 0.342 . . . . 0.0 111.096 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.673 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 3.4 mmp_? -128.39 90.42 3.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 0.0 110.484 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.438 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 21.6 pt20 -119.08 114.93 23.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.911 -178.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.786 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -160.05 149.79 19.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.803 178.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.533 ' H ' HD11 ' A' ' 127' ' ' LEU . 45.7 t -104.61 125.29 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.708 0.29 . . . . 0.0 110.336 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.7 160.31 25.61 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.757 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 44.0 tt0 -103.96 125.05 50.06 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.491 HG23 HD11 ' A' ' 123' ' ' ILE . 62.5 t -129.44 116.7 40.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.619 -169.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.608 ' HG2' HG22 ' A' ' 82' ' ' VAL . 12.2 ptt180 -109.13 145.31 35.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.62 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -157.75 151.0 23.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -171.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 21.6 m -94.38 126.81 39.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.402 171.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.428 HD11 ' CE1' ' A' ' 68' ' ' PHE . 55.5 mt -122.38 139.37 53.91 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -170.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.465 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 12.6 t70 -79.43 156.11 28.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.037 173.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.738 ' HB2' ' HB3' ' A' ' 107' ' ' PRO . 25.9 ptt180 -63.14 -21.52 66.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.084 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.458 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 4.0 pt20 -87.97 -4.49 58.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.251 0.548 . . . . 0.0 110.087 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.409 ' CA ' ' H ' ' A' ' 104' ' ' LEU . . . 87.2 38.89 7.6 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.116 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.465 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 80.4 t60 -100.35 114.05 27.25 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 p -48.95 116.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.089 172.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.3 mt -104.84 -40.38 5.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.982 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -147.78 146.55 29.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.388 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.756 HG13 ' HG3' ' A' ' 99' ' ' LYS . 58.8 t -143.18 129.87 17.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 m -136.04 120.39 17.98 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.71 HD22 ' HB2' ' A' ' 84' ' ' SER . 35.3 tp -60.36 120.11 9.24 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.608 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -90.95 -46.74 14.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.894 -175.415 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -148.61 143.82 26.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.127 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.71 ' HB2' HD22 ' A' ' 81' ' ' LEU . 30.1 t -134.45 108.47 8.15 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.13 -37.99 89.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.081 -175.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.613 ' H ' HD22 ' A' ' 87' ' ' LEU . . . 167.8 56.84 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.882 -178.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.714 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -121.07 74.79 28.66 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -177.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 3.6 Cg_exo -75.96 -65.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.457 2.104 . . . . 0.0 111.639 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.2 t -74.02 -24.12 59.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.267 0.556 . . . . 0.0 110.181 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.714 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 31.0 mt -73.06 -31.49 64.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.346 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -54.41 -45.59 72.97 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.785 0.678 . . . . 0.0 112.144 -172.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -54.21 -49.4 69.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -172.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.481 ' CB ' ' HG3' ' A' ' 60' ' ' ARG . 9.2 tp10 -78.29 -53.45 7.29 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -175.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 90' ' ' LEU . 38.6 pt -63.03 -34.28 65.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -174.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.672 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.8 mm-40 -82.18 -28.78 31.86 Favored 'General case' 0 C--O 1.212 -0.91 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.691 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.32 -41.05 75.38 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.466 HD13 ' H ' ' A' ' 51' ' ' TYR . 1.4 tp -68.27 -56.95 6.83 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.684 -1.143 . . . . 0.0 112.097 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.784 HG12 HG21 ' A' ' 123' ' ' ILE . 85.8 t -88.41 -48.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.756 ' HG3' HG13 ' A' ' 79' ' ' VAL . 37.7 ttmt -64.91 -21.88 66.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.244 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 5.9 tpp180 -95.39 -35.44 11.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.042 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.567 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -106.18 74.3 1.03 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.629 0.252 . . . . 0.0 110.859 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 14.0 m -94.21 99.46 3.82 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.991 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.672 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 94.8 Cg_endo -100.6 151.82 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.711 2.941 . . . . 0.0 114.525 -173.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.558 HD21 ' HD2' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -143.8 114.91 5.56 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 173.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.657 ' HA ' ' CZ ' ' A' ' 44' ' ' ARG . 2.6 Cg_endo -74.15 -58.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.678 2.252 . . . . 0.0 112.838 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 4.6 t -72.72 124.63 90.98 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.737 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.738 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 12.1 Cg_exo -70.41 105.68 1.64 Allowed 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.539 2.159 . . . . 0.0 111.162 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.742 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 69.3 Cg_endo -87.83 58.0 3.0 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.906 2.404 . . . . 0.0 112.862 -172.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.627 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -60.36 -41.65 94.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.112 0.482 . . . . 0.0 109.941 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -75.51 5.93 5.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.065 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.742 ' HB2' ' HB2' ' A' ' 108' ' ' PRO . . . -113.43 -24.85 9.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.43 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.835 ' HB3' HG11 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -123.85 19.97 9.29 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.29 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 109' ' ' ALA . 1.7 m -69.49 89.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 6.4 p30 162.51 -25.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 113.208 -1.815 . . . . 0.0 107.46 -168.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.456 ' C ' ' HG1' ' A' ' 116' ' ' THR . . . 165.08 -83.85 0.1 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.109 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.53 ' CA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -160.26 174.16 14.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.835 HG11 ' HB3' ' A' ' 112' ' ' TYR . 27.8 m -102.92 109.73 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.532 0.682 . . . . 0.0 110.799 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 35.0 tt0 -108.7 111.71 23.64 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 166.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.593 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -135.01 155.27 51.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -175.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.556 HG23 HG23 ' A' ' 82' ' ' VAL . 92.7 m -96.03 119.55 34.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.441 -175.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.593 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 42.6 mt -124.98 122.77 25.49 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.454 174.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.4 Cg_exo -72.72 119.32 6.02 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.897 1.731 . . . . 0.0 110.828 175.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.784 HG21 HG12 ' A' ' 98' ' ' VAL . 35.2 pt -91.58 103.63 14.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.41 124.46 41.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.024 0.916 . . . . 0.0 111.566 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -113.32 135.41 53.88 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 163.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.9 m -58.66 102.8 0.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.265 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.786 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.3 tt -86.53 81.15 8.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.127 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -69.28 -53.73 18.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.387 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -172.25 73.42 0.1 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.872 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.475 ' HB1' HD23 ' A' ' 90' ' ' LEU . . . -146.82 13.68 1.16 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.853 0.358 . . . . 0.0 111.023 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -95.78 27.76 14.97 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.225 -174.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 42.2 p90 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.766 179.119 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -69.03 -34.11 74.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.233 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.5 p -70.35 -33.95 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.08 0.467 . . . . 0.0 109.832 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.414 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 30.2 mmt180 -70.3 -43.46 70.31 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.747 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.903 HG23 ' HG2' ' A' ' 103' ' ' PRO . 53.9 mt -57.61 -42.14 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.885 175.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.3 m -56.92 -34.71 68.22 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.489 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.71 -35.69 80.92 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.889 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.8 -34.18 73.37 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.46 0.648 . . . . 0.0 109.64 178.186 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.448 HD11 HG22 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -68.12 -25.47 65.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.894 177.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.785 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 59.1 t30 -70.19 -34.57 73.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.553 176.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 1.9 ttt180 -59.88 -27.09 66.4 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.015 170.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.56 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 69.5 m-85 -106.01 25.67 10.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.906 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 48' ' ' PHE . 21.9 mtpp 74.13 102.41 0.07 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 124.075 0.859 . . . . 0.0 110.505 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.785 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 16.4 ttp180 -93.54 104.62 16.74 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.289 0.566 . . . . 0.0 110.607 -176.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.522 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -69.41 114.79 26.57 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.892 175.128 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HD2' ' HD1' ' A' ' 51' ' ' TYR . 34.7 Cg_exo -57.68 131.82 46.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.714 2.276 . . . . 0.0 111.573 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.728 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.16 -25.2 63.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.885 -170.615 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.401 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 14.5 m-20 -64.6 -32.45 74.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.0 0.429 . . . . 0.0 111.182 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 59' ' ' LYS . . . -74.15 -31.78 62.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.511 178.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.4 mm? -74.76 -42.6 57.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.665 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.731 ' HB3' ' HB2' ' A' ' 126' ' ' SER . 2.5 ptp180 -64.41 -17.95 64.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.751 0.31 . . . . 0.0 111.334 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.7 mt -108.33 4.41 24.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.921 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.649 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 39.2 ttmt -145.6 -75.27 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 111.556 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.679 ' HB2' HD12 ' A' ' 56' ' ' LEU . 33.5 mmt180 -106.85 87.57 2.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.844 0.354 . . . . 0.0 110.193 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.74 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . 5.2 mt-30 -85.95 156.17 20.59 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 170.44 116.76 0.39 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 118.851 -1.642 . . . . 0.0 113.854 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.863 ' H ' HD12 ' A' ' 127' ' ' LEU . 58.9 t -110.18 123.42 66.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.45 165.65 33.99 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.636 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 42.4 mt-30 -103.57 124.46 48.84 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.536 HG21 HD13 ' A' ' 123' ' ' ILE . 77.4 t -122.22 113.63 39.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.433 -173.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.531 ' HB3' HG21 ' A' ' 82' ' ' VAL . 20.6 ptt180 -108.38 141.03 40.81 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -156.9 157.59 35.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.559 0.695 . . . . 0.0 112.412 -171.457 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 6.4 m -101.92 129.91 48.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.577 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.523 HD11 ' CE1' ' A' ' 68' ' ' PHE . 48.2 mt -121.78 139.84 53.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.12 0.486 . . . . 0.0 112.286 -168.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.787 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 21.4 t70 -82.18 155.68 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.827 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HG3' ' HB3' ' A' ' 107' ' ' PRO . 58.0 ttt180 -51.51 -41.43 60.99 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -174.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -87.08 12.22 11.97 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.019 0.437 . . . . 0.0 111.038 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.33 53.82 4.27 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.421 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 67.9 t60 -112.4 114.97 27.96 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 4.1 p -48.79 120.35 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.523 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.1 mt -110.49 -40.26 4.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.744 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -152.66 146.01 24.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.279 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.762 HG11 ' HD3' ' A' ' 99' ' ' LYS . 28.4 t -142.39 130.91 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.7 m -128.24 128.16 44.17 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.819 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.9 tp -72.91 123.03 22.63 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.531 HG21 ' HB3' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -99.4 -52.03 9.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.461 -171.26 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.9 m -141.31 138.61 33.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.492 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.7 t -131.41 131.38 43.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.935 0.398 . . . . 0.0 110.698 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.03 8.38 26.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.489 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 103.11 69.98 0.83 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.702 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -115.57 89.7 23.46 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 4.6 Cg_exo -77.94 -84.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.591 2.194 . . . . 0.0 112.021 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.5 m -66.16 -18.32 65.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.332 0.587 . . . . 0.0 110.966 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 13.7 mt -75.41 -45.09 41.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.245 -176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 16.9 t70 -55.17 -41.75 72.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.079 -169.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -54.28 -49.71 68.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.819 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.94 -47.93 15.49 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.521 ' HB ' ' CE2' ' A' ' 125' ' ' PHE . 42.1 pt -63.35 -38.8 83.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.573 HE22 HD11 ' A' ' 123' ' ' ILE . 75.4 mm-40 -79.08 -31.34 44.36 Favored 'General case' 0 C--O 1.199 -1.594 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.605 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.84 -39.25 65.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 4.1 tp -67.53 -54.77 17.14 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.487 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.757 HG11 HG21 ' A' ' 123' ' ' ILE . 52.9 t -87.41 -45.52 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.762 ' HD3' HG11 ' A' ' 79' ' ' VAL . 3.2 tppp? -56.32 -40.23 74.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.148 0.579 . . . . 0.0 110.518 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -84.38 -31.02 24.95 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.828 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -105.65 63.15 0.68 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.808 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.478 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.7 m -89.13 99.43 1.59 Allowed Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.903 ' HG2' HG23 ' A' ' 41' ' ' ILE . 74.5 Cg_endo -103.55 166.59 0.23 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.922 3.082 . . . . 0.0 114.611 -170.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.518 HD21 ' CD ' ' A' ' 108' ' ' PRO . 37.1 tp -143.16 96.49 5.87 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.722 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.503 ' HG3' ' N ' ' A' ' 41' ' ' ILE . 33.1 Cg_endo -78.06 -44.92 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.3 2.0 . . . . 0.0 113.671 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.495 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 15.4 m -92.95 107.88 28.11 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.499 ' HB3' ' HG3' ' A' ' 72' ' ' ARG . 21.2 Cg_exo -66.59 106.12 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.312 2.675 . . . . 0.0 112.977 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.906 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 41.6 Cg_endo -88.87 65.76 2.77 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.543 2.829 . . . . 0.0 112.128 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.585 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -51.07 -51.7 50.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.78 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -78.79 9.33 4.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.79 -176.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.906 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -105.84 -30.15 9.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.165 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.622 ' HB2' ' HA ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -114.3 15.55 18.05 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 3.9 m -72.58 87.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 169.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 1.3 p-10 159.74 -19.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.916 -167.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.66 -86.7 0.1 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.391 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.633 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.2 OUTLIER -160.75 177.08 10.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 69' ' ' THR . 11.2 m -100.1 108.77 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 121.877 0.846 . . . . 0.0 110.105 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -113.63 112.49 23.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.629 HD12 ' HG ' ' A' ' 121' ' ' LEU . 2.1 pp -142.84 154.63 44.35 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.225 -173.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.449 HG23 HG21 ' A' ' 82' ' ' VAL . 92.8 m -92.44 125.85 37.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.421 -177.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.629 ' HG ' HD12 ' A' ' 119' ' ' LEU . 64.2 mt -130.38 122.85 20.17 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.393 176.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.3 Cg_exo -74.75 119.2 5.6 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.642 1.562 . . . . 0.0 110.726 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.757 HG21 HG11 ' A' ' 98' ' ' VAL . 20.6 pt -89.62 121.07 39.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -111.97 121.71 45.76 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 119.379 -0.928 . . . . 0.0 112.256 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.596 ' CD1' ' HG ' ' A' ' 56' ' ' LEU . 89.7 m-85 -114.09 131.54 56.36 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.409 -1.723 . . . . 0.0 106.816 163.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.731 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 8.7 m -56.98 103.42 0.11 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 -170.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.863 HD12 ' H ' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -97.65 108.85 21.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.915 -171.291 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.503 ' HB2' HE22 ' A' ' 61' ' ' GLN . 46.4 mtm105 . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.734 173.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.495 ' CH2' HD21 ' A' ' 121' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.62 0.247 . . . . 0.0 110.733 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 39' ' ' SER . 4.4 ppt_? -69.54 -28.19 65.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.156 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.496 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 13.1 m -66.47 -36.36 82.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 105' ' ' PRO . 17.8 mmm-85 -73.31 -43.69 60.43 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.338 177.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.746 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 34.8 mt -57.99 -36.84 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.634 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.466 ' O ' ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -61.38 -45.04 96.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.427 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.6 -38.66 95.97 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.499 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.746 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 8.5 ptt180 -56.69 -34.6 67.57 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.928 0.394 . . . . 0.0 110.13 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -32.26 47.62 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.623 -175.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.497 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 6.5 t30 -70.69 -29.19 65.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.035 0.921 . . . . 0.0 108.722 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -18.72 36.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.561 -1.654 . . . . 0.0 111.083 173.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -125.74 -57.64 1.44 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -158.37 102.85 1.76 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.333 0.653 . . . . 0.0 109.822 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 64.1 ttt-85 -128.54 103.53 7.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.35 0.595 . . . . 0.0 109.942 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.45 130.17 23.21 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.917 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.06 134.16 58.62 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.966 2.444 . . . . 0.0 111.936 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.592 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.9 -21.43 61.06 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.53 -174.263 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.78 -38.52 55.9 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.6 0.562 . . . . 0.0 110.762 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.11 -42.43 47.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.315 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.4 mm? -64.22 -34.81 78.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.963 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 21.7 mtm180 -62.71 -14.63 46.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.757 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.2 mp -119.62 14.36 12.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.75 0.31 . . . . 0.0 110.931 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.777 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 39.0 ttmt -142.25 -76.52 0.27 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.702 0.287 . . . . 0.0 110.859 -176.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.789 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 39.6 mmt180 -130.95 100.63 5.31 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.0 167.84 11.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.74 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.766 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.74 144.48 3.92 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.727 -1.225 . . . . 0.0 113.272 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 p -111.13 128.17 67.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.53 164.62 29.45 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.097 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.486 ' O ' HG23 ' A' ' 82' ' ' VAL . 35.8 tt0 -103.65 125.13 49.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.52 HG21 HD13 ' A' ' 123' ' ' ILE . 49.3 t -127.31 114.79 38.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.763 -171.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.594 ' HG2' HG22 ' A' ' 82' ' ' VAL . 5.1 ptp180 -114.68 144.35 43.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.49 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -160.1 164.07 33.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 7.3 m -108.4 131.93 54.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.562 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.609 HD21 ' HB3' ' A' ' 102' ' ' SER . 61.9 mt -119.05 138.29 52.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.73 -172.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.544 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 29.4 t70 -81.2 158.45 24.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.821 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.85 -36.67 70.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -81.6 3.11 26.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.12 0.486 . . . . 0.0 111.258 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . 81.4 35.52 22.95 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.298 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.544 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 54.1 t-80 -100.38 110.83 23.05 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 5.8 p -48.44 111.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.645 0.736 . . . . 0.0 111.002 173.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 48.9 mt -99.65 -23.5 15.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.581 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.69 157.58 36.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.836 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 ' HG3' ' A' ' 99' ' ' LYS . 13.6 p -159.82 133.85 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.2 m -144.48 130.15 19.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.704 0.288 . . . . 0.0 111.065 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 84' ' ' SER . 24.5 tp -74.78 110.1 8.8 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -84.84 -39.22 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.155 -171.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.0 m -150.56 151.15 32.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.762 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.732 ' HB2' HD21 ' A' ' 81' ' ' LEU . 45.7 t -140.11 142.77 36.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.875 0.369 . . . . 0.0 110.572 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.18 19.42 19.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.243 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.13 63.41 0.84 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.686 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.809 ' HA ' HD12 ' A' ' 90' ' ' LEU . 1.1 mm? -119.1 82.99 23.05 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.08 -83.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.369 2.046 . . . . 0.0 111.973 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 66.5 m -68.64 -17.91 64.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.397 0.618 . . . . 0.0 110.339 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 87' ' ' LEU . 16.2 mt -70.24 -34.03 72.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.632 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.549 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 3.7 t70 -54.12 -44.53 71.39 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.467 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 89' ' ' SER . 11.2 ptm180 -54.31 -48.49 71.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.505 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 8.1 tp10 -77.88 -53.46 7.45 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 122.016 -0.427 . . . . 0.0 111.789 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.539 HG12 ' O ' ' A' ' 90' ' ' LEU . 36.7 pt -64.76 -37.08 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -172.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.601 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.4 mm-40 -82.21 -28.31 32.06 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.45 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.669 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.88 -43.43 81.26 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.612 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -63.87 -58.37 7.0 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.008 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.864 HG11 HG21 ' A' ' 123' ' ' ILE . 93.0 t -89.05 -50.4 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.63 ' HG3' HG21 ' A' ' 79' ' ' VAL . 35.6 ttmt -67.32 -29.99 69.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.649 -173.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.669 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 4.1 tmt_? -89.07 -47.17 8.29 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.664 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.656 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -86.0 73.75 10.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.044 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.609 ' HB3' HD21 ' A' ' 70' ' ' LEU . 67.4 m -109.52 92.3 11.64 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-O 122.063 0.935 . . . . 0.0 110.531 171.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.665 ' HG2' ' HG3' ' A' ' 44' ' ' ARG . 3.3 Cg_endo -96.33 178.44 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 1 C-N-CA 125.457 4.105 . . . . 0.0 112.052 170.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.782 HD21 ' HD2' ' A' ' 108' ' ' PRO . 12.2 tp -134.65 99.15 13.0 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HB2' ' HB3' ' A' ' 40' ' ' ARG . 86.6 Cg_endo -77.15 -28.51 5.8 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.449 1.433 . . . . 0.0 112.77 -173.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.513 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 2.9 t -122.46 107.83 34.07 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.708 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.38 108.3 1.35 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.062 2.508 . . . . 0.0 112.612 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.782 ' HD2' HD21 ' A' ' 104' ' ' LEU . 41.9 Cg_endo -86.71 66.45 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.159 2.572 . . . . 0.0 111.312 177.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.703 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -49.69 -46.28 49.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.864 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.69 -32.49 67.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.592 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -81.09 -31.31 34.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.12 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.703 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -116.62 18.58 14.94 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 109' ' ' ALA . 3.2 m -71.29 88.95 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 168.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 2.0 p-10 159.34 -23.07 0.0 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.152 -168.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.56 -84.53 0.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.002 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.46 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.3 OUTLIER -159.67 175.69 12.89 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.218 0.607 . . . . 0.0 109.491 -176.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 69' ' ' THR . 4.0 m -103.02 107.99 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-O 121.396 0.617 . . . . 0.0 111.251 -174.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 1.1 tm-20 -103.57 112.14 24.92 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.662 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 3.5 pp -142.09 149.33 39.73 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.622 -173.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.2 m -87.94 124.58 33.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.627 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.662 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 32.2 mt -123.77 122.03 26.46 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.556 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.05 120.89 5.9 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.197 1.932 . . . . 0.0 110.933 176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.864 HG21 HG11 ' A' ' 98' ' ' VAL . 12.2 pt -104.69 123.19 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -126.26 124.31 40.09 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 122.206 1.003 . . . . 0.0 111.581 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.44 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 62.0 m-85 -113.17 139.13 49.02 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 168.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 14.4 m -57.99 101.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.805 0.336 . . . . 0.0 111.558 -172.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.766 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.4 OUTLIER -94.88 106.06 18.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.917 -174.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.304 177.577 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.512 ' CH2' HD21 ' A' ' 121' ' ' LEU . 1.4 p-90 . . . . . 0 N--CA 1.457 -0.094 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.15 -31.48 70.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 110.247 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.0 m -70.84 -34.53 71.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.469 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.559 ' CB ' ' HG2' ' A' ' 105' ' ' PRO . 48.9 mtt180 -64.8 -44.96 88.25 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.433 0.635 . . . . 0.0 109.443 174.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.531 HG23 ' HD2' ' A' ' 103' ' ' PRO . 75.8 mt -59.62 -38.67 76.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.322 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 m -55.75 -32.31 63.3 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.17 -43.01 82.28 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.713 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.625 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 9.2 mpt_? -69.07 -32.53 72.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.098 0.475 . . . . 0.0 110.769 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.418 HD11 HG22 ' A' ' 98' ' ' VAL . 0.7 OUTLIER -62.95 -32.41 73.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.422 0.63 . . . . 0.0 109.754 178.163 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.544 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 47.9 t30 -71.2 -31.29 67.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.822 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.531 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 2.0 ttt180 -53.34 -28.34 28.16 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.961 172.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -100.85 -57.09 2.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.705 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -173.56 116.98 0.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.544 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 55.4 ttp180 -133.47 103.83 6.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.217 0.532 . . . . 0.0 110.312 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -98.79 142.94 25.45 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.993 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.86 132.8 51.51 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.877 2.384 . . . . 0.0 111.83 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.674 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -62.36 -23.89 67.05 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -171.447 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.489 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 15.3 m-20 -65.2 -33.53 76.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.643 0.259 . . . . 0.0 110.815 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.84 71.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.249 0.547 . . . . 0.0 110.112 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -73.45 -40.31 64.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.61 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.713 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 83.2 mtt180 -55.65 -30.86 61.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.984 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 54' ' ' ASP . 61.6 mt -99.04 14.41 29.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.038 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.444 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 24.8 ttmm -145.8 -74.64 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 111.049 -177.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.55 ' HD2' HD23 ' A' ' 90' ' ' LEU . 23.0 mmt180 -127.38 84.44 2.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.384 0.612 . . . . 0.0 110.232 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.713 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 24.4 pt20 -94.27 115.29 27.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.06 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.811 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -154.79 130.02 2.74 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.56 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.88 ' H ' HD12 ' A' ' 127' ' ' LEU . 7.1 p -103.78 133.39 47.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.006 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.85 168.12 38.24 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.16 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.662 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 56.7 mt-30 -100.29 137.65 38.44 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 123' ' ' ILE . 39.8 t -128.22 114.03 32.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.237 0.541 . . . . 0.0 110.46 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 34.4 ttp180 -103.71 125.04 49.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -144.1 156.99 44.57 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.508 0.67 . . . . 0.0 112.625 -174.539 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.789 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 23.3 m -106.43 124.32 49.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.429 173.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.681 HD13 ' HG ' ' A' ' 104' ' ' LEU . 39.9 mt -116.96 147.69 42.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.24 0.543 . . . . 0.0 111.953 -169.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.614 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 29.3 t70 -88.41 161.81 16.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.399 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.416 ' HD2' ' HB3' ' A' ' 107' ' ' PRO . 8.1 tpt180 -48.96 -40.39 30.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.543 174.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -88.76 7.14 35.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.989 0.423 . . . . 0.0 111.062 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.61 40.25 27.63 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.162 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.614 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 45.2 t60 -103.06 123.81 47.34 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.48 118.89 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.417 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 71' ' ' ASP . 26.0 mt -106.19 -53.45 2.63 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.231 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.61 149.59 52.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.802 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' A' ' 68' ' ' PHE . 2.4 m -145.67 125.35 6.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.442 0.639 . . . . 0.0 110.857 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.9 m -124.71 123.83 40.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.425 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.448 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 23.1 tp -78.68 106.48 10.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.484 0.659 . . . . 0.0 109.882 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -86.66 -41.96 15.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.049 178.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.457 ' CA ' ' H ' ' A' ' 65' ' ' GLN . 13.2 t 68.67 -178.03 0.22 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.396 167.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.431 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 40.8 m -153.59 -56.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.024 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.59 -77.4 0.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.7 98.67 0.11 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.747 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.742 ' HA ' HD12 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -117.6 87.63 26.66 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.532 0.166 . . . . 0.0 110.655 -177.603 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.76 -81.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.685 2.257 . . . . 0.0 111.869 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.5 m -65.74 -18.46 65.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.525 0.679 . . . . 0.0 110.328 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 87' ' ' LEU . 25.2 mt -73.67 -36.13 65.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.191 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 4.4 t70 -54.18 -51.41 64.43 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 123.613 0.571 . . . . 0.0 111.725 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -54.58 -43.67 72.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -77.4 -53.92 7.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.833 0.349 . . . . 0.0 111.737 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 90' ' ' LEU . 40.2 pt -74.12 -33.08 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.654 -172.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.779 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 79.0 mm-40 -82.57 -24.11 34.14 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 120.981 0.42 . . . . 0.0 110.39 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.72 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.65 -47.27 80.12 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.648 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -65.11 -56.11 14.84 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.514 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.939 HG11 HG21 ' A' ' 123' ' ' ILE . 79.3 t -89.17 -50.11 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.779 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 34.9 ttmt -68.84 -30.09 68.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.238 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.72 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 2.6 tmt_? -86.86 -39.99 15.31 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.774 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.666 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -97.41 63.84 1.82 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.737 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.4 m -94.6 98.49 3.14 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 110.093 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 98.9 Cg_endo -108.65 172.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 124.195 3.263 . . . . 0.0 114.386 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.681 ' HG ' HD13 ' A' ' 70' ' ' LEU . 6.2 mt -143.89 120.59 6.52 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.733 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.559 ' HG2' ' CB ' ' A' ' 40' ' ' ARG . 6.2 Cg_exo -72.83 -54.13 0.12 Allowed 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.86 2.374 . . . . 0.0 111.936 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 25.4 m -88.7 115.22 62.84 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.411 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 106' ' ' THR . 30.5 Cg_endo -64.17 107.6 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.09 2.527 . . . . 0.0 112.225 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.66 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 81.3 Cg_endo -83.38 62.74 7.45 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.772 2.314 . . . . 0.0 111.832 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.823 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -59.18 -41.91 89.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.297 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.72 -7.95 48.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.622 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -99.38 -32.04 11.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.604 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.823 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -110.02 17.49 21.02 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -176.107 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 109' ' ' ALA . 3.4 m -70.57 88.09 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 168.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 2.6 p-10 161.93 -27.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.606 -1.634 . . . . 0.0 107.846 -170.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.85 -76.15 0.15 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.906 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.535 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.6 OUTLIER -160.27 174.42 14.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.789 ' O ' ' HA ' ' A' ' 69' ' ' THR . 15.8 m -103.3 108.94 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.377 0.608 . . . . 0.0 111.061 -175.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 28.0 tt0 -105.36 111.7 24.52 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.68 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -142.36 147.22 35.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.462 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 67' ' ' ARG . 86.8 m -87.59 122.13 30.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.33 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.68 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 26.0 mt -124.7 122.5 25.7 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.927 172.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.2 Cg_exo -73.8 119.93 6.15 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.771 1.647 . . . . 0.0 110.726 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.939 HG21 HG11 ' A' ' 98' ' ' VAL . 23.8 pt -95.46 99.52 9.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.59 ' HA ' HG23 ' A' ' 63' ' ' VAL . 5.5 p-10 -90.24 121.49 32.31 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.449 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 41.5 m-85 -113.36 141.3 47.21 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 163.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 3.3 m -64.15 101.87 0.45 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.88 HD12 ' H ' ' A' ' 63' ' ' VAL . 1.2 tt -90.13 84.11 6.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.204 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 128' ' ' ARG . 21.0 mtm180 . . . . . 0 N--CA 1.448 -0.554 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.46 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 4.9 t90 . . . . . 0 C--O 1.227 -0.129 0 CA-C-O 120.929 0.395 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.758 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . 17.3 ptp180 -69.15 -29.79 67.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.892 -173.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.0 p -64.69 -38.21 90.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.589 ' C ' ' HG3' ' A' ' 105' ' ' PRO . 4.2 mmm180 -74.76 -37.96 62.33 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.758 ' HB ' ' HA ' ' A' ' 38' ' ' ARG . 21.5 mt -57.69 -38.1 62.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.808 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 m -60.23 -45.71 92.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 174.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.51 -50.48 67.34 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.39 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.802 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -68.35 -29.29 67.99 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.213 0.507 . . . . 0.0 111.297 -177.375 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.78 -30.84 71.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.526 0.679 . . . . 0.0 109.654 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.565 ' HB2' ' HD3' ' A' ' 50' ' ' ARG . 8.4 t30 -71.31 -29.59 65.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.543 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.666 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 9.2 ttt180 -52.96 -25.04 10.7 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.223 172.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.546 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 74.4 m-85 -113.29 -59.15 2.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.266 176.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -164.62 103.38 0.82 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 122.394 0.278 . . . . 0.0 110.568 -174.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.565 ' HD3' ' HB2' ' A' ' 46' ' ' ASN . 15.7 ttt180 -133.17 106.43 7.59 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.605 0.716 . . . . 0.0 111.124 177.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.442 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.3 t80 -105.18 142.97 25.79 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.2 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.96 132.21 50.93 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.92 2.413 . . . . 0.0 112.108 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.55 -24.89 66.95 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.236 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -55.97 -41.74 75.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.67 0.271 . . . . 0.0 110.832 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.64 -30.87 68.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.87 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.6 mm? -74.44 -41.51 60.72 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.613 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 28.4 mtm180 -61.28 -24.39 66.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.246 0.546 . . . . 0.0 110.162 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.8 tp -91.57 -13.72 31.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.748 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.661 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 38.2 ttpt -131.64 -72.46 0.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.88 -172.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.661 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 36.8 mmt180 -109.69 92.02 3.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.853 0.359 . . . . 0.0 110.315 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 90' ' ' LEU . 42.6 mt-30 -86.54 169.34 12.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.572 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.61 119.71 0.81 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.472 -1.347 . . . . 0.0 113.627 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.06 123.57 66.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.34 165.7 36.17 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 68.7 mt-30 -103.09 130.82 50.35 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 t -119.57 114.29 43.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.364 -171.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.523 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 31.3 ttp85 -107.65 137.63 45.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.638 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.586 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -152.28 153.65 34.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.494 0.664 . . . . 0.0 111.948 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 30.4 m -99.18 133.58 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.299 170.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.586 HD11 ' CE1' ' A' ' 68' ' ' PHE . 63.7 mt -121.92 140.23 52.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.379 0.609 . . . . 0.0 112.211 -170.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.638 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 17.1 t70 -83.88 159.64 21.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.565 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.448 ' HG3' ' OH ' ' A' ' 112' ' ' TYR . 22.2 ttt180 -53.39 -40.58 65.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.866 0.365 . . . . 0.0 111.452 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -89.46 16.2 8.01 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 111.056 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.452 ' CA ' ' HA ' ' A' ' 103' ' ' PRO . . . 71.89 46.17 38.78 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.811 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.638 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 51.2 t-80 -104.3 114.3 28.45 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.3 p -49.21 123.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.112 0.482 . . . . 0.0 111.162 173.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.606 HD12 HG22 ' A' ' 69' ' ' THR . 35.3 mt -110.0 -45.97 3.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.266 0.555 . . . . 0.0 110.571 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.28 149.14 52.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.981 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 m -136.74 124.22 32.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.0 m -144.11 121.76 11.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.5 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.635 HD21 ' HB2' ' A' ' 84' ' ' SER . 25.8 tp -76.18 111.95 12.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 173.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.753 HG21 HG23 ' A' ' 120' ' ' THR . 0.2 OUTLIER -85.36 -38.35 12.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.68 -170.684 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.451 ' HB3' ' HG3' ' A' ' 65' ' ' GLN . 8.4 t -148.05 149.17 31.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.635 ' HB2' HD21 ' A' ' 81' ' ' LEU . 46.3 t -149.07 149.14 30.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.22 0.533 . . . . 0.0 111.216 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.99 -18.09 15.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.583 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.414 ' C ' HD13 ' A' ' 87' ' ' LEU . . . 120.43 80.63 0.62 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.944 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.8 HD11 HD11 ' A' ' 127' ' ' LEU . 0.4 OUTLIER -117.51 91.23 37.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.87 -79.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.992 2.461 . . . . 0.0 112.556 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 92' ' ' ARG . 53.6 p -70.58 -18.62 62.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.394 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.735 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 17.9 mt -74.34 -39.93 62.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.131 -175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 15.4 t70 -54.58 -43.24 71.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.785 -170.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.4 ' CZ ' ' HA ' ' A' ' 89' ' ' SER . 4.1 ptp180 -54.01 -52.33 61.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -172.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -78.25 -48.03 16.65 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.909 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 90' ' ' LEU . 42.4 pt -62.98 -36.83 77.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.656 0.265 . . . . 0.0 111.4 -176.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.665 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.9 mm-40 -82.79 -25.85 32.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.073 0.463 . . . . 0.0 110.633 177.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.757 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -57.1 -45.55 83.31 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.657 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -64.87 -56.82 11.05 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.0 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.802 HG11 HG21 ' A' ' 123' ' ' ILE . 94.2 t -89.3 -50.52 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.665 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 35.1 ttmt -70.14 -27.47 64.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.619 0.247 . . . . 0.0 111.391 -173.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.757 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 20.9 tpt180 -88.34 -41.73 12.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.911 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.636 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -91.78 78.26 5.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.063 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.569 ' HB3' HD21 ' A' ' 70' ' ' LEU . 17.2 m -111.65 90.25 12.33 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.349 171.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.802 ' HG2' ' HG2' ' A' ' 44' ' ' ARG . 9.5 Cg_endo -104.91 -179.98 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.926 1 C-N-CA 125.992 4.462 . . . . 0.0 111.383 171.565 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.489 ' HG ' HD13 ' A' ' 70' ' ' LEU . 35.7 mt -136.38 127.95 17.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 169.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.715 ' HD3' ' HD2' ' A' ' 44' ' ' ARG . 57.0 Cg_endo -74.75 -24.23 13.59 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.514 2.143 . . . . 0.0 111.836 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 t -132.89 116.33 14.62 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.112 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.73 108.78 0.4 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.93 2.42 . . . . 0.0 111.717 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.53 ' HG2' ' CE2' ' A' ' 112' ' ' TYR . 82.0 Cg_endo -75.62 65.08 6.61 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.683 2.255 . . . . 0.0 111.563 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.586 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.2 -41.98 80.4 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.818 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.8 2.29 4.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.573 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.23 -34.74 5.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.509 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.653 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -115.2 16.75 16.89 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -174.008 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.6 m -71.38 88.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 1.2 p-10 159.82 -29.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 113.661 -1.608 . . . . 0.0 107.404 -168.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.38 -84.55 0.1 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.355 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.495 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 1.3 p -149.6 167.39 26.5 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -171.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 69' ' ' THR . 20.7 m -107.71 122.43 62.0 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 CA-C-O 120.904 0.383 . . . . 0.0 111.014 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -112.8 120.04 40.09 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.663 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -140.14 143.35 36.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.972 0.415 . . . . 0.0 111.606 -175.337 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.753 HG23 HG21 ' A' ' 82' ' ' VAL . 98.9 m -96.3 116.34 28.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.857 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.663 ' HG ' HD12 ' A' ' 119' ' ' LEU . 62.7 mt -119.21 122.76 29.27 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.275 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.696 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.3 Cg_exo -73.12 120.73 6.76 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.056 1.837 . . . . 0.0 111.427 177.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.802 HG21 HG11 ' A' ' 98' ' ' VAL . 21.6 pt -102.49 117.73 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -119.61 123.47 43.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.184 0.993 . . . . 0.0 112.508 -175.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.572 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 89.7 m-85 -115.23 133.02 56.42 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.604 166.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -57.66 103.73 0.15 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.044 0.45 . . . . 0.0 111.971 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.8 HD11 HD11 ' A' ' 87' ' ' LEU . 12.5 mt -84.01 104.0 13.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.181 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 121.348 0.594 . . . . 0.0 110.267 175.619 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 38' ' ' ARG . 10.8 ptp180 -68.48 -41.44 80.09 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.767 -171.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.8 p -64.79 -36.36 84.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.143 0.497 . . . . 0.0 110.434 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.47 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 30.8 mmt180 -73.93 -43.25 58.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.347 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.54 HG12 ' HD3' ' A' ' 105' ' ' PRO . 76.0 mt -57.01 -43.58 81.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.3 m -60.31 -30.61 69.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.881 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.33 -52.57 34.79 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.274 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 1.018 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.7 -28.41 65.81 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 175.19 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -53.86 -35.04 61.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.523 0.678 . . . . 0.0 109.362 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.765 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 7.1 t30 -71.93 -34.18 68.85 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.941 177.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -52.88 -28.15 21.79 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.277 173.651 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.582 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 95.8 m-85 -95.39 -59.23 1.93 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.947 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 21.1 mmmt -178.28 114.47 0.07 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.336 1.054 . . . . 0.0 108.923 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.765 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 41.8 ttp180 -129.54 105.38 8.04 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.273 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 2.7 t80 -90.32 134.92 30.34 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.844 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 32.3 Cg_exo -60.32 132.4 43.66 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.327 2.685 . . . . 0.0 112.566 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.608 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.21 -27.41 65.7 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.266 -171.122 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.19 -40.82 74.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.851 0.358 . . . . 0.0 110.713 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.51 -30.99 62.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.565 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.7 mm? -65.91 -38.48 88.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.884 0.373 . . . . 0.0 110.204 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -61.8 -17.32 55.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.534 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.1 mt -111.99 -0.68 15.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 111.129 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -128.44 -70.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.03 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.753 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 28.9 mmt180 -136.68 101.53 4.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.318 0.58 . . . . 0.0 110.107 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.549 ' HG3' ' HA ' ' A' ' 127' ' ' LEU . 17.7 pt20 -113.48 160.37 18.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.546 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.752 ' HA3' HD11 ' A' ' 87' ' ' LEU . . . 153.27 142.89 3.56 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.389 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -107.31 125.53 63.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.993 0.425 . . . . 0.0 109.996 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.15 164.4 26.19 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.421 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 48.2 mt-30 -103.85 129.28 51.31 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 68' ' ' PHE . 51.6 t -127.74 118.18 48.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.598 ' HG2' HG22 ' A' ' 82' ' ' VAL . 15.6 ptt180 -112.96 143.65 43.89 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -159.57 152.92 22.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.41 0.624 . . . . 0.0 112.502 -168.523 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.6 m -95.16 126.45 40.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.468 171.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.498 HD11 ' CE1' ' A' ' 68' ' ' PHE . 51.0 mt -117.34 143.82 45.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.173 0.511 . . . . 0.0 111.99 -170.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.754 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 22.2 t70 -86.28 154.96 20.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.13 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -53.21 -35.01 59.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.202 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -99.72 13.15 34.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.16 0.505 . . . . 0.0 111.154 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.53 40.59 12.56 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.812 -0.631 . . . . 0.0 113.388 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.754 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 57.2 t-80 -103.31 118.02 35.83 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.13 113.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.22 0.533 . . . . 0.0 111.149 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.44 -48.72 4.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.46 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.81 155.68 46.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.605 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -149.98 129.6 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 123.485 0.491 . . . . 0.0 110.026 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -142.32 125.66 16.58 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.279 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 84' ' ' SER . 34.2 tp -70.0 122.45 19.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.598 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -97.48 -41.65 11.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.183 -174.227 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 m -149.35 131.05 15.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.872 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.614 ' HB2' HD21 ' A' ' 81' ' ' LEU . 45.0 t -138.95 111.01 7.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.61 -62.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.14 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.463 ' H ' HD22 ' A' ' 87' ' ' LEU . . . -157.05 62.85 0.32 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.876 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.859 ' HA ' HD12 ' A' ' 90' ' ' LEU . 1.6 mm? -114.35 86.78 12.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 4.7 Cg_exo -77.16 -78.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.435 2.09 . . . . 0.0 111.545 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.1 p -74.79 -18.67 60.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.69 0.757 . . . . 0.0 110.242 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.859 HD12 ' HA ' ' A' ' 87' ' ' LEU . 10.5 mt -70.44 -38.7 74.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.404 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -54.49 -50.85 66.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.413 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.2 -40.88 71.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.221 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.493 ' CB ' ' HG3' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -78.22 -53.2 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.516 -173.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 90' ' ' LEU . 37.0 pt -64.74 -36.05 76.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.677 0.275 . . . . 0.0 111.727 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.642 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.9 mm-40 -79.22 -27.55 42.5 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 120.955 0.407 . . . . 0.0 110.506 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.38 -46.34 76.53 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 173.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.511 HD23 HG23 ' A' ' 98' ' ' VAL . 1.4 tp -67.59 -54.96 15.44 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.742 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.916 HG11 HG21 ' A' ' 123' ' ' ILE . 95.1 t -87.81 -48.62 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.642 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 40.3 ttmt -65.05 -23.29 67.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.046 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.497 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 30.9 tpt180 -93.6 -27.33 16.66 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.009 173.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.577 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -114.71 75.16 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.808 0.337 . . . . 0.0 111.29 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.4 m -108.34 95.06 14.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.225 0.536 . . . . 0.0 110.275 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 1.018 ' HB2' ' HG3' ' A' ' 44' ' ' ARG . 84.8 Cg_endo -113.74 122.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 124.482 3.454 . . . . 0.0 114.604 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.456 HD23 ' HD2' ' A' ' 105' ' ' PRO . 1.1 mt -92.02 123.75 61.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 172.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.549 ' HG3' ' HD3' ' A' ' 44' ' ' ARG . 1.7 Cg_endo -77.88 -59.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.568 2.179 . . . . 0.0 112.267 177.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.611 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 t -65.5 129.18 94.31 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.983 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.4 103.46 1.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.844 2.363 . . . . 0.0 112.267 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.8 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 68.5 Cg_endo -85.81 55.99 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.732 2.288 . . . . 0.0 111.524 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.74 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -54.38 -45.83 72.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.575 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.82 -6.84 51.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.291 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.8 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -98.36 -21.61 16.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.511 -177.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.837 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -124.3 17.79 9.04 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.142 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.4 m -71.1 89.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.965 0.888 . . . . 0.0 108.896 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 17.6 p-10 157.43 -13.78 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 113.19 -1.823 . . . . 0.0 107.903 -172.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.06 -90.72 0.1 Allowed Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.032 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.2 OUTLIER -160.57 175.09 13.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.308 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' A' ' 112' ' ' TYR . 10.8 m -101.99 114.47 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.417 0.627 . . . . 0.0 111.115 -175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -115.72 112.69 22.42 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 172.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.5 HD12 ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -144.11 152.61 41.17 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.328 -175.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.487 HG23 HG21 ' A' ' 82' ' ' VAL . 86.6 m -90.47 124.67 35.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.151 0.501 . . . . 0.0 111.77 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.5 ' HG ' HD12 ' A' ' 119' ' ' LEU . 57.8 mt -126.76 123.45 23.79 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.861 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 11.5 Cg_exo -70.61 120.09 6.83 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.066 1.844 . . . . 0.0 111.277 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.916 HG21 HG11 ' A' ' 98' ' ' VAL . 33.0 pt -94.5 99.17 9.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -98.95 123.62 43.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.068 0.937 . . . . 0.0 111.923 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.575 ' HE2' ' HE2' ' A' ' 53' ' ' LYS . 59.8 m-85 -115.16 125.25 53.2 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 162.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.9 p -57.55 105.12 0.22 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.503 0.668 . . . . 0.0 111.327 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.739 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -83.19 99.26 9.83 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.759 -173.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 . . . . . 0 C--N 1.322 -0.61 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.52 174.691 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.6 t90 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.567 0.222 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -67.85 -30.03 69.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.104 0.478 . . . . 0.0 110.515 -174.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.4 -36.45 82.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.171 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.429 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 24.1 mmm180 -73.64 -41.36 62.85 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.346 0.594 . . . . 0.0 109.589 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.4 HG23 ' HG2' ' A' ' 103' ' ' PRO . 87.6 mt -61.39 -42.35 93.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.041 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t -55.59 -39.62 70.95 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.002 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.14 99.1 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.878 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.646 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 8.6 mpt_? -69.35 -34.69 74.98 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.787 0.327 . . . . 0.0 110.809 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.61 HD11 HG22 ' A' ' 98' ' ' VAL . 1.1 tt -65.11 -27.68 68.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.72 0.771 . . . . 0.0 109.581 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.62 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 10.3 t30 -71.96 -37.67 69.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.885 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -56.73 -27.8 59.89 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.609 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.503 ' HE2' ' HB3' ' A' ' 103' ' ' PRO . 94.9 m-85 -88.51 -56.87 3.13 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.866 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 mtmm 172.96 103.43 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.209 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.62 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 52.7 ttp180 -108.4 103.03 12.1 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -72.38 131.59 84.73 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.59 131.14 32.11 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.71 2.274 . . . . 0.0 112.131 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.92 -21.33 63.29 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.407 -173.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 9.7 t0 -52.97 -38.59 62.27 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.505 0.503 . . . . 0.0 110.792 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.74 -43.65 45.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.154 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.2 mm? -64.07 -41.02 97.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.323 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.705 ' HG3' ' HG ' ' A' ' 58' ' ' LEU . 27.6 ptt180 -61.66 -19.72 62.62 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.361 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.705 ' HG ' ' HG3' ' A' ' 57' ' ' ARG . 82.9 mt -116.07 14.17 15.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.461 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.737 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 40.3 ttpt -151.21 -74.48 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 0.0 111.791 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.737 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 24.4 mmt180 -112.1 84.89 2.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.522 0.677 . . . . 0.0 110.183 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 126' ' ' SER . 16.1 pt20 -111.19 166.52 11.02 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.272 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.75 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.59 147.34 4.57 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.186 -1.483 . . . . 0.0 113.91 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.76 ' H ' HD12 ' A' ' 127' ' ' LEU . 61.9 t -116.13 124.94 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -151.97 166.15 30.87 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.432 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.621 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 56.8 mt-30 -101.85 132.15 47.78 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.482 HG12 ' CD2' ' A' ' 68' ' ' PHE . 56.1 t -124.26 113.23 35.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.404 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 64.9 ttt180 -103.02 121.75 43.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -177.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -142.53 165.64 26.84 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.466 0.651 . . . . 0.0 112.121 -171.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.743 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 11.9 m -114.99 127.78 55.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.005 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 68' ' ' PHE . 46.5 mt -116.3 132.34 56.7 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.246 0.546 . . . . 0.0 111.784 -169.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 26.5 t70 -71.65 155.32 40.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.42 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.448 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 46.2 mtp180 -59.32 -18.81 41.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.294 -175.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -108.1 14.9 24.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.923 0.392 . . . . 0.0 111.279 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 77.54 49.26 7.38 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.714 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 19.1 t60 -114.84 126.49 54.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.87 121.91 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.187 0.517 . . . . 0.0 111.42 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 71' ' ' ASP . 52.7 mt -111.88 -47.53 3.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.251 0.548 . . . . 0.0 110.587 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.88 150.61 51.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.858 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.44 116.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.314 0.578 . . . . 0.0 110.386 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.6 m -127.43 127.12 43.59 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.888 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.6 tp -77.32 112.31 13.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.249 0.547 . . . . 0.0 110.466 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -96.28 -43.81 12.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.496 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 21.3 t 65.96 173.1 0.23 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.743 169.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.621 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 26.5 m -146.7 -67.11 0.27 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.23 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.25 -86.08 0.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.66 96.8 0.1 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.995 -174.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.863 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -120.1 84.46 33.52 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.149 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.36 -76.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 111.956 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 m -70.32 -18.42 63.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.529 0.68 . . . . 0.0 110.136 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.863 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.8 mt -75.8 -36.7 59.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.387 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 14.4 t70 -54.54 -47.76 72.78 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.671 0.607 . . . . 0.0 111.834 -172.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -52.71 -51.9 58.44 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -170.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.52 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 22.8 tt0 -77.97 -48.21 16.77 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.221 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 90' ' ' LEU . 38.3 pt -62.76 -35.99 73.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 120.578 0.228 . . . . 0.0 111.217 -176.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.602 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 74.5 mm-40 -82.32 -28.25 31.77 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-O 120.951 0.405 . . . . 0.0 110.589 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.676 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.96 -46.5 78.56 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 170.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 tp -67.26 -55.66 13.04 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.904 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.884 HG11 HG21 ' A' ' 123' ' ' ILE . 72.1 t -87.83 -49.05 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.9 ttmt -66.52 -19.71 65.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.666 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.676 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 14.2 tpp180 -91.24 -49.94 6.1 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.68 169.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.616 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -90.87 64.76 5.58 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.698 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -89.7 99.48 1.79 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.145 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.646 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 71.9 Cg_endo -102.31 174.76 0.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.737 2.958 . . . . 0.0 114.176 -174.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.582 HD21 ' HD2' ' A' ' 108' ' ' PRO . 32.0 tp -144.69 102.13 4.59 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.726 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 6.1 Cg_exo -68.25 -77.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.134 1.889 . . . . 0.0 112.866 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.433 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.5 p -80.59 119.03 75.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.702 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 26.8 Cg_exo -62.75 108.65 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.209 2.606 . . . . 0.0 112.806 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.853 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 86.4 Cg_endo -83.02 62.15 7.59 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.172 2.581 . . . . 0.0 111.68 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.713 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -52.33 -44.69 65.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.612 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.94 -9.97 59.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.123 -176.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.853 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -99.35 -23.88 15.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.818 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.713 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -117.02 17.58 14.88 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.317 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.546 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.8 m -71.68 88.42 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 168.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.546 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 1.7 p-10 157.17 -16.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 113.989 -1.46 . . . . 0.0 108.002 -168.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.37 -85.1 0.14 Allowed Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.421 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.538 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.2 OUTLIER -154.71 176.5 12.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.743 ' O ' ' HA ' ' A' ' 69' ' ' THR . 3.7 m -99.98 107.61 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.995 0.903 . . . . 0.0 110.183 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 31.8 tt0 -107.95 111.16 23.12 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.04 175.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.762 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -147.33 155.06 41.67 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.346 -172.874 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.581 HG23 HG21 ' A' ' 82' ' ' VAL . 89.3 m -98.08 118.66 35.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.531 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.762 ' HG ' HD12 ' A' ' 119' ' ' LEU . 30.5 mt -124.18 127.76 25.24 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.409 175.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.5 Cg_exo -72.22 119.36 6.11 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.942 1.761 . . . . 0.0 110.768 175.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.884 HG21 HG11 ' A' ' 98' ' ' VAL . 40.7 pt -90.29 103.25 14.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -101.71 123.44 45.7 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.763 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -114.33 150.55 34.35 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 166.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 7.8 m -63.26 101.81 0.34 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.638 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.76 HD12 ' H ' ' A' ' 63' ' ' VAL . 1.3 tt -89.58 102.63 15.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.905 0.383 . . . . 0.0 110.379 -174.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.3 mtp180 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.775 178.298 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.511 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.602 0.239 . . . . 0.0 111.217 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -67.93 -38.31 82.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.23 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.82 -30.57 65.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.884 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.464 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 60.0 mtt180 -68.2 -41.72 80.93 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 172.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 37' ' ' TRP . 88.8 mt -59.05 -46.03 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.855 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.7 m -56.47 -29.79 62.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.892 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.69 -43.03 69.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.567 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.51 -34.27 74.04 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.102 0.477 . . . . 0.0 110.465 178.076 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 101' ' ' ALA . 1.3 tt -61.17 -33.48 73.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.96 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.845 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 34.4 t30 -70.85 -37.87 73.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.696 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -27.39 34.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.901 175.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.79 -62.07 1.29 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.236 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 29.6 mtpp -164.0 103.14 0.88 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.845 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 56.3 ttp180 -117.81 103.29 9.83 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.58 176.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -77.3 112.8 25.92 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.11 131.38 44.94 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.592 2.194 . . . . 0.0 112.107 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.59 ' HE2' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -58.66 -22.69 57.55 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.683 -174.337 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.614 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 6.6 m-20 -55.07 -39.11 68.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.754 0.312 . . . . 0.0 110.982 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.12 -36.21 61.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.215 0.531 . . . . 0.0 110.417 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.4 mm? -67.6 -35.62 79.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.745 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.614 ' HE ' ' HA ' ' A' ' 54' ' ' ASP . 46.8 mtm180 -54.1 -39.42 66.36 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 111.923 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.5 mp -94.62 -23.41 17.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.287 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.751 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 6.6 ttpp -113.56 -81.9 0.6 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.77 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 19.3 mmt180 -103.19 83.07 2.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.4 0.619 . . . . 0.0 111.42 -173.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.434 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.1 OUTLIER -105.29 144.06 32.6 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.854 173.219 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 1.013 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 162.08 131.9 1.27 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.675 -170.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.84 125.53 58.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.985 0.421 . . . . 0.0 110.843 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.7 164.76 24.34 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 55.5 mt-30 -115.42 127.13 55.14 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.402 HG23 ' CE2' ' A' ' 68' ' ' PHE . 27.4 m -118.07 139.64 44.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.347 0.594 . . . . 0.0 110.825 -174.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 45.4 ttp180 -112.98 138.09 50.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.908 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -154.96 148.91 25.72 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.343 0.592 . . . . 0.0 112.116 -177.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 15.3 m -93.51 129.72 39.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 169.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.675 HD13 ' HG ' ' A' ' 104' ' ' LEU . 47.5 mt -121.31 136.69 54.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.203 0.525 . . . . 0.0 111.915 -170.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.721 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 14.4 t70 -83.56 161.73 21.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.677 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG2' ' N ' ' A' ' 73' ' ' GLN . 2.4 ptp180 -54.78 -35.9 64.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.693 0.282 . . . . 0.0 111.632 -177.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.484 ' N ' ' HG2' ' A' ' 72' ' ' ARG . 15.4 pt20 -87.39 12.05 13.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.351 . . . . 0.0 111.26 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 103' ' ' PRO . . . 75.85 34.17 48.93 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.876 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.721 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 35.3 t-80 -92.57 104.8 17.06 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.8 p -48.92 123.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.467 0.651 . . . . 0.0 111.377 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 13.6 mt -107.7 -43.08 4.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.528 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.85 153.58 51.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.865 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.435 ' HB ' ' HD2' ' A' ' 99' ' ' LYS . 11.3 m -140.15 129.36 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.302 0.572 . . . . 0.0 110.812 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.6 m -145.42 120.48 10.08 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.868 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 84' ' ' SER . 26.1 tp -72.97 108.25 5.78 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.519 HG21 HG23 ' A' ' 120' ' ' THR . 0.2 OUTLIER -80.46 -42.36 21.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.898 -172.808 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 65' ' ' GLN . 8.6 t -140.22 147.27 39.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.212 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.487 ' HB2' HD21 ' A' ' 81' ' ' LEU . 28.6 t -142.88 131.88 23.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.831 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.54 17.5 6.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.013 0.435 . . . . 0.0 110.856 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.517 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 94.86 65.92 1.0 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.926 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.912 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -111.81 90.08 12.4 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 117.085 0.442 . . . . 0.0 109.954 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 6.1 Cg_exo -73.91 -74.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.714 2.276 . . . . 0.0 111.802 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.4 m -74.89 -19.22 60.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.431 0.634 . . . . 0.0 110.386 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.912 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 9.6 mt -76.89 -42.37 40.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.762 -172.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.575 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 28.6 t70 -54.95 -50.16 69.59 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.67 0.606 . . . . 0.0 112.414 -170.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -53.25 -44.28 68.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -77.05 -53.17 8.14 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.794 0.33 . . . . 0.0 111.784 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 34.0 pt -60.53 -35.85 66.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.631 -176.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.689 HE22 HD11 ' A' ' 123' ' ' ILE . 51.3 mm-40 -82.91 -21.58 34.15 Favored 'General case' 0 C--O 1.205 -1.273 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.129 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.05 -54.06 44.52 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.142 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.664 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -75.72 -46.24 32.21 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.543 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.862 HG11 HG21 ' A' ' 123' ' ' ILE . 30.8 t -62.55 -49.21 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.54 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 1.3 tppp? -70.82 -35.63 72.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.191 -169.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -80.71 -34.9 34.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.848 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.619 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -101.15 67.65 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.193 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.0 m -97.33 97.69 4.12 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.182 0.515 . . . . 0.0 109.781 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.619 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 88.0 Cg_endo -107.93 173.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.245 3.297 . . . . 0.0 114.553 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.675 ' HG ' HD13 ' A' ' 70' ' ' LEU . 14.1 mt -140.61 122.39 9.45 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.617 171.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.488 ' HD3' HG12 ' A' ' 41' ' ' ILE . 12.2 Cg_endo -82.06 -40.17 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.657 2.238 . . . . 0.0 111.676 174.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.464 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 12.8 m -94.92 103.46 11.73 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.374 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.87 106.76 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.564 2.176 . . . . 0.0 112.234 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.707 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 67.9 Cg_endo -83.0 58.19 6.25 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.751 2.301 . . . . 0.0 111.813 -176.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.783 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.55 -46.21 77.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.832 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.92 -23.02 66.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.158 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.707 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.72 -35.89 18.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.075 -175.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.783 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -105.78 15.91 26.04 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.008 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 3.6 m -72.15 89.52 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 169.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 2.3 p30 159.75 -22.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.212 -169.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 162.42 -85.09 0.11 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.737 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.551 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -159.4 173.22 16.57 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.723 HG13 ' HB3' ' A' ' 112' ' ' TYR . 24.5 m -104.98 110.4 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 121.328 0.585 . . . . 0.0 110.961 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 43.9 tt0 -107.78 110.65 22.5 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 170.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.604 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.7 pp -135.41 155.62 50.26 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.39 -174.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.519 HG23 HG21 ' A' ' 82' ' ' VAL . 99.9 m -101.08 129.13 46.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.107 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.604 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 54.3 mt -128.56 130.49 23.51 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 2.9 Cg_exo -76.12 121.48 6.17 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.791 2.327 . . . . 0.0 111.565 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.862 HG21 HG11 ' A' ' 98' ' ' VAL . 43.0 pt -97.76 99.98 9.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.49 119.04 29.58 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.124 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.59 ' CE2' ' HE2' ' A' ' 53' ' ' LYS . 83.2 m-85 -116.25 120.19 38.14 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 162.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.5 m -58.74 102.5 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -169.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 1.013 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 3.4 mt -73.23 114.13 11.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.104 0.478 . . . . 0.0 110.248 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.639 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.684 ' HA ' ' HG2' ' A' ' 40' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 39' ' ' SER . 9.6 ptp180 -63.6 -39.96 95.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.243 0.544 . . . . 0.0 109.874 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.581 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 3.5 m -67.58 -30.39 69.99 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.602 -178.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.684 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 16.8 mmt180 -71.72 -43.35 66.02 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.283 176.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.629 HG23 ' HD2' ' A' ' 103' ' ' PRO . 76.2 mt -59.85 -49.04 85.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.222 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.1 t -57.04 -30.24 64.08 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.605 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -68.21 -44.94 73.64 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.043 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.509 ' NE ' ' HB3' ' A' ' 105' ' ' PRO . 9.5 mpt_? -69.66 -34.49 74.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.973 0.416 . . . . 0.0 110.322 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 101' ' ' ALA . 2.7 tt -59.52 -32.28 70.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.761 0.791 . . . . 0.0 109.076 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 1.031 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 28.4 t30 -70.99 -42.32 69.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.156 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 8.0 ptt180 -61.29 -18.54 58.99 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.298 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -100.54 -58.47 1.89 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.153 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -162.59 103.08 1.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.864 0.466 . . . . 0.0 110.314 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 1.031 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 5.7 tpt180 -134.05 103.12 5.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.413 ' HB3' HD21 ' A' ' 56' ' ' LEU . 1.8 t80 -89.16 138.14 29.08 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.223 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.56 131.62 41.8 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.806 2.337 . . . . 0.0 111.996 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.01 -25.68 67.07 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.037 -173.542 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.1 -41.05 67.84 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.323 0.389 . . . . 0.0 110.913 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.1 -38.73 75.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.743 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.5 mm? -66.53 -38.73 87.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.549 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 69.8 mtt180 -65.71 -13.95 60.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.386 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.6 mt -110.85 2.1 18.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.792 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.596 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 21.1 ttmm -137.92 -74.42 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.532 -173.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.596 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 38.4 mmt180 -126.55 106.4 9.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 110.335 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.473 ' O ' HD13 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -117.78 158.19 25.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.612 178.437 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.976 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 153.29 144.17 3.85 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 119.79 -1.195 . . . . 0.0 113.345 -177.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.763 ' H ' HD12 ' A' ' 127' ' ' LEU . 2.8 p -104.13 122.77 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.373 0.606 . . . . 0.0 110.132 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.79 151.35 21.25 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.688 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 21.9 tt0 -105.63 135.42 47.06 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.53 131.67 71.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.014 0.435 . . . . 0.0 110.777 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -115.04 140.9 48.67 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.31 153.74 27.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.209 0.528 . . . . 0.0 111.757 -175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.676 ' CG2' ' HB ' ' A' ' 116' ' ' THR . 21.1 m -96.89 130.39 44.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.8 173.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 49.6 mt -118.35 133.98 55.43 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.111 0.481 . . . . 0.0 111.677 -173.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.71 155.9 30.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.186 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 72' ' ' ARG . 32.0 ttm180 -55.75 -33.71 64.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.003 0.43 . . . . 0.0 110.285 175.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -76.68 6.25 6.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.129 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.23 36.82 63.61 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.395 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -113.29 122.45 47.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 8.6 p -48.75 127.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.927 0.767 . . . . 0.0 111.522 172.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.419 ' CD1' HG21 ' A' ' 116' ' ' THR . 36.0 mt -113.71 -43.85 3.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.224 0.535 . . . . 0.0 110.73 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.79 154.21 48.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.168 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.508 HG11 ' HG3' ' A' ' 99' ' ' LYS . 3.1 m -147.66 127.08 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.0 m -144.64 127.83 16.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 tp -76.38 108.64 9.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.754 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -74.63 -34.26 34.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.637 0.732 . . . . 0.0 109.056 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 14.9 t 75.29 171.39 0.27 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.605 170.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -153.67 -52.44 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.682 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.93 -79.1 0.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 168.49 103.68 0.17 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.513 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.772 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.7 OUTLIER -119.39 103.96 46.22 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.244 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -84.44 -81.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.24 1.96 . . . . 0.0 111.991 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.2 p -71.0 -19.02 62.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.192 0.52 . . . . 0.0 110.529 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.772 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 8.9 mt -75.12 -32.26 61.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.908 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 15.8 t70 -54.48 -50.38 67.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.896 -171.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 93' ' ' GLU . 17.0 ptp180 -52.64 -46.89 67.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.569 -175.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.451 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 11.1 mt-10 -78.46 -53.94 6.7 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.51 HD11 ' HG ' ' A' ' 87' ' ' LEU . 34.2 pt -62.32 -33.91 61.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.553 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 56.1 mm-40 -82.02 -29.56 31.94 Favored 'General case' 0 C--O 1.203 -1.392 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.371 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.78 68.47 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.136 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.717 HD23 HG23 ' A' ' 98' ' ' VAL . 0.7 OUTLIER -63.81 -54.64 31.95 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.763 176.857 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.872 HG11 HG21 ' A' ' 123' ' ' ILE . 39.4 t -85.15 -48.55 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.553 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -63.59 -34.34 77.59 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.211 0.604 . . . . 0.0 110.865 -174.33 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -76.49 -48.3 19.99 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.247 0.546 . . . . 0.0 109.689 177.68 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.628 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -93.34 58.83 2.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.398 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.501 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.9 m -95.84 99.23 4.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.334 0.588 . . . . 0.0 109.939 174.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.629 ' HD2' HG23 ' A' ' 41' ' ' ILE . 72.9 Cg_endo -103.42 176.17 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 124.712 3.608 . . . . 0.0 113.441 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.663 HD21 ' HD2' ' A' ' 108' ' ' PRO . 38.5 tp -142.04 91.0 8.16 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.509 ' HB3' ' NE ' ' A' ' 44' ' ' ARG . 11.9 Cg_endo -70.46 -53.13 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.246 1.964 . . . . 0.0 112.824 -174.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.539 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 23.2 p -92.08 106.25 16.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -68.3 106.16 1.35 Allowed 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.822 2.348 . . . . 0.0 112.621 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.663 ' HD2' HD21 ' A' ' 104' ' ' LEU . 44.9 Cg_endo -86.66 61.18 4.4 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.195 2.596 . . . . 0.0 111.194 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.737 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.46 -41.54 80.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.17 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.99 -25.76 67.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.511 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.97 -29.76 21.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.84 ' HD2' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.72 16.41 16.39 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -172.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.5 m -71.36 88.36 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.1 p30 154.95 -15.35 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 113.426 -1.716 . . . . 0.0 108.609 -167.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 168.96 -100.21 0.16 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.828 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.676 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.3 OUTLIER -161.15 176.67 11.04 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.498 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.84 HG13 ' HD2' ' A' ' 112' ' ' TYR . 12.3 m -101.5 108.77 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.585 0.707 . . . . 0.0 110.754 -177.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -99.0 111.25 23.7 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.596 HD12 ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -134.49 152.85 52.06 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.843 -173.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.754 HG23 HG21 ' A' ' 82' ' ' VAL . 54.8 m -103.42 128.07 50.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.395 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.596 ' HG ' HD12 ' A' ' 119' ' ' LEU . 98.3 mt -132.94 125.19 19.03 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.481 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.688 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 3.2 Cg_exo -79.97 120.18 4.14 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.947 1.764 . . . . 0.0 111.785 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.872 HG21 HG11 ' A' ' 98' ' ' VAL . 41.6 pt -96.6 98.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 3.4 p-10 -107.03 124.94 50.37 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.693 -176.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.427 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 82.8 m-85 -111.75 141.65 45.09 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 165.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.4 m -57.76 102.49 0.1 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.034 0.445 . . . . 0.0 111.614 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.976 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -85.9 69.69 10.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.331 -175.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.813 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.33 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 . . . . . 0 C--O 1.225 -0.197 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -67.95 -35.76 78.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.453 -170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 p -63.48 -40.39 96.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.266 0.555 . . . . 0.0 110.144 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.511 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 50.8 mmm-85 -74.99 -46.24 36.56 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.268 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.551 HG23 ' HG2' ' A' ' 103' ' ' PRO . 58.3 mt -57.46 -43.19 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.549 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.7 m -59.73 -44.43 93.76 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.603 0.24 . . . . 0.0 111.51 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.85 -33.98 88.7 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.457 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.646 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 27.9 ttt85 -69.83 -35.73 75.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.75 0.309 . . . . 0.0 110.347 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -64.28 -31.55 72.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.379 0.609 . . . . 0.0 109.667 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.643 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 11.4 t30 -70.97 -30.69 67.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.631 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 47.9 ttt180 -70.18 -29.03 65.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.84 171.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 49' ' ' LYS . 61.3 m-85 -99.62 25.25 7.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.202 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 48' ' ' PHE . 13.0 tmtt? 74.2 103.36 0.07 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.493 0.664 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.643 ' HB3' ' HA ' ' A' ' 46' ' ' ASN . 32.3 ttt180 -137.89 108.0 6.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.191 -176.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.552 ' HB3' HD21 ' A' ' 56' ' ' LEU . 6.2 t80 -61.78 134.6 94.06 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.43 129.13 8.55 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.987 2.458 . . . . 0.0 112.06 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.758 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -71.49 -25.28 62.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.125 -163.406 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -66.93 -33.26 75.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.958 0.408 . . . . 0.0 110.77 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.85 -30.32 70.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.415 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.6 mm? -78.41 -41.68 32.31 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.765 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 51.4 mtm180 -75.1 -10.89 59.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.05 -0.406 . . . . 0.0 111.994 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 33.3 tp -105.58 17.06 24.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.466 0.65 . . . . 0.0 109.803 176.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.549 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 25.0 ttmm -146.01 -54.27 0.27 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.371 -175.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.88 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 17.9 mmt180 -126.32 83.28 2.15 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.866 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.594 ' HB2' ' O ' ' A' ' 126' ' ' SER . 0.8 OUTLIER -100.15 137.3 38.78 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.552 -179.051 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.918 ' HA3' HD11 ' A' ' 87' ' ' LEU . . . 171.99 160.61 20.92 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.669 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.416 ' H ' HD12 ' A' ' 127' ' ' LEU . 2.6 p -116.35 125.72 73.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.173 0.511 . . . . 0.0 110.527 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.93 159.27 23.46 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.558 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 49.9 tt0 -104.27 123.74 47.9 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 121' ' ' LEU . 9.5 p -127.01 126.68 68.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.408 0.623 . . . . 0.0 111.041 -167.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -115.82 144.94 43.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.717 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -158.97 155.14 27.02 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.066 0.46 . . . . 0.0 110.937 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 22.0 m -100.52 129.35 46.45 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 171.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 75.5 mt -113.95 140.59 48.27 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.724 0.773 . . . . 0.0 112.146 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 27.9 t70 -77.7 165.16 24.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.85 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.505 ' HA ' ' OH ' ' A' ' 112' ' ' TYR . 38.6 mtp180 -54.39 -35.72 63.15 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.531 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -83.03 6.16 19.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 110.817 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . 72.8 40.1 53.49 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.623 -176.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 71.1 t60 -108.14 138.16 44.89 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.379 -0.41 . . . . 0.0 110.349 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 100' ' ' ARG . 10.5 p -59.24 130.94 23.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.348 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 71' ' ' ASP . 56.5 mt -120.27 -40.77 2.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.292 0.568 . . . . 0.0 110.282 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.2 148.04 51.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.981 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.77 123.99 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 123.564 0.54 . . . . 0.0 109.807 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.1 m -144.53 118.75 9.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.841 0.353 . . . . 0.0 111.376 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 84' ' ' SER . 34.3 tp -85.03 106.73 16.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -87.24 -46.69 16.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.196 -170.184 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 m -144.78 112.64 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.662 ' HB2' HD21 ' A' ' 81' ' ' LEU . 34.5 t -106.32 137.77 43.69 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.59 -7.56 59.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.266 0.555 . . . . 0.0 110.536 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.73 -86.23 0.14 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 1.032 ' HA ' HD12 ' A' ' 90' ' ' LEU . 2.3 mm? 44.24 59.03 13.38 Favored Pre-proline 0 CA--C 1.534 0.335 0 O-C-N 124.304 0.649 . . . . 0.0 112.495 173.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -61.92 -71.44 0.03 OUTLIER 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 121.334 1.356 . . . . 0.0 111.936 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 t -76.92 -18.64 58.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.462 0.649 . . . . 0.0 110.055 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 1.032 HD12 ' HA ' ' A' ' 87' ' ' LEU . 6.6 mt -75.91 -41.31 52.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.517 -172.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.456 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 19.2 t70 -53.95 -47.0 71.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.502 -172.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -54.64 -37.28 65.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.471 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.88 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 2.3 tp10 -78.49 -54.88 5.68 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.0 pt -68.8 -35.46 69.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.562 -173.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.605 ' NE2' HD11 ' A' ' 123' ' ' ILE . 56.5 mm-40 -79.87 -27.55 40.06 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.788 0.328 . . . . 0.0 110.649 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.24 -46.95 76.03 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.117 173.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.533 ' O ' HD21 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -63.97 -57.59 9.25 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.698 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.673 HG11 HG21 ' A' ' 123' ' ' ILE . 80.5 t -87.6 -48.82 15.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.588 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.7 ttmt -67.18 -27.09 66.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.044 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.545 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 3.2 tmt_? -85.43 -53.92 4.9 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.016 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -96.49 65.52 2.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.739 0.304 . . . . 0.0 111.105 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.486 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 16.1 m -78.04 107.85 6.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.807 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.646 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 39.6 Cg_endo -101.49 139.41 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 124.022 3.148 . . . . 0.0 113.963 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -125.98 107.11 25.28 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 171.374 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.511 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 11.5 Cg_exo -65.05 -62.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 122.715 2.277 . . . . 0.0 112.622 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.499 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 8.8 t -80.73 123.28 82.58 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.706 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 14.9 Cg_exo -69.47 107.67 1.85 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.047 2.498 . . . . 0.0 111.862 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.572 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 43.1 Cg_endo -84.52 59.97 5.91 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.927 2.418 . . . . 0.0 111.542 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.687 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -54.27 -48.88 70.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.086 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -75.02 6.95 3.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.707 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -106.96 -38.1 6.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.801 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -106.88 18.05 22.33 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.4 m -69.9 87.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 122.447 1.118 . . . . 0.0 108.34 172.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 5.5 p30 166.54 -39.04 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.109 -1.86 . . . . 0.0 107.526 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.08 -75.17 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.987 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.478 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.8 OUTLIER -160.14 174.07 14.83 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.953 0.501 . . . . 0.0 109.958 -178.188 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.801 HG13 ' HB3' ' A' ' 112' ' ' TYR . 10.4 m -105.02 109.07 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 121.282 0.563 . . . . 0.0 110.861 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -103.42 111.77 24.36 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 169.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.6 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -142.97 150.18 39.34 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.91 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.404 ' CG2' ' HG2' ' A' ' 65' ' ' GLN . 32.2 m -99.79 128.14 45.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.209 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.6 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 83.7 mt -126.73 123.54 23.85 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.559 176.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 51.9 Cg_endo -73.32 123.64 8.87 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.547 1.498 . . . . 0.0 111.921 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.673 HG21 HG11 ' A' ' 98' ' ' VAL . 8.1 pt -98.45 97.84 6.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.42 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -104.16 124.07 48.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.673 0.749 . . . . 0.0 112.199 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.443 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 71.0 m-85 -117.06 151.2 37.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.397 169.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.594 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 10.3 m -61.02 102.8 0.22 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.063 0.227 . . . . 0.0 110.656 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.909 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.3 tt -83.26 77.15 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.236 0.541 . . . . 0.0 110.787 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.485 175.285 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.522 ' CZ3' HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.191 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -67.89 -33.13 74.14 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.315 -170.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.5 p -70.85 -31.28 67.92 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.474 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 21.5 mmt180 -68.19 -46.18 71.35 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.516 HG23 ' HD2' ' A' ' 103' ' ' PRO . 88.8 mt -57.45 -44.76 85.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.211 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.5 t -56.2 -36.31 68.27 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.539 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.75 -42.4 98.6 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.507 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.672 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.75 -32.29 70.74 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.114 0.483 . . . . 0.0 110.7 177.159 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.27 -31.43 71.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.477 0.656 . . . . 0.0 109.696 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.622 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 10.0 t30 -71.52 -34.26 69.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.598 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -54.02 -25.56 21.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.592 173.066 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.582 ' HE2' ' HB3' ' A' ' 103' ' ' PRO . 97.5 m-85 -100.0 -61.11 1.41 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.017 174.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 11.6 mmmm -170.72 110.31 0.36 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.487 0.715 . . . . 0.0 109.533 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.622 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 45.7 ttp180 -125.03 111.91 15.93 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.985 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.632 ' H ' HD11 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -82.63 137.93 44.3 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.505 177.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.87 131.2 40.55 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.582 2.188 . . . . 0.0 111.622 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.63 -23.35 62.93 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.65 -171.493 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -53.69 -46.57 70.76 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.265 0.353 . . . . 0.0 111.145 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.9 -29.87 68.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.016 0.436 . . . . 0.0 111.477 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.2 mm? -75.47 -42.35 53.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 0.0 110.34 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 57' ' ' ARG . 59.9 mtt180 -70.65 -12.01 61.29 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 pp -109.79 7.74 24.29 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.972 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.607 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 19.3 ttpp -158.14 -69.8 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.607 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 22.2 mmt180 -90.23 82.6 6.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.257 1.027 . . . . 0.0 110.063 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.614 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . 24.4 mt-30 -105.17 159.16 16.07 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.345 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.445 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.29 131.6 1.72 Allowed Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.795 -1.193 . . . . 0.0 112.656 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.578 HG22 ' HB2' ' A' ' 124' ' ' ASP . 60.6 t -104.22 123.08 57.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.98 166.4 30.42 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.142 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.581 ' H ' ' HA ' ' A' ' 83' ' ' SER . 47.7 mt-30 -102.75 131.43 49.6 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 123' ' ' ILE . 20.8 t -126.66 117.08 47.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.069 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.623 ' HD3' ' OE2' ' A' ' 118' ' ' GLU . 10.8 ttm180 -109.48 139.49 44.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.568 -176.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CD1' HD21 ' A' ' 70' ' ' LEU . 8.1 p90 -159.2 154.64 25.73 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 26.4 m -96.86 140.9 30.74 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.357 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.742 HD13 ' HB2' ' A' ' 104' ' ' LEU . 65.4 mt -124.37 138.58 54.36 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.588 0.709 . . . . 0.0 112.683 -170.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.629 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 13.6 t70 -73.04 157.65 36.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.435 172.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -57.67 -27.35 62.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.876 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -100.39 15.27 28.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.864 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.708 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 75.8 46.76 13.21 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.094 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.629 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 53.2 t60 -110.52 122.23 47.24 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.6 p -50.57 116.38 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.551 0.691 . . . . 0.0 111.488 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.5 mt -100.81 -44.48 5.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.521 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.44 161.94 33.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.02 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.493 HG21 ' HG3' ' A' ' 99' ' ' LYS . 7.5 p -160.23 117.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.372 0.606 . . . . 0.0 109.589 175.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.2 m -124.37 112.83 17.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.714 -177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.0 tp -69.38 105.77 2.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.56 0.695 . . . . 0.0 109.818 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -86.98 -54.83 7.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.491 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.581 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 32.4 t 63.18 -175.01 0.15 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.249 170.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -152.03 -63.13 0.17 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.79 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.96 -37.98 13.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.975 0.417 . . . . 0.0 111.396 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.76 104.17 2.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.406 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.861 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 1.7 mm? -103.01 103.41 33.79 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' LEU . 2.7 Cg_exo -75.48 -80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.959 2.439 . . . . 0.0 112.862 -173.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 m -69.34 -19.5 63.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.442 0.639 . . . . 0.0 110.387 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.861 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.7 mt -75.7 -31.55 59.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.203 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 9.9 t70 -54.26 -48.9 70.66 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.602 0.564 . . . . 0.0 111.665 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -53.21 -45.7 68.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -171.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.574 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 16.8 tt0 -78.77 -53.35 7.21 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.961 -176.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' A' ' 60' ' ' ARG . 38.7 pt -67.1 -37.31 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.664 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 78.6 mm-40 -81.59 -25.72 35.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 120.881 0.372 . . . . 0.0 110.908 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.87 -43.47 77.18 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 169.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.632 HD11 ' H ' ' A' ' 51' ' ' TYR . 1.4 tp -67.6 -56.81 7.96 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.824 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.685 HG11 HG21 ' A' ' 123' ' ' ILE . 63.9 t -88.53 -49.13 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -175.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.664 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.6 ttmt -65.16 -22.56 66.93 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.003 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 2.6 tmt_? -90.99 -55.21 3.64 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.885 -0.509 . . . . 0.0 109.766 173.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.636 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -84.21 73.73 10.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 0.0 110.807 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.424 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 9.1 m -99.27 98.01 6.09 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 121.335 0.588 . . . . 0.0 109.577 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.672 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 93.6 Cg_endo -105.43 176.46 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 124.227 3.285 . . . . 0.0 113.686 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.742 ' HB2' HD13 ' A' ' 70' ' ' LEU . 4.0 tt -144.02 115.36 5.52 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.561 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 5.1 Cg_exo -70.75 -72.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.71 2.273 . . . . 0.0 112.757 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -86.16 117.22 68.32 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.492 -177.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.516 ' HA ' HD21 ' A' ' 104' ' ' LEU . 24.8 Cg_exo -64.06 106.44 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.266 2.644 . . . . 0.0 112.293 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.737 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 61.4 Cg_endo -88.72 67.41 2.83 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.228 2.619 . . . . 0.0 112.071 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.78 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.69 -43.4 76.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.19 0.519 . . . . 0.0 110.051 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -72.52 -2.17 18.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.636 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.737 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -105.52 -29.69 10.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.78 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -106.66 16.52 24.42 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.576 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.6 m -71.44 89.16 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 168.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 1.1 p-10 161.29 -24.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.89 -169.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.4 -76.01 0.19 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.697 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.469 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -159.99 173.86 15.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.115 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 69' ' ' THR . 4.4 m -105.04 109.1 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.024 0.44 . . . . 0.0 111.235 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.623 ' OE2' ' HD3' ' A' ' 67' ' ' ARG . 32.6 tt0 -110.0 112.17 24.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.631 HD13 HD11 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -122.59 150.36 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.463 -175.465 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.453 HG23 HG21 ' A' ' 82' ' ' VAL . 29.3 m -102.09 119.01 38.09 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.413 0.625 . . . . 0.0 110.181 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.631 HD11 HD13 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -116.66 122.87 31.12 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -175.352 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 2.6 Cg_exo -75.29 120.16 5.86 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.603 1.535 . . . . 0.0 111.564 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.685 HG21 HG11 ' A' ' 98' ' ' VAL . 4.3 pt -104.0 114.8 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.578 ' HB2' HG22 ' A' ' 63' ' ' VAL . 5.1 p-10 -118.97 125.25 48.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.027 0.918 . . . . 0.0 111.794 -176.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.521 ' HE1' ' HE2' ' A' ' 53' ' ' LYS . 98.6 m-85 -114.22 131.02 56.62 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.215 -1.357 . . . . 0.0 107.8 167.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.9 m -60.52 102.93 0.2 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.992 0.182 . . . . 0.0 111.282 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.614 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 3.3 mt -76.6 87.91 3.29 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.456 0.646 . . . . 0.0 110.498 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 . . . . . 0 N--CA 1.444 -0.757 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.523 179.687 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.6 m0 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 120.303 0.097 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -67.02 -44.09 81.18 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.7 p -65.72 -38.75 90.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.43 0.633 . . . . 0.0 109.744 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.629 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 1.7 mmt180 -68.6 -47.57 66.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.751 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.49 HG23 ' HG2' ' A' ' 103' ' ' PRO . 43.7 mt -62.64 -37.55 79.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.589 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.8 m -55.09 -37.54 66.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.332 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -66.72 -44.59 89.13 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.057 176.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 47' ' ' ARG . 11.5 mpt_? -70.16 -32.36 70.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.032 0.444 . . . . 0.0 111.37 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.442 HD11 HG22 ' A' ' 98' ' ' VAL . 0.9 OUTLIER -63.14 -32.68 74.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.642 0.734 . . . . 0.0 109.367 176.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.689 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 14.4 t-20 -71.14 -30.97 67.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.589 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.515 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 3.2 ttt180 -58.45 -18.82 31.59 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.651 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -115.44 -59.34 2.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.366 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -160.43 105.64 1.47 Allowed 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 122.942 0.497 . . . . 0.0 109.798 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.689 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 22.0 tpt180 -105.78 102.52 11.96 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.08 176.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.603 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -90.3 125.7 59.17 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.364 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.34 132.36 29.21 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.37 2.047 . . . . 0.0 111.523 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.502 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.68 -23.62 66.21 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.581 -175.134 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.31 -42.84 82.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.913 0.387 . . . . 0.0 110.837 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.74 71.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.802 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.704 ' HG ' ' HE2' ' A' ' 125' ' ' PHE . 3.7 mm? -75.91 -41.31 52.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.259 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.64 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 98.5 mtt180 -58.08 -29.72 65.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.134 0.493 . . . . 0.0 111.307 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.9 mt -100.07 17.11 21.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.097 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.846 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 38.4 ttmt -145.86 -77.59 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.372 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.846 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 36.3 mmt180 -126.71 98.06 5.23 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -176.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.64 ' HG2' ' HA ' ' A' ' 57' ' ' ARG . 47.4 mt-30 -92.66 115.87 28.5 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.904 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -155.53 125.28 1.63 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.737 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.724 HG23 ' HA ' ' A' ' 124' ' ' ASP . 7.1 p -103.91 133.22 48.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.175 0.512 . . . . 0.0 109.969 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.05 168.44 34.54 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.622 -175.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.687 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 83.2 mt-30 -99.74 140.53 33.81 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.459 HG12 ' CD2' ' A' ' 68' ' ' PHE . 53.7 t -128.7 114.18 32.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.695 -173.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 22.7 ttp180 -106.2 129.08 54.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -147.83 151.51 36.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.295 0.569 . . . . 0.0 112.191 -174.218 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 9.0 m -99.94 125.61 45.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 169.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 41.7 mt -116.26 134.68 54.64 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.168 0.508 . . . . 0.0 111.757 -170.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 16.4 t70 -73.96 154.02 39.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.314 177.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -49.4 -40.75 37.37 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.34 0.4 . . . . 0.0 111.805 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -89.35 14.03 12.15 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 111.309 -176.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.47 47.13 9.17 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.118 177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 38.8 t-80 -109.58 116.18 31.28 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 p -48.74 115.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.331 0.586 . . . . 0.0 111.554 173.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.0 mt -103.3 -41.89 5.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.978 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -139.25 146.08 39.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.818 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 99' ' ' LYS . 1.4 m -143.76 117.13 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.422 0.63 . . . . 0.0 110.951 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 m -130.13 125.66 35.62 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.87 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.9 tp -71.6 119.07 15.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.205 0.526 . . . . 0.0 110.065 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.54 HG21 HG23 ' A' ' 120' ' ' THR . 0.1 OUTLIER -96.71 -38.78 8.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.982 179.467 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 12.4 t 67.06 -178.26 0.21 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.404 170.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.555 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 39.8 m -154.92 -58.04 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.289 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.13 -66.6 0.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.327 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.65 104.82 0.19 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.753 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.82 ' HA ' HD12 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -118.42 77.82 13.98 Favored Pre-proline 0 C--N 1.32 -0.686 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.358 -178.745 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.63 -78.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.234 1.956 . . . . 0.0 111.809 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.9 m -67.68 -17.63 64.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.413 0.625 . . . . 0.0 110.297 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.82 HD12 ' HA ' ' A' ' 87' ' ' LEU . 17.6 mt -75.21 -33.66 61.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.921 -176.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 18.5 t70 -53.98 -50.52 66.37 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.591 0.557 . . . . 0.0 112.031 -173.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.574 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 0.7 OUTLIER -54.56 -48.6 71.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.114 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.76 -55.19 5.54 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -174.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 90' ' ' LEU . 36.0 pt -68.61 -34.05 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.407 0.623 . . . . 0.0 110.933 -171.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.816 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.8 mm-40 -84.66 -17.46 38.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.005 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 92' ' ' ARG . . . -55.64 -55.78 28.05 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.835 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.613 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.2 -48.19 21.32 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.148 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.722 HG11 HG21 ' A' ' 123' ' ' ILE . 55.8 t -70.54 -49.49 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.816 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.9 ttmt -73.97 -16.53 61.07 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 122.064 -0.398 . . . . 0.0 110.724 -173.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -88.29 -47.37 8.47 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.678 171.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.606 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -92.32 67.79 4.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.801 0.334 . . . . 0.0 110.914 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.2 m -95.57 99.67 5.06 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.291 0.567 . . . . 0.0 110.005 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 90.8 Cg_endo -102.79 176.32 0.18 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.042 3.161 . . . . 0.0 113.711 -175.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 48.9 tp -142.9 85.6 9.87 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.304 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.629 ' CG ' ' HB2' ' A' ' 40' ' ' ARG . 10.0 Cg_endo -59.44 -53.94 2.99 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.278 1.986 . . . . 0.0 112.677 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.618 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.4 m -81.03 116.74 64.54 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.75 99.23 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.986 2.457 . . . . 0.0 111.118 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.829 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 37.9 Cg_endo -90.93 66.45 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.363 2.708 . . . . 0.0 112.386 -171.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.724 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.59 -45.92 84.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.203 0.525 . . . . 0.0 109.921 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -67.22 -6.28 17.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.7 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.829 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -101.41 -36.19 8.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.488 -178.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.774 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -112.43 18.85 18.12 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -171.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.2 m -69.26 88.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.134 0.969 . . . . 0.0 108.686 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 3.8 p30 164.11 -27.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.459 -1.7 . . . . 0.0 107.636 -170.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 172.28 -81.92 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.09 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.486 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.3 OUTLIER -160.81 175.49 12.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.761 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.774 HG13 ' HB3' ' A' ' 112' ' ' TYR . 10.7 m -102.35 108.69 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.329 0.585 . . . . 0.0 110.842 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 37.0 tt0 -108.8 112.5 24.8 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 170.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.651 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -136.38 154.35 50.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 -173.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.54 HG23 HG21 ' A' ' 82' ' ' VAL . 98.6 m -98.43 113.44 25.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.703 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.651 ' HG ' HD12 ' A' ' 119' ' ' LEU . 42.7 mt -117.95 123.76 29.31 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.19 176.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.2 Cg_exo -73.53 118.9 5.67 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.994 1.796 . . . . 0.0 111.212 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.722 HG21 HG11 ' A' ' 98' ' ' VAL . 33.5 pt -93.61 116.68 35.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.724 ' HA ' HG23 ' A' ' 63' ' ' VAL . 1.5 t70 -100.53 120.91 40.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.996 0.903 . . . . 0.0 112.856 -172.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.704 ' HE2' ' HG ' ' A' ' 56' ' ' LEU . 6.7 m-85 -115.6 130.53 56.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 160.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 61' ' ' GLN . 13.4 m -59.19 103.46 0.18 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.294 0.497 . . . . 0.0 110.703 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.904 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -77.76 66.76 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.059 -177.481 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 121.182 0.515 . . . . 0.0 109.857 179.142 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HE1' ' HB ' ' A' ' 106' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.288 0.566 . . . . 0.0 109.55 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 38' ' ' ARG . 5.7 ptp180 -66.02 -31.97 73.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.83 -177.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.3 p -71.23 -33.13 69.59 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 10.1 mmt180 -70.65 -46.28 63.54 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.559 ' N ' ' HG3' ' A' ' 105' ' ' PRO . 80.3 mt -57.31 -45.8 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.866 175.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.9 m -61.42 -34.43 75.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.485 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.537 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -66.38 -37.81 93.07 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.44 -0.886 . . . . 0.0 110.996 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.654 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -69.22 -33.71 73.72 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.314 0.578 . . . . 0.0 110.185 176.657 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.39 -26.02 67.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.777 177.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.632 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.4 t-20 -70.56 -33.58 71.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.39 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.546 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 1.4 ttt180 -55.27 -28.4 53.13 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.357 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.582 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 91.2 m-85 -99.45 -58.99 1.8 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.219 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 48' ' ' PHE . 32.5 mtmt -178.91 103.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.521 1.128 . . . . 0.0 108.691 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.632 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 55.4 ttp180 -110.77 104.39 13.03 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.791 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.559 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -92.24 126.58 52.32 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.26 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.93 133.13 51.63 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 123.009 2.473 . . . . 0.0 112.462 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.61 -26.3 66.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.216 -169.723 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.68 -35.82 77.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.17 0.51 . . . . 0.0 110.5 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.46 63.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.6 mm? -75.98 -42.69 47.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.671 0.272 . . . . 0.0 110.965 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 4.4 ptp180 -66.6 -11.91 55.56 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.952 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -112.94 10.57 18.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.24 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.599 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 23.1 ttmm -150.92 -77.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.121 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 1.064 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 28.5 mmt180 -112.34 84.58 2.0 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 3.6 pm0 -94.91 170.95 9.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.274 -178.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.754 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.58 123.28 0.99 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.093 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.631 HG12 HD12 ' A' ' 127' ' ' LEU . 6.9 p -104.76 125.55 59.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.223 0.535 . . . . 0.0 109.866 176.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.67 165.15 28.8 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.883 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 36.2 tt0 -103.98 124.37 48.88 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.441 HG21 HD13 ' A' ' 123' ' ' ILE . 60.5 t -128.63 118.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.73 -170.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 1.2 ptp180 -113.14 145.54 40.77 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -156.86 157.6 35.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.311 0.577 . . . . 0.0 111.788 -175.142 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.676 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 1.9 m -107.74 127.56 53.79 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 172.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.657 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 36.6 mt -117.56 132.04 56.59 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.253 0.549 . . . . 0.0 111.997 -166.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.537 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 20.6 t70 -68.79 152.22 45.6 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.23 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.465 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 69.6 mtt180 -61.41 -17.27 53.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.449 -1.25 . . . . 0.0 112.414 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -101.03 3.83 41.79 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.321 0.582 . . . . 0.0 110.331 175.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 86.89 41.49 6.71 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.25 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.537 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 79.9 t60 -114.35 125.63 54.08 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 8.6 p -53.3 122.25 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.357 0.598 . . . . 0.0 111.267 175.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.8 mt -104.34 -40.84 5.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.632 0.729 . . . . 0.0 109.552 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.59 151.55 47.37 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.636 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.17 122.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.358 0.599 . . . . 0.0 110.027 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.1 m -129.3 127.63 41.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.343 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 84' ' ' SER . 25.4 tp -75.54 107.81 7.93 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.651 HG21 HG23 ' A' ' 120' ' ' THR . 0.1 OUTLIER -83.42 -41.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.382 -170.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.6 m -154.44 135.31 13.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.88 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.667 ' HB2' HD21 ' A' ' 81' ' ' LEU . 34.1 t -122.93 135.86 54.65 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.79 -19.36 41.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.657 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.474 ' H ' HD22 ' A' ' 87' ' ' LEU . . . 133.12 63.33 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.973 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.913 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -118.23 87.65 30.27 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.391 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.97 -73.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.554 2.169 . . . . 0.0 111.769 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 9.3 m -72.91 -18.92 61.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.34 0.59 . . . . 0.0 110.245 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.913 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 17.0 mt -76.83 -37.25 56.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.719 -175.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.445 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 17.0 t70 -54.6 -48.82 71.7 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.189 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 89' ' ' SER . 16.8 ptp180 -54.34 -42.25 70.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.595 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 1.064 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 4.9 tp10 -77.79 -54.66 6.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.978 0.418 . . . . 0.0 111.949 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.525 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 38.1 pt -72.48 -33.48 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.754 -172.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.623 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 77.1 mm-40 -82.52 -25.95 32.95 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 120.867 0.365 . . . . 0.0 110.737 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.552 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.01 -43.44 77.7 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 169.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.722 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -66.6 -57.05 8.04 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.14 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.736 HG11 HG21 ' A' ' 123' ' ' ILE . 79.3 t -88.42 -49.49 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.623 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 36.3 ttmt -65.54 -24.65 67.17 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.63 0.372 . . . . 0.0 111.329 -174.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.552 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 28.3 tpt180 -97.14 -35.78 10.68 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.492 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.469 ' HB1' ' CD2' ' A' ' 48' ' ' PHE . . . -102.78 61.78 0.81 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.834 177.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.494 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 6.3 m -83.11 104.64 3.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.261 0.553 . . . . 0.0 109.995 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.654 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 37.9 Cg_endo -99.81 153.32 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.769 2.979 . . . . 0.0 114.604 -171.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.742 HD21 ' HD2' ' A' ' 108' ' ' PRO . 22.4 tp -125.41 100.48 32.11 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.342 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.637 ' HA ' ' NE ' ' A' ' 44' ' ' ARG . 2.4 Cg_endo -69.0 -81.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.142 1.894 . . . . 0.0 113.278 -174.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.43 ' HB ' ' HE1' ' A' ' 37' ' ' TRP . 31.5 m -79.91 110.21 15.13 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 27.0 Cg_exo -62.16 108.01 0.63 Allowed 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.898 2.399 . . . . 0.0 112.098 -175.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.742 ' HD2' HD21 ' A' ' 104' ' ' LEU . 97.9 Cg_endo -75.49 62.48 6.26 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.072 2.515 . . . . 0.0 111.569 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.77 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -58.33 -35.47 71.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.383 0.611 . . . . 0.0 110.24 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.33 -7.79 27.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.945 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.45 -21.53 10.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -175.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.77 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -131.76 19.56 4.64 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -168.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.1 m -69.8 89.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 122.412 1.101 . . . . 0.0 109.753 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.4 p30 160.94 -16.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 112.723 -2.035 . . . . 0.0 107.752 -172.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 172.2 -92.46 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.341 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.537 ' OG1' HG22 ' A' ' 69' ' ' THR . 0.6 OUTLIER -161.44 176.41 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 122.894 0.477 . . . . 0.0 110.245 -173.664 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.688 HG13 ' HD2' ' A' ' 112' ' ' TYR . 2.9 m -104.94 119.03 53.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.485 -173.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -104.14 112.45 25.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.565 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -133.52 154.3 50.95 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.631 -174.311 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.651 HG23 HG21 ' A' ' 82' ' ' VAL . 62.5 m -109.23 123.3 49.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.772 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.565 ' HG ' HD12 ' A' ' 119' ' ' LEU . 65.1 mt -129.91 128.38 22.89 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.366 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.2 Cg_exo -73.45 119.36 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.647 1.565 . . . . 0.0 110.385 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.736 HG21 HG11 ' A' ' 98' ' ' VAL . 19.4 pt -95.42 126.04 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -114.94 121.54 43.48 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.26 -176.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.525 ' CE1' ' HB ' ' A' ' 94' ' ' ILE . 75.7 m-85 -113.25 120.03 39.77 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 159.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.9 m -56.43 103.66 0.11 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.118 0.485 . . . . 0.0 111.381 -168.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.754 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.1 mt -70.78 94.87 1.07 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.451 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 . . . . . 0 N--CA 1.442 -0.848 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.645 -179.756 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.587 ' O ' HG13 ' A' ' 41' ' ' ILE . 8.7 p-90 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HA ' HD12 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -69.16 -36.05 76.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.374 0.534 . . . . 0.0 111.666 -174.321 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -33.62 74.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.805 0.812 . . . . 0.0 109.795 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.524 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 27.0 mmm180 -73.0 -32.73 65.33 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.507 175.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 38' ' ' ARG . 62.1 mt -61.04 -39.71 83.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.512 173.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -55.14 -39.94 70.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.835 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.16 -36.5 92.98 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.952 173.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.688 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -69.36 -34.9 75.28 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.374 0.607 . . . . 0.0 110.097 178.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -67.13 -26.76 66.84 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.3 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.631 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 11.6 t30 -70.43 -33.38 71.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.788 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 7.6 ptt180 -60.41 -17.99 47.71 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.018 173.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -109.58 -58.54 2.03 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.495 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -167.88 101.41 0.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.694 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.631 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 17.0 ttp180 -111.55 102.31 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.218 171.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.56 ' HD1' ' HD2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -97.63 117.11 65.7 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.568 -173.452 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.56 ' HD2' ' HD1' ' A' ' 51' ' ' TYR . 52.8 Cg_exo -53.35 131.06 41.46 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.659 2.239 . . . . 0.0 111.65 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.67 -25.2 67.24 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.552 -173.067 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -56.61 -43.26 80.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.046 0.45 . . . . 0.0 110.803 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.18 -30.81 69.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 110.554 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.554 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 3.6 mm? -74.55 -32.94 62.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.524 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.873 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 22.2 mtm180 -62.0 -20.32 63.78 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.748 0.308 . . . . 0.0 111.54 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 mp -107.15 14.84 25.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.65 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.823 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 37.5 ttpt -150.79 -84.61 0.09 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.295 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.823 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 32.3 mmt-85 -122.02 86.27 2.55 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.936 -0.478 . . . . 0.0 111.426 -174.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.873 ' HG2' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -111.68 115.23 28.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.151 0.501 . . . . 0.0 110.448 172.705 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.83 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -146.54 140.05 8.47 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.544 175.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.918 HG12 HD12 ' A' ' 127' ' ' LEU . 7.1 p -103.61 138.14 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.991 0.424 . . . . 0.0 109.915 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.556 ' HA3' ' OG ' ' A' ' 83' ' ' SER . . . -168.02 169.27 41.29 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.684 -176.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 54.0 mt-30 -98.87 141.07 32.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.462 HG12 ' CE2' ' A' ' 68' ' ' PHE . 55.4 t -130.83 114.65 27.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.5 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 21.9 ttm180 -111.71 141.37 45.4 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -174.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CE2' HG12 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -159.22 155.5 27.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.153 0.501 . . . . 0.0 111.605 -176.883 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 48.8 m -98.47 123.92 42.88 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 170.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.461 HD11 ' CE1' ' A' ' 68' ' ' PHE . 73.0 mt -113.42 148.45 35.84 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.145 0.498 . . . . 0.0 112.29 -170.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.662 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 33.4 t70 -92.79 166.68 12.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.627 175.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -53.87 -39.81 66.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -90.12 9.1 29.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.042 0.448 . . . . 0.0 111.164 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 103' ' ' PRO . . . 77.13 47.3 9.34 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.084 -175.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 47.7 t-80 -100.28 100.77 11.63 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.3 p -47.47 115.01 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.763 0.792 . . . . 0.0 111.457 176.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 15.5 mt -98.32 -35.3 10.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.987 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -136.31 143.76 44.33 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.102 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.5 m -119.19 129.46 75.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.035 0.445 . . . . 0.0 110.082 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 69.8 m -130.99 122.23 26.47 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.323 0.582 . . . . 0.0 110.911 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.5 tp -78.96 115.62 18.76 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.783 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -121.64 -25.17 2.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.118 -177.558 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.556 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 7.5 t -48.96 119.54 3.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.913 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -144.35 43.49 1.41 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.428 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.69 13.88 18.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.089 0.471 . . . . 0.0 110.33 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.61 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 81.18 61.1 2.15 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.768 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.762 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.8 OUTLIER -110.84 84.15 4.05 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.495 -179.304 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.61 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 5.7 Cg_exo -78.05 -75.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.677 2.251 . . . . 0.0 112.142 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.3 p -69.29 -18.98 63.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.495 0.664 . . . . 0.0 110.497 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.762 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 28.4 mt -74.62 -39.59 62.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.269 -175.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.532 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 4.8 t70 -53.4 -50.47 65.1 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.585 0.553 . . . . 0.0 111.875 -173.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -54.58 -45.65 73.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.63 -53.51 7.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.792 0.329 . . . . 0.0 111.332 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.671 HG12 ' O ' ' A' ' 90' ' ' LEU . 48.1 pt -70.26 -32.45 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -171.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.588 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 25.7 mm-40 -82.48 -30.04 30.18 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.281 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.54 -44.66 81.1 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 170.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.61 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -60.88 -59.42 5.41 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.289 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.754 HG11 HG21 ' A' ' 123' ' ' ILE . 76.2 t -89.94 -49.39 13.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.588 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 38.1 ttmt -66.18 -27.23 67.85 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -172.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.549 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 29.8 tpt180 -91.2 -30.8 16.46 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.492 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.599 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -108.08 67.69 0.68 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.936 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.463 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 5.5 m -96.49 97.96 3.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.226 0.536 . . . . 0.0 110.458 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.688 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 37.5 Cg_endo -104.14 168.56 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.471 3.447 . . . . 0.0 114.599 -173.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.588 HD13 ' HG3' ' A' ' 108' ' ' PRO . 19.9 mt -145.39 122.4 6.15 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.309 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 7.9 Cg_endo -82.39 -47.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.587 2.191 . . . . 0.0 111.664 175.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.0 m -90.27 113.31 56.93 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.742 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.18 108.3 0.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.601 2.2 . . . . 0.0 111.451 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.692 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 94.3 Cg_endo -82.07 51.1 3.67 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.831 2.354 . . . . 0.0 112.901 -173.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.642 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -60.74 -37.7 82.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.284 0.564 . . . . 0.0 109.625 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -75.06 3.71 8.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.875 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.51 -23.44 9.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.777 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.729 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -127.5 18.27 6.91 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.289 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.4 m -70.36 88.32 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 122.198 0.999 . . . . 0.0 109.19 175.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.4 p30 158.58 -12.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 113.284 -1.78 . . . . 0.0 108.645 -170.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.13 -87.08 0.1 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.449 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.436 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.7 OUTLIER -160.23 175.39 12.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -175.647 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.729 HG13 ' HB3' ' A' ' 112' ' ' TYR . 5.7 m -103.22 107.94 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -109.82 110.06 20.93 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 170.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.523 HD12 ' HG ' ' A' ' 121' ' ' LEU . 1.4 pp -143.46 146.36 33.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.875 0.369 . . . . 0.0 110.308 -174.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 65' ' ' GLN . 86.2 m -93.98 117.08 29.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.191 -177.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.523 ' HG ' HD12 ' A' ' 119' ' ' LEU . 46.9 mt -111.13 122.87 36.66 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.5 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 4.7 Cg_exo -74.08 119.14 5.69 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.885 1.723 . . . . 0.0 110.617 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.754 HG21 HG11 ' A' ' 98' ' ' VAL . 18.7 pt -98.34 118.26 44.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.499 ' HA ' HG23 ' A' ' 63' ' ' VAL . 12.6 t70 -108.03 122.23 46.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.719 0.771 . . . . 0.0 112.087 -172.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.481 ' CE2' ' HG ' ' A' ' 56' ' ' LEU . 34.3 m-85 -115.9 142.04 47.3 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 162.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m -67.8 103.04 1.33 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.603 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.918 HD12 HG12 ' A' ' 63' ' ' VAL . 2.0 mt -77.97 81.49 4.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.461 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 . . . . . 0 N--CA 1.44 -0.927 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.475 -179.646 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.557 ' CZ2' HD21 ' A' ' 121' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.637 0.256 . . . . 0.0 111.364 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -68.87 -30.6 69.15 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.117 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.6 p -62.41 -40.01 95.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.075 176.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.462 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 16.2 mmm180 -73.64 -39.65 64.34 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.707 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.663 HG23 ' HD2' ' A' ' 103' ' ' PRO . 79.4 mt -60.36 -50.49 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.173 176.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 m -58.51 -43.26 89.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.841 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.14 -36.32 93.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.86 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.633 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 11.4 ttt-85 -69.16 -32.02 71.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 120.851 0.358 . . . . 0.0 110.328 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.846 ' HB3' ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -62.99 -31.46 72.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.207 0.527 . . . . 0.0 109.966 178.532 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.746 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 26.7 t-20 -71.74 -35.19 70.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.61 174.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 68.3 ttt180 -67.09 -26.65 66.83 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.608 175.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -92.03 7.58 41.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.564 172.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? 67.99 102.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.263 -175.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.846 ' HD2' ' HB3' ' A' ' 45' ' ' LEU . 4.6 ptm180 -118.17 130.31 56.03 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.402 ' HB3' HD21 ' A' ' 56' ' ' LEU . 16.9 t80 -60.91 132.3 91.93 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.39 129.86 13.82 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.55 2.833 . . . . 0.0 112.301 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.821 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -64.53 -20.9 66.5 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.795 -172.442 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -52.6 -41.25 63.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.669 0.271 . . . . 0.0 111.08 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.89 -36.14 59.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.761 0.315 . . . . 0.0 111.338 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 93' ' ' GLU . 3.5 mm? -74.23 -43.04 58.64 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.308 -175.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -76.07 -15.42 60.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.973 0.416 . . . . 0.0 111.358 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.9 tp -86.23 -9.73 55.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.674 0.749 . . . . 0.0 109.266 174.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.87 ' HD2' ' HG2' ' A' ' 93' ' ' GLU . 23.2 ttmm -115.03 -57.76 2.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.47 -173.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.774 ' HG3' ' HB2' ' A' ' 93' ' ' GLU . 30.1 mmt180 -127.08 122.45 34.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.784 -175.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -126.41 114.57 18.37 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 1.011 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -149.7 143.09 10.36 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.961 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.583 ' H ' HD12 ' A' ' 127' ' ' LEU . 5.3 p -104.43 127.64 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.027 0.441 . . . . 0.0 109.947 176.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.39 167.51 32.98 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.465 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 82' ' ' VAL . 80.9 mm-40 -101.86 131.54 48.14 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.8 t -126.6 114.18 36.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.204 0.526 . . . . 0.0 110.339 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 27.0 ttm180 -101.32 141.89 33.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -157.71 152.42 25.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.989 0.423 . . . . 0.0 111.299 -178.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.764 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 9.4 m -101.64 127.31 48.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.641 173.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.719 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 28.2 mt -119.5 135.4 54.79 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.1 -172.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.431 ' HB2' HD21 ' A' ' 77' ' ' LEU . 20.2 t70 -76.07 152.77 36.76 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.896 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -55.06 -26.64 39.03 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 123.4 0.437 . . . . 0.0 111.787 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -84.31 -1.79 55.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 110.687 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.8 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 88.45 23.71 36.0 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.851 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.425 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 58.3 t-80 -95.92 117.48 30.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.494 0.188 . . . . 0.0 110.553 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -48.99 120.42 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.374 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 71' ' ' ASP . 55.7 mt -109.77 -51.26 2.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.713 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -132.42 154.78 49.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.392 -177.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.967 HG11 ' HG3' ' A' ' 99' ' ' LYS . 57.9 t -139.82 122.99 17.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 44.0 m -119.22 105.94 11.86 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.9 tp -68.24 110.79 4.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.55 0.69 . . . . 0.0 110.664 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.686 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -99.3 -52.83 8.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.929 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.543 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 23.1 t 65.7 177.91 0.21 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.203 172.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.528 ' OG ' ' HG2' ' A' ' 65' ' ' GLN . 50.3 m -139.17 -69.7 0.42 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.097 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.36 -75.83 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.504 ' C ' ' HD3' ' A' ' 88' ' ' PRO . . . -176.9 97.51 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.329 -175.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -120.56 68.55 15.09 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 178.243 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 3.6 Cg_exo -77.81 -66.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.386 2.057 . . . . 0.0 112.139 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.6 t -73.11 -18.63 61.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.689 0.757 . . . . 0.0 109.78 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.712 HD12 ' HA ' ' A' ' 87' ' ' LEU . 32.8 mt -76.02 -30.74 58.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.576 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.52 -45.88 69.9 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.808 0.693 . . . . 0.0 111.896 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.583 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 8.5 ptp180 -53.01 -51.09 62.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -172.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.87 ' HG2' ' HD2' ' A' ' 59' ' ' LYS . 1.7 mp0 -77.04 -55.39 5.5 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 90' ' ' LEU . 22.2 pt -69.88 -32.82 53.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 111.386 -172.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.807 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 75.1 mm-40 -83.49 -18.32 38.92 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.507 176.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -54.73 -55.23 32.09 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.851 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.664 HD23 HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -75.75 -52.43 10.48 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.031 177.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.725 HG11 HG21 ' A' ' 123' ' ' ILE . 91.3 t -65.44 -49.43 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.967 ' HG3' HG11 ' A' ' 79' ' ' VAL . 40.4 ttmt -74.61 -29.24 61.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.556 0.217 . . . . 0.0 110.906 -172.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.584 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -78.11 -42.13 32.92 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.828 176.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.556 ' HB2' HH11 ' A' ' 100' ' ' ARG . . . -117.11 73.98 0.89 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.692 0.282 . . . . 0.0 111.663 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.7 m -82.96 108.71 13.4 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.105 0.479 . . . . 0.0 110.35 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.663 ' HD2' HG23 ' A' ' 41' ' ' ILE . 16.2 Cg_endo -97.12 139.08 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.23 3.287 . . . . 0.0 113.947 -175.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.8 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 40.3 tp -116.31 91.51 33.14 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 174.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.462 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 53.1 Cg_endo -79.45 -39.35 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.293 1.995 . . . . 0.0 113.603 -174.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.425 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.5 m -102.9 110.81 64.24 Favored Pre-proline 0 C--N 1.319 -0.761 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.92 107.77 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.242 2.628 . . . . 0.0 112.954 -175.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.731 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 48.9 Cg_endo -89.8 66.57 2.12 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.299 2.666 . . . . 0.0 111.659 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.818 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.1 -41.29 78.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.416 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -73.46 1.44 9.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.859 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.731 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -110.89 -27.97 8.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.691 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.818 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -105.16 16.31 25.99 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.5 m -72.27 87.89 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 11.3 p-10 157.18 -9.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.417 -171.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.68 -80.16 0.2 Allowed Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.063 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.489 ' C ' ' HB3' ' A' ' 112' ' ' TYR . 1.0 OUTLIER -156.42 176.17 13.05 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.764 ' O ' ' HA ' ' A' ' 69' ' ' THR . 6.6 m -99.26 106.22 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 119.676 1.125 . . . . 0.0 110.259 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -105.52 109.22 21.12 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 168.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.688 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -139.73 147.45 40.9 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.493 -172.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.686 HG23 HG21 ' A' ' 82' ' ' VAL . 36.3 m -94.43 113.65 25.54 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.778 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.688 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 35.0 mt -114.73 126.8 27.47 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.992 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 6.2 Cg_exo -75.29 118.78 5.31 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 121.401 1.401 . . . . 0.0 110.636 177.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.725 HG21 HG11 ' A' ' 98' ' ' VAL . 32.5 pt -93.3 97.1 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -99.03 121.88 41.55 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 122.302 1.048 . . . . 0.0 112.041 -171.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.446 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 84.9 m-85 -114.74 142.83 45.99 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.754 -1.567 . . . . 0.0 107.057 165.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.1 m -65.56 103.35 0.84 Allowed 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.246 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 1.011 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -75.42 61.8 1.29 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.791 -176.567 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 . . . . . 0 N--CA 1.447 -0.581 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.454 179.69 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.473 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.227 -0.126 0 CA-C-O 120.665 0.269 . . . . 0.0 111.078 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -33.87 75.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.666 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.1 m -67.08 -35.87 80.76 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 18.2 mmt180 -70.65 -42.01 71.39 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.918 177.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.683 HG23 ' HG2' ' A' ' 103' ' ' PRO . 92.2 mt -59.65 -44.06 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.2 177.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.9 t -55.68 -37.62 68.56 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.801 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -69.46 -37.63 79.07 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.081 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.64 -34.11 73.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.154 0.502 . . . . 0.0 110.634 178.209 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.607 HD11 HG13 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -68.27 -26.9 65.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.641 0.734 . . . . 0.0 109.526 177.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.689 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 5.9 t30 -70.28 -35.1 73.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.258 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.55 -29.86 59.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.624 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -96.29 -59.33 1.86 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.515 178.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -158.53 119.31 3.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.121 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.689 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -136.07 102.61 5.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.404 0.621 . . . . 0.0 110.275 174.59 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.508 ' HB3' HD21 ' A' ' 56' ' ' LEU . 3.1 t80 -86.53 132.09 43.8 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.848 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.32 130.19 36.48 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 122.741 2.294 . . . . 0.0 112.363 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.577 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -60.81 -29.39 69.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.354 -170.521 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.78 -33.82 70.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 0.0 110.316 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.79 -39.14 61.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.293 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.4 mm? -64.53 -40.97 96.6 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.743 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.478 ' HD3' HH11 ' A' ' 128' ' ' ARG . 60.5 mtt180 -59.07 -22.71 61.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.867 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.7 mt -102.43 -8.67 20.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.793 0.33 . . . . 0.0 110.964 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -112.51 -68.77 0.91 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.827 -176.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.656 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 6.0 ppt_? -155.01 142.9 20.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.062 0.458 . . . . 0.0 110.888 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.519 ' O ' HD22 ' A' ' 90' ' ' LEU . 13.0 mm100 -138.5 177.74 7.66 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 1.043 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.22 146.75 4.42 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.52 -1.324 . . . . 0.0 113.989 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.3 t -106.35 124.16 61.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.28 163.31 26.4 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.699 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 82' ' ' VAL . 85.0 mt-30 -106.45 125.87 51.54 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 121' ' ' LEU . 12.1 p -123.85 125.0 70.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.64 -170.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -113.47 134.96 54.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.838 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.7 OUTLIER -157.11 158.13 35.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.955 0.407 . . . . 0.0 111.694 -175.325 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.597 ' CG2' ' HB ' ' A' ' 116' ' ' THR . 26.6 m -99.37 134.21 42.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.229 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.52 HD13 ' HB2' ' A' ' 104' ' ' LEU . 75.7 mt -117.01 142.97 46.28 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.573 0.545 . . . . 0.0 111.255 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -97.43 169.83 9.47 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.874 175.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -50.81 -42.61 58.38 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -94.37 24.3 4.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.728 0.299 . . . . 0.0 111.48 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.681 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 68.11 47.77 57.31 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.185 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 55.9 t-80 -100.51 117.43 34.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 p -48.88 122.9 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 123.816 0.697 . . . . 0.0 110.913 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 88.6 mt -116.71 -44.99 2.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.35 158.13 40.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 99' ' ' LYS . 13.4 m -145.32 117.28 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.533 0.521 . . . . 0.0 110.178 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.2 m -141.7 131.93 24.92 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.864 0.364 . . . . 0.0 111.249 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.7 tp -83.63 120.0 25.44 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.619 HG21 HG23 ' A' ' 120' ' ' THR . 0.1 OUTLIER -95.9 -58.74 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.345 -175.282 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.9 m -141.84 113.36 7.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.921 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.5 t -107.08 117.14 33.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.21 -46.82 66.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.496 -175.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.691 ' H ' HD22 ' A' ' 87' ' ' LEU . . . -176.35 58.91 0.1 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.913 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.891 ' HA ' HD12 ' A' ' 90' ' ' LEU . 1.6 mm? -118.05 89.61 35.07 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.33 -83.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.23 1.953 . . . . 0.0 111.338 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 3.5 m -67.41 -17.92 64.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.674 0.75 . . . . 0.0 110.104 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.891 HD12 ' HA ' ' A' ' 87' ' ' LEU . 8.0 mt -75.5 -33.49 60.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.215 -175.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 13.6 t70 -54.87 -49.69 70.53 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.76 0.662 . . . . 0.0 111.371 -173.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 89' ' ' SER . 5.0 ptp180 -53.86 -50.53 66.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.094 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 20.7 tt0 -77.99 -42.06 33.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -173.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.565 HG13 ' HG2' ' A' ' 95' ' ' GLN . 30.3 pt -60.63 -40.68 85.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.885 -177.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.672 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 50.1 mm-40 -82.39 -30.52 30.18 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.957 0.408 . . . . 0.0 110.94 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.92 -52.31 64.57 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.923 173.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.777 HD23 HG23 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -62.2 -56.58 17.21 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.949 -178.684 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.958 HG11 HG21 ' A' ' 123' ' ' ILE . 58.5 t -88.14 -50.54 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -176.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.672 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 35.6 ttmt -63.7 -38.8 92.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.409 0.151 . . . . 0.0 111.409 -172.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -79.23 -16.85 55.88 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.662 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.37 53.09 0.77 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.474 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 51.0 m -65.45 107.4 1.45 Allowed Pre-proline 0 C--O 1.234 0.279 0 O-C-N 123.514 0.509 . . . . 0.0 110.79 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.683 ' HG2' HG23 ' A' ' 41' ' ' ILE . 50.2 Cg_endo -101.79 154.87 0.35 Allowed 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 123.847 3.032 . . . . 0.0 114.002 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.681 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 2.1 tp -142.57 107.63 5.55 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.141 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HB3' HH11 ' A' ' 44' ' ' ARG . 4.0 Cg_exo -75.0 -56.94 0.06 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.22 1.947 . . . . 0.0 112.435 178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.496 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 10.6 m -90.2 110.36 39.94 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.684 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.529 ' HA ' HD21 ' A' ' 104' ' ' LEU . 42.2 Cg_endo -68.64 107.13 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.942 2.428 . . . . 0.0 112.16 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.884 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 51.1 Cg_endo -87.88 71.3 2.93 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.018 2.478 . . . . 0.0 111.754 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.647 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -56.29 -46.56 79.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.93 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -76.09 7.82 3.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.796 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.884 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.17 -23.26 10.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.485 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.705 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -122.01 16.68 10.85 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -177.738 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.7 m -71.65 89.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.971 0.891 . . . . 0.0 108.954 172.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 3.5 p30 161.61 -28.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.082 -169.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 175.7 -89.4 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.111 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.651 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -161.6 175.56 11.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.705 HG13 ' HB3' ' A' ' 112' ' ' TYR . 11.5 m -102.85 109.31 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.313 0.578 . . . . 0.0 110.98 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 43.2 tt0 -111.93 111.62 22.68 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 170.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.569 HD12 ' HG ' ' A' ' 121' ' ' LEU . 3.8 pp -137.01 155.11 50.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.162 -175.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.619 HG23 HG21 ' A' ' 82' ' ' VAL . 86.4 m -95.11 125.45 39.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.374 -176.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' A' ' 119' ' ' LEU . 77.9 mt -125.74 131.4 24.0 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.093 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 6.4 Cg_exo -74.47 121.43 6.77 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.071 1.847 . . . . 0.0 111.369 175.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.958 HG21 HG11 ' A' ' 98' ' ' VAL . 3.1 pt -96.25 98.31 7.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -94.04 121.11 35.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.892 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 80.4 m-85 -116.93 128.89 55.66 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 163.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 m -63.59 102.92 0.48 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.719 0.295 . . . . 0.0 111.022 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 1.043 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 5.0 mt -64.12 103.84 0.66 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.259 0.552 . . . . 0.0 111.551 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.478 HH11 ' HD3' ' A' ' 57' ' ' ARG . 64.5 mtp180 . . . . . 0 N--CA 1.448 -0.53 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.071 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.459 ' O ' HG13 ' A' ' 41' ' ' ILE . 12.0 p-90 . . . . . 0 N--CA 1.455 -0.175 0 N-CA-C 111.329 0.122 . . . . 0.0 111.329 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.545 ' HD3' ' N ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -69.2 -25.4 64.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.243 0.544 . . . . 0.0 110.125 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.545 ' N ' ' HD3' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -71.95 -34.58 69.12 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.509 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.519 ' CB ' ' HG2' ' A' ' 105' ' ' PRO . 34.1 mmt180 -74.24 -36.12 63.87 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.377 175.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.624 HG23 ' HD2' ' A' ' 103' ' ' PRO . 61.8 mt -57.32 -47.22 84.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.713 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.1 m -56.23 -35.13 67.0 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.011 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.23 -52.35 47.93 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.386 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.769 ' HD3' ' HB2' ' A' ' 103' ' ' PRO . 9.4 ptp180 -70.08 -27.46 64.63 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.538 -0.39 . . . . 0.0 111.731 175.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tt -54.25 -38.1 65.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -71.08 -31.67 68.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.297 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HB3' ' HA ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -53.16 -26.64 17.78 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.382 173.129 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -101.75 -57.16 2.13 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.479 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.537 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 4.2 mtpp -172.76 102.8 0.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.097 -177.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -144.69 104.56 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.203 0.525 . . . . 0.0 110.26 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.522 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.5 t80 -96.47 144.5 27.95 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.299 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -53.05 133.59 52.62 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.101 2.534 . . . . 0.0 112.397 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.545 ' HE2' ' HE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -62.02 -21.13 64.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.633 -171.82 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -53.07 -37.57 61.74 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.452 0.47 . . . . 0.0 110.827 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.71 -38.97 53.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.637 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.757 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.6 mm? -69.41 -41.54 76.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.068 -173.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.597 ' HA ' ' HG3' ' A' ' 61' ' ' GLN . 7.8 ptp85 -67.16 -8.88 34.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.14 0.495 . . . . 0.0 110.851 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 47.0 tp -118.93 12.81 12.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.262 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.698 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 25.3 ttmm -154.47 -67.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.693 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.82 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 36.6 mmt180 -119.98 84.53 2.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.675 0.274 . . . . 0.0 110.308 -177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.597 ' HG3' ' HA ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -86.15 177.65 7.46 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.622 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.52 122.42 0.94 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.244 -1.455 . . . . 0.0 113.787 176.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -110.82 124.48 67.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.34 166.6 33.23 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.825 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.483 ' O ' HG23 ' A' ' 82' ' ' VAL . 2.7 mp0 -102.12 124.38 47.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 178.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.408 HG21 HD13 ' A' ' 123' ' ' ILE . 76.2 t -119.73 114.23 43.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.293 -173.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HB2' HG21 ' A' ' 82' ' ' VAL . 26.7 ttt180 -115.03 124.71 52.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.748 -174.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -148.13 163.85 35.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.306 0.574 . . . . 0.0 112.136 -174.143 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 40.9 m -105.2 131.99 51.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.014 174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 104' ' ' LEU . 86.8 mt -118.76 142.0 48.1 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -172.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.587 ' OD1' ' HG2' ' A' ' 73' ' ' GLN . 13.8 t70 -89.58 160.18 16.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.244 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.582 ' HG2' ' N ' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -58.47 -32.09 68.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.687 0.279 . . . . 0.0 111.322 -177.53 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.587 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 25.4 pt20 -94.04 14.51 19.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.204 0.526 . . . . 0.0 111.246 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.47 ' HA2' ' H ' ' A' ' 104' ' ' LEU . . . 78.01 33.8 39.94 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.248 177.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.484 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 52.0 t-80 -97.1 101.88 13.54 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.44 122.26 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 121.388 0.614 . . . . 0.0 110.92 173.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 15.2 mt -108.21 -40.79 5.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.437 -175.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.5 158.43 39.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.27 117.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.167 0.508 . . . . 0.0 109.997 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.7 m -140.58 120.93 14.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.917 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 29.3 tp -81.41 106.37 13.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -82.22 -44.64 19.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.894 -170.668 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.1 m -155.41 155.14 33.05 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.372 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.494 ' HB2' ' CD2' ' A' ' 87' ' ' LEU . 53.4 p -163.34 147.44 10.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.85 0.357 . . . . 0.0 110.944 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.5 -9.38 58.87 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -173.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.41 ' C ' HD13 ' A' ' 87' ' ' LEU . . . 120.67 73.13 0.34 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.176 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.916 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -114.4 96.62 43.65 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -177.373 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.67 -83.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.75 2.3 . . . . 0.0 111.888 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 m -66.15 -18.29 65.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.63 0.728 . . . . 0.0 110.107 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.916 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 20.4 mt -75.78 -39.28 57.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.056 -176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.42 -50.93 68.51 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -169.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.564 ' HD2' ' H ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -61.63 -36.13 79.88 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.005 -171.43 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.82 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 8.8 tp10 -76.59 -52.64 9.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 90' ' ' LEU . 39.9 pt -65.11 -35.02 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.565 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 69.9 mm-40 -81.81 -28.68 33.0 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.678 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -57.45 -48.22 79.75 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.576 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -61.81 -58.16 9.04 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.216 -178.434 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.813 HG11 HG21 ' A' ' 123' ' ' ILE . 91.6 t -89.22 -50.05 13.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 8.9 ttpp -70.7 -24.99 62.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -170.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.595 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 9.6 tpp180 -90.99 -24.98 19.93 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.061 174.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.61 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -114.04 73.41 0.82 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.312 -178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.8 m -108.43 95.02 14.82 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.392 0.615 . . . . 0.0 110.59 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.769 ' HB2' ' HD3' ' A' ' 44' ' ' ARG . 61.1 Cg_endo -112.51 110.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 124.723 3.615 . . . . 0.0 114.04 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.674 HD23 ' HD2' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -86.32 123.42 71.44 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 171.055 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.674 ' HD2' HD23 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -80.6 -57.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.73 2.287 . . . . 0.0 112.751 -177.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -63.43 116.24 24.19 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.37 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.52 106.02 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.106 2.537 . . . . 0.0 112.171 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.67 ' HG3' HD13 ' A' ' 104' ' ' LEU . 63.7 Cg_endo -94.64 45.77 0.21 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.995 2.463 . . . . 0.0 112.82 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.605 ' O ' HG13 ' A' ' 113' ' ' VAL . . . -57.17 -41.51 79.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 109.91 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.03 -18.27 63.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.355 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.84 -29.45 22.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.779 -177.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.908 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -121.43 19.15 11.34 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -171.032 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.5 m -69.15 89.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 122.092 0.949 . . . . 0.0 108.947 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 7.0 p30 161.67 -18.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.943 -169.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.7 -87.82 0.1 Allowed Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.113 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.622 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -162.36 176.09 10.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.851 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.908 HG13 ' HB3' ' A' ' 112' ' ' TYR . 12.6 m -102.21 109.49 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 121.541 0.686 . . . . 0.0 110.719 -175.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 25.8 tt0 -107.96 110.94 22.8 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 173.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.598 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -141.04 155.26 46.2 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -174.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 50.6 m -98.74 122.75 42.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.147 0.499 . . . . 0.0 111.264 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.598 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 47.8 mt -118.22 123.88 29.07 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.993 174.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 5.2 Cg_exo -73.3 119.72 6.15 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.311 2.007 . . . . 0.0 111.241 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.813 HG21 HG11 ' A' ' 98' ' ' VAL . 32.0 pt -99.17 101.9 12.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -104.3 122.44 45.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.224 1.011 . . . . 0.0 111.722 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.622 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 85.4 m-85 -114.13 129.74 56.61 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.865 -1.516 . . . . 0.0 106.94 165.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.3 m -57.63 103.2 0.12 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.153 0.502 . . . . 0.0 111.979 -169.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.821 HD11 HD11 ' A' ' 87' ' ' LEU . 13.3 mt -80.46 82.15 6.55 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.771 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.803 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.521 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.626 ' HA ' ' HG2' ' A' ' 40' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HG3' ' N ' ' A' ' 39' ' ' SER . 2.1 ptp180 -67.84 -32.68 73.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.202 0.91 . . . . 0.0 109.872 -176.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.404 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 3.3 p -66.53 -36.44 82.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.938 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.626 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 10.2 mmt180 -69.52 -44.62 70.66 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.575 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.673 HG23 ' HG2' ' A' ' 103' ' ' PRO . 83.8 mt -63.68 -43.86 98.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.585 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.8 m -57.25 -33.58 67.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.946 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.63 -34.67 73.21 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.682 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.793 ' HD3' ' HB3' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -70.75 -40.31 72.77 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 121.279 0.561 . . . . 0.0 110.151 178.1 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.05 -25.77 64.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.75 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.975 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 24.4 t-20 -69.3 -33.99 74.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.986 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.44 -20.45 63.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.949 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.474 ' CD2' ' HB1' ' A' ' 101' ' ' ALA . 97.3 m-85 -106.71 -60.28 1.69 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.615 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -164.99 102.93 0.77 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.548 0.739 . . . . 0.0 109.037 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.975 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 24.6 tpt180 -113.54 103.15 10.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.527 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 0.9 OUTLIER -105.45 132.31 20.99 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.525 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 32.4 Cg_exo -58.97 132.1 45.55 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.824 2.349 . . . . 0.0 111.721 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.495 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -61.19 -23.14 65.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.958 -173.4 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.72 -40.21 83.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.565 0.222 . . . . 0.0 110.853 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.0 -33.65 75.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.113 0.483 . . . . 0.0 110.475 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -72.65 -41.56 65.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 57' ' ' ARG . 49.5 mtm180 -58.07 -31.07 66.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.012 0.434 . . . . 0.0 110.422 176.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.9 tp -93.85 -0.49 55.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.951 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.781 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 24.5 ttmm -142.04 -75.42 0.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -175.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.781 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 26.3 mmt180 -119.79 89.78 3.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.901 0.381 . . . . 0.0 110.427 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.407 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.2 pt20 -92.14 179.17 5.65 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.521 177.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.576 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.26 124.05 1.05 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.169 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.725 ' H ' HD12 ' A' ' 127' ' ' LEU . 7.3 p -110.36 127.05 67.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.44 167.07 36.16 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.727 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.672 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 50.3 mt-30 -102.3 125.11 48.91 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 123' ' ' ILE . 24.3 t -121.47 114.42 43.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.712 -176.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.691 ' HG2' HG22 ' A' ' 82' ' ' VAL . 5.9 ptp180 -106.19 144.17 33.28 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -152.91 152.0 30.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.094 0.473 . . . . 0.0 111.853 -174.172 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 22.5 m -96.41 126.94 41.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.371 171.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.685 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 58.7 mt -117.8 135.76 53.85 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.203 0.525 . . . . 0.0 112.069 -169.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.611 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 15.4 t70 -77.27 152.51 34.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.476 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.3 ttp-105 -60.98 -25.28 66.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.119 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -89.61 -1.43 58.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.968 0.413 . . . . 0.0 111.012 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.96 36.88 6.53 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.04 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.611 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 28.1 t-80 -104.3 120.96 42.34 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 p -53.81 117.27 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.313 0.578 . . . . 0.0 111.07 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.2 mt -101.86 -37.46 8.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.477 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -146.89 152.97 39.56 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.66 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.0 m -147.24 132.37 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 123.45 0.469 . . . . 0.0 109.836 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -144.28 132.67 22.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.37 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.724 HD21 ' HB2' ' A' ' 84' ' ' SER . 37.3 tp -75.5 120.88 21.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.732 HG21 HG23 ' A' ' 120' ' ' THR . 0.2 OUTLIER -96.67 -47.63 12.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.899 -173.645 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -142.26 145.46 34.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.346 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.724 ' HB2' HD21 ' A' ' 81' ' ' LEU . 40.7 t -137.8 148.61 45.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.023 0.44 . . . . 0.0 111.212 -176.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.58 15.32 25.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.219 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.81 76.02 1.31 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.173 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.733 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -116.51 71.11 4.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.803 0.302 . . . . 0.0 110.295 178.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.85 -68.36 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 121.804 1.669 . . . . 0.0 112.482 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 7.9 m -72.08 -18.69 61.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.233 0.54 . . . . 0.0 110.035 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.733 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 26.2 mt -77.32 -32.35 55.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.145 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.552 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 7.3 t70 -53.39 -37.95 62.94 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.4 0.438 . . . . 0.0 111.88 -173.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 13.6 ptm180 -53.57 -54.79 32.45 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -78.53 -55.12 5.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.572 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.525 HG13 ' HG2' ' A' ' 95' ' ' GLN . 40.0 pt -60.21 -38.88 78.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.646 -172.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.729 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 76.0 mm-40 -84.58 -20.86 30.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.603 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 92' ' ' ARG . . . -55.1 -54.1 47.45 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.163 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.608 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.77 -48.72 17.82 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.06 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.835 HG11 HG21 ' A' ' 123' ' ' ILE . 55.8 t -70.26 -50.18 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.729 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.3 ttmt -75.88 -32.1 59.53 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.318 -0.239 . . . . 0.0 111.361 -171.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 100' ' ' ARG . 8.3 tpp180 -89.16 -18.8 26.42 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.052 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 97' ' ' LEU . . . -120.24 56.4 0.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.603 0.24 . . . . 0.0 111.098 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 19.4 m -80.52 106.75 5.73 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.114 0.483 . . . . 0.0 110.112 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.683 ' CB ' ' HB3' ' A' ' 44' ' ' ARG . 62.9 Cg_endo -101.78 165.1 0.33 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 124.038 3.159 . . . . 0.0 114.486 -171.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 33.2 tp -142.08 94.25 7.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.159 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.793 ' HB3' ' HD3' ' A' ' 44' ' ' ARG . 50.5 Cg_endo -77.25 -49.7 0.1 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.442 2.095 . . . . 0.0 113.665 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 22.3 m -88.58 110.45 37.03 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.01 107.68 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.112 2.542 . . . . 0.0 112.451 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.729 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 52.1 Cg_endo -89.15 59.99 2.31 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.135 2.557 . . . . 0.0 111.853 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.662 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.05 -47.05 75.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.165 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.2 10.0 2.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.433 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -112.12 -30.39 7.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.932 0.396 . . . . 0.0 111.616 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.662 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -121.16 18.41 11.58 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.402 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -70.59 88.3 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.212 1.006 . . . . 0.0 108.446 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.8 p30 158.92 -15.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 113.116 -1.856 . . . . 0.0 108.383 -168.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.91 -90.84 0.1 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.175 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.432 ' CA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -161.06 177.03 10.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -175.151 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 69' ' ' THR . 12.9 m -102.75 109.88 27.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.467 0.651 . . . . 0.0 110.861 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 24.7 tt0 -109.35 109.99 21.02 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.73 HD12 ' HG ' ' A' ' 121' ' ' LEU . 1.5 pp -135.12 152.37 51.58 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.656 -173.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.732 HG23 HG21 ' A' ' 82' ' ' VAL . 87.9 m -96.72 113.44 25.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.212 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.73 ' HG ' HD12 ' A' ' 119' ' ' LEU . 62.5 mt -119.48 122.94 28.97 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.965 0.412 . . . . 0.0 110.711 177.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 12.0 Cg_exo -70.65 119.19 6.14 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.709 1.606 . . . . 0.0 110.554 174.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.835 HG21 HG11 ' A' ' 98' ' ' VAL . 35.1 pt -93.98 118.77 40.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -107.47 120.31 41.83 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 118.821 -1.151 . . . . 0.0 112.35 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.532 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 37.9 m-85 -115.65 126.69 54.46 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 160.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.0 m -56.54 104.01 0.13 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.242 0.544 . . . . 0.0 111.052 -172.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.725 HD12 ' H ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -100.6 105.46 16.86 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.854 -171.379 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 128' ' ' ARG . 38.6 mtp-105 . . . . . 0 N--CA 1.441 -0.878 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.45 ' HD2' ' N ' ' A' ' 39' ' ' SER . 7.5 ppt_? -68.12 -31.02 70.32 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -168.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.45 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 32.2 m -69.16 -32.52 71.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 0.0 109.823 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -75.86 -44.49 40.48 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.75 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.417 HG23 ' HD2' ' A' ' 103' ' ' PRO . 86.5 mt -58.77 -43.45 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.937 177.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 t -57.43 -38.8 74.98 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.882 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.13 -42.25 96.6 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.843 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.517 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.38 -33.77 73.54 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.803 0.335 . . . . 0.0 110.72 178.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.568 HD11 HG22 ' A' ' 98' ' ' VAL . 2.1 tt -62.15 -31.93 72.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.398 0.618 . . . . 0.0 109.832 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.728 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 8.7 t30 -71.69 -34.26 69.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.797 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -29.64 58.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.682 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.516 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 98.8 m-85 -94.73 -59.22 1.97 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.78 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 34.1 mmtt -174.82 104.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.622 0.769 . . . . 0.0 109.488 -177.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.728 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 29.1 ttp180 -128.28 103.91 7.43 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.485 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -81.41 138.17 48.29 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.382 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -49.87 131.53 29.83 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.132 2.555 . . . . 0.0 111.961 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.757 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -63.96 -23.68 67.43 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -170.495 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -58.76 -38.58 78.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.652 0.263 . . . . 0.0 111.069 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.03 -30.74 70.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.787 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.1 mm? -77.25 -41.47 40.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.918 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 41.0 mtm180 -62.85 -23.04 67.11 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.381 0.61 . . . . 0.0 110.5 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 tp -102.09 4.04 39.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.753 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.544 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 40.3 ttpt -149.71 -75.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.544 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 26.2 mmt180 -99.03 84.27 3.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.453 0.644 . . . . 0.0 110.742 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 126' ' ' SER . 10.7 pt20 -104.95 127.78 52.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.948 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 1.002 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -179.55 129.77 1.41 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.268 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.887 ' H ' HD12 ' A' ' 127' ' ' LEU . 96.2 t -104.96 127.17 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.119 0.485 . . . . 0.0 110.238 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.85 166.61 30.92 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.662 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 56.0 mt-30 -101.02 136.82 40.25 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 123' ' ' ILE . 39.0 t -129.5 114.21 30.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.562 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.545 ' HG2' HG22 ' A' ' 82' ' ' VAL . 13.3 ptt180 -115.35 139.38 50.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -154.3 163.37 40.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.655 -171.401 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 2.7 m -106.62 120.74 42.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.887 172.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.519 HD11 ' CE1' ' A' ' 68' ' ' PHE . 73.1 mt -106.48 138.52 42.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.75 -173.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 22.6 t70 -74.71 153.89 38.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.25 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 72' ' ' ARG . 4.2 ttp180 -61.05 -24.76 66.45 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.281 0.363 . . . . 0.0 111.333 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -80.6 -8.58 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.114 0.483 . . . . 0.0 110.421 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.761 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 89.04 35.42 8.19 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.268 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.455 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 70.8 t60 -109.2 124.61 51.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.665 0.269 . . . . 0.0 110.557 -178.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -51.86 125.31 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.558 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.519 ' CD1' HG21 ' A' ' 116' ' ' THR . 35.3 mt -115.18 -51.29 2.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.235 0.54 . . . . 0.0 110.558 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.37 152.42 49.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.379 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.4 m -146.37 128.94 8.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.137 0.494 . . . . 0.0 110.208 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.1 m -134.68 123.95 24.52 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.585 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.9 tp -76.72 108.43 9.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.294 0.569 . . . . 0.0 110.299 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.668 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -83.35 -42.26 17.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.982 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.424 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 23.1 t 66.93 176.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.904 169.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.427 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 68.7 m -158.63 -67.74 0.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.979 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.23 -76.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.4 ' C ' HD13 ' A' ' 87' ' ' LEU . . . 166.41 98.83 0.13 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.343 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.798 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -119.67 82.47 26.53 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -177.483 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.9 -75.28 0.01 OUTLIER 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.442 2.095 . . . . 0.0 111.866 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.506 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 8.4 m -70.69 -19.08 62.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.373 0.606 . . . . 0.0 110.197 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.798 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 14.6 mt -75.75 -34.08 60.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.715 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.462 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 1.8 t70 -54.33 -44.01 71.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.299 -175.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 89' ' ' SER . 11.6 ptp180 -53.58 -52.63 59.16 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -172.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 19.3 mt-10 -78.83 -54.21 6.31 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 90' ' ' LEU . 40.7 pt -63.32 -36.96 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.645 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.8 mm-40 -82.21 -26.83 32.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 122.055 -0.403 . . . . 0.0 110.825 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.642 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.85 -44.72 82.43 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.659 HD23 HG23 ' A' ' 98' ' ' VAL . 1.4 tp -68.24 -55.29 12.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.636 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 123' ' ' ILE . 81.3 t -88.75 -48.27 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.645 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 16.4 ttpp -70.33 -15.13 62.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.391 -175.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.642 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 20.3 tpp180 -98.59 -35.14 10.31 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.797 170.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.612 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -101.13 64.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 110.969 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.6 m -93.79 100.82 5.09 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.28 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.612 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 72.3 Cg_endo -101.73 173.78 0.26 Allowed 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.919 3.079 . . . . 0.0 113.689 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.761 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 17.0 tp -143.22 97.33 5.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.326 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -72.42 -62.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.652 1.568 . . . . 0.0 111.933 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.667 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -76.62 111.57 16.66 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.828 177.712 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 2.7 Cg_exo -77.15 103.58 1.77 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.421 2.748 . . . . 0.0 112.406 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.719 ' HD2' HD21 ' A' ' 104' ' ' LEU . 41.3 Cg_endo -83.07 68.94 7.3 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.075 2.516 . . . . 0.0 110.913 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.792 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.27 -42.29 73.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.189 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.42 8.84 3.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.02 0.438 . . . . 0.0 111.46 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.42 -16.84 12.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.938 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.792 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -133.02 17.01 4.16 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.0 m -72.0 87.57 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 2.2 p-10 157.79 -25.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.078 -167.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 172.64 -92.68 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.896 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.631 ' HB ' HG22 ' A' ' 69' ' ' THR . 0.6 OUTLIER -158.89 174.75 14.51 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.784 0.434 . . . . 0.0 109.913 -175.716 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.758 HG13 ' CD2' ' A' ' 112' ' ' TYR . 2.9 m -103.72 109.74 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 CA-C-O 121.114 0.483 . . . . 0.0 111.607 -171.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 24.9 tt0 -97.51 112.02 24.05 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.511 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.3 pp -142.26 155.14 45.21 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.668 HG23 HG21 ' A' ' 82' ' ' VAL . 87.1 m -101.07 126.49 47.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.614 -175.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.511 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 69.9 mt -129.41 123.49 21.48 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.36 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.9 Cg_exo -76.22 121.21 6.0 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.006 1.804 . . . . 0.0 110.886 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.778 HG21 HG11 ' A' ' 98' ' ' VAL . 24.1 pt -96.59 112.57 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.52 120.98 36.71 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.84 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.458 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 95.9 m-85 -114.94 129.56 56.73 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 159.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 31.8 m -57.23 103.11 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -169.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 1.002 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -87.5 98.07 11.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.258 -177.511 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 128' ' ' ARG . 6.2 ppt_? . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.311 . . . . 0.0 111.704 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.538 ' CZ2' HD21 ' A' ' 121' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -68.21 -37.88 81.34 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.19 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 p -68.95 -31.29 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.326 0.584 . . . . 0.0 109.804 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.465 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 5.4 mmm-85 -68.84 -39.56 79.9 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.414 176.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.557 HG23 ' HD2' ' A' ' 103' ' ' PRO . 83.4 mt -63.91 -51.2 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.124 176.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.2 m -56.42 -32.74 65.16 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.784 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.81 -47.03 92.25 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.962 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -69.19 -34.77 75.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.854 0.359 . . . . 0.0 111.017 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.692 HD11 HG22 ' A' ' 98' ' ' VAL . 1.4 tt -62.44 -30.67 71.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.664 0.745 . . . . 0.0 109.652 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 1.099 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 8.4 t30 -70.89 -34.83 71.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.542 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -34.9 70.5 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.702 172.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -91.91 -59.53 2.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.515 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -162.14 102.09 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.503 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 1.099 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 12.7 tpt180 -130.88 103.34 6.51 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.491 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.423 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.1 t80 -87.32 131.88 42.9 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.823 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.8 131.71 45.65 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.732 2.288 . . . . 0.0 112.001 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.85 -23.68 65.32 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.27 -173.048 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -55.59 -42.9 75.47 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.577 0.548 . . . . 0.0 110.231 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.64 -41.03 79.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.632 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -62.44 -41.12 98.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.845 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.585 ' HG2' ' HB2' ' A' ' 126' ' ' SER . 98.5 mtt180 -59.51 -15.52 18.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.3 -24.02 9.12 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.04 0.448 . . . . 0.0 111.114 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.964 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 18.0 ttmm -102.45 -72.63 0.68 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.964 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 30.5 mmt180 -124.22 84.33 2.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.377 0.608 . . . . 0.0 110.14 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 126' ' ' SER . 14.1 pt20 -98.92 115.96 30.07 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.041 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.972 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -165.72 143.23 8.25 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.489 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.819 ' H ' HD12 ' A' ' 127' ' ' LEU . 46.7 t -103.58 123.42 57.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.0 165.24 26.29 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.36 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.731 ' H ' ' HA ' ' A' ' 83' ' ' SER . 48.9 mt-30 -105.15 143.42 33.36 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.4 114.62 21.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.637 0.732 . . . . 0.0 109.576 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.437 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 27.1 ttt180 -106.51 138.42 42.73 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.422 ' CE1' HD11 ' A' ' 70' ' ' LEU . 1.2 p90 -159.95 171.58 19.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.318 0.58 . . . . 0.0 111.956 -173.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 7.8 m -118.82 130.03 55.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.946 173.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.422 HD11 ' CE1' ' A' ' 68' ' ' PHE . 70.2 mt -111.14 140.46 45.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.762 -172.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.1 160.35 23.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.73 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.441 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 42.1 mtm180 -54.07 -36.86 63.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.298 0.57 . . . . 0.0 110.878 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -81.1 0.07 37.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.229 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 80.71 45.32 7.88 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.109 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -110.93 124.53 52.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.7 p -57.24 111.09 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.497 0.665 . . . . 0.0 110.703 174.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.413 ' CD1' HG21 ' A' ' 116' ' ' THR . 80.5 mt -100.99 -41.04 6.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.931 -178.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.28 158.27 40.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.222 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 m -144.89 121.65 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 123.613 0.57 . . . . 0.0 109.915 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 35.7 m -126.29 114.89 18.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.057 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.8 tp -78.29 118.74 20.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.427 0.632 . . . . 0.0 110.662 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -108.1 -58.42 3.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.26 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.731 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 19.1 t 62.05 179.64 0.13 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.979 0.419 . . . . 0.0 111.32 176.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.9 m -154.58 -74.36 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.87 -68.68 0.32 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -169.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.95 84.25 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.825 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.928 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -120.68 93.44 48.54 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -176.785 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.15 -79.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.578 2.185 . . . . 0.0 111.347 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -75.92 -17.2 59.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.543 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.928 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.7 mt -72.1 -38.3 69.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.728 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 14.0 t70 -54.58 -51.14 66.21 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.607 0.567 . . . . 0.0 111.61 -172.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.418 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 9.4 ptp180 -53.73 -40.54 66.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.128 -177.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HG2' ' HG3' ' A' ' 92' ' ' ARG . 5.7 mm-40 -78.07 -58.11 3.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.56 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 32.5 pt -66.75 -43.74 89.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.723 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.861 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 48.4 mm-40 -67.98 -51.16 50.58 Favored 'General case' 0 C--O 1.193 -1.893 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.643 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.46 -31.28 61.82 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.097 0.862 . . . . 0.0 111.434 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.451 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -53.82 -54.47 38.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.838 173.424 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.73 HG11 HG21 ' A' ' 123' ' ' ILE . 79.9 t -86.48 -33.55 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.306 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.861 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.5 ttmt -66.72 -25.15 66.38 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.4 1.08 . . . . 0.0 110.951 -169.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -104.23 -19.4 14.13 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.967 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.507 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -112.44 45.52 1.29 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.797 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.7 m -81.75 107.54 8.59 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.116 0.484 . . . . 0.0 110.255 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 41' ' ' ILE . 73.0 Cg_endo -99.79 175.07 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.539 2.826 . . . . 0.0 113.259 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.828 HD21 ' HD2' ' A' ' 108' ' ' PRO . 16.1 tp -143.46 90.52 7.16 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.921 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.456 ' CG ' ' HB2' ' A' ' 40' ' ' ARG . 10.1 Cg_endo -67.36 -62.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.984 1.79 . . . . 0.0 112.078 -177.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.604 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 t -79.1 116.97 64.18 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 5.6 Cg_exo -80.06 103.04 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.068 2.512 . . . . 0.0 111.626 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.828 ' HD2' HD21 ' A' ' 104' ' ' LEU . 45.2 Cg_endo -81.66 68.92 7.9 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.904 2.403 . . . . 0.0 111.764 -177.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.606 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -58.91 -42.85 90.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.646 178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -67.72 1.9 2.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.832 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -112.53 -35.85 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.676 0.274 . . . . 0.0 111.575 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.646 ' CD2' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -118.79 17.51 13.47 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -171.169 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.5 m -70.98 89.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 2.4 p-10 160.87 -26.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.744 -1.571 . . . . 0.0 107.588 -170.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 175.21 -88.25 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.936 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.503 ' HB ' HG22 ' A' ' 69' ' ' THR . 0.8 OUTLIER -160.0 175.7 12.7 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 122.933 0.493 . . . . 0.0 110.01 -174.283 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.646 HG13 ' CD2' ' A' ' 112' ' ' TYR . 2.6 m -103.2 108.98 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.301 0.572 . . . . 0.0 110.778 -175.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 8.5 tm-20 -103.27 111.65 24.14 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.681 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -151.72 156.44 40.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.155 0.502 . . . . 0.0 111.943 -171.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 61.4 m -96.13 126.39 41.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.189 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.681 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 33.0 mt -128.54 137.9 31.92 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.092 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 3.4 Cg_endo -87.57 119.8 1.41 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.329 2.019 . . . . 0.0 112.066 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.73 HG21 HG11 ' A' ' 98' ' ' VAL . 9.8 pt -97.07 97.87 6.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.745 0.784 . . . . 0.0 109.198 172.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -97.16 125.72 41.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.043 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.56 ' CE1' ' HB ' ' A' ' 94' ' ' ILE . 83.5 m-85 -114.28 151.42 32.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 168.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.585 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 5.0 m -64.86 102.58 0.61 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.089 -0.245 . . . . 0.0 111.296 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.972 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -92.1 95.15 9.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.106 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.408 ' HB2' ' OE1' ' A' ' 61' ' ' GLN . 80.1 mtm180 . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 120.966 0.412 . . . . 0.0 110.224 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.504 ' O ' HG13 ' A' ' 41' ' ' ILE . 2.4 p-90 . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.409 ' HG3' ' N ' ' A' ' 39' ' ' SER . 13.6 ptt180 -66.59 -39.17 88.27 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.956 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.409 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 2.1 m -66.75 -33.79 76.42 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.517 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 33.0 mmm180 -75.87 -36.28 59.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.458 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.621 HG23 ' HG2' ' A' ' 103' ' ' PRO . 59.8 mt -58.09 -46.14 88.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.83 174.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -55.93 -42.56 76.29 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.783 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.99 -37.35 94.16 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.768 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.689 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 1.6 ttm180 -67.77 -34.91 77.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.157 0.503 . . . . 0.0 110.352 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.68 -29.72 70.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.552 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.694 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 44.7 t30 -71.14 -36.89 72.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.582 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -57.47 -30.56 65.17 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.772 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -94.96 -56.68 2.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.183 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -175.35 102.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.414 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.694 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 28.1 ttp180 -130.73 104.12 6.99 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.062 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.594 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -84.9 133.63 43.04 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.825 178.032 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -56.37 132.2 50.42 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.888 2.392 . . . . 0.0 111.737 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HE3' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.03 -23.43 65.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.086 -172.086 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.83 -33.74 73.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.042 0.448 . . . . 0.0 110.953 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.47 -32.41 60.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.7 mm? -71.8 -34.43 69.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.725 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 30.4 mtm180 -69.35 -10.32 57.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.624 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.45 17.43 12.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.397 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.68 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 19.6 ttmm -150.75 -76.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.818 0.342 . . . . 0.0 111.096 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.68 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 3.4 mmp_? -128.39 90.42 3.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 0.0 110.484 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.443 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 21.6 pt20 -119.08 114.93 23.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.911 -178.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.785 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -160.05 149.79 19.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.803 178.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.573 ' H ' HD12 ' A' ' 127' ' ' LEU . 45.7 t -104.61 125.29 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.708 0.29 . . . . 0.0 110.336 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.7 160.31 25.61 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.757 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 44.0 tt0 -103.96 125.05 50.06 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.467 HG21 HD13 ' A' ' 123' ' ' ILE . 62.5 t -129.44 116.7 40.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.619 -169.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.608 ' HG2' HG22 ' A' ' 82' ' ' VAL . 12.2 ptt180 -109.13 145.31 35.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.627 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -157.75 151.0 23.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -171.403 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 21.6 m -94.38 126.81 39.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.402 171.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.484 HD11 ' CE1' ' A' ' 68' ' ' PHE . 55.5 mt -122.38 139.37 53.91 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -170.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 12.6 t70 -79.43 156.11 28.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.037 173.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.749 ' HB2' ' HB3' ' A' ' 107' ' ' PRO . 25.9 ptt180 -63.14 -21.52 66.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.084 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.465 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 29.7 pt20 -87.97 -4.49 58.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.251 0.548 . . . . 0.0 110.087 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.455 ' CA ' ' H ' ' A' ' 104' ' ' LEU . . . 87.2 38.89 7.6 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.116 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.557 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 44.6 t-80 -100.35 114.05 27.25 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 p -48.95 116.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.089 172.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.3 mt -104.84 -40.38 5.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.982 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -147.78 146.55 29.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.388 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.753 HG11 ' HG3' ' A' ' 99' ' ' LYS . 58.8 t -143.18 129.87 17.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 m -136.04 120.39 17.98 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.72 HD21 ' HB2' ' A' ' 84' ' ' SER . 35.3 tp -60.36 120.11 9.24 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.608 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -90.95 -46.74 14.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.894 -175.415 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -148.61 143.82 26.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.127 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.72 ' HB2' HD21 ' A' ' 81' ' ' LEU . 30.1 t -134.45 108.47 8.15 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.13 -37.99 89.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.081 -175.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.642 ' H ' HD22 ' A' ' 87' ' ' LEU . . . 167.8 56.84 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.882 -178.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.727 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -121.07 74.79 28.66 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -177.287 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 3.6 Cg_exo -75.96 -65.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.457 2.104 . . . . 0.0 111.639 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.2 t -74.02 -24.12 59.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.267 0.556 . . . . 0.0 110.181 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.727 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 31.0 mt -73.06 -31.49 64.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.346 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 17.6 t70 -54.41 -45.59 72.97 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.785 0.678 . . . . 0.0 112.144 -172.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -54.21 -49.4 69.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -172.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.472 ' CB ' ' HG3' ' A' ' 60' ' ' ARG . 9.2 tp10 -78.29 -53.45 7.29 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -175.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 90' ' ' LEU . 38.6 pt -63.03 -34.28 65.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -174.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.681 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.8 mm-40 -82.18 -28.78 31.86 Favored 'General case' 0 C--O 1.212 -0.91 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.691 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.32 -41.05 75.38 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 98' ' ' VAL . 1.4 tp -68.27 -56.95 6.83 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.684 -1.143 . . . . 0.0 112.097 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.92 HG11 HG21 ' A' ' 123' ' ' ILE . 85.8 t -88.41 -48.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.753 ' HG3' HG11 ' A' ' 79' ' ' VAL . 37.7 ttmt -64.91 -21.88 66.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.244 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.502 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 5.9 tpp180 -95.39 -35.44 11.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.042 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.562 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -106.18 74.3 1.03 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.629 0.252 . . . . 0.0 110.859 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 14.0 m -94.21 99.46 3.82 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.991 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.689 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 94.8 Cg_endo -100.6 151.82 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.711 2.941 . . . . 0.0 114.525 -173.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.578 HD23 ' HD2' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -143.8 114.91 5.56 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 173.573 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.642 ' HA ' ' CZ ' ' A' ' 44' ' ' ARG . 2.6 Cg_endo -74.15 -58.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.678 2.252 . . . . 0.0 112.838 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 4.6 t -72.72 124.63 90.98 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.737 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.749 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 12.1 Cg_exo -70.41 105.68 1.64 Allowed 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.539 2.159 . . . . 0.0 111.162 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.827 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 69.3 Cg_endo -87.83 58.0 3.0 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.906 2.404 . . . . 0.0 112.862 -172.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.634 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -60.36 -41.65 94.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.112 0.482 . . . . 0.0 109.941 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -75.51 5.93 5.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.065 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.827 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.43 -24.85 9.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.43 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.837 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -123.85 19.97 9.29 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.29 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.7 m -69.49 89.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 6.4 p30 162.51 -25.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 113.208 -1.815 . . . . 0.0 107.46 -168.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.08 -83.85 0.1 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.109 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.535 ' CA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -160.26 174.16 14.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' A' ' 112' ' ' TYR . 27.8 m -102.92 109.73 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.532 0.682 . . . . 0.0 110.799 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 35.0 tt0 -108.7 111.71 23.64 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 166.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.594 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -135.01 155.27 51.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -175.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.549 HG23 HG21 ' A' ' 82' ' ' VAL . 92.7 m -96.03 119.55 34.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.441 -175.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.594 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 42.6 mt -124.98 122.77 25.49 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.454 174.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.4 Cg_exo -72.72 119.32 6.02 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.897 1.731 . . . . 0.0 110.828 175.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.92 HG21 HG11 ' A' ' 98' ' ' VAL . 35.2 pt -91.58 103.63 14.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.41 124.46 41.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.024 0.916 . . . . 0.0 111.566 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.444 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 86.4 m-85 -113.32 135.41 53.88 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 163.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.9 m -58.66 102.8 0.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.265 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.785 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.3 tt -86.53 81.15 8.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.127 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.387 -179.342 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.6 m -130.25 15.4 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.071 0.462 . . . . 0.0 110.898 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -88.84 -24.03 22.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.59 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -93.66 -26.67 16.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.24 0.543 . . . . 0.0 110.247 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.648 ' HG3' ' HD3' ' A' ' 12' ' ' PRO . 66.6 mm-40 -84.87 41.72 0.88 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.869 -169.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -81.5 35.14 0.39 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.254 0.549 . . . . 0.0 111.197 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.5 t -106.25 -0.37 10.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.768 0.794 . . . . 0.0 109.083 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.28 25.84 50.01 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.582 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.57 108.94 5.21 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.78 0.324 . . . . 0.0 110.956 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 90.6 Cg_endo -83.81 144.65 11.11 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.867 2.378 . . . . 0.0 111.749 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.648 ' HD3' ' HG3' ' A' ' 6' ' ' GLN . 24.2 Cg_exo -63.12 115.81 3.2 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.755 2.304 . . . . 0.0 111.699 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.13 79.38 1.38 Allowed 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.734 2.289 . . . . 0.0 112.452 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.06 121.58 2.36 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.63 ' HE ' ' HB2' ' A' ' 17' ' ' ASP . 20.9 ttt180 -79.28 112.15 16.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.853 0.359 . . . . 0.0 111.309 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.57 95.48 7.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.63 ' HB2' ' HE ' ' A' ' 15' ' ' ARG . 24.8 t70 -115.7 159.8 20.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.984 -173.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -53.95 -43.86 70.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.185 0.517 . . . . 0.0 110.308 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 m -83.55 -48.55 10.14 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.215 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.887 ' HB1' ' HB3' ' A' ' 25' ' ' ARG . . . -97.72 59.8 1.5 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.488 -174.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.694 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -86.86 -56.38 0.34 Allowed Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.987 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.694 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 9.9 Cg_endo -90.28 -88.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.293 1.995 . . . . 0.0 113.347 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -118.28 -2.64 11.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.042 0.448 . . . . 0.0 111.231 -176.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.42 ' OG1' ' HD2' ' A' ' 22' ' ' PRO . 1.1 p -77.98 40.35 0.32 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.372 -173.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.887 ' HB3' ' HB1' ' A' ' 20' ' ' ALA . 21.5 ptt180 -138.69 2.9 2.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.461 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.1 mt -119.98 -9.11 9.7 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.368 0.604 . . . . 0.0 110.777 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 m -101.98 107.96 54.52 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.398 -172.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -83.58 59.09 6.23 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.836 2.357 . . . . 0.0 112.213 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 54.3 31.57 14.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.094 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.31 30.62 18.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.475 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -83.38 -47.84 11.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.408 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 51.69 58.49 5.42 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.591 0.557 . . . . 0.0 111.702 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.4 119.15 0.58 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.041 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -85.34 65.72 9.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.289 0.566 . . . . 0.0 110.041 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -144.14 146.79 32.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.994 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.413 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 54.8 t30 -68.93 94.31 0.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -75.6 -23.37 56.44 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -171.088 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -69.03 -34.11 74.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.233 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.5 p -70.35 -33.95 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.08 0.467 . . . . 0.0 109.832 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.414 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 30.2 mmt180 -70.3 -43.46 70.31 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.747 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.903 HG23 ' HG2' ' A' ' 103' ' ' PRO . 53.9 mt -57.61 -42.14 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.885 175.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.3 m -56.92 -34.71 68.22 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.489 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.71 -35.69 80.92 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.889 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.8 -34.18 73.37 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.46 0.648 . . . . 0.0 109.64 178.186 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.448 HD11 HG22 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -68.12 -25.47 65.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.894 177.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.785 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 59.1 t30 -70.19 -34.57 73.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.553 176.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 1.9 ttt180 -59.88 -27.09 66.4 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.015 170.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.56 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 69.5 m-85 -106.01 25.67 10.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.906 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 48' ' ' PHE . 21.9 mtpp 74.13 102.41 0.07 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 124.075 0.859 . . . . 0.0 110.505 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.785 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 16.4 ttp180 -93.54 104.62 16.74 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.289 0.566 . . . . 0.0 110.607 -176.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.522 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -69.41 114.79 26.57 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.892 175.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HD2' ' HD1' ' A' ' 51' ' ' TYR . 34.7 Cg_exo -57.68 131.82 46.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.714 2.276 . . . . 0.0 111.573 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.728 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.16 -25.2 63.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.885 -170.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.401 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 14.5 m-20 -64.6 -32.45 74.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.0 0.429 . . . . 0.0 111.182 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 59' ' ' LYS . . . -74.15 -31.78 62.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.511 178.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.4 mm? -74.76 -42.6 57.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.665 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.731 ' HB3' ' HB2' ' A' ' 126' ' ' SER . 2.5 ptp180 -64.41 -17.95 64.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.751 0.31 . . . . 0.0 111.334 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.7 mt -108.33 4.41 24.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.921 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.649 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 39.2 ttmt -145.6 -75.27 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 111.556 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.679 ' HB2' HD12 ' A' ' 56' ' ' LEU . 33.5 mmt180 -106.85 87.57 2.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.844 0.354 . . . . 0.0 110.193 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.74 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . 4.7 mt-30 -85.95 156.17 20.59 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 170.44 116.76 0.39 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 118.851 -1.642 . . . . 0.0 113.854 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.863 ' H ' HD12 ' A' ' 127' ' ' LEU . 58.9 t -110.18 123.42 66.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.45 165.65 33.99 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.636 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 42.4 mt-30 -103.57 124.46 48.84 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.536 HG21 HD13 ' A' ' 123' ' ' ILE . 77.4 t -122.22 113.63 39.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.433 -173.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.531 ' HB3' HG21 ' A' ' 82' ' ' VAL . 20.6 ptt180 -108.38 141.03 40.81 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -156.9 157.59 35.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.559 0.695 . . . . 0.0 112.412 -171.457 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 6.4 m -101.92 129.91 48.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.577 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.523 HD11 ' CE1' ' A' ' 68' ' ' PHE . 48.2 mt -121.78 139.84 53.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.12 0.486 . . . . 0.0 112.286 -168.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.787 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 21.4 t70 -82.18 155.68 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.827 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HG3' ' HB3' ' A' ' 107' ' ' PRO . 58.0 ttt180 -51.51 -41.43 60.99 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -174.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -87.08 12.22 11.97 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.019 0.437 . . . . 0.0 111.038 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.33 53.82 4.27 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.421 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 67.9 t60 -112.4 114.97 27.96 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 4.1 p -48.79 120.35 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.523 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.1 mt -110.49 -40.26 4.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.744 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -152.66 146.01 24.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.279 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.762 HG11 ' HD3' ' A' ' 99' ' ' LYS . 28.4 t -142.39 130.91 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.7 m -128.24 128.16 44.17 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.819 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.9 tp -72.91 123.03 22.63 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.531 HG21 ' HB3' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -99.4 -52.03 9.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.461 -171.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.9 m -141.31 138.61 33.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.492 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.7 t -131.41 131.38 43.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.935 0.398 . . . . 0.0 110.698 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.03 8.38 26.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.489 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 103.11 69.98 0.83 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.702 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -115.57 89.7 23.46 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HG2' ' O ' ' A' ' 131' ' ' GLY . 4.6 Cg_exo -77.94 -84.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.591 2.194 . . . . 0.0 112.021 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.5 m -66.16 -18.32 65.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.332 0.587 . . . . 0.0 110.966 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 13.7 mt -75.41 -45.09 41.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.245 -176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 16.9 t70 -55.17 -41.75 72.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.079 -169.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -54.28 -49.71 68.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.819 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.94 -47.93 15.49 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.521 ' HB ' ' CE2' ' A' ' 125' ' ' PHE . 42.1 pt -63.35 -38.8 83.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.573 HE22 HD11 ' A' ' 123' ' ' ILE . 75.4 mm-40 -79.08 -31.34 44.36 Favored 'General case' 0 C--O 1.199 -1.594 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.605 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.84 -39.25 65.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 4.1 tp -67.53 -54.77 17.14 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.487 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.757 HG11 HG21 ' A' ' 123' ' ' ILE . 52.9 t -87.41 -45.52 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.762 ' HD3' HG11 ' A' ' 79' ' ' VAL . 3.2 tppp? -56.32 -40.23 74.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.148 0.579 . . . . 0.0 110.518 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -84.38 -31.02 24.95 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.828 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -105.65 63.15 0.68 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.808 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.478 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.7 m -89.13 99.43 1.59 Allowed Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.903 ' HG2' HG23 ' A' ' 41' ' ' ILE . 74.5 Cg_endo -103.55 166.59 0.23 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.922 3.082 . . . . 0.0 114.611 -170.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.518 HD21 ' CD ' ' A' ' 108' ' ' PRO . 37.1 tp -143.16 96.49 5.87 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.722 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.503 ' HG3' ' N ' ' A' ' 41' ' ' ILE . 33.1 Cg_endo -78.06 -44.92 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.3 2.0 . . . . 0.0 113.671 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.495 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 15.4 m -92.95 107.88 28.11 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.499 ' HB3' ' HG3' ' A' ' 72' ' ' ARG . 21.2 Cg_exo -66.59 106.12 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.312 2.675 . . . . 0.0 112.977 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.906 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 41.6 Cg_endo -88.87 65.76 2.77 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.543 2.829 . . . . 0.0 112.128 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.585 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -51.07 -51.7 50.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.78 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -78.79 9.33 4.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.79 -176.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.906 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -105.84 -30.15 9.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.165 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.622 ' HB2' ' HA ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -114.3 15.55 18.05 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 3.9 m -72.58 87.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 169.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 1.3 p-10 159.74 -19.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.916 -167.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.66 -86.7 0.1 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.391 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.633 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.2 OUTLIER -160.75 177.08 10.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 69' ' ' THR . 11.2 m -100.1 108.77 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 121.877 0.846 . . . . 0.0 110.105 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -113.63 112.49 23.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.629 HD12 ' HG ' ' A' ' 121' ' ' LEU . 2.1 pp -142.84 154.63 44.35 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.225 -173.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.449 HG23 HG21 ' A' ' 82' ' ' VAL . 92.8 m -92.44 125.85 37.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.421 -177.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.629 ' HG ' HD12 ' A' ' 119' ' ' LEU . 64.2 mt -130.38 122.85 20.17 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.393 176.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.3 Cg_exo -74.75 119.2 5.6 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.642 1.562 . . . . 0.0 110.726 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.757 HG21 HG11 ' A' ' 98' ' ' VAL . 20.6 pt -89.62 121.07 39.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -111.97 121.71 45.76 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 119.379 -0.928 . . . . 0.0 112.256 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.596 ' CD1' ' HG ' ' A' ' 56' ' ' LEU . 89.7 m-85 -114.09 131.54 56.36 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.409 -1.723 . . . . 0.0 106.816 163.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.731 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 8.7 m -56.98 103.42 0.11 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 -170.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.863 HD12 ' H ' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -97.65 108.85 21.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.915 -171.291 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.479 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 46.4 mtm105 -84.15 -53.2 5.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.734 173.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 165.52 50.11 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.776 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.414 ' CB ' HD21 ' A' ' 90' ' ' LEU . . . -90.95 172.27 8.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.773 0.321 . . . . 0.0 110.799 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 88' ' ' PRO . . . 83.6 24.27 50.77 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 40.0 p90 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.327 -177.238 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 tttm . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 121.125 0.488 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.2 t -117.99 -58.1 3.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.264 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -96.62 91.56 5.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.204 0.526 . . . . 0.0 110.817 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 5' ' ' GLU . 4.0 pt-20 -101.63 104.49 15.35 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.704 0.764 . . . . 0.0 109.148 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -70.75 -59.47 2.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.699 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.8 t -108.08 119.13 38.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.944 0.402 . . . . 0.0 110.259 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.09 78.85 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.516 0.674 . . . . 0.0 109.712 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.61 -179.16 41.79 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.317 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -115.61 93.62 37.59 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.917 0.359 . . . . 0.0 110.816 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.47 114.22 3.86 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.137 2.558 . . . . 0.0 111.738 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 73.1 Cg_endo -75.73 155.74 39.64 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.475 2.117 . . . . 0.0 112.12 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 6.8 Cg_exo -73.98 52.2 2.57 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.199 2.599 . . . . 0.0 112.071 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.62 103.64 0.22 Allowed Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 mtm180 -91.33 49.88 1.67 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 59.55 29.58 19.16 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.387 0.613 . . . . 0.0 110.057 -173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -68.92 140.02 55.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.95 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.4 tttp 53.63 52.25 13.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.781 0.801 . . . . 0.0 110.5 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.4 m -132.25 5.2 4.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.017 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.1 47.99 1.51 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.27 0.557 . . . . 0.0 110.679 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -77.68 -55.6 1.23 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.542 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 90.6 Cg_endo -87.08 23.97 0.78 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.277 1.984 . . . . 0.0 112.28 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 67.06 104.04 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.153 -177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.6 m -66.9 -18.95 65.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.756 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -66.35 -11.64 52.29 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.959 0.409 . . . . 0.0 110.398 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.3 mt -112.51 19.1 17.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.367 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.7 m -139.98 78.16 24.94 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.835 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.09 133.46 18.08 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.441 2.094 . . . . 0.0 110.613 171.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -126.55 3.05 6.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.8 99.54 8.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.727 0.299 . . . . 0.0 110.973 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -83.12 155.5 23.78 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.86 70.31 4.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -173.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.487 ' HA2' ' CE2' ' A' ' 37' ' ' TRP . . . 107.33 -163.16 13.18 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.654 -0.784 . . . . 0.0 114.011 170.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 57.56 61.54 2.43 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.649 0.78 . . . . 0.0 112.207 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.401 ' CG ' ' H ' ' A' ' 36' ' ' ASN . 14.2 t70 -155.55 -168.27 2.77 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.401 ' H ' ' CG ' ' A' ' 35' ' ' ASP . 17.7 m120 -83.08 6.72 18.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.106 0.479 . . . . 0.0 110.357 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.495 ' CH2' HD21 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -61.78 -30.76 71.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.733 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 39' ' ' SER . 4.4 ppt_? -69.54 -28.19 65.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.156 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.496 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 13.1 m -66.47 -36.36 82.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 105' ' ' PRO . 17.8 mmm-85 -73.31 -43.69 60.43 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.338 177.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.746 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 34.8 mt -57.99 -36.84 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.634 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.466 ' O ' ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -61.38 -45.04 96.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.427 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.6 -38.66 95.97 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.499 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.746 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 8.5 ptt180 -56.69 -34.6 67.57 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.928 0.394 . . . . 0.0 110.13 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -32.26 47.62 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.623 -175.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.497 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 6.5 t30 -70.69 -29.19 65.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.035 0.921 . . . . 0.0 108.722 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -18.72 36.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.561 -1.654 . . . . 0.0 111.083 173.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -125.74 -57.64 1.44 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -158.37 102.85 1.76 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.333 0.653 . . . . 0.0 109.822 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 64.1 ttt-85 -128.54 103.53 7.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.35 0.595 . . . . 0.0 109.942 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.45 130.17 23.21 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.917 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.06 134.16 58.62 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.966 2.444 . . . . 0.0 111.936 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.592 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.9 -21.43 61.06 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.53 -174.263 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.78 -38.52 55.9 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.6 0.562 . . . . 0.0 110.762 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.11 -42.43 47.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.315 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.4 mm? -64.22 -34.81 78.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.963 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 21.7 mtm180 -62.71 -14.63 46.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.757 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.2 mp -119.62 14.36 12.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.75 0.31 . . . . 0.0 110.931 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.777 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 39.0 ttmt -142.25 -76.52 0.27 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.702 0.287 . . . . 0.0 110.859 -176.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.789 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 39.6 mmt180 -130.95 100.63 5.31 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.0 167.84 11.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.74 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.766 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.74 144.48 3.92 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.727 -1.225 . . . . 0.0 113.272 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 p -111.13 128.17 67.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.53 164.62 29.45 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.097 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.486 ' O ' HG23 ' A' ' 82' ' ' VAL . 35.8 tt0 -103.65 125.13 49.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.52 HG21 HD13 ' A' ' 123' ' ' ILE . 49.3 t -127.31 114.79 38.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.763 -171.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.594 ' HG2' HG22 ' A' ' 82' ' ' VAL . 5.1 ptp180 -114.68 144.35 43.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.49 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -160.1 164.07 33.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 7.3 m -108.4 131.93 54.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.562 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.609 HD21 ' HB3' ' A' ' 102' ' ' SER . 61.9 mt -119.05 138.29 52.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.73 -172.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.544 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 29.4 t70 -81.2 158.45 24.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.821 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.85 -36.67 70.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -81.6 3.11 26.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.12 0.486 . . . . 0.0 111.258 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . 81.4 35.52 22.95 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.298 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.544 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 54.1 t-80 -100.38 110.83 23.05 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 5.8 p -48.44 111.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.645 0.736 . . . . 0.0 111.002 173.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 48.9 mt -99.65 -23.5 15.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.581 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.69 157.58 36.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.836 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 ' HG3' ' A' ' 99' ' ' LYS . 13.6 p -159.82 133.85 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.2 m -144.48 130.15 19.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.704 0.288 . . . . 0.0 111.065 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 84' ' ' SER . 24.5 tp -74.78 110.1 8.8 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -84.84 -39.22 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.155 -171.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.0 m -150.56 151.15 32.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.762 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.732 ' HB2' HD21 ' A' ' 81' ' ' LEU . 45.7 t -140.11 142.77 36.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.875 0.369 . . . . 0.0 110.572 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.18 19.42 19.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.243 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.13 63.41 0.84 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.686 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.809 ' HA ' HD12 ' A' ' 90' ' ' LEU . 1.1 mm? -119.1 82.99 23.05 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.08 -83.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.369 2.046 . . . . 0.0 111.973 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 66.5 m -68.64 -17.91 64.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.397 0.618 . . . . 0.0 110.339 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 87' ' ' LEU . 16.2 mt -70.24 -34.03 72.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.632 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.549 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 3.7 t70 -54.12 -44.53 71.39 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.467 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 89' ' ' SER . 11.2 ptm180 -54.31 -48.49 71.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.505 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 8.1 tp10 -77.88 -53.46 7.45 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 122.016 -0.427 . . . . 0.0 111.789 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.539 HG12 ' O ' ' A' ' 90' ' ' LEU . 36.7 pt -64.76 -37.08 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -172.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.601 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.4 mm-40 -82.21 -28.31 32.06 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.45 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.669 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.88 -43.43 81.26 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.612 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -63.87 -58.37 7.0 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.008 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.864 HG11 HG21 ' A' ' 123' ' ' ILE . 93.0 t -89.05 -50.4 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.63 ' HG3' HG21 ' A' ' 79' ' ' VAL . 35.6 ttmt -67.32 -29.99 69.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.649 -173.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.669 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 4.1 tmt_? -89.07 -47.17 8.29 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.664 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.656 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -86.0 73.75 10.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.044 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.609 ' HB3' HD21 ' A' ' 70' ' ' LEU . 67.4 m -109.52 92.3 11.64 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-O 122.063 0.935 . . . . 0.0 110.531 171.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.665 ' HG2' ' HG3' ' A' ' 44' ' ' ARG . 3.3 Cg_endo -96.33 178.44 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 1 C-N-CA 125.457 4.105 . . . . 0.0 112.052 170.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.782 HD21 ' HD2' ' A' ' 108' ' ' PRO . 12.2 tp -134.65 99.15 13.0 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HB2' ' HB3' ' A' ' 40' ' ' ARG . 86.6 Cg_endo -77.15 -28.51 5.8 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.449 1.433 . . . . 0.0 112.77 -173.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.513 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 2.9 t -122.46 107.83 34.07 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.708 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.38 108.3 1.35 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.062 2.508 . . . . 0.0 112.612 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.782 ' HD2' HD21 ' A' ' 104' ' ' LEU . 41.9 Cg_endo -86.71 66.45 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.159 2.572 . . . . 0.0 111.312 177.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.703 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -49.69 -46.28 49.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.864 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.69 -32.49 67.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.592 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -81.09 -31.31 34.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.12 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.703 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -116.62 18.58 14.94 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 109' ' ' ALA . 3.2 m -71.29 88.95 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 168.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 2.0 p-10 159.34 -23.07 0.0 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.152 -168.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.56 -84.53 0.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.002 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.46 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.3 OUTLIER -159.67 175.69 12.89 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.218 0.607 . . . . 0.0 109.491 -176.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 69' ' ' THR . 4.0 m -103.02 107.99 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-O 121.396 0.617 . . . . 0.0 111.251 -174.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 1.1 tm-20 -103.57 112.14 24.92 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.662 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 3.5 pp -142.09 149.33 39.73 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.622 -173.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.2 m -87.94 124.58 33.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.627 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.662 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 32.2 mt -123.77 122.03 26.46 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.556 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.05 120.89 5.9 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.197 1.932 . . . . 0.0 110.933 176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.864 HG21 HG11 ' A' ' 98' ' ' VAL . 12.2 pt -104.69 123.19 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -126.26 124.31 40.09 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 122.206 1.003 . . . . 0.0 111.581 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.44 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 62.0 m-85 -113.17 139.13 49.02 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 168.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 14.4 m -57.99 101.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.805 0.336 . . . . 0.0 111.558 -172.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.766 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.4 OUTLIER -94.88 106.06 18.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.917 -174.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -131.61 19.08 4.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.304 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.25 -110.78 1.57 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.362 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -81.99 45.91 0.96 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -172.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -169.87 101.5 0.17 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.194 -0.527 . . . . 0.0 111.899 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 9.1 p90 . . . . . 0 C--O 1.244 0.814 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.448 179.078 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.562 ' HG2' ' H ' ' A' ' 4' ' ' GLN . 4.7 ttmp? . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.485 HG23 ' HG3' ' A' ' 4' ' ' GLN . 29.3 m -73.49 -28.57 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.282 0.563 . . . . 0.0 110.144 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.562 ' H ' ' HG2' ' A' ' 2' ' ' LYS . 45.7 mt-30 -99.57 75.55 1.95 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.934 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -87.11 41.91 1.0 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.738 0.78 . . . . 0.0 109.259 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -84.49 -55.13 4.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.932 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.4 m -84.26 84.25 7.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.015 0.436 . . . . 0.0 110.526 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.0 t -103.04 -50.0 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.366 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.41 -155.53 23.54 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.304 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 67.83 74.01 0.33 Allowed Pre-proline 0 N--CA 1.464 0.273 0 C-N-CA 123.442 0.697 . . . . 0.0 111.364 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.586 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 70.2 Cg_endo -75.73 130.92 12.96 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.488 2.125 . . . . 0.0 112.032 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 37.5 Cg_endo -92.69 100.09 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.269 2.646 . . . . 0.0 112.645 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 11' ' ' PRO . 3.4 Cg_exo -80.12 74.94 5.31 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.014 2.476 . . . . 0.0 111.641 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.74 -51.61 4.34 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.253 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -121.67 -80.35 0.62 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.788 -0.242 . . . . 0.0 110.971 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . . . 61.83 96.2 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.816 0.697 . . . . 0.0 111.451 -177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -76.64 -42.41 42.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.583 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.1 tptt 53.11 80.67 0.1 Allowed 'General case' 0 C--O 1.235 0.308 0 O-C-N 124.025 0.828 . . . . 0.0 111.502 174.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -81.0 60.59 4.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.115 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.68 88.98 7.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.472 0.653 . . . . 0.0 110.198 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.412 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -91.01 169.07 12.31 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.834 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 54.3 Cg_exo -54.26 -19.82 17.83 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 121.984 1.789 . . . . 0.0 112.732 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -81.93 -15.7 52.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.902 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.3 p -88.79 38.58 0.89 Allowed 'General case' 0 C--N 1.332 -0.165 0 O-C-N 121.942 -0.474 . . . . 0.0 111.221 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -116.82 -53.95 2.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.205 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 26' ' ' LEU . 3.5 mm? -103.17 28.73 6.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.249 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 p -112.61 93.58 24.2 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.088 0.47 . . . . 0.0 111.067 177.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -78.97 58.94 7.16 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.657 2.238 . . . . 0.0 112.092 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -127.63 139.76 52.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.639 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 63.32 74.04 0.44 Allowed 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.892 0.745 . . . . 0.0 112.44 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -81.74 50.58 1.54 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.124 0.488 . . . . 0.0 110.913 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.4 167.54 14.82 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.11 -146.18 5.35 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.328 -1.415 . . . . 0.0 113.676 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.4 mp0 -75.77 124.23 26.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.091 -0.554 . . . . 0.0 112.085 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 36' ' ' ASN . 5.3 p-10 -159.61 -72.99 0.08 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.509 169.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.503 ' H ' ' CG ' ' A' ' 35' ' ' ASP . 28.0 p-10 -178.44 38.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.512 ' CH2' HD21 ' A' ' 121' ' ' LEU . 1.4 p-90 -63.95 -29.99 71.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.829 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.15 -31.48 70.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 110.247 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.0 m -70.84 -34.53 71.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.469 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.559 ' CB ' ' HG2' ' A' ' 105' ' ' PRO . 48.9 mtt180 -64.8 -44.96 88.25 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.433 0.635 . . . . 0.0 109.443 174.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.531 HG23 ' HD2' ' A' ' 103' ' ' PRO . 75.8 mt -59.62 -38.67 76.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.322 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 m -55.75 -32.31 63.3 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.17 -43.01 82.28 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.713 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.625 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 9.2 mpt_? -69.07 -32.53 72.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.098 0.475 . . . . 0.0 110.769 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.418 HD11 HG22 ' A' ' 98' ' ' VAL . 0.7 OUTLIER -62.95 -32.41 73.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.422 0.63 . . . . 0.0 109.754 178.163 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.544 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 47.9 t30 -71.2 -31.29 67.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.822 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.531 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 2.0 ttt180 -53.34 -28.34 28.16 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.961 172.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -100.85 -57.09 2.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.705 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -173.56 116.98 0.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.544 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 55.4 ttp180 -133.47 103.83 6.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.217 0.532 . . . . 0.0 110.312 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -98.79 142.94 25.45 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.993 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.86 132.8 51.51 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.877 2.384 . . . . 0.0 111.83 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.674 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -62.36 -23.89 67.05 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -171.447 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.489 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 15.3 m-20 -65.2 -33.53 76.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.643 0.259 . . . . 0.0 110.815 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.84 71.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.249 0.547 . . . . 0.0 110.112 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -73.45 -40.31 64.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.61 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.713 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 83.2 mtt180 -55.65 -30.86 61.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.984 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 54' ' ' ASP . 61.6 mt -99.04 14.41 29.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.038 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.444 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 24.8 ttmm -145.8 -74.64 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 111.049 -177.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.55 ' HD2' HD23 ' A' ' 90' ' ' LEU . 23.0 mmt180 -127.38 84.44 2.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.384 0.612 . . . . 0.0 110.232 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.713 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 24.4 pt20 -94.27 115.29 27.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.06 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.811 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -154.79 130.02 2.74 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.56 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.88 ' H ' HD12 ' A' ' 127' ' ' LEU . 7.1 p -103.78 133.39 47.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.006 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.85 168.12 38.24 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.16 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.662 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 56.7 mt-30 -100.29 137.65 38.44 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 123' ' ' ILE . 39.8 t -128.22 114.03 32.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.237 0.541 . . . . 0.0 110.46 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 34.4 ttp180 -103.71 125.04 49.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -144.1 156.99 44.57 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.508 0.67 . . . . 0.0 112.625 -174.539 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.789 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 23.3 m -106.43 124.32 49.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.429 173.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.681 HD13 ' HG ' ' A' ' 104' ' ' LEU . 39.9 mt -116.96 147.69 42.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.24 0.543 . . . . 0.0 111.953 -169.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.614 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 29.3 t70 -88.41 161.81 16.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.399 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.416 ' HD2' ' HB3' ' A' ' 107' ' ' PRO . 8.1 tpt180 -48.96 -40.39 30.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.543 174.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -88.76 7.14 35.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.989 0.423 . . . . 0.0 111.062 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.61 40.25 27.63 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.162 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.614 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 45.2 t60 -103.06 123.81 47.34 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.48 118.89 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.417 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 71' ' ' ASP . 26.0 mt -106.19 -53.45 2.63 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.231 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.61 149.59 52.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.802 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' A' ' 68' ' ' PHE . 2.4 m -145.67 125.35 6.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.442 0.639 . . . . 0.0 110.857 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.9 m -124.71 123.83 40.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.425 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.448 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 23.1 tp -78.68 106.48 10.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.484 0.659 . . . . 0.0 109.882 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -86.66 -41.96 15.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.049 178.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.457 ' CA ' ' H ' ' A' ' 65' ' ' GLN . 13.2 t 68.67 -178.03 0.22 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.396 167.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.431 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 40.8 m -153.59 -56.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.024 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.59 -77.4 0.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.7 98.67 0.11 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.747 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.742 ' HA ' HD12 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -117.6 87.63 26.66 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.532 0.166 . . . . 0.0 110.655 -177.603 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.76 -81.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.685 2.257 . . . . 0.0 111.869 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.5 m -65.74 -18.46 65.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.525 0.679 . . . . 0.0 110.328 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 87' ' ' LEU . 25.2 mt -73.67 -36.13 65.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.191 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 4.4 t70 -54.18 -51.41 64.43 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 123.613 0.571 . . . . 0.0 111.725 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -54.58 -43.67 72.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -77.4 -53.92 7.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.833 0.349 . . . . 0.0 111.737 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 90' ' ' LEU . 40.2 pt -74.12 -33.08 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.654 -172.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.779 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 79.0 mm-40 -82.57 -24.11 34.14 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 120.981 0.42 . . . . 0.0 110.39 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.72 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.65 -47.27 80.12 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.648 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -65.11 -56.11 14.84 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.514 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.939 HG11 HG21 ' A' ' 123' ' ' ILE . 79.3 t -89.17 -50.11 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.779 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 34.9 ttmt -68.84 -30.09 68.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.238 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.72 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 2.6 tmt_? -86.86 -39.99 15.31 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.774 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.666 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -97.41 63.84 1.82 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.737 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.4 m -94.6 98.49 3.14 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 110.093 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 98.9 Cg_endo -108.65 172.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 124.195 3.263 . . . . 0.0 114.386 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.681 ' HG ' HD13 ' A' ' 70' ' ' LEU . 6.2 mt -143.89 120.59 6.52 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.733 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.559 ' HG2' ' CB ' ' A' ' 40' ' ' ARG . 6.2 Cg_exo -72.83 -54.13 0.12 Allowed 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.86 2.374 . . . . 0.0 111.936 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 25.4 m -88.7 115.22 62.84 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.411 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 106' ' ' THR . 30.5 Cg_endo -64.17 107.6 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.09 2.527 . . . . 0.0 112.225 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.66 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 81.3 Cg_endo -83.38 62.74 7.45 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.772 2.314 . . . . 0.0 111.832 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.823 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -59.18 -41.91 89.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.297 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.72 -7.95 48.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.622 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -99.38 -32.04 11.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.604 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.823 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -110.02 17.49 21.02 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -176.107 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 109' ' ' ALA . 3.4 m -70.57 88.09 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 168.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 2.6 p-10 161.93 -27.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.606 -1.634 . . . . 0.0 107.846 -170.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.85 -76.15 0.15 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.906 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.535 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.6 OUTLIER -160.27 174.42 14.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.789 ' O ' ' HA ' ' A' ' 69' ' ' THR . 15.8 m -103.3 108.94 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.377 0.608 . . . . 0.0 111.061 -175.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 28.0 tt0 -105.36 111.7 24.52 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.68 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -142.36 147.22 35.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.462 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 67' ' ' ARG . 86.8 m -87.59 122.13 30.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.33 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.68 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 26.0 mt -124.7 122.5 25.7 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.927 172.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.2 Cg_exo -73.8 119.93 6.15 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.771 1.647 . . . . 0.0 110.726 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.939 HG21 HG11 ' A' ' 98' ' ' VAL . 23.8 pt -95.46 99.52 9.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.59 ' HA ' HG23 ' A' ' 63' ' ' VAL . 5.5 p-10 -90.24 121.49 32.31 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.449 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 41.5 m-85 -113.36 141.3 47.21 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 163.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 3.3 m -64.15 101.87 0.45 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.88 HD12 ' H ' ' A' ' 63' ' ' VAL . 1.2 tt -90.13 84.11 6.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.204 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 128' ' ' ARG . 21.0 mtm180 -77.31 -20.18 55.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.46 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 141.06 106.02 0.61 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.528 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.509 ' CB ' HD21 ' A' ' 90' ' ' LEU . . . -157.58 155.2 29.77 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.05 31.69 19.55 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.317 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 21.2 p90 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.629 -0.701 . . . . 0.0 110.423 -177.973 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.916 0.389 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.11 -31.15 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.43 0.633 . . . . 0.0 109.694 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -137.04 -28.66 0.94 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.368 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.82 63.42 8.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.436 -176.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -85.26 52.9 2.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.364 0.602 . . . . 0.0 109.978 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.7 t -95.94 102.32 14.1 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.893 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 p -102.4 99.62 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.499 0.666 . . . . 0.0 110.658 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.89 108.9 0.58 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.129 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.05 80.94 67.2 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.938 0.399 . . . . 0.0 109.946 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 87.0 Cg_endo -82.15 129.5 6.06 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.641 2.227 . . . . 0.0 112.799 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 3.3 Cg_exo -77.77 104.24 1.83 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.085 2.523 . . . . 0.0 110.725 171.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 11.4 Cg_exo -69.84 120.1 6.93 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.771 2.314 . . . . 0.0 112.29 -173.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.76 -35.13 79.35 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -147.8 -66.32 0.25 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.289 -0.455 . . . . 0.0 109.773 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.42 124.51 42.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.183 0.516 . . . . 0.0 111.854 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -161.59 -157.72 0.51 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? 56.34 40.09 29.91 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.201 0.524 . . . . 0.0 110.278 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -98.74 -44.83 6.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.045 -174.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.39 118.64 4.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.666 0.269 . . . . 0.0 111.063 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.93 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -126.33 -62.78 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.5 173.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.93 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 2.5 Cg_endo -85.07 -10.47 8.05 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.083 1.855 . . . . 0.0 111.797 171.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.506 ' OE1' ' HD2' ' A' ' 22' ' ' PRO . 25.1 mp0 -83.41 -9.69 58.87 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.543 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.463 ' HA ' ' OG1' ' A' ' 27' ' ' THR . 4.9 m -64.79 -7.53 11.42 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.97 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.451 ' HG3' ' HG ' ' A' ' 26' ' ' LEU . 35.3 ptt180 -75.33 -16.04 60.44 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.935 -0.478 . . . . 0.0 110.981 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.451 ' HG ' ' HG3' ' A' ' 25' ' ' ARG . 80.0 mt -115.95 17.43 15.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.953 0.406 . . . . 0.0 110.856 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 24' ' ' THR . 41.5 p -122.75 86.06 49.7 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.87 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.96 145.76 15.83 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.965 2.443 . . . . 0.0 111.166 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -79.56 -10.65 59.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.067 0.461 . . . . 0.0 110.966 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.01 120.58 26.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.44 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -86.14 -41.53 14.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.475 -173.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 59.69 -157.43 0.33 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.848 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.42 103.44 0.2 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.549 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -81.23 138.89 35.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.083 0.468 . . . . 0.0 109.827 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -174.73 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.873 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -154.79 30.66 0.41 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.65 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -88.69 -37.2 15.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.42 -174.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.758 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . 17.3 ptp180 -69.15 -29.79 67.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.892 -173.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.0 p -64.69 -38.21 90.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.589 ' C ' ' HG3' ' A' ' 105' ' ' PRO . 4.2 mmm180 -74.76 -37.96 62.33 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.758 ' HB ' ' HA ' ' A' ' 38' ' ' ARG . 21.5 mt -57.69 -38.1 62.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.808 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 m -60.23 -45.71 92.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 174.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.51 -50.48 67.34 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.39 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.802 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -68.35 -29.29 67.99 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.213 0.507 . . . . 0.0 111.297 -177.375 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.78 -30.84 71.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.526 0.679 . . . . 0.0 109.654 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.565 ' HB2' ' HD3' ' A' ' 50' ' ' ARG . 8.4 t30 -71.31 -29.59 65.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.543 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.666 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 9.2 ttt180 -52.96 -25.04 10.7 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.223 172.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.546 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 74.4 m-85 -113.29 -59.15 2.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.266 176.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -164.62 103.38 0.82 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 122.394 0.278 . . . . 0.0 110.568 -174.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.565 ' HD3' ' HB2' ' A' ' 46' ' ' ASN . 15.7 ttt180 -133.17 106.43 7.59 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.605 0.716 . . . . 0.0 111.124 177.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.442 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.3 t80 -105.18 142.97 25.79 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.2 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.96 132.21 50.93 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.92 2.413 . . . . 0.0 112.108 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.55 -24.89 66.95 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.236 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -55.97 -41.74 75.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.67 0.271 . . . . 0.0 110.832 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.64 -30.87 68.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.87 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.6 mm? -74.44 -41.51 60.72 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.613 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 28.4 mtm180 -61.28 -24.39 66.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.246 0.546 . . . . 0.0 110.162 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.8 tp -91.57 -13.72 31.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.748 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.661 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 38.2 ttpt -131.64 -72.46 0.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.88 -172.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.661 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 36.8 mmt180 -109.69 92.02 3.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.853 0.359 . . . . 0.0 110.315 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 90' ' ' LEU . 42.6 mt-30 -86.54 169.34 12.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.572 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.61 119.71 0.81 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.472 -1.347 . . . . 0.0 113.627 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.06 123.57 66.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.34 165.7 36.17 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 68.7 mt-30 -103.09 130.82 50.35 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 t -119.57 114.29 43.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.364 -171.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.523 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 31.3 ttp85 -107.65 137.63 45.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.638 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.586 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -152.28 153.65 34.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.494 0.664 . . . . 0.0 111.948 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 30.4 m -99.18 133.58 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.299 170.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.586 HD11 ' CE1' ' A' ' 68' ' ' PHE . 63.7 mt -121.92 140.23 52.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.379 0.609 . . . . 0.0 112.211 -170.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.638 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 17.1 t70 -83.88 159.64 21.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.565 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.448 ' HG3' ' OH ' ' A' ' 112' ' ' TYR . 22.2 ttt180 -53.39 -40.58 65.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.866 0.365 . . . . 0.0 111.452 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -89.46 16.2 8.01 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 111.056 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.452 ' CA ' ' HA ' ' A' ' 103' ' ' PRO . . . 71.89 46.17 38.78 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.811 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.638 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 51.2 t-80 -104.3 114.3 28.45 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.3 p -49.21 123.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.112 0.482 . . . . 0.0 111.162 173.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.606 HD12 HG22 ' A' ' 69' ' ' THR . 35.3 mt -110.0 -45.97 3.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.266 0.555 . . . . 0.0 110.571 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.28 149.14 52.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.981 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 m -136.74 124.22 32.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.0 m -144.11 121.76 11.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.5 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.635 HD21 ' HB2' ' A' ' 84' ' ' SER . 25.8 tp -76.18 111.95 12.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 173.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.753 HG21 HG23 ' A' ' 120' ' ' THR . 0.2 OUTLIER -85.36 -38.35 12.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.68 -170.684 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.451 ' HB3' ' HG3' ' A' ' 65' ' ' GLN . 8.4 t -148.05 149.17 31.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.635 ' HB2' HD21 ' A' ' 81' ' ' LEU . 46.3 t -149.07 149.14 30.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.22 0.533 . . . . 0.0 111.216 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.99 -18.09 15.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.583 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.414 ' C ' HD13 ' A' ' 87' ' ' LEU . . . 120.43 80.63 0.62 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.944 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.8 HD11 HD11 ' A' ' 127' ' ' LEU . 0.4 OUTLIER -117.51 91.23 37.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.87 -79.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.992 2.461 . . . . 0.0 112.556 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 92' ' ' ARG . 53.6 p -70.58 -18.62 62.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.394 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.735 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 17.9 mt -74.34 -39.93 62.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.131 -175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 15.4 t70 -54.58 -43.24 71.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.785 -170.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.4 ' CZ ' ' HA ' ' A' ' 89' ' ' SER . 4.1 ptp180 -54.01 -52.33 61.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -172.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -78.25 -48.03 16.65 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.909 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 90' ' ' LEU . 42.4 pt -62.98 -36.83 77.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.656 0.265 . . . . 0.0 111.4 -176.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.665 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.9 mm-40 -82.79 -25.85 32.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.073 0.463 . . . . 0.0 110.633 177.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.757 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -57.1 -45.55 83.31 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.657 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -64.87 -56.82 11.05 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.0 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.802 HG11 HG21 ' A' ' 123' ' ' ILE . 94.2 t -89.3 -50.52 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.665 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 35.1 ttmt -70.14 -27.47 64.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.619 0.247 . . . . 0.0 111.391 -173.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.757 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 20.9 tpt180 -88.34 -41.73 12.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.911 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.636 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -91.78 78.26 5.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.063 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.569 ' HB3' HD21 ' A' ' 70' ' ' LEU . 17.2 m -111.65 90.25 12.33 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.349 171.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.802 ' HG2' ' HG2' ' A' ' 44' ' ' ARG . 9.5 Cg_endo -104.91 -179.98 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.926 1 C-N-CA 125.992 4.462 . . . . 0.0 111.383 171.565 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.489 ' HG ' HD13 ' A' ' 70' ' ' LEU . 35.7 mt -136.38 127.95 17.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 169.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.715 ' HD3' ' HD2' ' A' ' 44' ' ' ARG . 57.0 Cg_endo -74.75 -24.23 13.59 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.514 2.143 . . . . 0.0 111.836 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 t -132.89 116.33 14.62 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.112 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.73 108.78 0.4 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.93 2.42 . . . . 0.0 111.717 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.53 ' HG2' ' CE2' ' A' ' 112' ' ' TYR . 82.0 Cg_endo -75.62 65.08 6.61 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.683 2.255 . . . . 0.0 111.563 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.586 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.2 -41.98 80.4 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.818 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.8 2.29 4.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.573 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.23 -34.74 5.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.509 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.653 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -115.2 16.75 16.89 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -174.008 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.6 m -71.38 88.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 1.2 p-10 159.82 -29.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 113.661 -1.608 . . . . 0.0 107.404 -168.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.38 -84.55 0.1 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.355 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.495 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 1.3 p -149.6 167.39 26.5 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -171.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 69' ' ' THR . 20.7 m -107.71 122.43 62.0 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 CA-C-O 120.904 0.383 . . . . 0.0 111.014 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -112.8 120.04 40.09 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.663 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -140.14 143.35 36.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.972 0.415 . . . . 0.0 111.606 -175.337 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.753 HG23 HG21 ' A' ' 82' ' ' VAL . 98.9 m -96.3 116.34 28.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.857 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.663 ' HG ' HD12 ' A' ' 119' ' ' LEU . 62.7 mt -119.21 122.76 29.27 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.275 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.696 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.3 Cg_exo -73.12 120.73 6.76 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.056 1.837 . . . . 0.0 111.427 177.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.802 HG21 HG11 ' A' ' 98' ' ' VAL . 21.6 pt -102.49 117.73 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -119.61 123.47 43.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.184 0.993 . . . . 0.0 112.508 -175.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.572 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 89.7 m-85 -115.23 133.02 56.42 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.604 166.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -57.66 103.73 0.15 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.044 0.45 . . . . 0.0 111.971 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.8 HD11 HD11 ' A' ' 87' ' ' LEU . 12.5 mt -84.01 104.0 13.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.181 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -149.81 29.05 0.76 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.348 0.594 . . . . 0.0 110.267 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -149.14 -77.68 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.462 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.421 ' HB3' HD21 ' A' ' 90' ' ' LEU . . . -98.43 36.14 1.67 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.246 0.546 . . . . 0.0 111.092 -176.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.606 ' HA3' HD22 ' A' ' 127' ' ' LEU . . . 177.83 109.49 0.25 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.456 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 . . . . . 0 N--CA 1.438 -1.053 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.41 178.291 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 121.166 0.507 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.4 t -117.14 -39.85 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 172.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -116.22 94.91 4.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.666 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -80.33 76.57 7.13 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -95.68 50.83 1.24 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.477 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.32 -32.28 64.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.138 176.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.69 157.42 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.959 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.34 84.57 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.932 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.7 101.49 11.77 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 120.606 0.241 . . . . 0.0 111.286 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.26 142.86 68.47 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.783 2.322 . . . . 0.0 110.865 173.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 14.3 Cg_endo -56.23 110.35 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.092 2.528 . . . . 0.0 112.115 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 25.4 Cg_exo -62.99 122.94 11.38 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.408 2.738 . . . . 0.0 112.848 -174.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -102.26 -170.98 27.11 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.825 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -104.26 153.42 21.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.837 0.351 . . . . 0.0 110.342 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.17 49.73 1.87 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.125 0.488 . . . . 0.0 111.08 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.2 135.08 41.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.499 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.7 tttm 71.81 -52.97 0.69 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.086 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m 61.49 70.9 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.637 0.732 . . . . 0.0 110.544 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.47 84.92 1.63 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.198 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.445 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -80.35 165.79 44.1 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.164 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 87.0 Cg_exo -48.36 -32.62 20.49 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.542 2.161 . . . . 0.0 113.262 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -68.9 -39.74 79.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.384 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.6 p -85.88 30.1 0.68 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.034 0.445 . . . . 0.0 111.207 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.691 ' HG3' ' HG ' ' A' ' 26' ' ' LEU . 36.1 ptt180 -72.12 -25.5 61.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.259 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.691 ' HG ' ' HG3' ' A' ' 25' ' ' ARG . 97.2 mt -129.96 31.43 4.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.068 0.461 . . . . 0.0 110.792 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.7 m -146.6 103.72 3.97 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.43 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -83.98 124.9 3.51 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.801 2.334 . . . . 0.0 112.703 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -105.05 119.12 38.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.913 0.387 . . . . 0.0 110.62 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.502 ' HB1' ' HB1' ' A' ' 111' ' ' ALA . . . -94.61 101.77 13.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.078 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -87.28 83.97 7.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.066 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.47 -33.98 28.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.511 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -156.68 134.9 4.22 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -75.85 73.74 2.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.507 0.67 . . . . 0.0 110.644 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 t70 72.44 -5.86 1.71 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.184 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -75.96 -8.55 57.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.145 0.498 . . . . 0.0 110.698 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -78.83 -17.08 56.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.328 -175.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 38' ' ' ARG . 10.8 ptp180 -68.48 -41.44 80.09 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.767 -171.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.8 p -64.79 -36.36 84.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.143 0.497 . . . . 0.0 110.434 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.47 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 30.8 mmt180 -73.93 -43.25 58.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.347 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.54 HG12 ' HD3' ' A' ' 105' ' ' PRO . 76.0 mt -57.01 -43.58 81.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.3 m -60.31 -30.61 69.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.881 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.33 -52.57 34.79 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.274 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 1.018 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.7 -28.41 65.81 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 175.19 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -53.86 -35.04 61.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.523 0.678 . . . . 0.0 109.362 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.765 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 7.1 t30 -71.93 -34.18 68.85 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.941 177.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -52.88 -28.15 21.79 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.277 173.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.582 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 95.8 m-85 -95.39 -59.23 1.93 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.947 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 21.1 mmmt -178.28 114.47 0.07 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.336 1.054 . . . . 0.0 108.923 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.765 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 41.8 ttp180 -129.54 105.38 8.04 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.273 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 2.7 t80 -90.32 134.92 30.34 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.844 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 32.3 Cg_exo -60.32 132.4 43.66 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.327 2.685 . . . . 0.0 112.566 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.608 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.21 -27.41 65.7 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.266 -171.122 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.19 -40.82 74.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.851 0.358 . . . . 0.0 110.713 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.51 -30.99 62.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.565 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.7 mm? -65.91 -38.48 88.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.884 0.373 . . . . 0.0 110.204 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -61.8 -17.32 55.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.534 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.1 mt -111.99 -0.68 15.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 111.129 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -128.44 -70.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.03 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.753 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 28.9 mmt180 -136.68 101.53 4.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.318 0.58 . . . . 0.0 110.107 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.549 ' HG3' ' HA ' ' A' ' 127' ' ' LEU . 3.2 pt20 -113.48 160.37 18.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.546 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.752 ' HA3' HD11 ' A' ' 87' ' ' LEU . . . 153.27 142.89 3.56 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.389 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -107.31 125.53 63.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.993 0.425 . . . . 0.0 109.996 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.15 164.4 26.19 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.421 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 48.2 mt-30 -103.85 129.28 51.31 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 68' ' ' PHE . 51.6 t -127.74 118.18 48.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.598 ' HG2' HG22 ' A' ' 82' ' ' VAL . 15.6 ptt180 -112.96 143.65 43.89 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -159.57 152.92 22.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.41 0.624 . . . . 0.0 112.502 -168.523 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.6 m -95.16 126.45 40.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.468 171.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.498 HD11 ' CE1' ' A' ' 68' ' ' PHE . 51.0 mt -117.34 143.82 45.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.173 0.511 . . . . 0.0 111.99 -170.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.754 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 22.2 t70 -86.28 154.96 20.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.13 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -53.21 -35.01 59.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.202 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -99.72 13.15 34.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.16 0.505 . . . . 0.0 111.154 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.53 40.59 12.56 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.812 -0.631 . . . . 0.0 113.388 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.754 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 57.2 t-80 -103.31 118.02 35.83 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.13 113.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.22 0.533 . . . . 0.0 111.149 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.44 -48.72 4.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.46 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.81 155.68 46.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.605 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -149.98 129.6 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 123.485 0.491 . . . . 0.0 110.026 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -142.32 125.66 16.58 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.279 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 84' ' ' SER . 34.2 tp -70.0 122.45 19.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.598 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -97.48 -41.65 11.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.183 -174.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 m -149.35 131.05 15.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.872 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.614 ' HB2' HD21 ' A' ' 81' ' ' LEU . 45.0 t -138.95 111.01 7.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.61 -62.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.14 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.463 ' H ' HD22 ' A' ' 87' ' ' LEU . . . -157.05 62.85 0.32 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.876 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.859 ' HA ' HD12 ' A' ' 90' ' ' LEU . 1.6 mm? -114.35 86.78 12.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 4.7 Cg_exo -77.16 -78.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.435 2.09 . . . . 0.0 111.545 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.1 p -74.79 -18.67 60.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.69 0.757 . . . . 0.0 110.242 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.859 HD12 ' HA ' ' A' ' 87' ' ' LEU . 10.5 mt -70.44 -38.7 74.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.404 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -54.49 -50.85 66.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.413 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.2 -40.88 71.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.221 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.493 ' CB ' ' HG3' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -78.22 -53.2 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.516 -173.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 90' ' ' LEU . 37.0 pt -64.74 -36.05 76.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.677 0.275 . . . . 0.0 111.727 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.642 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.9 mm-40 -79.22 -27.55 42.5 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 120.955 0.407 . . . . 0.0 110.506 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.38 -46.34 76.53 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 173.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.511 HD23 HG23 ' A' ' 98' ' ' VAL . 1.4 tp -67.59 -54.96 15.44 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.742 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.916 HG11 HG21 ' A' ' 123' ' ' ILE . 95.1 t -87.81 -48.62 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.642 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 40.3 ttmt -65.05 -23.29 67.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.046 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.497 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 30.9 tpt180 -93.6 -27.33 16.66 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.009 173.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.577 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -114.71 75.16 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.808 0.337 . . . . 0.0 111.29 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.4 m -108.34 95.06 14.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.225 0.536 . . . . 0.0 110.275 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 1.018 ' HB2' ' HG3' ' A' ' 44' ' ' ARG . 84.8 Cg_endo -113.74 122.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 124.482 3.454 . . . . 0.0 114.604 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.456 HD23 ' HD2' ' A' ' 105' ' ' PRO . 1.1 mt -92.02 123.75 61.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 172.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.549 ' HG3' ' HD3' ' A' ' 44' ' ' ARG . 1.7 Cg_endo -77.88 -59.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.568 2.179 . . . . 0.0 112.267 177.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.611 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 t -65.5 129.18 94.31 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.983 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.4 103.46 1.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.844 2.363 . . . . 0.0 112.267 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.8 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 68.5 Cg_endo -85.81 55.99 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.732 2.288 . . . . 0.0 111.524 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.74 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -54.38 -45.83 72.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.575 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.82 -6.84 51.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.291 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.8 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -98.36 -21.61 16.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.511 -177.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.837 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -124.3 17.79 9.04 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.142 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.4 m -71.1 89.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.965 0.888 . . . . 0.0 108.896 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 17.6 p-10 157.43 -13.78 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 113.19 -1.823 . . . . 0.0 107.903 -172.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.06 -90.72 0.1 Allowed Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.032 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.2 OUTLIER -160.57 175.09 13.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.308 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' A' ' 112' ' ' TYR . 10.8 m -101.99 114.47 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.417 0.627 . . . . 0.0 111.115 -175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -115.72 112.69 22.42 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 172.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.5 HD12 ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -144.11 152.61 41.17 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.328 -175.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.487 HG23 HG21 ' A' ' 82' ' ' VAL . 86.6 m -90.47 124.67 35.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.151 0.501 . . . . 0.0 111.77 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.5 ' HG ' HD12 ' A' ' 119' ' ' LEU . 57.8 mt -126.76 123.45 23.79 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.861 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 11.5 Cg_exo -70.61 120.09 6.83 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.066 1.844 . . . . 0.0 111.277 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.916 HG21 HG11 ' A' ' 98' ' ' VAL . 33.0 pt -94.5 99.17 9.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -98.95 123.62 43.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.068 0.937 . . . . 0.0 111.923 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.575 ' HE2' ' HE2' ' A' ' 53' ' ' LYS . 59.8 m-85 -115.16 125.25 53.2 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 162.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.9 p -57.55 105.12 0.22 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.503 0.668 . . . . 0.0 111.327 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.739 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -83.19 99.26 9.83 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.759 -173.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.464 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 53.4 mtp180 -81.0 -47.96 12.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.52 174.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.58 66.8 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.931 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.639 ' HB3' HD21 ' A' ' 90' ' ' LEU . . . -105.47 5.58 31.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.122 0.487 . . . . 0.0 110.839 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -97.92 62.38 0.93 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.602 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 21.2 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.993 -177.65 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.0 mttp . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.3 t 55.73 69.05 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.437 0.637 . . . . 0.0 111.472 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -149.96 159.68 44.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.424 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.31 126.28 54.84 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -105.03 12.69 31.94 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.835 -172.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.7 m 67.64 -80.54 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.145 0.578 . . . . 0.0 111.116 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 36.6 t -119.55 -28.72 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.154 0.502 . . . . 0.0 110.349 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.52 10.12 48.39 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.832 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.52 127.62 29.99 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.38 125.69 5.83 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.589 2.193 . . . . 0.0 112.76 -178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.47 114.5 4.05 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.941 2.427 . . . . 0.0 111.6 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.58 66.16 6.53 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.928 2.418 . . . . 0.0 113.061 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.33 70.63 0.99 Allowed Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.215 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.62 ' HD3' ' O ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -154.94 131.51 10.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.158 0.504 . . . . 0.0 111.131 178.136 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.6 147.85 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.35 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -85.84 20.23 2.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.919 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -118.12 -16.94 9.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.72 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 p -126.0 -72.85 0.64 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.935 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.95 43.16 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.445 0.641 . . . . 0.0 110.88 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.433 ' N ' ' HD2' ' A' ' 22' ' ' PRO . . . -76.04 -48.49 3.49 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.57 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 21' ' ' ALA . 72.1 Cg_endo -75.73 40.54 0.72 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.286 1.99 . . . . 0.0 112.926 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 58.03 41.73 23.72 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.22 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -66.52 -18.43 65.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.288 0.566 . . . . 0.0 110.909 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 25' ' ' ARG . 1.6 ptm180 -72.06 -20.81 61.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.982 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.6 tp -166.36 70.77 0.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.673 ' HB ' ' HD3' ' A' ' 28' ' ' PRO . 17.3 m -63.05 -54.59 44.85 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.427 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.673 ' HD3' ' HB ' ' A' ' 27' ' ' THR . 71.7 Cg_endo -80.44 106.25 1.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.615 1.543 . . . . 0.0 110.643 170.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.432 ' HE1' ' HB3' ' A' ' 31' ' ' GLN . 3.6 t80 -74.68 82.87 2.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.387 0.613 . . . . 0.0 110.59 -175.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.45 71.95 9.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.228 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.432 ' HB3' ' HE1' ' A' ' 29' ' ' TYR . 21.9 pt20 -85.77 67.15 9.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.329 0.585 . . . . 0.0 110.904 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.54 -41.26 8.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.759 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -134.88 90.21 0.24 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -92.83 -11.82 32.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.112 0.482 . . . . 0.0 110.575 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -118.94 -73.97 0.62 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.674 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -114.77 77.56 1.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.099 0.476 . . . . 0.0 110.319 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -119.18 -37.46 3.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.042 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -67.85 -30.03 69.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.104 0.478 . . . . 0.0 110.515 -174.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.4 -36.45 82.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.171 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.429 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 24.1 mmm180 -73.64 -41.36 62.85 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.346 0.594 . . . . 0.0 109.589 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.4 HG23 ' HG2' ' A' ' 103' ' ' PRO . 87.6 mt -61.39 -42.35 93.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.041 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t -55.59 -39.62 70.95 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.002 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.14 99.1 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.878 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.646 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 8.6 mpt_? -69.35 -34.69 74.98 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.787 0.327 . . . . 0.0 110.809 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.61 HD11 HG22 ' A' ' 98' ' ' VAL . 1.1 tt -65.11 -27.68 68.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.72 0.771 . . . . 0.0 109.581 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.62 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 10.3 t30 -71.96 -37.67 69.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.885 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -56.73 -27.8 59.89 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.609 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.503 ' HE2' ' HB3' ' A' ' 103' ' ' PRO . 94.9 m-85 -88.51 -56.87 3.13 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.866 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 mtmm 172.96 103.43 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.209 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.62 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 52.7 ttp180 -108.4 103.03 12.1 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -72.38 131.59 84.73 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.59 131.14 32.11 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.71 2.274 . . . . 0.0 112.131 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.92 -21.33 63.29 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.407 -173.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 9.7 t0 -52.97 -38.59 62.27 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.505 0.503 . . . . 0.0 110.792 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.74 -43.65 45.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.154 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.2 mm? -64.07 -41.02 97.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.323 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.705 ' HG3' ' HG ' ' A' ' 58' ' ' LEU . 27.6 ptt180 -61.66 -19.72 62.62 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.361 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.705 ' HG ' ' HG3' ' A' ' 57' ' ' ARG . 82.9 mt -116.07 14.17 15.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.461 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.737 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 40.3 ttpt -151.21 -74.48 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 0.0 111.791 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.737 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 24.4 mmt180 -112.1 84.89 2.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.522 0.677 . . . . 0.0 110.183 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 126' ' ' SER . 3.1 pt20 -111.19 166.52 11.02 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.272 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.75 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.59 147.34 4.57 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.186 -1.483 . . . . 0.0 113.91 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.76 ' H ' HD12 ' A' ' 127' ' ' LEU . 61.9 t -116.13 124.94 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -151.97 166.15 30.87 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.432 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.621 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 56.8 mt-30 -101.85 132.15 47.78 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.482 HG12 ' CD2' ' A' ' 68' ' ' PHE . 56.1 t -124.26 113.23 35.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.404 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 64.9 ttt180 -103.02 121.75 43.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -177.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -142.53 165.64 26.84 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.466 0.651 . . . . 0.0 112.121 -171.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.743 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 11.9 m -114.99 127.78 55.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.005 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 68' ' ' PHE . 46.5 mt -116.3 132.34 56.7 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.246 0.546 . . . . 0.0 111.784 -169.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 26.5 t70 -71.65 155.32 40.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.42 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.448 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 46.2 mtp180 -59.32 -18.81 41.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.294 -175.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -108.1 14.9 24.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.923 0.392 . . . . 0.0 111.279 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 77.54 49.26 7.38 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.714 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 19.1 t60 -114.84 126.49 54.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.87 121.91 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.187 0.517 . . . . 0.0 111.42 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 71' ' ' ASP . 52.7 mt -111.88 -47.53 3.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.251 0.548 . . . . 0.0 110.587 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.88 150.61 51.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.858 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.44 116.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.314 0.578 . . . . 0.0 110.386 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.6 m -127.43 127.12 43.59 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.888 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.6 tp -77.32 112.31 13.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.249 0.547 . . . . 0.0 110.466 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -96.28 -43.81 12.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.496 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 21.3 t 65.96 173.1 0.23 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.743 169.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.621 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 26.5 m -146.7 -67.11 0.27 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.23 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.25 -86.08 0.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.66 96.8 0.1 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.995 -174.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.863 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -120.1 84.46 33.52 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.149 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.36 -76.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 111.956 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 m -70.32 -18.42 63.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.529 0.68 . . . . 0.0 110.136 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.863 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.8 mt -75.8 -36.7 59.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.387 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 14.4 t70 -54.54 -47.76 72.78 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.671 0.607 . . . . 0.0 111.834 -172.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -52.71 -51.9 58.44 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -170.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.52 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 22.8 tt0 -77.97 -48.21 16.77 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.221 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 90' ' ' LEU . 38.3 pt -62.76 -35.99 73.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 120.578 0.228 . . . . 0.0 111.217 -176.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.602 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 74.5 mm-40 -82.32 -28.25 31.77 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-O 120.951 0.405 . . . . 0.0 110.589 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.676 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.96 -46.5 78.56 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 170.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 tp -67.26 -55.66 13.04 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.904 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.884 HG11 HG21 ' A' ' 123' ' ' ILE . 72.1 t -87.83 -49.05 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.9 ttmt -66.52 -19.71 65.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.666 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.676 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 14.2 tpp180 -91.24 -49.94 6.1 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.68 169.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.616 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -90.87 64.76 5.58 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.698 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -89.7 99.48 1.79 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.145 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.646 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 71.9 Cg_endo -102.31 174.76 0.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.737 2.958 . . . . 0.0 114.176 -174.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.582 HD21 ' HD2' ' A' ' 108' ' ' PRO . 32.0 tp -144.69 102.13 4.59 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.726 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 6.1 Cg_exo -68.25 -77.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.134 1.889 . . . . 0.0 112.866 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.433 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.5 p -80.59 119.03 75.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.702 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 26.8 Cg_exo -62.75 108.65 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.209 2.606 . . . . 0.0 112.806 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.853 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 86.4 Cg_endo -83.02 62.15 7.59 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.172 2.581 . . . . 0.0 111.68 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.713 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -52.33 -44.69 65.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.612 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.94 -9.97 59.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.123 -176.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.853 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -99.35 -23.88 15.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.818 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.713 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -117.02 17.58 14.88 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.317 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.546 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.8 m -71.68 88.42 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 168.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.546 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 1.7 p-10 157.17 -16.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 113.989 -1.46 . . . . 0.0 108.002 -168.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.37 -85.1 0.14 Allowed Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.421 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.538 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.2 OUTLIER -154.71 176.5 12.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.743 ' O ' ' HA ' ' A' ' 69' ' ' THR . 3.7 m -99.98 107.61 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.995 0.903 . . . . 0.0 110.183 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 31.8 tt0 -107.95 111.16 23.12 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.04 175.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.762 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -147.33 155.06 41.67 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.346 -172.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.581 HG23 HG21 ' A' ' 82' ' ' VAL . 89.3 m -98.08 118.66 35.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.531 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.762 ' HG ' HD12 ' A' ' 119' ' ' LEU . 30.5 mt -124.18 127.76 25.24 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.409 175.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.5 Cg_exo -72.22 119.36 6.11 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.942 1.761 . . . . 0.0 110.768 175.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.884 HG21 HG11 ' A' ' 98' ' ' VAL . 40.7 pt -90.29 103.25 14.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -101.71 123.44 45.7 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.763 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -114.33 150.55 34.35 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 166.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 7.8 m -63.26 101.81 0.34 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.638 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.76 HD12 ' H ' ' A' ' 63' ' ' VAL . 1.3 tt -89.58 102.63 15.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.905 0.383 . . . . 0.0 110.379 -174.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.469 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 36.3 mtp180 -98.59 -58.36 1.98 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.775 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.55 -156.61 8.48 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.892 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.485 ' CB ' HD21 ' A' ' 90' ' ' LEU . . . 69.47 -55.79 0.57 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.688 0.795 . . . . 0.0 112.007 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.48 -32.96 85.06 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.836 -0.506 . . . . 0.0 111.836 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.89 176.292 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.772 0.32 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 4' ' ' GLN . 2.5 p -90.16 -72.5 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.047 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.641 ' H ' HG13 ' A' ' 3' ' ' VAL . 61.0 tt0 159.02 57.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.671 0.789 . . . . 0.0 109.581 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -165.35 115.2 1.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.647 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -128.34 3.52 5.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.008 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.9 t -75.88 -33.6 59.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.235 0.541 . . . . 0.0 109.922 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.37 5.42 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.825 0.821 . . . . 0.0 109.648 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.94 -166.44 33.03 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.97 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -128.53 111.52 19.27 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.6 0.2 . . . . 0.0 110.88 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 28.8 Cg_exo -62.48 137.96 67.88 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.849 2.366 . . . . 0.0 111.896 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 29.8 Cg_exo -61.58 120.33 7.92 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.986 2.457 . . . . 0.0 112.067 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.79 57.47 6.51 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.893 2.395 . . . . 0.0 112.663 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.19 161.07 24.16 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.231 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.533 ' HG2' ' H ' ' A' ' 17' ' ' ASP . 32.8 ttp-105 -142.84 136.95 29.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.28 25.81 10.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.235 0.54 . . . . 0.0 110.36 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.533 ' H ' ' HG2' ' A' ' 15' ' ' ARG . 12.7 m-20 -124.03 76.02 1.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.654 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -105.58 -78.36 0.57 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.1 p -85.01 57.54 4.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.069 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.643 ' HA ' ' HB ' ' A' ' 24' ' ' THR . . . -140.46 71.62 1.37 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.983 -176.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.829 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -110.58 -66.55 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 1.3 Cg_endo -83.35 -82.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.323 2.015 . . . . 0.0 113.289 -174.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -101.87 23.93 10.69 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.922 0.392 . . . . 0.0 111.552 -174.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.643 ' HB ' ' HA ' ' A' ' 20' ' ' ALA . 2.4 m -96.91 19.69 12.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.991 0.901 . . . . 0.0 110.139 176.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HE ' ' HA ' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -105.95 -50.87 3.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 171.209 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.1 mt -138.85 82.13 1.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.016 173.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 5.7 t -68.38 134.2 91.07 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.348 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 27' ' ' THR . 40.1 Cg_exo -58.15 107.21 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.844 2.362 . . . . 0.0 111.89 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -79.89 79.21 6.44 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.811 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.71 141.3 57.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.92 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -135.87 138.1 42.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.907 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.93 116.3 10.62 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.59 79.89 0.27 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.361 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -128.87 148.48 50.91 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 172.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -101.93 -26.56 13.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.013 0.435 . . . . 0.0 110.883 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.549 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 64.9 t30 -91.58 -1.32 57.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.441 -175.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.511 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.5 OUTLIER -60.23 -33.5 72.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.602 0.239 . . . . 0.0 111.217 -177.3 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -67.93 -38.31 82.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.23 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.82 -30.57 65.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.884 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 60.0 mtt180 -68.2 -41.72 80.93 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 172.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 37' ' ' TRP . 88.8 mt -59.05 -46.03 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.855 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.7 m -56.47 -29.79 62.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.892 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.69 -43.03 69.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.567 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.51 -34.27 74.04 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.102 0.477 . . . . 0.0 110.465 178.076 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 101' ' ' ALA . 1.3 tt -61.17 -33.48 73.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.96 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.845 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 34.4 t30 -70.85 -37.87 73.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.696 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -27.39 34.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.901 175.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.79 -62.07 1.29 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.236 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 29.6 mtpp -164.0 103.14 0.88 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.845 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 56.3 ttp180 -117.81 103.29 9.83 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.58 176.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -77.3 112.8 25.92 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.11 131.38 44.94 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.592 2.194 . . . . 0.0 112.107 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.59 ' HE2' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -58.66 -22.69 57.55 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.683 -174.337 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.614 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 6.6 m-20 -55.07 -39.11 68.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.754 0.312 . . . . 0.0 110.982 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.12 -36.21 61.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.215 0.531 . . . . 0.0 110.417 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.4 mm? -67.6 -35.62 79.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.745 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.614 ' HE ' ' HA ' ' A' ' 54' ' ' ASP . 46.8 mtm180 -54.1 -39.42 66.36 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 111.923 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.5 mp -94.62 -23.41 17.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.287 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.751 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 6.6 ttpp -113.56 -81.9 0.6 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.77 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 19.3 mmt180 -103.19 83.07 2.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.4 0.619 . . . . 0.0 111.42 -173.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.501 HE22 ' CB ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -105.29 144.06 32.6 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.854 173.219 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 1.013 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 162.08 131.9 1.27 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.675 -170.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.84 125.53 58.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.985 0.421 . . . . 0.0 110.843 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.7 164.76 24.34 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 55.5 mt-30 -115.42 127.13 55.14 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.402 HG23 ' CE2' ' A' ' 68' ' ' PHE . 27.4 m -118.07 139.64 44.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.347 0.594 . . . . 0.0 110.825 -174.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 45.4 ttp180 -112.98 138.09 50.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.908 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -154.96 148.91 25.72 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.343 0.592 . . . . 0.0 112.116 -177.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 15.3 m -93.51 129.72 39.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 169.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.675 HD13 ' HG ' ' A' ' 104' ' ' LEU . 47.5 mt -121.31 136.69 54.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.203 0.525 . . . . 0.0 111.915 -170.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.721 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 14.4 t70 -83.56 161.73 21.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.677 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG2' ' N ' ' A' ' 73' ' ' GLN . 2.4 ptp180 -54.78 -35.9 64.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.693 0.282 . . . . 0.0 111.632 -177.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.484 ' N ' ' HG2' ' A' ' 72' ' ' ARG . 15.4 pt20 -87.39 12.05 13.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.351 . . . . 0.0 111.26 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 103' ' ' PRO . . . 75.85 34.17 48.93 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.876 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.721 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 35.3 t-80 -92.57 104.8 17.06 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.8 p -48.92 123.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.467 0.651 . . . . 0.0 111.377 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 13.6 mt -107.7 -43.08 4.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.528 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.85 153.58 51.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.865 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.435 ' HB ' ' HD2' ' A' ' 99' ' ' LYS . 11.3 m -140.15 129.36 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.302 0.572 . . . . 0.0 110.812 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.6 m -145.42 120.48 10.08 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.868 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 84' ' ' SER . 26.1 tp -72.97 108.25 5.78 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.519 HG21 HG23 ' A' ' 120' ' ' THR . 0.2 OUTLIER -80.46 -42.36 21.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.898 -172.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 65' ' ' GLN . 8.6 t -140.22 147.27 39.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.212 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.487 ' HB2' HD21 ' A' ' 81' ' ' LEU . 28.6 t -142.88 131.88 23.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.831 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.54 17.5 6.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.013 0.435 . . . . 0.0 110.856 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.517 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 94.86 65.92 1.0 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.926 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.912 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -111.81 90.08 12.4 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 117.085 0.442 . . . . 0.0 109.954 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 6.1 Cg_exo -73.91 -74.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.714 2.276 . . . . 0.0 111.802 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.4 m -74.89 -19.22 60.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.431 0.634 . . . . 0.0 110.386 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.912 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 9.6 mt -76.89 -42.37 40.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.762 -172.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.575 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 28.6 t70 -54.95 -50.16 69.59 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.67 0.606 . . . . 0.0 112.414 -170.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -53.25 -44.28 68.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -77.05 -53.17 8.14 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.794 0.33 . . . . 0.0 111.784 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 34.0 pt -60.53 -35.85 66.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.631 -176.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.689 HE22 HD11 ' A' ' 123' ' ' ILE . 51.3 mm-40 -82.91 -21.58 34.15 Favored 'General case' 0 C--O 1.205 -1.273 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.129 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.05 -54.06 44.52 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.142 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.664 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -75.72 -46.24 32.21 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.543 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.862 HG11 HG21 ' A' ' 123' ' ' ILE . 30.8 t -62.55 -49.21 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.54 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 1.3 tppp? -70.82 -35.63 72.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.191 -169.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -80.71 -34.9 34.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.848 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.619 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -101.15 67.65 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.193 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.0 m -97.33 97.69 4.12 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.182 0.515 . . . . 0.0 109.781 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.619 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 88.0 Cg_endo -107.93 173.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.245 3.297 . . . . 0.0 114.553 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.675 ' HG ' HD13 ' A' ' 70' ' ' LEU . 14.1 mt -140.61 122.39 9.45 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.617 171.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.488 ' HD3' HG12 ' A' ' 41' ' ' ILE . 12.2 Cg_endo -82.06 -40.17 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.657 2.238 . . . . 0.0 111.676 174.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.464 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 12.8 m -94.92 103.46 11.73 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.374 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.87 106.76 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.564 2.176 . . . . 0.0 112.234 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.707 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 67.9 Cg_endo -83.0 58.19 6.25 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.751 2.301 . . . . 0.0 111.813 -176.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.783 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.55 -46.21 77.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.832 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.92 -23.02 66.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.158 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.707 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.72 -35.89 18.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.075 -175.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.783 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -105.78 15.91 26.04 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.008 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 3.6 m -72.15 89.52 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 169.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 2.3 p30 159.75 -22.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.212 -169.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 162.42 -85.09 0.11 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.737 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.551 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -159.4 173.22 16.57 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.723 HG13 ' HB3' ' A' ' 112' ' ' TYR . 24.5 m -104.98 110.4 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 121.328 0.585 . . . . 0.0 110.961 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 43.9 tt0 -107.78 110.65 22.5 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 170.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.604 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.7 pp -135.41 155.62 50.26 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.39 -174.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.519 HG23 HG21 ' A' ' 82' ' ' VAL . 99.9 m -101.08 129.13 46.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.107 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.604 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 54.3 mt -128.56 130.49 23.51 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 2.9 Cg_exo -76.12 121.48 6.17 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.791 2.327 . . . . 0.0 111.565 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.862 HG21 HG11 ' A' ' 98' ' ' VAL . 43.0 pt -97.76 99.98 9.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.49 119.04 29.58 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.124 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.59 ' CE2' ' HE2' ' A' ' 53' ' ' LYS . 83.2 m-85 -116.25 120.19 38.14 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 162.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.5 m -58.74 102.5 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -169.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 1.013 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 3.4 mt -73.23 114.13 11.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.104 0.478 . . . . 0.0 110.248 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.68 24.75 4.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.639 -175.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 145.42 61.12 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.819 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.501 ' CB ' HE22 ' A' ' 61' ' ' GLN . . . -169.0 164.55 11.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 89.29 -6.68 83.24 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.543 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 30.0 p90 . . . . . 0 C--O 1.252 1.195 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.014 179.026 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.77 29.24 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.215 0.531 . . . . 0.0 110.561 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -131.81 50.26 2.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -89.28 78.22 7.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.37 -170.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -91.52 -60.41 1.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.154 0.502 . . . . 0.0 110.349 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' A' ' 10' ' ' ALA . 23.9 t -94.64 117.97 30.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.52 -177.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.81 -57.36 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.542 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.84 24.63 14.4 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.106 -0.569 . . . . 0.0 113.605 -174.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.485 ' HB3' ' OG ' ' A' ' 7' ' ' SER . . . -114.64 111.86 45.89 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.432 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 36.4 Cg_endo -66.23 121.46 8.76 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.654 2.236 . . . . 0.0 111.823 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 40.3 Cg_endo -67.93 122.78 9.93 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.695 2.263 . . . . 0.0 111.782 178.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 28.0 Cg_exo -62.08 111.39 1.23 Allowed 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.7 2.266 . . . . 0.0 111.994 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -93.34 -54.4 1.71 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.632 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -127.6 110.42 12.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.727 0.299 . . . . 0.0 111.265 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.66 -55.59 4.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 46.54 73.18 0.19 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.328 -1.306 . . . . 0.0 112.85 170.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -137.66 138.53 39.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.622 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 m -88.68 -18.3 28.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.343 0.592 . . . . 0.0 110.333 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.3 61.7 6.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.806 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.743 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -118.73 -60.25 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.869 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 4.1 Cg_exo -74.99 -87.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.925 1.75 . . . . 0.0 113.041 -176.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -110.49 -27.57 8.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.609 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -78.22 44.53 0.5 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.228 0.537 . . . . 0.0 111.497 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.719 ' HG3' ' HG ' ' A' ' 26' ' ' LEU . 8.6 ptp180 -100.43 -18.94 16.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.247 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.719 ' HG ' ' HG3' ' A' ' 25' ' ' ARG . 83.9 mt -117.07 11.28 14.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.267 0.556 . . . . 0.0 110.384 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.1 p -89.33 121.37 69.44 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.722 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -68.92 103.91 1.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.532 2.155 . . . . 0.0 109.965 172.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -90.32 45.3 1.25 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.534 0.683 . . . . 0.0 110.637 -174.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 111' ' ' ALA . . . -90.31 -10.58 43.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.422 170.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.43 ' H ' ' HG2' ' A' ' 31' ' ' GLN . 8.0 pt20 -82.7 60.94 5.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.803 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.9 130.87 38.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.912 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.03 21.6 0.17 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.054 -0.594 . . . . 0.0 111.802 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -116.55 -40.39 3.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.051 -176.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.5 t70 66.72 139.14 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.509 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 178.46 -27.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.311 -1.313 . . . . 0.0 107.819 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.684 ' HA ' ' HG2' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -74.99 -8.18 55.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.118 -178.032 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 39' ' ' SER . 9.6 ptp180 -63.6 -39.96 95.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.243 0.544 . . . . 0.0 109.874 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.581 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 3.5 m -67.58 -30.39 69.99 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.602 -178.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.684 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 16.8 mmt180 -71.72 -43.35 66.02 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.283 176.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.629 HG23 ' HD2' ' A' ' 103' ' ' PRO . 76.2 mt -59.85 -49.04 85.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.222 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.1 t -57.04 -30.24 64.08 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.605 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -68.21 -44.94 73.64 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.043 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.509 ' NE ' ' HB3' ' A' ' 105' ' ' PRO . 9.5 mpt_? -69.66 -34.49 74.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.973 0.416 . . . . 0.0 110.322 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 101' ' ' ALA . 2.7 tt -59.52 -32.28 70.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.761 0.791 . . . . 0.0 109.076 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 1.031 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 28.4 t30 -70.99 -42.32 69.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.156 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 8.0 ptt180 -61.29 -18.54 58.99 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.298 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -100.54 -58.47 1.89 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.153 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -162.59 103.08 1.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.864 0.466 . . . . 0.0 110.314 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 1.031 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 5.7 tpt180 -134.05 103.12 5.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.413 ' HB3' HD21 ' A' ' 56' ' ' LEU . 1.8 t80 -89.16 138.14 29.08 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.223 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.56 131.62 41.8 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.806 2.337 . . . . 0.0 111.996 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.01 -25.68 67.07 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.037 -173.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.1 -41.05 67.84 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.323 0.389 . . . . 0.0 110.913 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.1 -38.73 75.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.743 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.5 mm? -66.53 -38.73 87.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.549 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 69.8 mtt180 -65.71 -13.95 60.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.386 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.6 mt -110.85 2.1 18.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.792 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.596 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 21.1 ttmm -137.92 -74.42 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.532 -173.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.596 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 38.4 mmt180 -126.55 106.4 9.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 110.335 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.473 ' O ' HD13 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -117.78 158.19 25.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.612 178.437 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.976 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 153.29 144.17 3.85 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 119.79 -1.195 . . . . 0.0 113.345 -177.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.763 ' H ' HD12 ' A' ' 127' ' ' LEU . 2.8 p -104.13 122.77 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.373 0.606 . . . . 0.0 110.132 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.79 151.35 21.25 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.688 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 21.9 tt0 -105.63 135.42 47.06 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.53 131.67 71.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.014 0.435 . . . . 0.0 110.777 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -115.04 140.9 48.67 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.31 153.74 27.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.209 0.528 . . . . 0.0 111.757 -175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.676 ' CG2' ' HB ' ' A' ' 116' ' ' THR . 21.1 m -96.89 130.39 44.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.8 173.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 49.6 mt -118.35 133.98 55.43 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.111 0.481 . . . . 0.0 111.677 -173.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.71 155.9 30.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.186 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 72' ' ' ARG . 32.0 ttm180 -55.75 -33.71 64.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.003 0.43 . . . . 0.0 110.285 175.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -76.68 6.25 6.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.129 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.23 36.82 63.61 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.395 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -113.29 122.45 47.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 8.6 p -48.75 127.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.927 0.767 . . . . 0.0 111.522 172.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.419 ' CD1' HG21 ' A' ' 116' ' ' THR . 36.0 mt -113.71 -43.85 3.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.224 0.535 . . . . 0.0 110.73 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.79 154.21 48.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.168 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.508 HG11 ' HG3' ' A' ' 99' ' ' LYS . 3.1 m -147.66 127.08 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.0 m -144.64 127.83 16.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 tp -76.38 108.64 9.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.754 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -74.63 -34.26 34.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.637 0.732 . . . . 0.0 109.056 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 14.9 t 75.29 171.39 0.27 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.605 170.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -153.67 -52.44 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.682 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.93 -79.1 0.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 168.49 103.68 0.17 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.513 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.772 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.7 OUTLIER -119.39 103.96 46.22 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.244 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -84.44 -81.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.24 1.96 . . . . 0.0 111.991 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.2 p -71.0 -19.02 62.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.192 0.52 . . . . 0.0 110.529 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.772 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 8.9 mt -75.12 -32.26 61.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.908 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 15.8 t70 -54.48 -50.38 67.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.896 -171.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 93' ' ' GLU . 17.0 ptp180 -52.64 -46.89 67.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.569 -175.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.451 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 11.1 mt-10 -78.46 -53.94 6.7 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.51 HD11 ' HG ' ' A' ' 87' ' ' LEU . 34.2 pt -62.32 -33.91 61.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.553 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 56.1 mm-40 -82.02 -29.56 31.94 Favored 'General case' 0 C--O 1.203 -1.392 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.371 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.78 68.47 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.136 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.717 HD23 HG23 ' A' ' 98' ' ' VAL . 0.7 OUTLIER -63.81 -54.64 31.95 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.763 176.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.872 HG11 HG21 ' A' ' 123' ' ' ILE . 39.4 t -85.15 -48.55 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.553 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -63.59 -34.34 77.59 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.211 0.604 . . . . 0.0 110.865 -174.33 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -76.49 -48.3 19.99 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.247 0.546 . . . . 0.0 109.689 177.68 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.628 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -93.34 58.83 2.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.398 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.501 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.9 m -95.84 99.23 4.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.334 0.588 . . . . 0.0 109.939 174.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.629 ' HD2' HG23 ' A' ' 41' ' ' ILE . 72.9 Cg_endo -103.42 176.17 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 124.712 3.608 . . . . 0.0 113.441 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.663 HD21 ' HD2' ' A' ' 108' ' ' PRO . 38.5 tp -142.04 91.0 8.16 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.509 ' HB3' ' NE ' ' A' ' 44' ' ' ARG . 11.9 Cg_endo -70.46 -53.13 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.246 1.964 . . . . 0.0 112.824 -174.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.539 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 23.2 p -92.08 106.25 16.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -68.3 106.16 1.35 Allowed 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.822 2.348 . . . . 0.0 112.621 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.663 ' HD2' HD21 ' A' ' 104' ' ' LEU . 44.9 Cg_endo -86.66 61.18 4.4 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.195 2.596 . . . . 0.0 111.194 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.737 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.46 -41.54 80.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.17 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.99 -25.76 67.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.511 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.97 -29.76 21.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.84 ' HD2' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.72 16.41 16.39 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -172.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.5 m -71.36 88.36 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.1 p30 154.95 -15.35 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 113.426 -1.716 . . . . 0.0 108.609 -167.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 168.96 -100.21 0.16 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.828 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.676 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.3 OUTLIER -161.15 176.67 11.04 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.84 HG13 ' HD2' ' A' ' 112' ' ' TYR . 12.3 m -101.5 108.77 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.585 0.707 . . . . 0.0 110.754 -177.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -99.0 111.25 23.7 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.596 HD12 ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -134.49 152.85 52.06 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.843 -173.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.754 HG23 HG21 ' A' ' 82' ' ' VAL . 54.8 m -103.42 128.07 50.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.395 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.596 ' HG ' HD12 ' A' ' 119' ' ' LEU . 98.3 mt -132.94 125.19 19.03 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.481 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.688 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 3.2 Cg_exo -79.97 120.18 4.14 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.947 1.764 . . . . 0.0 111.785 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.872 HG21 HG11 ' A' ' 98' ' ' VAL . 41.6 pt -96.6 98.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 3.4 p-10 -107.03 124.94 50.37 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.693 -176.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.427 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 82.8 m-85 -111.75 141.65 45.09 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 165.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.4 m -57.76 102.49 0.1 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.034 0.445 . . . . 0.0 111.614 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.976 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -85.9 69.69 10.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.331 -175.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 25.76 5.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.33 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 162.12 179.15 36.57 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.481 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.564 ' HB1' HD21 ' A' ' 90' ' ' LEU . . . 74.37 -50.01 0.67 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.557 0.743 . . . . 0.0 112.479 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.529 ' HA3' HD21 ' A' ' 127' ' ' LEU . . . -71.04 -25.33 75.94 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.381 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 29.4 p90 . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.716 178.104 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.8 mttp . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 110.559 -0.163 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 67.9 t 72.85 -49.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.623 0.769 . . . . 0.0 112.418 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -60.71 -24.85 65.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -173.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.439 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 27.5 mp0 -65.68 -35.07 79.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.183 0.516 . . . . 0.0 109.937 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -81.57 -22.52 37.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.453 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m -85.85 67.89 10.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.354 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.01 -51.6 38.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.91 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.91 163.06 33.02 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.729 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.98 106.82 13.81 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.684 0.278 . . . . 0.0 110.637 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -62.09 135.1 52.89 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.759 2.306 . . . . 0.0 111.87 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.76 119.95 6.56 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.674 2.249 . . . . 0.0 112.392 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.52 -12.23 20.53 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.073 2.515 . . . . 0.0 112.115 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.21 139.45 15.65 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -102.73 148.71 25.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.007 0.432 . . . . 0.0 111.081 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -160.08 99.51 1.36 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.519 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -125.87 130.79 52.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.136 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -133.61 104.71 6.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.707 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.2 p 64.46 -7.16 0.25 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.644 1.178 . . . . 0.0 113.742 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 24' ' ' THR . . . -94.68 36.35 1.18 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.599 0.714 . . . . 0.0 110.859 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.671 ' H ' ' HD2' ' A' ' 22' ' ' PRO . . . -114.7 -54.53 0.04 OUTLIER Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.492 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.671 ' HD2' ' H ' ' A' ' 21' ' ' ALA . 56.6 Cg_endo -72.71 -19.22 24.42 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 121.492 1.461 . . . . 0.0 111.775 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.44 ' NE2' ' HA ' ' A' ' 23' ' ' GLN . 12.8 mm-40 -120.7 41.07 3.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.22 0.533 . . . . 0.0 111.066 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 21' ' ' ALA . 14.8 t -98.46 29.54 3.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.017 0.913 . . . . 0.0 108.877 172.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -96.12 -73.42 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.467 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.6 mp -141.46 65.61 1.38 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.495 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -67.67 126.02 92.04 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 121.073 0.463 . . . . 0.0 111.231 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -83.64 14.52 2.37 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.954 2.436 . . . . 0.0 112.387 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -103.93 31.39 4.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.492 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.505 ' HB1' HG12 ' A' ' 117' ' ' VAL . . . -88.33 20.58 3.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.81 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -81.47 73.1 8.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.402 0.62 . . . . 0.0 109.751 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.21 -4.56 59.1 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.107 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.6 115.94 4.04 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.187 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 1.1 pm0 -91.52 -1.62 57.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.266 0.555 . . . . 0.0 110.372 177.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -97.55 119.31 35.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -72.81 119.05 16.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.028 0.442 . . . . 0.0 110.728 -174.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 -82.43 25.04 0.65 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.797 -174.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -67.95 -35.76 78.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.453 -170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 p -63.48 -40.39 96.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.266 0.555 . . . . 0.0 110.144 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.511 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 50.8 mmm-85 -74.99 -46.24 36.56 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.268 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.551 HG23 ' HG2' ' A' ' 103' ' ' PRO . 58.3 mt -57.46 -43.19 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.549 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.7 m -59.73 -44.43 93.76 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.603 0.24 . . . . 0.0 111.51 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.85 -33.98 88.7 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.457 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.646 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 27.9 ttt85 -69.83 -35.73 75.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.75 0.309 . . . . 0.0 110.347 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -64.28 -31.55 72.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.379 0.609 . . . . 0.0 109.667 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.643 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 11.4 t30 -70.97 -30.69 67.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.631 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 47.9 ttt180 -70.18 -29.03 65.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.84 171.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 49' ' ' LYS . 61.3 m-85 -99.62 25.25 7.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.202 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 48' ' ' PHE . 13.0 tmtt? 74.2 103.36 0.07 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.493 0.664 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.643 ' HB3' ' HA ' ' A' ' 46' ' ' ASN . 32.3 ttt180 -137.89 108.0 6.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.191 -176.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.552 ' HB3' HD21 ' A' ' 56' ' ' LEU . 6.2 t80 -61.78 134.6 94.06 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.43 129.13 8.55 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.987 2.458 . . . . 0.0 112.06 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.758 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -71.49 -25.28 62.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.125 -163.406 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -66.93 -33.26 75.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.958 0.408 . . . . 0.0 110.77 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.85 -30.32 70.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.415 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.6 mm? -78.41 -41.68 32.31 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.765 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 51.4 mtm180 -75.1 -10.89 59.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.05 -0.406 . . . . 0.0 111.994 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 33.3 tp -105.58 17.06 24.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.466 0.65 . . . . 0.0 109.803 176.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.549 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 25.0 ttmm -146.01 -54.27 0.27 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.371 -175.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.88 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 17.9 mmt180 -126.32 83.28 2.15 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.866 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.594 ' HB2' ' O ' ' A' ' 126' ' ' SER . 0.8 OUTLIER -100.15 137.3 38.78 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.552 -179.051 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.918 ' HA3' HD11 ' A' ' 87' ' ' LEU . . . 171.99 160.61 20.92 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.669 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.416 ' H ' HD12 ' A' ' 127' ' ' LEU . 2.6 p -116.35 125.72 73.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.173 0.511 . . . . 0.0 110.527 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.93 159.27 23.46 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.558 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 49.9 tt0 -104.27 123.74 47.9 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 121' ' ' LEU . 9.5 p -127.01 126.68 68.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.408 0.623 . . . . 0.0 111.041 -167.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -115.82 144.94 43.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.717 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -158.97 155.14 27.02 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.066 0.46 . . . . 0.0 110.937 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 22.0 m -100.52 129.35 46.45 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 171.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 75.5 mt -113.95 140.59 48.27 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.724 0.773 . . . . 0.0 112.146 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 27.9 t70 -77.7 165.16 24.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.85 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.505 ' HA ' ' OH ' ' A' ' 112' ' ' TYR . 38.6 mtp180 -54.39 -35.72 63.15 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.531 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -83.03 6.16 19.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 110.817 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . 72.8 40.1 53.49 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.623 -176.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 71.1 t60 -108.14 138.16 44.89 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.379 -0.41 . . . . 0.0 110.349 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 100' ' ' ARG . 10.5 p -59.24 130.94 23.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.348 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 71' ' ' ASP . 56.5 mt -120.27 -40.77 2.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.292 0.568 . . . . 0.0 110.282 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.2 148.04 51.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.981 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.77 123.99 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 123.564 0.54 . . . . 0.0 109.807 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.1 m -144.53 118.75 9.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.841 0.353 . . . . 0.0 111.376 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 84' ' ' SER . 34.3 tp -85.03 106.73 16.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -87.24 -46.69 16.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.196 -170.184 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 m -144.78 112.64 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.662 ' HB2' HD21 ' A' ' 81' ' ' LEU . 34.5 t -106.32 137.77 43.69 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.59 -7.56 59.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.266 0.555 . . . . 0.0 110.536 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.73 -86.23 0.14 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.032 ' HA ' HD12 ' A' ' 90' ' ' LEU . 2.3 mm? 44.24 59.03 13.38 Favored Pre-proline 0 CA--C 1.534 0.335 0 O-C-N 124.304 0.649 . . . . 0.0 112.495 173.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -61.92 -71.44 0.03 OUTLIER 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 121.334 1.356 . . . . 0.0 111.936 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 t -76.92 -18.64 58.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.462 0.649 . . . . 0.0 110.055 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 1.032 HD12 ' HA ' ' A' ' 87' ' ' LEU . 6.6 mt -75.91 -41.31 52.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.517 -172.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.456 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 19.2 t70 -53.95 -47.0 71.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.502 -172.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -54.64 -37.28 65.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.471 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.88 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 2.3 tp10 -78.49 -54.88 5.68 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.0 pt -68.8 -35.46 69.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.562 -173.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.605 ' NE2' HD11 ' A' ' 123' ' ' ILE . 56.5 mm-40 -79.87 -27.55 40.06 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.788 0.328 . . . . 0.0 110.649 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.24 -46.95 76.03 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.117 173.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.533 ' O ' HD21 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -63.97 -57.59 9.25 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.698 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.673 HG11 HG21 ' A' ' 123' ' ' ILE . 80.5 t -87.6 -48.82 15.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.588 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.7 ttmt -67.18 -27.09 66.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.044 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.545 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 3.2 tmt_? -85.43 -53.92 4.9 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.016 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -96.49 65.52 2.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.739 0.304 . . . . 0.0 111.105 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.486 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 16.1 m -78.04 107.85 6.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.807 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.646 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 39.6 Cg_endo -101.49 139.41 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 124.022 3.148 . . . . 0.0 113.963 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -125.98 107.11 25.28 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 171.374 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.511 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 11.5 Cg_exo -65.05 -62.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 122.715 2.277 . . . . 0.0 112.622 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.499 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 8.8 t -80.73 123.28 82.58 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.706 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 14.9 Cg_exo -69.47 107.67 1.85 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.047 2.498 . . . . 0.0 111.862 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.572 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 43.1 Cg_endo -84.52 59.97 5.91 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.927 2.418 . . . . 0.0 111.542 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.687 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -54.27 -48.88 70.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.086 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -75.02 6.95 3.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.707 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -106.96 -38.1 6.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.801 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -106.88 18.05 22.33 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.4 m -69.9 87.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 122.447 1.118 . . . . 0.0 108.34 172.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 5.5 p30 166.54 -39.04 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.109 -1.86 . . . . 0.0 107.526 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.08 -75.17 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.987 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.478 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.8 OUTLIER -160.14 174.07 14.83 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.953 0.501 . . . . 0.0 109.958 -178.188 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.801 HG13 ' HB3' ' A' ' 112' ' ' TYR . 10.4 m -105.02 109.07 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 121.282 0.563 . . . . 0.0 110.861 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -103.42 111.77 24.36 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 169.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.6 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -142.97 150.18 39.34 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.91 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.404 ' CG2' ' HG2' ' A' ' 65' ' ' GLN . 32.2 m -99.79 128.14 45.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.209 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.6 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 83.7 mt -126.73 123.54 23.85 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.559 176.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 51.9 Cg_endo -73.32 123.64 8.87 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.547 1.498 . . . . 0.0 111.921 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.673 HG21 HG11 ' A' ' 98' ' ' VAL . 8.1 pt -98.45 97.84 6.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.42 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -104.16 124.07 48.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.673 0.749 . . . . 0.0 112.199 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.443 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 71.0 m-85 -117.06 151.2 37.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.397 169.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.594 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 10.3 m -61.02 102.8 0.22 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.063 0.227 . . . . 0.0 110.656 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.909 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.3 tt -83.26 77.15 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.236 0.541 . . . . 0.0 110.787 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -142.45 105.93 4.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.485 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 148.7 -57.36 0.47 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.3 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 90' ' ' LEU . . . -121.3 -171.12 2.15 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.427 ' CA ' HD11 ' A' ' 90' ' ' LEU . . . 91.42 8.76 63.88 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.1 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 24.9 p90 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.487 -0.768 . . . . 0.0 109.815 176.724 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.4 tttm . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 121.061 0.458 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.8 m -125.2 2.34 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.776 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.561 ' HG3' ' HB2' ' A' ' 7' ' ' SER . 44.6 tp60 -108.75 47.21 0.92 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.495 0.664 . . . . 0.0 109.308 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -74.89 118.41 17.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.662 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 64.35 70.09 0.5 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.595 0.712 . . . . 0.0 109.652 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.561 ' HB2' ' HG3' ' A' ' 4' ' ' GLN . 28.3 t -77.98 140.13 39.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.461 -175.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.3 m -99.05 175.43 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.823 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.04 158.22 18.45 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.957 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.488 ' O ' ' HD3' ' A' ' 12' ' ' PRO . . . -104.32 119.81 52.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.639 0.257 . . . . 0.0 110.963 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 18.1 Cg_endo -92.51 105.25 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.383 2.722 . . . . 0.0 112.286 176.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 10' ' ' ALA . 56.2 Cg_exo -52.09 -45.31 39.82 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.384 2.723 . . . . 0.0 114.71 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 12' ' ' PRO . 58.8 Cg_endo -71.77 54.48 2.05 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 121.923 1.748 . . . . 0.0 113.273 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.77 -42.99 24.42 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 15' ' ' ARG . 19.0 mtm180 -120.2 64.59 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.195 0.521 . . . . 0.0 109.991 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.33 68.36 10.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.347 0.594 . . . . 0.0 110.458 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -89.04 154.2 20.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.683 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' A' ' 18' ' ' LYS . 11.4 mptt -110.36 77.43 1.05 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.87 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.3 m -78.57 97.77 5.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.246 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.79 109.23 8.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.07 0.462 . . . . 0.0 110.767 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.708 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -151.0 174.08 3.84 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.55 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.708 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 9.8 Cg_endo -54.44 -22.91 29.12 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.157 1.904 . . . . 0.0 112.522 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -81.93 -26.2 34.25 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.6 p -82.79 27.43 0.53 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.106 0.479 . . . . 0.0 111.739 -174.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 22' ' ' PRO . 29.2 ptt180 -125.93 -4.25 6.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.728 173.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.404 ' HG ' ' HG3' ' A' ' 25' ' ' ARG . 92.4 mt -143.02 36.94 1.4 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.606 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.507 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 15.2 t -105.52 138.5 19.6 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 27' ' ' THR . 2.7 Cg_exo -77.54 61.1 7.35 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.388 2.725 . . . . 0.0 113.058 -176.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -131.38 109.58 10.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.03 0.443 . . . . 0.0 110.534 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.897 ' HB1' ' HA ' ' A' ' 111' ' ' ALA . . . -99.04 -68.19 0.81 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.722 176.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -174.33 -46.86 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.59 177.35 5.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.182 171.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.759 ' HA2' ' HZ2' ' A' ' 37' ' ' TRP . . . 118.66 3.9 13.67 Favored Glycine 0 CA--C 1.504 -0.631 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.924 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -95.87 -16.46 21.79 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.81 0.814 . . . . 0.0 108.893 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -110.36 162.79 14.31 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.222 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.465 ' OD1' ' HG2' ' A' ' 38' ' ' ARG . 43.1 t-20 -100.67 117.01 33.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.999 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.759 ' HZ2' ' HA2' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -104.87 1.86 29.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -175.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.465 ' HG2' ' OD1' ' A' ' 36' ' ' ASN . 25.0 ptt180 -67.89 -33.13 74.14 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.315 -170.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.5 p -70.85 -31.28 67.92 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.474 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 21.5 mmt180 -68.19 -46.18 71.35 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.516 HG23 ' HD2' ' A' ' 103' ' ' PRO . 88.8 mt -57.45 -44.76 85.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.211 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.5 t -56.2 -36.31 68.27 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.539 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.75 -42.4 98.6 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.507 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.672 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.75 -32.29 70.74 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.114 0.483 . . . . 0.0 110.7 177.159 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.27 -31.43 71.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.477 0.656 . . . . 0.0 109.696 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.622 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 10.0 t30 -71.52 -34.26 69.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.598 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -54.02 -25.56 21.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.592 173.066 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.582 ' HE2' ' HB3' ' A' ' 103' ' ' PRO . 97.5 m-85 -100.0 -61.11 1.41 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.017 174.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 11.6 mmmm -170.72 110.31 0.36 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.487 0.715 . . . . 0.0 109.533 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.622 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 45.7 ttp180 -125.03 111.91 15.93 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.985 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.632 ' H ' HD11 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -82.63 137.93 44.3 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.505 177.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.87 131.2 40.55 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.582 2.188 . . . . 0.0 111.622 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.63 -23.35 62.93 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.65 -171.493 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -53.69 -46.57 70.76 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.265 0.353 . . . . 0.0 111.145 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.9 -29.87 68.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.016 0.436 . . . . 0.0 111.477 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.2 mm? -75.47 -42.35 53.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 0.0 110.34 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 57' ' ' ARG . 59.9 mtt180 -70.65 -12.01 61.29 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 pp -109.79 7.74 24.29 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.972 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.607 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 19.3 ttpp -158.14 -69.8 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.607 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 22.2 mmt180 -90.23 82.6 6.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.257 1.027 . . . . 0.0 110.063 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.614 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . 24.4 mt-30 -105.17 159.16 16.07 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.345 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.445 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.29 131.6 1.72 Allowed Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.795 -1.193 . . . . 0.0 112.656 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.578 HG22 ' HB2' ' A' ' 124' ' ' ASP . 60.6 t -104.22 123.08 57.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.98 166.4 30.42 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.142 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.581 ' H ' ' HA ' ' A' ' 83' ' ' SER . 47.7 mt-30 -102.75 131.43 49.6 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 123' ' ' ILE . 20.8 t -126.66 117.08 47.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.069 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.623 ' HD3' ' OE2' ' A' ' 118' ' ' GLU . 10.8 ttm180 -109.48 139.49 44.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.568 -176.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CD1' HD21 ' A' ' 70' ' ' LEU . 8.1 p90 -159.2 154.64 25.73 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 26.4 m -96.86 140.9 30.74 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.357 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.742 HD13 ' HB2' ' A' ' 104' ' ' LEU . 65.4 mt -124.37 138.58 54.36 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.588 0.709 . . . . 0.0 112.683 -170.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.629 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 13.6 t70 -73.04 157.65 36.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.435 172.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -57.67 -27.35 62.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.876 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -100.39 15.27 28.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.864 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.708 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 75.8 46.76 13.21 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.094 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.629 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 53.2 t60 -110.52 122.23 47.24 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.6 p -50.57 116.38 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.551 0.691 . . . . 0.0 111.488 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.5 mt -100.81 -44.48 5.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.521 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.44 161.94 33.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.02 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.493 HG21 ' HG3' ' A' ' 99' ' ' LYS . 7.5 p -160.23 117.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.372 0.606 . . . . 0.0 109.589 175.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.2 m -124.37 112.83 17.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.714 -177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.0 tp -69.38 105.77 2.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.56 0.695 . . . . 0.0 109.818 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -86.98 -54.83 7.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.491 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.581 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 32.4 t 63.18 -175.01 0.15 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.249 170.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -152.03 -63.13 0.17 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.79 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.96 -37.98 13.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.975 0.417 . . . . 0.0 111.396 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.76 104.17 2.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.406 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.861 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 1.7 mm? -103.01 103.41 33.79 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' LEU . 2.7 Cg_exo -75.48 -80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.959 2.439 . . . . 0.0 112.862 -173.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 m -69.34 -19.5 63.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.442 0.639 . . . . 0.0 110.387 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.861 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.7 mt -75.7 -31.55 59.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.203 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 9.9 t70 -54.26 -48.9 70.66 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.602 0.564 . . . . 0.0 111.665 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -53.21 -45.7 68.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -171.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.574 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 16.8 tt0 -78.77 -53.35 7.21 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.961 -176.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' A' ' 60' ' ' ARG . 38.7 pt -67.1 -37.31 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.664 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 78.6 mm-40 -81.59 -25.72 35.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 120.881 0.372 . . . . 0.0 110.908 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.87 -43.47 77.18 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 169.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.632 HD11 ' H ' ' A' ' 51' ' ' TYR . 1.4 tp -67.6 -56.81 7.96 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.824 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.685 HG11 HG21 ' A' ' 123' ' ' ILE . 63.9 t -88.53 -49.13 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -175.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.664 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.6 ttmt -65.16 -22.56 66.93 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.003 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 2.6 tmt_? -90.99 -55.21 3.64 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.885 -0.509 . . . . 0.0 109.766 173.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.636 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -84.21 73.73 10.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 0.0 110.807 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.424 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 9.1 m -99.27 98.01 6.09 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 121.335 0.588 . . . . 0.0 109.577 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.672 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 93.6 Cg_endo -105.43 176.46 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 124.227 3.285 . . . . 0.0 113.686 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.742 ' HB2' HD13 ' A' ' 70' ' ' LEU . 4.0 tt -144.02 115.36 5.52 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.561 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 5.1 Cg_exo -70.75 -72.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.71 2.273 . . . . 0.0 112.757 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -86.16 117.22 68.32 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.492 -177.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.516 ' HA ' HD21 ' A' ' 104' ' ' LEU . 24.8 Cg_exo -64.06 106.44 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.266 2.644 . . . . 0.0 112.293 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.737 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 61.4 Cg_endo -88.72 67.41 2.83 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.228 2.619 . . . . 0.0 112.071 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.78 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.69 -43.4 76.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.19 0.519 . . . . 0.0 110.051 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -72.52 -2.17 18.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.636 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.897 ' HA ' ' HB1' ' A' ' 30' ' ' ALA . . . -105.52 -29.69 10.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.78 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -106.66 16.52 24.42 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.576 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.6 m -71.44 89.16 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 168.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 1.1 p-10 161.29 -24.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.89 -169.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.4 -76.01 0.19 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.697 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.469 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -159.99 173.86 15.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.115 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 69' ' ' THR . 4.4 m -105.04 109.1 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.024 0.44 . . . . 0.0 111.235 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.623 ' OE2' ' HD3' ' A' ' 67' ' ' ARG . 32.6 tt0 -110.0 112.17 24.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.631 HD13 HD11 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -122.59 150.36 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.463 -175.465 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.453 HG23 HG21 ' A' ' 82' ' ' VAL . 29.3 m -102.09 119.01 38.09 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.413 0.625 . . . . 0.0 110.181 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.631 HD11 HD13 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -116.66 122.87 31.12 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -175.352 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 2.6 Cg_exo -75.29 120.16 5.86 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.603 1.535 . . . . 0.0 111.564 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.685 HG21 HG11 ' A' ' 98' ' ' VAL . 4.3 pt -104.0 114.8 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.578 ' HB2' HG22 ' A' ' 63' ' ' VAL . 5.1 p-10 -118.97 125.25 48.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.027 0.918 . . . . 0.0 111.794 -176.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.521 ' HE1' ' HE2' ' A' ' 53' ' ' LYS . 98.6 m-85 -114.22 131.02 56.62 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.215 -1.357 . . . . 0.0 107.8 167.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.9 m -60.52 102.93 0.2 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.992 0.182 . . . . 0.0 111.282 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.614 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 3.3 mt -76.6 87.91 3.29 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.456 0.646 . . . . 0.0 110.498 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -80.71 -42.26 22.23 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.523 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -170.03 52.32 0.2 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.376 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.555 ' HB1' HD21 ' A' ' 90' ' ' LEU . . . -124.31 -156.64 0.73 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.579 ' HA2' HD11 ' A' ' 90' ' ' LEU . . . 103.88 -6.88 48.36 Favored Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -176.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 43.0 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.274 -178.318 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.7 tptt . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.15 -9.09 11.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.129 0.49 . . . . 0.0 110.864 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -81.91 69.2 8.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.688 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.546 ' O ' ' HB3' ' A' ' 13' ' ' PRO . 9.8 tp10 -128.83 91.3 3.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.565 175.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -81.69 83.85 6.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.275 -176.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.0 m -104.9 95.09 5.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.499 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.1 t -86.99 91.0 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.292 0.568 . . . . 0.0 109.849 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.16 -128.39 1.67 Allowed Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.38 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.418 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -80.31 -57.45 0.64 Allowed Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -175.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 46.5 Cg_endo -67.04 130.68 23.44 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.15 1.9 . . . . 0.0 113.123 -175.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 23.8 Cg_exo -66.19 143.41 71.08 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.973 2.448 . . . . 0.0 111.238 172.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.546 ' HB3' ' O ' ' A' ' 5' ' ' GLU . 31.4 Cg_exo -61.3 87.82 0.09 OUTLIER 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.623 2.882 . . . . 0.0 113.854 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.79 112.39 0.9 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.222 173.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -111.55 141.66 44.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.827 0.346 . . . . 0.0 110.217 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.29 88.15 2.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.198 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.469 ' OD2' ' HG3' ' A' ' 18' ' ' LYS . 6.0 p-10 -66.8 -26.39 66.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.72 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HG3' ' OD2' ' A' ' 17' ' ' ASP . 50.8 mttp -104.73 81.32 1.75 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.281 0.562 . . . . 0.0 109.867 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 m -85.27 68.03 10.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.672 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.3 42.42 1.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.297 0.57 . . . . 0.0 110.535 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -65.7 -51.39 49.78 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.231 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 98.7 Cg_endo -80.58 26.99 0.57 Allowed 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.846 1.698 . . . . 0.0 112.464 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.439 ' C ' ' H ' ' A' ' 25' ' ' ARG . 90.7 mt-30 -132.94 -62.95 0.79 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.225 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.6 m 71.16 -37.38 0.39 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.808 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.439 ' H ' ' C ' ' A' ' 23' ' ' GLN . 37.1 mmt180 63.35 8.55 3.53 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.668 0.747 . . . . 0.0 110.321 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 60.69 37.62 18.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.954 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.6 p -115.92 98.42 51.08 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 121.121 0.486 . . . . 0.0 111.407 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.36 149.97 40.77 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.437 2.091 . . . . 0.0 111.366 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -77.64 53.25 1.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.438 0.637 . . . . 0.0 110.978 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.58 -5.06 56.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.373 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -81.81 57.59 3.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.537 0.684 . . . . 0.0 110.788 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.13 24.91 8.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.564 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.33 71.52 2.99 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.922 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -72.55 68.84 0.83 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.654 0.381 . . . . 0.0 111.595 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 18.6 t70 173.99 -26.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.318 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 35' ' ' ASP . 60.2 m-80 70.64 2.56 4.17 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.845 -171.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.6 m0 54.74 22.69 4.29 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.885 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 35' ' ' ASP . 16.7 ptt180 -67.02 -44.09 81.18 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -170.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.7 p -65.72 -38.75 90.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.43 0.633 . . . . 0.0 109.744 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.629 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 1.7 mmt180 -68.6 -47.57 66.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.751 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.49 HG23 ' HG2' ' A' ' 103' ' ' PRO . 43.7 mt -62.64 -37.55 79.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.589 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.8 m -55.09 -37.54 66.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.332 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -66.72 -44.59 89.13 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.057 176.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 47' ' ' ARG . 11.5 mpt_? -70.16 -32.36 70.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.032 0.444 . . . . 0.0 111.37 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.442 HD11 HG22 ' A' ' 98' ' ' VAL . 0.9 OUTLIER -63.14 -32.68 74.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.642 0.734 . . . . 0.0 109.367 176.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.689 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 14.4 t-20 -71.14 -30.97 67.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.589 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.515 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 3.2 ttt180 -58.45 -18.82 31.59 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.651 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -115.44 -59.34 2.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.366 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -160.43 105.64 1.47 Allowed 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 122.942 0.497 . . . . 0.0 109.798 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.689 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 22.0 tpt180 -105.78 102.52 11.96 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.08 176.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.603 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -90.3 125.7 59.17 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.364 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.34 132.36 29.21 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.37 2.047 . . . . 0.0 111.523 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.502 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.68 -23.62 66.21 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.581 -175.134 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.31 -42.84 82.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.913 0.387 . . . . 0.0 110.837 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.74 71.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.802 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.704 ' HG ' ' HE2' ' A' ' 125' ' ' PHE . 3.7 mm? -75.91 -41.31 52.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.259 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.64 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 98.5 mtt180 -58.08 -29.72 65.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.134 0.493 . . . . 0.0 111.307 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.9 mt -100.07 17.11 21.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.097 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.846 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 38.4 ttmt -145.86 -77.59 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.372 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.846 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 36.3 mmt180 -126.71 98.06 5.23 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -176.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.64 ' HG2' ' HA ' ' A' ' 57' ' ' ARG . 47.4 mt-30 -92.66 115.87 28.5 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.904 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -155.53 125.28 1.63 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.737 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.724 HG23 ' HA ' ' A' ' 124' ' ' ASP . 7.1 p -103.91 133.22 48.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.175 0.512 . . . . 0.0 109.969 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.05 168.44 34.54 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.622 -175.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.687 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 83.2 mt-30 -99.74 140.53 33.81 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.459 HG12 ' CD2' ' A' ' 68' ' ' PHE . 53.7 t -128.7 114.18 32.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.695 -173.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 22.7 ttp180 -106.2 129.08 54.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -147.83 151.51 36.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.295 0.569 . . . . 0.0 112.191 -174.218 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 9.0 m -99.94 125.61 45.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 169.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 41.7 mt -116.26 134.68 54.64 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.168 0.508 . . . . 0.0 111.757 -170.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 16.4 t70 -73.96 154.02 39.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.314 177.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -49.4 -40.75 37.37 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.34 0.4 . . . . 0.0 111.805 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -89.35 14.03 12.15 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 111.309 -176.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.47 47.13 9.17 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.118 177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 38.8 t-80 -109.58 116.18 31.28 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 p -48.74 115.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.331 0.586 . . . . 0.0 111.554 173.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.0 mt -103.3 -41.89 5.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.978 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -139.25 146.08 39.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.818 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 99' ' ' LYS . 1.4 m -143.76 117.13 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.422 0.63 . . . . 0.0 110.951 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 m -130.13 125.66 35.62 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.87 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.9 tp -71.6 119.07 15.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.205 0.526 . . . . 0.0 110.065 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.54 HG21 HG23 ' A' ' 120' ' ' THR . 0.1 OUTLIER -96.71 -38.78 8.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.982 179.467 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 12.4 t 67.06 -178.26 0.21 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.404 170.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.555 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 39.8 m -154.92 -58.04 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.289 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.13 -66.6 0.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.327 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.65 104.82 0.19 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.753 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.82 ' HA ' HD12 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -118.42 77.82 13.98 Favored Pre-proline 0 C--N 1.32 -0.686 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.358 -178.745 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.63 -78.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.234 1.956 . . . . 0.0 111.809 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.9 m -67.68 -17.63 64.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.413 0.625 . . . . 0.0 110.297 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.82 HD12 ' HA ' ' A' ' 87' ' ' LEU . 17.6 mt -75.21 -33.66 61.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.921 -176.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 18.5 t70 -53.98 -50.52 66.37 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.591 0.557 . . . . 0.0 112.031 -173.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.574 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 0.7 OUTLIER -54.56 -48.6 71.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.114 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.76 -55.19 5.54 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -174.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 90' ' ' LEU . 36.0 pt -68.61 -34.05 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.407 0.623 . . . . 0.0 110.933 -171.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.816 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.8 mm-40 -84.66 -17.46 38.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.005 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 92' ' ' ARG . . . -55.64 -55.78 28.05 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.835 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.613 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.2 -48.19 21.32 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.148 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.722 HG11 HG21 ' A' ' 123' ' ' ILE . 55.8 t -70.54 -49.49 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.816 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.9 ttmt -73.97 -16.53 61.07 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 122.064 -0.398 . . . . 0.0 110.724 -173.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -88.29 -47.37 8.47 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.678 171.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.606 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -92.32 67.79 4.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.801 0.334 . . . . 0.0 110.914 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.2 m -95.57 99.67 5.06 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.291 0.567 . . . . 0.0 110.005 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 90.8 Cg_endo -102.79 176.32 0.18 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.042 3.161 . . . . 0.0 113.711 -175.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 48.9 tp -142.9 85.6 9.87 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.304 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.629 ' CG ' ' HB2' ' A' ' 40' ' ' ARG . 10.0 Cg_endo -59.44 -53.94 2.99 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.278 1.986 . . . . 0.0 112.677 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.618 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.4 m -81.03 116.74 64.54 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.75 99.23 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.986 2.457 . . . . 0.0 111.118 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.829 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 37.9 Cg_endo -90.93 66.45 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.363 2.708 . . . . 0.0 112.386 -171.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.724 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.59 -45.92 84.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.203 0.525 . . . . 0.0 109.921 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -67.22 -6.28 17.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.7 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.829 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -101.41 -36.19 8.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.488 -178.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.774 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -112.43 18.85 18.12 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -171.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.2 m -69.26 88.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.134 0.969 . . . . 0.0 108.686 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 3.8 p30 164.11 -27.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.459 -1.7 . . . . 0.0 107.636 -170.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 172.28 -81.92 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.09 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.486 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.3 OUTLIER -160.81 175.49 12.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.761 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.774 HG13 ' HB3' ' A' ' 112' ' ' TYR . 10.7 m -102.35 108.69 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.329 0.585 . . . . 0.0 110.842 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 37.0 tt0 -108.8 112.5 24.8 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 170.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.651 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -136.38 154.35 50.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 -173.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.54 HG23 HG21 ' A' ' 82' ' ' VAL . 98.6 m -98.43 113.44 25.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.703 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.651 ' HG ' HD12 ' A' ' 119' ' ' LEU . 42.7 mt -117.95 123.76 29.31 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.19 176.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.2 Cg_exo -73.53 118.9 5.67 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.994 1.796 . . . . 0.0 111.212 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.722 HG21 HG11 ' A' ' 98' ' ' VAL . 33.5 pt -93.61 116.68 35.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.724 ' HA ' HG23 ' A' ' 63' ' ' VAL . 1.5 t70 -100.53 120.91 40.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.996 0.903 . . . . 0.0 112.856 -172.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.704 ' HE2' ' HG ' ' A' ' 56' ' ' LEU . 6.7 m-85 -115.6 130.53 56.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 160.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 61' ' ' GLN . 13.4 m -59.19 103.46 0.18 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.294 0.497 . . . . 0.0 110.703 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.904 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -77.76 66.76 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.059 -177.481 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -84.64 -53.29 5.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.182 0.515 . . . . 0.0 109.857 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -137.92 110.4 0.75 Allowed Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.757 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.656 ' HB1' HD21 ' A' ' 90' ' ' LEU . . . -124.68 168.01 13.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.114 0.483 . . . . 0.0 112.029 -173.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -98.46 76.9 0.57 Allowed Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 33.9 p90 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.357 -178.43 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.727 0.299 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.3 t -82.81 -56.79 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 52.55 68.56 0.81 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.684 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -162.52 -53.24 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.863 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 64.47 81.73 0.2 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.416 0.627 . . . . 0.0 109.809 -173.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -73.66 -28.24 61.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.247 -177.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.68 162.36 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.612 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.42 156.08 11.45 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.486 ' O ' ' HD3' ' A' ' 12' ' ' PRO . . . -115.01 93.5 35.02 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 120.582 0.23 . . . . 0.0 110.585 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -91.85 103.82 0.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.224 2.616 . . . . 0.0 111.614 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . 26.2 Cg_exo -62.5 112.76 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.732 2.288 . . . . 0.0 111.983 -177.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 15.8 Cg_exo -67.84 102.12 0.73 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.072 2.515 . . . . 0.0 111.94 -177.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.16 18.62 0.65 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.144 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.572 ' NE ' ' HA ' ' A' ' 15' ' ' ARG . 1.9 mmp_? 57.75 38.04 27.32 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 122.584 0.353 . . . . 0.0 111.759 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 12' ' ' PRO . . . -85.41 53.86 2.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.327 0.584 . . . . 0.0 110.004 177.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -116.31 115.8 26.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.533 -177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -131.99 11.02 4.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.292 177.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -61.08 -67.13 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.565 -173.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.32 41.98 1.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.136 0.494 . . . . 0.0 111.027 -177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.673 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -61.56 -56.19 35.49 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.312 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 68.4 Cg_endo -88.05 -2.7 7.12 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.023 1.815 . . . . 0.0 112.431 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -88.76 -27.02 21.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.344 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -81.06 44.15 0.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.857 0.837 . . . . 0.0 110.49 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -101.27 -31.0 11.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.275 172.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -167.02 88.21 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.694 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.3 m -59.84 121.43 58.06 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.816 171.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.08 20.72 0.63 Allowed 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.944 2.43 . . . . 0.0 114.153 -171.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -173.24 107.95 0.16 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.072 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.3 118.46 22.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.408 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -88.58 95.37 10.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.948 0.404 . . . . 0.0 110.633 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.57 117.89 30.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.041 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.6 67.99 3.55 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.803 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 37' ' ' TRP . 0.4 OUTLIER -81.21 80.95 7.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.319 0.58 . . . . 0.0 109.857 178.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -119.15 -40.81 2.79 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.581 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -135.74 32.57 2.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.87 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -90.08 -25.86 20.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.55 -177.203 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 38' ' ' ARG . 5.7 ptp180 -66.02 -31.97 73.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.83 -177.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.3 p -71.23 -33.13 69.59 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 10.1 mmt180 -70.65 -46.28 63.54 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.559 ' N ' ' HG3' ' A' ' 105' ' ' PRO . 80.3 mt -57.31 -45.8 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.866 175.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.9 m -61.42 -34.43 75.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.485 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.537 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -66.38 -37.81 93.07 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.44 -0.886 . . . . 0.0 110.996 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.654 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -69.22 -33.71 73.72 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.314 0.578 . . . . 0.0 110.185 176.657 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.39 -26.02 67.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.777 177.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.632 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.4 t-20 -70.56 -33.58 71.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.39 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.546 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 1.4 ttt180 -55.27 -28.4 53.13 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.357 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.582 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 91.2 m-85 -99.45 -58.99 1.8 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.219 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 48' ' ' PHE . 32.5 mtmt -178.91 103.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.521 1.128 . . . . 0.0 108.691 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.632 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 55.4 ttp180 -110.77 104.39 13.03 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.791 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.559 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -92.24 126.58 52.32 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.26 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.93 133.13 51.63 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 123.009 2.473 . . . . 0.0 112.462 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.61 -26.3 66.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.216 -169.723 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.68 -35.82 77.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.17 0.51 . . . . 0.0 110.5 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.46 63.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.6 mm? -75.98 -42.69 47.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.671 0.272 . . . . 0.0 110.965 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 4.4 ptp180 -66.6 -11.91 55.56 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.952 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -112.94 10.57 18.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.24 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.599 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 23.1 ttmm -150.92 -77.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.121 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 1.064 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 28.5 mmt180 -112.34 84.58 2.0 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -94.91 170.95 9.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.274 -178.345 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.754 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.58 123.28 0.99 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.093 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.631 HG12 HD12 ' A' ' 127' ' ' LEU . 6.9 p -104.76 125.55 59.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.223 0.535 . . . . 0.0 109.866 176.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.67 165.15 28.8 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.883 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 36.2 tt0 -103.98 124.37 48.88 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.441 HG21 HD13 ' A' ' 123' ' ' ILE . 60.5 t -128.63 118.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.73 -170.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 1.2 ptp180 -113.14 145.54 40.77 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -156.86 157.6 35.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.311 0.577 . . . . 0.0 111.788 -175.142 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.676 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 1.9 m -107.74 127.56 53.79 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 172.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.657 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 36.6 mt -117.56 132.04 56.59 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.253 0.549 . . . . 0.0 111.997 -166.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.537 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 20.6 t70 -68.79 152.22 45.6 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.23 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.465 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 69.6 mtt180 -61.41 -17.27 53.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.449 -1.25 . . . . 0.0 112.414 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -101.03 3.83 41.79 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.321 0.582 . . . . 0.0 110.331 175.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 86.89 41.49 6.71 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.25 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.537 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 79.9 t60 -114.35 125.63 54.08 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 8.6 p -53.3 122.25 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.357 0.598 . . . . 0.0 111.267 175.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.8 mt -104.34 -40.84 5.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.632 0.729 . . . . 0.0 109.552 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.59 151.55 47.37 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.636 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.17 122.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.358 0.599 . . . . 0.0 110.027 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.1 m -129.3 127.63 41.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.343 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 84' ' ' SER . 25.4 tp -75.54 107.81 7.93 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.651 HG21 HG23 ' A' ' 120' ' ' THR . 0.1 OUTLIER -83.42 -41.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.382 -170.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.6 m -154.44 135.31 13.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.88 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.667 ' HB2' HD21 ' A' ' 81' ' ' LEU . 34.1 t -122.93 135.86 54.65 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.79 -19.36 41.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.657 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.474 ' H ' HD22 ' A' ' 87' ' ' LEU . . . 133.12 63.33 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.973 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.913 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -118.23 87.65 30.27 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.97 -73.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.554 2.169 . . . . 0.0 111.769 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 9.3 m -72.91 -18.92 61.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.34 0.59 . . . . 0.0 110.245 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.913 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 17.0 mt -76.83 -37.25 56.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.719 -175.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.445 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 17.0 t70 -54.6 -48.82 71.7 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.189 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 89' ' ' SER . 16.8 ptp180 -54.34 -42.25 70.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.595 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 1.064 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 4.9 tp10 -77.79 -54.66 6.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.978 0.418 . . . . 0.0 111.949 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.525 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 38.1 pt -72.48 -33.48 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.754 -172.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.623 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 77.1 mm-40 -82.52 -25.95 32.95 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 120.867 0.365 . . . . 0.0 110.737 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.552 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.01 -43.44 77.7 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 169.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.722 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -66.6 -57.05 8.04 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.14 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.736 HG11 HG21 ' A' ' 123' ' ' ILE . 79.3 t -88.42 -49.49 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.623 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 36.3 ttmt -65.54 -24.65 67.17 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.63 0.372 . . . . 0.0 111.329 -174.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.552 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 28.3 tpt180 -97.14 -35.78 10.68 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.492 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.469 ' HB1' ' CD2' ' A' ' 48' ' ' PHE . . . -102.78 61.78 0.81 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.834 177.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.494 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 6.3 m -83.11 104.64 3.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.261 0.553 . . . . 0.0 109.995 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.654 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 37.9 Cg_endo -99.81 153.32 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.769 2.979 . . . . 0.0 114.604 -171.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.742 HD21 ' HD2' ' A' ' 108' ' ' PRO . 22.4 tp -125.41 100.48 32.11 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.342 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.637 ' HA ' ' NE ' ' A' ' 44' ' ' ARG . 2.4 Cg_endo -69.0 -81.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.142 1.894 . . . . 0.0 113.278 -174.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.43 ' HB ' ' HE1' ' A' ' 37' ' ' TRP . 31.5 m -79.91 110.21 15.13 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 27.0 Cg_exo -62.16 108.01 0.63 Allowed 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.898 2.399 . . . . 0.0 112.098 -175.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.742 ' HD2' HD21 ' A' ' 104' ' ' LEU . 97.9 Cg_endo -75.49 62.48 6.26 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.072 2.515 . . . . 0.0 111.569 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.77 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -58.33 -35.47 71.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.383 0.611 . . . . 0.0 110.24 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.33 -7.79 27.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.945 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.45 -21.53 10.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -175.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.77 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -131.76 19.56 4.64 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -168.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.1 m -69.8 89.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 122.412 1.101 . . . . 0.0 109.753 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.4 p30 160.94 -16.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 112.723 -2.035 . . . . 0.0 107.752 -172.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 172.2 -92.46 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.341 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.537 ' OG1' HG22 ' A' ' 69' ' ' THR . 0.6 OUTLIER -161.44 176.41 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 122.894 0.477 . . . . 0.0 110.245 -173.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.688 HG13 ' HD2' ' A' ' 112' ' ' TYR . 2.9 m -104.94 119.03 53.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.485 -173.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -104.14 112.45 25.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.565 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -133.52 154.3 50.95 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.631 -174.311 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.651 HG23 HG21 ' A' ' 82' ' ' VAL . 62.5 m -109.23 123.3 49.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.772 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.565 ' HG ' HD12 ' A' ' 119' ' ' LEU . 65.1 mt -129.91 128.38 22.89 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.366 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.2 Cg_exo -73.45 119.36 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.647 1.565 . . . . 0.0 110.385 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.736 HG21 HG11 ' A' ' 98' ' ' VAL . 19.4 pt -95.42 126.04 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -114.94 121.54 43.48 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.26 -176.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.525 ' CE1' ' HB ' ' A' ' 94' ' ' ILE . 75.7 m-85 -113.25 120.03 39.77 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 159.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.9 m -56.43 103.66 0.11 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.118 0.485 . . . . 0.0 111.381 -168.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.754 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.1 mt -70.78 94.87 1.07 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.451 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -132.41 31.07 4.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.645 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -153.98 -112.74 0.48 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.006 -1.092 . . . . 0.0 113.85 -172.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' HB3' HD21 ' A' ' 90' ' ' LEU . . . -79.24 46.31 0.71 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -167.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -113.44 33.19 5.66 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 172.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.445 ' CE1' ' HA ' ' A' ' 130' ' ' ALA . 39.0 p90 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.364 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.516 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 14.3 mptt . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.589 0.233 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.4 m -96.84 -25.18 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.187 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -80.08 -31.02 39.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.427 0.632 . . . . 0.0 110.373 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.516 ' OE1' ' HA ' ' A' ' 2' ' ' LYS . 17.8 mp0 -76.88 8.49 3.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.139 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -92.98 3.51 55.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.933 0.397 . . . . 0.0 110.332 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.8 t -91.1 -162.69 0.94 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.158 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.8 t 61.26 61.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.766 0.793 . . . . 0.0 109.877 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.94 14.49 28.94 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.666 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.478 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -63.45 -54.61 42.32 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.811 -0.194 . . . . 0.0 111.369 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 62.2 Cg_endo -73.76 129.75 13.87 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 121.658 1.572 . . . . 0.0 112.072 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 24.5 Cg_exo -63.22 139.9 74.68 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.817 2.344 . . . . 0.0 111.645 177.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.91 40.28 0.79 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.999 2.466 . . . . 0.0 112.577 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.98 -111.17 3.77 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.961 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -143.01 127.34 17.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.716 0.293 . . . . 0.0 110.431 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.56 96.54 3.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.918 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.44 -25.7 41.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.467 0.651 . . . . 0.0 109.574 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' A' ' 18' ' ' LYS . 16.0 ptpt -86.72 142.71 27.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.062 -176.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -102.72 -22.19 13.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.25 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.54 84.71 7.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.19 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.595 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -146.91 -54.04 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 14.7 Cg_exo -68.4 -88.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.949 1.766 . . . . 0.0 113.021 -175.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.421 ' H ' ' HB2' ' A' ' 22' ' ' PRO . 4.7 tp-100 -129.17 32.32 4.73 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.63 0.729 . . . . 0.0 110.3 -177.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 p -68.78 -11.44 60.36 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.493 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -73.3 -15.29 61.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.126 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.4 mt -115.64 45.39 1.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.171 0.51 . . . . 0.0 110.311 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 12.9 t -78.56 133.56 62.99 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.011 176.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 27' ' ' THR . 5.7 Cg_endo -86.67 79.93 1.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.188 2.592 . . . . 0.0 112.629 -177.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.428 ' CE1' ' HB3' ' A' ' 32' ' ' ALA . 67.9 t80 -106.73 108.11 19.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.479 176.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.85 127.5 8.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.749 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 53.22 65.77 1.42 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.963 0.79 . . . . 0.0 111.156 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.57 ' HA ' ' CZ2' ' A' ' 37' ' ' TRP . . . -138.54 47.87 1.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.492 -177.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -135.62 38.35 1.8 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.046 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 49.63 62.75 2.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 122.144 0.973 . . . . 0.0 110.166 -171.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.13 39.58 0.65 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.804 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 57.13 61.89 2.41 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.016 -172.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.587 ' O ' HG13 ' A' ' 41' ' ' ILE . 8.7 p-90 -127.27 -51.99 1.4 Allowed 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.82 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HA ' HD12 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -69.16 -36.05 76.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.374 0.534 . . . . 0.0 111.666 -174.321 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -33.62 74.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.805 0.812 . . . . 0.0 109.795 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.524 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 27.0 mmm180 -73.0 -32.73 65.33 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.507 175.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 38' ' ' ARG . 62.1 mt -61.04 -39.71 83.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.512 173.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -55.14 -39.94 70.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.835 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.16 -36.5 92.98 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.952 173.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.688 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -69.36 -34.9 75.28 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.374 0.607 . . . . 0.0 110.097 178.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -67.13 -26.76 66.84 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.3 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.631 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 11.6 t30 -70.43 -33.38 71.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.788 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 7.6 ptt180 -60.41 -17.99 47.71 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.018 173.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -109.58 -58.54 2.03 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.495 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -167.88 101.41 0.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.694 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.631 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 17.0 ttp180 -111.55 102.31 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.218 171.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.56 ' HD1' ' HD2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -97.63 117.11 65.7 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.568 -173.452 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.56 ' HD2' ' HD1' ' A' ' 51' ' ' TYR . 52.8 Cg_exo -53.35 131.06 41.46 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.659 2.239 . . . . 0.0 111.65 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.67 -25.2 67.24 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.552 -173.067 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -56.61 -43.26 80.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.046 0.45 . . . . 0.0 110.803 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.18 -30.81 69.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 110.554 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.554 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 3.6 mm? -74.55 -32.94 62.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.524 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.873 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 22.2 mtm180 -62.0 -20.32 63.78 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.748 0.308 . . . . 0.0 111.54 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 mp -107.15 14.84 25.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.65 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.823 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 37.5 ttpt -150.79 -84.61 0.09 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.295 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.823 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 32.3 mmt-85 -122.02 86.27 2.55 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.936 -0.478 . . . . 0.0 111.426 -174.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.873 ' HG2' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -111.68 115.23 28.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.151 0.501 . . . . 0.0 110.448 172.705 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.83 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -146.54 140.05 8.47 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.544 175.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.918 HG12 HD12 ' A' ' 127' ' ' LEU . 7.1 p -103.61 138.14 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.991 0.424 . . . . 0.0 109.915 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.556 ' HA3' ' OG ' ' A' ' 83' ' ' SER . . . -168.02 169.27 41.29 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.684 -176.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 54.0 mt-30 -98.87 141.07 32.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.462 HG12 ' CE2' ' A' ' 68' ' ' PHE . 55.4 t -130.83 114.65 27.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.5 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 21.9 ttm180 -111.71 141.37 45.4 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -174.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CE2' HG12 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -159.22 155.5 27.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.153 0.501 . . . . 0.0 111.605 -176.883 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 48.8 m -98.47 123.92 42.88 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 170.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.461 HD11 ' CE1' ' A' ' 68' ' ' PHE . 73.0 mt -113.42 148.45 35.84 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.145 0.498 . . . . 0.0 112.29 -170.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.662 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 33.4 t70 -92.79 166.68 12.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.627 175.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -53.87 -39.81 66.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -90.12 9.1 29.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.042 0.448 . . . . 0.0 111.164 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 103' ' ' PRO . . . 77.13 47.3 9.34 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.084 -175.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 47.7 t-80 -100.28 100.77 11.63 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.3 p -47.47 115.01 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.763 0.792 . . . . 0.0 111.457 176.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 15.5 mt -98.32 -35.3 10.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.987 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -136.31 143.76 44.33 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.102 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.5 m -119.19 129.46 75.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.035 0.445 . . . . 0.0 110.082 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 69.8 m -130.99 122.23 26.47 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.323 0.582 . . . . 0.0 110.911 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.5 tp -78.96 115.62 18.76 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.783 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -121.64 -25.17 2.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.118 -177.558 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.556 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 7.5 t -48.96 119.54 3.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.913 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -144.35 43.49 1.41 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.428 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.69 13.88 18.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.089 0.471 . . . . 0.0 110.33 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.61 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 81.18 61.1 2.15 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.768 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.762 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.8 OUTLIER -110.84 84.15 4.05 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.495 -179.304 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.61 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 5.7 Cg_exo -78.05 -75.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.677 2.251 . . . . 0.0 112.142 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.3 p -69.29 -18.98 63.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.495 0.664 . . . . 0.0 110.497 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.762 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 28.4 mt -74.62 -39.59 62.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.269 -175.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.532 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 4.8 t70 -53.4 -50.47 65.1 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.585 0.553 . . . . 0.0 111.875 -173.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -54.58 -45.65 73.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.63 -53.51 7.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.792 0.329 . . . . 0.0 111.332 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.671 HG12 ' O ' ' A' ' 90' ' ' LEU . 48.1 pt -70.26 -32.45 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -171.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.588 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 25.7 mm-40 -82.48 -30.04 30.18 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.281 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.54 -44.66 81.1 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 170.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.61 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -60.88 -59.42 5.41 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.289 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.754 HG11 HG21 ' A' ' 123' ' ' ILE . 76.2 t -89.94 -49.39 13.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.588 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 38.1 ttmt -66.18 -27.23 67.85 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -172.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.549 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 29.8 tpt180 -91.2 -30.8 16.46 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.492 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.599 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -108.08 67.69 0.68 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.936 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.463 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 5.5 m -96.49 97.96 3.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.226 0.536 . . . . 0.0 110.458 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.688 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 37.5 Cg_endo -104.14 168.56 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.471 3.447 . . . . 0.0 114.599 -173.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.588 HD13 ' HG3' ' A' ' 108' ' ' PRO . 19.9 mt -145.39 122.4 6.15 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.309 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 7.9 Cg_endo -82.39 -47.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.587 2.191 . . . . 0.0 111.664 175.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.0 m -90.27 113.31 56.93 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.742 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.18 108.3 0.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.601 2.2 . . . . 0.0 111.451 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.692 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 94.3 Cg_endo -82.07 51.1 3.67 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.831 2.354 . . . . 0.0 112.901 -173.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.642 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -60.74 -37.7 82.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.284 0.564 . . . . 0.0 109.625 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -75.06 3.71 8.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.875 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.51 -23.44 9.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.777 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.729 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -127.5 18.27 6.91 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.289 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.4 m -70.36 88.32 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 122.198 0.999 . . . . 0.0 109.19 175.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.4 p30 158.58 -12.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 113.284 -1.78 . . . . 0.0 108.645 -170.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.13 -87.08 0.1 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.449 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.436 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.7 OUTLIER -160.23 175.39 12.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -175.647 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.729 HG13 ' HB3' ' A' ' 112' ' ' TYR . 5.7 m -103.22 107.94 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -109.82 110.06 20.93 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 170.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.523 HD12 ' HG ' ' A' ' 121' ' ' LEU . 1.4 pp -143.46 146.36 33.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.875 0.369 . . . . 0.0 110.308 -174.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 65' ' ' GLN . 86.2 m -93.98 117.08 29.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.191 -177.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.523 ' HG ' HD12 ' A' ' 119' ' ' LEU . 46.9 mt -111.13 122.87 36.66 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.5 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 4.7 Cg_exo -74.08 119.14 5.69 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.885 1.723 . . . . 0.0 110.617 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.754 HG21 HG11 ' A' ' 98' ' ' VAL . 18.7 pt -98.34 118.26 44.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.499 ' HA ' HG23 ' A' ' 63' ' ' VAL . 12.6 t70 -108.03 122.23 46.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.719 0.771 . . . . 0.0 112.087 -172.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.481 ' CE2' ' HG ' ' A' ' 56' ' ' LEU . 34.3 m-85 -115.9 142.04 47.3 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 162.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m -67.8 103.04 1.33 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.603 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.918 HD12 HG12 ' A' ' 63' ' ' VAL . 2.0 mt -77.97 81.49 4.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.461 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -93.24 -52.34 4.59 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.475 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.13 69.71 0.53 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.966 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.681 ' HB2' HE22 ' A' ' 61' ' ' GLN . . . -168.33 -169.24 1.05 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 86' ' ' GLY . . . 93.53 23.16 24.61 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.397 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.4 p90 . . . . . 0 C--O 1.247 0.927 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.563 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 5' ' ' GLU . 29.4 mtpp . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.749 0.309 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.42 -60.09 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -99.57 -17.48 17.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 2' ' ' LYS . 1.2 mp0 -77.39 49.97 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.486 175.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -168.45 85.25 0.18 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 m -60.59 122.21 14.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.614 -174.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.6 m -100.45 175.07 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.964 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.33 79.9 0.26 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.53 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.82 85.91 40.33 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.768 0.318 . . . . 0.0 110.327 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.4 Cg_endo -84.2 144.23 10.47 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.213 2.609 . . . . 0.0 112.245 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 24.0 Cg_exo -64.85 115.46 3.26 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.879 2.386 . . . . 0.0 111.55 176.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.39 87.18 0.64 Allowed 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.892 2.394 . . . . 0.0 112.921 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.16 57.73 3.36 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.927 175.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -94.84 95.91 8.99 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.78 157.74 29.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.162 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -153.66 -58.99 0.13 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.983 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.636 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -110.63 104.0 12.64 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 173.715 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 11.4 m -66.34 -66.5 0.54 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.799 -173.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.58 59.01 0.8 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.847 0.356 . . . . 0.0 111.457 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.91 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -137.8 -63.69 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.817 175.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.91 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 1.1 Cg_endo -86.64 -28.05 0.66 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 122.24 1.96 . . . . 0.0 111.724 175.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.449 ' C ' ' H ' ' A' ' 25' ' ' ARG . 48.7 mt-30 -83.53 -138.98 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.437 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.637 ' HA ' ' HB ' ' A' ' 27' ' ' THR . 20.5 m 74.33 -31.94 0.22 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.775 0.43 . . . . 0.0 111.129 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.449 ' H ' ' C ' ' A' ' 23' ' ' GLN . 14.2 ptt180 -57.06 -33.2 67.01 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.266 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.6 mt -117.84 25.97 10.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.203 0.525 . . . . 0.0 110.171 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.637 ' HB ' ' HA ' ' A' ' 24' ' ' THR . 21.8 m -128.98 78.76 75.8 Favored Pre-proline 0 N--CA 1.445 -0.683 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.284 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.11 100.59 1.4 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.862 2.375 . . . . 0.0 111.726 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -79.52 83.46 5.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.61 -37.01 0.62 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.985 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 60.55 -92.67 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.821 0.7 . . . . 0.0 111.118 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 59.99 13.33 3.64 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.72 109.82 1.12 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.597 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -83.94 -6.71 59.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.413 0.625 . . . . 0.0 110.669 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.93 -103.66 0.06 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -169.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -88.42 72.06 8.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.121 0.486 . . . . 0.0 111.745 -167.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.557 ' CZ2' HD21 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -134.32 -24.83 1.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.364 174.258 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -68.87 -30.6 69.15 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.117 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.6 p -62.41 -40.01 95.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.075 176.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.462 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 16.2 mmm180 -73.64 -39.65 64.34 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.707 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.663 HG23 ' HD2' ' A' ' 103' ' ' PRO . 79.4 mt -60.36 -50.49 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.173 176.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 m -58.51 -43.26 89.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.841 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.14 -36.32 93.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.86 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.633 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 11.4 ttt-85 -69.16 -32.02 71.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 120.851 0.358 . . . . 0.0 110.328 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.846 ' HB3' ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -62.99 -31.46 72.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.207 0.527 . . . . 0.0 109.966 178.532 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.746 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 26.7 t-20 -71.74 -35.19 70.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.61 174.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 68.3 ttt180 -67.09 -26.65 66.83 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.608 175.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -92.03 7.58 41.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.564 172.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? 67.99 102.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.263 -175.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.846 ' HD2' ' HB3' ' A' ' 45' ' ' LEU . 4.6 ptm180 -118.17 130.31 56.03 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.402 ' HB3' HD21 ' A' ' 56' ' ' LEU . 16.9 t80 -60.91 132.3 91.93 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.39 129.86 13.82 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.55 2.833 . . . . 0.0 112.301 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.821 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -64.53 -20.9 66.5 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.795 -172.442 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -52.6 -41.25 63.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.669 0.271 . . . . 0.0 111.08 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.89 -36.14 59.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.761 0.315 . . . . 0.0 111.338 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 93' ' ' GLU . 3.5 mm? -74.23 -43.04 58.64 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.308 -175.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -76.07 -15.42 60.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.973 0.416 . . . . 0.0 111.358 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.9 tp -86.23 -9.73 55.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.674 0.749 . . . . 0.0 109.266 174.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.87 ' HD2' ' HG2' ' A' ' 93' ' ' GLU . 23.2 ttmm -115.03 -57.76 2.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.47 -173.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.774 ' HG3' ' HB2' ' A' ' 93' ' ' GLU . 30.1 mmt180 -127.08 122.45 34.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.784 -175.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.609 ' H ' ' HB2' ' A' ' 130' ' ' ALA . 38.3 mt-30 -126.41 114.57 18.37 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 1.011 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -149.7 143.09 10.36 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.961 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.583 ' H ' HD12 ' A' ' 127' ' ' LEU . 5.3 p -104.43 127.64 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.027 0.441 . . . . 0.0 109.947 176.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.39 167.51 32.98 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.465 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 82' ' ' VAL . 80.9 mm-40 -101.86 131.54 48.14 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.8 t -126.6 114.18 36.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.204 0.526 . . . . 0.0 110.339 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 27.0 ttm180 -101.32 141.89 33.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -157.71 152.42 25.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.989 0.423 . . . . 0.0 111.299 -178.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.764 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 9.4 m -101.64 127.31 48.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.641 173.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.719 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 28.2 mt -119.5 135.4 54.79 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.1 -172.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' HB2' HD21 ' A' ' 77' ' ' LEU . 20.2 t70 -76.07 152.77 36.76 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.896 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -55.06 -26.64 39.03 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 123.4 0.437 . . . . 0.0 111.787 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -84.31 -1.79 55.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 110.687 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.8 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 88.45 23.71 36.0 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.851 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.425 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 58.3 t-80 -95.92 117.48 30.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.494 0.188 . . . . 0.0 110.553 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -48.99 120.42 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.374 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 71' ' ' ASP . 55.7 mt -109.77 -51.26 2.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.713 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -132.42 154.78 49.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.392 -177.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.967 HG11 ' HG3' ' A' ' 99' ' ' LYS . 57.9 t -139.82 122.99 17.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 44.0 m -119.22 105.94 11.86 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.9 tp -68.24 110.79 4.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.55 0.69 . . . . 0.0 110.664 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.686 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -99.3 -52.83 8.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.929 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.543 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 23.1 t 65.7 177.91 0.21 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.203 172.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.528 ' OG ' ' HG2' ' A' ' 65' ' ' GLN . 50.3 m -139.17 -69.7 0.42 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.097 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.36 -75.83 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.504 ' C ' ' HD3' ' A' ' 88' ' ' PRO . . . -176.9 97.51 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.329 -175.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -120.56 68.55 15.09 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 178.243 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 3.6 Cg_exo -77.81 -66.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.386 2.057 . . . . 0.0 112.139 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.6 t -73.11 -18.63 61.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.689 0.757 . . . . 0.0 109.78 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.718 HD21 ' HB3' ' A' ' 130' ' ' ALA . 32.8 mt -76.02 -30.74 58.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.576 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.52 -45.88 69.9 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.808 0.693 . . . . 0.0 111.896 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.583 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 8.5 ptp180 -53.01 -51.09 62.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -172.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.87 ' HG2' ' HD2' ' A' ' 59' ' ' LYS . 1.7 mp0 -77.04 -55.39 5.5 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 90' ' ' LEU . 22.2 pt -69.88 -32.82 53.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 111.386 -172.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.807 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 75.1 mm-40 -83.49 -18.32 38.92 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.507 176.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -54.73 -55.23 32.09 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.851 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.664 HD23 HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -75.75 -52.43 10.48 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.031 177.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.725 HG11 HG21 ' A' ' 123' ' ' ILE . 91.3 t -65.44 -49.43 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.967 ' HG3' HG11 ' A' ' 79' ' ' VAL . 40.4 ttmt -74.61 -29.24 61.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.556 0.217 . . . . 0.0 110.906 -172.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.584 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -78.11 -42.13 32.92 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.828 176.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.556 ' HB2' HH11 ' A' ' 100' ' ' ARG . . . -117.11 73.98 0.89 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.692 0.282 . . . . 0.0 111.663 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.7 m -82.96 108.71 13.4 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.105 0.479 . . . . 0.0 110.35 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.663 ' HD2' HG23 ' A' ' 41' ' ' ILE . 16.2 Cg_endo -97.12 139.08 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.23 3.287 . . . . 0.0 113.947 -175.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.8 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 40.3 tp -116.31 91.51 33.14 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 174.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.462 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 53.1 Cg_endo -79.45 -39.35 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.293 1.995 . . . . 0.0 113.603 -174.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.425 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.5 m -102.9 110.81 64.24 Favored Pre-proline 0 C--N 1.319 -0.761 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.92 107.77 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.242 2.628 . . . . 0.0 112.954 -175.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.731 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 48.9 Cg_endo -89.8 66.57 2.12 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.299 2.666 . . . . 0.0 111.659 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.818 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.1 -41.29 78.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.416 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -73.46 1.44 9.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.859 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.731 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -110.89 -27.97 8.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.691 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.818 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -105.16 16.31 25.99 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.5 m -72.27 87.89 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 11.3 p-10 157.18 -9.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.417 -171.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.68 -80.16 0.2 Allowed Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.063 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.489 ' C ' ' HB3' ' A' ' 112' ' ' TYR . 1.0 OUTLIER -156.42 176.17 13.05 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.764 ' O ' ' HA ' ' A' ' 69' ' ' THR . 6.6 m -99.26 106.22 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 119.676 1.125 . . . . 0.0 110.259 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -105.52 109.22 21.12 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 168.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.688 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -139.73 147.45 40.9 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.493 -172.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.686 HG23 HG21 ' A' ' 82' ' ' VAL . 36.3 m -94.43 113.65 25.54 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.778 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.688 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 35.0 mt -114.73 126.8 27.47 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.992 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 6.2 Cg_exo -75.29 118.78 5.31 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 121.401 1.401 . . . . 0.0 110.636 177.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.725 HG21 HG11 ' A' ' 98' ' ' VAL . 32.5 pt -93.3 97.1 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -99.03 121.88 41.55 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 122.302 1.048 . . . . 0.0 112.041 -171.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.446 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 84.9 m-85 -114.74 142.83 45.99 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.754 -1.567 . . . . 0.0 107.057 165.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.1 m -65.56 103.35 0.84 Allowed 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.246 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 1.011 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -75.42 61.8 1.29 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.791 -176.567 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -79.4 -43.43 23.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.454 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 132' ' ' PHE . . . -179.69 126.33 1.03 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.798 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.718 ' HB3' HD21 ' A' ' 90' ' ' LEU . . . -146.3 71.14 1.24 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.99 4.93 66.55 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -166.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.613 ' HD2' ' H ' ' A' ' 130' ' ' ALA . 92.4 m-85 . . . . . 0 N--CA 1.435 -1.2 0 CA-C-N 114.401 -0.9 . . . . 0.0 109.374 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.887 0.375 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 m -135.96 25.05 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.142 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 58.58 69.4 0.73 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.649 -171.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -53.24 -47.7 68.83 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.024 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -126.61 107.22 10.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.271 0.558 . . . . 0.0 110.258 176.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.446 ' HB2' ' CB ' ' A' ' 10' ' ' ALA . 5.8 p -119.8 88.69 2.98 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.677 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.8 m -87.45 -22.88 6.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.338 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.9 30.45 10.01 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.106 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' CB ' ' HB2' ' A' ' 7' ' ' SER . . . -111.26 115.85 51.85 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.727 0.298 . . . . 0.0 110.66 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 6.1 Cg_exo -78.79 124.4 6.21 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.301 2.667 . . . . 0.0 111.727 178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.625 ' HB2' ' HA ' ' A' ' 16' ' ' ALA . 16.0 Cg_exo -68.3 112.23 2.73 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 123.029 2.486 . . . . 0.0 111.77 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.89 129.99 32.88 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.92 2.413 . . . . 0.0 112.614 -176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.28 -86.77 0.7 Allowed Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.433 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 15' ' ' ARG . 18.7 mtp180 -86.75 77.62 9.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.935 0.398 . . . . 0.0 110.712 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.625 ' HA ' ' HB2' ' A' ' 12' ' ' PRO . . . -74.21 -21.24 59.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.602 0.715 . . . . 0.0 109.184 171.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -88.03 94.79 9.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.727 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -140.83 58.01 1.56 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.302 0.572 . . . . 0.0 109.539 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -79.42 116.46 19.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.698 0.761 . . . . 0.0 110.561 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.492 ' HB1' ' HA ' ' A' ' 25' ' ' ARG . . . -108.4 40.16 1.83 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.321 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.681 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -80.02 -52.65 1.01 Allowed Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.992 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 7.9 Cg_exo -74.07 -150.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.445 2.097 . . . . 0.0 111.965 177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -71.24 -9.8 58.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.322 . . . . 0.0 111.032 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.437 ' HA ' HG23 ' A' ' 27' ' ' THR . 14.6 p -61.03 -15.31 30.69 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.673 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.561 ' HG3' ' HG ' ' A' ' 26' ' ' LEU . 13.4 ptp180 -64.18 -25.69 68.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.22 177.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.561 ' HG ' ' HG3' ' A' ' 25' ' ' ARG . 96.2 mt -125.22 53.23 1.54 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.171 0.51 . . . . 0.0 110.622 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 24' ' ' THR . 12.4 p -106.57 123.25 39.33 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.997 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.36 117.93 5.3 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.713 2.275 . . . . 0.0 111.542 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -96.14 118.7 33.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.313 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.95 -52.29 0.11 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.446 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 56.53 53.31 8.69 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.671 0.748 . . . . 0.0 110.57 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.59 57.0 2.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.302 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.94 63.73 4.02 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.216 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -84.01 176.37 8.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.904 0.383 . . . . 0.0 110.684 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 36' ' ' ASN . 22.6 t70 -130.54 152.56 49.78 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 26.9 t-20 75.8 -15.15 0.72 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.599 0.562 . . . . 0.0 111.038 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.473 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -58.93 -27.71 65.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.078 178.589 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -33.87 75.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.666 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.1 m -67.08 -35.87 80.76 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 18.2 mmt180 -70.65 -42.01 71.39 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.918 177.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.683 HG23 ' HG2' ' A' ' 103' ' ' PRO . 92.2 mt -59.65 -44.06 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.2 177.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.9 t -55.68 -37.62 68.56 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.801 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -69.46 -37.63 79.07 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.081 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.64 -34.11 73.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.154 0.502 . . . . 0.0 110.634 178.209 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.607 HD11 HG13 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -68.27 -26.9 65.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.641 0.734 . . . . 0.0 109.526 177.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.689 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 5.9 t30 -70.28 -35.1 73.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.258 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.55 -29.86 59.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.624 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -96.29 -59.33 1.86 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.515 178.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -158.53 119.31 3.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.121 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.689 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -136.07 102.61 5.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.404 0.621 . . . . 0.0 110.275 174.59 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.508 ' HB3' HD21 ' A' ' 56' ' ' LEU . 3.1 t80 -86.53 132.09 43.8 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.848 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.32 130.19 36.48 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 122.741 2.294 . . . . 0.0 112.363 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.577 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -60.81 -29.39 69.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.354 -170.521 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.78 -33.82 70.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 0.0 110.316 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.79 -39.14 61.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.293 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.4 mm? -64.53 -40.97 96.6 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.743 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.478 ' HD3' HH11 ' A' ' 128' ' ' ARG . 60.5 mtt180 -59.07 -22.71 61.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.867 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.7 mt -102.43 -8.67 20.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.793 0.33 . . . . 0.0 110.964 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -112.51 -68.77 0.91 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.827 -176.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.656 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 6.0 ppt_? -155.01 142.9 20.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.062 0.458 . . . . 0.0 110.888 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.519 ' O ' HD22 ' A' ' 90' ' ' LEU . 13.0 mm100 -138.5 177.74 7.66 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 1.043 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.22 146.75 4.42 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.52 -1.324 . . . . 0.0 113.989 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.3 t -106.35 124.16 61.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.28 163.31 26.4 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.699 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 82' ' ' VAL . 85.0 mt-30 -106.45 125.87 51.54 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 121' ' ' LEU . 12.1 p -123.85 125.0 70.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.64 -170.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -113.47 134.96 54.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.838 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.7 OUTLIER -157.11 158.13 35.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.955 0.407 . . . . 0.0 111.694 -175.325 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.597 ' CG2' ' HB ' ' A' ' 116' ' ' THR . 26.6 m -99.37 134.21 42.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.229 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.52 HD13 ' HB2' ' A' ' 104' ' ' LEU . 75.7 mt -117.01 142.97 46.28 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.573 0.545 . . . . 0.0 111.255 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -97.43 169.83 9.47 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.874 175.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -50.81 -42.61 58.38 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -94.37 24.3 4.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.728 0.299 . . . . 0.0 111.48 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.681 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 68.11 47.77 57.31 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.185 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 55.9 t-80 -100.51 117.43 34.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 p -48.88 122.9 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 123.816 0.697 . . . . 0.0 110.913 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 88.6 mt -116.71 -44.99 2.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.35 158.13 40.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 99' ' ' LYS . 13.4 m -145.32 117.28 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.533 0.521 . . . . 0.0 110.178 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.2 m -141.7 131.93 24.92 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.864 0.364 . . . . 0.0 111.249 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.7 tp -83.63 120.0 25.44 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.619 HG21 HG23 ' A' ' 120' ' ' THR . 0.1 OUTLIER -95.9 -58.74 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.345 -175.282 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.9 m -141.84 113.36 7.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.921 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.5 t -107.08 117.14 33.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.21 -46.82 66.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.496 -175.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.691 ' H ' HD22 ' A' ' 87' ' ' LEU . . . -176.35 58.91 0.1 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.913 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.891 ' HA ' HD12 ' A' ' 90' ' ' LEU . 1.6 mm? -118.05 89.61 35.07 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.33 -83.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.23 1.953 . . . . 0.0 111.338 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 3.5 m -67.41 -17.92 64.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.674 0.75 . . . . 0.0 110.104 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.891 HD12 ' HA ' ' A' ' 87' ' ' LEU . 8.0 mt -75.5 -33.49 60.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.215 -175.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 13.6 t70 -54.87 -49.69 70.53 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.76 0.662 . . . . 0.0 111.371 -173.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 89' ' ' SER . 5.0 ptp180 -53.86 -50.53 66.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.094 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 20.7 tt0 -77.99 -42.06 33.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -173.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.565 HG13 ' HG2' ' A' ' 95' ' ' GLN . 30.3 pt -60.63 -40.68 85.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.885 -177.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.672 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 50.1 mm-40 -82.39 -30.52 30.18 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.957 0.408 . . . . 0.0 110.94 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.92 -52.31 64.57 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.923 173.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.777 HD23 HG23 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -62.2 -56.58 17.21 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.949 -178.684 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.958 HG11 HG21 ' A' ' 123' ' ' ILE . 58.5 t -88.14 -50.54 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -176.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.672 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 35.6 ttmt -63.7 -38.8 92.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.409 0.151 . . . . 0.0 111.409 -172.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -79.23 -16.85 55.88 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.662 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.37 53.09 0.77 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.474 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 51.0 m -65.45 107.4 1.45 Allowed Pre-proline 0 C--O 1.234 0.279 0 O-C-N 123.514 0.509 . . . . 0.0 110.79 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.683 ' HG2' HG23 ' A' ' 41' ' ' ILE . 50.2 Cg_endo -101.79 154.87 0.35 Allowed 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 123.847 3.032 . . . . 0.0 114.002 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.681 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 2.1 tp -142.57 107.63 5.55 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.141 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HB3' HH11 ' A' ' 44' ' ' ARG . 4.0 Cg_exo -75.0 -56.94 0.06 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.22 1.947 . . . . 0.0 112.435 178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.496 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 10.6 m -90.2 110.36 39.94 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.684 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.529 ' HA ' HD21 ' A' ' 104' ' ' LEU . 42.2 Cg_endo -68.64 107.13 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.942 2.428 . . . . 0.0 112.16 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.884 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 51.1 Cg_endo -87.88 71.3 2.93 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.018 2.478 . . . . 0.0 111.754 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.647 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -56.29 -46.56 79.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.93 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -76.09 7.82 3.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.796 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.884 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.17 -23.26 10.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.485 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.705 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -122.01 16.68 10.85 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -177.738 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.7 m -71.65 89.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.971 0.891 . . . . 0.0 108.954 172.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 3.5 p30 161.61 -28.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.082 -169.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 175.7 -89.4 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.111 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.651 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -161.6 175.56 11.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.705 HG13 ' HB3' ' A' ' 112' ' ' TYR . 11.5 m -102.85 109.31 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.313 0.578 . . . . 0.0 110.98 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 43.2 tt0 -111.93 111.62 22.68 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 170.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.569 HD12 ' HG ' ' A' ' 121' ' ' LEU . 3.8 pp -137.01 155.11 50.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.162 -175.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.619 HG23 HG21 ' A' ' 82' ' ' VAL . 86.4 m -95.11 125.45 39.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.374 -176.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' A' ' 119' ' ' LEU . 77.9 mt -125.74 131.4 24.0 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.093 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 6.4 Cg_exo -74.47 121.43 6.77 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.071 1.847 . . . . 0.0 111.369 175.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.958 HG21 HG11 ' A' ' 98' ' ' VAL . 3.1 pt -96.25 98.31 7.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -94.04 121.11 35.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.892 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 80.4 m-85 -116.93 128.89 55.66 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 163.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 m -63.59 102.92 0.48 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.719 0.295 . . . . 0.0 111.022 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 1.043 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 5.0 mt -64.12 103.84 0.66 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.259 0.552 . . . . 0.0 111.551 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.478 HH11 ' HD3' ' A' ' 57' ' ' ARG . 64.5 mtp180 -102.7 -15.13 16.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.071 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 177.07 -151.98 11.69 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.411 ' CB ' HD21 ' A' ' 90' ' ' LEU . . . 69.81 -63.92 0.37 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.092 0.557 . . . . 0.0 111.283 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -90.38 56.62 3.53 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 25.4 p90 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.584 -178.101 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.456 ' HE2' ' OE2' ' A' ' 5' ' ' GLU . 59.9 mtpt . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 120.825 0.345 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.0 m -111.53 -17.59 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.427 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -83.87 37.86 0.61 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.086 0.47 . . . . 0.0 111.017 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.456 ' OE2' ' HE2' ' A' ' 2' ' ' LYS . 7.6 mm-40 -92.12 124.48 36.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.938 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -74.37 85.1 1.96 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.2 m -78.87 155.7 28.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.721 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.83 99.37 8.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.093 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.91 149.26 17.17 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.877 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.1 100.53 47.26 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.44 121.15 3.75 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.66 2.24 . . . . 0.0 112.294 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . 75.8 Cg_exo -50.02 -45.07 34.59 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.431 2.754 . . . . 0.0 114.064 176.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 12' ' ' PRO . 5.1 Cg_exo -81.16 3.63 7.65 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.173 1.916 . . . . 0.0 112.584 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.58 -142.49 38.75 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.603 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 15' ' ' ARG . 20.5 mmm180 -115.39 43.48 2.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.376 0.607 . . . . 0.0 109.902 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.69 119.37 30.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.345 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -99.7 -50.48 4.03 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -142.66 114.18 7.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.804 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.3 p -99.0 72.31 1.89 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.068 0.461 . . . . 0.0 111.498 -175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.29 72.56 10.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.682 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.733 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -65.71 -50.71 53.71 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.659 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.733 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 11.3 Cg_endo -92.63 -166.84 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.639 2.226 . . . . 0.0 110.496 168.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -86.17 43.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.359 0.599 . . . . 0.0 110.486 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 p -75.57 -7.97 55.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.938 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 25' ' ' ARG . 2.0 ptm180 -70.19 -15.75 62.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.164 176.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.2 tp -107.25 37.8 2.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.563 0.697 . . . . 0.0 109.535 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.728 ' H ' ' HD2' ' A' ' 28' ' ' PRO . 89.0 m -114.68 -54.63 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.36 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.728 ' HD2' ' H ' ' A' ' 27' ' ' THR . 54.4 Cg_endo -68.91 169.06 18.66 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.145 1.897 . . . . 0.0 112.36 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -81.05 61.45 4.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.062 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.15 -89.68 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.483 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.427 ' HG2' ' HB2' ' A' ' 111' ' ' ALA . 8.3 pt20 -152.42 28.98 0.56 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.02 0.438 . . . . 0.0 110.505 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.42 68.3 9.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.652 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.11 -147.29 18.46 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.92 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.71 18.72 7.19 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -172.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -78.72 155.58 29.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.934 0.397 . . . . 0.0 109.969 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.426 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 76.5 m-20 -88.7 54.44 3.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.19 0.519 . . . . 0.0 110.6 -178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.459 ' O ' HG13 ' A' ' 41' ' ' ILE . 12.0 p-90 -71.62 -36.28 70.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.329 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.545 ' HD3' ' N ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -69.2 -25.4 64.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.243 0.544 . . . . 0.0 110.125 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.545 ' N ' ' HD3' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -71.95 -34.58 69.12 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.509 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.519 ' CB ' ' HG2' ' A' ' 105' ' ' PRO . 34.1 mmt180 -74.24 -36.12 63.87 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.377 175.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.624 HG23 ' HD2' ' A' ' 103' ' ' PRO . 61.8 mt -57.32 -47.22 84.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.713 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.1 m -56.23 -35.13 67.0 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.011 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.23 -52.35 47.93 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.386 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.769 ' HD3' ' HB2' ' A' ' 103' ' ' PRO . 9.4 ptp180 -70.08 -27.46 64.63 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.538 -0.39 . . . . 0.0 111.731 175.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tt -54.25 -38.1 65.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -71.08 -31.67 68.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.297 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HB3' ' HA ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -53.16 -26.64 17.78 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.382 173.129 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -101.75 -57.16 2.13 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.479 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.537 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 4.2 mtpp -172.76 102.8 0.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.097 -177.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -144.69 104.56 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.203 0.525 . . . . 0.0 110.26 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.522 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.5 t80 -96.47 144.5 27.95 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.299 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -53.05 133.59 52.62 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.101 2.534 . . . . 0.0 112.397 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.545 ' HE2' ' HE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -62.02 -21.13 64.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.633 -171.82 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -53.07 -37.57 61.74 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.452 0.47 . . . . 0.0 110.827 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.71 -38.97 53.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.637 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.757 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.6 mm? -69.41 -41.54 76.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.068 -173.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.597 ' HA ' ' HG3' ' A' ' 61' ' ' GLN . 7.8 ptp85 -67.16 -8.88 34.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.14 0.495 . . . . 0.0 110.851 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 47.0 tp -118.93 12.81 12.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.262 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.698 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 25.3 ttmm -154.47 -67.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.693 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.82 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 36.6 mmt180 -119.98 84.53 2.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.675 0.274 . . . . 0.0 110.308 -177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.597 ' HG3' ' HA ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -86.15 177.65 7.46 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.622 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.52 122.42 0.94 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.244 -1.455 . . . . 0.0 113.787 176.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -110.82 124.48 67.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.34 166.6 33.23 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.825 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.483 ' O ' HG23 ' A' ' 82' ' ' VAL . 2.7 mp0 -102.12 124.38 47.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 178.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.408 HG21 HD13 ' A' ' 123' ' ' ILE . 76.2 t -119.73 114.23 43.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.293 -173.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HB2' HG21 ' A' ' 82' ' ' VAL . 26.7 ttt180 -115.03 124.71 52.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.748 -174.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -148.13 163.85 35.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.306 0.574 . . . . 0.0 112.136 -174.143 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 40.9 m -105.2 131.99 51.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.014 174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 104' ' ' LEU . 86.8 mt -118.76 142.0 48.1 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -172.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.587 ' OD1' ' HG2' ' A' ' 73' ' ' GLN . 13.8 t70 -89.58 160.18 16.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.244 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.582 ' HG2' ' N ' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -58.47 -32.09 68.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.687 0.279 . . . . 0.0 111.322 -177.53 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.587 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 25.4 pt20 -94.04 14.51 19.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.204 0.526 . . . . 0.0 111.246 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.47 ' HA2' ' H ' ' A' ' 104' ' ' LEU . . . 78.01 33.8 39.94 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.248 177.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.484 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 52.0 t-80 -97.1 101.88 13.54 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.44 122.26 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 121.388 0.614 . . . . 0.0 110.92 173.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 15.2 mt -108.21 -40.79 5.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.437 -175.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.5 158.43 39.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.27 117.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.167 0.508 . . . . 0.0 109.997 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.7 m -140.58 120.93 14.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.917 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 29.3 tp -81.41 106.37 13.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -82.22 -44.64 19.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.894 -170.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.1 m -155.41 155.14 33.05 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.372 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.494 ' HB2' ' CD2' ' A' ' 87' ' ' LEU . 53.4 p -163.34 147.44 10.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.85 0.357 . . . . 0.0 110.944 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.5 -9.38 58.87 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -173.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.41 ' C ' HD13 ' A' ' 87' ' ' LEU . . . 120.67 73.13 0.34 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.176 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.916 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -114.4 96.62 43.65 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -177.373 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.67 -83.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.75 2.3 . . . . 0.0 111.888 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 m -66.15 -18.29 65.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.63 0.728 . . . . 0.0 110.107 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.916 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 20.4 mt -75.78 -39.28 57.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.056 -176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.42 -50.93 68.51 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -169.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.564 ' HD2' ' H ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -61.63 -36.13 79.88 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.005 -171.43 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.82 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 8.8 tp10 -76.59 -52.64 9.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 90' ' ' LEU . 39.9 pt -65.11 -35.02 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.565 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 69.9 mm-40 -81.81 -28.68 33.0 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.678 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -57.45 -48.22 79.75 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.576 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -61.81 -58.16 9.04 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.216 -178.434 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.813 HG11 HG21 ' A' ' 123' ' ' ILE . 91.6 t -89.22 -50.05 13.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 8.9 ttpp -70.7 -24.99 62.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -170.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.595 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 9.6 tpp180 -90.99 -24.98 19.93 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.061 174.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.61 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -114.04 73.41 0.82 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.312 -178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.8 m -108.43 95.02 14.82 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.392 0.615 . . . . 0.0 110.59 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.769 ' HB2' ' HD3' ' A' ' 44' ' ' ARG . 61.1 Cg_endo -112.51 110.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 124.723 3.615 . . . . 0.0 114.04 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.674 HD23 ' HD2' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -86.32 123.42 71.44 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 171.055 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.674 ' HD2' HD23 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -80.6 -57.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.73 2.287 . . . . 0.0 112.751 -177.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -63.43 116.24 24.19 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.37 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.52 106.02 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.106 2.537 . . . . 0.0 112.171 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.67 ' HG3' HD13 ' A' ' 104' ' ' LEU . 63.7 Cg_endo -94.64 45.77 0.21 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.995 2.463 . . . . 0.0 112.82 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.605 ' O ' HG13 ' A' ' 113' ' ' VAL . . . -57.17 -41.51 79.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 109.91 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.03 -18.27 63.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.355 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.84 -29.45 22.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.779 -177.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.908 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -121.43 19.15 11.34 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -171.032 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.5 m -69.15 89.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 122.092 0.949 . . . . 0.0 108.947 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 7.0 p30 161.67 -18.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.943 -169.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.7 -87.82 0.1 Allowed Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.113 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.622 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -162.36 176.09 10.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.851 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.908 HG13 ' HB3' ' A' ' 112' ' ' TYR . 12.6 m -102.21 109.49 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 121.541 0.686 . . . . 0.0 110.719 -175.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 25.8 tt0 -107.96 110.94 22.8 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 173.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.598 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -141.04 155.26 46.2 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -174.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 50.6 m -98.74 122.75 42.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.147 0.499 . . . . 0.0 111.264 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.598 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 47.8 mt -118.22 123.88 29.07 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.993 174.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 5.2 Cg_exo -73.3 119.72 6.15 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.311 2.007 . . . . 0.0 111.241 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.813 HG21 HG11 ' A' ' 98' ' ' VAL . 32.0 pt -99.17 101.9 12.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -104.3 122.44 45.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.224 1.011 . . . . 0.0 111.722 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.622 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 85.4 m-85 -114.13 129.74 56.61 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.865 -1.516 . . . . 0.0 106.94 165.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.3 m -57.63 103.2 0.12 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.153 0.502 . . . . 0.0 111.979 -169.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.821 HD11 HD11 ' A' ' 87' ' ' LEU . 13.3 mt -80.46 82.15 6.55 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.771 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.06 31.84 6.32 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.521 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -158.85 -102.76 0.19 Allowed Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.997 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.463 ' O ' HD11 ' A' ' 90' ' ' LEU . . . -69.68 94.34 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 176.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 117.85 59.41 0.29 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -174.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 11.1 p90 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 119.206 -0.426 . . . . 0.0 111.205 -174.687 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 6.9 ptpp? . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 121.343 0.592 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.6 m -137.89 5.54 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.617 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -117.89 -18.1 9.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.987 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.474 ' OE1' ' HA ' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -102.87 137.81 40.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.167 0.508 . . . . 0.0 110.612 178.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -112.18 134.35 53.78 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.356 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.6 m -120.53 -35.89 3.31 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.865 176.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 t 51.17 81.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.502 0.667 . . . . 0.0 110.509 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.78 32.86 1.36 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -64.45 -48.72 74.42 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.707 -0.246 . . . . 0.0 111.102 178.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 39.2 Cg_endo -69.32 120.24 7.11 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.454 1.436 . . . . 0.0 110.268 170.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.506 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 19.7 Cg_endo -59.1 127.39 23.98 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.661 2.241 . . . . 0.0 112.32 -175.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 11.6 Cg_exo -71.16 71.99 2.2 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.782 2.321 . . . . 0.0 111.18 176.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.65 -141.48 10.39 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.01 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -115.02 42.31 2.22 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 70.7 -62.67 0.44 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 124.009 0.818 . . . . 0.0 109.994 -172.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 56.31 71.65 0.55 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.994 171.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -82.97 54.11 2.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.428 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.3 m -76.03 -12.62 60.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.695 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.459 ' HA ' ' OG1' ' A' ' 24' ' ' THR . . . -79.19 45.86 0.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.323 0.582 . . . . 0.0 110.733 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.581 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -60.78 -49.46 89.42 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.836 -177.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 2.9 Cg_exo -77.96 32.05 0.44 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 122.426 2.084 . . . . 0.0 112.358 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 60.4 33.84 20.68 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.474 0.654 . . . . 0.0 110.948 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.459 ' OG1' ' HA ' ' A' ' 20' ' ' ALA . 9.5 p -81.18 36.25 0.41 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.162 0.506 . . . . 0.0 111.301 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -69.37 -36.85 77.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.9 tp -171.72 98.0 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.515 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.8 m -53.32 124.95 41.62 Favored Pre-proline 0 N--CA 1.451 -0.404 0 O-C-N 123.487 0.492 . . . . 0.0 111.512 -176.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.52 148.89 84.35 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.053 2.502 . . . . 0.0 112.684 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.462 ' HD2' ' HB2' ' A' ' 31' ' ' GLN . 72.7 t80 -148.28 135.2 20.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.263 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.727 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . . . -79.39 75.48 5.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.221 0.534 . . . . 0.0 109.922 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.462 ' HB2' ' HD2' ' A' ' 29' ' ' TYR . 52.3 tt0 -85.58 136.31 33.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.67 -176.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.66 104.55 14.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.89 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.43 -127.45 6.08 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.22 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -76.44 -177.86 4.35 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.927 0.394 . . . . 0.0 110.501 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.496 ' OD1' ' HG2' ' A' ' 38' ' ' ARG . 10.0 t70 -78.99 118.95 21.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.886 0.851 . . . . 0.0 112.217 -174.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -146.43 23.07 1.31 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 167.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.626 ' HA ' ' HG2' ' A' ' 40' ' ' ARG . 0.2 OUTLIER -138.48 -24.76 0.94 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -168.51 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.496 ' HG2' ' OD1' ' A' ' 35' ' ' ASP . 2.1 ptp180 -67.84 -32.68 73.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.202 0.91 . . . . 0.0 109.872 -176.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.404 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 3.3 p -66.53 -36.44 82.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.938 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.626 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 10.2 mmt180 -69.52 -44.62 70.66 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.575 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.673 HG23 ' HG2' ' A' ' 103' ' ' PRO . 83.8 mt -63.68 -43.86 98.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.585 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.8 m -57.25 -33.58 67.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.946 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.63 -34.67 73.21 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.682 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.793 ' HD3' ' HB3' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -70.75 -40.31 72.77 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 121.279 0.561 . . . . 0.0 110.151 178.1 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.05 -25.77 64.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.75 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.975 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 24.4 t-20 -69.3 -33.99 74.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.986 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.44 -20.45 63.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.949 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.474 ' CD2' ' HB1' ' A' ' 101' ' ' ALA . 97.3 m-85 -106.71 -60.28 1.69 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.615 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -164.99 102.93 0.77 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.548 0.739 . . . . 0.0 109.037 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.975 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 24.6 tpt180 -113.54 103.15 10.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.527 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 0.9 OUTLIER -105.45 132.31 20.99 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.525 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 32.4 Cg_exo -58.97 132.1 45.55 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.824 2.349 . . . . 0.0 111.721 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.495 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -61.19 -23.14 65.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.958 -173.4 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.72 -40.21 83.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.565 0.222 . . . . 0.0 110.853 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.0 -33.65 75.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.113 0.483 . . . . 0.0 110.475 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -72.65 -41.56 65.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 57' ' ' ARG . 49.5 mtm180 -58.07 -31.07 66.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.012 0.434 . . . . 0.0 110.422 176.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.9 tp -93.85 -0.49 55.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.951 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.781 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 24.5 ttmm -142.04 -75.42 0.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -175.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.781 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 26.3 mmt180 -119.79 89.78 3.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.901 0.381 . . . . 0.0 110.427 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.407 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.2 pt20 -92.14 179.17 5.65 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.521 177.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.576 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.26 124.05 1.05 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.169 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.725 ' H ' HD12 ' A' ' 127' ' ' LEU . 7.3 p -110.36 127.05 67.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.44 167.07 36.16 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.727 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.672 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 50.3 mt-30 -102.3 125.11 48.91 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 123' ' ' ILE . 24.3 t -121.47 114.42 43.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.712 -176.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.691 ' HG2' HG22 ' A' ' 82' ' ' VAL . 5.9 ptp180 -106.19 144.17 33.28 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -152.91 152.0 30.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.094 0.473 . . . . 0.0 111.853 -174.172 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 22.5 m -96.41 126.94 41.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.371 171.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.685 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 58.7 mt -117.8 135.76 53.85 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.203 0.525 . . . . 0.0 112.069 -169.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.611 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 15.4 t70 -77.27 152.51 34.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.476 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.3 ttp-105 -60.98 -25.28 66.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.119 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -89.61 -1.43 58.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.968 0.413 . . . . 0.0 111.012 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.96 36.88 6.53 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.04 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.611 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 28.1 t-80 -104.3 120.96 42.34 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 p -53.81 117.27 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.313 0.578 . . . . 0.0 111.07 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.2 mt -101.86 -37.46 8.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.477 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -146.89 152.97 39.56 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.66 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.0 m -147.24 132.37 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 123.45 0.469 . . . . 0.0 109.836 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -144.28 132.67 22.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.37 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.724 HD21 ' HB2' ' A' ' 84' ' ' SER . 37.3 tp -75.5 120.88 21.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.732 HG21 HG23 ' A' ' 120' ' ' THR . 0.2 OUTLIER -96.67 -47.63 12.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.899 -173.645 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -142.26 145.46 34.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.346 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.724 ' HB2' HD21 ' A' ' 81' ' ' LEU . 40.7 t -137.8 148.61 45.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.023 0.44 . . . . 0.0 111.212 -176.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.58 15.32 25.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.219 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.81 76.02 1.31 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.173 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.733 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -116.51 71.11 4.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.803 0.302 . . . . 0.0 110.295 178.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.85 -68.36 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 121.804 1.669 . . . . 0.0 112.482 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 7.9 m -72.08 -18.69 61.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.233 0.54 . . . . 0.0 110.035 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.733 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 26.2 mt -77.32 -32.35 55.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.145 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.552 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 7.3 t70 -53.39 -37.95 62.94 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.4 0.438 . . . . 0.0 111.88 -173.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 13.6 ptm180 -53.57 -54.79 32.45 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -78.53 -55.12 5.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.572 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.525 HG13 ' HG2' ' A' ' 95' ' ' GLN . 40.0 pt -60.21 -38.88 78.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.646 -172.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.729 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 76.0 mm-40 -84.58 -20.86 30.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.603 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 92' ' ' ARG . . . -55.1 -54.1 47.45 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.163 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.608 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.77 -48.72 17.82 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.06 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.835 HG11 HG21 ' A' ' 123' ' ' ILE . 55.8 t -70.26 -50.18 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.729 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.3 ttmt -75.88 -32.1 59.53 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.318 -0.239 . . . . 0.0 111.361 -171.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 100' ' ' ARG . 8.3 tpp180 -89.16 -18.8 26.42 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.052 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 97' ' ' LEU . . . -120.24 56.4 0.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.603 0.24 . . . . 0.0 111.098 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 19.4 m -80.52 106.75 5.73 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.114 0.483 . . . . 0.0 110.112 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.683 ' CB ' ' HB3' ' A' ' 44' ' ' ARG . 62.9 Cg_endo -101.78 165.1 0.33 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 124.038 3.159 . . . . 0.0 114.486 -171.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 33.2 tp -142.08 94.25 7.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.159 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.793 ' HB3' ' HD3' ' A' ' 44' ' ' ARG . 50.5 Cg_endo -77.25 -49.7 0.1 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.442 2.095 . . . . 0.0 113.665 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 22.3 m -88.58 110.45 37.03 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.01 107.68 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.112 2.542 . . . . 0.0 112.451 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.729 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 52.1 Cg_endo -89.15 59.99 2.31 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.135 2.557 . . . . 0.0 111.853 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.662 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.05 -47.05 75.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.165 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.2 10.0 2.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.433 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -112.12 -30.39 7.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.932 0.396 . . . . 0.0 111.616 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.662 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -121.16 18.41 11.58 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.402 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -70.59 88.3 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.212 1.006 . . . . 0.0 108.446 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.8 p30 158.92 -15.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 113.116 -1.856 . . . . 0.0 108.383 -168.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.91 -90.84 0.1 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.175 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.432 ' CA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -161.06 177.03 10.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -175.151 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 69' ' ' THR . 12.9 m -102.75 109.88 27.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.467 0.651 . . . . 0.0 110.861 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 24.7 tt0 -109.35 109.99 21.02 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.73 HD12 ' HG ' ' A' ' 121' ' ' LEU . 1.5 pp -135.12 152.37 51.58 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.656 -173.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.732 HG23 HG21 ' A' ' 82' ' ' VAL . 87.9 m -96.72 113.44 25.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.212 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.73 ' HG ' HD12 ' A' ' 119' ' ' LEU . 62.5 mt -119.48 122.94 28.97 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.965 0.412 . . . . 0.0 110.711 177.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 12.0 Cg_exo -70.65 119.19 6.14 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.709 1.606 . . . . 0.0 110.554 174.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.835 HG21 HG11 ' A' ' 98' ' ' VAL . 35.1 pt -93.98 118.77 40.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -107.47 120.31 41.83 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 118.821 -1.151 . . . . 0.0 112.35 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.532 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 37.9 m-85 -115.65 126.69 54.46 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 160.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.0 m -56.54 104.01 0.13 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.242 0.544 . . . . 0.0 111.052 -172.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.725 HD12 ' H ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -100.6 105.46 16.86 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.854 -171.379 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 128' ' ' ARG . 38.6 mtp-105 -86.75 -47.0 9.48 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 173.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 164.11 54.99 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.741 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -81.65 -5.42 58.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 0.0 111.787 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -91.12 40.01 3.02 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.941 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 20.7 p90 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.314 -0.851 . . . . 0.0 110.342 -176.78 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.859 0.361 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 16.6 m -124.05 -44.55 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.481 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER 172.69 79.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -99.08 141.38 31.92 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.729 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -105.06 108.24 19.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.731 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.2 m -85.61 128.32 34.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.599 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -146.99 31.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 122.452 1.12 . . . . 0.0 109.195 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.15 68.05 1.18 Allowed Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.974 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -62.82 114.74 13.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.64 0.257 . . . . 0.0 110.892 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 4.1 Cg_exo -81.64 123.87 4.41 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.351 2.7 . . . . 0.0 112.174 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.2 147.8 48.68 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.634 2.222 . . . . 0.0 112.115 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.89 55.92 5.78 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.962 2.442 . . . . 0.0 112.126 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.52 -170.52 29.57 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.015 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 1.5 mpt_? -114.19 104.45 12.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.864 0.364 . . . . 0.0 110.099 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.6 -20.16 19.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.667 -178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.73 55.47 1.37 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.32 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -88.55 57.63 4.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.713 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.0 p 49.01 68.74 0.66 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.076 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.57 38.53 3.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.409 0.624 . . . . 0.0 111.215 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.726 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -91.81 -52.98 0.28 Allowed Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.002 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 5.7 Cg_exo -80.19 -160.18 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.606 2.204 . . . . 0.0 111.324 175.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -86.49 23.59 1.59 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.278 0.561 . . . . 0.0 110.922 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.633 ' HA ' ' OG1' ' A' ' 27' ' ' THR . 3.0 p -68.98 -5.27 20.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.021 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.46 -13.44 61.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.442 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.7 tp -150.83 37.53 0.65 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.165 0.507 . . . . 0.0 111.109 -176.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.633 ' OG1' ' HA ' ' A' ' 24' ' ' THR . 1.8 m -81.99 137.14 46.73 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.221 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 27' ' ' THR . 7.1 Cg_exo -73.58 77.67 2.54 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.815 2.343 . . . . 0.0 112.3 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.552 ' CZ ' ' HB ' ' A' ' 27' ' ' THR . 69.3 m-85 -76.44 126.19 30.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.591 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.73 -32.82 8.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.94 0.4 . . . . 0.0 110.404 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -89.3 43.03 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.374 0.607 . . . . 0.0 110.892 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.32 22.82 3.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.162 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.62 157.35 8.5 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.992 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -96.79 71.6 2.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.558 0.694 . . . . 0.0 110.152 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.31 140.59 58.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.418 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -87.52 103.56 15.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -99.29 16.85 21.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.029 177.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.45 ' HD2' ' N ' ' A' ' 39' ' ' SER . 7.5 ppt_? -68.12 -31.02 70.32 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -168.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.45 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 32.2 m -69.16 -32.52 71.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 0.0 109.823 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -75.86 -44.49 40.48 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.75 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.417 HG23 ' HD2' ' A' ' 103' ' ' PRO . 86.5 mt -58.77 -43.45 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.937 177.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 t -57.43 -38.8 74.98 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.882 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.13 -42.25 96.6 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.843 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.517 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.38 -33.77 73.54 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.803 0.335 . . . . 0.0 110.72 178.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.568 HD11 HG22 ' A' ' 98' ' ' VAL . 2.1 tt -62.15 -31.93 72.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.398 0.618 . . . . 0.0 109.832 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.728 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 8.7 t30 -71.69 -34.26 69.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.797 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -29.64 58.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.682 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.516 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 98.8 m-85 -94.73 -59.22 1.97 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.78 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 34.1 mmtt -174.82 104.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.622 0.769 . . . . 0.0 109.488 -177.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.728 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 29.1 ttp180 -128.28 103.91 7.43 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.485 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -81.41 138.17 48.29 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.382 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -49.87 131.53 29.83 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.132 2.555 . . . . 0.0 111.961 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.757 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -63.96 -23.68 67.43 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -170.495 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -58.76 -38.58 78.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.652 0.263 . . . . 0.0 111.069 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.03 -30.74 70.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.787 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.1 mm? -77.25 -41.47 40.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.918 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 41.0 mtm180 -62.85 -23.04 67.11 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.381 0.61 . . . . 0.0 110.5 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 tp -102.09 4.04 39.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.753 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.544 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 40.3 ttpt -149.71 -75.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.544 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 26.2 mmt180 -99.03 84.27 3.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.453 0.644 . . . . 0.0 110.742 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 126' ' ' SER . 10.7 pt20 -104.95 127.78 52.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.948 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 1.002 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -179.55 129.77 1.41 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.268 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.887 ' H ' HD12 ' A' ' 127' ' ' LEU . 96.2 t -104.96 127.17 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.119 0.485 . . . . 0.0 110.238 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.85 166.61 30.92 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.662 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 56.0 mt-30 -101.02 136.82 40.25 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 123' ' ' ILE . 39.0 t -129.5 114.21 30.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.562 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.545 ' HG2' HG22 ' A' ' 82' ' ' VAL . 13.3 ptt180 -115.35 139.38 50.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -154.3 163.37 40.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.655 -171.401 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 2.7 m -106.62 120.74 42.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.887 172.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.519 HD11 ' CE1' ' A' ' 68' ' ' PHE . 73.1 mt -106.48 138.52 42.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.75 -173.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 22.6 t70 -74.71 153.89 38.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.25 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 72' ' ' ARG . 4.2 ttp180 -61.05 -24.76 66.45 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.281 0.363 . . . . 0.0 111.333 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -80.6 -8.58 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.114 0.483 . . . . 0.0 110.421 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.761 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 89.04 35.42 8.19 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.268 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.455 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 70.8 t60 -109.2 124.61 51.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.665 0.269 . . . . 0.0 110.557 -178.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -51.86 125.31 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.558 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.519 ' CD1' HG21 ' A' ' 116' ' ' THR . 35.3 mt -115.18 -51.29 2.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.235 0.54 . . . . 0.0 110.558 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.37 152.42 49.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.379 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.4 m -146.37 128.94 8.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.137 0.494 . . . . 0.0 110.208 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.1 m -134.68 123.95 24.52 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.585 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.9 tp -76.72 108.43 9.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.294 0.569 . . . . 0.0 110.299 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.668 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -83.35 -42.26 17.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.982 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.424 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 23.1 t 66.93 176.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.904 169.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.427 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 68.7 m -158.63 -67.74 0.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.979 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.23 -76.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.4 ' C ' HD13 ' A' ' 87' ' ' LEU . . . 166.41 98.83 0.13 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.343 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.798 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -119.67 82.47 26.53 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -177.483 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.9 -75.28 0.01 OUTLIER 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.442 2.095 . . . . 0.0 111.866 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.506 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 8.4 m -70.69 -19.08 62.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.373 0.606 . . . . 0.0 110.197 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.798 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 14.6 mt -75.75 -34.08 60.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.715 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.462 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 1.8 t70 -54.33 -44.01 71.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.299 -175.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 89' ' ' SER . 11.6 ptp180 -53.58 -52.63 59.16 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -172.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 19.3 mt-10 -78.83 -54.21 6.31 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 90' ' ' LEU . 40.7 pt -63.32 -36.96 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.645 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.8 mm-40 -82.21 -26.83 32.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 122.055 -0.403 . . . . 0.0 110.825 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.642 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.85 -44.72 82.43 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.659 HD23 HG23 ' A' ' 98' ' ' VAL . 1.4 tp -68.24 -55.29 12.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.636 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 123' ' ' ILE . 81.3 t -88.75 -48.27 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.645 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 16.4 ttpp -70.33 -15.13 62.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.391 -175.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.642 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 20.3 tpp180 -98.59 -35.14 10.31 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.797 170.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.612 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -101.13 64.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 110.969 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.6 m -93.79 100.82 5.09 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.28 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.612 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 72.3 Cg_endo -101.73 173.78 0.26 Allowed 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.919 3.079 . . . . 0.0 113.689 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.761 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 17.0 tp -143.22 97.33 5.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.326 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -72.42 -62.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.652 1.568 . . . . 0.0 111.933 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.667 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -76.62 111.57 16.66 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.828 177.712 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 2.7 Cg_exo -77.15 103.58 1.77 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.421 2.748 . . . . 0.0 112.406 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.719 ' HD2' HD21 ' A' ' 104' ' ' LEU . 41.3 Cg_endo -83.07 68.94 7.3 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.075 2.516 . . . . 0.0 110.913 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.792 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.27 -42.29 73.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.189 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.426 ' OD1' ' HD2' ' A' ' 28' ' ' PRO . 2.1 m-20 -77.42 8.84 3.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.02 0.438 . . . . 0.0 111.46 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.42 -16.84 12.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.938 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.792 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -133.02 17.01 4.16 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.0 m -72.0 87.57 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 2.2 p-10 157.79 -25.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.078 -167.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 172.64 -92.68 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.896 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.631 ' HB ' HG22 ' A' ' 69' ' ' THR . 0.6 OUTLIER -158.89 174.75 14.51 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.784 0.434 . . . . 0.0 109.913 -175.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.758 HG13 ' CD2' ' A' ' 112' ' ' TYR . 2.9 m -103.72 109.74 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 CA-C-O 121.114 0.483 . . . . 0.0 111.607 -171.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 24.9 tt0 -97.51 112.02 24.05 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.511 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.3 pp -142.26 155.14 45.21 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.668 HG23 HG21 ' A' ' 82' ' ' VAL . 87.1 m -101.07 126.49 47.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.614 -175.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.511 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 69.9 mt -129.41 123.49 21.48 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.36 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.9 Cg_exo -76.22 121.21 6.0 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.006 1.804 . . . . 0.0 110.886 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.778 HG21 HG11 ' A' ' 98' ' ' VAL . 24.1 pt -96.59 112.57 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.52 120.98 36.71 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.84 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.458 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 95.9 m-85 -114.94 129.56 56.73 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 159.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 31.8 m -57.23 103.11 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -169.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 1.002 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -87.5 98.07 11.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.258 -177.511 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 128' ' ' ARG . 6.2 ppt_? -134.3 6.2 3.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.311 . . . . 0.0 111.704 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -168.15 40.5 0.23 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.847 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -155.51 39.46 0.39 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.314 0.578 . . . . 0.0 110.019 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -168.98 -38.07 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.129 -174.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 39.8 p90 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.11 -179.794 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.4 t 60.6 87.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 121.375 0.607 . . . . 0.0 110.532 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -108.9 78.48 1.14 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.618 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.515 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -88.46 -8.63 54.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.156 -179.705 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -54.03 -29.7 44.68 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.451 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -69.19 -19.52 63.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.172 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 5' ' ' GLU . 3.2 p -76.38 -9.01 12.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.357 0.599 . . . . 0.0 110.008 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.39 17.93 11.2 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.71 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -89.16 -53.35 0.34 Allowed Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 119.938 -0.077 . . . . 0.0 111.089 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 9.3 Cg_endo -92.81 114.57 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.833 2.356 . . . . 0.0 111.231 173.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 25.5 Cg_exo -62.39 112.34 1.55 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.823 2.349 . . . . 0.0 112.527 -177.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.67 -18.67 19.41 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.594 2.196 . . . . 0.0 112.174 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.0 -155.68 16.13 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.91 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -91.1 150.32 21.45 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.68 0.276 . . . . 0.0 110.736 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.11 15.46 9.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.318 0.58 . . . . 0.0 110.33 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -141.31 148.18 39.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.973 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm 54.61 64.39 1.83 Allowed 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.583 0.552 . . . . 0.0 110.248 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -81.65 68.79 8.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.579 0.704 . . . . 0.0 110.861 -175.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.31 54.62 0.79 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.08 177.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -76.33 165.3 53.93 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.956 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 1.4 Cg_endo -43.17 -36.92 6.35 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.462 2.775 . . . . 0.0 114.21 -177.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -93.37 -19.09 21.67 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -173.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.8 p -89.54 45.19 1.26 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.648 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -85.47 -76.6 0.32 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.006 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 29.3 tp -133.2 17.62 4.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.724 0.773 . . . . 0.0 110.046 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.434 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.3 p -127.84 61.96 53.9 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.879 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.452 ' HD3' ' C ' ' A' ' 26' ' ' LEU . 86.9 Cg_endo -97.32 27.04 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.09 2.527 . . . . 0.0 112.024 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -128.14 101.61 6.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.296 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.655 ' HB1' HG12 ' A' ' 117' ' ' VAL . . . -81.98 56.41 3.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.048 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -162.57 108.45 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.12 151.07 33.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.476 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.04 -144.03 15.5 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.756 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -113.79 150.06 34.01 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -81.75 68.4 8.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.627 0.727 . . . . 0.0 110.766 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -119.24 -14.24 9.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.39 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.55 ' H ' ' HD1' ' A' ' 37' ' ' TRP . 0.8 OUTLIER -74.26 -19.87 60.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.553 -173.153 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -68.21 -37.88 81.34 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.19 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 p -68.95 -31.29 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.326 0.584 . . . . 0.0 109.804 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.465 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 5.4 mmm-85 -68.84 -39.56 79.9 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.414 176.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.557 HG23 ' HD2' ' A' ' 103' ' ' PRO . 83.4 mt -63.91 -51.2 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.124 176.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.2 m -56.42 -32.74 65.16 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.784 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.81 -47.03 92.25 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.962 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -69.19 -34.77 75.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.854 0.359 . . . . 0.0 111.017 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.692 HD11 HG22 ' A' ' 98' ' ' VAL . 1.4 tt -62.44 -30.67 71.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.664 0.745 . . . . 0.0 109.652 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 1.099 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 8.4 t30 -70.89 -34.83 71.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.542 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -34.9 70.5 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.702 172.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -91.91 -59.53 2.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.515 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -162.14 102.09 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.503 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 1.099 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 12.7 tpt180 -130.88 103.34 6.51 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.491 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.423 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.1 t80 -87.32 131.88 42.9 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.823 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.8 131.71 45.65 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.732 2.288 . . . . 0.0 112.001 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.85 -23.68 65.32 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.27 -173.048 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -55.59 -42.9 75.47 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.577 0.548 . . . . 0.0 110.231 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.64 -41.03 79.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.632 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -62.44 -41.12 98.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.845 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.585 ' HG2' ' HB2' ' A' ' 126' ' ' SER . 98.5 mtt180 -59.51 -15.52 18.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.3 -24.02 9.12 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.04 0.448 . . . . 0.0 111.114 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.964 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 18.0 ttmm -102.45 -72.63 0.68 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.964 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 30.5 mmt180 -124.22 84.33 2.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.377 0.608 . . . . 0.0 110.14 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 126' ' ' SER . 14.1 pt20 -98.92 115.96 30.07 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.041 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.972 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -165.72 143.23 8.25 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.489 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.819 ' H ' HD12 ' A' ' 127' ' ' LEU . 46.7 t -103.58 123.42 57.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.0 165.24 26.29 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.36 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.731 ' H ' ' HA ' ' A' ' 83' ' ' SER . 48.9 mt-30 -105.15 143.42 33.36 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.4 114.62 21.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.637 0.732 . . . . 0.0 109.576 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.437 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 27.1 ttt180 -106.51 138.42 42.73 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.422 ' CE1' HD11 ' A' ' 70' ' ' LEU . 1.2 p90 -159.95 171.58 19.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.318 0.58 . . . . 0.0 111.956 -173.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 7.8 m -118.82 130.03 55.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.946 173.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.422 HD11 ' CE1' ' A' ' 68' ' ' PHE . 70.2 mt -111.14 140.46 45.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.762 -172.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.1 160.35 23.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.73 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.441 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 42.1 mtm180 -54.07 -36.86 63.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.298 0.57 . . . . 0.0 110.878 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -81.1 0.07 37.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.229 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 80.71 45.32 7.88 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.109 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -110.93 124.53 52.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.7 p -57.24 111.09 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.497 0.665 . . . . 0.0 110.703 174.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' CD1' HG21 ' A' ' 116' ' ' THR . 80.5 mt -100.99 -41.04 6.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.931 -178.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.28 158.27 40.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.222 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 m -144.89 121.65 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 123.613 0.57 . . . . 0.0 109.915 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 35.7 m -126.29 114.89 18.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.057 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.8 tp -78.29 118.74 20.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.427 0.632 . . . . 0.0 110.662 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -108.1 -58.42 3.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.26 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.731 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 19.1 t 62.05 179.64 0.13 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.979 0.419 . . . . 0.0 111.32 176.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.9 m -154.58 -74.36 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.87 -68.68 0.32 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -169.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.95 84.25 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.825 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.928 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -120.68 93.44 48.54 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -176.785 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.15 -79.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.578 2.185 . . . . 0.0 111.347 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -75.92 -17.2 59.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.543 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.928 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.7 mt -72.1 -38.3 69.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.728 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 14.0 t70 -54.58 -51.14 66.21 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.607 0.567 . . . . 0.0 111.61 -172.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.418 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 9.4 ptp180 -53.73 -40.54 66.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.128 -177.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HG2' ' HG3' ' A' ' 92' ' ' ARG . 5.7 mm-40 -78.07 -58.11 3.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.56 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 32.5 pt -66.75 -43.74 89.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.723 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.861 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 48.4 mm-40 -67.98 -51.16 50.58 Favored 'General case' 0 C--O 1.193 -1.893 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.643 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.46 -31.28 61.82 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.097 0.862 . . . . 0.0 111.434 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.451 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -53.82 -54.47 38.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.838 173.424 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.73 HG11 HG21 ' A' ' 123' ' ' ILE . 79.9 t -86.48 -33.55 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.306 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.861 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.5 ttmt -66.72 -25.15 66.38 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.4 1.08 . . . . 0.0 110.951 -169.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -104.23 -19.4 14.13 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.967 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.507 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -112.44 45.52 1.29 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.797 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.7 m -81.75 107.54 8.59 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.116 0.484 . . . . 0.0 110.255 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 41' ' ' ILE . 73.0 Cg_endo -99.79 175.07 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.539 2.826 . . . . 0.0 113.259 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.828 HD21 ' HD2' ' A' ' 108' ' ' PRO . 16.1 tp -143.46 90.52 7.16 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.921 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.456 ' CG ' ' HB2' ' A' ' 40' ' ' ARG . 10.1 Cg_endo -67.36 -62.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.984 1.79 . . . . 0.0 112.078 -177.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.604 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 t -79.1 116.97 64.18 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 5.6 Cg_exo -80.06 103.04 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.068 2.512 . . . . 0.0 111.626 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.828 ' HD2' HD21 ' A' ' 104' ' ' LEU . 45.2 Cg_endo -81.66 68.92 7.9 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.904 2.403 . . . . 0.0 111.764 -177.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.606 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -58.91 -42.85 90.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.646 178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -67.72 1.9 2.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.832 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -112.53 -35.85 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.676 0.274 . . . . 0.0 111.575 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.646 ' CD2' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -118.79 17.51 13.47 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -171.169 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.5 m -70.98 89.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 2.4 p-10 160.87 -26.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.744 -1.571 . . . . 0.0 107.588 -170.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 175.21 -88.25 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.936 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.503 ' HB ' HG22 ' A' ' 69' ' ' THR . 0.8 OUTLIER -160.0 175.7 12.7 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 122.933 0.493 . . . . 0.0 110.01 -174.283 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.655 HG12 ' HB1' ' A' ' 30' ' ' ALA . 2.6 m -103.2 108.98 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.301 0.572 . . . . 0.0 110.778 -175.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 8.5 tm-20 -103.27 111.65 24.14 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.681 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -151.72 156.44 40.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.155 0.502 . . . . 0.0 111.943 -171.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 61.4 m -96.13 126.39 41.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.189 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.681 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 33.0 mt -128.54 137.9 31.92 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.092 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 3.4 Cg_endo -87.57 119.8 1.41 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.329 2.019 . . . . 0.0 112.066 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.73 HG21 HG11 ' A' ' 98' ' ' VAL . 9.8 pt -97.07 97.87 6.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.745 0.784 . . . . 0.0 109.198 172.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -97.16 125.72 41.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.043 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.56 ' CE1' ' HB ' ' A' ' 94' ' ' ILE . 83.5 m-85 -114.28 151.42 32.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 168.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.585 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 5.0 m -64.86 102.58 0.61 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.089 -0.245 . . . . 0.0 111.296 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.972 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -92.1 95.15 9.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.106 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.408 ' HB2' ' OE1' ' A' ' 61' ' ' GLN . 80.1 mtm180 -81.23 -53.13 6.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.966 0.412 . . . . 0.0 110.224 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -165.87 79.23 0.12 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.566 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -144.53 168.37 20.31 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.93 -50.23 2.82 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.471 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 7.0 p90 . . . . . 0 C--O 1.245 0.839 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 175.744 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 120.959 0.409 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.6 t -116.76 -51.76 4.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -179.95 82.89 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.302 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.16 58.51 2.51 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.576 -171.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -92.82 -60.28 1.85 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.045 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.9 t -112.11 41.96 1.87 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.259 0.552 . . . . 0.0 110.052 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 m -116.27 1.82 8.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.332 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.56 3.51 61.26 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.024 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.3 140.57 13.21 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.412 -0.394 . . . . 0.0 109.966 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.55 113.73 2.42 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.472 2.115 . . . . 0.0 110.912 173.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 37.7 Cg_exo -60.26 124.26 14.82 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.744 2.296 . . . . 0.0 112.379 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 3.0 Cg_exo -76.84 8.7 2.99 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.185 2.59 . . . . 0.0 111.994 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.27 -154.19 34.66 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.141 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 54.7 mmt-85 -126.14 -78.03 0.59 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.14 12.8 8.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.3 0.571 . . . . 0.0 109.801 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.13 3.05 28.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.823 -176.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.953 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -101.77 -43.46 5.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.151 0.501 . . . . 0.0 110.094 174.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 60.82 15.95 6.39 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.646 168.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HA ' ' OG1' ' A' ' 24' ' ' THR . . . 49.59 43.13 23.97 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.446 -176.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.552 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -113.08 -61.99 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.172 -176.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 42.8 Cg_endo -69.19 -79.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.784 1.656 . . . . 0.0 113.171 -176.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -144.0 91.27 2.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.937 0.399 . . . . 0.0 110.345 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 20' ' ' ALA . 16.8 p -122.64 28.71 7.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.651 177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -95.46 3.46 54.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.583 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.6 tp -169.0 36.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.557 0.694 . . . . 0.0 109.154 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.482 ' H ' ' CD ' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -127.17 -53.75 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.858 -170.445 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.482 ' CD ' ' H ' ' A' ' 27' ' ' THR . 32.3 Cg_exo -59.22 112.03 1.1 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.384 2.056 . . . . 0.0 113.351 -175.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -81.92 127.37 32.96 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.85 67.53 4.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.952 0.406 . . . . 0.0 111.83 -176.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -90.48 53.06 2.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.449 0.642 . . . . 0.0 110.739 177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.89 129.08 37.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.582 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.44 7.34 2.27 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.175 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -105.25 38.93 1.83 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.119 0.485 . . . . 0.0 110.392 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -152.62 146.02 24.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.162 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -88.59 44.35 1.2 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.291 0.567 . . . . 0.0 110.961 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.504 ' O ' HG13 ' A' ' 41' ' ' ILE . 2.4 p-90 -55.85 -38.56 70.24 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.05 -176.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.409 ' HG3' ' N ' ' A' ' 39' ' ' SER . 13.6 ptt180 -66.59 -39.17 88.27 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.956 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.409 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 2.1 m -66.75 -33.79 76.42 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.517 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 33.0 mmm180 -75.87 -36.28 59.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.458 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.621 HG23 ' HG2' ' A' ' 103' ' ' PRO . 59.8 mt -58.09 -46.14 88.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.83 174.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -55.93 -42.56 76.29 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.783 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.99 -37.35 94.16 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.768 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.689 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 1.6 ttm180 -67.77 -34.91 77.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.157 0.503 . . . . 0.0 110.352 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.68 -29.72 70.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.552 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.694 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 44.7 t30 -71.14 -36.89 72.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.582 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -57.47 -30.56 65.17 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.772 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -94.96 -56.68 2.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.183 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -175.35 102.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.414 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.694 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 28.1 ttp180 -130.73 104.12 6.99 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.062 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.594 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -84.9 133.63 43.04 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.825 178.032 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -56.37 132.2 50.42 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.888 2.392 . . . . 0.0 111.737 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HE3' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.03 -23.43 65.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.086 -172.086 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.83 -33.74 73.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.042 0.448 . . . . 0.0 110.953 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.47 -32.41 60.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.7 mm? -71.8 -34.43 69.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.725 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 30.4 mtm180 -69.35 -10.32 57.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.624 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.45 17.43 12.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.397 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.68 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 19.6 ttmm -150.75 -76.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.818 0.342 . . . . 0.0 111.096 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.68 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 3.4 mmp_? -128.39 90.42 3.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 0.0 110.484 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.443 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 21.6 pt20 -119.08 114.93 23.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.911 -178.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.785 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -160.05 149.79 19.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.803 178.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.573 ' H ' HD12 ' A' ' 127' ' ' LEU . 45.7 t -104.61 125.29 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.708 0.29 . . . . 0.0 110.336 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.7 160.31 25.61 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.757 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 44.0 tt0 -103.96 125.05 50.06 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.467 HG21 HD13 ' A' ' 123' ' ' ILE . 62.5 t -129.44 116.7 40.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.619 -169.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.608 ' HG2' HG22 ' A' ' 82' ' ' VAL . 12.2 ptt180 -109.13 145.31 35.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.627 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -157.75 151.0 23.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -171.403 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 21.6 m -94.38 126.81 39.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.402 171.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.484 HD11 ' CE1' ' A' ' 68' ' ' PHE . 55.5 mt -122.38 139.37 53.91 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -170.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 12.6 t70 -79.43 156.11 28.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.037 173.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.749 ' HB2' ' HB3' ' A' ' 107' ' ' PRO . 25.9 ptt180 -63.14 -21.52 66.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.084 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.465 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 29.7 pt20 -87.97 -4.49 58.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.251 0.548 . . . . 0.0 110.087 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.455 ' CA ' ' H ' ' A' ' 104' ' ' LEU . . . 87.2 38.89 7.6 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.116 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.557 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 44.6 t-80 -100.35 114.05 27.25 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 p -48.95 116.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.089 172.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.3 mt -104.84 -40.38 5.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.982 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -147.78 146.55 29.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.388 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.753 HG11 ' HG3' ' A' ' 99' ' ' LYS . 58.8 t -143.18 129.87 17.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 m -136.04 120.39 17.98 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.72 HD21 ' HB2' ' A' ' 84' ' ' SER . 35.3 tp -60.36 120.11 9.24 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.608 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -90.95 -46.74 14.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.894 -175.415 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -148.61 143.82 26.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.127 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.72 ' HB2' HD21 ' A' ' 81' ' ' LEU . 30.1 t -134.45 108.47 8.15 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.13 -37.99 89.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.081 -175.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.642 ' H ' HD22 ' A' ' 87' ' ' LEU . . . 167.8 56.84 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.882 -178.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.727 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -121.07 74.79 28.66 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -177.287 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 3.6 Cg_exo -75.96 -65.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.457 2.104 . . . . 0.0 111.639 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.2 t -74.02 -24.12 59.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.267 0.556 . . . . 0.0 110.181 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.727 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 31.0 mt -73.06 -31.49 64.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.346 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 17.6 t70 -54.41 -45.59 72.97 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.785 0.678 . . . . 0.0 112.144 -172.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -54.21 -49.4 69.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -172.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.472 ' CB ' ' HG3' ' A' ' 60' ' ' ARG . 9.2 tp10 -78.29 -53.45 7.29 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -175.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 90' ' ' LEU . 38.6 pt -63.03 -34.28 65.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -174.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.681 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.8 mm-40 -82.18 -28.78 31.86 Favored 'General case' 0 C--O 1.212 -0.91 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.691 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.32 -41.05 75.38 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 98' ' ' VAL . 1.4 tp -68.27 -56.95 6.83 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.684 -1.143 . . . . 0.0 112.097 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.92 HG11 HG21 ' A' ' 123' ' ' ILE . 85.8 t -88.41 -48.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.753 ' HG3' HG11 ' A' ' 79' ' ' VAL . 37.7 ttmt -64.91 -21.88 66.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.244 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.502 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 5.9 tpp180 -95.39 -35.44 11.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.042 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.562 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -106.18 74.3 1.03 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.629 0.252 . . . . 0.0 110.859 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 14.0 m -94.21 99.46 3.82 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.991 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.689 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 94.8 Cg_endo -100.6 151.82 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.711 2.941 . . . . 0.0 114.525 -173.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.578 HD23 ' HD2' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -143.8 114.91 5.56 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 173.573 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.642 ' HA ' ' CZ ' ' A' ' 44' ' ' ARG . 2.6 Cg_endo -74.15 -58.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.678 2.252 . . . . 0.0 112.838 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 4.6 t -72.72 124.63 90.98 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.737 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.749 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 12.1 Cg_exo -70.41 105.68 1.64 Allowed 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.539 2.159 . . . . 0.0 111.162 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.827 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 69.3 Cg_endo -87.83 58.0 3.0 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.906 2.404 . . . . 0.0 112.862 -172.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.634 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -60.36 -41.65 94.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.112 0.482 . . . . 0.0 109.941 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -75.51 5.93 5.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.065 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.827 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.43 -24.85 9.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.43 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.837 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -123.85 19.97 9.29 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.29 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.7 m -69.49 89.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 6.4 p30 162.51 -25.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 113.208 -1.815 . . . . 0.0 107.46 -168.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.08 -83.85 0.1 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.109 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.535 ' CA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -160.26 174.16 14.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' A' ' 112' ' ' TYR . 27.8 m -102.92 109.73 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.532 0.682 . . . . 0.0 110.799 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 35.0 tt0 -108.7 111.71 23.64 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 166.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.594 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -135.01 155.27 51.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -175.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.549 HG23 HG21 ' A' ' 82' ' ' VAL . 92.7 m -96.03 119.55 34.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.441 -175.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.594 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 42.6 mt -124.98 122.77 25.49 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.454 174.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.4 Cg_exo -72.72 119.32 6.02 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.897 1.731 . . . . 0.0 110.828 175.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.92 HG21 HG11 ' A' ' 98' ' ' VAL . 35.2 pt -91.58 103.63 14.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.41 124.46 41.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.024 0.916 . . . . 0.0 111.566 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.444 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 86.4 m-85 -113.32 135.41 53.88 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 163.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.9 m -58.66 102.8 0.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.265 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.785 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.3 tt -86.53 81.15 8.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.127 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -69.28 -53.73 18.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.387 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -172.25 73.42 0.1 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.872 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.461 ' HB1' HD21 ' A' ' 90' ' ' LEU . . . -146.82 13.68 1.16 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.853 0.358 . . . . 0.0 111.023 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -95.78 27.76 14.97 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.225 -174.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 42.2 p90 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.766 179.119 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -69.03 -34.11 74.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.233 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.5 p -70.35 -33.95 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.08 0.467 . . . . 0.0 109.832 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.414 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 30.2 mmt180 -70.3 -43.46 70.31 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.747 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.903 HG23 ' HG2' ' A' ' 103' ' ' PRO . 53.9 mt -57.61 -42.14 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.885 175.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.3 m -56.92 -34.71 68.22 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.489 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.71 -35.69 80.92 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.889 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.8 -34.18 73.37 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.46 0.648 . . . . 0.0 109.64 178.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.448 HD11 HG22 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -68.12 -25.47 65.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.894 177.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.785 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 59.1 t30 -70.19 -34.57 73.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.553 176.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 1.9 ttt180 -59.88 -27.09 66.4 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.015 170.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.56 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 69.5 m-85 -106.01 25.67 10.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.906 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 48' ' ' PHE . 21.9 mtpp 74.13 102.41 0.07 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 124.075 0.859 . . . . 0.0 110.505 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.785 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 16.4 ttp180 -93.54 104.62 16.74 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.289 0.566 . . . . 0.0 110.607 -176.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.522 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -69.41 114.79 26.57 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.892 175.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HD2' ' HD1' ' A' ' 51' ' ' TYR . 34.7 Cg_exo -57.68 131.82 46.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.714 2.276 . . . . 0.0 111.573 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.728 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.16 -25.2 63.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.885 -170.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.401 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 14.5 m-20 -64.6 -32.45 74.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.0 0.429 . . . . 0.0 111.182 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 59' ' ' LYS . . . -74.15 -31.78 62.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.511 178.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.4 mm? -74.76 -42.6 57.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.665 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.731 ' HB3' ' HB2' ' A' ' 126' ' ' SER . 2.5 ptp180 -64.41 -17.95 64.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.751 0.31 . . . . 0.0 111.334 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.7 mt -108.33 4.41 24.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.921 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.649 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 39.2 ttmt -145.6 -75.27 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 111.556 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.679 ' HB2' HD12 ' A' ' 56' ' ' LEU . 33.5 mmt180 -106.85 87.57 2.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.844 0.354 . . . . 0.0 110.193 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.74 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . 4.7 mt-30 -85.95 156.17 20.59 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 170.44 116.76 0.39 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 118.851 -1.642 . . . . 0.0 113.854 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.863 ' H ' HD12 ' A' ' 127' ' ' LEU . 58.9 t -110.18 123.42 66.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.45 165.65 33.99 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.636 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 42.4 mt-30 -103.57 124.46 48.84 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.536 HG21 HD13 ' A' ' 123' ' ' ILE . 77.4 t -122.22 113.63 39.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.433 -173.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.531 ' HB3' HG21 ' A' ' 82' ' ' VAL . 20.6 ptt180 -108.38 141.03 40.81 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -156.9 157.59 35.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.559 0.695 . . . . 0.0 112.412 -171.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 6.4 m -101.92 129.91 48.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.577 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.523 HD11 ' CE1' ' A' ' 68' ' ' PHE . 48.2 mt -121.78 139.84 53.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.12 0.486 . . . . 0.0 112.286 -168.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.787 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 21.4 t70 -82.18 155.68 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.827 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HG3' ' HB3' ' A' ' 107' ' ' PRO . 58.0 ttt180 -51.51 -41.43 60.99 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -174.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -87.08 12.22 11.97 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.019 0.437 . . . . 0.0 111.038 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.33 53.82 4.27 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.421 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 67.9 t60 -112.4 114.97 27.96 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 4.1 p -48.79 120.35 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.523 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.1 mt -110.49 -40.26 4.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.744 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -152.66 146.01 24.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.279 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.762 HG11 ' HD3' ' A' ' 99' ' ' LYS . 28.4 t -142.39 130.91 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.7 m -128.24 128.16 44.17 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.819 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.9 tp -72.91 123.03 22.63 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.531 HG21 ' HB3' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -99.4 -52.03 9.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.461 -171.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.9 m -141.31 138.61 33.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.492 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.7 t -131.41 131.38 43.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.935 0.398 . . . . 0.0 110.698 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.03 8.38 26.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.489 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 103.11 69.98 0.83 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.702 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -115.57 89.7 23.46 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 4.6 Cg_exo -77.94 -84.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.591 2.194 . . . . 0.0 112.021 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.5 m -66.16 -18.32 65.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.332 0.587 . . . . 0.0 110.966 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 13.7 mt -75.41 -45.09 41.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.245 -176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 16.9 t70 -55.17 -41.75 72.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.079 -169.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -54.28 -49.71 68.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.819 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.94 -47.93 15.49 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.521 ' HB ' ' CE2' ' A' ' 125' ' ' PHE . 42.1 pt -63.35 -38.8 83.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.573 HE22 HD11 ' A' ' 123' ' ' ILE . 75.4 mm-40 -79.08 -31.34 44.36 Favored 'General case' 0 C--O 1.199 -1.594 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.605 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.84 -39.25 65.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 4.1 tp -67.53 -54.77 17.14 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.487 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.757 HG11 HG21 ' A' ' 123' ' ' ILE . 52.9 t -87.41 -45.52 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.762 ' HD3' HG11 ' A' ' 79' ' ' VAL . 3.2 tppp? -56.32 -40.23 74.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.148 0.579 . . . . 0.0 110.518 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -84.38 -31.02 24.95 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.828 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -105.65 63.15 0.68 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.808 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.478 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.7 m -89.13 99.43 1.59 Allowed Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.903 ' HG2' HG23 ' A' ' 41' ' ' ILE . 74.5 Cg_endo -103.55 166.59 0.23 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.922 3.082 . . . . 0.0 114.611 -170.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.518 HD21 ' CD ' ' A' ' 108' ' ' PRO . 37.1 tp -143.16 96.49 5.87 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.722 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.503 ' HG3' ' N ' ' A' ' 41' ' ' ILE . 33.1 Cg_endo -78.06 -44.92 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.3 2.0 . . . . 0.0 113.671 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.495 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 15.4 m -92.95 107.88 28.11 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.499 ' HB3' ' HG3' ' A' ' 72' ' ' ARG . 21.2 Cg_exo -66.59 106.12 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.312 2.675 . . . . 0.0 112.977 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.906 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 41.6 Cg_endo -88.87 65.76 2.77 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.543 2.829 . . . . 0.0 112.128 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.585 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -51.07 -51.7 50.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.78 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -78.79 9.33 4.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.79 -176.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.906 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -105.84 -30.15 9.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.165 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.622 ' HB2' ' HA ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -114.3 15.55 18.05 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 3.9 m -72.58 87.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 169.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 4.7 p30 159.74 -19.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.916 -167.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.66 -86.7 0.1 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.391 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.633 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.2 OUTLIER -160.75 177.08 10.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 69' ' ' THR . 11.2 m -100.1 108.77 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 121.877 0.846 . . . . 0.0 110.105 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -113.63 112.49 23.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.629 HD12 ' HG ' ' A' ' 121' ' ' LEU . 2.1 pp -142.84 154.63 44.35 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.225 -173.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.449 HG23 HG21 ' A' ' 82' ' ' VAL . 92.8 m -92.44 125.85 37.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.421 -177.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.629 ' HG ' HD12 ' A' ' 119' ' ' LEU . 64.2 mt -130.38 122.85 20.17 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.393 176.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.3 Cg_exo -74.75 119.2 5.6 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.642 1.562 . . . . 0.0 110.726 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.757 HG21 HG11 ' A' ' 98' ' ' VAL . 20.6 pt -89.62 121.07 39.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -111.97 121.71 45.76 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 119.379 -0.928 . . . . 0.0 112.256 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.596 ' CD1' ' HG ' ' A' ' 56' ' ' LEU . 89.7 m-85 -114.09 131.54 56.36 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.409 -1.723 . . . . 0.0 106.816 163.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.731 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 8.7 m -56.98 103.42 0.11 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 -170.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.863 HD12 ' H ' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -97.65 108.85 21.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.915 -171.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.479 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 46.4 mtm105 . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.734 173.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.495 ' CH2' HD21 ' A' ' 121' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 120.62 0.247 . . . . 0.0 110.733 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 39' ' ' SER . 4.4 ppt_? -69.54 -28.19 65.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.156 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.496 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 13.1 m -66.47 -36.36 82.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 105' ' ' PRO . 17.8 mmm-85 -73.31 -43.69 60.43 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.338 177.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.746 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 34.8 mt -57.99 -36.84 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.634 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.466 ' O ' ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -61.38 -45.04 96.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.6 -38.66 95.97 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.499 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.746 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 8.5 ptt180 -56.69 -34.6 67.57 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.928 0.394 . . . . 0.0 110.13 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -32.26 47.62 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.623 -175.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.497 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 6.5 t30 -70.69 -29.19 65.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.035 0.921 . . . . 0.0 108.722 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -18.72 36.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.561 -1.654 . . . . 0.0 111.083 173.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -125.74 -57.64 1.44 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -158.37 102.85 1.76 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.333 0.653 . . . . 0.0 109.822 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 64.1 ttt-85 -128.54 103.53 7.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.35 0.595 . . . . 0.0 109.942 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.45 130.17 23.21 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.917 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.06 134.16 58.62 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.966 2.444 . . . . 0.0 111.936 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.592 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.9 -21.43 61.06 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.53 -174.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.78 -38.52 55.9 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.6 0.562 . . . . 0.0 110.762 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.11 -42.43 47.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.315 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.4 mm? -64.22 -34.81 78.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.963 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 21.7 mtm180 -62.71 -14.63 46.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.757 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.2 mp -119.62 14.36 12.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.75 0.31 . . . . 0.0 110.931 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.777 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 39.0 ttmt -142.25 -76.52 0.27 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.702 0.287 . . . . 0.0 110.859 -176.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.789 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 39.6 mmt180 -130.95 100.63 5.31 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.0 167.84 11.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.74 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.766 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.74 144.48 3.92 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.727 -1.225 . . . . 0.0 113.272 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 p -111.13 128.17 67.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.53 164.62 29.45 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.097 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.486 ' O ' HG23 ' A' ' 82' ' ' VAL . 35.8 tt0 -103.65 125.13 49.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.52 HG21 HD13 ' A' ' 123' ' ' ILE . 49.3 t -127.31 114.79 38.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.763 -171.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.594 ' HG2' HG22 ' A' ' 82' ' ' VAL . 5.1 ptp180 -114.68 144.35 43.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.49 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -160.1 164.07 33.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 7.3 m -108.4 131.93 54.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.562 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.609 HD21 ' HB3' ' A' ' 102' ' ' SER . 61.9 mt -119.05 138.29 52.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.73 -172.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.544 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 29.4 t70 -81.2 158.45 24.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.821 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.85 -36.67 70.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -81.6 3.11 26.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.12 0.486 . . . . 0.0 111.258 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . 81.4 35.52 22.95 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.298 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.544 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 42.4 t60 -100.38 110.83 23.05 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 5.8 p -48.44 111.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.645 0.736 . . . . 0.0 111.002 173.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 48.9 mt -99.65 -23.5 15.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.581 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.69 157.58 36.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.836 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 ' HG3' ' A' ' 99' ' ' LYS . 13.6 p -159.82 133.85 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.2 m -144.48 130.15 19.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.704 0.288 . . . . 0.0 111.065 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 84' ' ' SER . 24.5 tp -74.78 110.1 8.8 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -84.84 -39.22 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.155 -171.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.0 m -150.56 151.15 32.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.762 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.732 ' HB2' HD21 ' A' ' 81' ' ' LEU . 45.7 t -140.11 142.77 36.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.875 0.369 . . . . 0.0 110.572 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.18 19.42 19.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.243 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.13 63.41 0.84 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.686 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.809 ' HA ' HD12 ' A' ' 90' ' ' LEU . 1.1 mm? -119.1 82.99 23.05 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.08 -83.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.369 2.046 . . . . 0.0 111.973 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 66.5 m -68.64 -17.91 64.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.397 0.618 . . . . 0.0 110.339 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 87' ' ' LEU . 16.2 mt -70.24 -34.03 72.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.632 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.549 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 3.7 t70 -54.12 -44.53 71.39 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.467 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 89' ' ' SER . 11.2 ptm180 -54.31 -48.49 71.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.505 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 8.1 tp10 -77.88 -53.46 7.45 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 122.016 -0.427 . . . . 0.0 111.789 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.539 HG12 ' O ' ' A' ' 90' ' ' LEU . 36.7 pt -64.76 -37.08 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -172.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.601 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.4 mm-40 -82.21 -28.31 32.06 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.45 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.669 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.88 -43.43 81.26 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.612 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -63.87 -58.37 7.0 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.008 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.864 HG11 HG21 ' A' ' 123' ' ' ILE . 93.0 t -89.05 -50.4 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.63 ' HG3' HG21 ' A' ' 79' ' ' VAL . 35.6 ttmt -67.32 -29.99 69.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.649 -173.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.669 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 4.1 tmt_? -89.07 -47.17 8.29 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.664 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.656 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -86.0 73.75 10.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.044 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.609 ' HB3' HD21 ' A' ' 70' ' ' LEU . 67.4 m -109.52 92.3 11.64 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-O 122.063 0.935 . . . . 0.0 110.531 171.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.665 ' HG2' ' HG3' ' A' ' 44' ' ' ARG . 3.3 Cg_endo -96.33 178.44 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 1 C-N-CA 125.457 4.105 . . . . 0.0 112.052 170.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.782 HD21 ' HD2' ' A' ' 108' ' ' PRO . 12.2 tp -134.65 99.15 13.0 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HB2' ' HB3' ' A' ' 40' ' ' ARG . 86.6 Cg_endo -77.15 -28.51 5.8 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.449 1.433 . . . . 0.0 112.77 -173.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.513 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 2.9 t -122.46 107.83 34.07 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.708 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.38 108.3 1.35 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.062 2.508 . . . . 0.0 112.612 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.782 ' HD2' HD21 ' A' ' 104' ' ' LEU . 41.9 Cg_endo -86.71 66.45 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.159 2.572 . . . . 0.0 111.312 177.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.703 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -49.69 -46.28 49.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.864 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.69 -32.49 67.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.592 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -81.09 -31.31 34.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.12 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.703 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -116.62 18.58 14.94 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 109' ' ' ALA . 3.2 m -71.29 88.95 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 168.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 6.9 p30 159.34 -23.07 0.0 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.152 -168.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.56 -84.53 0.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.002 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.46 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.3 OUTLIER -159.67 175.69 12.89 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.218 0.607 . . . . 0.0 109.491 -176.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 69' ' ' THR . 4.0 m -103.02 107.99 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-O 121.396 0.617 . . . . 0.0 111.251 -174.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 1.1 tm-20 -103.57 112.14 24.92 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.662 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 3.5 pp -142.09 149.33 39.73 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.622 -173.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.2 m -87.94 124.58 33.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.627 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.662 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 32.2 mt -123.77 122.03 26.46 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.556 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.05 120.89 5.9 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.197 1.932 . . . . 0.0 110.933 176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.864 HG21 HG11 ' A' ' 98' ' ' VAL . 12.2 pt -104.69 123.19 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -126.26 124.31 40.09 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 122.206 1.003 . . . . 0.0 111.581 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.44 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 62.0 m-85 -113.17 139.13 49.02 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 168.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 14.4 m -57.99 101.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.805 0.336 . . . . 0.0 111.558 -172.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.766 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.4 OUTLIER -94.88 106.06 18.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.917 -174.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.304 177.577 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.512 ' CH2' HD21 ' A' ' 121' ' ' LEU . 1.4 p-90 . . . . . 0 N--CA 1.457 -0.094 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.15 -31.48 70.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 110.247 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.0 m -70.84 -34.53 71.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.469 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.559 ' CB ' ' HG2' ' A' ' 105' ' ' PRO . 48.9 mtt180 -64.8 -44.96 88.25 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.433 0.635 . . . . 0.0 109.443 174.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.531 HG23 ' HD2' ' A' ' 103' ' ' PRO . 75.8 mt -59.62 -38.67 76.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.322 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 m -55.75 -32.31 63.3 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.17 -43.01 82.28 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.713 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.625 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 9.2 mpt_? -69.07 -32.53 72.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.098 0.475 . . . . 0.0 110.769 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.418 HD11 HG22 ' A' ' 98' ' ' VAL . 0.7 OUTLIER -62.95 -32.41 73.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.422 0.63 . . . . 0.0 109.754 178.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.544 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.8 t-20 -71.2 -31.29 67.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.822 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.531 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 2.0 ttt180 -53.34 -28.34 28.16 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.961 172.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -100.85 -57.09 2.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.705 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -173.56 116.98 0.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.544 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 55.4 ttp180 -133.47 103.83 6.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.217 0.532 . . . . 0.0 110.312 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -98.79 142.94 25.45 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.993 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.86 132.8 51.51 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.877 2.384 . . . . 0.0 111.83 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.674 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -62.36 -23.89 67.05 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -171.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.489 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 15.3 m-20 -65.2 -33.53 76.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.643 0.259 . . . . 0.0 110.815 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.84 71.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.249 0.547 . . . . 0.0 110.112 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -73.45 -40.31 64.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.61 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.713 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 83.2 mtt180 -55.65 -30.86 61.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.984 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 54' ' ' ASP . 61.6 mt -99.04 14.41 29.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.038 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.444 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 24.8 ttmm -145.8 -74.64 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 111.049 -177.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.55 ' HD2' HD23 ' A' ' 90' ' ' LEU . 23.0 mmt180 -127.38 84.44 2.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.384 0.612 . . . . 0.0 110.232 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.713 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 24.4 pt20 -94.27 115.29 27.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.06 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.811 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -154.79 130.02 2.74 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.56 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.88 ' H ' HD12 ' A' ' 127' ' ' LEU . 7.1 p -103.78 133.39 47.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.006 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.85 168.12 38.24 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.16 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.662 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 56.7 mt-30 -100.29 137.65 38.44 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 123' ' ' ILE . 39.8 t -128.22 114.03 32.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.237 0.541 . . . . 0.0 110.46 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 34.4 ttp180 -103.71 125.04 49.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -144.1 156.99 44.57 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.508 0.67 . . . . 0.0 112.625 -174.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.789 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 23.3 m -106.43 124.32 49.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.429 173.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.681 HD13 ' HG ' ' A' ' 104' ' ' LEU . 39.9 mt -116.96 147.69 42.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.24 0.543 . . . . 0.0 111.953 -169.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.614 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 29.3 t70 -88.41 161.81 16.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.399 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.416 ' HD2' ' HB3' ' A' ' 107' ' ' PRO . 8.1 tpt180 -48.96 -40.39 30.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.543 174.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -88.76 7.14 35.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.989 0.423 . . . . 0.0 111.062 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.61 40.25 27.63 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.162 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.614 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 45.2 t60 -103.06 123.81 47.34 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.48 118.89 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.417 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 71' ' ' ASP . 26.0 mt -106.19 -53.45 2.63 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.231 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.61 149.59 52.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.802 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' A' ' 68' ' ' PHE . 2.4 m -145.67 125.35 6.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.442 0.639 . . . . 0.0 110.857 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.9 m -124.71 123.83 40.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.425 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.448 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 23.1 tp -78.68 106.48 10.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.484 0.659 . . . . 0.0 109.882 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -86.66 -41.96 15.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.049 178.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.457 ' CA ' ' H ' ' A' ' 65' ' ' GLN . 13.2 t 68.67 -178.03 0.22 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.396 167.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.431 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 40.8 m -153.59 -56.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.024 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.59 -77.4 0.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.7 98.67 0.11 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.747 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.742 ' HA ' HD12 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -117.6 87.63 26.66 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.532 0.166 . . . . 0.0 110.655 -177.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.76 -81.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.685 2.257 . . . . 0.0 111.869 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.5 m -65.74 -18.46 65.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.525 0.679 . . . . 0.0 110.328 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 87' ' ' LEU . 25.2 mt -73.67 -36.13 65.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.191 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 4.4 t70 -54.18 -51.41 64.43 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 123.613 0.571 . . . . 0.0 111.725 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -54.58 -43.67 72.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -77.4 -53.92 7.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.833 0.349 . . . . 0.0 111.737 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 90' ' ' LEU . 40.2 pt -74.12 -33.08 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.654 -172.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.779 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 79.0 mm-40 -82.57 -24.11 34.14 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 120.981 0.42 . . . . 0.0 110.39 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.72 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.65 -47.27 80.12 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.648 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -65.11 -56.11 14.84 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.514 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.939 HG11 HG21 ' A' ' 123' ' ' ILE . 79.3 t -89.17 -50.11 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.779 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 34.9 ttmt -68.84 -30.09 68.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.238 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.72 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 2.6 tmt_? -86.86 -39.99 15.31 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.774 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.666 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -97.41 63.84 1.82 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.737 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.4 m -94.6 98.49 3.14 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 110.093 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 98.9 Cg_endo -108.65 172.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 124.195 3.263 . . . . 0.0 114.386 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.681 ' HG ' HD13 ' A' ' 70' ' ' LEU . 6.2 mt -143.89 120.59 6.52 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.733 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.559 ' HG2' ' CB ' ' A' ' 40' ' ' ARG . 6.2 Cg_exo -72.83 -54.13 0.12 Allowed 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.86 2.374 . . . . 0.0 111.936 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 25.4 m -88.7 115.22 62.84 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.411 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 106' ' ' THR . 30.5 Cg_endo -64.17 107.6 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.09 2.527 . . . . 0.0 112.225 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.66 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 81.3 Cg_endo -83.38 62.74 7.45 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.772 2.314 . . . . 0.0 111.832 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.823 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -59.18 -41.91 89.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.297 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.72 -7.95 48.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.622 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -99.38 -32.04 11.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.604 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.823 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -110.02 17.49 21.02 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -176.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 109' ' ' ALA . 3.4 m -70.57 88.09 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 168.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 7.5 p30 161.93 -27.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.606 -1.634 . . . . 0.0 107.846 -170.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.85 -76.15 0.15 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.906 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.535 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.6 OUTLIER -160.27 174.42 14.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.789 ' O ' ' HA ' ' A' ' 69' ' ' THR . 15.8 m -103.3 108.94 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.377 0.608 . . . . 0.0 111.061 -175.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 28.0 tt0 -105.36 111.7 24.52 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.68 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -142.36 147.22 35.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.462 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 67' ' ' ARG . 86.8 m -87.59 122.13 30.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.33 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.68 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 26.0 mt -124.7 122.5 25.7 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.927 172.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.2 Cg_exo -73.8 119.93 6.15 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.771 1.647 . . . . 0.0 110.726 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.939 HG21 HG11 ' A' ' 98' ' ' VAL . 23.8 pt -95.46 99.52 9.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.59 ' HA ' HG23 ' A' ' 63' ' ' VAL . 5.5 p-10 -90.24 121.49 32.31 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.449 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 41.5 m-85 -113.36 141.3 47.21 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 163.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 3.3 m -64.15 101.87 0.45 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.88 HD12 ' H ' ' A' ' 63' ' ' VAL . 1.2 tt -90.13 84.11 6.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.204 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 128' ' ' ARG . 21.0 mtm180 . . . . . 0 N--CA 1.448 -0.554 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.46 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 4.9 t90 . . . . . 0 C--O 1.227 -0.129 0 CA-C-O 120.929 0.395 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.758 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . 17.3 ptp180 -69.15 -29.79 67.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.892 -173.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.0 p -64.69 -38.21 90.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.589 ' C ' ' HG3' ' A' ' 105' ' ' PRO . 4.2 mmm180 -74.76 -37.96 62.33 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.758 ' HB ' ' HA ' ' A' ' 38' ' ' ARG . 21.5 mt -57.69 -38.1 62.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.808 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 m -60.23 -45.71 92.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 174.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.51 -50.48 67.34 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.39 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.802 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -68.35 -29.29 67.99 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.213 0.507 . . . . 0.0 111.297 -177.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.78 -30.84 71.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.526 0.679 . . . . 0.0 109.654 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.565 ' HB2' ' HD3' ' A' ' 50' ' ' ARG . 8.4 t30 -71.31 -29.59 65.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.543 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.666 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 9.2 ttt180 -52.96 -25.04 10.7 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.223 172.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.546 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 74.4 m-85 -113.29 -59.15 2.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.266 176.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -164.62 103.38 0.82 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 122.394 0.278 . . . . 0.0 110.568 -174.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.565 ' HD3' ' HB2' ' A' ' 46' ' ' ASN . 15.7 ttt180 -133.17 106.43 7.59 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.605 0.716 . . . . 0.0 111.124 177.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.442 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.3 t80 -105.18 142.97 25.79 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.2 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.96 132.21 50.93 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.92 2.413 . . . . 0.0 112.108 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.55 -24.89 66.95 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -55.97 -41.74 75.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.67 0.271 . . . . 0.0 110.832 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.64 -30.87 68.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.87 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.6 mm? -74.44 -41.51 60.72 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.613 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 28.4 mtm180 -61.28 -24.39 66.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.246 0.546 . . . . 0.0 110.162 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.8 tp -91.57 -13.72 31.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.748 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.661 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 38.2 ttpt -131.64 -72.46 0.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.88 -172.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.661 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 36.8 mmt180 -109.69 92.02 3.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.853 0.359 . . . . 0.0 110.315 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 90' ' ' LEU . 42.6 mt-30 -86.54 169.34 12.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.572 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.61 119.71 0.81 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.472 -1.347 . . . . 0.0 113.627 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.06 123.57 66.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.34 165.7 36.17 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 68.7 mt-30 -103.09 130.82 50.35 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 t -119.57 114.29 43.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.364 -171.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.523 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 31.3 ttp85 -107.65 137.63 45.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.638 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.586 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -152.28 153.65 34.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.494 0.664 . . . . 0.0 111.948 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 30.4 m -99.18 133.58 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.299 170.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.586 HD11 ' CE1' ' A' ' 68' ' ' PHE . 63.7 mt -121.92 140.23 52.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.379 0.609 . . . . 0.0 112.211 -170.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.638 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 17.1 t70 -83.88 159.64 21.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.565 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.448 ' HG3' ' OH ' ' A' ' 112' ' ' TYR . 22.2 ttt180 -53.39 -40.58 65.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.866 0.365 . . . . 0.0 111.452 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -89.46 16.2 8.01 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 111.056 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.452 ' CA ' ' HA ' ' A' ' 103' ' ' PRO . . . 71.89 46.17 38.78 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.811 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.638 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 72.2 t60 -104.3 114.3 28.45 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.3 p -49.21 123.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.112 0.482 . . . . 0.0 111.162 173.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.606 HD12 HG22 ' A' ' 69' ' ' THR . 35.3 mt -110.0 -45.97 3.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.266 0.555 . . . . 0.0 110.571 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.28 149.14 52.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.981 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 m -136.74 124.22 32.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.0 m -144.11 121.76 11.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.5 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.635 HD21 ' HB2' ' A' ' 84' ' ' SER . 25.8 tp -76.18 111.95 12.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 173.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.753 HG21 HG23 ' A' ' 120' ' ' THR . 0.2 OUTLIER -85.36 -38.35 12.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.68 -170.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.451 ' HB3' ' HG3' ' A' ' 65' ' ' GLN . 8.4 t -148.05 149.17 31.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.635 ' HB2' HD21 ' A' ' 81' ' ' LEU . 46.3 t -149.07 149.14 30.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.22 0.533 . . . . 0.0 111.216 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.99 -18.09 15.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.583 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.414 ' C ' HD13 ' A' ' 87' ' ' LEU . . . 120.43 80.63 0.62 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.944 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.8 HD11 HD11 ' A' ' 127' ' ' LEU . 0.4 OUTLIER -117.51 91.23 37.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.87 -79.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.992 2.461 . . . . 0.0 112.556 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 92' ' ' ARG . 53.6 p -70.58 -18.62 62.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.394 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.735 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 17.9 mt -74.34 -39.93 62.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.131 -175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 15.4 t70 -54.58 -43.24 71.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.785 -170.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.4 ' CZ ' ' HA ' ' A' ' 89' ' ' SER . 4.1 ptp180 -54.01 -52.33 61.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -172.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -78.25 -48.03 16.65 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.909 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 90' ' ' LEU . 42.4 pt -62.98 -36.83 77.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.656 0.265 . . . . 0.0 111.4 -176.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.665 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.9 mm-40 -82.79 -25.85 32.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.073 0.463 . . . . 0.0 110.633 177.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.757 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -57.1 -45.55 83.31 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.657 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -64.87 -56.82 11.05 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.0 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.802 HG11 HG21 ' A' ' 123' ' ' ILE . 94.2 t -89.3 -50.52 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.665 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 35.1 ttmt -70.14 -27.47 64.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.619 0.247 . . . . 0.0 111.391 -173.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.757 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 20.9 tpt180 -88.34 -41.73 12.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.911 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.636 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -91.78 78.26 5.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.063 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.569 ' HB3' HD21 ' A' ' 70' ' ' LEU . 17.2 m -111.65 90.25 12.33 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.349 171.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.802 ' HG2' ' HG2' ' A' ' 44' ' ' ARG . 9.5 Cg_endo -104.91 -179.98 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.926 1 C-N-CA 125.992 4.462 . . . . 0.0 111.383 171.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.489 ' HG ' HD13 ' A' ' 70' ' ' LEU . 35.7 mt -136.38 127.95 17.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 169.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.715 ' HD3' ' HD2' ' A' ' 44' ' ' ARG . 57.0 Cg_endo -74.75 -24.23 13.59 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.514 2.143 . . . . 0.0 111.836 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 t -132.89 116.33 14.62 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.112 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.73 108.78 0.4 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.93 2.42 . . . . 0.0 111.717 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.53 ' HG2' ' CE2' ' A' ' 112' ' ' TYR . 82.0 Cg_endo -75.62 65.08 6.61 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.683 2.255 . . . . 0.0 111.563 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.586 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.2 -41.98 80.4 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.818 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.8 2.29 4.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.573 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.23 -34.74 5.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.509 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.653 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -115.2 16.75 16.89 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -174.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.6 m -71.38 88.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 4.9 p30 159.82 -29.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 113.661 -1.608 . . . . 0.0 107.404 -168.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.38 -84.55 0.1 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.355 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.495 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 1.3 p -149.6 167.39 26.5 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -171.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 69' ' ' THR . 20.7 m -107.71 122.43 62.0 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 CA-C-O 120.904 0.383 . . . . 0.0 111.014 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -112.8 120.04 40.09 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.663 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -140.14 143.35 36.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.972 0.415 . . . . 0.0 111.606 -175.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.753 HG23 HG21 ' A' ' 82' ' ' VAL . 98.9 m -96.3 116.34 28.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.857 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.663 ' HG ' HD12 ' A' ' 119' ' ' LEU . 62.7 mt -119.21 122.76 29.27 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.275 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.696 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.3 Cg_exo -73.12 120.73 6.76 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.056 1.837 . . . . 0.0 111.427 177.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.802 HG21 HG11 ' A' ' 98' ' ' VAL . 21.6 pt -102.49 117.73 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -119.61 123.47 43.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.184 0.993 . . . . 0.0 112.508 -175.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.572 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 89.7 m-85 -115.23 133.02 56.42 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.604 166.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -57.66 103.73 0.15 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.044 0.45 . . . . 0.0 111.971 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.8 HD11 HD11 ' A' ' 87' ' ' LEU . 12.5 mt -84.01 104.0 13.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.181 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 121.348 0.594 . . . . 0.0 110.267 175.619 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 38' ' ' ARG . 10.8 ptp180 -68.48 -41.44 80.09 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.767 -171.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.8 p -64.79 -36.36 84.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.143 0.497 . . . . 0.0 110.434 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.47 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 30.8 mmt180 -73.93 -43.25 58.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.347 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.54 HG12 ' HD3' ' A' ' 105' ' ' PRO . 76.0 mt -57.01 -43.58 81.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.3 m -60.31 -30.61 69.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.881 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.33 -52.57 34.79 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.274 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 1.018 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.7 -28.41 65.81 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 175.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -53.86 -35.04 61.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.523 0.678 . . . . 0.0 109.362 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.765 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 24.1 t-20 -71.93 -34.18 68.85 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.941 177.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -52.88 -28.15 21.79 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.277 173.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.582 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 95.8 m-85 -95.39 -59.23 1.93 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.947 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 21.1 mmmt -178.28 114.47 0.07 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.336 1.054 . . . . 0.0 108.923 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.765 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 41.8 ttp180 -129.54 105.38 8.04 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.273 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 2.7 t80 -90.32 134.92 30.34 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.844 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 32.3 Cg_exo -60.32 132.4 43.66 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.327 2.685 . . . . 0.0 112.566 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.608 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.21 -27.41 65.7 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.266 -171.122 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.19 -40.82 74.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.851 0.358 . . . . 0.0 110.713 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.51 -30.99 62.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.565 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.7 mm? -65.91 -38.48 88.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.884 0.373 . . . . 0.0 110.204 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -61.8 -17.32 55.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.534 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.1 mt -111.99 -0.68 15.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 111.129 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -128.44 -70.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.03 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.753 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 28.9 mmt180 -136.68 101.53 4.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.318 0.58 . . . . 0.0 110.107 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.549 ' HG3' ' HA ' ' A' ' 127' ' ' LEU . 3.2 pt20 -113.48 160.37 18.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.546 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.752 ' HA3' HD11 ' A' ' 87' ' ' LEU . . . 153.27 142.89 3.56 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.389 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -107.31 125.53 63.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.993 0.425 . . . . 0.0 109.996 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.15 164.4 26.19 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.421 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 48.2 mt-30 -103.85 129.28 51.31 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 68' ' ' PHE . 51.6 t -127.74 118.18 48.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.598 ' HG2' HG22 ' A' ' 82' ' ' VAL . 15.6 ptt180 -112.96 143.65 43.89 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -159.57 152.92 22.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.41 0.624 . . . . 0.0 112.502 -168.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.6 m -95.16 126.45 40.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.468 171.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.498 HD11 ' CE1' ' A' ' 68' ' ' PHE . 51.0 mt -117.34 143.82 45.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.173 0.511 . . . . 0.0 111.99 -170.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.754 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 22.2 t70 -86.28 154.96 20.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.13 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -53.21 -35.01 59.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.202 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -99.72 13.15 34.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.16 0.505 . . . . 0.0 111.154 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.53 40.59 12.56 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.812 -0.631 . . . . 0.0 113.388 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.754 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 68.8 t60 -103.31 118.02 35.83 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.13 113.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.22 0.533 . . . . 0.0 111.149 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.44 -48.72 4.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.46 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.81 155.68 46.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.605 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -149.98 129.6 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 123.485 0.491 . . . . 0.0 110.026 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -142.32 125.66 16.58 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.279 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 84' ' ' SER . 34.2 tp -70.0 122.45 19.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.598 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -97.48 -41.65 11.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.183 -174.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 m -149.35 131.05 15.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.872 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.614 ' HB2' HD21 ' A' ' 81' ' ' LEU . 45.0 t -138.95 111.01 7.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.61 -62.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.14 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.463 ' H ' HD22 ' A' ' 87' ' ' LEU . . . -157.05 62.85 0.32 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.876 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.859 ' HA ' HD12 ' A' ' 90' ' ' LEU . 1.6 mm? -114.35 86.78 12.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 4.7 Cg_exo -77.16 -78.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.435 2.09 . . . . 0.0 111.545 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.1 p -74.79 -18.67 60.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.69 0.757 . . . . 0.0 110.242 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.859 HD12 ' HA ' ' A' ' 87' ' ' LEU . 10.5 mt -70.44 -38.7 74.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.404 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -54.49 -50.85 66.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.413 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.2 -40.88 71.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.221 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.493 ' CB ' ' HG3' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -78.22 -53.2 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.516 -173.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 90' ' ' LEU . 37.0 pt -64.74 -36.05 76.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.677 0.275 . . . . 0.0 111.727 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.642 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.9 mm-40 -79.22 -27.55 42.5 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 120.955 0.407 . . . . 0.0 110.506 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.38 -46.34 76.53 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 173.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.511 HD23 HG23 ' A' ' 98' ' ' VAL . 1.4 tp -67.59 -54.96 15.44 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.742 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.916 HG11 HG21 ' A' ' 123' ' ' ILE . 95.1 t -87.81 -48.62 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.642 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 40.3 ttmt -65.05 -23.29 67.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.046 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.497 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 30.9 tpt180 -93.6 -27.33 16.66 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.009 173.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.577 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -114.71 75.16 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.808 0.337 . . . . 0.0 111.29 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.4 m -108.34 95.06 14.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.225 0.536 . . . . 0.0 110.275 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 1.018 ' HB2' ' HG3' ' A' ' 44' ' ' ARG . 84.8 Cg_endo -113.74 122.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 124.482 3.454 . . . . 0.0 114.604 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.456 HD23 ' HD2' ' A' ' 105' ' ' PRO . 1.1 mt -92.02 123.75 61.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 172.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.549 ' HG3' ' HD3' ' A' ' 44' ' ' ARG . 1.7 Cg_endo -77.88 -59.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.568 2.179 . . . . 0.0 112.267 177.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.611 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 t -65.5 129.18 94.31 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.983 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.4 103.46 1.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.844 2.363 . . . . 0.0 112.267 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.8 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 68.5 Cg_endo -85.81 55.99 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.732 2.288 . . . . 0.0 111.524 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.74 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -54.38 -45.83 72.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.575 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.82 -6.84 51.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.291 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.8 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -98.36 -21.61 16.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.511 -177.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.837 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -124.3 17.79 9.04 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.4 m -71.1 89.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.965 0.888 . . . . 0.0 108.896 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER 157.43 -13.78 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 113.19 -1.823 . . . . 0.0 107.903 -172.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.06 -90.72 0.1 Allowed Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.032 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.2 OUTLIER -160.57 175.09 13.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.308 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' A' ' 112' ' ' TYR . 10.8 m -101.99 114.47 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.417 0.627 . . . . 0.0 111.115 -175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -115.72 112.69 22.42 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 172.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.5 HD12 ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -144.11 152.61 41.17 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.328 -175.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.487 HG23 HG21 ' A' ' 82' ' ' VAL . 86.6 m -90.47 124.67 35.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.151 0.501 . . . . 0.0 111.77 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.5 ' HG ' HD12 ' A' ' 119' ' ' LEU . 57.8 mt -126.76 123.45 23.79 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.861 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 11.5 Cg_exo -70.61 120.09 6.83 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.066 1.844 . . . . 0.0 111.277 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.916 HG21 HG11 ' A' ' 98' ' ' VAL . 33.0 pt -94.5 99.17 9.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -98.95 123.62 43.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.068 0.937 . . . . 0.0 111.923 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.575 ' HE2' ' HE2' ' A' ' 53' ' ' LYS . 59.8 m-85 -115.16 125.25 53.2 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 162.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.9 p -57.55 105.12 0.22 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.503 0.668 . . . . 0.0 111.327 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.739 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -83.19 99.26 9.83 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.759 -173.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.464 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 53.4 mtp180 . . . . . 0 C--N 1.322 -0.61 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.52 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.6 t90 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.567 0.222 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -67.85 -30.03 69.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.104 0.478 . . . . 0.0 110.515 -174.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.4 -36.45 82.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.171 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.429 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 24.1 mmm180 -73.64 -41.36 62.85 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.346 0.594 . . . . 0.0 109.589 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.4 HG23 ' HG2' ' A' ' 103' ' ' PRO . 87.6 mt -61.39 -42.35 93.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.041 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t -55.59 -39.62 70.95 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.002 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.14 99.1 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.878 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.646 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 8.6 mpt_? -69.35 -34.69 74.98 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.787 0.327 . . . . 0.0 110.809 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.61 HD11 HG22 ' A' ' 98' ' ' VAL . 1.1 tt -65.11 -27.68 68.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.72 0.771 . . . . 0.0 109.581 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.62 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 10.3 t30 -71.96 -37.67 69.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.885 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -56.73 -27.8 59.89 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.609 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.503 ' HE2' ' HB3' ' A' ' 103' ' ' PRO . 94.9 m-85 -88.51 -56.87 3.13 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.866 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 mtmm 172.96 103.43 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.209 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.62 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 52.7 ttp180 -108.4 103.03 12.1 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -72.38 131.59 84.73 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.59 131.14 32.11 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.71 2.274 . . . . 0.0 112.131 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.92 -21.33 63.29 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.407 -173.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 9.7 t0 -52.97 -38.59 62.27 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.505 0.503 . . . . 0.0 110.792 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.74 -43.65 45.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.154 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.2 mm? -64.07 -41.02 97.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.323 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.705 ' HG3' ' HG ' ' A' ' 58' ' ' LEU . 27.6 ptt180 -61.66 -19.72 62.62 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.361 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.705 ' HG ' ' HG3' ' A' ' 57' ' ' ARG . 82.9 mt -116.07 14.17 15.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.461 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.737 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 40.3 ttpt -151.21 -74.48 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 0.0 111.791 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.737 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 24.4 mmt180 -112.1 84.89 2.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.522 0.677 . . . . 0.0 110.183 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 126' ' ' SER . 3.1 pt20 -111.19 166.52 11.02 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.272 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.75 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.59 147.34 4.57 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.186 -1.483 . . . . 0.0 113.91 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.76 ' H ' HD12 ' A' ' 127' ' ' LEU . 61.9 t -116.13 124.94 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -151.97 166.15 30.87 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.432 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.621 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 56.8 mt-30 -101.85 132.15 47.78 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.482 HG12 ' CD2' ' A' ' 68' ' ' PHE . 56.1 t -124.26 113.23 35.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.404 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 64.9 ttt180 -103.02 121.75 43.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -177.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -142.53 165.64 26.84 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.466 0.651 . . . . 0.0 112.121 -171.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.743 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 11.9 m -114.99 127.78 55.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.005 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 68' ' ' PHE . 46.5 mt -116.3 132.34 56.7 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.246 0.546 . . . . 0.0 111.784 -169.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 26.5 t70 -71.65 155.32 40.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.42 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.448 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 46.2 mtp180 -59.32 -18.81 41.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.294 -175.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.741 HE21 ' HA ' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -108.1 14.9 24.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.923 0.392 . . . . 0.0 111.279 177.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 77.54 49.26 7.38 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.714 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 19.1 t60 -114.84 126.49 54.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.87 121.91 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.187 0.517 . . . . 0.0 111.42 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 71' ' ' ASP . 52.7 mt -111.88 -47.53 3.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.251 0.548 . . . . 0.0 110.587 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.88 150.61 51.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.858 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.44 116.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.314 0.578 . . . . 0.0 110.386 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.6 m -127.43 127.12 43.59 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.888 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.6 tp -77.32 112.31 13.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.249 0.547 . . . . 0.0 110.466 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -96.28 -43.81 12.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.496 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 21.3 t 65.96 173.1 0.23 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.743 169.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.621 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 26.5 m -146.7 -67.11 0.27 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.23 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.25 -86.08 0.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.66 96.8 0.1 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.995 -174.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.863 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -120.1 84.46 33.52 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.36 -76.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 111.956 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 m -70.32 -18.42 63.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.529 0.68 . . . . 0.0 110.136 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.863 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.8 mt -75.8 -36.7 59.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.387 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 14.4 t70 -54.54 -47.76 72.78 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.671 0.607 . . . . 0.0 111.834 -172.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -52.71 -51.9 58.44 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -170.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.52 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 22.8 tt0 -77.97 -48.21 16.77 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.221 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 90' ' ' LEU . 38.3 pt -62.76 -35.99 73.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 120.578 0.228 . . . . 0.0 111.217 -176.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.602 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 74.5 mm-40 -82.32 -28.25 31.77 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-O 120.951 0.405 . . . . 0.0 110.589 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.676 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.96 -46.5 78.56 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 170.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 tp -67.26 -55.66 13.04 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.904 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.884 HG11 HG21 ' A' ' 123' ' ' ILE . 72.1 t -87.83 -49.05 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.9 ttmt -66.52 -19.71 65.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.666 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.676 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 14.2 tpp180 -91.24 -49.94 6.1 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.68 169.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.616 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -90.87 64.76 5.58 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.698 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -89.7 99.48 1.79 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.145 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.646 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 71.9 Cg_endo -102.31 174.76 0.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.737 2.958 . . . . 0.0 114.176 -174.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.582 HD21 ' HD2' ' A' ' 108' ' ' PRO . 32.0 tp -144.69 102.13 4.59 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.726 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 6.1 Cg_exo -68.25 -77.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.134 1.889 . . . . 0.0 112.866 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.433 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.5 p -80.59 119.03 75.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.702 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 26.8 Cg_exo -62.75 108.65 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.209 2.606 . . . . 0.0 112.806 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.853 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 86.4 Cg_endo -83.02 62.15 7.59 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.172 2.581 . . . . 0.0 111.68 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.713 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -52.33 -44.69 65.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.612 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.94 -9.97 59.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.123 -176.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.853 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -99.35 -23.88 15.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.818 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.713 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -117.02 17.58 14.88 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.546 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.8 m -71.68 88.42 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 168.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.546 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 5.7 p30 157.17 -16.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 113.989 -1.46 . . . . 0.0 108.002 -168.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.37 -85.1 0.14 Allowed Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.421 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.538 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.2 OUTLIER -154.71 176.5 12.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.743 ' O ' ' HA ' ' A' ' 69' ' ' THR . 3.7 m -99.98 107.61 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.995 0.903 . . . . 0.0 110.183 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 31.8 tt0 -107.95 111.16 23.12 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.04 175.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.762 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -147.33 155.06 41.67 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.346 -172.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.581 HG23 HG21 ' A' ' 82' ' ' VAL . 89.3 m -98.08 118.66 35.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.531 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.762 ' HG ' HD12 ' A' ' 119' ' ' LEU . 30.5 mt -124.18 127.76 25.24 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.409 175.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.5 Cg_exo -72.22 119.36 6.11 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.942 1.761 . . . . 0.0 110.768 175.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.884 HG21 HG11 ' A' ' 98' ' ' VAL . 40.7 pt -90.29 103.25 14.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -101.71 123.44 45.7 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.763 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -114.33 150.55 34.35 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 166.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 7.8 m -63.26 101.81 0.34 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.638 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.76 HD12 ' H ' ' A' ' 63' ' ' VAL . 1.3 tt -89.58 102.63 15.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.905 0.383 . . . . 0.0 110.379 -174.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.469 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 36.3 mtp180 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.775 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.511 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.602 0.239 . . . . 0.0 111.217 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -67.93 -38.31 82.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.23 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.82 -30.57 65.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.884 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.464 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 60.0 mtt180 -68.2 -41.72 80.93 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 172.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 37' ' ' TRP . 88.8 mt -59.05 -46.03 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.855 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.7 m -56.47 -29.79 62.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.892 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.69 -43.03 69.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.567 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.51 -34.27 74.04 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.102 0.477 . . . . 0.0 110.465 178.076 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 101' ' ' ALA . 1.3 tt -61.17 -33.48 73.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.96 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.845 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.2 t-20 -70.85 -37.87 73.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.696 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -27.39 34.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.901 175.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.79 -62.07 1.29 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.236 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 29.6 mtpp -164.0 103.14 0.88 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.845 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 56.3 ttp180 -117.81 103.29 9.83 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.58 176.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -77.3 112.8 25.92 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.11 131.38 44.94 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.592 2.194 . . . . 0.0 112.107 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.59 ' HE2' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -58.66 -22.69 57.55 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.683 -174.337 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.614 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 6.6 m-20 -55.07 -39.11 68.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.754 0.312 . . . . 0.0 110.982 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.12 -36.21 61.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.215 0.531 . . . . 0.0 110.417 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.4 mm? -67.6 -35.62 79.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.745 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.614 ' HE ' ' HA ' ' A' ' 54' ' ' ASP . 46.8 mtm180 -54.1 -39.42 66.36 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 111.923 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.5 mp -94.62 -23.41 17.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.287 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.751 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 6.6 ttpp -113.56 -81.9 0.6 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.77 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 19.3 mmt180 -103.19 83.07 2.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.4 0.619 . . . . 0.0 111.42 -173.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.434 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.1 OUTLIER -105.29 144.06 32.6 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.854 173.219 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 1.013 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 162.08 131.9 1.27 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.675 -170.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.84 125.53 58.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.985 0.421 . . . . 0.0 110.843 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.7 164.76 24.34 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 55.5 mt-30 -115.42 127.13 55.14 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.402 HG23 ' CE2' ' A' ' 68' ' ' PHE . 27.4 m -118.07 139.64 44.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.347 0.594 . . . . 0.0 110.825 -174.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 45.4 ttp180 -112.98 138.09 50.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.908 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -154.96 148.91 25.72 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.343 0.592 . . . . 0.0 112.116 -177.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 15.3 m -93.51 129.72 39.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 169.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.675 HD13 ' HG ' ' A' ' 104' ' ' LEU . 47.5 mt -121.31 136.69 54.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.203 0.525 . . . . 0.0 111.915 -170.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.721 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 14.4 t70 -83.56 161.73 21.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.677 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG2' ' N ' ' A' ' 73' ' ' GLN . 2.4 ptp180 -54.78 -35.9 64.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.693 0.282 . . . . 0.0 111.632 -177.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.484 ' N ' ' HG2' ' A' ' 72' ' ' ARG . 15.4 pt20 -87.39 12.05 13.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.351 . . . . 0.0 111.26 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 103' ' ' PRO . . . 75.85 34.17 48.93 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.876 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.721 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 64.6 t60 -92.57 104.8 17.06 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.8 p -48.92 123.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.467 0.651 . . . . 0.0 111.377 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 13.6 mt -107.7 -43.08 4.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.528 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.85 153.58 51.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.865 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.435 ' HB ' ' HD2' ' A' ' 99' ' ' LYS . 11.3 m -140.15 129.36 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.302 0.572 . . . . 0.0 110.812 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.6 m -145.42 120.48 10.08 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.868 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 84' ' ' SER . 26.1 tp -72.97 108.25 5.78 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.519 HG21 HG23 ' A' ' 120' ' ' THR . 0.2 OUTLIER -80.46 -42.36 21.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.898 -172.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 65' ' ' GLN . 8.6 t -140.22 147.27 39.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.212 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.487 ' HB2' HD21 ' A' ' 81' ' ' LEU . 28.6 t -142.88 131.88 23.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.831 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.54 17.5 6.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.013 0.435 . . . . 0.0 110.856 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.517 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 94.86 65.92 1.0 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.926 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.912 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -111.81 90.08 12.4 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 117.085 0.442 . . . . 0.0 109.954 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 6.1 Cg_exo -73.91 -74.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.714 2.276 . . . . 0.0 111.802 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.4 m -74.89 -19.22 60.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.431 0.634 . . . . 0.0 110.386 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.912 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 9.6 mt -76.89 -42.37 40.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.762 -172.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.575 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 28.6 t70 -54.95 -50.16 69.59 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.67 0.606 . . . . 0.0 112.414 -170.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -53.25 -44.28 68.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -77.05 -53.17 8.14 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.794 0.33 . . . . 0.0 111.784 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 34.0 pt -60.53 -35.85 66.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.631 -176.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.689 HE22 HD11 ' A' ' 123' ' ' ILE . 51.3 mm-40 -82.91 -21.58 34.15 Favored 'General case' 0 C--O 1.205 -1.273 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.129 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.05 -54.06 44.52 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.142 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.664 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -75.72 -46.24 32.21 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.543 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.862 HG11 HG21 ' A' ' 123' ' ' ILE . 30.8 t -62.55 -49.21 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.54 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 1.3 tppp? -70.82 -35.63 72.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.191 -169.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -80.71 -34.9 34.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.848 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.619 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -101.15 67.65 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.193 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.0 m -97.33 97.69 4.12 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.182 0.515 . . . . 0.0 109.781 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.619 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 88.0 Cg_endo -107.93 173.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.245 3.297 . . . . 0.0 114.553 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.675 ' HG ' HD13 ' A' ' 70' ' ' LEU . 14.1 mt -140.61 122.39 9.45 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.617 171.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.488 ' HD3' HG12 ' A' ' 41' ' ' ILE . 12.2 Cg_endo -82.06 -40.17 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.657 2.238 . . . . 0.0 111.676 174.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.464 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 12.8 m -94.92 103.46 11.73 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.374 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.87 106.76 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.564 2.176 . . . . 0.0 112.234 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.707 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 67.9 Cg_endo -83.0 58.19 6.25 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.751 2.301 . . . . 0.0 111.813 -176.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.783 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.55 -46.21 77.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.832 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.92 -23.02 66.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.158 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.707 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.72 -35.89 18.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.075 -175.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.783 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -105.78 15.91 26.04 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.008 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 3.6 m -72.15 89.52 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 169.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 2.3 p30 159.75 -22.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.212 -169.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 162.42 -85.09 0.11 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.737 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.551 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -159.4 173.22 16.57 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.723 HG13 ' HB3' ' A' ' 112' ' ' TYR . 24.5 m -104.98 110.4 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 121.328 0.585 . . . . 0.0 110.961 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 43.9 tt0 -107.78 110.65 22.5 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 170.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.604 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.7 pp -135.41 155.62 50.26 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.39 -174.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.519 HG23 HG21 ' A' ' 82' ' ' VAL . 99.9 m -101.08 129.13 46.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.107 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.604 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 54.3 mt -128.56 130.49 23.51 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 2.9 Cg_exo -76.12 121.48 6.17 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.791 2.327 . . . . 0.0 111.565 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.862 HG21 HG11 ' A' ' 98' ' ' VAL . 43.0 pt -97.76 99.98 9.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.49 119.04 29.58 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.124 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.59 ' CE2' ' HE2' ' A' ' 53' ' ' LYS . 83.2 m-85 -116.25 120.19 38.14 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 162.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.5 m -58.74 102.5 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -169.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 1.013 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 3.4 mt -73.23 114.13 11.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.104 0.478 . . . . 0.0 110.248 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.639 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.684 ' HA ' ' HG2' ' A' ' 40' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 39' ' ' SER . 9.6 ptp180 -63.6 -39.96 95.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.243 0.544 . . . . 0.0 109.874 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.581 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 3.5 m -67.58 -30.39 69.99 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.602 -178.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.684 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 16.8 mmt180 -71.72 -43.35 66.02 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.283 176.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.629 HG23 ' HD2' ' A' ' 103' ' ' PRO . 76.2 mt -59.85 -49.04 85.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.222 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.1 t -57.04 -30.24 64.08 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.605 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -68.21 -44.94 73.64 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.043 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.509 ' NE ' ' HB3' ' A' ' 105' ' ' PRO . 9.5 mpt_? -69.66 -34.49 74.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.973 0.416 . . . . 0.0 110.322 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 101' ' ' ALA . 2.7 tt -59.52 -32.28 70.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.761 0.791 . . . . 0.0 109.076 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 1.031 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 28.4 t30 -70.99 -42.32 69.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.156 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 8.0 ptt180 -61.29 -18.54 58.99 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.298 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -100.54 -58.47 1.89 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.153 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -162.59 103.08 1.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.864 0.466 . . . . 0.0 110.314 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 1.031 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 5.7 tpt180 -134.05 103.12 5.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.413 ' HB3' HD21 ' A' ' 56' ' ' LEU . 1.8 t80 -89.16 138.14 29.08 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.223 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.56 131.62 41.8 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.806 2.337 . . . . 0.0 111.996 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.01 -25.68 67.07 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.037 -173.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.1 -41.05 67.84 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.323 0.389 . . . . 0.0 110.913 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.1 -38.73 75.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.743 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.5 mm? -66.53 -38.73 87.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.549 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 69.8 mtt180 -65.71 -13.95 60.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.386 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.6 mt -110.85 2.1 18.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.792 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.596 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 21.1 ttmm -137.92 -74.42 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.532 -173.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.596 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 38.4 mmt180 -126.55 106.4 9.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 110.335 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.473 ' O ' HD13 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -117.78 158.19 25.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.612 178.437 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.976 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 153.29 144.17 3.85 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 119.79 -1.195 . . . . 0.0 113.345 -177.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.763 ' H ' HD12 ' A' ' 127' ' ' LEU . 2.8 p -104.13 122.77 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.373 0.606 . . . . 0.0 110.132 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.79 151.35 21.25 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.688 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 21.9 tt0 -105.63 135.42 47.06 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.53 131.67 71.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.014 0.435 . . . . 0.0 110.777 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -115.04 140.9 48.67 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.31 153.74 27.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.209 0.528 . . . . 0.0 111.757 -175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.676 ' CG2' ' HB ' ' A' ' 116' ' ' THR . 21.1 m -96.89 130.39 44.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.8 173.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 49.6 mt -118.35 133.98 55.43 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.111 0.481 . . . . 0.0 111.677 -173.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.71 155.9 30.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.186 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 72' ' ' ARG . 32.0 ttm180 -55.75 -33.71 64.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.003 0.43 . . . . 0.0 110.285 175.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -76.68 6.25 6.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.129 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.23 36.82 63.61 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.395 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -113.29 122.45 47.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 8.6 p -48.75 127.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.927 0.767 . . . . 0.0 111.522 172.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.419 ' CD1' HG21 ' A' ' 116' ' ' THR . 36.0 mt -113.71 -43.85 3.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.224 0.535 . . . . 0.0 110.73 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.79 154.21 48.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.168 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.508 HG11 ' HG3' ' A' ' 99' ' ' LYS . 3.1 m -147.66 127.08 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.0 m -144.64 127.83 16.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 tp -76.38 108.64 9.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.754 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -74.63 -34.26 34.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.637 0.732 . . . . 0.0 109.056 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 14.9 t 75.29 171.39 0.27 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.605 170.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -153.67 -52.44 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.682 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.93 -79.1 0.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 168.49 103.68 0.17 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.513 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.772 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.7 OUTLIER -119.39 103.96 46.22 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -84.44 -81.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.24 1.96 . . . . 0.0 111.991 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.2 p -71.0 -19.02 62.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.192 0.52 . . . . 0.0 110.529 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.772 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 8.9 mt -75.12 -32.26 61.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.908 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 15.8 t70 -54.48 -50.38 67.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.896 -171.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 93' ' ' GLU . 17.0 ptp180 -52.64 -46.89 67.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.569 -175.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.451 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 11.1 mt-10 -78.46 -53.94 6.7 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.51 HD11 ' HG ' ' A' ' 87' ' ' LEU . 34.2 pt -62.32 -33.91 61.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.553 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 56.1 mm-40 -82.02 -29.56 31.94 Favored 'General case' 0 C--O 1.203 -1.392 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.371 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.78 68.47 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.136 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.717 HD23 HG23 ' A' ' 98' ' ' VAL . 0.7 OUTLIER -63.81 -54.64 31.95 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.763 176.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.872 HG11 HG21 ' A' ' 123' ' ' ILE . 39.4 t -85.15 -48.55 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.553 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -63.59 -34.34 77.59 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.211 0.604 . . . . 0.0 110.865 -174.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -76.49 -48.3 19.99 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.247 0.546 . . . . 0.0 109.689 177.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.628 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -93.34 58.83 2.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.398 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.501 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.9 m -95.84 99.23 4.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.334 0.588 . . . . 0.0 109.939 174.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.629 ' HD2' HG23 ' A' ' 41' ' ' ILE . 72.9 Cg_endo -103.42 176.17 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 124.712 3.608 . . . . 0.0 113.441 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.663 HD21 ' HD2' ' A' ' 108' ' ' PRO . 38.5 tp -142.04 91.0 8.16 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.509 ' HB3' ' NE ' ' A' ' 44' ' ' ARG . 11.9 Cg_endo -70.46 -53.13 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.246 1.964 . . . . 0.0 112.824 -174.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.539 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 23.2 p -92.08 106.25 16.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -68.3 106.16 1.35 Allowed 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.822 2.348 . . . . 0.0 112.621 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.663 ' HD2' HD21 ' A' ' 104' ' ' LEU . 44.9 Cg_endo -86.66 61.18 4.4 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.195 2.596 . . . . 0.0 111.194 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.737 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.46 -41.54 80.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.17 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.99 -25.76 67.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.511 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.97 -29.76 21.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.84 ' HD2' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.72 16.41 16.39 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -172.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.5 m -71.36 88.36 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.655 HD22 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 154.95 -15.35 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 113.426 -1.716 . . . . 0.0 108.609 -167.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.655 ' N ' HD22 ' A' ' 114' ' ' ASN . . . 168.96 -100.21 0.16 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.828 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.676 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.3 OUTLIER -161.15 176.67 11.04 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.84 HG13 ' HD2' ' A' ' 112' ' ' TYR . 12.3 m -101.5 108.77 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.585 0.707 . . . . 0.0 110.754 -177.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -99.0 111.25 23.7 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.596 HD12 ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -134.49 152.85 52.06 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.843 -173.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.754 HG23 HG21 ' A' ' 82' ' ' VAL . 54.8 m -103.42 128.07 50.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.395 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.596 ' HG ' HD12 ' A' ' 119' ' ' LEU . 98.3 mt -132.94 125.19 19.03 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.481 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.688 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 3.2 Cg_exo -79.97 120.18 4.14 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.947 1.764 . . . . 0.0 111.785 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.872 HG21 HG11 ' A' ' 98' ' ' VAL . 41.6 pt -96.6 98.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 3.4 p-10 -107.03 124.94 50.37 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.693 -176.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.427 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 82.8 m-85 -111.75 141.65 45.09 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 165.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.4 m -57.76 102.49 0.1 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.034 0.445 . . . . 0.0 111.614 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.976 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -85.9 69.69 10.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.331 -175.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.813 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.33 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 . . . . . 0 C--O 1.225 -0.197 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -67.95 -35.76 78.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.453 -170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 p -63.48 -40.39 96.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.266 0.555 . . . . 0.0 110.144 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.511 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 50.8 mmm-85 -74.99 -46.24 36.56 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.268 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.551 HG23 ' HG2' ' A' ' 103' ' ' PRO . 58.3 mt -57.46 -43.19 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.549 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.7 m -59.73 -44.43 93.76 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.603 0.24 . . . . 0.0 111.51 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.85 -33.98 88.7 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.457 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.646 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 27.9 ttt85 -69.83 -35.73 75.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.75 0.309 . . . . 0.0 110.347 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -64.28 -31.55 72.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.379 0.609 . . . . 0.0 109.667 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.643 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 11.4 t30 -70.97 -30.69 67.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.631 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 47.9 ttt180 -70.18 -29.03 65.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.84 171.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 49' ' ' LYS . 61.3 m-85 -99.62 25.25 7.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.202 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 48' ' ' PHE . 13.0 tmtt? 74.2 103.36 0.07 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.493 0.664 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.643 ' HB3' ' HA ' ' A' ' 46' ' ' ASN . 32.3 ttt180 -137.89 108.0 6.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.191 -176.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.552 ' HB3' HD21 ' A' ' 56' ' ' LEU . 6.2 t80 -61.78 134.6 94.06 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.43 129.13 8.55 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.987 2.458 . . . . 0.0 112.06 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.758 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -71.49 -25.28 62.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.125 -163.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -66.93 -33.26 75.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.958 0.408 . . . . 0.0 110.77 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.85 -30.32 70.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.415 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.6 mm? -78.41 -41.68 32.31 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.765 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 51.4 mtm180 -75.1 -10.89 59.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.05 -0.406 . . . . 0.0 111.994 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 33.3 tp -105.58 17.06 24.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.466 0.65 . . . . 0.0 109.803 176.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.549 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 25.0 ttmm -146.01 -54.27 0.27 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.371 -175.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.88 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 17.9 mmt180 -126.32 83.28 2.15 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.866 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.594 ' HB2' ' O ' ' A' ' 126' ' ' SER . 0.8 OUTLIER -100.15 137.3 38.78 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.552 -179.051 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.918 ' HA3' HD11 ' A' ' 87' ' ' LEU . . . 171.99 160.61 20.92 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.669 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.416 ' H ' HD12 ' A' ' 127' ' ' LEU . 2.6 p -116.35 125.72 73.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.173 0.511 . . . . 0.0 110.527 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.93 159.27 23.46 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.558 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 49.9 tt0 -104.27 123.74 47.9 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 121' ' ' LEU . 9.5 p -127.01 126.68 68.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.408 0.623 . . . . 0.0 111.041 -167.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -115.82 144.94 43.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.717 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -158.97 155.14 27.02 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.066 0.46 . . . . 0.0 110.937 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 22.0 m -100.52 129.35 46.45 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 171.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 75.5 mt -113.95 140.59 48.27 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.724 0.773 . . . . 0.0 112.146 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 27.9 t70 -77.7 165.16 24.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.85 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.505 ' HA ' ' OH ' ' A' ' 112' ' ' TYR . 38.6 mtp180 -54.39 -35.72 63.15 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.531 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -83.03 6.16 19.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 110.817 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . 72.8 40.1 53.49 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.623 -176.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 71.1 t60 -108.14 138.16 44.89 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.379 -0.41 . . . . 0.0 110.349 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 100' ' ' ARG . 10.5 p -59.24 130.94 23.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.348 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 71' ' ' ASP . 56.5 mt -120.27 -40.77 2.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.292 0.568 . . . . 0.0 110.282 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.2 148.04 51.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.981 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.77 123.99 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 123.564 0.54 . . . . 0.0 109.807 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.1 m -144.53 118.75 9.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.841 0.353 . . . . 0.0 111.376 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 84' ' ' SER . 34.3 tp -85.03 106.73 16.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -87.24 -46.69 16.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.196 -170.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 m -144.78 112.64 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.662 ' HB2' HD21 ' A' ' 81' ' ' LEU . 34.5 t -106.32 137.77 43.69 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.59 -7.56 59.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.266 0.555 . . . . 0.0 110.536 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.73 -86.23 0.14 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 1.032 ' HA ' HD12 ' A' ' 90' ' ' LEU . 2.3 mm? 44.24 59.03 13.38 Favored Pre-proline 0 CA--C 1.534 0.335 0 O-C-N 124.304 0.649 . . . . 0.0 112.495 173.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -61.92 -71.44 0.03 OUTLIER 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 121.334 1.356 . . . . 0.0 111.936 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 t -76.92 -18.64 58.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.462 0.649 . . . . 0.0 110.055 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 1.032 HD12 ' HA ' ' A' ' 87' ' ' LEU . 6.6 mt -75.91 -41.31 52.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.517 -172.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.456 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 19.2 t70 -53.95 -47.0 71.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.502 -172.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -54.64 -37.28 65.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.471 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.88 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 2.3 tp10 -78.49 -54.88 5.68 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.0 pt -68.8 -35.46 69.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.562 -173.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.605 ' NE2' HD11 ' A' ' 123' ' ' ILE . 56.5 mm-40 -79.87 -27.55 40.06 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.788 0.328 . . . . 0.0 110.649 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.24 -46.95 76.03 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.117 173.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.533 ' O ' HD21 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -63.97 -57.59 9.25 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.698 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.673 HG11 HG21 ' A' ' 123' ' ' ILE . 80.5 t -87.6 -48.82 15.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.588 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.7 ttmt -67.18 -27.09 66.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.044 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.545 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 3.2 tmt_? -85.43 -53.92 4.9 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.016 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -96.49 65.52 2.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.739 0.304 . . . . 0.0 111.105 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.486 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 16.1 m -78.04 107.85 6.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.807 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.646 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 39.6 Cg_endo -101.49 139.41 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 124.022 3.148 . . . . 0.0 113.963 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -125.98 107.11 25.28 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 171.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.511 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 11.5 Cg_exo -65.05 -62.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 122.715 2.277 . . . . 0.0 112.622 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.499 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 8.8 t -80.73 123.28 82.58 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.706 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 14.9 Cg_exo -69.47 107.67 1.85 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.047 2.498 . . . . 0.0 111.862 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.572 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 43.1 Cg_endo -84.52 59.97 5.91 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.927 2.418 . . . . 0.0 111.542 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.687 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -54.27 -48.88 70.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.086 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -75.02 6.95 3.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.707 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -106.96 -38.1 6.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.801 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -106.88 18.05 22.33 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.4 m -69.9 87.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 122.447 1.118 . . . . 0.0 108.34 172.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 5.5 p30 166.54 -39.04 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.109 -1.86 . . . . 0.0 107.526 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.08 -75.17 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.987 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.478 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.8 OUTLIER -160.14 174.07 14.83 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.953 0.501 . . . . 0.0 109.958 -178.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.801 HG13 ' HB3' ' A' ' 112' ' ' TYR . 10.4 m -105.02 109.07 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 121.282 0.563 . . . . 0.0 110.861 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -103.42 111.77 24.36 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 169.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.6 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -142.97 150.18 39.34 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.91 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.404 ' CG2' ' HG2' ' A' ' 65' ' ' GLN . 32.2 m -99.79 128.14 45.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.209 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.6 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 83.7 mt -126.73 123.54 23.85 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.559 176.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 51.9 Cg_endo -73.32 123.64 8.87 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.547 1.498 . . . . 0.0 111.921 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.673 HG21 HG11 ' A' ' 98' ' ' VAL . 8.1 pt -98.45 97.84 6.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.42 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -104.16 124.07 48.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.673 0.749 . . . . 0.0 112.199 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.443 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 71.0 m-85 -117.06 151.2 37.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.397 169.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.594 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 10.3 m -61.02 102.8 0.22 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.063 0.227 . . . . 0.0 110.656 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.909 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.3 tt -83.26 77.15 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.236 0.541 . . . . 0.0 110.787 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.485 175.285 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.522 ' CZ3' HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.191 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -67.89 -33.13 74.14 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.315 -170.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.5 p -70.85 -31.28 67.92 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.474 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 21.5 mmt180 -68.19 -46.18 71.35 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.516 HG23 ' HD2' ' A' ' 103' ' ' PRO . 88.8 mt -57.45 -44.76 85.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.211 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.5 t -56.2 -36.31 68.27 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.539 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.75 -42.4 98.6 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.507 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.672 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.75 -32.29 70.74 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.114 0.483 . . . . 0.0 110.7 177.159 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.27 -31.43 71.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.477 0.656 . . . . 0.0 109.696 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.622 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 10.0 t30 -71.52 -34.26 69.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.598 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -54.02 -25.56 21.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.592 173.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.582 ' HE2' ' HB3' ' A' ' 103' ' ' PRO . 97.5 m-85 -100.0 -61.11 1.41 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.017 174.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 11.6 mmmm -170.72 110.31 0.36 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.487 0.715 . . . . 0.0 109.533 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.622 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 45.7 ttp180 -125.03 111.91 15.93 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.985 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.632 ' H ' HD11 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -82.63 137.93 44.3 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.505 177.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.87 131.2 40.55 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.582 2.188 . . . . 0.0 111.622 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.63 -23.35 62.93 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.65 -171.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -53.69 -46.57 70.76 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.265 0.353 . . . . 0.0 111.145 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.9 -29.87 68.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.016 0.436 . . . . 0.0 111.477 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.2 mm? -75.47 -42.35 53.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 0.0 110.34 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 57' ' ' ARG . 59.9 mtt180 -70.65 -12.01 61.29 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 pp -109.79 7.74 24.29 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.972 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.607 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 19.3 ttpp -158.14 -69.8 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.607 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 22.2 mmt180 -90.23 82.6 6.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.257 1.027 . . . . 0.0 110.063 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.614 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . 24.4 mt-30 -105.17 159.16 16.07 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.345 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.445 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.29 131.6 1.72 Allowed Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.795 -1.193 . . . . 0.0 112.656 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.578 HG22 ' HB2' ' A' ' 124' ' ' ASP . 60.6 t -104.22 123.08 57.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.98 166.4 30.42 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.142 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.581 ' H ' ' HA ' ' A' ' 83' ' ' SER . 53.8 mt-30 -102.75 131.43 49.6 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 123' ' ' ILE . 20.8 t -126.66 117.08 47.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.069 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.623 ' HD3' ' OE2' ' A' ' 118' ' ' GLU . 10.8 ttm180 -109.48 139.49 44.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.568 -176.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CD1' HD21 ' A' ' 70' ' ' LEU . 8.1 p90 -159.2 154.64 25.73 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 26.4 m -96.86 140.9 30.74 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.357 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.742 HD13 ' HB2' ' A' ' 104' ' ' LEU . 65.4 mt -124.37 138.58 54.36 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.588 0.709 . . . . 0.0 112.683 -170.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.629 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 13.6 t70 -73.04 157.65 36.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.435 172.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -57.67 -27.35 62.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.876 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -100.39 15.27 28.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.864 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.708 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 75.8 46.76 13.21 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.094 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.629 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 53.2 t60 -110.52 122.23 47.24 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.6 p -50.57 116.38 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.551 0.691 . . . . 0.0 111.488 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.5 mt -100.81 -44.48 5.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.521 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.44 161.94 33.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.02 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.493 HG21 ' HG3' ' A' ' 99' ' ' LYS . 7.5 p -160.23 117.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.372 0.606 . . . . 0.0 109.589 175.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.2 m -124.37 112.83 17.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.714 -177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.0 tp -69.38 105.77 2.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.56 0.695 . . . . 0.0 109.818 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -86.98 -54.83 7.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.491 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.581 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 32.4 t 63.18 -175.01 0.15 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.249 170.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -152.03 -63.13 0.17 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.79 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.96 -37.98 13.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.975 0.417 . . . . 0.0 111.396 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.76 104.17 2.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.406 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.861 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 1.7 mm? -103.01 103.41 33.79 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' LEU . 2.7 Cg_exo -75.48 -80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.959 2.439 . . . . 0.0 112.862 -173.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 m -69.34 -19.5 63.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.442 0.639 . . . . 0.0 110.387 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.861 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.7 mt -75.7 -31.55 59.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.203 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 9.9 t70 -54.26 -48.9 70.66 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.602 0.564 . . . . 0.0 111.665 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -53.21 -45.7 68.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -171.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.574 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 16.8 tt0 -78.77 -53.35 7.21 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.961 -176.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' A' ' 60' ' ' ARG . 38.7 pt -67.1 -37.31 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.664 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 78.6 mm-40 -81.59 -25.72 35.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 120.881 0.372 . . . . 0.0 110.908 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.87 -43.47 77.18 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 169.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.632 HD11 ' H ' ' A' ' 51' ' ' TYR . 1.4 tp -67.6 -56.81 7.96 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.824 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.685 HG11 HG21 ' A' ' 123' ' ' ILE . 63.9 t -88.53 -49.13 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -175.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.664 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.6 ttmt -65.16 -22.56 66.93 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.003 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 2.6 tmt_? -90.99 -55.21 3.64 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.885 -0.509 . . . . 0.0 109.766 173.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.636 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -84.21 73.73 10.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 0.0 110.807 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.424 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 9.1 m -99.27 98.01 6.09 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 121.335 0.588 . . . . 0.0 109.577 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.672 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 93.6 Cg_endo -105.43 176.46 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 124.227 3.285 . . . . 0.0 113.686 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.742 ' HB2' HD13 ' A' ' 70' ' ' LEU . 4.0 tt -144.02 115.36 5.52 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.561 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 5.1 Cg_exo -70.75 -72.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.71 2.273 . . . . 0.0 112.757 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -86.16 117.22 68.32 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.492 -177.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.516 ' HA ' HD21 ' A' ' 104' ' ' LEU . 24.8 Cg_exo -64.06 106.44 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.266 2.644 . . . . 0.0 112.293 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.737 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 61.4 Cg_endo -88.72 67.41 2.83 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.228 2.619 . . . . 0.0 112.071 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.78 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.69 -43.4 76.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.19 0.519 . . . . 0.0 110.051 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -72.52 -2.17 18.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.636 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.737 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -105.52 -29.69 10.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.78 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -106.66 16.52 24.42 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.576 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.6 m -71.44 89.16 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 168.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 4.4 p30 161.29 -24.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.89 -169.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.4 -76.01 0.19 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.697 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.469 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -159.99 173.86 15.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.115 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 69' ' ' THR . 4.4 m -105.04 109.1 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.024 0.44 . . . . 0.0 111.235 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.623 ' OE2' ' HD3' ' A' ' 67' ' ' ARG . 32.6 tt0 -110.0 112.17 24.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.631 HD13 HD11 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -122.59 150.36 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.463 -175.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.453 HG23 HG21 ' A' ' 82' ' ' VAL . 29.3 m -102.09 119.01 38.09 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.413 0.625 . . . . 0.0 110.181 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.631 HD11 HD13 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -116.66 122.87 31.12 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -175.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 2.6 Cg_exo -75.29 120.16 5.86 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.603 1.535 . . . . 0.0 111.564 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.685 HG21 HG11 ' A' ' 98' ' ' VAL . 4.3 pt -104.0 114.8 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.578 ' HB2' HG22 ' A' ' 63' ' ' VAL . 5.1 p-10 -118.97 125.25 48.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.027 0.918 . . . . 0.0 111.794 -176.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.521 ' HE1' ' HE2' ' A' ' 53' ' ' LYS . 98.6 m-85 -114.22 131.02 56.62 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.215 -1.357 . . . . 0.0 107.8 167.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.9 m -60.52 102.93 0.2 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.992 0.182 . . . . 0.0 111.282 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.614 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 3.3 mt -76.6 87.91 3.29 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.456 0.646 . . . . 0.0 110.498 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 . . . . . 0 N--CA 1.444 -0.757 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.523 179.687 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.6 m0 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 120.303 0.097 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -67.02 -44.09 81.18 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.7 p -65.72 -38.75 90.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.43 0.633 . . . . 0.0 109.744 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.629 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 1.7 mmt180 -68.6 -47.57 66.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.751 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.49 HG23 ' HG2' ' A' ' 103' ' ' PRO . 43.7 mt -62.64 -37.55 79.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.589 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.8 m -55.09 -37.54 66.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.332 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -66.72 -44.59 89.13 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.057 176.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 47' ' ' ARG . 11.5 mpt_? -70.16 -32.36 70.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.032 0.444 . . . . 0.0 111.37 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.442 HD11 HG22 ' A' ' 98' ' ' VAL . 0.9 OUTLIER -63.14 -32.68 74.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.642 0.734 . . . . 0.0 109.367 176.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.689 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 14.4 t-20 -71.14 -30.97 67.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.589 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.515 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 3.2 ttt180 -58.45 -18.82 31.59 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.651 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -115.44 -59.34 2.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.366 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -160.43 105.64 1.47 Allowed 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 122.942 0.497 . . . . 0.0 109.798 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.689 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 22.0 tpt180 -105.78 102.52 11.96 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.08 176.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.603 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -90.3 125.7 59.17 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.364 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.34 132.36 29.21 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.37 2.047 . . . . 0.0 111.523 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.502 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.68 -23.62 66.21 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.581 -175.134 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.31 -42.84 82.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.913 0.387 . . . . 0.0 110.837 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.74 71.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.802 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.704 ' HG ' ' HE2' ' A' ' 125' ' ' PHE . 3.7 mm? -75.91 -41.31 52.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.259 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.64 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 98.5 mtt180 -58.08 -29.72 65.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.134 0.493 . . . . 0.0 111.307 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.9 mt -100.07 17.11 21.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.097 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.846 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 38.4 ttmt -145.86 -77.59 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.372 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.846 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 36.3 mmt180 -126.71 98.06 5.23 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -176.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.64 ' HG2' ' HA ' ' A' ' 57' ' ' ARG . 47.4 mt-30 -92.66 115.87 28.5 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.904 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -155.53 125.28 1.63 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.737 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.724 HG23 ' HA ' ' A' ' 124' ' ' ASP . 7.1 p -103.91 133.22 48.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.175 0.512 . . . . 0.0 109.969 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.05 168.44 34.54 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.622 -175.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.687 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 83.2 mt-30 -99.74 140.53 33.81 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.459 HG12 ' CD2' ' A' ' 68' ' ' PHE . 53.7 t -128.7 114.18 32.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.695 -173.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 22.7 ttp180 -106.2 129.08 54.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -147.83 151.51 36.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.295 0.569 . . . . 0.0 112.191 -174.218 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 9.0 m -99.94 125.61 45.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 169.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 41.7 mt -116.26 134.68 54.64 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.168 0.508 . . . . 0.0 111.757 -170.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 16.4 t70 -73.96 154.02 39.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.314 177.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -49.4 -40.75 37.37 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.34 0.4 . . . . 0.0 111.805 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -89.35 14.03 12.15 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 111.309 -176.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.47 47.13 9.17 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.118 177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 73.6 t60 -109.58 116.18 31.28 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 p -48.74 115.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.331 0.586 . . . . 0.0 111.554 173.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.0 mt -103.3 -41.89 5.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.978 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -139.25 146.08 39.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.818 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 99' ' ' LYS . 1.4 m -143.76 117.13 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.422 0.63 . . . . 0.0 110.951 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 m -130.13 125.66 35.62 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.87 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.9 tp -71.6 119.07 15.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.205 0.526 . . . . 0.0 110.065 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.54 HG21 HG23 ' A' ' 120' ' ' THR . 0.1 OUTLIER -96.71 -38.78 8.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.982 179.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 12.4 t 67.06 -178.26 0.21 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.404 170.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.555 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 39.8 m -154.92 -58.04 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.289 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.13 -66.6 0.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.327 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.65 104.82 0.19 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.753 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.82 ' HA ' HD12 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -118.42 77.82 13.98 Favored Pre-proline 0 C--N 1.32 -0.686 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.358 -178.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.63 -78.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.234 1.956 . . . . 0.0 111.809 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.9 m -67.68 -17.63 64.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.413 0.625 . . . . 0.0 110.297 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.82 HD12 ' HA ' ' A' ' 87' ' ' LEU . 17.6 mt -75.21 -33.66 61.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.921 -176.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 18.5 t70 -53.98 -50.52 66.37 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.591 0.557 . . . . 0.0 112.031 -173.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.574 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 0.7 OUTLIER -54.56 -48.6 71.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.114 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.76 -55.19 5.54 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -174.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 90' ' ' LEU . 36.0 pt -68.61 -34.05 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.407 0.623 . . . . 0.0 110.933 -171.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.816 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.8 mm-40 -84.66 -17.46 38.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.005 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 92' ' ' ARG . . . -55.64 -55.78 28.05 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.835 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.613 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.2 -48.19 21.32 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.148 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.722 HG11 HG21 ' A' ' 123' ' ' ILE . 55.8 t -70.54 -49.49 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.816 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.9 ttmt -73.97 -16.53 61.07 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 122.064 -0.398 . . . . 0.0 110.724 -173.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -88.29 -47.37 8.47 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.678 171.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.606 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -92.32 67.79 4.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.801 0.334 . . . . 0.0 110.914 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.2 m -95.57 99.67 5.06 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.291 0.567 . . . . 0.0 110.005 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 90.8 Cg_endo -102.79 176.32 0.18 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.042 3.161 . . . . 0.0 113.711 -175.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 48.9 tp -142.9 85.6 9.87 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.304 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.629 ' CG ' ' HB2' ' A' ' 40' ' ' ARG . 10.0 Cg_endo -59.44 -53.94 2.99 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.278 1.986 . . . . 0.0 112.677 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.618 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.4 m -81.03 116.74 64.54 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.75 99.23 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.986 2.457 . . . . 0.0 111.118 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.829 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 37.9 Cg_endo -90.93 66.45 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.363 2.708 . . . . 0.0 112.386 -171.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.724 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.59 -45.92 84.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.203 0.525 . . . . 0.0 109.921 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -67.22 -6.28 17.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.7 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.829 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -101.41 -36.19 8.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.488 -178.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.774 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -112.43 18.85 18.12 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -171.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.2 m -69.26 88.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.134 0.969 . . . . 0.0 108.686 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 3.8 p30 164.11 -27.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.459 -1.7 . . . . 0.0 107.636 -170.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 172.28 -81.92 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.09 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.486 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.3 OUTLIER -160.81 175.49 12.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.774 HG13 ' HB3' ' A' ' 112' ' ' TYR . 10.7 m -102.35 108.69 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.329 0.585 . . . . 0.0 110.842 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 37.0 tt0 -108.8 112.5 24.8 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 170.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.651 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -136.38 154.35 50.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 -173.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.54 HG23 HG21 ' A' ' 82' ' ' VAL . 98.6 m -98.43 113.44 25.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.703 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.651 ' HG ' HD12 ' A' ' 119' ' ' LEU . 42.7 mt -117.95 123.76 29.31 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.19 176.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.2 Cg_exo -73.53 118.9 5.67 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.994 1.796 . . . . 0.0 111.212 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.722 HG21 HG11 ' A' ' 98' ' ' VAL . 33.5 pt -93.61 116.68 35.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.724 ' HA ' HG23 ' A' ' 63' ' ' VAL . 1.5 t70 -100.53 120.91 40.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.996 0.903 . . . . 0.0 112.856 -172.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.704 ' HE2' ' HG ' ' A' ' 56' ' ' LEU . 6.7 m-85 -115.6 130.53 56.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 160.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 61' ' ' GLN . 13.4 m -59.19 103.46 0.18 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.294 0.497 . . . . 0.0 110.703 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.904 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -77.76 66.76 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.059 -177.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 121.182 0.515 . . . . 0.0 109.857 179.142 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.43 ' HE1' ' HB ' ' A' ' 106' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.288 0.566 . . . . 0.0 109.55 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 38' ' ' ARG . 5.7 ptp180 -66.02 -31.97 73.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.83 -177.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.3 p -71.23 -33.13 69.59 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 10.1 mmt180 -70.65 -46.28 63.54 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.559 ' N ' ' HG3' ' A' ' 105' ' ' PRO . 80.3 mt -57.31 -45.8 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.866 175.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.9 m -61.42 -34.43 75.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.485 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.537 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -66.38 -37.81 93.07 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.44 -0.886 . . . . 0.0 110.996 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.654 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -69.22 -33.71 73.72 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.314 0.578 . . . . 0.0 110.185 176.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.39 -26.02 67.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.777 177.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.632 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.4 t-20 -70.56 -33.58 71.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.39 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.546 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 1.4 ttt180 -55.27 -28.4 53.13 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.357 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.582 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 91.2 m-85 -99.45 -58.99 1.8 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.219 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 48' ' ' PHE . 32.5 mtmt -178.91 103.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.521 1.128 . . . . 0.0 108.691 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.632 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 55.4 ttp180 -110.77 104.39 13.03 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.791 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.559 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -92.24 126.58 52.32 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.26 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.93 133.13 51.63 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 123.009 2.473 . . . . 0.0 112.462 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.61 -26.3 66.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.216 -169.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.68 -35.82 77.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.17 0.51 . . . . 0.0 110.5 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.46 63.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.6 mm? -75.98 -42.69 47.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.671 0.272 . . . . 0.0 110.965 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 4.4 ptp180 -66.6 -11.91 55.56 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.952 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -112.94 10.57 18.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.24 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.599 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 23.1 ttmm -150.92 -77.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.121 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 1.064 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 28.5 mmt180 -112.34 84.58 2.0 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -94.91 170.95 9.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.274 -178.345 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.754 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.58 123.28 0.99 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.093 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.631 HG12 HD12 ' A' ' 127' ' ' LEU . 6.9 p -104.76 125.55 59.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.223 0.535 . . . . 0.0 109.866 176.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.67 165.15 28.8 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.883 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 36.2 tt0 -103.98 124.37 48.88 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.441 HG21 HD13 ' A' ' 123' ' ' ILE . 60.5 t -128.63 118.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.73 -170.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 1.2 ptp180 -113.14 145.54 40.77 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -156.86 157.6 35.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.311 0.577 . . . . 0.0 111.788 -175.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.676 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 1.9 m -107.74 127.56 53.79 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 172.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.657 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 36.6 mt -117.56 132.04 56.59 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.253 0.549 . . . . 0.0 111.997 -166.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.537 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 20.6 t70 -68.79 152.22 45.6 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.23 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.465 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 69.6 mtt180 -61.41 -17.27 53.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.449 -1.25 . . . . 0.0 112.414 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -101.03 3.83 41.79 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.321 0.582 . . . . 0.0 110.331 175.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 86.89 41.49 6.71 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.25 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.537 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 79.9 t60 -114.35 125.63 54.08 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 8.6 p -53.3 122.25 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.357 0.598 . . . . 0.0 111.267 175.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.8 mt -104.34 -40.84 5.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.632 0.729 . . . . 0.0 109.552 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.59 151.55 47.37 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.636 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.17 122.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.358 0.599 . . . . 0.0 110.027 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.1 m -129.3 127.63 41.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.343 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 84' ' ' SER . 25.4 tp -75.54 107.81 7.93 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.651 HG21 HG23 ' A' ' 120' ' ' THR . 0.1 OUTLIER -83.42 -41.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.382 -170.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.6 m -154.44 135.31 13.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.88 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.667 ' HB2' HD21 ' A' ' 81' ' ' LEU . 34.1 t -122.93 135.86 54.65 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.79 -19.36 41.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.657 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.474 ' H ' HD22 ' A' ' 87' ' ' LEU . . . 133.12 63.33 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.973 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.913 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -118.23 87.65 30.27 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.97 -73.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.554 2.169 . . . . 0.0 111.769 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 9.3 m -72.91 -18.92 61.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.34 0.59 . . . . 0.0 110.245 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.913 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 17.0 mt -76.83 -37.25 56.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.719 -175.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.445 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 17.0 t70 -54.6 -48.82 71.7 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.189 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 89' ' ' SER . 16.8 ptp180 -54.34 -42.25 70.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.595 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 1.064 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 4.9 tp10 -77.79 -54.66 6.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.978 0.418 . . . . 0.0 111.949 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.525 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 38.1 pt -72.48 -33.48 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.754 -172.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.623 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 77.1 mm-40 -82.52 -25.95 32.95 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 120.867 0.365 . . . . 0.0 110.737 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.552 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.01 -43.44 77.7 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 169.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.722 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -66.6 -57.05 8.04 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.14 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.736 HG11 HG21 ' A' ' 123' ' ' ILE . 79.3 t -88.42 -49.49 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.623 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 36.3 ttmt -65.54 -24.65 67.17 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.63 0.372 . . . . 0.0 111.329 -174.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.552 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 28.3 tpt180 -97.14 -35.78 10.68 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.492 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.469 ' HB1' ' CD2' ' A' ' 48' ' ' PHE . . . -102.78 61.78 0.81 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.834 177.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.494 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 6.3 m -83.11 104.64 3.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.261 0.553 . . . . 0.0 109.995 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.654 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 37.9 Cg_endo -99.81 153.32 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.769 2.979 . . . . 0.0 114.604 -171.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.742 HD21 ' HD2' ' A' ' 108' ' ' PRO . 22.4 tp -125.41 100.48 32.11 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.342 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.637 ' HA ' ' NE ' ' A' ' 44' ' ' ARG . 2.4 Cg_endo -69.0 -81.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.142 1.894 . . . . 0.0 113.278 -174.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.43 ' HB ' ' HE1' ' A' ' 37' ' ' TRP . 31.5 m -79.91 110.21 15.13 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 27.0 Cg_exo -62.16 108.01 0.63 Allowed 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.898 2.399 . . . . 0.0 112.098 -175.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.742 ' HD2' HD21 ' A' ' 104' ' ' LEU . 97.9 Cg_endo -75.49 62.48 6.26 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.072 2.515 . . . . 0.0 111.569 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.77 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -58.33 -35.47 71.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.383 0.611 . . . . 0.0 110.24 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.33 -7.79 27.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.945 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.45 -21.53 10.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -175.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.77 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -131.76 19.56 4.64 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -168.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.1 m -69.8 89.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 122.412 1.101 . . . . 0.0 109.753 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.674 HD22 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 160.94 -16.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 112.723 -2.035 . . . . 0.0 107.752 -172.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.674 ' N ' HD22 ' A' ' 114' ' ' ASN . . . 172.2 -92.46 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.341 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.537 ' OG1' HG22 ' A' ' 69' ' ' THR . 0.6 OUTLIER -161.44 176.41 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 122.894 0.477 . . . . 0.0 110.245 -173.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.688 HG13 ' HD2' ' A' ' 112' ' ' TYR . 2.9 m -104.94 119.03 53.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.485 -173.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -104.14 112.45 25.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.565 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -133.52 154.3 50.95 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.631 -174.311 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.651 HG23 HG21 ' A' ' 82' ' ' VAL . 62.5 m -109.23 123.3 49.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.772 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.565 ' HG ' HD12 ' A' ' 119' ' ' LEU . 65.1 mt -129.91 128.38 22.89 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.366 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.2 Cg_exo -73.45 119.36 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.647 1.565 . . . . 0.0 110.385 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.736 HG21 HG11 ' A' ' 98' ' ' VAL . 19.4 pt -95.42 126.04 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -114.94 121.54 43.48 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.26 -176.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.525 ' CE1' ' HB ' ' A' ' 94' ' ' ILE . 75.7 m-85 -113.25 120.03 39.77 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 159.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.9 m -56.43 103.66 0.11 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.118 0.485 . . . . 0.0 111.381 -168.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.754 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.1 mt -70.78 94.87 1.07 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.451 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 . . . . . 0 N--CA 1.442 -0.848 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.645 -179.756 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.587 ' O ' HG13 ' A' ' 41' ' ' ILE . 8.7 p-90 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HA ' HD12 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -69.16 -36.05 76.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.374 0.534 . . . . 0.0 111.666 -174.321 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -33.62 74.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.805 0.812 . . . . 0.0 109.795 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.524 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 27.0 mmm180 -73.0 -32.73 65.33 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.507 175.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 38' ' ' ARG . 62.1 mt -61.04 -39.71 83.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.512 173.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -55.14 -39.94 70.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.835 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.16 -36.5 92.98 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.952 173.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.688 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -69.36 -34.9 75.28 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.374 0.607 . . . . 0.0 110.097 178.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -67.13 -26.76 66.84 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.3 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.631 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 11.6 t30 -70.43 -33.38 71.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.788 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 7.6 ptt180 -60.41 -17.99 47.71 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.018 173.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -109.58 -58.54 2.03 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.495 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -167.88 101.41 0.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.694 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.631 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 17.0 ttp180 -111.55 102.31 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.218 171.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.56 ' HD1' ' HD2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -97.63 117.11 65.7 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.568 -173.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.56 ' HD2' ' HD1' ' A' ' 51' ' ' TYR . 52.8 Cg_exo -53.35 131.06 41.46 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.659 2.239 . . . . 0.0 111.65 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.67 -25.2 67.24 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.552 -173.067 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -56.61 -43.26 80.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.046 0.45 . . . . 0.0 110.803 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.18 -30.81 69.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 110.554 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.554 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 3.6 mm? -74.55 -32.94 62.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.524 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.873 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 22.2 mtm180 -62.0 -20.32 63.78 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.748 0.308 . . . . 0.0 111.54 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 mp -107.15 14.84 25.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.65 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.823 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 37.5 ttpt -150.79 -84.61 0.09 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.295 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.823 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 32.3 mmt-85 -122.02 86.27 2.55 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.936 -0.478 . . . . 0.0 111.426 -174.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.873 ' HG2' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -111.68 115.23 28.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.151 0.501 . . . . 0.0 110.448 172.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.83 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -146.54 140.05 8.47 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.544 175.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.918 HG12 HD12 ' A' ' 127' ' ' LEU . 7.1 p -103.61 138.14 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.991 0.424 . . . . 0.0 109.915 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.556 ' HA3' ' OG ' ' A' ' 83' ' ' SER . . . -168.02 169.27 41.29 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.684 -176.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 54.0 mt-30 -98.87 141.07 32.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.462 HG12 ' CE2' ' A' ' 68' ' ' PHE . 55.4 t -130.83 114.65 27.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.5 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 21.9 ttm180 -111.71 141.37 45.4 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -174.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CE2' HG12 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -159.22 155.5 27.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.153 0.501 . . . . 0.0 111.605 -176.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 48.8 m -98.47 123.92 42.88 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 170.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.461 HD11 ' CE1' ' A' ' 68' ' ' PHE . 73.0 mt -113.42 148.45 35.84 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.145 0.498 . . . . 0.0 112.29 -170.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.662 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 33.4 t70 -92.79 166.68 12.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.627 175.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -53.87 -39.81 66.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -90.12 9.1 29.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.042 0.448 . . . . 0.0 111.164 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 103' ' ' PRO . . . 77.13 47.3 9.34 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.084 -175.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 78.9 t60 -100.28 100.77 11.63 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.3 p -47.47 115.01 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.763 0.792 . . . . 0.0 111.457 176.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 15.5 mt -98.32 -35.3 10.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.987 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -136.31 143.76 44.33 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.102 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.5 m -119.19 129.46 75.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.035 0.445 . . . . 0.0 110.082 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 69.8 m -130.99 122.23 26.47 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.323 0.582 . . . . 0.0 110.911 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.5 tp -78.96 115.62 18.76 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.783 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -121.64 -25.17 2.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.118 -177.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.556 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 7.5 t -48.96 119.54 3.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.913 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -144.35 43.49 1.41 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.428 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.69 13.88 18.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.089 0.471 . . . . 0.0 110.33 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.61 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 81.18 61.1 2.15 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.768 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.762 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.8 OUTLIER -110.84 84.15 4.05 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.495 -179.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.61 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 5.7 Cg_exo -78.05 -75.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.677 2.251 . . . . 0.0 112.142 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.3 p -69.29 -18.98 63.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.495 0.664 . . . . 0.0 110.497 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.762 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 28.4 mt -74.62 -39.59 62.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.269 -175.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.532 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 4.8 t70 -53.4 -50.47 65.1 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.585 0.553 . . . . 0.0 111.875 -173.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -54.58 -45.65 73.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.63 -53.51 7.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.792 0.329 . . . . 0.0 111.332 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.671 HG12 ' O ' ' A' ' 90' ' ' LEU . 48.1 pt -70.26 -32.45 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -171.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.588 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 25.7 mm-40 -82.48 -30.04 30.18 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.281 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.54 -44.66 81.1 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 170.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.61 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -60.88 -59.42 5.41 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.289 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.754 HG11 HG21 ' A' ' 123' ' ' ILE . 76.2 t -89.94 -49.39 13.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.588 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 38.1 ttmt -66.18 -27.23 67.85 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -172.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.549 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 29.8 tpt180 -91.2 -30.8 16.46 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.492 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.599 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -108.08 67.69 0.68 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.936 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.463 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 5.5 m -96.49 97.96 3.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.226 0.536 . . . . 0.0 110.458 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.688 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 37.5 Cg_endo -104.14 168.56 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.471 3.447 . . . . 0.0 114.599 -173.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.588 HD13 ' HG3' ' A' ' 108' ' ' PRO . 19.9 mt -145.39 122.4 6.15 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.309 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 7.9 Cg_endo -82.39 -47.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.587 2.191 . . . . 0.0 111.664 175.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.0 m -90.27 113.31 56.93 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.742 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.18 108.3 0.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.601 2.2 . . . . 0.0 111.451 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.692 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 94.3 Cg_endo -82.07 51.1 3.67 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.831 2.354 . . . . 0.0 112.901 -173.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.642 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -60.74 -37.7 82.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.284 0.564 . . . . 0.0 109.625 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -75.06 3.71 8.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.875 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.51 -23.44 9.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.777 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.729 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -127.5 18.27 6.91 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.289 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.4 m -70.36 88.32 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 122.198 0.999 . . . . 0.0 109.19 175.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.601 HD22 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 158.58 -12.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 113.284 -1.78 . . . . 0.0 108.645 -170.014 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.601 ' N ' HD22 ' A' ' 114' ' ' ASN . . . 163.13 -87.08 0.1 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.449 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.436 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.7 OUTLIER -160.23 175.39 12.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -175.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.729 HG13 ' HB3' ' A' ' 112' ' ' TYR . 5.7 m -103.22 107.94 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -109.82 110.06 20.93 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 170.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.523 HD12 ' HG ' ' A' ' 121' ' ' LEU . 1.4 pp -143.46 146.36 33.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.875 0.369 . . . . 0.0 110.308 -174.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 65' ' ' GLN . 86.2 m -93.98 117.08 29.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.191 -177.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.523 ' HG ' HD12 ' A' ' 119' ' ' LEU . 46.9 mt -111.13 122.87 36.66 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.5 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 4.7 Cg_exo -74.08 119.14 5.69 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.885 1.723 . . . . 0.0 110.617 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.754 HG21 HG11 ' A' ' 98' ' ' VAL . 18.7 pt -98.34 118.26 44.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.499 ' HA ' HG23 ' A' ' 63' ' ' VAL . 12.6 t70 -108.03 122.23 46.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.719 0.771 . . . . 0.0 112.087 -172.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.481 ' CE2' ' HG ' ' A' ' 56' ' ' LEU . 34.3 m-85 -115.9 142.04 47.3 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 162.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m -67.8 103.04 1.33 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.603 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.918 HD12 HG12 ' A' ' 63' ' ' VAL . 2.0 mt -77.97 81.49 4.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.461 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 . . . . . 0 N--CA 1.44 -0.927 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.475 -179.646 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.557 ' CZ2' HD21 ' A' ' 121' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.637 0.256 . . . . 0.0 111.364 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -68.87 -30.6 69.15 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.117 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.6 p -62.41 -40.01 95.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.075 176.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.462 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 16.2 mmm180 -73.64 -39.65 64.34 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.707 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.663 HG23 ' HD2' ' A' ' 103' ' ' PRO . 79.4 mt -60.36 -50.49 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.173 176.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 m -58.51 -43.26 89.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.841 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.14 -36.32 93.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.86 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.633 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 11.4 ttt-85 -69.16 -32.02 71.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 120.851 0.358 . . . . 0.0 110.328 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.846 ' HB3' ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -62.99 -31.46 72.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.207 0.527 . . . . 0.0 109.966 178.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.746 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 26.7 t-20 -71.74 -35.19 70.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.61 174.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 68.3 ttt180 -67.09 -26.65 66.83 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.608 175.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -92.03 7.58 41.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.564 172.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? 67.99 102.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.263 -175.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.846 ' HD2' ' HB3' ' A' ' 45' ' ' LEU . 4.6 ptm180 -118.17 130.31 56.03 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.402 ' HB3' HD21 ' A' ' 56' ' ' LEU . 16.9 t80 -60.91 132.3 91.93 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.39 129.86 13.82 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.55 2.833 . . . . 0.0 112.301 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.821 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -64.53 -20.9 66.5 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.795 -172.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -52.6 -41.25 63.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.669 0.271 . . . . 0.0 111.08 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.89 -36.14 59.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.761 0.315 . . . . 0.0 111.338 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 93' ' ' GLU . 3.5 mm? -74.23 -43.04 58.64 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.308 -175.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -76.07 -15.42 60.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.973 0.416 . . . . 0.0 111.358 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.9 tp -86.23 -9.73 55.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.674 0.749 . . . . 0.0 109.266 174.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.87 ' HD2' ' HG2' ' A' ' 93' ' ' GLU . 23.2 ttmm -115.03 -57.76 2.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.47 -173.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.774 ' HG3' ' HB2' ' A' ' 93' ' ' GLU . 30.1 mmt180 -127.08 122.45 34.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.784 -175.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -126.41 114.57 18.37 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 1.011 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -149.7 143.09 10.36 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.961 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.583 ' H ' HD12 ' A' ' 127' ' ' LEU . 5.3 p -104.43 127.64 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.027 0.441 . . . . 0.0 109.947 176.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.39 167.51 32.98 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.465 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 82' ' ' VAL . 14.6 mm100 -101.86 131.54 48.14 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.8 t -126.6 114.18 36.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.204 0.526 . . . . 0.0 110.339 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 27.0 ttm180 -101.32 141.89 33.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -157.71 152.42 25.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.989 0.423 . . . . 0.0 111.299 -178.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.764 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 9.4 m -101.64 127.31 48.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.641 173.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.719 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 28.2 mt -119.5 135.4 54.79 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.1 -172.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.431 ' HB2' HD21 ' A' ' 77' ' ' LEU . 20.2 t70 -76.07 152.77 36.76 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.896 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -55.06 -26.64 39.03 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 123.4 0.437 . . . . 0.0 111.787 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -84.31 -1.79 55.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 110.687 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.8 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 88.45 23.71 36.0 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.851 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.425 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 58.1 t60 -95.92 117.48 30.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.494 0.188 . . . . 0.0 110.553 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -48.99 120.42 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.374 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 71' ' ' ASP . 55.7 mt -109.77 -51.26 2.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.713 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -132.42 154.78 49.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.392 -177.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.967 HG11 ' HG3' ' A' ' 99' ' ' LYS . 57.9 t -139.82 122.99 17.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 44.0 m -119.22 105.94 11.86 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.9 tp -68.24 110.79 4.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.55 0.69 . . . . 0.0 110.664 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.686 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -99.3 -52.83 8.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.929 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.543 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 23.1 t 65.7 177.91 0.21 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.203 172.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.528 ' OG ' ' HG2' ' A' ' 65' ' ' GLN . 50.3 m -139.17 -69.7 0.42 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.097 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.36 -75.83 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.504 ' C ' ' HD3' ' A' ' 88' ' ' PRO . . . -176.9 97.51 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.329 -175.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -120.56 68.55 15.09 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 178.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 3.6 Cg_exo -77.81 -66.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.386 2.057 . . . . 0.0 112.139 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.6 t -73.11 -18.63 61.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.689 0.757 . . . . 0.0 109.78 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.712 HD12 ' HA ' ' A' ' 87' ' ' LEU . 32.8 mt -76.02 -30.74 58.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.576 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.52 -45.88 69.9 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.808 0.693 . . . . 0.0 111.896 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.583 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 8.5 ptp180 -53.01 -51.09 62.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -172.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.87 ' HG2' ' HD2' ' A' ' 59' ' ' LYS . 1.7 mp0 -77.04 -55.39 5.5 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 90' ' ' LEU . 22.2 pt -69.88 -32.82 53.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 111.386 -172.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.807 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 75.1 mm-40 -83.49 -18.32 38.92 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.507 176.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -54.73 -55.23 32.09 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.851 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.664 HD23 HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -75.75 -52.43 10.48 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.031 177.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.725 HG11 HG21 ' A' ' 123' ' ' ILE . 91.3 t -65.44 -49.43 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.967 ' HG3' HG11 ' A' ' 79' ' ' VAL . 40.4 ttmt -74.61 -29.24 61.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.556 0.217 . . . . 0.0 110.906 -172.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.584 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -78.11 -42.13 32.92 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.828 176.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.556 ' HB2' HH11 ' A' ' 100' ' ' ARG . . . -117.11 73.98 0.89 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.692 0.282 . . . . 0.0 111.663 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.7 m -82.96 108.71 13.4 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.105 0.479 . . . . 0.0 110.35 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.663 ' HD2' HG23 ' A' ' 41' ' ' ILE . 16.2 Cg_endo -97.12 139.08 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.23 3.287 . . . . 0.0 113.947 -175.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.8 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 40.3 tp -116.31 91.51 33.14 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 174.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.462 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 53.1 Cg_endo -79.45 -39.35 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.293 1.995 . . . . 0.0 113.603 -174.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.425 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.5 m -102.9 110.81 64.24 Favored Pre-proline 0 C--N 1.319 -0.761 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.92 107.77 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.242 2.628 . . . . 0.0 112.954 -175.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.731 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 48.9 Cg_endo -89.8 66.57 2.12 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.299 2.666 . . . . 0.0 111.659 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.818 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.1 -41.29 78.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.416 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -73.46 1.44 9.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.859 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.731 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -110.89 -27.97 8.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.691 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.818 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -105.16 16.31 25.99 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.5 m -72.27 87.89 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER 157.18 -9.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.417 -171.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.68 -80.16 0.2 Allowed Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.063 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.489 ' C ' ' HB3' ' A' ' 112' ' ' TYR . 1.0 OUTLIER -156.42 176.17 13.05 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.764 ' O ' ' HA ' ' A' ' 69' ' ' THR . 6.6 m -99.26 106.22 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 119.676 1.125 . . . . 0.0 110.259 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -105.52 109.22 21.12 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 168.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.688 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -139.73 147.45 40.9 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.493 -172.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.686 HG23 HG21 ' A' ' 82' ' ' VAL . 36.3 m -94.43 113.65 25.54 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.778 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.688 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 35.0 mt -114.73 126.8 27.47 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.992 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 6.2 Cg_exo -75.29 118.78 5.31 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 121.401 1.401 . . . . 0.0 110.636 177.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.725 HG21 HG11 ' A' ' 98' ' ' VAL . 32.5 pt -93.3 97.1 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -99.03 121.88 41.55 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 122.302 1.048 . . . . 0.0 112.041 -171.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.446 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 84.9 m-85 -114.74 142.83 45.99 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.754 -1.567 . . . . 0.0 107.057 165.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.1 m -65.56 103.35 0.84 Allowed 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.246 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 1.011 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -75.42 61.8 1.29 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.791 -176.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 . . . . . 0 N--CA 1.447 -0.581 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.454 179.69 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.473 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.227 -0.126 0 CA-C-O 120.665 0.269 . . . . 0.0 111.078 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -33.87 75.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.666 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.1 m -67.08 -35.87 80.76 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 18.2 mmt180 -70.65 -42.01 71.39 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.918 177.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.683 HG23 ' HG2' ' A' ' 103' ' ' PRO . 92.2 mt -59.65 -44.06 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.2 177.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.9 t -55.68 -37.62 68.56 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.801 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -69.46 -37.63 79.07 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.081 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.64 -34.11 73.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.154 0.502 . . . . 0.0 110.634 178.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.607 HD11 HG13 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -68.27 -26.9 65.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.641 0.734 . . . . 0.0 109.526 177.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.689 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 5.9 t30 -70.28 -35.1 73.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.258 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.55 -29.86 59.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.624 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -96.29 -59.33 1.86 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.515 178.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -158.53 119.31 3.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.121 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.689 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -136.07 102.61 5.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.404 0.621 . . . . 0.0 110.275 174.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.508 ' HB3' HD21 ' A' ' 56' ' ' LEU . 3.1 t80 -86.53 132.09 43.8 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.848 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.32 130.19 36.48 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 122.741 2.294 . . . . 0.0 112.363 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.577 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -60.81 -29.39 69.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.354 -170.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.78 -33.82 70.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 0.0 110.316 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.79 -39.14 61.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.293 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.4 mm? -64.53 -40.97 96.6 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.743 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.478 ' HD3' HH11 ' A' ' 128' ' ' ARG . 60.5 mtt180 -59.07 -22.71 61.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.867 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.7 mt -102.43 -8.67 20.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.793 0.33 . . . . 0.0 110.964 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -112.51 -68.77 0.91 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.827 -176.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.656 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 6.0 ppt_? -155.01 142.9 20.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.062 0.458 . . . . 0.0 110.888 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.519 ' O ' HD22 ' A' ' 90' ' ' LEU . 13.0 mm100 -138.5 177.74 7.66 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 1.043 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.22 146.75 4.42 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.52 -1.324 . . . . 0.0 113.989 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.3 t -106.35 124.16 61.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.28 163.31 26.4 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.699 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 82' ' ' VAL . 85.0 mt-30 -106.45 125.87 51.54 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 121' ' ' LEU . 12.1 p -123.85 125.0 70.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.64 -170.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -113.47 134.96 54.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.838 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.7 OUTLIER -157.11 158.13 35.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.955 0.407 . . . . 0.0 111.694 -175.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.597 ' CG2' ' HB ' ' A' ' 116' ' ' THR . 26.6 m -99.37 134.21 42.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.229 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.52 HD13 ' HB2' ' A' ' 104' ' ' LEU . 75.7 mt -117.01 142.97 46.28 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.573 0.545 . . . . 0.0 111.255 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -97.43 169.83 9.47 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.874 175.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -50.81 -42.61 58.38 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -94.37 24.3 4.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.728 0.299 . . . . 0.0 111.48 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.681 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 68.11 47.77 57.31 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.185 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 66.3 t60 -100.51 117.43 34.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 p -48.88 122.9 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 123.816 0.697 . . . . 0.0 110.913 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 88.6 mt -116.71 -44.99 2.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.35 158.13 40.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 99' ' ' LYS . 13.4 m -145.32 117.28 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.533 0.521 . . . . 0.0 110.178 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.2 m -141.7 131.93 24.92 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.864 0.364 . . . . 0.0 111.249 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.7 tp -83.63 120.0 25.44 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.619 HG21 HG23 ' A' ' 120' ' ' THR . 0.1 OUTLIER -95.9 -58.74 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.345 -175.282 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.9 m -141.84 113.36 7.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.921 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.5 t -107.08 117.14 33.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.21 -46.82 66.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.496 -175.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.691 ' H ' HD22 ' A' ' 87' ' ' LEU . . . -176.35 58.91 0.1 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.913 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.891 ' HA ' HD12 ' A' ' 90' ' ' LEU . 1.6 mm? -118.05 89.61 35.07 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.33 -83.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.23 1.953 . . . . 0.0 111.338 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 3.5 m -67.41 -17.92 64.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.674 0.75 . . . . 0.0 110.104 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.891 HD12 ' HA ' ' A' ' 87' ' ' LEU . 8.0 mt -75.5 -33.49 60.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.215 -175.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 13.6 t70 -54.87 -49.69 70.53 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.76 0.662 . . . . 0.0 111.371 -173.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 89' ' ' SER . 5.0 ptp180 -53.86 -50.53 66.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.094 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 20.7 tt0 -77.99 -42.06 33.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -173.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.565 HG13 ' HG2' ' A' ' 95' ' ' GLN . 30.3 pt -60.63 -40.68 85.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.885 -177.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.672 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 50.1 mm-40 -82.39 -30.52 30.18 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.957 0.408 . . . . 0.0 110.94 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.92 -52.31 64.57 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.923 173.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.777 HD23 HG23 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -62.2 -56.58 17.21 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.949 -178.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.958 HG11 HG21 ' A' ' 123' ' ' ILE . 58.5 t -88.14 -50.54 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -176.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.672 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 35.6 ttmt -63.7 -38.8 92.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.409 0.151 . . . . 0.0 111.409 -172.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -79.23 -16.85 55.88 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.662 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.37 53.09 0.77 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.474 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 51.0 m -65.45 107.4 1.45 Allowed Pre-proline 0 C--O 1.234 0.279 0 O-C-N 123.514 0.509 . . . . 0.0 110.79 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.683 ' HG2' HG23 ' A' ' 41' ' ' ILE . 50.2 Cg_endo -101.79 154.87 0.35 Allowed 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 123.847 3.032 . . . . 0.0 114.002 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.681 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 2.1 tp -142.57 107.63 5.55 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.141 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HB3' HH11 ' A' ' 44' ' ' ARG . 4.0 Cg_exo -75.0 -56.94 0.06 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.22 1.947 . . . . 0.0 112.435 178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.496 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 10.6 m -90.2 110.36 39.94 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.684 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.529 ' HA ' HD21 ' A' ' 104' ' ' LEU . 42.2 Cg_endo -68.64 107.13 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.942 2.428 . . . . 0.0 112.16 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.884 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 51.1 Cg_endo -87.88 71.3 2.93 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.018 2.478 . . . . 0.0 111.754 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.647 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -56.29 -46.56 79.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.93 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -76.09 7.82 3.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.796 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.884 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.17 -23.26 10.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.485 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.705 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -122.01 16.68 10.85 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -177.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.7 m -71.65 89.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.971 0.891 . . . . 0.0 108.954 172.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 3.5 p30 161.61 -28.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.082 -169.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 175.7 -89.4 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.111 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.651 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -161.6 175.56 11.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.705 HG13 ' HB3' ' A' ' 112' ' ' TYR . 11.5 m -102.85 109.31 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.313 0.578 . . . . 0.0 110.98 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 43.2 tt0 -111.93 111.62 22.68 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 170.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.569 HD12 ' HG ' ' A' ' 121' ' ' LEU . 3.8 pp -137.01 155.11 50.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.162 -175.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.619 HG23 HG21 ' A' ' 82' ' ' VAL . 86.4 m -95.11 125.45 39.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.374 -176.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' A' ' 119' ' ' LEU . 77.9 mt -125.74 131.4 24.0 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.093 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 6.4 Cg_exo -74.47 121.43 6.77 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.071 1.847 . . . . 0.0 111.369 175.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.958 HG21 HG11 ' A' ' 98' ' ' VAL . 3.1 pt -96.25 98.31 7.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -94.04 121.11 35.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.892 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 80.4 m-85 -116.93 128.89 55.66 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 163.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 m -63.59 102.92 0.48 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.719 0.295 . . . . 0.0 111.022 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 1.043 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 5.0 mt -64.12 103.84 0.66 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.259 0.552 . . . . 0.0 111.551 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.478 HH11 ' HD3' ' A' ' 57' ' ' ARG . 64.5 mtp180 . . . . . 0 N--CA 1.448 -0.53 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.071 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.459 ' O ' HG13 ' A' ' 41' ' ' ILE . 12.0 p-90 . . . . . 0 N--CA 1.455 -0.175 0 N-CA-C 111.329 0.122 . . . . 0.0 111.329 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.545 ' HD3' ' N ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -69.2 -25.4 64.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.243 0.544 . . . . 0.0 110.125 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.545 ' N ' ' HD3' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -71.95 -34.58 69.12 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.519 ' CB ' ' HG2' ' A' ' 105' ' ' PRO . 34.1 mmt180 -74.24 -36.12 63.87 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.377 175.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.624 HG23 ' HD2' ' A' ' 103' ' ' PRO . 61.8 mt -57.32 -47.22 84.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.713 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.1 m -56.23 -35.13 67.0 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.011 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.23 -52.35 47.93 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.386 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.769 ' HD3' ' HB2' ' A' ' 103' ' ' PRO . 9.4 ptp180 -70.08 -27.46 64.63 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.538 -0.39 . . . . 0.0 111.731 175.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tt -54.25 -38.1 65.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -71.08 -31.67 68.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.297 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HB3' ' HA ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -53.16 -26.64 17.78 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.382 173.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -101.75 -57.16 2.13 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.479 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.537 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 4.2 mtpp -172.76 102.8 0.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.097 -177.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -144.69 104.56 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.203 0.525 . . . . 0.0 110.26 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.522 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.5 t80 -96.47 144.5 27.95 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.299 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -53.05 133.59 52.62 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.101 2.534 . . . . 0.0 112.397 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.545 ' HE2' ' HE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -62.02 -21.13 64.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.633 -171.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -53.07 -37.57 61.74 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.452 0.47 . . . . 0.0 110.827 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.71 -38.97 53.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.637 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.757 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.6 mm? -69.41 -41.54 76.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.068 -173.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.597 ' HA ' ' HG3' ' A' ' 61' ' ' GLN . 7.8 ptp85 -67.16 -8.88 34.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.14 0.495 . . . . 0.0 110.851 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 47.0 tp -118.93 12.81 12.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.262 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.698 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 25.3 ttmm -154.47 -67.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.693 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.82 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 36.6 mmt180 -119.98 84.53 2.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.675 0.274 . . . . 0.0 110.308 -177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.597 ' HG3' ' HA ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -86.15 177.65 7.46 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.622 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.52 122.42 0.94 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.244 -1.455 . . . . 0.0 113.787 176.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -110.82 124.48 67.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.34 166.6 33.23 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.825 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.483 ' O ' HG23 ' A' ' 82' ' ' VAL . 2.7 mp0 -102.12 124.38 47.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 178.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.408 HG21 HD13 ' A' ' 123' ' ' ILE . 76.2 t -119.73 114.23 43.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.293 -173.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HB2' HG21 ' A' ' 82' ' ' VAL . 26.7 ttt180 -115.03 124.71 52.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.748 -174.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -148.13 163.85 35.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.306 0.574 . . . . 0.0 112.136 -174.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 40.9 m -105.2 131.99 51.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.014 174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 104' ' ' LEU . 86.8 mt -118.76 142.0 48.1 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -172.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.587 ' OD1' ' HG2' ' A' ' 73' ' ' GLN . 13.8 t70 -89.58 160.18 16.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.244 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.582 ' HG2' ' N ' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -58.47 -32.09 68.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.687 0.279 . . . . 0.0 111.322 -177.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.587 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 25.4 pt20 -94.04 14.51 19.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.204 0.526 . . . . 0.0 111.246 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.47 ' HA2' ' H ' ' A' ' 104' ' ' LEU . . . 78.01 33.8 39.94 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.248 177.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.484 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 67.6 t60 -97.1 101.88 13.54 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.44 122.26 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 121.388 0.614 . . . . 0.0 110.92 173.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 15.2 mt -108.21 -40.79 5.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.437 -175.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.5 158.43 39.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.27 117.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.167 0.508 . . . . 0.0 109.997 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.7 m -140.58 120.93 14.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.917 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 29.3 tp -81.41 106.37 13.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -82.22 -44.64 19.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.894 -170.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.1 m -155.41 155.14 33.05 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.372 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.494 ' HB2' ' CD2' ' A' ' 87' ' ' LEU . 53.4 p -163.34 147.44 10.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.85 0.357 . . . . 0.0 110.944 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.5 -9.38 58.87 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -173.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.41 ' C ' HD13 ' A' ' 87' ' ' LEU . . . 120.67 73.13 0.34 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.176 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.916 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -114.4 96.62 43.65 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -177.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.67 -83.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.75 2.3 . . . . 0.0 111.888 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 m -66.15 -18.29 65.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.63 0.728 . . . . 0.0 110.107 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.916 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 20.4 mt -75.78 -39.28 57.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.056 -176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.42 -50.93 68.51 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -169.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.564 ' HD2' ' H ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -61.63 -36.13 79.88 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.005 -171.43 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.82 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 8.8 tp10 -76.59 -52.64 9.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 90' ' ' LEU . 39.9 pt -65.11 -35.02 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.565 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 69.9 mm-40 -81.81 -28.68 33.0 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.678 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -57.45 -48.22 79.75 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.576 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -61.81 -58.16 9.04 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.216 -178.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.813 HG11 HG21 ' A' ' 123' ' ' ILE . 91.6 t -89.22 -50.05 13.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 8.9 ttpp -70.7 -24.99 62.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -170.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.595 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 9.6 tpp180 -90.99 -24.98 19.93 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.061 174.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.61 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -114.04 73.41 0.82 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.312 -178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.8 m -108.43 95.02 14.82 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.392 0.615 . . . . 0.0 110.59 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.769 ' HB2' ' HD3' ' A' ' 44' ' ' ARG . 61.1 Cg_endo -112.51 110.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 124.723 3.615 . . . . 0.0 114.04 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.674 HD23 ' HD2' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -86.32 123.42 71.44 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 171.055 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.674 ' HD2' HD23 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -80.6 -57.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.73 2.287 . . . . 0.0 112.751 -177.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -63.43 116.24 24.19 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.37 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.52 106.02 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.106 2.537 . . . . 0.0 112.171 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.67 ' HG3' HD13 ' A' ' 104' ' ' LEU . 63.7 Cg_endo -94.64 45.77 0.21 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.995 2.463 . . . . 0.0 112.82 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.605 ' O ' HG13 ' A' ' 113' ' ' VAL . . . -57.17 -41.51 79.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 109.91 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.03 -18.27 63.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.355 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.84 -29.45 22.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.779 -177.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.908 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -121.43 19.15 11.34 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -171.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.5 m -69.15 89.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 122.092 0.949 . . . . 0.0 108.947 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 7.0 p30 161.67 -18.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.943 -169.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.7 -87.82 0.1 Allowed Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.113 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.622 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -162.36 176.09 10.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.908 HG13 ' HB3' ' A' ' 112' ' ' TYR . 12.6 m -102.21 109.49 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 121.541 0.686 . . . . 0.0 110.719 -175.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 25.8 tt0 -107.96 110.94 22.8 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 173.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.598 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -141.04 155.26 46.2 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -174.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 50.6 m -98.74 122.75 42.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.147 0.499 . . . . 0.0 111.264 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.598 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 47.8 mt -118.22 123.88 29.07 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.993 174.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 5.2 Cg_exo -73.3 119.72 6.15 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.311 2.007 . . . . 0.0 111.241 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.813 HG21 HG11 ' A' ' 98' ' ' VAL . 32.0 pt -99.17 101.9 12.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -104.3 122.44 45.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.224 1.011 . . . . 0.0 111.722 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.622 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 85.4 m-85 -114.13 129.74 56.61 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.865 -1.516 . . . . 0.0 106.94 165.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.3 m -57.63 103.2 0.12 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.153 0.502 . . . . 0.0 111.979 -169.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.821 HD11 HD11 ' A' ' 87' ' ' LEU . 13.3 mt -80.46 82.15 6.55 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.771 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.803 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.521 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.626 ' HA ' ' HG2' ' A' ' 40' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HG3' ' N ' ' A' ' 39' ' ' SER . 2.1 ptp180 -67.84 -32.68 73.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.202 0.91 . . . . 0.0 109.872 -176.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.404 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 3.3 p -66.53 -36.44 82.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.938 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.626 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 10.2 mmt180 -69.52 -44.62 70.66 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.575 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.673 HG23 ' HG2' ' A' ' 103' ' ' PRO . 83.8 mt -63.68 -43.86 98.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.585 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.8 m -57.25 -33.58 67.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.946 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.63 -34.67 73.21 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.682 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.793 ' HD3' ' HB3' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -70.75 -40.31 72.77 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 121.279 0.561 . . . . 0.0 110.151 178.1 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.05 -25.77 64.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.75 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.975 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 24.4 t-20 -69.3 -33.99 74.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.986 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.44 -20.45 63.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.949 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.474 ' CD2' ' HB1' ' A' ' 101' ' ' ALA . 97.3 m-85 -106.71 -60.28 1.69 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.615 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -164.99 102.93 0.77 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.548 0.739 . . . . 0.0 109.037 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.975 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 24.6 tpt180 -113.54 103.15 10.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.527 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 0.9 OUTLIER -105.45 132.31 20.99 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 32.4 Cg_exo -58.97 132.1 45.55 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.824 2.349 . . . . 0.0 111.721 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.495 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -61.19 -23.14 65.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.958 -173.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.72 -40.21 83.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.565 0.222 . . . . 0.0 110.853 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.0 -33.65 75.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.113 0.483 . . . . 0.0 110.475 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -72.65 -41.56 65.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 57' ' ' ARG . 49.5 mtm180 -58.07 -31.07 66.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.012 0.434 . . . . 0.0 110.422 176.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.9 tp -93.85 -0.49 55.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.951 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.781 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 24.5 ttmm -142.04 -75.42 0.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -175.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.781 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 26.3 mmt180 -119.79 89.78 3.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.901 0.381 . . . . 0.0 110.427 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.407 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.2 pt20 -92.14 179.17 5.65 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.521 177.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.576 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.26 124.05 1.05 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.169 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.725 ' H ' HD12 ' A' ' 127' ' ' LEU . 7.3 p -110.36 127.05 67.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.44 167.07 36.16 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.727 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.672 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 50.3 mt-30 -102.3 125.11 48.91 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 123' ' ' ILE . 24.3 t -121.47 114.42 43.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.712 -176.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.691 ' HG2' HG22 ' A' ' 82' ' ' VAL . 5.9 ptp180 -106.19 144.17 33.28 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -152.91 152.0 30.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.094 0.473 . . . . 0.0 111.853 -174.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 22.5 m -96.41 126.94 41.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.371 171.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.685 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 58.7 mt -117.8 135.76 53.85 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.203 0.525 . . . . 0.0 112.069 -169.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.611 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 15.4 t70 -77.27 152.51 34.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.476 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.3 ttp-105 -60.98 -25.28 66.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.119 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -89.61 -1.43 58.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.968 0.413 . . . . 0.0 111.012 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.96 36.88 6.53 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.04 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.611 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 55.6 t60 -104.3 120.96 42.34 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 p -53.81 117.27 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.313 0.578 . . . . 0.0 111.07 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.472 HD23 ' HD2' ' A' ' 75' ' ' HIS . 42.2 mt -101.86 -37.46 8.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.477 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -146.89 152.97 39.56 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.66 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.0 m -147.24 132.37 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 123.45 0.469 . . . . 0.0 109.836 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -144.28 132.67 22.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.37 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.724 HD21 ' HB2' ' A' ' 84' ' ' SER . 37.3 tp -75.5 120.88 21.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.732 HG21 HG23 ' A' ' 120' ' ' THR . 0.2 OUTLIER -96.67 -47.63 12.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.899 -173.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -142.26 145.46 34.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.346 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.724 ' HB2' HD21 ' A' ' 81' ' ' LEU . 40.7 t -137.8 148.61 45.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.023 0.44 . . . . 0.0 111.212 -176.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.58 15.32 25.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.219 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.81 76.02 1.31 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.173 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.733 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -116.51 71.11 4.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.803 0.302 . . . . 0.0 110.295 178.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.85 -68.36 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 121.804 1.669 . . . . 0.0 112.482 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 7.9 m -72.08 -18.69 61.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.233 0.54 . . . . 0.0 110.035 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.733 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 26.2 mt -77.32 -32.35 55.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.145 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.552 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 7.3 t70 -53.39 -37.95 62.94 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.4 0.438 . . . . 0.0 111.88 -173.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 13.6 ptm180 -53.57 -54.79 32.45 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -78.53 -55.12 5.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.525 HG13 ' HG2' ' A' ' 95' ' ' GLN . 40.0 pt -60.21 -38.88 78.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.646 -172.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.729 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 76.0 mm-40 -84.58 -20.86 30.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.603 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 92' ' ' ARG . . . -55.1 -54.1 47.45 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.163 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.608 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.77 -48.72 17.82 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.06 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.835 HG11 HG21 ' A' ' 123' ' ' ILE . 55.8 t -70.26 -50.18 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.729 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.3 ttmt -75.88 -32.1 59.53 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.318 -0.239 . . . . 0.0 111.361 -171.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 100' ' ' ARG . 8.3 tpp180 -89.16 -18.8 26.42 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.052 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 97' ' ' LEU . . . -120.24 56.4 0.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.603 0.24 . . . . 0.0 111.098 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 19.4 m -80.52 106.75 5.73 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.114 0.483 . . . . 0.0 110.112 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.683 ' CB ' ' HB3' ' A' ' 44' ' ' ARG . 62.9 Cg_endo -101.78 165.1 0.33 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 124.038 3.159 . . . . 0.0 114.486 -171.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 33.2 tp -142.08 94.25 7.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.159 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.793 ' HB3' ' HD3' ' A' ' 44' ' ' ARG . 50.5 Cg_endo -77.25 -49.7 0.1 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.442 2.095 . . . . 0.0 113.665 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 22.3 m -88.58 110.45 37.03 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.01 107.68 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.112 2.542 . . . . 0.0 112.451 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.729 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 52.1 Cg_endo -89.15 59.99 2.31 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.135 2.557 . . . . 0.0 111.853 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.662 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.05 -47.05 75.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.165 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.2 10.0 2.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.433 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -112.12 -30.39 7.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.932 0.396 . . . . 0.0 111.616 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.662 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -121.16 18.41 11.58 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.402 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -70.59 88.3 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.212 1.006 . . . . 0.0 108.446 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.654 HD22 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 158.92 -15.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 113.116 -1.856 . . . . 0.0 108.383 -168.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.654 ' N ' HD22 ' A' ' 114' ' ' ASN . . . 163.91 -90.84 0.1 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.175 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.432 ' CA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -161.06 177.03 10.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -175.151 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 69' ' ' THR . 12.9 m -102.75 109.88 27.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.467 0.651 . . . . 0.0 110.861 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 24.7 tt0 -109.35 109.99 21.02 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.73 HD12 ' HG ' ' A' ' 121' ' ' LEU . 1.5 pp -135.12 152.37 51.58 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.656 -173.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.732 HG23 HG21 ' A' ' 82' ' ' VAL . 87.9 m -96.72 113.44 25.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.212 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.73 ' HG ' HD12 ' A' ' 119' ' ' LEU . 62.5 mt -119.48 122.94 28.97 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.965 0.412 . . . . 0.0 110.711 177.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 12.0 Cg_exo -70.65 119.19 6.14 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.709 1.606 . . . . 0.0 110.554 174.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.835 HG21 HG11 ' A' ' 98' ' ' VAL . 35.1 pt -93.98 118.77 40.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -107.47 120.31 41.83 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 118.821 -1.151 . . . . 0.0 112.35 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.532 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 37.9 m-85 -115.65 126.69 54.46 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 160.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.0 m -56.54 104.01 0.13 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.242 0.544 . . . . 0.0 111.052 -172.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.725 HD12 ' H ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -100.6 105.46 16.86 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.854 -171.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 128' ' ' ARG . 38.6 mtp-105 . . . . . 0 N--CA 1.441 -0.878 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.45 ' HD2' ' N ' ' A' ' 39' ' ' SER . 7.5 ppt_? -68.12 -31.02 70.32 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -168.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.45 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 32.2 m -69.16 -32.52 71.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 0.0 109.823 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -75.86 -44.49 40.48 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.75 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.417 HG23 ' HD2' ' A' ' 103' ' ' PRO . 86.5 mt -58.77 -43.45 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.937 177.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 t -57.43 -38.8 74.98 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.882 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.13 -42.25 96.6 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.843 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.517 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.38 -33.77 73.54 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.803 0.335 . . . . 0.0 110.72 178.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.568 HD11 HG22 ' A' ' 98' ' ' VAL . 2.1 tt -62.15 -31.93 72.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.398 0.618 . . . . 0.0 109.832 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.728 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 8.7 t30 -71.69 -34.26 69.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.797 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -29.64 58.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.682 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.516 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 98.8 m-85 -94.73 -59.22 1.97 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.78 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 34.1 mmtt -174.82 104.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.622 0.769 . . . . 0.0 109.488 -177.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.728 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 29.1 ttp180 -128.28 103.91 7.43 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.485 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -81.41 138.17 48.29 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.382 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -49.87 131.53 29.83 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.132 2.555 . . . . 0.0 111.961 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.757 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -63.96 -23.68 67.43 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -170.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -58.76 -38.58 78.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.652 0.263 . . . . 0.0 111.069 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.03 -30.74 70.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.787 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.1 mm? -77.25 -41.47 40.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.918 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 41.0 mtm180 -62.85 -23.04 67.11 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.381 0.61 . . . . 0.0 110.5 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 tp -102.09 4.04 39.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.753 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.544 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 40.3 ttpt -149.71 -75.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.544 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 26.2 mmt180 -99.03 84.27 3.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.453 0.644 . . . . 0.0 110.742 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 126' ' ' SER . 10.7 pt20 -104.95 127.78 52.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.948 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 1.002 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -179.55 129.77 1.41 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.268 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.887 ' H ' HD12 ' A' ' 127' ' ' LEU . 96.2 t -104.96 127.17 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.119 0.485 . . . . 0.0 110.238 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.85 166.61 30.92 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.662 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 56.0 mt-30 -101.02 136.82 40.25 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 123' ' ' ILE . 39.0 t -129.5 114.21 30.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.562 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.545 ' HG2' HG22 ' A' ' 82' ' ' VAL . 13.3 ptt180 -115.35 139.38 50.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -154.3 163.37 40.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.655 -171.401 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 2.7 m -106.62 120.74 42.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.887 172.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.519 HD11 ' CE1' ' A' ' 68' ' ' PHE . 73.1 mt -106.48 138.52 42.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.75 -173.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 22.6 t70 -74.71 153.89 38.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.25 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 72' ' ' ARG . 4.2 ttp180 -61.05 -24.76 66.45 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.281 0.363 . . . . 0.0 111.333 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -80.6 -8.58 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.114 0.483 . . . . 0.0 110.421 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.761 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 89.04 35.42 8.19 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.268 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.455 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 70.8 t60 -109.2 124.61 51.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.665 0.269 . . . . 0.0 110.557 -178.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -51.86 125.31 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.558 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.519 ' CD1' HG21 ' A' ' 116' ' ' THR . 35.3 mt -115.18 -51.29 2.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.235 0.54 . . . . 0.0 110.558 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.37 152.42 49.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.379 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.4 m -146.37 128.94 8.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.137 0.494 . . . . 0.0 110.208 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.1 m -134.68 123.95 24.52 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.585 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.9 tp -76.72 108.43 9.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.294 0.569 . . . . 0.0 110.299 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.668 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -83.35 -42.26 17.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.982 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.424 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 23.1 t 66.93 176.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.904 169.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.427 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 68.7 m -158.63 -67.74 0.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.979 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.23 -76.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.4 ' C ' HD13 ' A' ' 87' ' ' LEU . . . 166.41 98.83 0.13 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.343 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.798 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -119.67 82.47 26.53 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -177.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.9 -75.28 0.01 OUTLIER 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.442 2.095 . . . . 0.0 111.866 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.506 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 8.4 m -70.69 -19.08 62.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.373 0.606 . . . . 0.0 110.197 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.798 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 14.6 mt -75.75 -34.08 60.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.715 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.462 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 1.8 t70 -54.33 -44.01 71.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.299 -175.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 89' ' ' SER . 11.6 ptp180 -53.58 -52.63 59.16 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -172.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 19.3 mt-10 -78.83 -54.21 6.31 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 90' ' ' LEU . 40.7 pt -63.32 -36.96 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.645 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.8 mm-40 -82.21 -26.83 32.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 122.055 -0.403 . . . . 0.0 110.825 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.642 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.85 -44.72 82.43 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.659 HD23 HG23 ' A' ' 98' ' ' VAL . 1.4 tp -68.24 -55.29 12.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.636 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 123' ' ' ILE . 81.3 t -88.75 -48.27 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.645 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 16.4 ttpp -70.33 -15.13 62.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.391 -175.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.642 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 20.3 tpp180 -98.59 -35.14 10.31 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.797 170.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.612 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -101.13 64.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 110.969 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.6 m -93.79 100.82 5.09 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.28 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.612 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 72.3 Cg_endo -101.73 173.78 0.26 Allowed 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.919 3.079 . . . . 0.0 113.689 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.761 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 17.0 tp -143.22 97.33 5.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.326 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -72.42 -62.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.652 1.568 . . . . 0.0 111.933 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.667 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -76.62 111.57 16.66 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.828 177.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 2.7 Cg_exo -77.15 103.58 1.77 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.421 2.748 . . . . 0.0 112.406 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.719 ' HD2' HD21 ' A' ' 104' ' ' LEU . 41.3 Cg_endo -83.07 68.94 7.3 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.075 2.516 . . . . 0.0 110.913 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.792 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.27 -42.29 73.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.189 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.42 8.84 3.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.02 0.438 . . . . 0.0 111.46 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.42 -16.84 12.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.938 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.792 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -133.02 17.01 4.16 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.0 m -72.0 87.57 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 7.7 p30 157.79 -25.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.078 -167.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 172.64 -92.68 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.896 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.631 ' HB ' HG22 ' A' ' 69' ' ' THR . 0.6 OUTLIER -158.89 174.75 14.51 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.784 0.434 . . . . 0.0 109.913 -175.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.758 HG13 ' CD2' ' A' ' 112' ' ' TYR . 2.9 m -103.72 109.74 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 CA-C-O 121.114 0.483 . . . . 0.0 111.607 -171.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 24.9 tt0 -97.51 112.02 24.05 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.511 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.3 pp -142.26 155.14 45.21 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.668 HG23 HG21 ' A' ' 82' ' ' VAL . 87.1 m -101.07 126.49 47.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.614 -175.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.511 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 69.9 mt -129.41 123.49 21.48 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.36 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.9 Cg_exo -76.22 121.21 6.0 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.006 1.804 . . . . 0.0 110.886 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.778 HG21 HG11 ' A' ' 98' ' ' VAL . 24.1 pt -96.59 112.57 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.52 120.98 36.71 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.84 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.458 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 95.9 m-85 -114.94 129.56 56.73 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 159.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 31.8 m -57.23 103.11 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -169.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 1.002 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -87.5 98.07 11.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.258 -177.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 128' ' ' ARG . 6.2 ppt_? . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.311 . . . . 0.0 111.704 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.538 ' CZ2' HD21 ' A' ' 121' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -68.21 -37.88 81.34 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.19 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 p -68.95 -31.29 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.326 0.584 . . . . 0.0 109.804 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.465 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 5.4 mmm-85 -68.84 -39.56 79.9 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.414 176.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.557 HG23 ' HD2' ' A' ' 103' ' ' PRO . 83.4 mt -63.91 -51.2 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.124 176.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.2 m -56.42 -32.74 65.16 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.784 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.81 -47.03 92.25 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.962 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -69.19 -34.77 75.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.854 0.359 . . . . 0.0 111.017 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.692 HD11 HG22 ' A' ' 98' ' ' VAL . 1.4 tt -62.44 -30.67 71.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.664 0.745 . . . . 0.0 109.652 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 1.099 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 8.4 t30 -70.89 -34.83 71.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.542 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -34.9 70.5 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.702 172.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -91.91 -59.53 2.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.515 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -162.14 102.09 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.503 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 1.099 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 12.7 tpt180 -130.88 103.34 6.51 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.491 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.423 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.1 t80 -87.32 131.88 42.9 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.823 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.8 131.71 45.65 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.732 2.288 . . . . 0.0 112.001 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.85 -23.68 65.32 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.27 -173.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -55.59 -42.9 75.47 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.577 0.548 . . . . 0.0 110.231 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.64 -41.03 79.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.632 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -62.44 -41.12 98.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.845 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.585 ' HG2' ' HB2' ' A' ' 126' ' ' SER . 98.5 mtt180 -59.51 -15.52 18.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.3 -24.02 9.12 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.04 0.448 . . . . 0.0 111.114 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.964 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 18.0 ttmm -102.45 -72.63 0.68 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.964 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 30.5 mmt180 -124.22 84.33 2.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.377 0.608 . . . . 0.0 110.14 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 126' ' ' SER . 14.1 pt20 -98.92 115.96 30.07 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.041 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.972 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -165.72 143.23 8.25 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.489 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.819 ' H ' HD12 ' A' ' 127' ' ' LEU . 46.7 t -103.58 123.42 57.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.0 165.24 26.29 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.36 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.731 ' H ' ' HA ' ' A' ' 83' ' ' SER . 56.2 mt-30 -105.15 143.42 33.36 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.4 114.62 21.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.637 0.732 . . . . 0.0 109.576 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.437 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 27.1 ttt180 -106.51 138.42 42.73 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.422 ' CE1' HD11 ' A' ' 70' ' ' LEU . 1.2 p90 -159.95 171.58 19.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.318 0.58 . . . . 0.0 111.956 -173.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 7.8 m -118.82 130.03 55.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.946 173.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.422 HD11 ' CE1' ' A' ' 68' ' ' PHE . 70.2 mt -111.14 140.46 45.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.762 -172.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.1 160.35 23.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.73 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.441 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 42.1 mtm180 -54.07 -36.86 63.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.298 0.57 . . . . 0.0 110.878 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -81.1 0.07 37.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.229 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 80.71 45.32 7.88 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.109 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -110.93 124.53 52.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.7 p -57.24 111.09 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.497 0.665 . . . . 0.0 110.703 174.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.413 ' CD1' HG21 ' A' ' 116' ' ' THR . 80.5 mt -100.99 -41.04 6.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.931 -178.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.28 158.27 40.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.222 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 m -144.89 121.65 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 123.613 0.57 . . . . 0.0 109.915 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 35.7 m -126.29 114.89 18.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.057 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.8 tp -78.29 118.74 20.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.427 0.632 . . . . 0.0 110.662 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -108.1 -58.42 3.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.26 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.731 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 19.1 t 62.05 179.64 0.13 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.979 0.419 . . . . 0.0 111.32 176.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.9 m -154.58 -74.36 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.87 -68.68 0.32 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -169.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.95 84.25 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.825 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.928 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -120.68 93.44 48.54 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -176.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.15 -79.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.578 2.185 . . . . 0.0 111.347 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -75.92 -17.2 59.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.543 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.928 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.7 mt -72.1 -38.3 69.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.728 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 14.0 t70 -54.58 -51.14 66.21 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.607 0.567 . . . . 0.0 111.61 -172.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.418 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 9.4 ptp180 -53.73 -40.54 66.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.128 -177.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HG2' ' HG3' ' A' ' 92' ' ' ARG . 5.7 mm-40 -78.07 -58.11 3.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.56 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 32.5 pt -66.75 -43.74 89.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.723 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.861 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 48.4 mm-40 -67.98 -51.16 50.58 Favored 'General case' 0 C--O 1.193 -1.893 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.643 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.46 -31.28 61.82 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.097 0.862 . . . . 0.0 111.434 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.451 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -53.82 -54.47 38.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.838 173.424 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.73 HG11 HG21 ' A' ' 123' ' ' ILE . 79.9 t -86.48 -33.55 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.306 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.861 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.5 ttmt -66.72 -25.15 66.38 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.4 1.08 . . . . 0.0 110.951 -169.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -104.23 -19.4 14.13 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.967 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.507 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -112.44 45.52 1.29 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.797 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.7 m -81.75 107.54 8.59 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.116 0.484 . . . . 0.0 110.255 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 41' ' ' ILE . 73.0 Cg_endo -99.79 175.07 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.539 2.826 . . . . 0.0 113.259 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.828 HD21 ' HD2' ' A' ' 108' ' ' PRO . 16.1 tp -143.46 90.52 7.16 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.921 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.456 ' CG ' ' HB2' ' A' ' 40' ' ' ARG . 10.1 Cg_endo -67.36 -62.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.984 1.79 . . . . 0.0 112.078 -177.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.604 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 t -79.1 116.97 64.18 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 5.6 Cg_exo -80.06 103.04 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.068 2.512 . . . . 0.0 111.626 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.828 ' HD2' HD21 ' A' ' 104' ' ' LEU . 45.2 Cg_endo -81.66 68.92 7.9 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.904 2.403 . . . . 0.0 111.764 -177.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.606 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -58.91 -42.85 90.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.646 178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -67.72 1.9 2.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.832 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -112.53 -35.85 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.676 0.274 . . . . 0.0 111.575 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.646 ' CD2' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -118.79 17.51 13.47 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -171.169 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.5 m -70.98 89.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 8.2 p30 160.87 -26.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.744 -1.571 . . . . 0.0 107.588 -170.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 175.21 -88.25 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.936 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.503 ' HB ' HG22 ' A' ' 69' ' ' THR . 0.8 OUTLIER -160.0 175.7 12.7 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 122.933 0.493 . . . . 0.0 110.01 -174.283 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.646 HG13 ' CD2' ' A' ' 112' ' ' TYR . 2.6 m -103.2 108.98 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.301 0.572 . . . . 0.0 110.778 -175.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 8.5 tm-20 -103.27 111.65 24.14 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.681 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -151.72 156.44 40.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.155 0.502 . . . . 0.0 111.943 -171.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 61.4 m -96.13 126.39 41.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.189 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.681 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 33.0 mt -128.54 137.9 31.92 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.092 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 3.4 Cg_endo -87.57 119.8 1.41 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.329 2.019 . . . . 0.0 112.066 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.73 HG21 HG11 ' A' ' 98' ' ' VAL . 9.8 pt -97.07 97.87 6.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.745 0.784 . . . . 0.0 109.198 172.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -97.16 125.72 41.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.043 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.56 ' CE1' ' HB ' ' A' ' 94' ' ' ILE . 83.5 m-85 -114.28 151.42 32.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 168.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.585 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 5.0 m -64.86 102.58 0.61 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.089 -0.245 . . . . 0.0 111.296 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.972 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -92.1 95.15 9.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.106 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.408 ' HB2' ' OE1' ' A' ' 61' ' ' GLN . 80.1 mtm180 . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 120.966 0.412 . . . . 0.0 110.224 176.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.504 ' O ' HG13 ' A' ' 41' ' ' ILE . 2.4 p-90 . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.409 ' HG3' ' N ' ' A' ' 39' ' ' SER . 13.6 ptt180 -66.59 -39.17 88.27 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.956 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.409 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 2.1 m -66.75 -33.79 76.42 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.517 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 33.0 mmm180 -75.87 -36.28 59.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.458 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.621 HG23 ' HG2' ' A' ' 103' ' ' PRO . 59.8 mt -58.09 -46.14 88.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.83 174.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -55.93 -42.56 76.29 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.783 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.99 -37.35 94.16 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.768 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.689 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 1.6 ttm180 -67.77 -34.91 77.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.157 0.503 . . . . 0.0 110.352 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.68 -29.72 70.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.552 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.694 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.7 t-20 -71.14 -36.89 72.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.582 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -57.47 -30.56 65.17 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.772 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -94.96 -56.68 2.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.183 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -175.35 102.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.414 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.694 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 28.1 ttp180 -130.73 104.12 6.99 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.062 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.594 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -84.9 133.63 43.04 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.825 178.032 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -56.37 132.2 50.42 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.888 2.392 . . . . 0.0 111.737 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HE3' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.03 -23.43 65.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.086 -172.086 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.83 -33.74 73.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.042 0.448 . . . . 0.0 110.953 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.47 -32.41 60.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.7 mm? -71.8 -34.43 69.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.725 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 30.4 mtm180 -69.35 -10.32 57.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.624 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.45 17.43 12.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.397 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.68 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 19.6 ttmm -150.75 -76.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.818 0.342 . . . . 0.0 111.096 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.68 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 3.4 mmp_? -128.39 90.42 3.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 0.0 110.484 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.443 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 21.6 pt20 -119.08 114.93 23.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.911 -178.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.785 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -160.05 149.79 19.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.803 178.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.573 ' H ' HD12 ' A' ' 127' ' ' LEU . 45.7 t -104.61 125.29 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.708 0.29 . . . . 0.0 110.336 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.7 160.31 25.61 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.757 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 44.0 tt0 -103.96 125.05 50.06 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.467 HG21 HD13 ' A' ' 123' ' ' ILE . 62.5 t -129.44 116.7 40.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.619 -169.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.608 ' HG2' HG22 ' A' ' 82' ' ' VAL . 12.2 ptt180 -109.13 145.31 35.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.627 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -157.75 151.0 23.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -171.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 21.6 m -94.38 126.81 39.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.402 171.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.484 HD11 ' CE1' ' A' ' 68' ' ' PHE . 55.5 mt -122.38 139.37 53.91 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -170.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 12.6 t70 -79.43 156.11 28.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.037 173.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.749 ' HB2' ' HB3' ' A' ' 107' ' ' PRO . 25.9 ptt180 -63.14 -21.52 66.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.084 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.465 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 4.0 pt20 -87.97 -4.49 58.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.251 0.548 . . . . 0.0 110.087 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.455 ' CA ' ' H ' ' A' ' 104' ' ' LEU . . . 87.2 38.89 7.6 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.116 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.557 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 80.4 t60 -100.35 114.05 27.25 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 p -48.95 116.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.089 172.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.3 mt -104.84 -40.38 5.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.982 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -147.78 146.55 29.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.388 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.753 HG11 ' HG3' ' A' ' 99' ' ' LYS . 58.8 t -143.18 129.87 17.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 m -136.04 120.39 17.98 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.72 HD21 ' HB2' ' A' ' 84' ' ' SER . 35.3 tp -60.36 120.11 9.24 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.608 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -90.95 -46.74 14.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.894 -175.415 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -148.61 143.82 26.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.127 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.72 ' HB2' HD21 ' A' ' 81' ' ' LEU . 30.1 t -134.45 108.47 8.15 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.13 -37.99 89.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.081 -175.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.642 ' H ' HD22 ' A' ' 87' ' ' LEU . . . 167.8 56.84 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.882 -178.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.727 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -121.07 74.79 28.66 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -177.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 3.6 Cg_exo -75.96 -65.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.457 2.104 . . . . 0.0 111.639 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.2 t -74.02 -24.12 59.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.267 0.556 . . . . 0.0 110.181 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.727 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 31.0 mt -73.06 -31.49 64.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.346 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 17.6 t70 -54.41 -45.59 72.97 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.785 0.678 . . . . 0.0 112.144 -172.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -54.21 -49.4 69.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -172.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.472 ' CB ' ' HG3' ' A' ' 60' ' ' ARG . 9.2 tp10 -78.29 -53.45 7.29 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -175.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 90' ' ' LEU . 38.6 pt -63.03 -34.28 65.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -174.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.681 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.8 mm-40 -82.18 -28.78 31.86 Favored 'General case' 0 C--O 1.212 -0.91 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.691 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.32 -41.05 75.38 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 98' ' ' VAL . 1.4 tp -68.27 -56.95 6.83 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.684 -1.143 . . . . 0.0 112.097 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.92 HG11 HG21 ' A' ' 123' ' ' ILE . 85.8 t -88.41 -48.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.753 ' HG3' HG11 ' A' ' 79' ' ' VAL . 37.7 ttmt -64.91 -21.88 66.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.244 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.502 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 5.9 tpp180 -95.39 -35.44 11.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.042 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.562 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -106.18 74.3 1.03 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.629 0.252 . . . . 0.0 110.859 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 14.0 m -94.21 99.46 3.82 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.991 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.689 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 94.8 Cg_endo -100.6 151.82 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.711 2.941 . . . . 0.0 114.525 -173.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.578 HD23 ' HD2' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -143.8 114.91 5.56 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 173.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.642 ' HA ' ' CZ ' ' A' ' 44' ' ' ARG . 2.6 Cg_endo -74.15 -58.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.678 2.252 . . . . 0.0 112.838 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 4.6 t -72.72 124.63 90.98 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.737 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.749 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 12.1 Cg_exo -70.41 105.68 1.64 Allowed 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.539 2.159 . . . . 0.0 111.162 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.827 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 69.3 Cg_endo -87.83 58.0 3.0 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.906 2.404 . . . . 0.0 112.862 -172.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.634 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -60.36 -41.65 94.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.112 0.482 . . . . 0.0 109.941 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -75.51 5.93 5.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.065 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.827 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.43 -24.85 9.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.43 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.837 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -123.85 19.97 9.29 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.29 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.7 m -69.49 89.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 6.4 p30 162.51 -25.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 113.208 -1.815 . . . . 0.0 107.46 -168.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.08 -83.85 0.1 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.109 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.535 ' CA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -160.26 174.16 14.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' A' ' 112' ' ' TYR . 27.8 m -102.92 109.73 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.532 0.682 . . . . 0.0 110.799 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 35.0 tt0 -108.7 111.71 23.64 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 166.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.594 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -135.01 155.27 51.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -175.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.549 HG23 HG21 ' A' ' 82' ' ' VAL . 92.7 m -96.03 119.55 34.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.441 -175.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.594 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 42.6 mt -124.98 122.77 25.49 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.454 174.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.4 Cg_exo -72.72 119.32 6.02 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.897 1.731 . . . . 0.0 110.828 175.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.92 HG21 HG11 ' A' ' 98' ' ' VAL . 35.2 pt -91.58 103.63 14.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.41 124.46 41.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.024 0.916 . . . . 0.0 111.566 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.444 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 86.4 m-85 -113.32 135.41 53.88 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 163.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.9 m -58.66 102.8 0.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.265 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.785 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.3 tt -86.53 81.15 8.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.127 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.387 -179.342 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.6 m -130.25 15.4 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.071 0.462 . . . . 0.0 110.898 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -88.84 -24.03 22.66 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.59 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -93.66 -26.67 16.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.24 0.543 . . . . 0.0 110.247 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.648 ' HG3' ' HD3' ' A' ' 12' ' ' PRO . 12.8 mm100 -84.87 41.72 0.88 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.869 -169.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.3 m -81.5 35.14 0.39 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.254 0.549 . . . . 0.0 111.197 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.5 t -106.25 -0.37 10.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.768 0.794 . . . . 0.0 109.083 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.28 25.84 50.01 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.582 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.57 108.94 5.21 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.78 0.324 . . . . 0.0 110.956 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 90.6 Cg_endo -83.81 144.65 11.11 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.867 2.378 . . . . 0.0 111.749 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.648 ' HD3' ' HG3' ' A' ' 6' ' ' GLN . 24.2 Cg_exo -63.12 115.81 3.2 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.755 2.304 . . . . 0.0 111.699 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.13 79.38 1.38 Allowed 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.734 2.289 . . . . 0.0 112.452 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.06 121.58 2.36 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.63 ' HE ' ' HB2' ' A' ' 17' ' ' ASP . 20.9 ttt180 -79.28 112.15 16.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.853 0.359 . . . . 0.0 111.309 -177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.57 95.48 7.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.63 ' HB2' ' HE ' ' A' ' 15' ' ' ARG . 24.8 t70 -115.7 159.8 20.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.984 -173.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -53.95 -43.86 70.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.185 0.517 . . . . 0.0 110.308 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 m -83.55 -48.55 10.14 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.215 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.887 ' HB1' ' HB3' ' A' ' 25' ' ' ARG . . . -97.72 59.8 1.5 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.488 -174.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.694 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -86.86 -56.38 0.34 Allowed Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.987 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.694 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 9.9 Cg_endo -90.28 -88.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.293 1.995 . . . . 0.0 113.347 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -118.28 -2.64 11.1 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.042 0.448 . . . . 0.0 111.231 -176.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.42 ' OG1' ' HD2' ' A' ' 22' ' ' PRO . 1.1 p -77.98 40.35 0.32 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.372 -173.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.887 ' HB3' ' HB1' ' A' ' 20' ' ' ALA . 21.5 ptt180 -138.69 2.9 2.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.461 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 93.1 mt -119.98 -9.11 9.7 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.368 0.604 . . . . 0.0 110.777 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 m -101.98 107.96 54.52 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.398 -172.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -83.58 59.09 6.23 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.836 2.357 . . . . 0.0 112.213 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 54.3 31.57 14.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.094 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.31 30.62 18.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.475 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -83.38 -47.84 11.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.408 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 51.69 58.49 5.42 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.591 0.557 . . . . 0.0 111.702 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.4 119.15 0.58 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.041 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -85.34 65.72 9.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.289 0.566 . . . . 0.0 110.041 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -144.14 146.79 32.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.994 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.413 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 54.8 t30 -68.93 94.31 0.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -75.6 -23.37 56.44 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -171.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -69.03 -34.11 74.71 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.233 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.5 p -70.35 -33.95 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.08 0.467 . . . . 0.0 109.832 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.414 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 30.2 mmt180 -70.3 -43.46 70.31 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.747 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.903 HG23 ' HG2' ' A' ' 103' ' ' PRO . 53.9 mt -57.61 -42.14 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.885 175.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 62.3 m -56.92 -34.71 68.22 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.489 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.71 -35.69 80.92 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.889 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.8 -34.18 73.37 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.46 0.648 . . . . 0.0 109.64 178.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.448 HD11 HG22 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -68.12 -25.47 65.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.894 177.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.785 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 59.1 t30 -70.19 -34.57 73.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.553 176.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 1.9 ttt180 -59.88 -27.09 66.4 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.015 170.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.56 ' O ' ' HB2' ' A' ' 49' ' ' LYS . 69.5 m-85 -106.01 25.67 10.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.906 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 48' ' ' PHE . 21.9 mtpp 74.13 102.41 0.07 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 124.075 0.859 . . . . 0.0 110.505 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.785 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 16.4 ttp180 -93.54 104.62 16.74 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.289 0.566 . . . . 0.0 110.607 -176.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.522 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -69.41 114.79 26.57 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.892 175.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HD2' ' HD1' ' A' ' 51' ' ' TYR . 34.7 Cg_exo -57.68 131.82 46.44 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.714 2.276 . . . . 0.0 111.573 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.728 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.16 -25.2 63.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.885 -170.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.401 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 14.5 m-20 -64.6 -32.45 74.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.0 0.429 . . . . 0.0 111.182 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 59' ' ' LYS . . . -74.15 -31.78 62.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.511 178.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.4 mm? -74.76 -42.6 57.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.665 -178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.731 ' HB3' ' HB2' ' A' ' 126' ' ' SER . 2.5 ptp180 -64.41 -17.95 64.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.751 0.31 . . . . 0.0 111.334 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.7 mt -108.33 4.41 24.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.921 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.649 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 39.2 ttmt -145.6 -75.27 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.783 0.325 . . . . 0.0 111.556 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.679 ' HB2' HD12 ' A' ' 56' ' ' LEU . 33.5 mmt180 -106.85 87.57 2.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.844 0.354 . . . . 0.0 110.193 -176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.74 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . 4.7 mt-30 -85.95 156.17 20.59 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 170.44 116.76 0.39 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 118.851 -1.642 . . . . 0.0 113.854 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.863 ' H ' HD12 ' A' ' 127' ' ' LEU . 58.9 t -110.18 123.42 66.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.45 165.65 33.99 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.636 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 42.4 mt-30 -103.57 124.46 48.84 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.536 HG21 HD13 ' A' ' 123' ' ' ILE . 77.4 t -122.22 113.63 39.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.433 -173.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.531 ' HB3' HG21 ' A' ' 82' ' ' VAL . 20.6 ptt180 -108.38 141.03 40.81 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -156.9 157.59 35.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.559 0.695 . . . . 0.0 112.412 -171.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 6.4 m -101.92 129.91 48.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.577 174.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.523 HD11 ' CE1' ' A' ' 68' ' ' PHE . 48.2 mt -121.78 139.84 53.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.12 0.486 . . . . 0.0 112.286 -168.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.787 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 21.4 t70 -82.18 155.68 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.827 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.499 ' HG3' ' HB3' ' A' ' 107' ' ' PRO . 58.0 ttt180 -51.51 -41.43 60.99 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -174.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -87.08 12.22 11.97 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.019 0.437 . . . . 0.0 111.038 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.33 53.82 4.27 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.421 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 67.9 t60 -112.4 114.97 27.96 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 4.1 p -48.79 120.35 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.523 174.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.1 mt -110.49 -40.26 4.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.744 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -152.66 146.01 24.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.279 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.762 HG11 ' HD3' ' A' ' 99' ' ' LYS . 28.4 t -142.39 130.91 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 177.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.7 m -128.24 128.16 44.17 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.819 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 32.9 tp -72.91 123.03 22.63 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.531 HG21 ' HB3' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -99.4 -52.03 9.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.461 -171.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.9 m -141.31 138.61 33.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.492 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.7 t -131.41 131.38 43.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.935 0.398 . . . . 0.0 110.698 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -88.03 8.38 26.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.489 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 103.11 69.98 0.83 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.702 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -115.57 89.7 23.46 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HG2' ' O ' ' A' ' 131' ' ' GLY . 4.6 Cg_exo -77.94 -84.41 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.591 2.194 . . . . 0.0 112.021 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.5 m -66.16 -18.32 65.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.332 0.587 . . . . 0.0 110.966 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 13.7 mt -75.41 -45.09 41.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.245 -176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 16.9 t70 -55.17 -41.75 72.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.079 -169.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -54.28 -49.71 68.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.819 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.94 -47.93 15.49 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.521 ' HB ' ' CE2' ' A' ' 125' ' ' PHE . 42.1 pt -63.35 -38.8 83.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -175.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.573 HE22 HD11 ' A' ' 123' ' ' ILE . 75.4 mm-40 -79.08 -31.34 44.36 Favored 'General case' 0 C--O 1.199 -1.594 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.605 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.84 -39.25 65.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 4.1 tp -67.53 -54.77 17.14 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.189 -1.369 . . . . 0.0 111.487 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.757 HG11 HG21 ' A' ' 123' ' ' ILE . 52.9 t -87.41 -45.52 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.762 ' HD3' HG11 ' A' ' 79' ' ' VAL . 3.2 tppp? -56.32 -40.23 74.04 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.148 0.579 . . . . 0.0 110.518 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -84.38 -31.02 24.95 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.828 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.541 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -105.65 63.15 0.68 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.808 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.478 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.7 m -89.13 99.43 1.59 Allowed Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.903 ' HG2' HG23 ' A' ' 41' ' ' ILE . 74.5 Cg_endo -103.55 166.59 0.23 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.922 3.082 . . . . 0.0 114.611 -170.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.518 HD21 ' CD ' ' A' ' 108' ' ' PRO . 37.1 tp -143.16 96.49 5.87 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.722 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.503 ' HG3' ' N ' ' A' ' 41' ' ' ILE . 33.1 Cg_endo -78.06 -44.92 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.3 2.0 . . . . 0.0 113.671 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.495 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 15.4 m -92.95 107.88 28.11 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.499 ' HB3' ' HG3' ' A' ' 72' ' ' ARG . 21.2 Cg_exo -66.59 106.12 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.312 2.675 . . . . 0.0 112.977 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.906 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 41.6 Cg_endo -88.87 65.76 2.77 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.543 2.829 . . . . 0.0 112.128 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.585 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -51.07 -51.7 50.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.78 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -78.79 9.33 4.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.79 -176.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.906 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -105.84 -30.15 9.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.165 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.622 ' HB2' ' HA ' ' A' ' 116' ' ' THR . 0.1 OUTLIER -114.3 15.55 18.05 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 3.9 m -72.58 87.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 169.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 4.7 p30 159.74 -19.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.916 -167.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 163.66 -86.7 0.1 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.391 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.633 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.2 OUTLIER -160.75 177.08 10.8 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 69' ' ' THR . 11.2 m -100.1 108.77 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 CA-C-O 121.877 0.846 . . . . 0.0 110.105 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -113.63 112.49 23.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.629 HD12 ' HG ' ' A' ' 121' ' ' LEU . 2.1 pp -142.84 154.63 44.35 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.225 -173.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.449 HG23 HG21 ' A' ' 82' ' ' VAL . 92.8 m -92.44 125.85 37.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.421 -177.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.629 ' HG ' HD12 ' A' ' 119' ' ' LEU . 64.2 mt -130.38 122.85 20.17 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.393 176.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.3 Cg_exo -74.75 119.2 5.6 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.642 1.562 . . . . 0.0 110.726 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.757 HG21 HG11 ' A' ' 98' ' ' VAL . 20.6 pt -89.62 121.07 39.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -111.97 121.71 45.76 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 119.379 -0.928 . . . . 0.0 112.256 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.596 ' CD1' ' HG ' ' A' ' 56' ' ' LEU . 89.7 m-85 -114.09 131.54 56.36 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.409 -1.723 . . . . 0.0 106.816 163.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.731 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 8.7 m -56.98 103.42 0.11 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 -170.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.863 HD12 ' H ' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -97.65 108.85 21.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.915 -171.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.479 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 46.4 mtm105 -84.15 -53.2 5.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.734 173.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 165.52 50.11 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.776 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.414 ' CB ' HD21 ' A' ' 90' ' ' LEU . . . -90.95 172.27 8.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.773 0.321 . . . . 0.0 110.799 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 88' ' ' PRO . . . 83.6 24.27 50.77 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 40.0 p90 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.327 -177.238 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 tttm . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 121.125 0.488 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.2 t -117.99 -58.1 3.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.264 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -96.62 91.56 5.8 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.204 0.526 . . . . 0.0 110.817 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 5' ' ' GLU . 4.0 pt-20 -101.63 104.49 15.35 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.704 0.764 . . . . 0.0 109.148 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -70.75 -59.47 2.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.699 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.8 t -108.08 119.13 38.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.944 0.402 . . . . 0.0 110.259 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.09 78.85 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.516 0.674 . . . . 0.0 109.712 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.61 -179.16 41.79 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.317 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -115.61 93.62 37.59 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.917 0.359 . . . . 0.0 110.816 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.47 114.22 3.86 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.137 2.558 . . . . 0.0 111.738 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 73.1 Cg_endo -75.73 155.74 39.64 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.475 2.117 . . . . 0.0 112.12 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 6.8 Cg_exo -73.98 52.2 2.57 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.199 2.599 . . . . 0.0 112.071 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.62 103.64 0.22 Allowed Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 mtm180 -91.33 49.88 1.67 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 59.55 29.58 19.16 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.387 0.613 . . . . 0.0 110.057 -173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -68.92 140.02 55.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.95 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.4 tttp 53.63 52.25 13.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.781 0.801 . . . . 0.0 110.5 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.4 m -132.25 5.2 4.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.017 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.1 47.99 1.51 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.27 0.557 . . . . 0.0 110.679 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.641 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -77.68 -55.6 1.23 Allowed Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.542 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.641 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 90.6 Cg_endo -87.08 23.97 0.78 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.277 1.984 . . . . 0.0 112.28 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 67.06 104.04 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.153 -177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.6 m -66.9 -18.95 65.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.756 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -66.35 -11.64 52.29 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.959 0.409 . . . . 0.0 110.398 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.3 mt -112.51 19.1 17.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.367 177.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.7 m -139.98 78.16 24.94 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.835 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.09 133.46 18.08 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.441 2.094 . . . . 0.0 110.613 171.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -126.55 3.05 6.87 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -173.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.8 99.54 8.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.727 0.299 . . . . 0.0 110.973 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -83.12 155.5 23.78 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.86 70.31 4.22 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -173.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.487 ' HA2' ' CE2' ' A' ' 37' ' ' TRP . . . 107.33 -163.16 13.18 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.654 -0.784 . . . . 0.0 114.011 170.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 57.56 61.54 2.43 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.649 0.78 . . . . 0.0 112.207 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.401 ' CG ' ' H ' ' A' ' 36' ' ' ASN . 14.2 t70 -155.55 -168.27 2.77 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.401 ' H ' ' CG ' ' A' ' 35' ' ' ASP . 17.7 m120 -83.08 6.72 18.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.106 0.479 . . . . 0.0 110.357 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.495 ' CH2' HD21 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -61.78 -30.76 71.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.733 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 39' ' ' SER . 4.4 ppt_? -69.54 -28.19 65.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.156 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.496 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 13.1 m -66.47 -36.36 82.56 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 105' ' ' PRO . 17.8 mmm-85 -73.31 -43.69 60.43 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.338 177.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.746 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 34.8 mt -57.99 -36.84 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.634 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.466 ' O ' ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -61.38 -45.04 96.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.6 -38.66 95.97 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.499 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.746 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 8.5 ptt180 -56.69 -34.6 67.57 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.928 0.394 . . . . 0.0 110.13 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -32.26 47.62 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.623 -175.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.497 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 6.5 t30 -70.69 -29.19 65.42 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.035 0.921 . . . . 0.0 108.722 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.92 -18.72 36.0 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 113.561 -1.654 . . . . 0.0 111.083 173.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -125.74 -57.64 1.44 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -158.37 102.85 1.76 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.333 0.653 . . . . 0.0 109.822 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 64.1 ttt-85 -128.54 103.53 7.16 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.35 0.595 . . . . 0.0 109.942 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -107.45 130.17 23.21 Favored Pre-proline 0 N--CA 1.442 -0.843 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.917 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.06 134.16 58.62 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.966 2.444 . . . . 0.0 111.936 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.592 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.9 -21.43 61.06 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.53 -174.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.78 -38.52 55.9 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 123.6 0.562 . . . . 0.0 110.762 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.11 -42.43 47.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.315 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.4 mm? -64.22 -34.81 78.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.963 -175.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 21.7 mtm180 -62.71 -14.63 46.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.757 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.2 mp -119.62 14.36 12.66 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.75 0.31 . . . . 0.0 110.931 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.777 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 39.0 ttmt -142.25 -76.52 0.27 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.702 0.287 . . . . 0.0 110.859 -176.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.789 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 39.6 mmt180 -130.95 100.63 5.31 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.0 167.84 11.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.74 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.766 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.74 144.48 3.92 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.727 -1.225 . . . . 0.0 113.272 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 p -111.13 128.17 67.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 175.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.53 164.62 29.45 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.097 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.486 ' O ' HG23 ' A' ' 82' ' ' VAL . 35.8 tt0 -103.65 125.13 49.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.52 HG21 HD13 ' A' ' 123' ' ' ILE . 49.3 t -127.31 114.79 38.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.763 -171.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.594 ' HG2' HG22 ' A' ' 82' ' ' VAL . 5.1 ptp180 -114.68 144.35 43.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.49 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -160.1 164.07 33.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 7.3 m -108.4 131.93 54.27 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.562 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.609 HD21 ' HB3' ' A' ' 102' ' ' SER . 61.9 mt -119.05 138.29 52.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.73 -172.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.544 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 29.4 t70 -81.2 158.45 24.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.821 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.85 -36.67 70.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.896 0.379 . . . . 0.0 110.796 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -81.6 3.11 26.36 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.12 0.486 . . . . 0.0 111.258 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . 81.4 35.52 22.95 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.298 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.544 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 42.4 t60 -100.38 110.83 23.05 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 5.8 p -48.44 111.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.645 0.736 . . . . 0.0 111.002 173.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 48.9 mt -99.65 -23.5 15.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.581 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.69 157.58 36.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.836 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.63 HG21 ' HG3' ' A' ' 99' ' ' LYS . 13.6 p -159.82 133.85 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.2 m -144.48 130.15 19.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.704 0.288 . . . . 0.0 111.065 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 84' ' ' SER . 24.5 tp -74.78 110.1 8.8 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -84.84 -39.22 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.155 -171.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.0 m -150.56 151.15 32.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.762 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.732 ' HB2' HD21 ' A' ' 81' ' ' LEU . 45.7 t -140.11 142.77 36.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.875 0.369 . . . . 0.0 110.572 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -103.18 19.42 19.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.243 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.13 63.41 0.84 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.686 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.809 ' HA ' HD12 ' A' ' 90' ' ' LEU . 1.1 mm? -119.1 82.99 23.05 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -77.08 -83.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.369 2.046 . . . . 0.0 111.973 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 66.5 m -68.64 -17.91 64.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.397 0.618 . . . . 0.0 110.339 177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 87' ' ' LEU . 16.2 mt -70.24 -34.03 72.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.632 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.549 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 3.7 t70 -54.12 -44.53 71.39 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.467 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 89' ' ' SER . 11.2 ptm180 -54.31 -48.49 71.25 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -170.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.505 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 8.1 tp10 -77.88 -53.46 7.45 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 122.016 -0.427 . . . . 0.0 111.789 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.539 HG12 ' O ' ' A' ' 90' ' ' LEU . 36.7 pt -64.76 -37.08 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -172.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.601 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.4 mm-40 -82.21 -28.31 32.06 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.45 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.669 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.88 -43.43 81.26 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 169.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.612 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 0.6 OUTLIER -63.87 -58.37 7.0 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.008 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.864 HG11 HG21 ' A' ' 123' ' ' ILE . 93.0 t -89.05 -50.4 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.63 ' HG3' HG21 ' A' ' 79' ' ' VAL . 35.6 ttmt -67.32 -29.99 69.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.649 -173.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.669 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 4.1 tmt_? -89.07 -47.17 8.29 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.664 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.656 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -86.0 73.75 10.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.044 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.609 ' HB3' HD21 ' A' ' 70' ' ' LEU . 67.4 m -109.52 92.3 11.64 Favored Pre-proline 0 N--CA 1.447 -0.612 0 CA-C-O 122.063 0.935 . . . . 0.0 110.531 171.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.665 ' HG2' ' HG3' ' A' ' 44' ' ' ARG . 3.3 Cg_endo -96.33 178.44 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 1 C-N-CA 125.457 4.105 . . . . 0.0 112.052 170.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.782 HD21 ' HD2' ' A' ' 108' ' ' PRO . 12.2 tp -134.65 99.15 13.0 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.494 ' HB2' ' HB3' ' A' ' 40' ' ' ARG . 86.6 Cg_endo -77.15 -28.51 5.8 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 121.449 1.433 . . . . 0.0 112.77 -173.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.513 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 2.9 t -122.46 107.83 34.07 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.708 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.38 108.3 1.35 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.062 2.508 . . . . 0.0 112.612 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.782 ' HD2' HD21 ' A' ' 104' ' ' LEU . 41.9 Cg_endo -86.71 66.45 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.159 2.572 . . . . 0.0 111.312 177.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.703 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -49.69 -46.28 49.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.864 177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.69 -32.49 67.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.592 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -81.09 -31.31 34.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.12 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.703 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -116.62 18.58 14.94 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -173.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 109' ' ' ALA . 3.2 m -71.29 88.95 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 168.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 6.9 p30 159.34 -23.07 0.0 OUTLIER 'General case' 0 C--O 1.235 0.315 0 CA-C-N 113.892 -1.504 . . . . 0.0 108.152 -168.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.56 -84.53 0.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.002 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.46 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.3 OUTLIER -159.67 175.69 12.89 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.218 0.607 . . . . 0.0 109.491 -176.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 69' ' ' THR . 4.0 m -103.02 107.99 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.597 0 CA-C-O 121.396 0.617 . . . . 0.0 111.251 -174.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 1.1 tm-20 -103.57 112.14 24.92 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.662 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 3.5 pp -142.09 149.33 39.73 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.622 -173.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.2 m -87.94 124.58 33.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.627 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.662 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 32.2 mt -123.77 122.03 26.46 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.556 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.05 120.89 5.9 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.197 1.932 . . . . 0.0 110.933 176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.864 HG21 HG11 ' A' ' 98' ' ' VAL . 12.2 pt -104.69 123.19 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -126.26 124.31 40.09 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 122.206 1.003 . . . . 0.0 111.581 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.44 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 62.0 m-85 -113.17 139.13 49.02 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 168.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 14.4 m -57.99 101.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.805 0.336 . . . . 0.0 111.558 -172.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.766 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.4 OUTLIER -94.88 106.06 18.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.917 -174.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -131.61 19.08 4.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.304 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.25 -110.78 1.57 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.362 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -81.99 45.91 0.96 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -172.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -169.87 101.5 0.17 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.194 -0.527 . . . . 0.0 111.899 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 9.1 p90 . . . . . 0 C--O 1.244 0.814 0 CA-C-O 119.3 -0.381 . . . . 0.0 110.448 179.078 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.562 ' HG2' ' H ' ' A' ' 4' ' ' GLN . 4.7 ttmp? . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.485 HG23 ' HG3' ' A' ' 4' ' ' GLN . 29.3 m -73.49 -28.57 25.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.282 0.563 . . . . 0.0 110.144 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.562 ' H ' ' HG2' ' A' ' 2' ' ' LYS . 45.7 mt-30 -99.57 75.55 1.95 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.934 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -87.11 41.91 1.0 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.738 0.78 . . . . 0.0 109.259 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -84.49 -55.13 4.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.932 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.4 m -84.26 84.25 7.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.015 0.436 . . . . 0.0 110.526 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.0 t -103.04 -50.0 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.366 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.41 -155.53 23.54 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.304 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 67.83 74.01 0.33 Allowed Pre-proline 0 N--CA 1.464 0.273 0 C-N-CA 123.442 0.697 . . . . 0.0 111.364 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.586 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 70.2 Cg_endo -75.73 130.92 12.96 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.488 2.125 . . . . 0.0 112.032 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 37.5 Cg_endo -92.69 100.09 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.269 2.646 . . . . 0.0 112.645 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 11' ' ' PRO . 3.4 Cg_exo -80.12 74.94 5.31 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.014 2.476 . . . . 0.0 111.641 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.74 -51.61 4.34 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.253 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -121.67 -80.35 0.62 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.788 -0.242 . . . . 0.0 110.971 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . . . 61.83 96.2 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.816 0.697 . . . . 0.0 111.451 -177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -76.64 -42.41 42.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.583 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.1 tptt 53.11 80.67 0.1 Allowed 'General case' 0 C--O 1.235 0.308 0 O-C-N 124.025 0.828 . . . . 0.0 111.502 174.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 p -81.0 60.59 4.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.115 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.68 88.98 7.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.472 0.653 . . . . 0.0 110.198 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.412 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -91.01 169.07 12.31 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.834 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 54.3 Cg_exo -54.26 -19.82 17.83 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 121.984 1.789 . . . . 0.0 112.732 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -81.93 -15.7 52.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.902 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.3 p -88.79 38.58 0.89 Allowed 'General case' 0 C--N 1.332 -0.165 0 O-C-N 121.942 -0.474 . . . . 0.0 111.221 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -116.82 -53.95 2.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.205 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 26' ' ' LEU . 3.5 mm? -103.17 28.73 6.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.249 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 p -112.61 93.58 24.2 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.088 0.47 . . . . 0.0 111.067 177.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -78.97 58.94 7.16 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.657 2.238 . . . . 0.0 112.092 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -127.63 139.76 52.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.639 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 63.32 74.04 0.44 Allowed 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.892 0.745 . . . . 0.0 112.44 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -81.74 50.58 1.54 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.124 0.488 . . . . 0.0 110.913 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -125.4 167.54 14.82 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.11 -146.18 5.35 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 119.328 -1.415 . . . . 0.0 113.676 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.4 mp0 -75.77 124.23 26.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.091 -0.554 . . . . 0.0 112.085 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' A' ' 36' ' ' ASN . 5.3 p-10 -159.61 -72.99 0.08 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.509 169.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.503 ' H ' ' CG ' ' A' ' 35' ' ' ASP . 0.1 OUTLIER -178.44 38.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.512 ' CH2' HD21 ' A' ' 121' ' ' LEU . 1.4 p-90 -63.95 -29.99 71.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.829 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.15 -31.48 70.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.118 0.485 . . . . 0.0 110.247 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.0 m -70.84 -34.53 71.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.469 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.559 ' CB ' ' HG2' ' A' ' 105' ' ' PRO . 48.9 mtt180 -64.8 -44.96 88.25 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.433 0.635 . . . . 0.0 109.443 174.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.531 HG23 ' HD2' ' A' ' 103' ' ' PRO . 75.8 mt -59.62 -38.67 76.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.322 177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 m -55.75 -32.31 63.3 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.17 -43.01 82.28 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.713 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.625 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 9.2 mpt_? -69.07 -32.53 72.05 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.098 0.475 . . . . 0.0 110.769 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.418 HD11 HG22 ' A' ' 98' ' ' VAL . 0.7 OUTLIER -62.95 -32.41 73.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.422 0.63 . . . . 0.0 109.754 178.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.544 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.8 t-20 -71.2 -31.29 67.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.822 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.531 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 2.0 ttt180 -53.34 -28.34 28.16 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.961 172.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -100.85 -57.09 2.17 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.705 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -173.56 116.98 0.26 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.544 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 55.4 ttp180 -133.47 103.83 6.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.217 0.532 . . . . 0.0 110.312 177.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -98.79 142.94 25.45 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.993 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.86 132.8 51.51 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.877 2.384 . . . . 0.0 111.83 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.674 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -62.36 -23.89 67.05 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -171.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.489 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 15.3 m-20 -65.2 -33.53 76.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.643 0.259 . . . . 0.0 110.815 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.84 71.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.249 0.547 . . . . 0.0 110.112 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -73.45 -40.31 64.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.61 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.713 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 83.2 mtt180 -55.65 -30.86 61.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.984 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 54' ' ' ASP . 61.6 mt -99.04 14.41 29.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.038 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.444 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 24.8 ttmm -145.8 -74.64 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.701 0.286 . . . . 0.0 111.049 -177.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.55 ' HD2' HD23 ' A' ' 90' ' ' LEU . 23.0 mmt180 -127.38 84.44 2.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.384 0.612 . . . . 0.0 110.232 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.713 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 24.4 pt20 -94.27 115.29 27.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.06 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.811 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -154.79 130.02 2.74 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.56 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.88 ' H ' HD12 ' A' ' 127' ' ' LEU . 7.1 p -103.78 133.39 47.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.083 0.468 . . . . 0.0 110.006 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.85 168.12 38.24 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.16 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.662 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 56.7 mt-30 -100.29 137.65 38.44 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 123' ' ' ILE . 39.8 t -128.22 114.03 32.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.237 0.541 . . . . 0.0 110.46 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 34.4 ttp180 -103.71 125.04 49.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -144.1 156.99 44.57 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.508 0.67 . . . . 0.0 112.625 -174.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.789 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 23.3 m -106.43 124.32 49.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.429 173.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.681 HD13 ' HG ' ' A' ' 104' ' ' LEU . 39.9 mt -116.96 147.69 42.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.24 0.543 . . . . 0.0 111.953 -169.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.614 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 29.3 t70 -88.41 161.81 16.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.399 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.416 ' HD2' ' HB3' ' A' ' 107' ' ' PRO . 8.1 tpt180 -48.96 -40.39 30.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.543 174.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -88.76 7.14 35.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.989 0.423 . . . . 0.0 111.062 -176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.61 40.25 27.63 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.162 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.614 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 45.2 t60 -103.06 123.81 47.34 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -54.48 118.89 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.417 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.428 HD21 ' HB2' ' A' ' 71' ' ' ASP . 26.0 mt -106.19 -53.45 2.63 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.231 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.61 149.59 52.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.802 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' A' ' 68' ' ' PHE . 2.4 m -145.67 125.35 6.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.442 0.639 . . . . 0.0 110.857 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.9 m -124.71 123.83 40.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.425 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.448 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 23.1 tp -78.68 106.48 10.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.484 0.659 . . . . 0.0 109.882 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -86.66 -41.96 15.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.049 178.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.457 ' CA ' ' H ' ' A' ' 65' ' ' GLN . 13.2 t 68.67 -178.03 0.22 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.396 167.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.431 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 40.8 m -153.59 -56.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.024 -175.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.59 -77.4 0.59 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.7 98.67 0.11 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.747 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.742 ' HA ' HD12 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -117.6 87.63 26.66 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.532 0.166 . . . . 0.0 110.655 -177.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.76 -81.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.685 2.257 . . . . 0.0 111.869 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.5 m -65.74 -18.46 65.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.525 0.679 . . . . 0.0 110.328 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.742 HD12 ' HA ' ' A' ' 87' ' ' LEU . 25.2 mt -73.67 -36.13 65.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.191 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 4.4 t70 -54.18 -51.41 64.43 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 123.613 0.571 . . . . 0.0 111.725 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -54.58 -43.67 72.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -77.4 -53.92 7.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.833 0.349 . . . . 0.0 111.737 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 90' ' ' LEU . 40.2 pt -74.12 -33.08 34.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.654 -172.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.779 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 79.0 mm-40 -82.57 -24.11 34.14 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 120.981 0.42 . . . . 0.0 110.39 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.72 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.65 -47.27 80.12 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.648 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -65.11 -56.11 14.84 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.514 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.939 HG11 HG21 ' A' ' 123' ' ' ILE . 79.3 t -89.17 -50.11 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -176.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.779 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 34.9 ttmt -68.84 -30.09 68.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.238 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.72 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 2.6 tmt_? -86.86 -39.99 15.31 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.774 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.666 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -97.41 63.84 1.82 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.737 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.4 m -94.6 98.49 3.14 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.978 0.418 . . . . 0.0 110.093 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 98.9 Cg_endo -108.65 172.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 124.195 3.263 . . . . 0.0 114.386 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.681 ' HG ' HD13 ' A' ' 70' ' ' LEU . 6.2 mt -143.89 120.59 6.52 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.733 172.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.559 ' HG2' ' CB ' ' A' ' 40' ' ' ARG . 6.2 Cg_exo -72.83 -54.13 0.12 Allowed 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.86 2.374 . . . . 0.0 111.936 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 25.4 m -88.7 115.22 62.84 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.411 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 106' ' ' THR . 30.5 Cg_endo -64.17 107.6 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.09 2.527 . . . . 0.0 112.225 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.66 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 81.3 Cg_endo -83.38 62.74 7.45 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.772 2.314 . . . . 0.0 111.832 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.823 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -59.18 -41.91 89.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.297 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.72 -7.95 48.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.622 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.66 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -99.38 -32.04 11.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.604 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.823 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -110.02 17.49 21.02 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -176.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 109' ' ' ALA . 3.4 m -70.57 88.09 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 168.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 7.5 p30 161.93 -27.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.606 -1.634 . . . . 0.0 107.846 -170.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.85 -76.15 0.15 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.906 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.535 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.6 OUTLIER -160.27 174.42 14.23 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.789 ' O ' ' HA ' ' A' ' 69' ' ' THR . 15.8 m -103.3 108.94 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.377 0.608 . . . . 0.0 111.061 -175.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 28.0 tt0 -105.36 111.7 24.52 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.68 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -142.36 147.22 35.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.462 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 67' ' ' ARG . 86.8 m -87.59 122.13 30.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.33 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.68 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 26.0 mt -124.7 122.5 25.7 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.927 172.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.2 Cg_exo -73.8 119.93 6.15 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.771 1.647 . . . . 0.0 110.726 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.939 HG21 HG11 ' A' ' 98' ' ' VAL . 23.8 pt -95.46 99.52 9.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.59 ' HA ' HG23 ' A' ' 63' ' ' VAL . 5.5 p-10 -90.24 121.49 32.31 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.449 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.49 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 41.5 m-85 -113.36 141.3 47.21 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 163.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 3.3 m -64.15 101.87 0.45 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.88 HD12 ' H ' ' A' ' 63' ' ' VAL . 1.2 tt -90.13 84.11 6.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.204 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 128' ' ' ARG . 21.0 mtm180 -77.31 -20.18 55.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.46 178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 141.06 106.02 0.61 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.528 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.509 ' CB ' HD21 ' A' ' 90' ' ' LEU . . . -157.58 155.2 29.77 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.05 31.69 19.55 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.317 -177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 21.2 p90 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.629 -0.701 . . . . 0.0 110.423 -177.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.916 0.389 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.11 -31.15 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.43 0.633 . . . . 0.0 109.694 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -137.04 -28.66 0.94 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.368 177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.82 63.42 8.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.436 -176.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -85.26 52.9 2.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.364 0.602 . . . . 0.0 109.978 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.7 t -95.94 102.32 14.1 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.893 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 p -102.4 99.62 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.499 0.666 . . . . 0.0 110.658 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.89 108.9 0.58 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.129 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.05 80.94 67.2 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-O 120.938 0.399 . . . . 0.0 109.946 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 87.0 Cg_endo -82.15 129.5 6.06 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.641 2.227 . . . . 0.0 112.799 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 3.3 Cg_exo -77.77 104.24 1.83 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.085 2.523 . . . . 0.0 110.725 171.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 11.4 Cg_exo -69.84 120.1 6.93 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.771 2.314 . . . . 0.0 112.29 -173.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.76 -35.13 79.35 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -147.8 -66.32 0.25 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.289 -0.455 . . . . 0.0 109.773 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.42 124.51 42.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.183 0.516 . . . . 0.0 111.854 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -161.59 -157.72 0.51 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? 56.34 40.09 29.91 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.201 0.524 . . . . 0.0 110.278 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.3 m -98.74 -44.83 6.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.045 -174.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.39 118.64 4.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.666 0.269 . . . . 0.0 111.063 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.93 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -126.33 -62.78 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.5 173.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.93 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 2.5 Cg_endo -85.07 -10.47 8.05 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.083 1.855 . . . . 0.0 111.797 171.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.506 ' OE1' ' HD2' ' A' ' 22' ' ' PRO . 25.1 mp0 -83.41 -9.69 58.87 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.543 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.463 ' HA ' ' OG1' ' A' ' 27' ' ' THR . 4.9 m -64.79 -7.53 11.42 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.97 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.451 ' HG3' ' HG ' ' A' ' 26' ' ' LEU . 35.3 ptt180 -75.33 -16.04 60.44 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.935 -0.478 . . . . 0.0 110.981 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.451 ' HG ' ' HG3' ' A' ' 25' ' ' ARG . 80.0 mt -115.95 17.43 15.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.953 0.406 . . . . 0.0 110.856 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 24' ' ' THR . 41.5 p -122.75 86.06 49.7 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.87 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.96 145.76 15.83 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.965 2.443 . . . . 0.0 111.166 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -79.56 -10.65 59.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.067 0.461 . . . . 0.0 110.966 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.01 120.58 26.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.44 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -86.14 -41.53 14.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.475 -173.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 59.69 -157.43 0.33 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.848 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 157.42 103.44 0.2 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.549 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -81.23 138.89 35.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.083 0.468 . . . . 0.0 109.827 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -174.73 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.873 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -154.79 30.66 0.41 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.65 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -88.69 -37.2 15.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.42 -174.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.758 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . 17.3 ptp180 -69.15 -29.79 67.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.892 -173.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.0 p -64.69 -38.21 90.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.589 ' C ' ' HG3' ' A' ' 105' ' ' PRO . 4.2 mmm180 -74.76 -37.96 62.33 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.758 ' HB ' ' HA ' ' A' ' 38' ' ' ARG . 21.5 mt -57.69 -38.1 62.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.808 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 m -60.23 -45.71 92.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 174.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.51 -50.48 67.34 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.39 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.802 ' HG2' ' HG2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -68.35 -29.29 67.99 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.213 0.507 . . . . 0.0 111.297 -177.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.78 -30.84 71.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.526 0.679 . . . . 0.0 109.654 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.565 ' HB2' ' HD3' ' A' ' 50' ' ' ARG . 8.4 t30 -71.31 -29.59 65.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.931 -1.032 . . . . 0.0 109.543 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.666 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 9.2 ttt180 -52.96 -25.04 10.7 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.223 172.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.546 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 74.4 m-85 -113.29 -59.15 2.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.266 176.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 0.9 OUTLIER -164.62 103.38 0.82 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 122.394 0.278 . . . . 0.0 110.568 -174.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.565 ' HD3' ' HB2' ' A' ' 46' ' ' ASN . 15.7 ttt180 -133.17 106.43 7.59 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.605 0.716 . . . . 0.0 111.124 177.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.442 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.3 t80 -105.18 142.97 25.79 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.2 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.96 132.21 50.93 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.92 2.413 . . . . 0.0 112.108 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.55 -24.89 66.95 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -171.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -55.97 -41.74 75.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.67 0.271 . . . . 0.0 110.832 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.64 -30.87 68.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.87 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.6 mm? -74.44 -41.51 60.72 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.613 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 28.4 mtm180 -61.28 -24.39 66.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.246 0.546 . . . . 0.0 110.162 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.8 tp -91.57 -13.72 31.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.748 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.661 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 38.2 ttpt -131.64 -72.46 0.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.88 -172.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.661 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 36.8 mmt180 -109.69 92.02 3.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.853 0.359 . . . . 0.0 110.315 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 90' ' ' LEU . 42.6 mt-30 -86.54 169.34 12.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.572 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.61 119.71 0.81 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.472 -1.347 . . . . 0.0 113.627 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.06 123.57 66.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.34 165.7 36.17 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.696 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 68.7 mt-30 -103.09 130.82 50.35 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.6 t -119.57 114.29 43.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.364 -171.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.523 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 31.3 ttp85 -107.65 137.63 45.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.638 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.586 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -152.28 153.65 34.15 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.494 0.664 . . . . 0.0 111.948 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 30.4 m -99.18 133.58 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.299 170.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.586 HD11 ' CE1' ' A' ' 68' ' ' PHE . 63.7 mt -121.92 140.23 52.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.379 0.609 . . . . 0.0 112.211 -170.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.638 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 17.1 t70 -83.88 159.64 21.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.565 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.448 ' HG3' ' OH ' ' A' ' 112' ' ' TYR . 22.2 ttt180 -53.39 -40.58 65.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.866 0.365 . . . . 0.0 111.452 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -89.46 16.2 8.01 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 111.056 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.452 ' CA ' ' HA ' ' A' ' 103' ' ' PRO . . . 71.89 46.17 38.78 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.811 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.638 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 72.2 t60 -104.3 114.3 28.45 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.3 p -49.21 123.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.112 0.482 . . . . 0.0 111.162 173.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.606 HD12 HG22 ' A' ' 69' ' ' THR . 35.3 mt -110.0 -45.97 3.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.266 0.555 . . . . 0.0 110.571 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.28 149.14 52.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.981 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.5 m -136.74 124.22 32.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.0 m -144.11 121.76 11.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.5 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.635 HD21 ' HB2' ' A' ' 84' ' ' SER . 25.8 tp -76.18 111.95 12.14 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 173.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.753 HG21 HG23 ' A' ' 120' ' ' THR . 0.2 OUTLIER -85.36 -38.35 12.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.68 -170.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.451 ' HB3' ' HG3' ' A' ' 65' ' ' GLN . 8.4 t -148.05 149.17 31.6 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.635 ' HB2' HD21 ' A' ' 81' ' ' LEU . 46.3 t -149.07 149.14 30.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.22 0.533 . . . . 0.0 111.216 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -102.99 -18.09 15.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.583 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.414 ' C ' HD13 ' A' ' 87' ' ' LEU . . . 120.43 80.63 0.62 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.944 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.8 HD11 HD11 ' A' ' 127' ' ' LEU . 0.4 OUTLIER -117.51 91.23 37.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.87 -79.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.992 2.461 . . . . 0.0 112.556 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 92' ' ' ARG . 53.6 p -70.58 -18.62 62.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.394 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.735 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 17.9 mt -74.34 -39.93 62.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.131 -175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 15.4 t70 -54.58 -43.24 71.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.785 -170.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.4 ' CZ ' ' HA ' ' A' ' 89' ' ' SER . 4.1 ptp180 -54.01 -52.33 61.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -172.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -78.25 -48.03 16.65 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.909 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 90' ' ' LEU . 42.4 pt -62.98 -36.83 77.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.656 0.265 . . . . 0.0 111.4 -176.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.665 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.9 mm-40 -82.79 -25.85 32.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.073 0.463 . . . . 0.0 110.633 177.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.757 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -57.1 -45.55 83.31 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.657 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -64.87 -56.82 11.05 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.0 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.802 HG11 HG21 ' A' ' 123' ' ' ILE . 94.2 t -89.3 -50.52 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.665 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 35.1 ttmt -70.14 -27.47 64.58 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.619 0.247 . . . . 0.0 111.391 -173.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.757 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 20.9 tpt180 -88.34 -41.73 12.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.911 176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.636 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -91.78 78.26 5.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.063 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.569 ' HB3' HD21 ' A' ' 70' ' ' LEU . 17.2 m -111.65 90.25 12.33 Favored Pre-proline 0 N--CA 1.444 -0.767 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.349 171.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.802 ' HG2' ' HG2' ' A' ' 44' ' ' ARG . 9.5 Cg_endo -104.91 -179.98 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.926 1 C-N-CA 125.992 4.462 . . . . 0.0 111.383 171.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.489 ' HG ' HD13 ' A' ' 70' ' ' LEU . 35.7 mt -136.38 127.95 17.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 169.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.715 ' HD3' ' HD2' ' A' ' 44' ' ' ARG . 57.0 Cg_endo -74.75 -24.23 13.59 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.514 2.143 . . . . 0.0 111.836 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 t -132.89 116.33 14.62 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.112 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.73 108.78 0.4 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.93 2.42 . . . . 0.0 111.717 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.53 ' HG2' ' CE2' ' A' ' 112' ' ' TYR . 82.0 Cg_endo -75.62 65.08 6.61 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.683 2.255 . . . . 0.0 111.563 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.586 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.2 -41.98 80.4 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.818 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.8 2.29 4.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.573 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.23 -34.74 5.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.509 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.653 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -115.2 16.75 16.89 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -174.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.6 m -71.38 88.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 169.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 4.9 p30 159.82 -29.98 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 113.661 -1.608 . . . . 0.0 107.404 -168.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.38 -84.55 0.1 Allowed Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.355 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.495 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 1.3 p -149.6 167.39 26.5 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -171.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 69' ' ' THR . 20.7 m -107.71 122.43 62.0 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 CA-C-O 120.904 0.383 . . . . 0.0 111.014 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -112.8 120.04 40.09 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 171.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.663 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -140.14 143.35 36.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.972 0.415 . . . . 0.0 111.606 -175.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.753 HG23 HG21 ' A' ' 82' ' ' VAL . 98.9 m -96.3 116.34 28.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.857 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.663 ' HG ' HD12 ' A' ' 119' ' ' LEU . 62.7 mt -119.21 122.76 29.27 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.275 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.696 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.3 Cg_exo -73.12 120.73 6.76 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.056 1.837 . . . . 0.0 111.427 177.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.802 HG21 HG11 ' A' ' 98' ' ' VAL . 21.6 pt -102.49 117.73 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -119.61 123.47 43.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.184 0.993 . . . . 0.0 112.508 -175.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.572 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 89.7 m-85 -115.23 133.02 56.42 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.604 166.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 m -57.66 103.73 0.15 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.044 0.45 . . . . 0.0 111.971 -171.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.8 HD11 HD11 ' A' ' 87' ' ' LEU . 12.5 mt -84.01 104.0 13.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.181 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -149.81 29.05 0.76 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.348 0.594 . . . . 0.0 110.267 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -149.14 -77.68 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.462 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.421 ' HB3' HD21 ' A' ' 90' ' ' LEU . . . -98.43 36.14 1.67 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.246 0.546 . . . . 0.0 111.092 -176.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.606 ' HA3' HD22 ' A' ' 127' ' ' LEU . . . 177.83 109.49 0.25 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.456 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 . . . . . 0 N--CA 1.438 -1.053 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.41 178.291 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 N--CA 1.479 0.976 0 CA-C-O 121.166 0.507 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.4 t -117.14 -39.85 2.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 172.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -116.22 94.91 4.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.666 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -80.33 76.57 7.13 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.0 tp60 -95.68 50.83 1.24 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.477 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.32 -32.28 64.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.138 176.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.69 157.42 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.959 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.34 84.57 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.932 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.7 101.49 11.77 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 120.606 0.241 . . . . 0.0 111.286 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.26 142.86 68.47 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.783 2.322 . . . . 0.0 110.865 173.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 14.3 Cg_endo -56.23 110.35 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.092 2.528 . . . . 0.0 112.115 -177.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 25.4 Cg_exo -62.99 122.94 11.38 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.408 2.738 . . . . 0.0 112.848 -174.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -102.26 -170.98 27.11 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.825 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -104.26 153.42 21.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.837 0.351 . . . . 0.0 110.342 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.17 49.73 1.87 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.125 0.488 . . . . 0.0 111.08 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.2 135.08 41.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.499 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.7 tttm 71.81 -52.97 0.69 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.086 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m 61.49 70.9 0.57 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.637 0.732 . . . . 0.0 110.544 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.47 84.92 1.63 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.198 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.445 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -80.35 165.79 44.1 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.164 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 87.0 Cg_exo -48.36 -32.62 20.49 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.542 2.161 . . . . 0.0 113.262 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -68.9 -39.74 79.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.384 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.6 p -85.88 30.1 0.68 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.034 0.445 . . . . 0.0 111.207 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.691 ' HG3' ' HG ' ' A' ' 26' ' ' LEU . 36.1 ptt180 -72.12 -25.5 61.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.259 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.691 ' HG ' ' HG3' ' A' ' 25' ' ' ARG . 97.2 mt -129.96 31.43 4.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.068 0.461 . . . . 0.0 110.792 -177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.7 m -146.6 103.72 3.97 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.43 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -83.98 124.9 3.51 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.801 2.334 . . . . 0.0 112.703 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -105.05 119.12 38.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.913 0.387 . . . . 0.0 110.62 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.502 ' HB1' ' HB1' ' A' ' 111' ' ' ALA . . . -94.61 101.77 13.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.078 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -87.28 83.97 7.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.066 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.47 -33.98 28.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.511 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -156.68 134.9 4.22 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -75.85 73.74 2.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.507 0.67 . . . . 0.0 110.644 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 t70 72.44 -5.86 1.71 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.184 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -75.96 -8.55 57.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.145 0.498 . . . . 0.0 110.698 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -78.83 -17.08 56.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.328 -175.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 38' ' ' ARG . 10.8 ptp180 -68.48 -41.44 80.09 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.767 -171.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.8 p -64.79 -36.36 84.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.143 0.497 . . . . 0.0 110.434 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.47 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 30.8 mmt180 -73.93 -43.25 58.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.347 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.54 HG12 ' HD3' ' A' ' 105' ' ' PRO . 76.0 mt -57.01 -43.58 81.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.3 m -60.31 -30.61 69.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.881 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.33 -52.57 34.79 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.274 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 1.018 ' HG3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.7 -28.41 65.81 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 175.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -53.86 -35.04 61.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.523 0.678 . . . . 0.0 109.362 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.765 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 24.1 t-20 -71.93 -34.18 68.85 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.941 177.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -52.88 -28.15 21.79 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.277 173.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.582 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 95.8 m-85 -95.39 -59.23 1.93 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.947 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 21.1 mmmt -178.28 114.47 0.07 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.336 1.054 . . . . 0.0 108.923 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.765 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 41.8 ttp180 -129.54 105.38 8.04 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.273 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 2.7 t80 -90.32 134.92 30.34 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.844 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 32.3 Cg_exo -60.32 132.4 43.66 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.327 2.685 . . . . 0.0 112.566 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.608 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.21 -27.41 65.7 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.266 -171.122 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.19 -40.82 74.57 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.851 0.358 . . . . 0.0 110.713 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.51 -30.99 62.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.565 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.7 mm? -65.91 -38.48 88.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.884 0.373 . . . . 0.0 110.204 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -61.8 -17.32 55.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.534 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.1 mt -111.99 -0.68 15.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 111.129 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -128.44 -70.32 0.69 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.03 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.753 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 28.9 mmt180 -136.68 101.53 4.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.318 0.58 . . . . 0.0 110.107 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.549 ' HG3' ' HA ' ' A' ' 127' ' ' LEU . 3.2 pt20 -113.48 160.37 18.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.546 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.752 ' HA3' HD11 ' A' ' 87' ' ' LEU . . . 153.27 142.89 3.56 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.389 -176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -107.31 125.53 63.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.993 0.425 . . . . 0.0 109.996 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.15 164.4 26.19 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.421 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 48.2 mt-30 -103.85 129.28 51.31 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 68' ' ' PHE . 51.6 t -127.74 118.18 48.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.263 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.598 ' HG2' HG22 ' A' ' 82' ' ' VAL . 15.6 ptt180 -112.96 143.65 43.89 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -159.57 152.92 22.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.41 0.624 . . . . 0.0 112.502 -168.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.6 m -95.16 126.45 40.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.468 171.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.498 HD11 ' CE1' ' A' ' 68' ' ' PHE . 51.0 mt -117.34 143.82 45.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.173 0.511 . . . . 0.0 111.99 -170.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.754 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 22.2 t70 -86.28 154.96 20.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.13 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -53.21 -35.01 59.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.202 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -99.72 13.15 34.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.16 0.505 . . . . 0.0 111.154 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.53 40.59 12.56 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.812 -0.631 . . . . 0.0 113.388 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.754 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 68.8 t60 -103.31 118.02 35.83 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 175.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.8 p -53.13 113.32 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.22 0.533 . . . . 0.0 111.149 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.44 -48.72 4.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.46 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.81 155.68 46.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.605 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -149.98 129.6 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 123.485 0.491 . . . . 0.0 110.026 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -142.32 125.66 16.58 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.279 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 84' ' ' SER . 34.2 tp -70.0 122.45 19.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.598 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -97.48 -41.65 11.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.183 -174.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 m -149.35 131.05 15.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.872 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.614 ' HB2' HD21 ' A' ' 81' ' ' LEU . 45.0 t -138.95 111.01 7.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.61 -62.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.14 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.463 ' H ' HD22 ' A' ' 87' ' ' LEU . . . -157.05 62.85 0.32 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.876 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.859 ' HA ' HD12 ' A' ' 90' ' ' LEU . 1.6 mm? -114.35 86.78 12.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 4.7 Cg_exo -77.16 -78.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.435 2.09 . . . . 0.0 111.545 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.1 p -74.79 -18.67 60.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.69 0.757 . . . . 0.0 110.242 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.859 HD12 ' HA ' ' A' ' 87' ' ' LEU . 10.5 mt -70.44 -38.7 74.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.404 -177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -54.49 -50.85 66.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.413 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.2 -40.88 71.27 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.221 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.493 ' CB ' ' HG3' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -78.22 -53.2 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.516 -173.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 90' ' ' LEU . 37.0 pt -64.74 -36.05 76.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 120.677 0.275 . . . . 0.0 111.727 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.642 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.9 mm-40 -79.22 -27.55 42.5 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-O 120.955 0.407 . . . . 0.0 110.506 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.38 -46.34 76.53 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 173.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.511 HD23 HG23 ' A' ' 98' ' ' VAL . 1.4 tp -67.59 -54.96 15.44 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.742 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.916 HG11 HG21 ' A' ' 123' ' ' ILE . 95.1 t -87.81 -48.62 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -174.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.642 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 40.3 ttmt -65.05 -23.29 67.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.046 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.497 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 30.9 tpt180 -93.6 -27.33 16.66 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.009 173.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.577 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -114.71 75.16 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.808 0.337 . . . . 0.0 111.29 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.4 m -108.34 95.06 14.78 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.225 0.536 . . . . 0.0 110.275 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 1.018 ' HB2' ' HG3' ' A' ' 44' ' ' ARG . 84.8 Cg_endo -113.74 122.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 124.482 3.454 . . . . 0.0 114.604 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.456 HD23 ' HD2' ' A' ' 105' ' ' PRO . 1.1 mt -92.02 123.75 61.99 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 172.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.549 ' HG3' ' HD3' ' A' ' 44' ' ' ARG . 1.7 Cg_endo -77.88 -59.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.568 2.179 . . . . 0.0 112.267 177.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.611 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 t -65.5 129.18 94.31 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.983 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.4 103.46 1.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.844 2.363 . . . . 0.0 112.267 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.8 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 68.5 Cg_endo -85.81 55.99 3.92 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.732 2.288 . . . . 0.0 111.524 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.74 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -54.38 -45.83 72.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.575 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.82 -6.84 51.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.291 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.8 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -98.36 -21.61 16.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.511 -177.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.837 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -124.3 17.79 9.04 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -176.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.4 m -71.1 89.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.965 0.888 . . . . 0.0 108.896 173.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER 157.43 -13.78 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 113.19 -1.823 . . . . 0.0 107.903 -172.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.06 -90.72 0.1 Allowed Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.032 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.2 OUTLIER -160.57 175.09 13.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.308 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' A' ' 112' ' ' TYR . 10.8 m -101.99 114.47 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 121.417 0.627 . . . . 0.0 111.115 -175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -115.72 112.69 22.42 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 172.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.5 HD12 ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -144.11 152.61 41.17 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.328 -175.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.487 HG23 HG21 ' A' ' 82' ' ' VAL . 86.6 m -90.47 124.67 35.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.151 0.501 . . . . 0.0 111.77 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.5 ' HG ' HD12 ' A' ' 119' ' ' LEU . 57.8 mt -126.76 123.45 23.79 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.861 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 11.5 Cg_exo -70.61 120.09 6.83 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.066 1.844 . . . . 0.0 111.277 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.916 HG21 HG11 ' A' ' 98' ' ' VAL . 33.0 pt -94.5 99.17 9.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -98.95 123.62 43.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.068 0.937 . . . . 0.0 111.923 -173.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.575 ' HE2' ' HE2' ' A' ' 53' ' ' LYS . 59.8 m-85 -115.16 125.25 53.2 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 162.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.9 p -57.55 105.12 0.22 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.503 0.668 . . . . 0.0 111.327 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.739 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -83.19 99.26 9.83 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.759 -173.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.464 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 53.4 mtp180 -81.0 -47.96 12.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.52 174.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.58 66.8 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.931 175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.639 ' HB3' HD21 ' A' ' 90' ' ' LEU . . . -105.47 5.58 31.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.122 0.487 . . . . 0.0 110.839 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -97.92 62.38 0.93 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.602 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 21.2 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.993 -177.65 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.0 mttp . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.3 t 55.73 69.05 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.437 0.637 . . . . 0.0 111.472 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -149.96 159.68 44.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.424 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.31 126.28 54.84 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -105.03 12.69 31.94 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.835 -172.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.7 m 67.64 -80.54 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.145 0.578 . . . . 0.0 111.116 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 36.6 t -119.55 -28.72 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.154 0.502 . . . . 0.0 110.349 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.52 10.12 48.39 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.832 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.52 127.62 29.99 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.38 125.69 5.83 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.589 2.193 . . . . 0.0 112.76 -178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.47 114.5 4.05 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.941 2.427 . . . . 0.0 111.6 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.58 66.16 6.53 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.928 2.418 . . . . 0.0 113.061 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.33 70.63 0.99 Allowed Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.215 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.62 ' HD3' ' O ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -154.94 131.51 10.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.158 0.504 . . . . 0.0 111.131 178.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.6 147.85 33.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.35 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -85.84 20.23 2.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.919 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -118.12 -16.94 9.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.72 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 p -126.0 -72.85 0.64 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.935 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.95 43.16 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.445 0.641 . . . . 0.0 110.88 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.433 ' N ' ' HD2' ' A' ' 22' ' ' PRO . . . -76.04 -48.49 3.49 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.57 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 21' ' ' ALA . 72.1 Cg_endo -75.73 40.54 0.72 Allowed 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.286 1.99 . . . . 0.0 112.926 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 58.03 41.73 23.72 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.22 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -66.52 -18.43 65.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.288 0.566 . . . . 0.0 110.909 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 25' ' ' ARG . 1.6 ptm180 -72.06 -20.81 61.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.982 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 48.6 tp -166.36 70.77 0.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.673 ' HB ' ' HD3' ' A' ' 28' ' ' PRO . 17.3 m -63.05 -54.59 44.85 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.427 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.673 ' HD3' ' HB ' ' A' ' 27' ' ' THR . 71.7 Cg_endo -80.44 106.25 1.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.615 1.543 . . . . 0.0 110.643 170.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.432 ' HE1' ' HB3' ' A' ' 31' ' ' GLN . 3.6 t80 -74.68 82.87 2.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.387 0.613 . . . . 0.0 110.59 -175.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.45 71.95 9.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.228 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.432 ' HB3' ' HE1' ' A' ' 29' ' ' TYR . 3.8 pt20 -85.77 67.15 9.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.329 0.585 . . . . 0.0 110.904 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.54 -41.26 8.64 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.759 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -134.88 90.21 0.24 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -92.83 -11.82 32.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.112 0.482 . . . . 0.0 110.575 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -118.94 -73.97 0.62 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.674 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -114.77 77.56 1.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.099 0.476 . . . . 0.0 110.319 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -119.18 -37.46 3.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.042 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -67.85 -30.03 69.32 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.104 0.478 . . . . 0.0 110.515 -174.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.4 -36.45 82.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.171 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.429 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 24.1 mmm180 -73.64 -41.36 62.85 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.346 0.594 . . . . 0.0 109.589 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.4 HG23 ' HG2' ' A' ' 103' ' ' PRO . 87.6 mt -61.39 -42.35 93.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.041 177.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 t -55.59 -39.62 70.95 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.002 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.14 99.1 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.878 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.646 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 8.6 mpt_? -69.35 -34.69 74.98 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 120.787 0.327 . . . . 0.0 110.809 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.61 HD11 HG22 ' A' ' 98' ' ' VAL . 1.1 tt -65.11 -27.68 68.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.72 0.771 . . . . 0.0 109.581 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.62 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 10.3 t30 -71.96 -37.67 69.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.885 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -56.73 -27.8 59.89 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.609 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.503 ' HE2' ' HB3' ' A' ' 103' ' ' PRO . 94.9 m-85 -88.51 -56.87 3.13 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.866 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 mtmm 172.96 103.43 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.209 174.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.62 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 52.7 ttp180 -108.4 103.03 12.1 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -72.38 131.59 84.73 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.59 131.14 32.11 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.71 2.274 . . . . 0.0 112.131 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.92 -21.33 63.29 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.407 -173.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.411 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 9.7 t0 -52.97 -38.59 62.27 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.505 0.503 . . . . 0.0 110.792 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.74 -43.65 45.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.154 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.2 mm? -64.07 -41.02 97.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.323 -175.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.705 ' HG3' ' HG ' ' A' ' 58' ' ' LEU . 27.6 ptt180 -61.66 -19.72 62.62 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.95 0.405 . . . . 0.0 111.361 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.705 ' HG ' ' HG3' ' A' ' 57' ' ' ARG . 82.9 mt -116.07 14.17 15.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.461 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.737 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 40.3 ttpt -151.21 -74.48 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 0.0 111.791 -176.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.737 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 24.4 mmt180 -112.1 84.89 2.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.522 0.677 . . . . 0.0 110.183 -176.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 126' ' ' SER . 3.1 pt20 -111.19 166.52 11.02 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.272 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.75 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.59 147.34 4.57 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.186 -1.483 . . . . 0.0 113.91 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.76 ' H ' HD12 ' A' ' 127' ' ' LEU . 61.9 t -116.13 124.94 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -151.97 166.15 30.87 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.432 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.621 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 56.8 mt-30 -101.85 132.15 47.78 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.482 HG12 ' CD2' ' A' ' 68' ' ' PHE . 56.1 t -124.26 113.23 35.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.404 -176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 64.9 ttt180 -103.02 121.75 43.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -177.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.1 OUTLIER -142.53 165.64 26.84 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.466 0.651 . . . . 0.0 112.121 -171.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.743 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 11.9 m -114.99 127.78 55.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.005 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 68' ' ' PHE . 46.5 mt -116.3 132.34 56.7 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.246 0.546 . . . . 0.0 111.784 -169.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 26.5 t70 -71.65 155.32 40.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.42 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.448 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 46.2 mtp180 -59.32 -18.81 41.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.294 -175.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.741 HE21 ' HA ' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -108.1 14.9 24.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.923 0.392 . . . . 0.0 111.279 177.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 77.54 49.26 7.38 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.714 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 19.1 t60 -114.84 126.49 54.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.87 121.91 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.187 0.517 . . . . 0.0 111.42 176.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 71' ' ' ASP . 52.7 mt -111.88 -47.53 3.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.251 0.548 . . . . 0.0 110.587 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.88 150.61 51.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.858 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.44 116.74 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.314 0.578 . . . . 0.0 110.386 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.6 m -127.43 127.12 43.59 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.888 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.6 tp -77.32 112.31 13.91 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.249 0.547 . . . . 0.0 110.466 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.581 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -96.28 -43.81 12.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.496 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 21.3 t 65.96 173.1 0.23 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 114.78 -1.1 . . . . 0.0 112.743 169.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.621 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 26.5 m -146.7 -67.11 0.27 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.23 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -96.25 -86.08 0.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 179.66 96.8 0.1 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.995 -174.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.863 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -120.1 84.46 33.52 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -179.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.36 -76.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.536 2.157 . . . . 0.0 111.956 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 m -70.32 -18.42 63.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.529 0.68 . . . . 0.0 110.136 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.863 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.8 mt -75.8 -36.7 59.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.387 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 14.4 t70 -54.54 -47.76 72.78 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.671 0.607 . . . . 0.0 111.834 -172.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -52.71 -51.9 58.44 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -170.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.52 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 22.8 tt0 -77.97 -48.21 16.77 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.221 -176.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 90' ' ' LEU . 38.3 pt -62.76 -35.99 73.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 120.578 0.228 . . . . 0.0 111.217 -176.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.602 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 74.5 mm-40 -82.32 -28.25 31.77 Favored 'General case' 0 C--O 1.213 -0.818 0 CA-C-O 120.951 0.405 . . . . 0.0 110.589 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.676 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.96 -46.5 78.56 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 170.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 tp -67.26 -55.66 13.04 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.904 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.884 HG11 HG21 ' A' ' 123' ' ' ILE . 72.1 t -87.83 -49.05 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.9 ttmt -66.52 -19.71 65.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.666 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.676 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 14.2 tpp180 -91.24 -49.94 6.1 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.68 169.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.616 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -90.87 64.76 5.58 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.698 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -89.7 99.48 1.79 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.145 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.646 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 71.9 Cg_endo -102.31 174.76 0.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.737 2.958 . . . . 0.0 114.176 -174.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.582 HD21 ' HD2' ' A' ' 108' ' ' PRO . 32.0 tp -144.69 102.13 4.59 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.726 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 6.1 Cg_exo -68.25 -77.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.134 1.889 . . . . 0.0 112.866 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.433 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.5 p -80.59 119.03 75.06 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.702 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 26.8 Cg_exo -62.75 108.65 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.209 2.606 . . . . 0.0 112.806 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.853 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 86.4 Cg_endo -83.02 62.15 7.59 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.172 2.581 . . . . 0.0 111.68 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.713 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -52.33 -44.69 65.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.612 177.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.94 -9.97 59.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.123 -176.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.853 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -99.35 -23.88 15.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.818 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.713 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -117.02 17.58 14.88 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -178.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.546 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.8 m -71.68 88.42 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 168.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.546 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 5.7 p30 157.17 -16.17 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 113.989 -1.46 . . . . 0.0 108.002 -168.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.37 -85.1 0.14 Allowed Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.421 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.538 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.2 OUTLIER -154.71 176.5 12.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -177.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.743 ' O ' ' HA ' ' A' ' 69' ' ' THR . 3.7 m -99.98 107.61 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.995 0.903 . . . . 0.0 110.183 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 31.8 tt0 -107.95 111.16 23.12 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.04 175.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.762 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -147.33 155.06 41.67 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.346 -172.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.581 HG23 HG21 ' A' ' 82' ' ' VAL . 89.3 m -98.08 118.66 35.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.531 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.762 ' HG ' HD12 ' A' ' 119' ' ' LEU . 30.5 mt -124.18 127.76 25.24 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.409 175.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.5 Cg_exo -72.22 119.36 6.11 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.942 1.761 . . . . 0.0 110.768 175.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.884 HG21 HG11 ' A' ' 98' ' ' VAL . 40.7 pt -90.29 103.25 14.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -101.71 123.44 45.7 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.763 -171.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -114.33 150.55 34.35 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 166.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 7.8 m -63.26 101.81 0.34 Allowed 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.638 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.76 HD12 ' H ' ' A' ' 63' ' ' VAL . 1.3 tt -89.58 102.63 15.31 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.905 0.383 . . . . 0.0 110.379 -174.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.469 ' H ' ' NE2' ' A' ' 61' ' ' GLN . 36.3 mtp180 -98.59 -58.36 1.98 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.775 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.55 -156.61 8.48 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.892 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.485 ' CB ' HD21 ' A' ' 90' ' ' LEU . . . 69.47 -55.79 0.57 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.688 0.795 . . . . 0.0 112.007 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -65.48 -32.96 85.06 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.836 -0.506 . . . . 0.0 111.836 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.89 176.292 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.772 0.32 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 4' ' ' GLN . 2.5 p -90.16 -72.5 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 120.288 -0.565 . . . . 0.0 111.047 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.641 ' H ' HG13 ' A' ' 3' ' ' VAL . 61.0 tt0 159.02 57.69 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.671 0.789 . . . . 0.0 109.581 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -165.35 115.2 1.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.647 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -128.34 3.52 5.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.008 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.9 t -75.88 -33.6 59.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.235 0.541 . . . . 0.0 109.922 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.37 5.42 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.825 0.821 . . . . 0.0 109.648 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.94 -166.44 33.03 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.97 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -128.53 111.52 19.27 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.6 0.2 . . . . 0.0 110.88 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 28.8 Cg_exo -62.48 137.96 67.88 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.849 2.366 . . . . 0.0 111.896 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 29.8 Cg_exo -61.58 120.33 7.92 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.986 2.457 . . . . 0.0 112.067 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.79 57.47 6.51 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.893 2.395 . . . . 0.0 112.663 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.19 161.07 24.16 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.231 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.533 ' HG2' ' H ' ' A' ' 17' ' ' ASP . 32.8 ttp-105 -142.84 136.95 29.25 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.28 25.81 10.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.235 0.54 . . . . 0.0 110.36 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.533 ' H ' ' HG2' ' A' ' 15' ' ' ARG . 12.7 m-20 -124.03 76.02 1.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.654 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -105.58 -78.36 0.57 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 173.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.1 p -85.01 57.54 4.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.069 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.643 ' HA ' ' HB ' ' A' ' 24' ' ' THR . . . -140.46 71.62 1.37 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.983 -176.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.829 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -110.58 -66.55 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 1.3 Cg_endo -83.35 -82.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.323 2.015 . . . . 0.0 113.289 -174.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -101.87 23.93 10.69 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.922 0.392 . . . . 0.0 111.552 -174.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.643 ' HB ' ' HA ' ' A' ' 20' ' ' ALA . 2.4 m -96.91 19.69 12.29 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.991 0.901 . . . . 0.0 110.139 176.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HE ' ' HA ' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -105.95 -50.87 3.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 171.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.1 mt -138.85 82.13 1.88 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.016 173.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 5.7 t -68.38 134.2 91.07 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.348 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 27' ' ' THR . 40.1 Cg_exo -58.15 107.21 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.844 2.362 . . . . 0.0 111.89 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -79.89 79.21 6.44 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.811 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.71 141.3 57.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.92 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.732 HE21 ' HA ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -135.87 138.1 42.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.907 -178.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.93 116.3 10.62 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.59 79.89 0.27 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.361 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -128.87 148.48 50.91 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 172.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -101.93 -26.56 13.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.013 0.435 . . . . 0.0 110.883 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.549 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 64.9 t30 -91.58 -1.32 57.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.441 -175.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.511 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.5 OUTLIER -60.23 -33.5 72.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.602 0.239 . . . . 0.0 111.217 -177.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -67.93 -38.31 82.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.23 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.82 -30.57 65.64 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.884 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 60.0 mtt180 -68.2 -41.72 80.93 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 172.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 37' ' ' TRP . 88.8 mt -59.05 -46.03 92.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.855 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 39.7 m -56.47 -29.79 62.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.892 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.69 -43.03 69.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.567 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.51 -34.27 74.04 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.102 0.477 . . . . 0.0 110.465 178.076 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 101' ' ' ALA . 1.3 tt -61.17 -33.48 73.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.96 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.845 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.2 t-20 -70.85 -37.87 73.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.696 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -27.39 34.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.901 175.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.79 -62.07 1.29 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.236 176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 29.6 mtpp -164.0 103.14 0.88 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.845 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 56.3 ttp180 -117.81 103.29 9.83 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.58 176.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -77.3 112.8 25.92 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.11 131.38 44.94 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.592 2.194 . . . . 0.0 112.107 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.59 ' HE2' ' CE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -58.66 -22.69 57.55 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.683 -174.337 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.614 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 6.6 m-20 -55.07 -39.11 68.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.754 0.312 . . . . 0.0 110.982 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.12 -36.21 61.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.215 0.531 . . . . 0.0 110.417 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.4 mm? -67.6 -35.62 79.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.745 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.614 ' HE ' ' HA ' ' A' ' 54' ' ' ASP . 46.8 mtm180 -54.1 -39.42 66.36 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.828 0.347 . . . . 0.0 111.923 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.5 mp -94.62 -23.41 17.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.287 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.751 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 6.6 ttpp -113.56 -81.9 0.6 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.77 ' HD2' ' HA ' ' A' ' 90' ' ' LEU . 19.3 mmt180 -103.19 83.07 2.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.4 0.619 . . . . 0.0 111.42 -173.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.501 HE22 ' CB ' ' A' ' 130' ' ' ALA . 0.1 OUTLIER -105.29 144.06 32.6 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.854 173.219 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 1.013 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 162.08 131.9 1.27 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.675 -170.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.84 125.53 58.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.985 0.421 . . . . 0.0 110.843 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.7 164.76 24.34 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 55.5 mt-30 -115.42 127.13 55.14 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.402 HG23 ' CE2' ' A' ' 68' ' ' PHE . 27.4 m -118.07 139.64 44.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.347 0.594 . . . . 0.0 110.825 -174.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 45.4 ttp180 -112.98 138.09 50.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.908 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -154.96 148.91 25.72 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.343 0.592 . . . . 0.0 112.116 -177.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 15.3 m -93.51 129.72 39.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 169.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.675 HD13 ' HG ' ' A' ' 104' ' ' LEU . 47.5 mt -121.31 136.69 54.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.203 0.525 . . . . 0.0 111.915 -170.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.721 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 14.4 t70 -83.56 161.73 21.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.677 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG2' ' N ' ' A' ' 73' ' ' GLN . 2.4 ptp180 -54.78 -35.9 64.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.693 0.282 . . . . 0.0 111.632 -177.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.484 ' N ' ' HG2' ' A' ' 72' ' ' ARG . 15.4 pt20 -87.39 12.05 13.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.838 0.351 . . . . 0.0 111.26 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 103' ' ' PRO . . . 75.85 34.17 48.93 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.876 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.721 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 64.6 t60 -92.57 104.8 17.06 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.8 p -48.92 123.07 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.467 0.651 . . . . 0.0 111.377 173.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 13.6 mt -107.7 -43.08 4.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.528 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.85 153.58 51.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.865 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.435 ' HB ' ' HD2' ' A' ' 99' ' ' LYS . 11.3 m -140.15 129.36 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.302 0.572 . . . . 0.0 110.812 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.6 m -145.42 120.48 10.08 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.868 175.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 84' ' ' SER . 26.1 tp -72.97 108.25 5.78 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.519 HG21 HG23 ' A' ' 120' ' ' THR . 0.2 OUTLIER -80.46 -42.36 21.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.898 -172.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 65' ' ' GLN . 8.6 t -140.22 147.27 39.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.212 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.487 ' HB2' HD21 ' A' ' 81' ' ' LEU . 28.6 t -142.88 131.88 23.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.831 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.54 17.5 6.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.013 0.435 . . . . 0.0 110.856 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.517 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 94.86 65.92 1.0 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.926 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.912 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -111.81 90.08 12.4 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 117.085 0.442 . . . . 0.0 109.954 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 6.1 Cg_exo -73.91 -74.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.714 2.276 . . . . 0.0 111.802 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.4 m -74.89 -19.22 60.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.431 0.634 . . . . 0.0 110.386 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.912 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 9.6 mt -76.89 -42.37 40.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.762 -172.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.575 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 28.6 t70 -54.95 -50.16 69.59 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.67 0.606 . . . . 0.0 112.414 -170.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -53.25 -44.28 68.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -77.05 -53.17 8.14 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.794 0.33 . . . . 0.0 111.784 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 34.0 pt -60.53 -35.85 66.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.631 -176.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.689 HE22 HD11 ' A' ' 123' ' ' ILE . 51.3 mm-40 -82.91 -21.58 34.15 Favored 'General case' 0 C--O 1.205 -1.273 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.129 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.05 -54.06 44.52 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.142 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.664 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -75.72 -46.24 32.21 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.543 178.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.862 HG11 HG21 ' A' ' 123' ' ' ILE . 30.8 t -62.55 -49.21 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.54 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 1.3 tppp? -70.82 -35.63 72.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.191 -169.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -80.71 -34.9 34.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.848 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.619 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -101.15 67.65 1.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.193 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.0 m -97.33 97.69 4.12 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.182 0.515 . . . . 0.0 109.781 174.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.619 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 88.0 Cg_endo -107.93 173.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 124.245 3.297 . . . . 0.0 114.553 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.675 ' HG ' HD13 ' A' ' 70' ' ' LEU . 14.1 mt -140.61 122.39 9.45 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.617 171.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.488 ' HD3' HG12 ' A' ' 41' ' ' ILE . 12.2 Cg_endo -82.06 -40.17 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.657 2.238 . . . . 0.0 111.676 174.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.464 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 12.8 m -94.92 103.46 11.73 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.374 177.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.87 106.76 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.564 2.176 . . . . 0.0 112.234 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.707 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 67.9 Cg_endo -83.0 58.19 6.25 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.751 2.301 . . . . 0.0 111.813 -176.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.783 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.55 -46.21 77.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.832 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.92 -23.02 66.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.158 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.707 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.72 -35.89 18.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.075 -175.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.783 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.3 OUTLIER -105.78 15.91 26.04 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.008 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.505 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 3.6 m -72.15 89.52 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 169.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 2.3 p30 159.75 -22.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.212 -169.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 162.42 -85.09 0.11 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.737 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.551 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -159.4 173.22 16.57 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.723 HG13 ' HB3' ' A' ' 112' ' ' TYR . 24.5 m -104.98 110.4 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 121.328 0.585 . . . . 0.0 110.961 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 43.9 tt0 -107.78 110.65 22.5 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 170.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.604 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.7 pp -135.41 155.62 50.26 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.39 -174.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.519 HG23 HG21 ' A' ' 82' ' ' VAL . 99.9 m -101.08 129.13 46.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.107 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.604 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 54.3 mt -128.56 130.49 23.51 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 2.9 Cg_exo -76.12 121.48 6.17 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.791 2.327 . . . . 0.0 111.565 177.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.862 HG21 HG11 ' A' ' 98' ' ' VAL . 43.0 pt -97.76 99.98 9.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.49 119.04 29.58 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.347 -0.941 . . . . 0.0 111.124 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.59 ' CE2' ' HE2' ' A' ' 53' ' ' LYS . 83.2 m-85 -116.25 120.19 38.14 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 162.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.5 m -58.74 102.5 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -169.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 1.013 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 3.4 mt -73.23 114.13 11.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.104 0.478 . . . . 0.0 110.248 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.68 24.75 4.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.639 -175.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 145.42 61.12 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.819 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.501 ' CB ' HE22 ' A' ' 61' ' ' GLN . . . -169.0 164.55 11.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 89.29 -6.68 83.24 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.543 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 30.0 p90 . . . . . 0 C--O 1.252 1.195 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.014 179.026 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.8 m -126.77 29.24 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.215 0.531 . . . . 0.0 110.561 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -131.81 50.26 2.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -89.28 78.22 7.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.37 -170.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -91.52 -60.41 1.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.154 0.502 . . . . 0.0 110.349 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' A' ' 10' ' ' ALA . 23.9 t -94.64 117.97 30.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.52 -177.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.81 -57.36 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.542 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.84 24.63 14.4 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.106 -0.569 . . . . 0.0 113.605 -174.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.485 ' HB3' ' OG ' ' A' ' 7' ' ' SER . . . -114.64 111.86 45.89 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.432 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 36.4 Cg_endo -66.23 121.46 8.76 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.654 2.236 . . . . 0.0 111.823 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 40.3 Cg_endo -67.93 122.78 9.93 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.695 2.263 . . . . 0.0 111.782 178.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 28.0 Cg_exo -62.08 111.39 1.23 Allowed 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.7 2.266 . . . . 0.0 111.994 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -93.34 -54.4 1.71 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.632 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -127.6 110.42 12.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.727 0.299 . . . . 0.0 111.265 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.66 -55.59 4.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 46.54 73.18 0.19 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.328 -1.306 . . . . 0.0 112.85 170.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -137.66 138.53 39.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.622 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 m -88.68 -18.3 28.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.343 0.592 . . . . 0.0 110.333 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.3 61.7 6.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.806 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.743 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -118.73 -60.25 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.869 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 4.1 Cg_exo -74.99 -87.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.925 1.75 . . . . 0.0 113.041 -176.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -110.49 -27.57 8.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.609 -176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -78.22 44.53 0.5 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.228 0.537 . . . . 0.0 111.497 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.719 ' HG3' ' HG ' ' A' ' 26' ' ' LEU . 8.6 ptp180 -100.43 -18.94 16.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.247 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.719 ' HG ' ' HG3' ' A' ' 25' ' ' ARG . 83.9 mt -117.07 11.28 14.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.267 0.556 . . . . 0.0 110.384 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.1 p -89.33 121.37 69.44 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.722 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -68.92 103.91 1.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.532 2.155 . . . . 0.0 109.965 172.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -90.32 45.3 1.25 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.534 0.683 . . . . 0.0 110.637 -174.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 111' ' ' ALA . . . -90.31 -10.58 43.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.422 170.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.43 ' H ' ' HG2' ' A' ' 31' ' ' GLN . 8.0 pt20 -82.7 60.94 5.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.803 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.9 130.87 38.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.912 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.03 21.6 0.17 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.054 -0.594 . . . . 0.0 111.802 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -116.55 -40.39 3.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.051 -176.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.5 t70 66.72 139.14 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.509 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 178.46 -27.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.311 -1.313 . . . . 0.0 107.819 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.684 ' HA ' ' HG2' ' A' ' 40' ' ' ARG . 1.0 OUTLIER -74.99 -8.18 55.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.243 -1.344 . . . . 0.0 112.118 -178.032 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.581 ' HG3' ' N ' ' A' ' 39' ' ' SER . 9.6 ptp180 -63.6 -39.96 95.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.243 0.544 . . . . 0.0 109.874 176.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.581 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 3.5 m -67.58 -30.39 69.99 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.602 -178.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.684 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 16.8 mmt180 -71.72 -43.35 66.02 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.283 176.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.629 HG23 ' HD2' ' A' ' 103' ' ' PRO . 76.2 mt -59.85 -49.04 85.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.222 176.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.1 t -57.04 -30.24 64.08 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.605 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -68.21 -44.94 73.64 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.043 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.509 ' NE ' ' HB3' ' A' ' 105' ' ' PRO . 9.5 mpt_? -69.66 -34.49 74.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.973 0.416 . . . . 0.0 110.322 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 101' ' ' ALA . 2.7 tt -59.52 -32.28 70.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.761 0.791 . . . . 0.0 109.076 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 1.031 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 28.4 t30 -70.99 -42.32 69.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.156 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 8.0 ptt180 -61.29 -18.54 58.99 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.298 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -100.54 -58.47 1.89 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.153 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -162.59 103.08 1.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.864 0.466 . . . . 0.0 110.314 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 1.031 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 5.7 tpt180 -134.05 103.12 5.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 175.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.413 ' HB3' HD21 ' A' ' 56' ' ' LEU . 1.8 t80 -89.16 138.14 29.08 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.223 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.56 131.62 41.8 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.806 2.337 . . . . 0.0 111.996 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.01 -25.68 67.07 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.037 -173.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -54.1 -41.05 67.84 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.323 0.389 . . . . 0.0 110.913 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.1 -38.73 75.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.743 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.5 mm? -66.53 -38.73 87.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.549 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 69.8 mtt180 -65.71 -13.95 60.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.386 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 77.6 mt -110.85 2.1 18.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.792 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.596 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 21.1 ttmm -137.92 -74.42 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.532 -173.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.596 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 38.4 mmt180 -126.55 106.4 9.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 110.335 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.473 ' O ' HD13 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -117.78 158.19 25.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.612 178.437 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.976 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 153.29 144.17 3.85 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 119.79 -1.195 . . . . 0.0 113.345 -177.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.763 ' H ' HD12 ' A' ' 127' ' ' LEU . 2.8 p -104.13 122.77 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 121.373 0.606 . . . . 0.0 110.132 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.79 151.35 21.25 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.688 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 21.9 tt0 -105.63 135.42 47.06 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.53 131.67 71.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.014 0.435 . . . . 0.0 110.777 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -115.04 140.9 48.67 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.31 153.74 27.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.209 0.528 . . . . 0.0 111.757 -175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.676 ' CG2' ' HB ' ' A' ' 116' ' ' THR . 21.1 m -96.89 130.39 44.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.8 173.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 49.6 mt -118.35 133.98 55.43 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.111 0.481 . . . . 0.0 111.677 -173.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -77.71 155.9 30.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.186 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 72' ' ' ARG . 32.0 ttm180 -55.75 -33.71 64.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.003 0.43 . . . . 0.0 110.285 175.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -76.68 6.25 6.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.129 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.23 36.82 63.61 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.395 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -113.29 122.45 47.47 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 8.6 p -48.75 127.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.927 0.767 . . . . 0.0 111.522 172.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.419 ' CD1' HG21 ' A' ' 116' ' ' THR . 36.0 mt -113.71 -43.85 3.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.224 0.535 . . . . 0.0 110.73 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.79 154.21 48.24 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.168 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.508 HG11 ' HG3' ' A' ' 99' ' ' LYS . 3.1 m -147.66 127.08 4.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.0 m -144.64 127.83 16.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.5 tp -76.38 108.64 9.48 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.754 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -74.63 -34.26 34.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.637 0.732 . . . . 0.0 109.056 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 14.9 t 75.29 171.39 0.27 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.069 -1.423 . . . . 0.0 112.605 170.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m -153.67 -52.44 0.1 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.682 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.93 -79.1 0.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 168.49 103.68 0.17 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.513 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.772 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.7 OUTLIER -119.39 103.96 46.22 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -84.44 -81.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.24 1.96 . . . . 0.0 111.991 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.2 p -71.0 -19.02 62.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.192 0.52 . . . . 0.0 110.529 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.772 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 8.9 mt -75.12 -32.26 61.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.908 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 15.8 t70 -54.48 -50.38 67.9 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.896 -171.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 93' ' ' GLU . 17.0 ptp180 -52.64 -46.89 67.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.569 -175.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.451 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 11.1 mt-10 -78.46 -53.94 6.7 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.51 HD11 ' HG ' ' A' ' 87' ' ' LEU . 34.2 pt -62.32 -33.91 61.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.553 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 56.1 mm-40 -82.02 -29.56 31.94 Favored 'General case' 0 C--O 1.203 -1.392 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.371 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.37 -40.78 68.47 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.136 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.717 HD23 HG23 ' A' ' 98' ' ' VAL . 0.7 OUTLIER -63.81 -54.64 31.95 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.763 176.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.872 HG11 HG21 ' A' ' 123' ' ' ILE . 39.4 t -85.15 -48.55 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -174.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.553 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -63.59 -34.34 77.59 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.211 0.604 . . . . 0.0 110.865 -174.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -76.49 -48.3 19.99 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.247 0.546 . . . . 0.0 109.689 177.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.628 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -93.34 58.83 2.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.398 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.501 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 24.9 m -95.84 99.23 4.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.334 0.588 . . . . 0.0 109.939 174.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.629 ' HD2' HG23 ' A' ' 41' ' ' ILE . 72.9 Cg_endo -103.42 176.17 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 124.712 3.608 . . . . 0.0 113.441 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.663 HD21 ' HD2' ' A' ' 108' ' ' PRO . 38.5 tp -142.04 91.0 8.16 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.509 ' HB3' ' NE ' ' A' ' 44' ' ' ARG . 11.9 Cg_endo -70.46 -53.13 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.246 1.964 . . . . 0.0 112.824 -174.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.539 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 23.2 p -92.08 106.25 16.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -68.3 106.16 1.35 Allowed 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.822 2.348 . . . . 0.0 112.621 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.663 ' HD2' HD21 ' A' ' 104' ' ' LEU . 44.9 Cg_endo -86.66 61.18 4.4 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.195 2.596 . . . . 0.0 111.194 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.737 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.46 -41.54 80.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.17 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.99 -25.76 67.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.511 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.97 -29.76 21.79 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.84 ' HD2' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.72 16.41 16.39 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -172.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.5 m -71.36 88.36 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.655 HD22 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 154.95 -15.35 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 113.426 -1.716 . . . . 0.0 108.609 -167.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.655 ' N ' HD22 ' A' ' 114' ' ' ASN . . . 168.96 -100.21 0.16 Allowed Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.828 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.676 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.3 OUTLIER -161.15 176.67 11.04 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -177.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.84 HG13 ' HD2' ' A' ' 112' ' ' TYR . 12.3 m -101.5 108.77 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-O 121.585 0.707 . . . . 0.0 110.754 -177.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -99.0 111.25 23.7 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.596 HD12 ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -134.49 152.85 52.06 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.843 -173.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.754 HG23 HG21 ' A' ' 82' ' ' VAL . 54.8 m -103.42 128.07 50.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.395 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.596 ' HG ' HD12 ' A' ' 119' ' ' LEU . 98.3 mt -132.94 125.19 19.03 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.481 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.688 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 3.2 Cg_exo -79.97 120.18 4.14 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.947 1.764 . . . . 0.0 111.785 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.872 HG21 HG11 ' A' ' 98' ' ' VAL . 41.6 pt -96.6 98.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.559 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 3.4 p-10 -107.03 124.94 50.37 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.693 -176.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.427 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 82.8 m-85 -111.75 141.65 45.09 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 165.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.4 m -57.76 102.49 0.1 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.034 0.445 . . . . 0.0 111.614 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.976 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -85.9 69.69 10.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.331 -175.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 25.76 5.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.33 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 162.12 179.15 36.57 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.481 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.564 ' HB1' HD21 ' A' ' 90' ' ' LEU . . . 74.37 -50.01 0.67 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.557 0.743 . . . . 0.0 112.479 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.529 ' HA3' HD21 ' A' ' 127' ' ' LEU . . . -71.04 -25.33 75.94 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.381 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 29.4 p90 . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.716 178.104 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.8 mttp . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 110.559 -0.163 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 67.9 t 72.85 -49.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.623 0.769 . . . . 0.0 112.418 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -60.71 -24.85 65.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -173.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.439 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 27.5 mp0 -65.68 -35.07 79.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.183 0.516 . . . . 0.0 109.937 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -81.57 -22.52 37.72 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.453 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m -85.85 67.89 10.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.354 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.01 -51.6 38.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.91 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.91 163.06 33.02 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.729 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.98 106.82 13.81 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.684 0.278 . . . . 0.0 110.637 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -62.09 135.1 52.89 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.759 2.306 . . . . 0.0 111.87 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.76 119.95 6.56 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.674 2.249 . . . . 0.0 112.392 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.52 -12.23 20.53 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.073 2.515 . . . . 0.0 112.115 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.21 139.45 15.65 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -102.73 148.71 25.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.007 0.432 . . . . 0.0 111.081 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -160.08 99.51 1.36 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.519 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -125.87 130.79 52.04 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.136 -175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -133.61 104.71 6.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.707 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.2 p 64.46 -7.16 0.25 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.644 1.178 . . . . 0.0 113.742 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 24' ' ' THR . . . -94.68 36.35 1.18 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.599 0.714 . . . . 0.0 110.859 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.671 ' H ' ' HD2' ' A' ' 22' ' ' PRO . . . -114.7 -54.53 0.04 OUTLIER Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.492 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.671 ' HD2' ' H ' ' A' ' 21' ' ' ALA . 56.6 Cg_endo -72.71 -19.22 24.42 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 121.492 1.461 . . . . 0.0 111.775 175.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.44 ' NE2' ' HA ' ' A' ' 23' ' ' GLN . 12.8 mm-40 -120.7 41.07 3.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.22 0.533 . . . . 0.0 111.066 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 21' ' ' ALA . 14.8 t -98.46 29.54 3.6 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.017 0.913 . . . . 0.0 108.877 172.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -96.12 -73.42 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.467 178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.6 mp -141.46 65.61 1.38 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.495 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -67.67 126.02 92.04 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 121.073 0.463 . . . . 0.0 111.231 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -83.64 14.52 2.37 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.954 2.436 . . . . 0.0 112.387 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -103.93 31.39 4.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.492 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.505 ' HB1' HG12 ' A' ' 117' ' ' VAL . . . -88.33 20.58 3.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.81 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.539 HE22 HD13 ' A' ' 119' ' ' LEU . 6.1 tp-100 -81.47 73.1 8.52 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.402 0.62 . . . . 0.0 109.751 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.21 -4.56 59.1 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.107 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.6 115.94 4.04 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.187 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 1.1 pm0 -91.52 -1.62 57.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.266 0.555 . . . . 0.0 110.372 177.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -97.55 119.31 35.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 173.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -72.81 119.05 16.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.028 0.442 . . . . 0.0 110.728 -174.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 -82.43 25.04 0.65 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.797 -174.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -67.95 -35.76 78.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.453 -170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.8 p -63.48 -40.39 96.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.266 0.555 . . . . 0.0 110.144 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.511 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 50.8 mmm-85 -74.99 -46.24 36.56 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.268 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.551 HG23 ' HG2' ' A' ' 103' ' ' PRO . 58.3 mt -57.46 -43.19 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.549 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.7 m -59.73 -44.43 93.76 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.603 0.24 . . . . 0.0 111.51 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.85 -33.98 88.7 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.457 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.646 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 27.9 ttt85 -69.83 -35.73 75.01 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.75 0.309 . . . . 0.0 110.347 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -64.28 -31.55 72.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.379 0.609 . . . . 0.0 109.667 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.643 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 11.4 t30 -70.97 -30.69 67.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.631 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 47.9 ttt180 -70.18 -29.03 65.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.84 171.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 49' ' ' LYS . 61.3 m-85 -99.62 25.25 7.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.202 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 48' ' ' PHE . 13.0 tmtt? 74.2 103.36 0.07 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.493 0.664 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.643 ' HB3' ' HA ' ' A' ' 46' ' ' ASN . 32.3 ttt180 -137.89 108.0 6.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.191 -176.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.552 ' HB3' HD21 ' A' ' 56' ' ' LEU . 6.2 t80 -61.78 134.6 94.06 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.43 129.13 8.55 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.987 2.458 . . . . 0.0 112.06 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.758 ' HE2' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -71.49 -25.28 62.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.125 -163.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -66.93 -33.26 75.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.958 0.408 . . . . 0.0 110.77 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.85 -30.32 70.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.415 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.6 mm? -78.41 -41.68 32.31 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.765 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 51.4 mtm180 -75.1 -10.89 59.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.05 -0.406 . . . . 0.0 111.994 -174.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 33.3 tp -105.58 17.06 24.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.466 0.65 . . . . 0.0 109.803 176.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.549 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 25.0 ttmm -146.01 -54.27 0.27 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.371 -175.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.88 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 17.9 mmt180 -126.32 83.28 2.15 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.866 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.594 ' HB2' ' O ' ' A' ' 126' ' ' SER . 0.8 OUTLIER -100.15 137.3 38.78 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.552 -179.051 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.918 ' HA3' HD11 ' A' ' 87' ' ' LEU . . . 171.99 160.61 20.92 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.086 -1.054 . . . . 0.0 113.669 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.416 ' H ' HD12 ' A' ' 127' ' ' LEU . 2.6 p -116.35 125.72 73.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.173 0.511 . . . . 0.0 110.527 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.93 159.27 23.46 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.558 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 49.9 tt0 -104.27 123.74 47.9 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 121' ' ' LEU . 9.5 p -127.01 126.68 68.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.408 0.623 . . . . 0.0 111.041 -167.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -115.82 144.94 43.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.717 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -158.97 155.14 27.02 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.066 0.46 . . . . 0.0 110.937 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 22.0 m -100.52 129.35 46.45 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 171.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 75.5 mt -113.95 140.59 48.27 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.724 0.773 . . . . 0.0 112.146 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 27.9 t70 -77.7 165.16 24.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.85 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.505 ' HA ' ' OH ' ' A' ' 112' ' ' TYR . 38.6 mtp180 -54.39 -35.72 63.15 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.531 176.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -83.03 6.16 19.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 110.817 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 103' ' ' PRO . . . 72.8 40.1 53.49 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.623 -176.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 71.1 t60 -108.14 138.16 44.89 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.379 -0.41 . . . . 0.0 110.349 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 100' ' ' ARG . 10.5 p -59.24 130.94 23.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.348 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 71' ' ' ASP . 56.5 mt -120.27 -40.77 2.67 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.292 0.568 . . . . 0.0 110.282 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.2 148.04 51.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.981 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.77 123.99 58.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 123.564 0.54 . . . . 0.0 109.807 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 61.1 m -144.53 118.75 9.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.841 0.353 . . . . 0.0 111.376 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 84' ' ' SER . 34.3 tp -85.03 106.73 16.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 170.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -87.24 -46.69 16.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.196 -170.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 m -144.78 112.64 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.71 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.662 ' HB2' HD21 ' A' ' 81' ' ' LEU . 34.5 t -106.32 137.77 43.69 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 175.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.59 -7.56 59.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.266 0.555 . . . . 0.0 110.536 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.73 -86.23 0.14 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.032 ' HA ' HD12 ' A' ' 90' ' ' LEU . 2.3 mm? 44.24 59.03 13.38 Favored Pre-proline 0 CA--C 1.534 0.335 0 O-C-N 124.304 0.649 . . . . 0.0 112.495 173.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -61.92 -71.44 0.03 OUTLIER 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 121.334 1.356 . . . . 0.0 111.936 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.5 t -76.92 -18.64 58.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.462 0.649 . . . . 0.0 110.055 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 1.032 HD12 ' HA ' ' A' ' 87' ' ' LEU . 6.6 mt -75.91 -41.31 52.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.517 -172.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.456 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 19.2 t70 -53.95 -47.0 71.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.502 -172.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -54.64 -37.28 65.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.471 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.88 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 2.3 tp10 -78.49 -54.88 5.68 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -175.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.0 pt -68.8 -35.46 69.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.562 -173.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.605 ' NE2' HD11 ' A' ' 123' ' ' ILE . 56.5 mm-40 -79.87 -27.55 40.06 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.788 0.328 . . . . 0.0 110.649 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.24 -46.95 76.03 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 119.777 -0.769 . . . . 0.0 109.117 173.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.533 ' O ' HD21 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -63.97 -57.59 9.25 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.698 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.673 HG11 HG21 ' A' ' 123' ' ' ILE . 80.5 t -87.6 -48.82 15.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.588 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.7 ttmt -67.18 -27.09 66.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.044 -175.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.545 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 3.2 tmt_? -85.43 -53.92 4.9 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.016 174.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -96.49 65.52 2.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.739 0.304 . . . . 0.0 111.105 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.486 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 16.1 m -78.04 107.85 6.32 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.807 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.646 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 39.6 Cg_endo -101.49 139.41 0.19 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 124.022 3.148 . . . . 0.0 113.963 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -125.98 107.11 25.28 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 171.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.511 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 11.5 Cg_exo -65.05 -62.29 0.09 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 122.715 2.277 . . . . 0.0 112.622 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.499 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 8.8 t -80.73 123.28 82.58 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.706 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 14.9 Cg_exo -69.47 107.67 1.85 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.047 2.498 . . . . 0.0 111.862 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.572 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 43.1 Cg_endo -84.52 59.97 5.91 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.927 2.418 . . . . 0.0 111.542 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.687 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -54.27 -48.88 70.7 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.086 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -75.02 6.95 3.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.707 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -106.96 -38.1 6.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.566 177.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.801 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -106.88 18.05 22.33 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.4 m -69.9 87.92 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 122.447 1.118 . . . . 0.0 108.34 172.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 5.5 p30 166.54 -39.04 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.109 -1.86 . . . . 0.0 107.526 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.08 -75.17 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.987 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.478 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.8 OUTLIER -160.14 174.07 14.83 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.953 0.501 . . . . 0.0 109.958 -178.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.801 HG13 ' HB3' ' A' ' 112' ' ' TYR . 10.4 m -105.02 109.07 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 121.282 0.563 . . . . 0.0 110.861 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -103.42 111.77 24.36 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 169.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.6 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -142.97 150.18 39.34 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.91 -176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.404 ' CG2' ' HG2' ' A' ' 65' ' ' GLN . 32.2 m -99.79 128.14 45.9 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.209 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.6 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 83.7 mt -126.73 123.54 23.85 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.559 176.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 51.9 Cg_endo -73.32 123.64 8.87 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.547 1.498 . . . . 0.0 111.921 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.673 HG21 HG11 ' A' ' 98' ' ' VAL . 8.1 pt -98.45 97.84 6.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.42 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -104.16 124.07 48.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.673 0.749 . . . . 0.0 112.199 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.443 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 71.0 m-85 -117.06 151.2 37.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.397 169.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.594 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 10.3 m -61.02 102.8 0.22 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.063 0.227 . . . . 0.0 110.656 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.909 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.3 tt -83.26 77.15 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.236 0.541 . . . . 0.0 110.787 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -142.45 105.93 4.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.485 175.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 148.7 -57.36 0.47 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.3 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 90' ' ' LEU . . . -121.3 -171.12 2.15 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.427 ' CA ' HD11 ' A' ' 90' ' ' LEU . . . 91.42 8.76 63.88 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.1 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 24.9 p90 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.487 -0.768 . . . . 0.0 109.815 176.724 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.4 tttm . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 121.061 0.458 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.8 m -125.2 2.34 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.776 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.561 ' HG3' ' HB2' ' A' ' 7' ' ' SER . 44.6 tp60 -108.75 47.21 0.92 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.495 0.664 . . . . 0.0 109.308 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -74.89 118.41 17.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.662 -177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 64.35 70.09 0.5 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.595 0.712 . . . . 0.0 109.652 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.561 ' HB2' ' HG3' ' A' ' 4' ' ' GLN . 28.3 t -77.98 140.13 39.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.461 -175.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.3 m -99.05 175.43 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.823 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.04 158.22 18.45 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.957 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.488 ' O ' ' HD3' ' A' ' 12' ' ' PRO . . . -104.32 119.81 52.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.639 0.257 . . . . 0.0 110.963 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 18.1 Cg_endo -92.51 105.25 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.383 2.722 . . . . 0.0 112.286 176.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 10' ' ' ALA . 56.2 Cg_exo -52.09 -45.31 39.82 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.384 2.723 . . . . 0.0 114.71 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 12' ' ' PRO . 58.8 Cg_endo -71.77 54.48 2.05 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 121.923 1.748 . . . . 0.0 113.273 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.77 -42.99 24.42 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 15' ' ' ARG . 19.0 mtm180 -120.2 64.59 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.195 0.521 . . . . 0.0 109.991 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.33 68.36 10.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.347 0.594 . . . . 0.0 110.458 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -89.04 154.2 20.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.683 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' A' ' 18' ' ' LYS . 11.4 mptt -110.36 77.43 1.05 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.87 -178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.3 m -78.57 97.77 5.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.246 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.79 109.23 8.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.07 0.462 . . . . 0.0 110.767 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.708 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -151.0 174.08 3.84 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.55 -177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.708 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 9.8 Cg_endo -54.44 -22.91 29.12 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.157 1.904 . . . . 0.0 112.522 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -81.93 -26.2 34.25 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.6 p -82.79 27.43 0.53 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.106 0.479 . . . . 0.0 111.739 -174.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 22' ' ' PRO . 29.2 ptt180 -125.93 -4.25 6.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.728 173.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.404 ' HG ' ' HG3' ' A' ' 25' ' ' ARG . 92.4 mt -143.02 36.94 1.4 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.606 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.507 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 15.2 t -105.52 138.5 19.6 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 27' ' ' THR . 2.7 Cg_exo -77.54 61.1 7.35 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.388 2.725 . . . . 0.0 113.058 -176.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -131.38 109.58 10.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.03 0.443 . . . . 0.0 110.534 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.897 ' HB1' ' HA ' ' A' ' 111' ' ' ALA . . . -99.04 -68.19 0.81 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.722 176.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -174.33 -46.86 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.59 177.35 5.35 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.182 171.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.759 ' HA2' ' HZ2' ' A' ' 37' ' ' TRP . . . 118.66 3.9 13.67 Favored Glycine 0 CA--C 1.504 -0.631 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.924 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -95.87 -16.46 21.79 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.81 0.814 . . . . 0.0 108.893 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -110.36 162.79 14.31 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.222 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.465 ' OD1' ' HG2' ' A' ' 38' ' ' ARG . 43.1 t-20 -100.67 117.01 33.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.999 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.759 ' HZ2' ' HA2' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -104.87 1.86 29.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -175.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.465 ' HG2' ' OD1' ' A' ' 36' ' ' ASN . 25.0 ptt180 -67.89 -33.13 74.14 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.315 -170.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.5 p -70.85 -31.28 67.92 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.474 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 21.5 mmt180 -68.19 -46.18 71.35 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.516 HG23 ' HD2' ' A' ' 103' ' ' PRO . 88.8 mt -57.45 -44.76 85.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.211 177.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.5 t -56.2 -36.31 68.27 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.539 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.75 -42.4 98.6 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.148 -1.025 . . . . 0.0 111.507 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.672 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.75 -32.29 70.74 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.114 0.483 . . . . 0.0 110.7 177.159 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.27 -31.43 71.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.477 0.656 . . . . 0.0 109.696 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.622 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 10.0 t30 -71.52 -34.26 69.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.598 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -54.02 -25.56 21.86 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.592 173.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.582 ' HE2' ' HB3' ' A' ' 103' ' ' PRO . 97.5 m-85 -100.0 -61.11 1.41 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.017 174.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 11.6 mmmm -170.72 110.31 0.36 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.487 0.715 . . . . 0.0 109.533 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.622 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 45.7 ttp180 -125.03 111.91 15.93 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.985 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.632 ' H ' HD11 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -82.63 137.93 44.3 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.505 177.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.87 131.2 40.55 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.582 2.188 . . . . 0.0 111.622 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -59.63 -23.35 62.93 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.65 -171.493 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -53.69 -46.57 70.76 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 123.265 0.353 . . . . 0.0 111.145 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.9 -29.87 68.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.016 0.436 . . . . 0.0 111.477 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.2 mm? -75.47 -42.35 53.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 0.0 110.34 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 57' ' ' ARG . 59.9 mtt180 -70.65 -12.01 61.29 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 pp -109.79 7.74 24.29 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.946 -0.301 . . . . 0.0 110.972 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.607 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 19.3 ttpp -158.14 -69.8 0.09 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.607 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 22.2 mmt180 -90.23 82.6 6.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.257 1.027 . . . . 0.0 110.063 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.614 ' HB3' ' HA ' ' A' ' 127' ' ' LEU . 24.4 mt-30 -105.17 159.16 16.07 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.345 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.445 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.29 131.6 1.72 Allowed Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.795 -1.193 . . . . 0.0 112.656 177.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.578 HG22 ' HB2' ' A' ' 124' ' ' ASP . 60.6 t -104.22 123.08 57.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.98 166.4 30.42 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.142 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.581 ' H ' ' HA ' ' A' ' 83' ' ' SER . 53.8 mt-30 -102.75 131.43 49.6 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 123' ' ' ILE . 20.8 t -126.66 117.08 47.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.069 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.623 ' HD3' ' OE2' ' A' ' 118' ' ' GLU . 10.8 ttm180 -109.48 139.49 44.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.568 -176.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CD1' HD21 ' A' ' 70' ' ' LEU . 8.1 p90 -159.2 154.64 25.73 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.671 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 26.4 m -96.86 140.9 30.74 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.357 175.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.742 HD13 ' HB2' ' A' ' 104' ' ' LEU . 65.4 mt -124.37 138.58 54.36 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.588 0.709 . . . . 0.0 112.683 -170.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.629 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 13.6 t70 -73.04 157.65 36.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.435 172.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -57.67 -27.35 62.81 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.876 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -100.39 15.27 28.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.048 0.451 . . . . 0.0 110.864 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.708 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 75.8 46.76 13.21 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.094 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.629 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 53.2 t60 -110.52 122.23 47.24 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.6 p -50.57 116.38 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.551 0.691 . . . . 0.0 111.488 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.5 mt -100.81 -44.48 5.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.521 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -133.44 161.94 33.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.02 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.493 HG21 ' HG3' ' A' ' 99' ' ' LYS . 7.5 p -160.23 117.46 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-O 121.372 0.606 . . . . 0.0 109.589 175.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.2 m -124.37 112.83 17.41 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.714 -177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.0 tp -69.38 105.77 2.7 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.56 0.695 . . . . 0.0 109.818 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -86.98 -54.83 7.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.491 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.581 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 32.4 t 63.18 -175.01 0.15 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.249 170.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -152.03 -63.13 0.17 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.79 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.96 -37.98 13.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.975 0.417 . . . . 0.0 111.396 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.76 104.17 2.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.406 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.861 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 1.7 mm? -103.01 103.41 33.79 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 87' ' ' LEU . 2.7 Cg_exo -75.48 -80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.959 2.439 . . . . 0.0 112.862 -173.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.1 m -69.34 -19.5 63.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.442 0.639 . . . . 0.0 110.387 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.861 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.7 mt -75.7 -31.55 59.74 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.203 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 9.9 t70 -54.26 -48.9 70.66 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.602 0.564 . . . . 0.0 111.665 -173.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -53.21 -45.7 68.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -171.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.574 ' HB3' ' HG3' ' A' ' 60' ' ' ARG . 16.8 tt0 -78.77 -53.35 7.21 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.961 -176.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' A' ' 60' ' ' ARG . 38.7 pt -67.1 -37.31 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 -175.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.664 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 78.6 mm-40 -81.59 -25.72 35.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 120.881 0.372 . . . . 0.0 110.908 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -55.87 -43.47 77.18 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 169.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.632 HD11 ' H ' ' A' ' 51' ' ' TYR . 1.4 tp -67.6 -56.81 7.96 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.546 -1.206 . . . . 0.0 111.824 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.685 HG11 HG21 ' A' ' 123' ' ' ILE . 63.9 t -88.53 -49.13 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -175.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.664 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.6 ttmt -65.16 -22.56 66.93 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.003 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 2.6 tmt_? -90.99 -55.21 3.64 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.885 -0.509 . . . . 0.0 109.766 173.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.636 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -84.21 73.73 10.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 0.0 110.807 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.424 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 9.1 m -99.27 98.01 6.09 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 121.335 0.588 . . . . 0.0 109.577 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.672 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 93.6 Cg_endo -105.43 176.46 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 124.227 3.285 . . . . 0.0 113.686 -177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.742 ' HB2' HD13 ' A' ' 70' ' ' LEU . 4.0 tt -144.02 115.36 5.52 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.561 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 5.1 Cg_exo -70.75 -72.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.71 2.273 . . . . 0.0 112.757 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 0.5 OUTLIER -86.16 117.22 68.32 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.492 -177.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.516 ' HA ' HD21 ' A' ' 104' ' ' LEU . 24.8 Cg_exo -64.06 106.44 0.66 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.266 2.644 . . . . 0.0 112.293 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.737 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 61.4 Cg_endo -88.72 67.41 2.83 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.228 2.619 . . . . 0.0 112.071 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.78 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.69 -43.4 76.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.19 0.519 . . . . 0.0 110.051 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -72.52 -2.17 18.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.636 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.897 ' HA ' ' HB1' ' A' ' 30' ' ' ALA . . . -105.52 -29.69 10.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.78 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -106.66 16.52 24.42 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.576 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.6 m -71.44 89.16 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 168.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 4.4 p30 161.29 -24.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.89 -169.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 159.4 -76.01 0.19 Allowed Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.697 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.469 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -159.99 173.86 15.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.115 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 69' ' ' THR . 4.4 m -105.04 109.1 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.024 0.44 . . . . 0.0 111.235 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.623 ' OE2' ' HD3' ' A' ' 67' ' ' ARG . 32.6 tt0 -110.0 112.17 24.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 170.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.631 HD13 HD11 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -122.59 150.36 42.73 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.463 -175.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.453 HG23 HG21 ' A' ' 82' ' ' VAL . 29.3 m -102.09 119.01 38.09 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.413 0.625 . . . . 0.0 110.181 176.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.631 HD11 HD13 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -116.66 122.87 31.12 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -175.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 2.6 Cg_exo -75.29 120.16 5.86 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.603 1.535 . . . . 0.0 111.564 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.685 HG21 HG11 ' A' ' 98' ' ' VAL . 4.3 pt -104.0 114.8 44.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.578 ' HB2' HG22 ' A' ' 63' ' ' VAL . 5.1 p-10 -118.97 125.25 48.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.027 0.918 . . . . 0.0 111.794 -176.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.521 ' HE1' ' HE2' ' A' ' 53' ' ' LYS . 98.6 m-85 -114.22 131.02 56.62 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.215 -1.357 . . . . 0.0 107.8 167.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.9 m -60.52 102.93 0.2 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.992 0.182 . . . . 0.0 111.282 -174.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.614 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 3.3 mt -76.6 87.91 3.29 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.456 0.646 . . . . 0.0 110.498 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -80.71 -42.26 22.23 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.523 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -170.03 52.32 0.2 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.376 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.555 ' HB1' HD21 ' A' ' 90' ' ' LEU . . . -124.31 -156.64 0.73 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.579 ' HA2' HD11 ' A' ' 90' ' ' LEU . . . 103.88 -6.88 48.36 Favored Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -176.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 43.0 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.274 -178.318 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.7 tptt . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.15 -9.09 11.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.129 0.49 . . . . 0.0 110.864 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -81.91 69.2 8.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.688 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.546 ' O ' ' HB3' ' A' ' 13' ' ' PRO . 9.8 tp10 -128.83 91.3 3.19 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.565 175.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -81.69 83.85 6.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.275 -176.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.0 m -104.9 95.09 5.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.499 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.1 t -86.99 91.0 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.292 0.568 . . . . 0.0 109.849 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.16 -128.39 1.67 Allowed Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.38 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.418 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -80.31 -57.45 0.64 Allowed Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -175.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 46.5 Cg_endo -67.04 130.68 23.44 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.15 1.9 . . . . 0.0 113.123 -175.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.475 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 23.8 Cg_exo -66.19 143.41 71.08 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.973 2.448 . . . . 0.0 111.238 172.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.546 ' HB3' ' O ' ' A' ' 5' ' ' GLU . 31.4 Cg_exo -61.3 87.82 0.09 OUTLIER 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.623 2.882 . . . . 0.0 113.854 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.79 112.39 0.9 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.222 173.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -111.55 141.66 44.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.827 0.346 . . . . 0.0 110.217 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.29 88.15 2.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.198 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.469 ' OD2' ' HG3' ' A' ' 18' ' ' LYS . 6.0 p-10 -66.8 -26.39 66.92 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.72 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HG3' ' OD2' ' A' ' 17' ' ' ASP . 50.8 mttp -104.73 81.32 1.75 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.281 0.562 . . . . 0.0 109.867 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 m -85.27 68.03 10.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.672 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.3 42.42 1.1 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.297 0.57 . . . . 0.0 110.535 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -65.7 -51.39 49.78 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.231 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 98.7 Cg_endo -80.58 26.99 0.57 Allowed 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.846 1.698 . . . . 0.0 112.464 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.439 ' C ' ' H ' ' A' ' 25' ' ' ARG . 90.7 mt-30 -132.94 -62.95 0.79 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.225 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.6 m 71.16 -37.38 0.39 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.808 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.439 ' H ' ' C ' ' A' ' 23' ' ' GLN . 37.1 mmt180 63.35 8.55 3.53 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.668 0.747 . . . . 0.0 110.321 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 60.69 37.62 18.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.601 -1.636 . . . . 0.0 109.954 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.6 p -115.92 98.42 51.08 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-O 121.121 0.486 . . . . 0.0 111.407 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.36 149.97 40.77 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.437 2.091 . . . . 0.0 111.366 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -77.64 53.25 1.07 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.438 0.637 . . . . 0.0 110.978 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.58 -5.06 56.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.373 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -81.81 57.59 3.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.537 0.684 . . . . 0.0 110.788 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.13 24.91 8.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.564 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.33 71.52 2.99 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.922 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -72.55 68.84 0.83 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.654 0.381 . . . . 0.0 111.595 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 38' ' ' ARG . 18.6 t70 173.99 -26.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.318 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 35' ' ' ASP . 60.2 m-80 70.64 2.56 4.17 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.845 -171.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.6 m0 54.74 22.69 4.29 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.885 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 35' ' ' ASP . 16.7 ptt180 -67.02 -44.09 81.18 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -170.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.7 p -65.72 -38.75 90.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.43 0.633 . . . . 0.0 109.744 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.629 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 1.7 mmt180 -68.6 -47.57 66.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.751 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.49 HG23 ' HG2' ' A' ' 103' ' ' PRO . 43.7 mt -62.64 -37.55 79.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.589 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.8 m -55.09 -37.54 66.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.332 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -66.72 -44.59 89.13 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.057 176.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 47' ' ' ARG . 11.5 mpt_? -70.16 -32.36 70.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.032 0.444 . . . . 0.0 111.37 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.442 HD11 HG22 ' A' ' 98' ' ' VAL . 0.9 OUTLIER -63.14 -32.68 74.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.642 0.734 . . . . 0.0 109.367 176.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.689 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 14.4 t-20 -71.14 -30.97 67.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.589 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.515 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 3.2 ttt180 -58.45 -18.82 31.59 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.651 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -115.44 -59.34 2.02 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.366 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -160.43 105.64 1.47 Allowed 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 122.942 0.497 . . . . 0.0 109.798 -176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.689 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 22.0 tpt180 -105.78 102.52 11.96 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.08 176.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.603 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -90.3 125.7 59.17 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.364 179.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.34 132.36 29.21 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.37 2.047 . . . . 0.0 111.523 178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.502 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.68 -23.62 66.21 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.581 -175.134 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.31 -42.84 82.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.913 0.387 . . . . 0.0 110.837 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.29 -30.74 71.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.802 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.704 ' HG ' ' HE2' ' A' ' 125' ' ' PHE . 3.7 mm? -75.91 -41.31 52.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.259 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.64 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 98.5 mtt180 -58.08 -29.72 65.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.134 0.493 . . . . 0.0 111.307 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 72.9 mt -100.07 17.11 21.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.097 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.846 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 38.4 ttmt -145.86 -77.59 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.372 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.846 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 36.3 mmt180 -126.71 98.06 5.23 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -176.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.64 ' HG2' ' HA ' ' A' ' 57' ' ' ARG . 47.4 mt-30 -92.66 115.87 28.5 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.904 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -155.53 125.28 1.63 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.921 -1.133 . . . . 0.0 113.737 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.724 HG23 ' HA ' ' A' ' 124' ' ' ASP . 7.1 p -103.91 133.22 48.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.175 0.512 . . . . 0.0 109.969 176.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -158.05 168.44 34.54 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.622 -175.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.687 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 83.2 mt-30 -99.74 140.53 33.81 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.459 HG12 ' CD2' ' A' ' 68' ' ' PHE . 53.7 t -128.7 114.18 32.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.695 -173.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 22.7 ttp180 -106.2 129.08 54.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -147.83 151.51 36.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.295 0.569 . . . . 0.0 112.191 -174.218 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 9.0 m -99.94 125.61 45.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 169.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 41.7 mt -116.26 134.68 54.64 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.168 0.508 . . . . 0.0 111.757 -170.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 16.4 t70 -73.96 154.02 39.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.314 177.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -49.4 -40.75 37.37 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.34 0.4 . . . . 0.0 111.805 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -89.35 14.03 12.15 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.127 0.489 . . . . 0.0 111.309 -176.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.47 47.13 9.17 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.118 177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 73.6 t60 -109.58 116.18 31.28 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 p -48.74 115.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.331 0.586 . . . . 0.0 111.554 173.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.0 mt -103.3 -41.89 5.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.978 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -139.25 146.08 39.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.818 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 99' ' ' LYS . 1.4 m -143.76 117.13 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.422 0.63 . . . . 0.0 110.951 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.0 m -130.13 125.66 35.62 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.87 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.9 tp -71.6 119.07 15.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.205 0.526 . . . . 0.0 110.065 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.54 HG21 HG23 ' A' ' 120' ' ' THR . 0.1 OUTLIER -96.71 -38.78 8.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.434 -0.803 . . . . 0.0 108.982 179.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 12.4 t 67.06 -178.26 0.21 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.404 170.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.555 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 39.8 m -154.92 -58.04 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.289 -176.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -101.13 -66.6 0.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.327 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 161.65 104.82 0.19 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.812 -0.709 . . . . 0.0 111.753 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.82 ' HA ' HD12 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -118.42 77.82 13.98 Favored Pre-proline 0 C--N 1.32 -0.686 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.358 -178.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.63 -78.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.234 1.956 . . . . 0.0 111.809 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.9 m -67.68 -17.63 64.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.413 0.625 . . . . 0.0 110.297 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.82 HD12 ' HA ' ' A' ' 87' ' ' LEU . 17.6 mt -75.21 -33.66 61.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.921 -176.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 18.5 t70 -53.98 -50.52 66.37 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.591 0.557 . . . . 0.0 112.031 -173.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.574 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 0.7 OUTLIER -54.56 -48.6 71.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.114 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.76 -55.19 5.54 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -174.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 90' ' ' LEU . 36.0 pt -68.61 -34.05 63.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-O 121.407 0.623 . . . . 0.0 110.933 -171.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.816 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.8 mm-40 -84.66 -17.46 38.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.005 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 92' ' ' ARG . . . -55.64 -55.78 28.05 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.835 176.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.613 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.2 -48.19 21.32 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.148 179.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.722 HG11 HG21 ' A' ' 123' ' ' ILE . 55.8 t -70.54 -49.49 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.816 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 36.9 ttmt -73.97 -16.53 61.07 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 122.064 -0.398 . . . . 0.0 110.724 -173.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -88.29 -47.37 8.47 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.678 171.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.606 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -92.32 67.79 4.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.801 0.334 . . . . 0.0 110.914 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.2 m -95.57 99.67 5.06 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.291 0.567 . . . . 0.0 110.005 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 90.8 Cg_endo -102.79 176.32 0.18 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 124.042 3.161 . . . . 0.0 113.711 -175.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 48.9 tp -142.9 85.6 9.87 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.304 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.629 ' CG ' ' HB2' ' A' ' 40' ' ' ARG . 10.0 Cg_endo -59.44 -53.94 2.99 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.278 1.986 . . . . 0.0 112.677 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.618 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.4 m -81.03 116.74 64.54 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.75 99.23 1.28 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.986 2.457 . . . . 0.0 111.118 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.829 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 37.9 Cg_endo -90.93 66.45 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.363 2.708 . . . . 0.0 112.386 -171.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.724 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.59 -45.92 84.66 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.203 0.525 . . . . 0.0 109.921 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -67.22 -6.28 17.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.7 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.829 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -101.41 -36.19 8.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.488 -178.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.774 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -112.43 18.85 18.12 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -171.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.2 m -69.26 88.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-O 122.134 0.969 . . . . 0.0 108.686 175.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.441 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 3.8 p30 164.11 -27.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.459 -1.7 . . . . 0.0 107.636 -170.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 172.28 -81.92 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.09 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.486 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.3 OUTLIER -160.81 175.49 12.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -177.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.774 HG13 ' HB3' ' A' ' 112' ' ' TYR . 10.7 m -102.35 108.69 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.329 0.585 . . . . 0.0 110.842 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 37.0 tt0 -108.8 112.5 24.8 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 170.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.651 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -136.38 154.35 50.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 -173.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.54 HG23 HG21 ' A' ' 82' ' ' VAL . 98.6 m -98.43 113.44 25.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.703 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.651 ' HG ' HD12 ' A' ' 119' ' ' LEU . 42.7 mt -117.95 123.76 29.31 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.19 176.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.2 Cg_exo -73.53 118.9 5.67 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.994 1.796 . . . . 0.0 111.212 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.722 HG21 HG11 ' A' ' 98' ' ' VAL . 33.5 pt -93.61 116.68 35.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.724 ' HA ' HG23 ' A' ' 63' ' ' VAL . 1.5 t70 -100.53 120.91 40.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.996 0.903 . . . . 0.0 112.856 -172.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.704 ' HE2' ' HG ' ' A' ' 56' ' ' LEU . 6.7 m-85 -115.6 130.53 56.9 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 160.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 61' ' ' GLN . 13.4 m -59.19 103.46 0.18 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.294 0.497 . . . . 0.0 110.703 -177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.904 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -77.76 66.76 3.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.059 -177.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -84.64 -53.29 5.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.182 0.515 . . . . 0.0 109.857 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -137.92 110.4 0.75 Allowed Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.757 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.656 ' HB1' HD21 ' A' ' 90' ' ' LEU . . . -124.68 168.01 13.75 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.114 0.483 . . . . 0.0 112.029 -173.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -98.46 76.9 0.57 Allowed Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 33.9 p90 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.357 -178.43 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.727 0.299 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 64.3 t -82.81 -56.79 5.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 52.55 68.56 0.81 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.684 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -162.52 -53.24 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.863 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 64.47 81.73 0.2 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.416 0.627 . . . . 0.0 109.809 -173.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -73.66 -28.24 61.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.247 -177.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.68 162.36 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.612 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.42 156.08 11.45 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.486 ' O ' ' HD3' ' A' ' 12' ' ' PRO . . . -115.01 93.5 35.02 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 120.582 0.23 . . . . 0.0 110.585 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -91.85 103.82 0.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.224 2.616 . . . . 0.0 111.614 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . 26.2 Cg_exo -62.5 112.76 1.68 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.732 2.288 . . . . 0.0 111.983 -177.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 15.8 Cg_exo -67.84 102.12 0.73 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.072 2.515 . . . . 0.0 111.94 -177.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.16 18.62 0.65 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.144 -177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.572 ' NE ' ' HA ' ' A' ' 15' ' ' ARG . 1.9 mmp_? 57.75 38.04 27.32 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 122.584 0.353 . . . . 0.0 111.759 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 12' ' ' PRO . . . -85.41 53.86 2.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.327 0.584 . . . . 0.0 110.004 177.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -116.31 115.8 26.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.533 -177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -131.99 11.02 4.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.292 177.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.5 m -61.08 -67.13 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.565 -173.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.32 41.98 1.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.136 0.494 . . . . 0.0 111.027 -177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.673 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -61.56 -56.19 35.49 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.312 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 68.4 Cg_endo -88.05 -2.7 7.12 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.023 1.815 . . . . 0.0 112.431 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -88.76 -27.02 21.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.344 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -81.06 44.15 0.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.857 0.837 . . . . 0.0 110.49 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -101.27 -31.0 11.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.275 172.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -167.02 88.21 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.694 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.3 m -59.84 121.43 58.06 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.816 171.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.08 20.72 0.63 Allowed 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 122.944 2.43 . . . . 0.0 114.153 -171.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -173.24 107.95 0.16 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.072 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.3 118.46 22.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.408 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -88.58 95.37 10.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.948 0.404 . . . . 0.0 110.633 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.57 117.89 30.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.041 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.6 67.99 3.55 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.803 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 37' ' ' TRP . 0.4 OUTLIER -81.21 80.95 7.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.319 0.58 . . . . 0.0 109.857 178.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -119.15 -40.81 2.79 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.581 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -135.74 32.57 2.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.87 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 0.5 OUTLIER -90.08 -25.86 20.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.55 -177.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 38' ' ' ARG . 5.7 ptp180 -66.02 -31.97 73.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.83 -177.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.3 p -71.23 -33.13 69.59 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HB2' ' CG ' ' A' ' 105' ' ' PRO . 10.1 mmt180 -70.65 -46.28 63.54 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.559 ' N ' ' HG3' ' A' ' 105' ' ' PRO . 80.3 mt -57.31 -45.8 85.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.866 175.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.9 m -61.42 -34.43 75.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.485 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.537 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -66.38 -37.81 93.07 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.44 -0.886 . . . . 0.0 110.996 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.654 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.4 OUTLIER -69.22 -33.71 73.72 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.314 0.578 . . . . 0.0 110.185 176.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.39 -26.02 67.81 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.777 177.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.632 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.4 t-20 -70.56 -33.58 71.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.39 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.546 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 1.4 ttt180 -55.27 -28.4 53.13 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.357 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.582 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 91.2 m-85 -99.45 -58.99 1.8 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.219 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 48' ' ' PHE . 32.5 mtmt -178.91 103.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.521 1.128 . . . . 0.0 108.691 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.632 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 55.4 ttp180 -110.77 104.39 13.03 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.791 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.559 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.7 OUTLIER -92.24 126.58 52.32 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.26 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.93 133.13 51.63 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 123.009 2.473 . . . . 0.0 112.462 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.61 -26.3 66.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.216 -169.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.68 -35.82 77.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.17 0.51 . . . . 0.0 110.5 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.46 63.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.976 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.6 mm? -75.98 -42.69 47.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.671 0.272 . . . . 0.0 110.965 -178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' HA ' ' HB3' ' A' ' 61' ' ' GLN . 4.4 ptp180 -66.6 -11.91 55.56 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.952 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.1 tp -112.94 10.57 18.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.24 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.599 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 23.1 ttmm -150.92 -77.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.121 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 1.064 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 28.5 mmt180 -112.34 84.58 2.0 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -94.91 170.95 9.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.274 -178.345 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.754 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.58 123.28 0.99 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.174 -1.012 . . . . 0.0 113.093 178.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.631 HG12 HD12 ' A' ' 127' ' ' LEU . 6.9 p -104.76 125.55 59.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.223 0.535 . . . . 0.0 109.866 176.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.67 165.15 28.8 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.883 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 36.2 tt0 -103.98 124.37 48.88 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.441 HG21 HD13 ' A' ' 123' ' ' ILE . 60.5 t -128.63 118.63 47.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.73 -170.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 1.2 ptp180 -113.14 145.54 40.77 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -156.86 157.6 35.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.311 0.577 . . . . 0.0 111.788 -175.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.676 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 1.9 m -107.74 127.56 53.79 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 172.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.657 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 36.6 mt -117.56 132.04 56.59 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.253 0.549 . . . . 0.0 111.997 -166.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.537 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 20.6 t70 -68.79 152.22 45.6 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.23 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.465 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 69.6 mtt180 -61.41 -17.27 53.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.449 -1.25 . . . . 0.0 112.414 -175.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -101.03 3.83 41.79 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.321 0.582 . . . . 0.0 110.331 175.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 86.89 41.49 6.71 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.25 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.537 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 79.9 t60 -114.35 125.63 54.08 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 8.6 p -53.3 122.25 3.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.357 0.598 . . . . 0.0 111.267 175.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.8 mt -104.34 -40.84 5.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.632 0.729 . . . . 0.0 109.552 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -138.59 151.55 47.37 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.636 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.17 122.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.358 0.599 . . . . 0.0 110.027 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.1 m -129.3 127.63 41.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.343 -176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 84' ' ' SER . 25.4 tp -75.54 107.81 7.93 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 174.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.651 HG21 HG23 ' A' ' 120' ' ' THR . 0.1 OUTLIER -83.42 -41.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.382 -170.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.6 m -154.44 135.31 13.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.88 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.667 ' HB2' HD21 ' A' ' 81' ' ' LEU . 34.1 t -122.93 135.86 54.65 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.79 -19.36 41.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.657 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.474 ' H ' HD22 ' A' ' 87' ' ' LEU . . . 133.12 63.33 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.973 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.913 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -118.23 87.65 30.27 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.97 -73.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.554 2.169 . . . . 0.0 111.769 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 9.3 m -72.91 -18.92 61.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.34 0.59 . . . . 0.0 110.245 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.913 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 17.0 mt -76.83 -37.25 56.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.719 -175.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.445 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 17.0 t70 -54.6 -48.82 71.7 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.189 -174.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 89' ' ' SER . 16.8 ptp180 -54.34 -42.25 70.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.595 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 1.064 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 4.9 tp10 -77.79 -54.66 6.08 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.978 0.418 . . . . 0.0 111.949 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.525 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 38.1 pt -72.48 -33.48 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.754 -172.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.623 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 77.1 mm-40 -82.52 -25.95 32.95 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 120.867 0.365 . . . . 0.0 110.737 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.552 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.01 -43.44 77.7 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 169.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.722 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -66.6 -57.05 8.04 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.157 -1.383 . . . . 0.0 112.14 179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.736 HG11 HG21 ' A' ' 123' ' ' ILE . 79.3 t -88.42 -49.49 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.623 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 36.3 ttmt -65.54 -24.65 67.17 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.63 0.372 . . . . 0.0 111.329 -174.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.552 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 28.3 tpt180 -97.14 -35.78 10.68 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.492 175.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.469 ' HB1' ' CD2' ' A' ' 48' ' ' PHE . . . -102.78 61.78 0.81 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.834 177.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.494 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 6.3 m -83.11 104.64 3.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.261 0.553 . . . . 0.0 109.995 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.654 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 37.9 Cg_endo -99.81 153.32 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.769 2.979 . . . . 0.0 114.604 -171.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.742 HD21 ' HD2' ' A' ' 108' ' ' PRO . 22.4 tp -125.41 100.48 32.11 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.342 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.637 ' HA ' ' NE ' ' A' ' 44' ' ' ARG . 2.4 Cg_endo -69.0 -81.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.142 1.894 . . . . 0.0 113.278 -174.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.43 ' HB ' ' HE1' ' A' ' 37' ' ' TRP . 31.5 m -79.91 110.21 15.13 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 27.0 Cg_exo -62.16 108.01 0.63 Allowed 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.898 2.399 . . . . 0.0 112.098 -175.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.742 ' HD2' HD21 ' A' ' 104' ' ' LEU . 97.9 Cg_endo -75.49 62.48 6.26 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.072 2.515 . . . . 0.0 111.569 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.77 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -58.33 -35.47 71.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.383 0.611 . . . . 0.0 110.24 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.33 -7.79 27.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.945 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.45 -21.53 10.82 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -175.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.77 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -131.76 19.56 4.64 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -168.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.1 m -69.8 89.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-O 122.412 1.101 . . . . 0.0 109.753 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.674 HD22 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 160.94 -16.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 112.723 -2.035 . . . . 0.0 107.752 -172.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.674 ' N ' HD22 ' A' ' 114' ' ' ASN . . . 172.2 -92.46 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.341 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.537 ' OG1' HG22 ' A' ' 69' ' ' THR . 0.6 OUTLIER -161.44 176.41 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 122.894 0.477 . . . . 0.0 110.245 -173.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.688 HG13 ' HD2' ' A' ' 112' ' ' TYR . 2.9 m -104.94 119.03 53.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.485 -173.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -104.14 112.45 25.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.565 HD12 ' HG ' ' A' ' 121' ' ' LEU . 0.5 OUTLIER -133.52 154.3 50.95 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.631 -174.311 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.651 HG23 HG21 ' A' ' 82' ' ' VAL . 62.5 m -109.23 123.3 49.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.772 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.565 ' HG ' HD12 ' A' ' 119' ' ' LEU . 65.1 mt -129.91 128.38 22.89 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.366 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.2 Cg_exo -73.45 119.36 5.92 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.647 1.565 . . . . 0.0 110.385 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.736 HG21 HG11 ' A' ' 98' ' ' VAL . 19.4 pt -95.42 126.04 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -114.94 121.54 43.48 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.26 -176.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.525 ' CE1' ' HB ' ' A' ' 94' ' ' ILE . 75.7 m-85 -113.25 120.03 39.77 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 159.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.9 m -56.43 103.66 0.11 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.118 0.485 . . . . 0.0 111.381 -168.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.754 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.1 mt -70.78 94.87 1.07 Allowed 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.451 -174.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -132.41 31.07 4.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.645 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -153.98 -112.74 0.48 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.006 -1.092 . . . . 0.0 113.85 -172.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.524 ' HB3' HD21 ' A' ' 90' ' ' LEU . . . -79.24 46.31 0.71 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -167.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -113.44 33.19 5.66 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 172.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.445 ' CE1' ' HA ' ' A' ' 130' ' ' ALA . 39.0 p90 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.364 -177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.516 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 14.3 mptt . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.589 0.233 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.4 m -96.84 -25.18 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.187 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -80.08 -31.02 39.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.427 0.632 . . . . 0.0 110.373 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.516 ' OE1' ' HA ' ' A' ' 2' ' ' LYS . 17.8 mp0 -76.88 8.49 3.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.139 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -92.98 3.51 55.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.933 0.397 . . . . 0.0 110.332 177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.8 t -91.1 -162.69 0.94 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.158 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.8 t 61.26 61.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 121.766 0.793 . . . . 0.0 109.877 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.94 14.49 28.94 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.666 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.478 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -63.45 -54.61 42.32 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 115.811 -0.194 . . . . 0.0 111.369 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 62.2 Cg_endo -73.76 129.75 13.87 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 121.658 1.572 . . . . 0.0 112.072 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 24.5 Cg_exo -63.22 139.9 74.68 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.817 2.344 . . . . 0.0 111.645 177.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.91 40.28 0.79 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.999 2.466 . . . . 0.0 112.577 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.98 -111.17 3.77 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.961 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -143.01 127.34 17.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.716 0.293 . . . . 0.0 110.431 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.56 96.54 3.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.918 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.44 -25.7 41.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.467 0.651 . . . . 0.0 109.574 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HG2' ' H ' ' A' ' 18' ' ' LYS . 16.0 ptpt -86.72 142.71 27.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.062 -176.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.0 t -102.72 -22.19 13.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.25 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.54 84.71 7.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.19 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.595 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -146.91 -54.04 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -175.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 14.7 Cg_exo -68.4 -88.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.949 1.766 . . . . 0.0 113.021 -175.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.421 ' H ' ' HB2' ' A' ' 22' ' ' PRO . 4.7 tp-100 -129.17 32.32 4.73 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.63 0.729 . . . . 0.0 110.3 -177.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 p -68.78 -11.44 60.36 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.493 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -73.3 -15.29 61.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.126 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.4 mt -115.64 45.39 1.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.171 0.51 . . . . 0.0 110.311 177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 12.9 t -78.56 133.56 62.99 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.011 176.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 27' ' ' THR . 5.7 Cg_endo -86.67 79.93 1.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.188 2.592 . . . . 0.0 112.629 -177.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.428 ' CE1' ' HB3' ' A' ' 32' ' ' ALA . 67.9 t80 -106.73 108.11 19.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.479 176.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.85 127.5 8.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.749 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 53.22 65.77 1.42 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.963 0.79 . . . . 0.0 111.156 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.57 ' HA ' ' CZ2' ' A' ' 37' ' ' TRP . . . -138.54 47.87 1.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.492 -177.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -135.62 38.35 1.8 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.046 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 49.63 62.75 2.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 122.144 0.973 . . . . 0.0 110.166 -171.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.13 39.58 0.65 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.804 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 57.13 61.89 2.41 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.016 -172.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.587 ' O ' HG13 ' A' ' 41' ' ' ILE . 8.7 p-90 -127.27 -51.99 1.4 Allowed 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.82 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.594 ' HA ' HD12 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -69.16 -36.05 76.97 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.374 0.534 . . . . 0.0 111.666 -174.321 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -33.62 74.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.805 0.812 . . . . 0.0 109.795 177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.524 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 27.0 mmm180 -73.0 -32.73 65.33 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.507 175.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.594 HD12 ' HA ' ' A' ' 38' ' ' ARG . 62.1 mt -61.04 -39.71 83.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.512 173.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.3 m -55.14 -39.94 70.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.835 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.16 -36.5 92.98 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.636 -0.793 . . . . 0.0 111.952 173.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.688 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.2 OUTLIER -69.36 -34.9 75.28 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.374 0.607 . . . . 0.0 110.097 178.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 98' ' ' VAL . 0.4 OUTLIER -67.13 -26.76 66.84 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.3 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.631 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 11.6 t30 -70.43 -33.38 71.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.788 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 7.6 ptt180 -60.41 -17.99 47.71 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.018 173.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -109.58 -58.54 2.03 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.495 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -167.88 101.41 0.47 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.694 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.631 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 17.0 ttp180 -111.55 102.31 10.66 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.218 171.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.56 ' HD1' ' HD2' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -97.63 117.11 65.7 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.568 -173.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.56 ' HD2' ' HD1' ' A' ' 51' ' ' TYR . 52.8 Cg_exo -53.35 131.06 41.46 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.659 2.239 . . . . 0.0 111.65 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.67 -25.2 67.24 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.552 -173.067 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -56.61 -43.26 80.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.046 0.45 . . . . 0.0 110.803 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.18 -30.81 69.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.13 0.491 . . . . 0.0 110.554 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.554 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 3.6 mm? -74.55 -32.94 62.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.524 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.873 ' HA ' ' HG2' ' A' ' 61' ' ' GLN . 22.2 mtm180 -62.0 -20.32 63.78 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.748 0.308 . . . . 0.0 111.54 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.9 mp -107.15 14.84 25.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.65 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.823 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 37.5 ttpt -150.79 -84.61 0.09 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.295 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.823 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 32.3 mmt-85 -122.02 86.27 2.55 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.936 -0.478 . . . . 0.0 111.426 -174.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.873 ' HG2' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -111.68 115.23 28.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.151 0.501 . . . . 0.0 110.448 172.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.83 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -146.54 140.05 8.47 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.544 175.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.918 HG12 HD12 ' A' ' 127' ' ' LEU . 7.1 p -103.61 138.14 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.991 0.424 . . . . 0.0 109.915 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.556 ' HA3' ' OG ' ' A' ' 83' ' ' SER . . . -168.02 169.27 41.29 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.684 -176.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 54.0 mt-30 -98.87 141.07 32.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.462 HG12 ' CE2' ' A' ' 68' ' ' PHE . 55.4 t -130.83 114.65 27.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.5 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 21.9 ttm180 -111.71 141.37 45.4 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -174.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.462 ' CE2' HG12 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -159.22 155.5 27.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.153 0.501 . . . . 0.0 111.605 -176.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.711 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 48.8 m -98.47 123.92 42.88 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 170.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.461 HD11 ' CE1' ' A' ' 68' ' ' PHE . 73.0 mt -113.42 148.45 35.84 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.145 0.498 . . . . 0.0 112.29 -170.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.662 ' HB3' ' HB3' ' A' ' 75' ' ' HIS . 33.4 t70 -92.79 166.68 12.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.627 175.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -53.87 -39.81 66.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -90.12 9.1 29.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.042 0.448 . . . . 0.0 111.164 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 103' ' ' PRO . . . 77.13 47.3 9.34 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.084 -175.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.662 ' HB3' ' HB3' ' A' ' 71' ' ' ASP . 78.9 t60 -100.28 100.77 11.63 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.3 p -47.47 115.01 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.763 0.792 . . . . 0.0 111.457 176.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 15.5 mt -98.32 -35.3 10.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.987 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -136.31 143.76 44.33 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.102 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.5 m -119.19 129.46 75.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.035 0.445 . . . . 0.0 110.082 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 69.8 m -130.99 122.23 26.47 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.323 0.582 . . . . 0.0 110.911 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.5 tp -78.96 115.62 18.76 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.783 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 65' ' ' GLN . 0.9 OUTLIER -121.64 -25.17 2.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.118 -177.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.556 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 7.5 t -48.96 119.54 3.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.811 -1.54 . . . . 0.0 110.913 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -144.35 43.49 1.41 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.428 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.69 13.88 18.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.089 0.471 . . . . 0.0 110.33 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.61 ' O ' ' HD3' ' A' ' 88' ' ' PRO . . . 81.18 61.1 2.15 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.768 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.762 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.8 OUTLIER -110.84 84.15 4.05 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.495 -179.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.61 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 5.7 Cg_exo -78.05 -75.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.677 2.251 . . . . 0.0 112.142 -177.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.3 p -69.29 -18.98 63.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.495 0.664 . . . . 0.0 110.497 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.762 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 28.4 mt -74.62 -39.59 62.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.269 -175.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.532 ' OD2' ' HG3' ' A' ' 95' ' ' GLN . 4.8 t70 -53.4 -50.47 65.1 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.585 0.553 . . . . 0.0 111.875 -173.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -54.58 -45.65 73.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -76.63 -53.51 7.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.792 0.329 . . . . 0.0 111.332 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.671 HG12 ' O ' ' A' ' 90' ' ' LEU . 48.1 pt -70.26 -32.45 50.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -171.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.588 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 25.7 mm-40 -82.48 -30.04 30.18 Favored 'General case' 0 C--O 1.213 -0.852 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.281 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.54 -44.66 81.1 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 170.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.61 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -60.88 -59.42 5.41 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.289 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.754 HG11 HG21 ' A' ' 123' ' ' ILE . 76.2 t -89.94 -49.39 13.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.588 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 38.1 ttmt -66.18 -27.23 67.85 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -172.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.549 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 29.8 tpt180 -91.2 -30.8 16.46 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.492 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.599 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -108.08 67.69 0.68 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.936 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.463 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 5.5 m -96.49 97.96 3.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.226 0.536 . . . . 0.0 110.458 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.688 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 37.5 Cg_endo -104.14 168.56 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.471 3.447 . . . . 0.0 114.599 -173.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.588 HD13 ' HG3' ' A' ' 108' ' ' PRO . 19.9 mt -145.39 122.4 6.15 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.309 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.524 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 7.9 Cg_endo -82.39 -47.56 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.587 2.191 . . . . 0.0 111.664 175.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.0 m -90.27 113.31 56.93 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.742 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.18 108.3 0.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.601 2.2 . . . . 0.0 111.451 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.692 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 94.3 Cg_endo -82.07 51.1 3.67 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.831 2.354 . . . . 0.0 112.901 -173.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.642 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -60.74 -37.7 82.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.284 0.564 . . . . 0.0 109.625 175.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -75.06 3.71 8.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.875 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.51 -23.44 9.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.777 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.729 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -127.5 18.27 6.91 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.289 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.4 m -70.36 88.32 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 122.198 0.999 . . . . 0.0 109.19 175.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.601 HD22 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 158.58 -12.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 113.284 -1.78 . . . . 0.0 108.645 -170.014 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.601 ' N ' HD22 ' A' ' 114' ' ' ASN . . . 163.13 -87.08 0.1 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.449 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.436 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.7 OUTLIER -160.23 175.39 12.94 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -175.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.729 HG13 ' HB3' ' A' ' 112' ' ' TYR . 5.7 m -103.22 107.94 23.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -109.82 110.06 20.93 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 170.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.523 HD12 ' HG ' ' A' ' 121' ' ' LEU . 1.4 pp -143.46 146.36 33.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.875 0.369 . . . . 0.0 110.308 -174.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' A' ' 65' ' ' GLN . 86.2 m -93.98 117.08 29.6 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.191 -177.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.523 ' HG ' HD12 ' A' ' 119' ' ' LEU . 46.9 mt -111.13 122.87 36.66 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.5 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 4.7 Cg_exo -74.08 119.14 5.69 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.885 1.723 . . . . 0.0 110.617 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.754 HG21 HG11 ' A' ' 98' ' ' VAL . 18.7 pt -98.34 118.26 44.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.499 ' HA ' HG23 ' A' ' 63' ' ' VAL . 12.6 t70 -108.03 122.23 46.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.719 0.771 . . . . 0.0 112.087 -172.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.481 ' CE2' ' HG ' ' A' ' 56' ' ' LEU . 34.3 m-85 -115.9 142.04 47.3 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 162.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m -67.8 103.04 1.33 Allowed 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.603 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.918 HD12 HG12 ' A' ' 63' ' ' VAL . 2.0 mt -77.97 81.49 4.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.461 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -93.24 -52.34 4.59 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.475 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.13 69.71 0.53 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.966 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.681 ' HB2' HE22 ' A' ' 61' ' ' GLN . . . -168.33 -169.24 1.05 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 86' ' ' GLY . . . 93.53 23.16 24.61 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.397 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.4 p90 . . . . . 0 C--O 1.247 0.927 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.563 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 5' ' ' GLU . 29.4 mtpp . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.749 0.309 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.42 -60.09 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -99.57 -17.48 17.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 2' ' ' LYS . 1.2 mp0 -77.39 49.97 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.486 175.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -168.45 85.25 0.18 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 m -60.59 122.21 14.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.614 -174.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.6 m -100.45 175.07 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.964 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.33 79.9 0.26 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.53 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.82 85.91 40.33 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.768 0.318 . . . . 0.0 110.327 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.4 Cg_endo -84.2 144.23 10.47 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.213 2.609 . . . . 0.0 112.245 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 24.0 Cg_exo -64.85 115.46 3.26 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.879 2.386 . . . . 0.0 111.55 176.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.39 87.18 0.64 Allowed 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.892 2.394 . . . . 0.0 112.921 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.16 57.73 3.36 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.927 175.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -94.84 95.91 8.99 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.78 157.74 29.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.162 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -153.66 -58.99 0.13 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.983 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.636 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -110.63 104.0 12.64 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 173.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 23' ' ' GLN . 11.4 m -66.34 -66.5 0.54 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.799 -173.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.58 59.01 0.8 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.847 0.356 . . . . 0.0 111.457 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.91 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -137.8 -63.69 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.817 175.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.91 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 1.1 Cg_endo -86.64 -28.05 0.66 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 122.24 1.96 . . . . 0.0 111.724 175.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.449 ' C ' ' H ' ' A' ' 25' ' ' ARG . 48.7 mt-30 -83.53 -138.98 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.437 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.637 ' HA ' ' HB ' ' A' ' 27' ' ' THR . 20.5 m 74.33 -31.94 0.22 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.775 0.43 . . . . 0.0 111.129 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.449 ' H ' ' C ' ' A' ' 23' ' ' GLN . 14.2 ptt180 -57.06 -33.2 67.01 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.266 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.6 mt -117.84 25.97 10.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.203 0.525 . . . . 0.0 110.171 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.637 ' HB ' ' HA ' ' A' ' 24' ' ' THR . 21.8 m -128.98 78.76 75.8 Favored Pre-proline 0 N--CA 1.445 -0.683 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.284 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.11 100.59 1.4 Allowed 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.862 2.375 . . . . 0.0 111.726 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -79.52 83.46 5.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.61 -37.01 0.62 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.985 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 60.55 -92.67 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.821 0.7 . . . . 0.0 111.118 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 59.99 13.33 3.64 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.72 109.82 1.12 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.597 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -83.94 -6.71 59.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.413 0.625 . . . . 0.0 110.669 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.93 -103.66 0.06 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -169.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -88.42 72.06 8.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.121 0.486 . . . . 0.0 111.745 -167.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.557 ' CZ2' HD21 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -134.32 -24.83 1.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.364 174.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -68.87 -30.6 69.15 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.995 0.426 . . . . 0.0 110.117 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.6 p -62.41 -40.01 95.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.075 176.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.462 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 16.2 mmm180 -73.64 -39.65 64.34 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.707 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.663 HG23 ' HD2' ' A' ' 103' ' ' PRO . 79.4 mt -60.36 -50.49 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.173 176.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 m -58.51 -43.26 89.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.841 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.14 -36.32 93.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.86 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.633 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 11.4 ttt-85 -69.16 -32.02 71.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 120.851 0.358 . . . . 0.0 110.328 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.846 ' HB3' ' HD2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -62.99 -31.46 72.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.207 0.527 . . . . 0.0 109.966 178.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.746 ' HA ' ' HG2' ' A' ' 50' ' ' ARG . 26.7 t-20 -71.74 -35.19 70.05 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.61 174.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 44' ' ' ARG . 68.3 ttt180 -67.09 -26.65 66.83 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.608 175.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -92.03 7.58 41.59 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.564 172.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? 67.99 102.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.263 -175.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.846 ' HD2' ' HB3' ' A' ' 45' ' ' LEU . 4.6 ptm180 -118.17 130.31 56.03 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.402 ' HB3' HD21 ' A' ' 56' ' ' LEU . 16.9 t80 -60.91 132.3 91.93 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.39 129.86 13.82 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.55 2.833 . . . . 0.0 112.301 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.821 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -64.53 -20.9 66.5 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.795 -172.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -52.6 -41.25 63.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.669 0.271 . . . . 0.0 111.08 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.89 -36.14 59.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.761 0.315 . . . . 0.0 111.338 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 93' ' ' GLU . 3.5 mm? -74.23 -43.04 58.64 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.308 -175.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -76.07 -15.42 60.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.973 0.416 . . . . 0.0 111.358 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.9 tp -86.23 -9.73 55.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.674 0.749 . . . . 0.0 109.266 174.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.87 ' HD2' ' HG2' ' A' ' 93' ' ' GLU . 23.2 ttmm -115.03 -57.76 2.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.47 -173.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.774 ' HG3' ' HB2' ' A' ' 93' ' ' GLU . 30.1 mmt180 -127.08 122.45 34.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.784 -175.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.609 ' H ' ' HB2' ' A' ' 130' ' ' ALA . 38.3 mt-30 -126.41 114.57 18.37 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 1.011 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -149.7 143.09 10.36 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.961 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.583 ' H ' HD12 ' A' ' 127' ' ' LEU . 5.3 p -104.43 127.64 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.027 0.441 . . . . 0.0 109.947 176.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.39 167.51 32.98 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.465 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 82' ' ' VAL . 14.6 mm100 -101.86 131.54 48.14 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.8 t -126.6 114.18 36.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.204 0.526 . . . . 0.0 110.339 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 120' ' ' THR . 27.0 ttm180 -101.32 141.89 33.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CE1' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -157.71 152.42 25.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.989 0.423 . . . . 0.0 111.299 -178.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.764 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 9.4 m -101.64 127.31 48.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.641 173.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.719 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 28.2 mt -119.5 135.4 54.79 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.1 -172.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' HB2' HD21 ' A' ' 77' ' ' LEU . 20.2 t70 -76.07 152.77 36.76 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.896 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -55.06 -26.64 39.03 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 123.4 0.437 . . . . 0.0 111.787 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -84.31 -1.79 55.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.12 0.486 . . . . 0.0 110.687 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.8 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 88.45 23.71 36.0 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.851 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.425 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 58.1 t60 -95.92 117.48 30.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.494 0.188 . . . . 0.0 110.553 -177.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 p -48.99 120.42 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.374 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 71' ' ' ASP . 55.7 mt -109.77 -51.26 2.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.713 -177.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -132.42 154.78 49.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.392 -177.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.967 HG11 ' HG3' ' A' ' 99' ' ' LYS . 57.9 t -139.82 122.99 17.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 44.0 m -119.22 105.94 11.86 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.9 tp -68.24 110.79 4.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.55 0.69 . . . . 0.0 110.664 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.686 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -99.3 -52.83 8.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.929 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.543 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 23.1 t 65.7 177.91 0.21 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.203 172.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.528 ' OG ' ' HG2' ' A' ' 65' ' ' GLN . 50.3 m -139.17 -69.7 0.42 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.097 -176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -98.36 -75.83 0.54 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.504 ' C ' ' HD3' ' A' ' 88' ' ' PRO . . . -176.9 97.51 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.329 -175.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.712 ' HA ' HD12 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -120.56 68.55 15.09 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 178.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.504 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 3.6 Cg_exo -77.81 -66.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.386 2.057 . . . . 0.0 112.139 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.6 t -73.11 -18.63 61.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.689 0.757 . . . . 0.0 109.78 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.718 HD21 ' HB3' ' A' ' 130' ' ' ALA . 32.8 mt -76.02 -30.74 58.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.576 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.52 -45.88 69.9 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.808 0.693 . . . . 0.0 111.896 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.583 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 8.5 ptp180 -53.01 -51.09 62.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -172.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.87 ' HG2' ' HD2' ' A' ' 59' ' ' LYS . 1.7 mp0 -77.04 -55.39 5.5 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 90' ' ' LEU . 22.2 pt -69.88 -32.82 53.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 111.386 -172.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.807 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 75.1 mm-40 -83.49 -18.32 38.92 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.507 176.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -54.73 -55.23 32.09 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.851 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.664 HD23 HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -75.75 -52.43 10.48 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.031 177.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.725 HG11 HG21 ' A' ' 123' ' ' ILE . 91.3 t -65.44 -49.43 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.967 ' HG3' HG11 ' A' ' 79' ' ' VAL . 40.4 ttmt -74.61 -29.24 61.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.556 0.217 . . . . 0.0 110.906 -172.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.584 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -78.11 -42.13 32.92 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.828 176.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.556 ' HB2' HH11 ' A' ' 100' ' ' ARG . . . -117.11 73.98 0.89 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.692 0.282 . . . . 0.0 111.663 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 15.7 m -82.96 108.71 13.4 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.105 0.479 . . . . 0.0 110.35 175.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.663 ' HD2' HG23 ' A' ' 41' ' ' ILE . 16.2 Cg_endo -97.12 139.08 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.23 3.287 . . . . 0.0 113.947 -175.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.8 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 40.3 tp -116.31 91.51 33.14 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 174.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.462 ' HG2' ' HB2' ' A' ' 40' ' ' ARG . 53.1 Cg_endo -79.45 -39.35 0.32 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.293 1.995 . . . . 0.0 113.603 -174.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.425 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 26.5 m -102.9 110.81 64.24 Favored Pre-proline 0 C--N 1.319 -0.761 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.92 107.77 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.242 2.628 . . . . 0.0 112.954 -175.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.731 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 48.9 Cg_endo -89.8 66.57 2.12 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.299 2.666 . . . . 0.0 111.659 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.818 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -57.1 -41.29 78.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.416 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -73.46 1.44 9.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.859 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.731 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -110.89 -27.97 8.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.691 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.818 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -105.16 16.31 25.99 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.5 m -72.27 87.89 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 0.1 OUTLIER 157.18 -9.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.417 -171.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.68 -80.16 0.2 Allowed Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.063 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.489 ' C ' ' HB3' ' A' ' 112' ' ' TYR . 1.0 OUTLIER -156.42 176.17 13.05 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.764 ' O ' ' HA ' ' A' ' 69' ' ' THR . 6.6 m -99.26 106.22 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.637 0 CA-C-N 119.676 1.125 . . . . 0.0 110.259 -177.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -105.52 109.22 21.12 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 168.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.688 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.4 pp -139.73 147.45 40.9 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.493 -172.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.686 HG23 HG21 ' A' ' 82' ' ' VAL . 36.3 m -94.43 113.65 25.54 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.778 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.688 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 35.0 mt -114.73 126.8 27.47 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.992 175.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 6.2 Cg_exo -75.29 118.78 5.31 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 121.401 1.401 . . . . 0.0 110.636 177.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.725 HG21 HG11 ' A' ' 98' ' ' VAL . 32.5 pt -93.3 97.1 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -99.03 121.88 41.55 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 122.302 1.048 . . . . 0.0 112.041 -171.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.446 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 84.9 m-85 -114.74 142.83 45.99 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.754 -1.567 . . . . 0.0 107.057 165.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.1 m -65.56 103.35 0.84 Allowed 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.246 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 1.011 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -75.42 61.8 1.29 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.791 -176.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -79.4 -43.43 23.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.454 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 132' ' ' PHE . . . -179.69 126.33 1.03 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.798 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.718 ' HB3' HD21 ' A' ' 90' ' ' LEU . . . -146.3 71.14 1.24 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.99 4.93 66.55 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -166.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.613 ' HD2' ' H ' ' A' ' 130' ' ' ALA . 92.4 m-85 . . . . . 0 N--CA 1.435 -1.2 0 CA-C-N 114.401 -0.9 . . . . 0.0 109.374 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.887 0.375 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 m -135.96 25.05 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.142 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 58.58 69.4 0.73 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.649 -171.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -53.24 -47.7 68.83 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.024 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -126.61 107.22 10.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.271 0.558 . . . . 0.0 110.258 176.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.446 ' HB2' ' CB ' ' A' ' 10' ' ' ALA . 5.8 p -119.8 88.69 2.98 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.677 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.8 m -87.45 -22.88 6.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.338 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.9 30.45 10.01 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.106 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' CB ' ' HB2' ' A' ' 7' ' ' SER . . . -111.26 115.85 51.85 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.727 0.298 . . . . 0.0 110.66 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 6.1 Cg_exo -78.79 124.4 6.21 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.301 2.667 . . . . 0.0 111.727 178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.625 ' HB2' ' HA ' ' A' ' 16' ' ' ALA . 16.0 Cg_exo -68.3 112.23 2.73 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 123.029 2.486 . . . . 0.0 111.77 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.89 129.99 32.88 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.92 2.413 . . . . 0.0 112.614 -176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.28 -86.77 0.7 Allowed Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.433 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 15' ' ' ARG . 18.7 mtp180 -86.75 77.62 9.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.935 0.398 . . . . 0.0 110.712 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.625 ' HA ' ' HB2' ' A' ' 12' ' ' PRO . . . -74.21 -21.24 59.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.602 0.715 . . . . 0.0 109.184 171.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -88.03 94.79 9.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.727 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -140.83 58.01 1.56 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.302 0.572 . . . . 0.0 109.539 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -79.42 116.46 19.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.698 0.761 . . . . 0.0 110.561 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.492 ' HB1' ' HA ' ' A' ' 25' ' ' ARG . . . -108.4 40.16 1.83 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.321 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.681 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -80.02 -52.65 1.01 Allowed Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.992 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 7.9 Cg_exo -74.07 -150.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.445 2.097 . . . . 0.0 111.965 177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -71.24 -9.8 58.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.322 . . . . 0.0 111.032 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.437 ' HA ' HG23 ' A' ' 27' ' ' THR . 14.6 p -61.03 -15.31 30.69 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.673 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.561 ' HG3' ' HG ' ' A' ' 26' ' ' LEU . 13.4 ptp180 -64.18 -25.69 68.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.22 177.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.561 ' HG ' ' HG3' ' A' ' 25' ' ' ARG . 96.2 mt -125.22 53.23 1.54 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.171 0.51 . . . . 0.0 110.622 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 24' ' ' THR . 12.4 p -106.57 123.25 39.33 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.997 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.36 117.93 5.3 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.713 2.275 . . . . 0.0 111.542 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -96.14 118.7 33.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.313 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.95 -52.29 0.11 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.446 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 56.53 53.31 8.69 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.671 0.748 . . . . 0.0 110.57 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.59 57.0 2.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.302 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.94 63.73 4.02 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.216 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -84.01 176.37 8.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.904 0.383 . . . . 0.0 110.684 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 36' ' ' ASN . 22.6 t70 -130.54 152.56 49.78 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 26.9 t-20 75.8 -15.15 0.72 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.599 0.562 . . . . 0.0 111.038 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.473 ' O ' HG13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -58.93 -27.71 65.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.078 178.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -33.87 75.24 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.666 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.1 m -67.08 -35.87 80.76 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 18.2 mmt180 -70.65 -42.01 71.39 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.918 177.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.683 HG23 ' HG2' ' A' ' 103' ' ' PRO . 92.2 mt -59.65 -44.06 92.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.2 177.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.9 t -55.68 -37.62 68.56 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.801 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 46' ' ' ASN . . . -69.46 -37.63 79.07 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.081 177.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.64 -34.11 73.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.154 0.502 . . . . 0.0 110.634 178.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.607 HD11 HG13 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -68.27 -26.9 65.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.641 0.734 . . . . 0.0 109.526 177.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.689 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 5.9 t30 -70.28 -35.1 73.52 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.258 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.55 -29.86 59.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.624 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -96.29 -59.33 1.86 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.515 178.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -158.53 119.31 3.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.121 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.689 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -136.07 102.61 5.07 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.404 0.621 . . . . 0.0 110.275 174.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.508 ' HB3' HD21 ' A' ' 56' ' ' LEU . 3.1 t80 -86.53 132.09 43.8 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.848 178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.32 130.19 36.48 Favored 'Trans proline' 0 N--CA 1.476 0.459 0 C-N-CA 122.741 2.294 . . . . 0.0 112.363 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.577 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -60.81 -29.39 69.43 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.354 -170.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.78 -33.82 70.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 0.0 110.316 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.79 -39.14 61.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.293 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.4 mm? -64.53 -40.97 96.6 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.743 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.478 ' HD3' HH11 ' A' ' 128' ' ' ARG . 60.5 mtt180 -59.07 -22.71 61.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.867 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.7 mt -102.43 -8.67 20.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.793 0.33 . . . . 0.0 110.964 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -112.51 -68.77 0.91 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.827 -176.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.656 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 6.0 ppt_? -155.01 142.9 20.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.062 0.458 . . . . 0.0 110.888 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.519 ' O ' HD22 ' A' ' 90' ' ' LEU . 13.0 mm100 -138.5 177.74 7.66 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 1.043 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.22 146.75 4.42 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.52 -1.324 . . . . 0.0 113.989 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.3 t -106.35 124.16 61.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.28 163.31 26.4 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.699 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 82' ' ' VAL . 85.0 mt-30 -106.45 125.87 51.54 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 121' ' ' LEU . 12.1 p -123.85 125.0 70.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.64 -170.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -113.47 134.96 54.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.838 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.7 OUTLIER -157.11 158.13 35.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.955 0.407 . . . . 0.0 111.694 -175.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.597 ' CG2' ' HB ' ' A' ' 116' ' ' THR . 26.6 m -99.37 134.21 42.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.229 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.52 HD13 ' HB2' ' A' ' 104' ' ' LEU . 75.7 mt -117.01 142.97 46.28 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.573 0.545 . . . . 0.0 111.255 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -97.43 169.83 9.47 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.874 175.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -50.81 -42.61 58.38 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -171.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -94.37 24.3 4.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.728 0.299 . . . . 0.0 111.48 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.681 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 68.11 47.77 57.31 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.185 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 66.3 t60 -100.51 117.43 34.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.2 p -48.88 122.9 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 123.816 0.697 . . . . 0.0 110.913 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 88.6 mt -116.71 -44.99 2.81 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.35 158.13 40.68 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 99' ' ' LYS . 13.4 m -145.32 117.28 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.533 0.521 . . . . 0.0 110.178 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.2 m -141.7 131.93 24.92 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.864 0.364 . . . . 0.0 111.249 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.7 tp -83.63 120.0 25.44 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.619 HG21 HG23 ' A' ' 120' ' ' THR . 0.1 OUTLIER -95.9 -58.74 3.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.345 -175.282 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 66.9 m -141.84 113.36 7.72 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.921 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.5 t -107.08 117.14 33.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.21 -46.82 66.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.496 -175.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.691 ' H ' HD22 ' A' ' 87' ' ' LEU . . . -176.35 58.91 0.1 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.913 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.891 ' HA ' HD12 ' A' ' 90' ' ' LEU . 1.6 mm? -118.05 89.61 35.07 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.33 -83.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.23 1.953 . . . . 0.0 111.338 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 3.5 m -67.41 -17.92 64.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.674 0.75 . . . . 0.0 110.104 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.891 HD12 ' HA ' ' A' ' 87' ' ' LEU . 8.0 mt -75.5 -33.49 60.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.215 -175.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 13.6 t70 -54.87 -49.69 70.53 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.76 0.662 . . . . 0.0 111.371 -173.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 89' ' ' SER . 5.0 ptp180 -53.86 -50.53 66.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.094 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 20.7 tt0 -77.99 -42.06 33.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -173.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.565 HG13 ' HG2' ' A' ' 95' ' ' GLN . 30.3 pt -60.63 -40.68 85.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.885 -177.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.672 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 50.1 mm-40 -82.39 -30.52 30.18 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 120.957 0.408 . . . . 0.0 110.94 -178.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.92 -52.31 64.57 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.923 173.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.777 HD23 HG23 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -62.2 -56.58 17.21 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.949 -178.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.958 HG11 HG21 ' A' ' 123' ' ' ILE . 58.5 t -88.14 -50.54 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -176.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.672 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 35.6 ttmt -63.7 -38.8 92.46 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.409 0.151 . . . . 0.0 111.409 -172.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -79.23 -16.85 55.88 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.662 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.37 53.09 0.77 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.612 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.474 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 51.0 m -65.45 107.4 1.45 Allowed Pre-proline 0 C--O 1.234 0.279 0 O-C-N 123.514 0.509 . . . . 0.0 110.79 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.683 ' HG2' HG23 ' A' ' 41' ' ' ILE . 50.2 Cg_endo -101.79 154.87 0.35 Allowed 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 123.847 3.032 . . . . 0.0 114.002 -174.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.681 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 2.1 tp -142.57 107.63 5.55 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.141 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HB3' HH11 ' A' ' 44' ' ' ARG . 4.0 Cg_exo -75.0 -56.94 0.06 OUTLIER 'Trans proline' 0 CA--C 1.517 -0.36 0 C-N-CA 122.22 1.947 . . . . 0.0 112.435 178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.496 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 10.6 m -90.2 110.36 39.94 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.684 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.529 ' HA ' HD21 ' A' ' 104' ' ' LEU . 42.2 Cg_endo -68.64 107.13 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.942 2.428 . . . . 0.0 112.16 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.884 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 51.1 Cg_endo -87.88 71.3 2.93 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.018 2.478 . . . . 0.0 111.754 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.647 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -56.29 -46.56 79.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.93 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -76.09 7.82 3.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.796 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.884 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.17 -23.26 10.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.485 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.705 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -122.01 16.68 10.85 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 -177.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.7 m -71.65 89.07 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.971 0.891 . . . . 0.0 108.954 172.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 3.5 p30 161.61 -28.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.082 -169.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 175.7 -89.4 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.111 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.651 ' HA ' ' HB2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -161.6 175.56 11.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.705 HG13 ' HB3' ' A' ' 112' ' ' TYR . 11.5 m -102.85 109.31 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.313 0.578 . . . . 0.0 110.98 -176.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 43.2 tt0 -111.93 111.62 22.68 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 170.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.569 HD12 ' HG ' ' A' ' 121' ' ' LEU . 3.8 pp -137.01 155.11 50.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.162 -175.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.619 HG23 HG21 ' A' ' 82' ' ' VAL . 86.4 m -95.11 125.45 39.77 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.374 -176.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' A' ' 119' ' ' LEU . 77.9 mt -125.74 131.4 24.0 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.093 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 6.4 Cg_exo -74.47 121.43 6.77 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.071 1.847 . . . . 0.0 111.369 175.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.958 HG21 HG11 ' A' ' 98' ' ' VAL . 3.1 pt -96.25 98.31 7.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 172.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -94.04 121.11 35.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.892 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 80.4 m-85 -116.93 128.89 55.66 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 163.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.8 m -63.59 102.92 0.48 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.719 0.295 . . . . 0.0 111.022 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 1.043 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 5.0 mt -64.12 103.84 0.66 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.259 0.552 . . . . 0.0 111.551 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.478 HH11 ' HD3' ' A' ' 57' ' ' ARG . 64.5 mtp180 -102.7 -15.13 16.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.071 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 177.07 -151.98 11.69 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.411 ' CB ' HD21 ' A' ' 90' ' ' LEU . . . 69.81 -63.92 0.37 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.092 0.557 . . . . 0.0 111.283 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -90.38 56.62 3.53 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 25.4 p90 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.584 -178.101 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.456 ' HE2' ' OE2' ' A' ' 5' ' ' GLU . 59.9 mtpt . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 120.825 0.345 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.0 m -111.53 -17.59 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.427 -176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -83.87 37.86 0.61 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.086 0.47 . . . . 0.0 111.017 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.456 ' OE2' ' HE2' ' A' ' 2' ' ' LYS . 7.6 mm-40 -92.12 124.48 36.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.938 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -74.37 85.1 1.96 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.2 m -78.87 155.7 28.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.721 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.83 99.37 8.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.093 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.91 149.26 17.17 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.877 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.1 100.53 47.26 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.44 121.15 3.75 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.66 2.24 . . . . 0.0 112.294 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.403 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . 75.8 Cg_exo -50.02 -45.07 34.59 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.431 2.754 . . . . 0.0 114.064 176.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 12' ' ' PRO . 5.1 Cg_exo -81.16 3.63 7.65 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.173 1.916 . . . . 0.0 112.584 176.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.58 -142.49 38.75 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.603 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 15' ' ' ARG . 20.5 mmm180 -115.39 43.48 2.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.376 0.607 . . . . 0.0 109.902 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.69 119.37 30.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.345 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -99.7 -50.48 4.03 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -142.66 114.18 7.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.804 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.3 p -99.0 72.31 1.89 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.068 0.461 . . . . 0.0 111.498 -175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.29 72.56 10.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.682 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.733 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -65.71 -50.71 53.71 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.659 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.733 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 11.3 Cg_endo -92.63 -166.84 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.639 2.226 . . . . 0.0 110.496 168.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.437 HE21 ' HB3' ' A' ' 23' ' ' GLN . 16.1 mt-30 -86.17 43.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.359 0.599 . . . . 0.0 110.486 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 p -75.57 -7.97 55.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.938 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 25' ' ' ARG . 2.0 ptm180 -70.19 -15.75 62.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.164 176.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.2 tp -107.25 37.8 2.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.563 0.697 . . . . 0.0 109.535 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.728 ' H ' ' HD2' ' A' ' 28' ' ' PRO . 89.0 m -114.68 -54.63 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.36 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.728 ' HD2' ' H ' ' A' ' 27' ' ' THR . 54.4 Cg_endo -68.91 169.06 18.66 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.145 1.897 . . . . 0.0 112.36 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -81.05 61.45 4.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.062 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.15 -89.68 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.483 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.427 ' HG2' ' HB2' ' A' ' 111' ' ' ALA . 8.3 pt20 -152.42 28.98 0.56 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.02 0.438 . . . . 0.0 110.505 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.42 68.3 9.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.652 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.11 -147.29 18.46 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.92 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.71 18.72 7.19 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -172.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -78.72 155.58 29.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.934 0.397 . . . . 0.0 109.969 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.426 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 76.5 m-20 -88.7 54.44 3.03 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.19 0.519 . . . . 0.0 110.6 -178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.459 ' O ' HG13 ' A' ' 41' ' ' ILE . 12.0 p-90 -71.62 -36.28 70.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.329 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.545 ' HD3' ' N ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -69.2 -25.4 64.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.243 0.544 . . . . 0.0 110.125 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.545 ' N ' ' HD3' ' A' ' 38' ' ' ARG . 0.9 OUTLIER -71.95 -34.58 69.12 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.519 ' CB ' ' HG2' ' A' ' 105' ' ' PRO . 34.1 mmt180 -74.24 -36.12 63.87 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.377 175.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.624 HG23 ' HD2' ' A' ' 103' ' ' PRO . 61.8 mt -57.32 -47.22 84.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.713 172.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.1 m -56.23 -35.13 67.0 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.011 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.23 -52.35 47.93 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.386 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.769 ' HD3' ' HB2' ' A' ' 103' ' ' PRO . 9.4 ptp180 -70.08 -27.46 64.63 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.538 -0.39 . . . . 0.0 111.731 175.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tt -54.25 -38.1 65.4 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -71.08 -31.67 68.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.297 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HB3' ' HA ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -53.16 -26.64 17.78 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.382 173.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -101.75 -57.16 2.13 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.479 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.537 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 4.2 mtpp -172.76 102.8 0.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.097 -177.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -144.69 104.56 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.203 0.525 . . . . 0.0 110.26 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.522 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.5 t80 -96.47 144.5 27.95 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.299 -177.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -53.05 133.59 52.62 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.101 2.534 . . . . 0.0 112.397 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.545 ' HE2' ' HE2' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -62.02 -21.13 64.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.633 -171.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -53.07 -37.57 61.74 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.452 0.47 . . . . 0.0 110.827 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.71 -38.97 53.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.637 176.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.757 HD12 ' HB2' ' A' ' 60' ' ' ARG . 3.6 mm? -69.41 -41.54 76.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.068 -173.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.597 ' HA ' ' HG3' ' A' ' 61' ' ' GLN . 7.8 ptp85 -67.16 -8.88 34.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.14 0.495 . . . . 0.0 110.851 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 47.0 tp -118.93 12.81 12.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.262 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.698 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 25.3 ttmm -154.47 -67.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.693 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.82 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 36.6 mmt180 -119.98 84.53 2.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.675 0.274 . . . . 0.0 110.308 -177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.597 ' HG3' ' HA ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -86.15 177.65 7.46 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.622 ' N ' ' HB2' ' A' ' 125' ' ' PHE . . . 152.52 122.42 0.94 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.244 -1.455 . . . . 0.0 113.787 176.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -110.82 124.48 67.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.254 -0.646 . . . . 0.0 109.254 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.34 166.6 33.23 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.825 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.483 ' O ' HG23 ' A' ' 82' ' ' VAL . 2.7 mp0 -102.12 124.38 47.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 178.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.408 HG21 HD13 ' A' ' 123' ' ' ILE . 76.2 t -119.73 114.23 43.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.293 -173.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HB2' HG21 ' A' ' 82' ' ' VAL . 26.7 ttt180 -115.03 124.71 52.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.748 -174.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.57 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.4 OUTLIER -148.13 163.85 35.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.306 0.574 . . . . 0.0 112.136 -174.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 40.9 m -105.2 131.99 51.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.014 174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 104' ' ' LEU . 86.8 mt -118.76 142.0 48.1 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -172.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.587 ' OD1' ' HG2' ' A' ' 73' ' ' GLN . 13.8 t70 -89.58 160.18 16.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.244 173.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.582 ' HG2' ' N ' ' A' ' 73' ' ' GLN . 0.8 OUTLIER -58.47 -32.09 68.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.687 0.279 . . . . 0.0 111.322 -177.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.587 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 25.4 pt20 -94.04 14.51 19.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.204 0.526 . . . . 0.0 111.246 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.47 ' HA2' ' H ' ' A' ' 104' ' ' LEU . . . 78.01 33.8 39.94 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.248 177.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.484 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 67.6 t60 -97.1 101.88 13.54 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.44 122.26 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 121.388 0.614 . . . . 0.0 110.92 173.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 75' ' ' HIS . 15.2 mt -108.21 -40.79 5.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.437 -175.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.5 158.43 39.96 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.27 117.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.167 0.508 . . . . 0.0 109.997 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.7 m -140.58 120.93 14.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.917 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 29.3 tp -81.41 106.37 13.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -82.22 -44.64 19.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.894 -170.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.1 m -155.41 155.14 33.05 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.372 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.494 ' HB2' ' CD2' ' A' ' 87' ' ' LEU . 53.4 p -163.34 147.44 10.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.85 0.357 . . . . 0.0 110.944 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.5 -9.38 58.87 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -173.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.41 ' C ' HD13 ' A' ' 87' ' ' LEU . . . 120.67 73.13 0.34 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.176 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.916 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.5 OUTLIER -114.4 96.62 43.65 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -177.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.67 -83.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.75 2.3 . . . . 0.0 111.888 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 m -66.15 -18.29 65.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.63 0.728 . . . . 0.0 110.107 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.916 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 20.4 mt -75.78 -39.28 57.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.056 -176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.42 -50.93 68.51 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -169.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.564 ' HD2' ' H ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -61.63 -36.13 79.88 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 120.536 -0.466 . . . . 0.0 112.005 -171.43 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.82 ' HG2' ' HG3' ' A' ' 60' ' ' ARG . 8.8 tp10 -76.59 -52.64 9.33 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 90' ' ' LEU . 39.9 pt -65.11 -35.02 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.565 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 69.9 mm-40 -81.81 -28.68 33.0 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.678 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -57.45 -48.22 79.75 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.576 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -61.81 -58.16 9.04 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.216 -178.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.813 HG11 HG21 ' A' ' 123' ' ' ILE . 91.6 t -89.22 -50.05 13.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 8.9 ttpp -70.7 -24.99 62.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -170.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.595 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 9.6 tpp180 -90.99 -24.98 19.93 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.061 174.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.61 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -114.04 73.41 0.82 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.312 -178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.8 m -108.43 95.02 14.82 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.392 0.615 . . . . 0.0 110.59 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.769 ' HB2' ' HD3' ' A' ' 44' ' ' ARG . 61.1 Cg_endo -112.51 110.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 124.723 3.615 . . . . 0.0 114.04 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.674 HD23 ' HD2' ' A' ' 105' ' ' PRO . 1.0 OUTLIER -86.32 123.42 71.44 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 171.055 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.674 ' HD2' HD23 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -80.6 -57.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.73 2.287 . . . . 0.0 112.751 -177.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -63.43 116.24 24.19 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.37 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -62.52 106.02 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.106 2.537 . . . . 0.0 112.171 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.67 ' HG3' HD13 ' A' ' 104' ' ' LEU . 63.7 Cg_endo -94.64 45.77 0.21 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 122.995 2.463 . . . . 0.0 112.82 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.605 ' O ' HG13 ' A' ' 113' ' ' VAL . . . -57.17 -41.51 79.37 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 109.91 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.03 -18.27 63.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.355 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.586 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -86.84 -29.45 22.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.779 -177.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.908 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -121.43 19.15 11.34 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -171.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.5 m -69.15 89.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 122.092 0.949 . . . . 0.0 108.947 175.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 7.0 p30 161.67 -18.27 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.943 -169.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.7 -87.82 0.1 Allowed Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.113 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.622 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -162.36 176.09 10.89 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.908 HG13 ' HB3' ' A' ' 112' ' ' TYR . 12.6 m -102.21 109.49 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-O 121.541 0.686 . . . . 0.0 110.719 -175.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 25.8 tt0 -107.96 110.94 22.8 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 173.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.598 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -141.04 155.26 46.2 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -174.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 50.6 m -98.74 122.75 42.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.147 0.499 . . . . 0.0 111.264 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.598 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 47.8 mt -118.22 123.88 29.07 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.993 174.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 5.2 Cg_exo -73.3 119.72 6.15 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.311 2.007 . . . . 0.0 111.241 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.813 HG21 HG11 ' A' ' 98' ' ' VAL . 32.0 pt -99.17 101.9 12.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -104.3 122.44 45.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.224 1.011 . . . . 0.0 111.722 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.622 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 85.4 m-85 -114.13 129.74 56.61 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.865 -1.516 . . . . 0.0 106.94 165.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.3 m -57.63 103.2 0.12 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.153 0.502 . . . . 0.0 111.979 -169.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.821 HD11 HD11 ' A' ' 87' ' ' LEU . 13.3 mt -80.46 82.15 6.55 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.771 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.06 31.84 6.32 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.521 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -158.85 -102.76 0.19 Allowed Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.997 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.463 ' O ' HD11 ' A' ' 90' ' ' LEU . . . -69.68 94.34 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 176.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 117.85 59.41 0.29 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -174.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 11.1 p90 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 119.206 -0.426 . . . . 0.0 111.205 -174.687 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 6.9 ptpp? . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 121.343 0.592 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.6 m -137.89 5.54 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.617 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -117.89 -18.1 9.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.987 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.474 ' OE1' ' HA ' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -102.87 137.81 40.59 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.167 0.508 . . . . 0.0 110.612 178.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -112.18 134.35 53.78 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.356 176.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.6 m -120.53 -35.89 3.31 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.865 176.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 t 51.17 81.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 121.502 0.667 . . . . 0.0 110.509 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.78 32.86 1.36 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' N ' ' HD2' ' A' ' 11' ' ' PRO . . . -64.45 -48.72 74.42 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.707 -0.246 . . . . 0.0 111.102 178.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 10' ' ' ALA . 39.2 Cg_endo -69.32 120.24 7.11 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.454 1.436 . . . . 0.0 110.268 170.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.506 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 19.7 Cg_endo -59.1 127.39 23.98 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.661 2.241 . . . . 0.0 112.32 -175.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 11.6 Cg_exo -71.16 71.99 2.2 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.782 2.321 . . . . 0.0 111.18 176.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.65 -141.48 10.39 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.01 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -115.02 42.31 2.22 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 70.7 -62.67 0.44 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 124.009 0.818 . . . . 0.0 109.994 -172.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 56.31 71.65 0.55 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.994 171.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -82.97 54.11 2.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.428 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.3 m -76.03 -12.62 60.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.695 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.459 ' HA ' ' OG1' ' A' ' 24' ' ' THR . . . -79.19 45.86 0.67 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.323 0.582 . . . . 0.0 110.733 177.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.581 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -60.78 -49.46 89.42 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.836 -177.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 2.9 Cg_exo -77.96 32.05 0.44 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 122.426 2.084 . . . . 0.0 112.358 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 60.4 33.84 20.68 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.474 0.654 . . . . 0.0 110.948 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.459 ' OG1' ' HA ' ' A' ' 20' ' ' ALA . 9.5 p -81.18 36.25 0.41 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.162 0.506 . . . . 0.0 111.301 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -69.37 -36.85 77.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 174.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.9 tp -171.72 98.0 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.515 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.8 m -53.32 124.95 41.62 Favored Pre-proline 0 N--CA 1.451 -0.404 0 O-C-N 123.487 0.492 . . . . 0.0 111.512 -176.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.52 148.89 84.35 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.053 2.502 . . . . 0.0 112.684 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.462 ' HD2' ' HB2' ' A' ' 31' ' ' GLN . 72.7 t80 -148.28 135.2 20.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.263 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.727 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . . . -79.39 75.48 5.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.221 0.534 . . . . 0.0 109.922 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.462 ' HB2' ' HD2' ' A' ' 29' ' ' TYR . 8.3 tt0 -85.58 136.31 33.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.67 -176.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.66 104.55 14.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.89 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.43 -127.45 6.08 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.22 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -76.44 -177.86 4.35 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.927 0.394 . . . . 0.0 110.501 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.496 ' OD1' ' HG2' ' A' ' 38' ' ' ARG . 10.0 t70 -78.99 118.95 21.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.886 0.851 . . . . 0.0 112.217 -174.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -146.43 23.07 1.31 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 167.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.626 ' HA ' ' HG2' ' A' ' 40' ' ' ARG . 0.2 OUTLIER -138.48 -24.76 0.94 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -168.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.496 ' HG2' ' OD1' ' A' ' 35' ' ' ASP . 2.1 ptp180 -67.84 -32.68 73.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.202 0.91 . . . . 0.0 109.872 -176.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.404 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 3.3 p -66.53 -36.44 82.69 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.938 176.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.626 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 10.2 mmt180 -69.52 -44.62 70.66 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.575 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.673 HG23 ' HG2' ' A' ' 103' ' ' PRO . 83.8 mt -63.68 -43.86 98.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.585 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.8 m -57.25 -33.58 67.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.946 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.63 -34.67 73.21 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.682 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.793 ' HD3' ' HB3' ' A' ' 105' ' ' PRO . 0.8 OUTLIER -70.75 -40.31 72.77 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 121.279 0.561 . . . . 0.0 110.151 178.1 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.05 -25.77 64.63 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.75 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.975 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 24.4 t-20 -69.3 -33.99 74.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.986 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.44 -20.45 63.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.949 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.474 ' CD2' ' HB1' ' A' ' 101' ' ' ALA . 97.3 m-85 -106.71 -60.28 1.69 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.615 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -164.99 102.93 0.77 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.548 0.739 . . . . 0.0 109.037 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.975 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 24.6 tpt180 -113.54 103.15 10.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.527 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 0.9 OUTLIER -105.45 132.31 20.99 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 51' ' ' TYR . 32.4 Cg_exo -58.97 132.1 45.55 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.824 2.349 . . . . 0.0 111.721 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.495 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -61.19 -23.14 65.37 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.958 -173.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.72 -40.21 83.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.565 0.222 . . . . 0.0 110.853 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.0 -33.65 75.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.113 0.483 . . . . 0.0 110.475 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -72.65 -41.56 65.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 57' ' ' ARG . 49.5 mtm180 -58.07 -31.07 66.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.012 0.434 . . . . 0.0 110.422 176.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.9 tp -93.85 -0.49 55.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.951 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.781 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 24.5 ttmm -142.04 -75.42 0.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -175.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.781 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 26.3 mmt180 -119.79 89.78 3.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.901 0.381 . . . . 0.0 110.427 -177.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.407 ' O ' HD13 ' A' ' 90' ' ' LEU . 3.2 pt20 -92.14 179.17 5.65 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.521 177.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.576 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . 152.26 124.05 1.05 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.823 -1.18 . . . . 0.0 113.169 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.725 ' H ' HD12 ' A' ' 127' ' ' LEU . 7.3 p -110.36 127.05 67.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.44 167.07 36.16 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.727 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.672 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 50.3 mt-30 -102.3 125.11 48.91 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 123' ' ' ILE . 24.3 t -121.47 114.42 43.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.712 -176.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.691 ' HG2' HG22 ' A' ' 82' ' ' VAL . 5.9 ptp180 -106.19 144.17 33.28 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -152.91 152.0 30.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.094 0.473 . . . . 0.0 111.853 -174.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 22.5 m -96.41 126.94 41.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.371 171.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.685 ' HB3' ' HB2' ' A' ' 104' ' ' LEU . 58.7 mt -117.8 135.76 53.85 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.203 0.525 . . . . 0.0 112.069 -169.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.611 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 15.4 t70 -77.27 152.51 34.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.476 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.3 ttp-105 -60.98 -25.28 66.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.119 -176.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -89.61 -1.43 58.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.968 0.413 . . . . 0.0 111.012 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.96 36.88 6.53 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.04 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.611 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 55.6 t60 -104.3 120.96 42.34 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 p -53.81 117.27 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.313 0.578 . . . . 0.0 111.07 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.472 HD23 ' HD2' ' A' ' 75' ' ' HIS . 42.2 mt -101.86 -37.46 8.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.477 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -146.89 152.97 39.56 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.66 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.0 m -147.24 132.37 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 123.45 0.469 . . . . 0.0 109.836 177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.0 m -144.28 132.67 22.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.37 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.724 HD21 ' HB2' ' A' ' 84' ' ' SER . 37.3 tp -75.5 120.88 21.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.732 HG21 HG23 ' A' ' 120' ' ' THR . 0.2 OUTLIER -96.67 -47.63 12.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.899 -173.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -142.26 145.46 34.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.346 177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.724 ' HB2' HD21 ' A' ' 81' ' ' LEU . 40.7 t -137.8 148.61 45.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.023 0.44 . . . . 0.0 111.212 -176.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -106.58 15.32 25.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.219 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.81 76.02 1.31 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.173 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.733 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -116.51 71.11 4.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.803 0.302 . . . . 0.0 110.295 178.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.85 -68.36 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 121.804 1.669 . . . . 0.0 112.482 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 7.9 m -72.08 -18.69 61.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.233 0.54 . . . . 0.0 110.035 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.733 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 26.2 mt -77.32 -32.35 55.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.145 -177.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.552 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 7.3 t70 -53.39 -37.95 62.94 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.4 0.438 . . . . 0.0 111.88 -173.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 13.6 ptm180 -53.57 -54.79 32.45 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -176.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -78.53 -55.12 5.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -175.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.525 HG13 ' HG2' ' A' ' 95' ' ' GLN . 40.0 pt -60.21 -38.88 78.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.646 -172.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.729 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 76.0 mm-40 -84.58 -20.86 30.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.603 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' A' ' 92' ' ' ARG . . . -55.1 -54.1 47.45 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.163 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.608 HD22 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -76.77 -48.72 17.82 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.06 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.835 HG11 HG21 ' A' ' 123' ' ' ILE . 55.8 t -70.26 -50.18 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.729 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.3 ttmt -75.88 -32.1 59.53 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.318 -0.239 . . . . 0.0 111.361 -171.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 100' ' ' ARG . 8.3 tpp180 -89.16 -18.8 26.42 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.052 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 97' ' ' LEU . . . -120.24 56.4 0.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.603 0.24 . . . . 0.0 111.098 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 19.4 m -80.52 106.75 5.73 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.114 0.483 . . . . 0.0 110.112 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.683 ' CB ' ' HB3' ' A' ' 44' ' ' ARG . 62.9 Cg_endo -101.78 165.1 0.33 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 124.038 3.159 . . . . 0.0 114.486 -171.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 33.2 tp -142.08 94.25 7.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.159 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.793 ' HB3' ' HD3' ' A' ' 44' ' ' ARG . 50.5 Cg_endo -77.25 -49.7 0.1 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.442 2.095 . . . . 0.0 113.665 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 22.3 m -88.58 110.45 37.03 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.01 107.68 1.17 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.112 2.542 . . . . 0.0 112.451 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.729 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 52.1 Cg_endo -89.15 59.99 2.31 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.135 2.557 . . . . 0.0 111.853 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.662 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.05 -47.05 75.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.165 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.2 10.0 2.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.433 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -112.12 -30.39 7.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.932 0.396 . . . . 0.0 111.616 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.662 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -121.16 18.41 11.58 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.402 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -70.59 88.3 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.212 1.006 . . . . 0.0 108.446 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.654 HD22 ' N ' ' A' ' 115' ' ' GLY . 0.3 OUTLIER 158.92 -15.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 113.116 -1.856 . . . . 0.0 108.383 -168.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.654 ' N ' HD22 ' A' ' 114' ' ' ASN . . . 163.91 -90.84 0.1 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.175 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.432 ' CA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -161.06 177.03 10.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -175.151 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.666 ' O ' ' HA ' ' A' ' 69' ' ' THR . 12.9 m -102.75 109.88 27.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.467 0.651 . . . . 0.0 110.861 -178.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 24.7 tt0 -109.35 109.99 21.02 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 171.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.73 HD12 ' HG ' ' A' ' 121' ' ' LEU . 1.5 pp -135.12 152.37 51.58 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.656 -173.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.732 HG23 HG21 ' A' ' 82' ' ' VAL . 87.9 m -96.72 113.44 25.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.212 -174.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.73 ' HG ' HD12 ' A' ' 119' ' ' LEU . 62.5 mt -119.48 122.94 28.97 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.965 0.412 . . . . 0.0 110.711 177.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 12.0 Cg_exo -70.65 119.19 6.14 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 121.709 1.606 . . . . 0.0 110.554 174.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.835 HG21 HG11 ' A' ' 98' ' ' VAL . 35.1 pt -93.98 118.77 40.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -107.47 120.31 41.83 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 118.821 -1.151 . . . . 0.0 112.35 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.532 ' HB2' ' N ' ' A' ' 62' ' ' GLY . 37.9 m-85 -115.65 126.69 54.46 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 160.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.0 m -56.54 104.01 0.13 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.242 0.544 . . . . 0.0 111.052 -172.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.725 HD12 ' H ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -100.6 105.46 16.86 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.854 -171.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 128' ' ' ARG . 38.6 mtp-105 -86.75 -47.0 9.48 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 173.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 164.11 54.99 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.741 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -81.65 -5.42 58.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 0.0 111.787 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -91.12 40.01 3.02 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.941 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 20.7 p90 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.314 -0.851 . . . . 0.0 110.342 -176.78 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.859 0.361 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 16.6 m -124.05 -44.55 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.481 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER 172.69 79.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -99.08 141.38 31.92 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.729 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -105.06 108.24 19.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.731 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.2 m -85.61 128.32 34.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.599 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 p -146.99 31.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 122.452 1.12 . . . . 0.0 109.195 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.15 68.05 1.18 Allowed Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.974 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -62.82 114.74 13.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.64 0.257 . . . . 0.0 110.892 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 4.1 Cg_exo -81.64 123.87 4.41 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 123.351 2.7 . . . . 0.0 112.174 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.2 147.8 48.68 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.634 2.222 . . . . 0.0 112.115 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.89 55.92 5.78 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.962 2.442 . . . . 0.0 112.126 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.52 -170.52 29.57 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.015 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 1.5 mpt_? -114.19 104.45 12.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.864 0.364 . . . . 0.0 110.099 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.6 -20.16 19.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.667 -178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.73 55.47 1.37 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.32 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -88.55 57.63 4.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.713 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.0 p 49.01 68.74 0.66 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.076 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.57 38.53 3.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.409 0.624 . . . . 0.0 111.215 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.726 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -91.81 -52.98 0.28 Allowed Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.002 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 5.7 Cg_exo -80.19 -160.18 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.606 2.204 . . . . 0.0 111.324 175.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -86.49 23.59 1.59 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.278 0.561 . . . . 0.0 110.922 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.633 ' HA ' ' OG1' ' A' ' 27' ' ' THR . 3.0 p -68.98 -5.27 20.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.021 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.46 -13.44 61.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.442 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.7 tp -150.83 37.53 0.65 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.165 0.507 . . . . 0.0 111.109 -176.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.633 ' OG1' ' HA ' ' A' ' 24' ' ' THR . 1.8 m -81.99 137.14 46.73 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.221 177.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 27' ' ' THR . 7.1 Cg_exo -73.58 77.67 2.54 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.815 2.343 . . . . 0.0 112.3 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.552 ' CZ ' ' HB ' ' A' ' 27' ' ' THR . 69.3 m-85 -76.44 126.19 30.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.591 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -105.73 -32.82 8.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.94 0.4 . . . . 0.0 110.404 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -89.3 43.03 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.374 0.607 . . . . 0.0 110.892 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.32 22.82 3.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.162 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.62 157.35 8.5 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.992 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -96.79 71.6 2.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.558 0.694 . . . . 0.0 110.152 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.31 140.59 58.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.418 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -87.52 103.56 15.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.051 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -99.29 16.85 21.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.029 177.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.45 ' HD2' ' N ' ' A' ' 39' ' ' SER . 7.5 ppt_? -68.12 -31.02 70.32 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -168.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.45 ' N ' ' HD2' ' A' ' 38' ' ' ARG . 32.2 m -69.16 -32.52 71.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 0.0 109.823 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -75.86 -44.49 40.48 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.75 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.417 HG23 ' HD2' ' A' ' 103' ' ' PRO . 86.5 mt -58.77 -43.45 88.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.937 177.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 t -57.43 -38.8 74.98 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.882 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.13 -42.25 96.6 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.843 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.517 ' HB3' ' CB ' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -69.38 -33.77 73.54 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.803 0.335 . . . . 0.0 110.72 178.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.568 HD11 HG22 ' A' ' 98' ' ' VAL . 2.1 tt -62.15 -31.93 72.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.398 0.618 . . . . 0.0 109.832 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.728 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 8.7 t30 -71.69 -34.26 69.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.797 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -29.64 58.47 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.682 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.516 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 98.8 m-85 -94.73 -59.22 1.97 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.78 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 48' ' ' PHE . 34.1 mmtt -174.82 104.14 0.09 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.622 0.769 . . . . 0.0 109.488 -177.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.728 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 29.1 ttp180 -128.28 103.91 7.43 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.485 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -81.41 138.17 48.29 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.382 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -49.87 131.53 29.83 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.132 2.555 . . . . 0.0 111.961 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.757 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -63.96 -23.68 67.43 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -170.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -58.76 -38.58 78.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.652 0.263 . . . . 0.0 111.069 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.03 -30.74 70.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.787 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.1 mm? -77.25 -41.47 40.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.918 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 41.0 mtm180 -62.85 -23.04 67.11 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.381 0.61 . . . . 0.0 110.5 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.8 tp -102.09 4.04 39.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.753 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.544 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 40.3 ttpt -149.71 -75.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.544 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 26.2 mmt180 -99.03 84.27 3.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.453 0.644 . . . . 0.0 110.742 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 126' ' ' SER . 10.7 pt20 -104.95 127.78 52.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.948 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 1.002 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -179.55 129.77 1.41 Allowed Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.268 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.887 ' H ' HD12 ' A' ' 127' ' ' LEU . 96.2 t -104.96 127.17 59.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.119 0.485 . . . . 0.0 110.238 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.85 166.61 30.92 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.662 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 56.0 mt-30 -101.02 136.82 40.25 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 123' ' ' ILE . 39.0 t -129.5 114.21 30.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.562 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.545 ' HG2' HG22 ' A' ' 82' ' ' VAL . 13.3 ptt180 -115.35 139.38 50.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.3 OUTLIER -154.3 163.37 40.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.655 -171.401 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 2.7 m -106.62 120.74 42.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.887 172.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.519 HD11 ' CE1' ' A' ' 68' ' ' PHE . 73.1 mt -106.48 138.52 42.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.75 -173.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.455 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 22.6 t70 -74.71 153.89 38.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.25 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 72' ' ' ARG . 4.2 ttp180 -61.05 -24.76 66.45 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.281 0.363 . . . . 0.0 111.333 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -80.6 -8.58 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.114 0.483 . . . . 0.0 110.421 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.761 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 89.04 35.42 8.19 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.268 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.455 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 70.8 t60 -109.2 124.61 51.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.665 0.269 . . . . 0.0 110.557 -178.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.6 p -51.86 125.31 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.558 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.519 ' CD1' HG21 ' A' ' 116' ' ' THR . 35.3 mt -115.18 -51.29 2.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.235 0.54 . . . . 0.0 110.558 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.37 152.42 49.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.379 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.4 m -146.37 128.94 8.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.137 0.494 . . . . 0.0 110.208 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 57.1 m -134.68 123.95 24.52 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.585 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.9 tp -76.72 108.43 9.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.294 0.569 . . . . 0.0 110.299 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.668 HG21 HG23 ' A' ' 120' ' ' THR . 0.0 OUTLIER -83.35 -42.26 17.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.982 179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.424 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 23.1 t 66.93 176.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.904 169.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.427 ' OG ' ' HG3' ' A' ' 65' ' ' GLN . 68.7 m -158.63 -67.74 0.09 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.979 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -90.23 -76.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.4 ' C ' HD13 ' A' ' 87' ' ' LEU . . . 166.41 98.83 0.13 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.343 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.798 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -119.67 82.47 26.53 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -177.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.9 -75.28 0.01 OUTLIER 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.442 2.095 . . . . 0.0 111.866 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.506 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 8.4 m -70.69 -19.08 62.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.373 0.606 . . . . 0.0 110.197 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.798 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 14.6 mt -75.75 -34.08 60.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.715 -176.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.462 ' OD1' ' HG3' ' A' ' 95' ' ' GLN . 1.8 t70 -54.33 -44.01 71.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.299 -175.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 89' ' ' SER . 11.6 ptp180 -53.58 -52.63 59.16 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -172.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 92' ' ' ARG . 19.3 mt-10 -78.83 -54.21 6.31 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 90' ' ' LEU . 40.7 pt -63.32 -36.96 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -175.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.645 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 77.8 mm-40 -82.21 -26.83 32.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 122.055 -0.403 . . . . 0.0 110.825 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.642 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.85 -44.72 82.43 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.659 HD23 HG23 ' A' ' 98' ' ' VAL . 1.4 tp -68.24 -55.29 12.75 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.636 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 123' ' ' ILE . 81.3 t -88.75 -48.27 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.645 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 16.4 ttpp -70.33 -15.13 62.84 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.391 -175.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.642 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 20.3 tpp180 -98.59 -35.14 10.31 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.797 170.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.612 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -101.13 64.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 110.969 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.6 m -93.79 100.82 5.09 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.28 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.612 ' HD3' ' O ' ' A' ' 101' ' ' ALA . 72.3 Cg_endo -101.73 173.78 0.26 Allowed 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.919 3.079 . . . . 0.0 113.689 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.761 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 17.0 tp -143.22 97.33 5.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.326 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -72.42 -62.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.652 1.568 . . . . 0.0 111.933 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.667 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -76.62 111.57 16.66 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.828 177.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 2.7 Cg_exo -77.15 103.58 1.77 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.421 2.748 . . . . 0.0 112.406 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.719 ' HD2' HD21 ' A' ' 104' ' ' LEU . 41.3 Cg_endo -83.07 68.94 7.3 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.075 2.516 . . . . 0.0 110.913 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.792 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -55.27 -42.29 73.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.189 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.426 ' OD1' ' HD2' ' A' ' 28' ' ' PRO . 2.1 m-20 -77.42 8.84 3.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.02 0.438 . . . . 0.0 111.46 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.42 -16.84 12.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.938 176.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.792 ' CE1' ' HA ' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -133.02 17.01 4.16 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 114' ' ' ASN . 2.0 m -72.0 87.57 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.496 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 7.7 p30 157.79 -25.03 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.078 -167.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 172.64 -92.68 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.896 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.631 ' HB ' HG22 ' A' ' 69' ' ' THR . 0.6 OUTLIER -158.89 174.75 14.51 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.784 0.434 . . . . 0.0 109.913 -175.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.758 HG13 ' CD2' ' A' ' 112' ' ' TYR . 2.9 m -103.72 109.74 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 CA-C-O 121.114 0.483 . . . . 0.0 111.607 -171.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 24.9 tt0 -97.51 112.02 24.05 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 172.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.511 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.3 pp -142.26 155.14 45.21 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.668 HG23 HG21 ' A' ' 82' ' ' VAL . 87.1 m -101.07 126.49 47.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.614 -175.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.511 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 69.9 mt -129.41 123.49 21.48 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.36 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 5.9 Cg_exo -76.22 121.21 6.0 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.006 1.804 . . . . 0.0 110.886 175.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.778 HG21 HG11 ' A' ' 98' ' ' VAL . 24.1 pt -96.59 112.57 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.52 120.98 36.71 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.84 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.458 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 95.9 m-85 -114.94 129.56 56.73 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 159.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 61' ' ' GLN . 31.8 m -57.23 103.11 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -169.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 1.002 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.6 OUTLIER -87.5 98.07 11.19 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.258 -177.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 128' ' ' ARG . 6.2 ppt_? -134.3 6.2 3.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.311 . . . . 0.0 111.704 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -168.15 40.5 0.23 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.847 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -155.51 39.46 0.39 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.314 0.578 . . . . 0.0 110.019 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -168.98 -38.07 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.129 -174.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 39.8 p90 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.11 -179.794 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.4 t 60.6 87.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 121.375 0.607 . . . . 0.0 110.532 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -108.9 78.48 1.14 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.618 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.515 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -88.46 -8.63 54.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.156 -179.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -54.03 -29.7 44.68 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.451 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -69.19 -19.52 63.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.172 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 5' ' ' GLU . 3.2 p -76.38 -9.01 12.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.357 0.599 . . . . 0.0 110.008 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.39 17.93 11.2 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.71 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' A' ' 11' ' ' PRO . . . -89.16 -53.35 0.34 Allowed Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 119.938 -0.077 . . . . 0.0 111.089 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 10' ' ' ALA . 9.3 Cg_endo -92.81 114.57 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.833 2.356 . . . . 0.0 111.231 173.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 25.5 Cg_exo -62.39 112.34 1.55 Allowed 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.823 2.349 . . . . 0.0 112.527 -177.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.67 -18.67 19.41 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.594 2.196 . . . . 0.0 112.174 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.0 -155.68 16.13 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.91 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -91.1 150.32 21.45 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.68 0.276 . . . . 0.0 110.736 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.11 15.46 9.89 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.318 0.58 . . . . 0.0 110.33 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -141.31 148.18 39.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.973 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm 54.61 64.39 1.83 Allowed 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.583 0.552 . . . . 0.0 110.248 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -81.65 68.79 8.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.579 0.704 . . . . 0.0 110.861 -175.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.31 54.62 0.79 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.08 177.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -76.33 165.3 53.93 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.956 178.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 1.4 Cg_endo -43.17 -36.92 6.35 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.462 2.775 . . . . 0.0 114.21 -177.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -93.37 -19.09 21.67 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -173.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.8 p -89.54 45.19 1.26 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.648 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -85.47 -76.6 0.32 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.006 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' C ' ' HD3' ' A' ' 28' ' ' PRO . 29.3 tp -133.2 17.62 4.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.724 0.773 . . . . 0.0 110.046 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.434 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 5.3 p -127.84 61.96 53.9 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.879 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.452 ' HD3' ' C ' ' A' ' 26' ' ' LEU . 86.9 Cg_endo -97.32 27.04 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.09 2.527 . . . . 0.0 112.024 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -128.14 101.61 6.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.296 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.655 ' HB1' HG12 ' A' ' 117' ' ' VAL . . . -81.98 56.41 3.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.048 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.1 tm0? -162.57 108.45 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.12 151.07 33.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.476 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.04 -144.03 15.5 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.756 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -113.79 150.06 34.01 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -81.75 68.4 8.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.627 0.727 . . . . 0.0 110.766 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -119.24 -14.24 9.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.39 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.55 ' H ' ' HD1' ' A' ' 37' ' ' TRP . 0.8 OUTLIER -74.26 -19.87 60.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.553 -173.153 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -68.21 -37.88 81.34 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.19 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 p -68.95 -31.29 70.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.326 0.584 . . . . 0.0 109.804 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.465 ' HG2' ' HA ' ' A' ' 37' ' ' TRP . 5.4 mmm-85 -68.84 -39.56 79.9 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.414 176.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.557 HG23 ' HD2' ' A' ' 103' ' ' PRO . 83.4 mt -63.91 -51.2 72.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.124 176.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.2 m -56.42 -32.74 65.16 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.784 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.81 -47.03 92.25 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.962 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -69.19 -34.77 75.42 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.854 0.359 . . . . 0.0 111.017 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.692 HD11 HG22 ' A' ' 98' ' ' VAL . 1.4 tt -62.44 -30.67 71.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.664 0.745 . . . . 0.0 109.652 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 1.099 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 8.4 t30 -70.89 -34.83 71.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.542 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -34.9 70.5 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.702 172.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -91.91 -59.53 2.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.515 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -162.14 102.09 1.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.503 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 1.099 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 12.7 tpt180 -130.88 103.34 6.51 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.491 178.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.423 ' HB3' HD21 ' A' ' 56' ' ' LEU . 2.1 t80 -87.32 131.88 42.9 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.135 -0.939 . . . . 0.0 108.823 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.8 131.71 45.65 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.732 2.288 . . . . 0.0 112.001 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -60.85 -23.68 65.32 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.27 -173.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -55.59 -42.9 75.47 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.577 0.548 . . . . 0.0 110.231 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.64 -41.03 79.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.632 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 53' ' ' LYS . 3.6 mm? -62.44 -41.12 98.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.845 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.585 ' HG2' ' HB2' ' A' ' 126' ' ' SER . 98.5 mtt180 -59.51 -15.52 18.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 mp -114.3 -24.02 9.12 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.04 0.448 . . . . 0.0 111.114 177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.964 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 18.0 ttmm -102.45 -72.63 0.68 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 -176.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.964 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 30.5 mmt180 -124.22 84.33 2.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.377 0.608 . . . . 0.0 110.14 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 126' ' ' SER . 14.1 pt20 -98.92 115.96 30.07 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.041 -179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.972 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -165.72 143.23 8.25 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.137 -1.03 . . . . 0.0 113.489 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.819 ' H ' HD12 ' A' ' 127' ' ' LEU . 46.7 t -103.58 123.42 57.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.0 165.24 26.29 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.36 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.731 ' H ' ' HA ' ' A' ' 83' ' ' SER . 56.2 mt-30 -105.15 143.42 33.36 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.4 114.62 21.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-O 121.637 0.732 . . . . 0.0 109.576 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.437 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 27.1 ttt180 -106.51 138.42 42.73 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.422 ' CE1' HD11 ' A' ' 70' ' ' LEU . 1.2 p90 -159.95 171.58 19.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.318 0.58 . . . . 0.0 111.956 -173.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 7.8 m -118.82 130.03 55.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.946 173.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.422 HD11 ' CE1' ' A' ' 68' ' ' PHE . 70.2 mt -111.14 140.46 45.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.762 -172.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.1 160.35 23.18 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.73 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.441 ' HG2' ' CZ ' ' A' ' 112' ' ' TYR . 42.1 mtm180 -54.07 -36.86 63.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.298 0.57 . . . . 0.0 110.878 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -81.1 0.07 37.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.229 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.562 ' HA2' ' HB3' ' A' ' 104' ' ' LEU . . . 80.71 45.32 7.88 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.109 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -110.93 124.53 52.28 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 102' ' ' SER . 7.7 p -57.24 111.09 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.497 0.665 . . . . 0.0 110.703 174.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' CD1' HG21 ' A' ' 116' ' ' THR . 80.5 mt -100.99 -41.04 6.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.931 -178.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -130.28 158.27 40.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.222 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.1 m -144.89 121.65 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 O-C-N 123.613 0.57 . . . . 0.0 109.915 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 67' ' ' ARG . 35.7 m -126.29 114.89 18.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.057 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.8 tp -78.29 118.74 20.78 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.427 0.632 . . . . 0.0 110.662 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -108.1 -58.42 3.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.26 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.731 ' HA ' ' H ' ' A' ' 65' ' ' GLN . 19.1 t 62.05 179.64 0.13 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.979 0.419 . . . . 0.0 111.32 176.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.9 m -154.58 -74.36 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.87 -68.68 0.32 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -169.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.95 84.25 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.825 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.928 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -120.68 93.44 48.54 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -176.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.15 -79.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.578 2.185 . . . . 0.0 111.347 177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.5 m -75.92 -17.2 59.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.543 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.928 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 15.7 mt -72.1 -38.3 69.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.728 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 14.0 t70 -54.58 -51.14 66.21 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.607 0.567 . . . . 0.0 111.61 -172.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.418 ' HG3' ' HG2' ' A' ' 93' ' ' GLU . 9.4 ptp180 -53.73 -40.54 66.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.128 -177.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HG2' ' HG3' ' A' ' 92' ' ' ARG . 5.7 mm-40 -78.07 -58.11 3.43 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.56 ' HB ' ' CE1' ' A' ' 125' ' ' PHE . 32.5 pt -66.75 -43.74 89.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.723 -175.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.861 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 48.4 mm-40 -67.98 -51.16 50.58 Favored 'General case' 0 C--O 1.193 -1.893 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.643 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.46 -31.28 61.82 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.097 0.862 . . . . 0.0 111.434 -172.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.451 HD23 HG23 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -53.82 -54.47 38.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.838 173.424 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.73 HG11 HG21 ' A' ' 123' ' ' ILE . 79.9 t -86.48 -33.55 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.306 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.861 ' HE3' ' HB3' ' A' ' 95' ' ' GLN . 37.5 ttmt -66.72 -25.15 66.38 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.4 1.08 . . . . 0.0 110.951 -169.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -104.23 -19.4 14.13 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.967 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.507 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -112.44 45.52 1.29 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.797 178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.7 m -81.75 107.54 8.59 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.116 0.484 . . . . 0.0 110.255 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 41' ' ' ILE . 73.0 Cg_endo -99.79 175.07 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.539 2.826 . . . . 0.0 113.259 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.828 HD21 ' HD2' ' A' ' 108' ' ' PRO . 16.1 tp -143.46 90.52 7.16 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.921 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.456 ' CG ' ' HB2' ' A' ' 40' ' ' ARG . 10.1 Cg_endo -67.36 -62.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.984 1.79 . . . . 0.0 112.078 -177.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.604 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 5.0 t -79.1 116.97 64.18 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 106' ' ' THR . 5.6 Cg_exo -80.06 103.04 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.068 2.512 . . . . 0.0 111.626 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.828 ' HD2' HD21 ' A' ' 104' ' ' LEU . 45.2 Cg_endo -81.66 68.92 7.9 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.904 2.403 . . . . 0.0 111.764 -177.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.606 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -58.91 -42.85 90.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.646 178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -67.72 1.9 2.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.832 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -112.53 -35.85 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.676 0.274 . . . . 0.0 111.575 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.646 ' CD2' HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -118.79 17.51 13.47 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -171.169 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 109' ' ' ALA . 2.5 m -70.98 89.12 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 8.2 p30 160.87 -26.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.744 -1.571 . . . . 0.0 107.588 -170.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 175.21 -88.25 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.936 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.503 ' HB ' HG22 ' A' ' 69' ' ' THR . 0.8 OUTLIER -160.0 175.7 12.7 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 122.933 0.493 . . . . 0.0 110.01 -174.283 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.655 HG12 ' HB1' ' A' ' 30' ' ' ALA . 2.6 m -103.2 108.98 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.301 0.572 . . . . 0.0 110.778 -175.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.406 ' HG2' ' OG1' ' A' ' 69' ' ' THR . 8.5 tm-20 -103.27 111.65 24.14 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.681 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -151.72 156.44 40.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.155 0.502 . . . . 0.0 111.943 -171.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 61.4 m -96.13 126.39 41.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.189 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.681 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 33.0 mt -128.54 137.9 31.92 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.092 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 3.4 Cg_endo -87.57 119.8 1.41 Allowed 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.329 2.019 . . . . 0.0 112.066 178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.73 HG21 HG11 ' A' ' 98' ' ' VAL . 9.8 pt -97.07 97.87 6.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.745 0.784 . . . . 0.0 109.198 172.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -97.16 125.72 41.85 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.043 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.56 ' CE1' ' HB ' ' A' ' 94' ' ' ILE . 83.5 m-85 -114.28 151.42 32.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 168.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.585 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 5.0 m -64.86 102.58 0.61 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.089 -0.245 . . . . 0.0 111.296 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.972 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -92.1 95.15 9.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.106 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.408 ' HB2' ' OE1' ' A' ' 61' ' ' GLN . 80.1 mtm180 -81.23 -53.13 6.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.966 0.412 . . . . 0.0 110.224 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -165.87 79.23 0.12 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.566 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -144.53 168.37 20.31 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.93 -50.23 2.82 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.471 -178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 7.0 p90 . . . . . 0 C--O 1.245 0.839 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 175.744 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 120.959 0.409 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.6 t -116.76 -51.76 4.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -179.95 82.89 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.302 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.16 58.51 2.51 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.576 -171.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -92.82 -60.28 1.85 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.045 -175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.9 t -112.11 41.96 1.87 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.259 0.552 . . . . 0.0 110.052 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 m -116.27 1.82 8.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.332 -178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.56 3.51 61.26 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.024 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.3 140.57 13.21 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.412 -0.394 . . . . 0.0 109.966 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.55 113.73 2.42 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.472 2.115 . . . . 0.0 110.912 173.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 37.7 Cg_exo -60.26 124.26 14.82 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.744 2.296 . . . . 0.0 112.379 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 12' ' ' PRO . 3.0 Cg_exo -76.84 8.7 2.99 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.185 2.59 . . . . 0.0 111.994 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.27 -154.19 34.66 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.141 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 54.7 mmt-85 -126.14 -78.03 0.59 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -86.14 12.8 8.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.3 0.571 . . . . 0.0 109.801 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.13 3.05 28.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.823 -176.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.953 ' HA ' ' HE3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -101.77 -43.46 5.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.151 0.501 . . . . 0.0 110.094 174.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 60.82 15.95 6.39 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.646 168.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HA ' ' OG1' ' A' ' 24' ' ' THR . . . 49.59 43.13 23.97 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.446 -176.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.552 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . . . -113.08 -61.99 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.172 -176.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 42.8 Cg_endo -69.19 -79.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.784 1.656 . . . . 0.0 113.171 -176.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -144.0 91.27 2.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.937 0.399 . . . . 0.0 110.345 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 20' ' ' ALA . 16.8 p -122.64 28.71 7.2 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.651 177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -95.46 3.46 54.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.583 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.6 tp -169.0 36.37 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.557 0.694 . . . . 0.0 109.154 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.482 ' H ' ' CD ' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -127.17 -53.75 0.03 OUTLIER Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.858 -170.445 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.482 ' CD ' ' H ' ' A' ' 27' ' ' THR . 32.3 Cg_exo -59.22 112.03 1.1 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.384 2.056 . . . . 0.0 113.351 -175.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -81.92 127.37 32.96 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.85 67.53 4.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.952 0.406 . . . . 0.0 111.83 -176.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -90.48 53.06 2.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.449 0.642 . . . . 0.0 110.739 177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.89 129.08 37.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.582 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.44 7.34 2.27 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.175 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -105.25 38.93 1.83 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.119 0.485 . . . . 0.0 110.392 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -152.62 146.02 24.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.162 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -88.59 44.35 1.2 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.291 0.567 . . . . 0.0 110.961 -178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.504 ' O ' HG13 ' A' ' 41' ' ' ILE . 2.4 p-90 -55.85 -38.56 70.24 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.05 -176.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.409 ' HG3' ' N ' ' A' ' 39' ' ' SER . 13.6 ptt180 -66.59 -39.17 88.27 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.861 0.362 . . . . 0.0 110.956 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.409 ' N ' ' HG3' ' A' ' 38' ' ' ARG . 2.1 m -66.75 -33.79 76.42 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.517 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . 33.0 mmm180 -75.87 -36.28 59.6 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.458 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.621 HG23 ' HG2' ' A' ' 103' ' ' PRO . 59.8 mt -58.09 -46.14 88.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.137 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.83 174.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -55.93 -42.56 76.29 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.783 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.99 -37.35 94.16 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.768 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.689 ' HB3' ' HB2' ' A' ' 103' ' ' PRO . 1.6 ttm180 -67.77 -34.91 77.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.157 0.503 . . . . 0.0 110.352 178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.68 -29.72 70.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.552 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.694 ' HA ' ' HB2' ' A' ' 50' ' ' ARG . 3.7 t-20 -71.14 -36.89 72.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.582 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -57.47 -30.56 65.17 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.772 174.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -94.96 -56.68 2.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.183 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -175.35 102.76 0.08 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.414 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.694 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 28.1 ttp180 -130.73 104.12 6.99 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.062 176.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.594 ' HB3' HD21 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -84.9 133.63 43.04 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.825 178.032 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -56.37 132.2 50.42 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.888 2.392 . . . . 0.0 111.737 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HE3' ' CA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -61.03 -23.43 65.42 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.086 -172.086 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.83 -33.74 73.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.042 0.448 . . . . 0.0 110.953 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.47 -32.41 60.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 51' ' ' TYR . 3.7 mm? -71.8 -34.43 69.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.725 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 30.4 mtm180 -69.35 -10.32 57.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.915 0.388 . . . . 0.0 111.624 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.45 17.43 12.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.397 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.68 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 19.6 ttmm -150.75 -76.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.818 0.342 . . . . 0.0 111.096 -175.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.68 ' HG2' ' HG2' ' A' ' 59' ' ' LYS . 3.4 mmp_? -128.39 90.42 3.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.807 0.337 . . . . 0.0 110.484 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.443 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 21.6 pt20 -119.08 114.93 23.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.911 -178.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.785 ' HA2' ' HG ' ' A' ' 127' ' ' LEU . . . -160.05 149.79 19.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.803 178.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.573 ' H ' HD12 ' A' ' 127' ' ' LEU . 45.7 t -104.61 125.29 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.708 0.29 . . . . 0.0 110.336 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.7 160.31 25.61 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.757 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 44.0 tt0 -103.96 125.05 50.06 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.467 HG21 HD13 ' A' ' 123' ' ' ILE . 62.5 t -129.44 116.7 40.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.619 -169.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.608 ' HG2' HG22 ' A' ' 82' ' ' VAL . 12.2 ptt180 -109.13 145.31 35.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.627 ' O ' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -157.75 151.0 23.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -171.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 21.6 m -94.38 126.81 39.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.402 171.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.484 HD11 ' CE1' ' A' ' 68' ' ' PHE . 55.5 mt -122.38 139.37 53.91 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -170.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' HB3' ' H ' ' A' ' 75' ' ' HIS . 12.6 t70 -79.43 156.11 28.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.037 173.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.749 ' HB2' ' HB3' ' A' ' 107' ' ' PRO . 25.9 ptt180 -63.14 -21.52 66.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.084 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.465 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 4.0 pt20 -87.97 -4.49 58.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.251 0.548 . . . . 0.0 110.087 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.455 ' CA ' ' H ' ' A' ' 104' ' ' LEU . . . 87.2 38.89 7.6 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.116 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.557 ' H ' ' HB3' ' A' ' 71' ' ' ASP . 80.4 t60 -100.35 114.05 27.25 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.2 p -48.95 116.43 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.089 172.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.3 mt -104.84 -40.38 5.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.982 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -147.78 146.55 29.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.388 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.753 HG11 ' HG3' ' A' ' 99' ' ' LYS . 58.8 t -143.18 129.87 17.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 m -136.04 120.39 17.98 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.72 HD21 ' HB2' ' A' ' 84' ' ' SER . 35.3 tp -60.36 120.11 9.24 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.608 HG22 ' HG2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -90.95 -46.74 14.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.894 -175.415 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -148.61 143.82 26.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.127 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.72 ' HB2' HD21 ' A' ' 81' ' ' LEU . 30.1 t -134.45 108.47 8.15 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.13 -37.99 89.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.081 -175.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.642 ' H ' HD22 ' A' ' 87' ' ' LEU . . . 167.8 56.84 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.882 -178.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.727 ' HB3' ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -121.07 74.79 28.66 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -177.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 86' ' ' GLY . 3.6 Cg_exo -75.96 -65.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.457 2.104 . . . . 0.0 111.639 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.2 t -74.02 -24.12 59.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.267 0.556 . . . . 0.0 110.181 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.727 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 31.0 mt -73.06 -31.49 64.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.346 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 87' ' ' LEU . 17.6 t70 -54.41 -45.59 72.97 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.785 0.678 . . . . 0.0 112.144 -172.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -54.21 -49.4 69.5 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -172.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.472 ' CB ' ' HG3' ' A' ' 60' ' ' ARG . 9.2 tp10 -78.29 -53.45 7.29 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -175.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 90' ' ' LEU . 38.6 pt -63.03 -34.28 65.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -174.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.681 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 75.8 mm-40 -82.18 -28.78 31.86 Favored 'General case' 0 C--O 1.212 -0.91 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.691 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 100' ' ' ARG . . . -56.32 -41.05 75.38 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 98' ' ' VAL . 1.4 tp -68.27 -56.95 6.83 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 114.684 -1.143 . . . . 0.0 112.097 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.92 HG11 HG21 ' A' ' 123' ' ' ILE . 85.8 t -88.41 -48.58 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.753 ' HG3' HG11 ' A' ' 79' ' ' VAL . 37.7 ttmt -64.91 -21.88 66.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.244 -176.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.502 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 5.9 tpp180 -95.39 -35.44 11.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.042 173.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.562 ' O ' ' HD3' ' A' ' 103' ' ' PRO . . . -106.18 74.3 1.03 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.629 0.252 . . . . 0.0 110.859 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 103' ' ' PRO . 14.0 m -94.21 99.46 3.82 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.991 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.689 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 94.8 Cg_endo -100.6 151.82 0.43 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.711 2.941 . . . . 0.0 114.525 -173.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.578 HD23 ' HD2' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -143.8 114.91 5.56 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 173.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.642 ' HA ' ' CZ ' ' A' ' 44' ' ' ARG . 2.6 Cg_endo -74.15 -58.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.678 2.252 . . . . 0.0 112.838 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 4.6 t -72.72 124.63 90.98 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.737 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.749 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 12.1 Cg_exo -70.41 105.68 1.64 Allowed 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.539 2.159 . . . . 0.0 111.162 176.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.827 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 69.3 Cg_endo -87.83 58.0 3.0 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.906 2.404 . . . . 0.0 112.862 -172.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.634 ' HA ' ' CE1' ' A' ' 112' ' ' TYR . . . -60.36 -41.65 94.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.112 0.482 . . . . 0.0 109.941 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -75.51 5.93 5.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.065 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.827 ' HB3' ' HB2' ' A' ' 108' ' ' PRO . . . -113.43 -24.85 9.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.43 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.837 ' HB3' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -123.85 19.97 9.29 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.29 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 109' ' ' ALA . 1.7 m -69.49 89.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 172.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 113' ' ' VAL . 6.4 p30 162.51 -25.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 113.208 -1.815 . . . . 0.0 107.46 -168.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.08 -83.85 0.1 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.109 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.535 ' CA ' ' HB2' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -160.26 174.16 14.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -178.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.837 HG13 ' HB3' ' A' ' 112' ' ' TYR . 27.8 m -102.92 109.73 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.532 0.682 . . . . 0.0 110.799 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.627 ' HA ' ' O ' ' A' ' 68' ' ' PHE . 35.0 tt0 -108.7 111.71 23.64 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 166.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.594 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 2.5 pp -135.01 155.27 51.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -175.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.549 HG23 HG21 ' A' ' 82' ' ' VAL . 92.7 m -96.03 119.55 34.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.441 -175.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.594 ' HG ' ' CD1' ' A' ' 119' ' ' LEU . 42.6 mt -124.98 122.77 25.49 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.454 174.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 65' ' ' GLN . 7.4 Cg_exo -72.72 119.32 6.02 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.897 1.731 . . . . 0.0 110.828 175.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.92 HG21 HG11 ' A' ' 98' ' ' VAL . 35.2 pt -91.58 103.63 14.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.41 124.46 41.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.024 0.916 . . . . 0.0 111.566 -175.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.444 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 86.4 m-85 -113.32 135.41 53.88 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 163.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.9 m -58.66 102.8 0.13 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.265 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.785 ' HG ' ' HA2' ' A' ' 62' ' ' GLY . 1.3 tt -86.53 81.15 8.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.127 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -69.28 -53.73 18.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.387 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -172.25 73.42 0.1 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.872 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.461 ' HB1' HD21 ' A' ' 90' ' ' LEU . . . -146.82 13.68 1.16 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.853 0.358 . . . . 0.0 111.023 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -95.78 27.76 14.97 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.225 -174.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 42.2 p90 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.766 179.119 . . . . . . . . 0 0 . 1 stop_ save_